PT J
AU Frangini, M
   Rampazzo, C
   Franzolin, E
   Lara, MC
   Vilà, MR
   Martí, R
   Bianchi, V
AF Frangini, Miriam
   Rampazzo, Chiara
   Franzolin, Elisa
   Lara, Mari-Carmen
   Vila, Maya R.
   Marti, Ramon
   Bianchi, Vera
TI Unchanged thymidine triphosphate pools and thymidine metabolism in two lines of thymidine kinase 2-mutated fibroblasts
SO FEBS JOURNAL
LA English
DT Article
DE dTTP pool turnover; mitochondrial DNA depletion syndrome; mitochondrial DNA precursors; p53R2; thymidine phosphorylase
ID mitochondrial-dna depletion; neurogastrointestinal encephalomyopathy; tk2 deficiency; deoxynucleotide pools; deoxyguanosine kinase; mtdna depletion; cell-extracts; myopathy; 5'-nucleotidases; mutations
AB Mitochondrial thymidine kinase (TK2) catalyzes the phosphorylation of thymidine in mitochondria. Its function becomes essential for dTTP synthesis in noncycling cells, where cytosolic dTTP synthesis via R1/R2 ribonucleotide reductase and thymidine kinase 1 is turned down. Mutations in the nuclear gene for TK2 cause a fatal mtDNA depletion syndrome. Only selected cell types are affected, suggesting that the other cells compensate for the TK2 deficiency by adapting the enzyme network that regulates dTTP synthesis outside S-phase. Here we looked for such metabolic adaptation in quiescent cultures of fibroblasts from two TK2-deficient patients with a slow-progressing syndrome. In cell extracts, we measured the activities of TK2, deoxycytidine kinase, thymidine phosphorylase, deoxynucleotidases and the amounts of the three ribonucleotide reductase subunits. Patient cells contained 40% or 5% TK2 activity and unchanged activities of the other enzymes. However, their mitochondrial and cytosolic dTTP pools were unchanged, and also the overall composition of the dNTP pools was normal. TK2-dependent phosphorylation of [H-3]thymidine in intact cells and the turnover of the dTTP pool showed that even the fibroblasts with 5% residual TK2 activity synthesized dTTP at an almost normal rate. Normal fibroblasts apparently contain more TK2 than needed to maintain dTTP during quiescence, which would explain why TK2-mutated fibroblasts do not manifest mtDNA depletion despite their reduced TK2 activity.
C1 [Frangini, Miriam; Rampazzo, Chiara; Franzolin, Elisa; Bianchi, Vera] Univ Padua, Dept Biol, I-35131 Padua, Italy.
   [Lara, Mari-Carmen; Vila, Maya R.; Marti, Ramon] Univ Vall Hebron, Inst Recerca Hosp, Barcelona, Spain.
C3 University of Padua; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR)
RP Bianchi, V (corresponding author), Univ Padua, Dept Biol, Via Ugo Bassi 58B, I-35131 Padua, Italy.
EM vbianchi@bio.unipd.it
FU Italian Telethon [GGP05001]; AIRC; Spanish Instituto de Salud Carlos III [PI 06/0735, CP 04/0240]
CR Akman HO, 2008, HUM MOL GENET, V17, P2433, DOI 10.1093/hmg/ddn143
   Barthélémy C, 2001, ANN NEUROL, V49, P607, DOI 10.1002/ana.1002.abs
   Bianchi V, 2003, J BIOL CHEM, V278, P46195, DOI 10.1074/jbc.R300032200
   BIANCHI V, 1987, MOL CELL BIOL, V7, P4218, DOI 10.1128/MCB.7.12.4218
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Chabes AL, 2003, P NATL ACAD SCI USA, V100, P3925, DOI 10.1073/pnas.0330774100
   Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646
   Ferraro P, 2005, J BIOL CHEM, V280, P24472, DOI 10.1074/jbc.M502869200
   Franzolin E, 2006, BIOCHEM BIOPH RES CO, V344, P30, DOI 10.1016/j.bbrc.2006.03.147
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   Martí R, 2004, CLIN CHEM, V50, P120, DOI 10.1373/clinchem.2003.026179
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Oskoui M, 2006, ARCH NEUROL-CHICAGO, V63, P1122, DOI 10.1001/archneur.63.8.1122
   Pontarin G, 2003, P NATL ACAD SCI USA, V100, P12159, DOI 10.1073/pnas.1635259100
   Pontarin G, 2007, J BIOL CHEM, V282, P16820, DOI 10.1074/jbc.M701310200
   Pontarin G, 2006, J BIOL CHEM, V281, P22720, DOI 10.1074/jbc.M604498200
   Rampazzo C, 2002, BIOCHEM BIOPH RES CO, V293, P258, DOI 10.1016/S0006-291X(02)00206-1
   Rampazzo C, 2007, J BIOL CHEM, V282, P34758, DOI 10.1074/jbc.M705923200
   REICHARD P, 1988, ANNU REV BIOCHEM, V57, P349, DOI 10.1146/annurev.bi.57.070188.002025
   Rylova SN, 2007, BIOCHEM PHARMACOL, V74, P169, DOI 10.1016/j.bcp.2007.03.029
   Saada A, 2003, BIOCHEM BIOPH RES CO, V310, P963, DOI 10.1016/j.bbrc.2003.09.104
   Saada A, 2003, MOL GENET METAB, V79, P1, DOI 10.1016/S1096-7192(03)00063-5
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   SHERMAN PA, 1989, ANAL BIOCHEM, V180, P222, DOI 10.1016/0003-2697(89)90420-X
   Vilá MR, 2008, J NEUROL SCI, V267, P137, DOI 10.1016/j.jns.2007.10.019
   Vilà MR, 2003, NEUROLOGY, V60, P1203, DOI 10.1212/01.WNL.0000055928.58122.47
   Wang LY, 2005, MOL GENET METAB, V84, P75, DOI 10.1016/j.ymgme.2004.09.005
   Wang LY, 2003, J BIOL CHEM, V278, P6963, DOI 10.1074/jbc.M206143200
   Zhou XS, 2008, HUM MOL GENET, V17, P2329, DOI 10.1093/hmg/ddn133
NR 30
TC 12
Z9 13
U1 0
U2 1
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1742-464X
EI 1742-4658
J9 FEBS J
JI FEBS J.
PD FEB 15
PY 2009
VL 276
IS 4
BP 1104
EP 1113
DI 10.1111/j.1742-4658.2008.06853.x
PG 10
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 397MN
UT WOS:000262666900019
PM 19154348
DA 2024-11-01
ER

PT J
AU Yis, U
   Seneca, S
   Dirik, E
   Kurul, SH
   Özer, E
   Çakmakçi, H
   De Meirleir, L
AF Yis, Uluc
   Seneca, Sara
   Dirik, Eray
   Kurul, Semra Hiz
   Ozer, Erdener
   Cakmakci, Handan
   De Meirleir, Linda
TI Unusual findings in Leigh syndrome caused by T8993C mutation
SO EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY
LA English
DT Article
DE Leigh syndrome; Mitochondrial m.8993T > C mutation; Oligoclonal bands
ID mitochondrial-dna; heterogeneity
AB The pathological nature of Leigh syndrome is highly variable and depends on the underlying mitochondrial or nuclear genome defect. Mitochondrial m.8993T>G and m.8993T>C mutations are responsible for both NARP (neurogenic weakness, ataxia and retinitis pigmentosa) and Leigh syndrome depending on the amount of mutant mtDNA. The clinical findings of Leigh syndrome caused by the m.8993T>C mutation are less severe than those associated with the m.8993T>G mutation, and ragged red fibers, oligoclonal bands in cerebrospinal fluid, and additional deficiencies of respiratory enzyme complexes are usually not found. This report presents a two year old girl with Leigh syndrome caused by a m.8993T>C mutation. Interestingly she had ragged red fibers in muscle tissue, oligoclonal bands in CSF and focal deficient histochemical staining for complexes I and IV. (C) 2008 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.
C1 [Yis, Uluc; Dirik, Eray; Kurul, Semra Hiz] Dokuz Eylul Univ, Sch Med, Div Child Neurol, Dept Pediat, TR-35340 Izmir, Turkey.
   [Seneca, Sara] Dutch Speaking Free Univ Brussels, Ctr Med Genet, Neurol AZ VUB, Brussels, Belgium.
   [Ozer, Erdener] Dokuz Eylul Univ, Sch Med, Dept Pathol, TR-35340 Izmir, Turkey.
   [Cakmakci, Handan] Dokuz Eylul Univ, Sch Med, Dept Radiol, TR-35340 Izmir, Turkey.
   [De Meirleir, Linda] Dutch Speaking Free Univ Brussels, Dept Pediat, Neurol AZ VUB, Brussels, Belgium.
C3 Dokuz Eylul University; Vrije Universiteit Brussel; Dokuz Eylul University; Dokuz Eylul University; Vrije Universiteit Brussel
RP Yis, U (corresponding author), Dokuz Eylul Univ, Sch Med, Div Child Neurol, Dept Pediat, TR-35340 Izmir, Turkey.
EM ulyis@yahoo.com
CR DEVRIES DD, 1993, ANN NEUROL, V34, P410, DOI 10.1002/ana.410340319
   DiMauro S, 1996, ANN NEUROL, V40, P5, DOI 10.1002/ana.410400104
   Fujioka K, 1998, INTERRIDGE NEWS, V7, P18
   Mattiazzi M, 2004, HUM MOL GENET, V13, P869, DOI 10.1093/hmg/ddh103
   Morava E, 2006, AM J MED GENET A, V140A, P863, DOI 10.1002/ajmg.a.31194
   Pato-Pato A, 2006, REV NEUROLOGIA, V42, P22, DOI 10.33588/rn.4201.2005404
   Santorelli FM, 1996, PEDIATR RES, V39, P914, DOI 10.1203/00006450-199605000-00028
   SANTORELLI FM, 1993, ANN NEUROL, V34, P827, DOI 10.1002/ana.410340612
NR 8
TC 12
Z9 13
U1 0
U2 14
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1090-3798
EI 
J9 EUR J PAEDIATR NEURO
JI Eur. J. Paediatr. Neurol.
PD NOV 15
PY 2009
VL 13
IS 6
BP 550
EP 552
DI 10.1016/j.ejpn.2008.10.009
PG 3
WC Clinical Neurology; Pediatrics
SC Neurosciences & Neurology; Pediatrics
GA 524AJ
UT WOS:000272115900014
PM 19046652
DA 2024-11-01
ER

PT J
AU Potluri, P
   Davila, A
   Ruiz-Pesini, E
   Mishmar, D
   O'Hearn, S
   Hancock, S
   Simon, M
   Scheffler, IE
   Wallace, DC
   Procaccio, V
AF Potluri, Prasanth
   Davila, Antonio
   Ruiz-Pesini, Eduardo
   Mishmar, Dan
   O'Hearn, Sean
   Hancock, Saege
   Simon, Mariella
   Scheffler, Immo E.
   Wallace, Douglas C.
   Procaccio, Vincent
TI A novel NDUFA1 mutation leads to a progressive mitochondrial complex I-specific neurodegenerative disease
SO MOLECULAR GENETICS AND METABOLISM
LA English
DT Article
DE Mitochondria; Mitochondrial disorders; Complex I; mtDNA; NDUFA1
ID hereditary optic neuropathy; bovine heart-mitochondria; tissue-culture cells; chloramphenicol resistance; adaptive selection; molecular-genetics; mammalian-cells; membrane domain; dna; subunits
AB Mitochondrial diseases have been shown to result from mutations in mitochondrial genes located in either the nuclear DNA (nDNA) or mitochondrial DNA (mtDNA). Mitochondrial OXPHOS complex I has 45 subunits encoded by 38 nuclear and 7 mitochondrial genes. Two male patients in a putative X-linked pedigree exhibiting a progressive neurodegenerative disorder and a severe muscle complex I enzyme defect were analyzed for mutations in the 38 nDNA and seven mtDNA encoded complex I subunits. The nDNA X-linked NDUFA1 gene (MWFE polypeptide) was discovered to harbor a novel missense mutation which changed a highly conserved glycine at position 32 to an arginine, shown to segregate with the disease. When this mutation was introduced into a NDUFA1 null hamster cell line, a substantial decrease in the complex I assembly and activity was observed. When the mtDNA of the patient was analyzed, potentially relevant missense mutations were observed in the complex I genes. Transmitochondrial cybrids containing the patient's mtDNA resulted in a mild complex I deficiency. Interestingly enough, the nDNA encoded MWFE polypeptide has been shown to interact with various mtDNA encoded complex I subunits. Therefore, we hypothesize that the novel G32R mutation in NDUFA1 is causing complex I deficiency either by itself or in synergy with additional mtDNA variants. (C) 2008 Elsevier Inc. All rights reserved.
C1 [Potluri, Prasanth; Davila, Antonio; Hancock, Saege; Simon, Mariella; Wallace, Douglas C.; Procaccio, Vincent] Univ Calif Irvine, Ctr Mol & Mitochondrial Med & Genet, Irvine, CA 92697 USA.
   [Ruiz-Pesini, Eduardo] Univ Zaragoza, ISCII, CIBERER, Dept Bioquim Biol Mol & Celular, E-50013 Zaragoza, Spain.
   [Ruiz-Pesini, Eduardo] Univ Zaragoza, Fundac ARAID, E-50013 Zaragoza, Spain.
   [Mishmar, Dan] Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel.
   [Mishmar, Dan] Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, IL-84105 Beer Sheva, Israel.
   [Hancock, Saege; Wallace, Douglas C.; Procaccio, Vincent] Univ Calif Irvine, Dept Pediat, Irvine, CA 92717 USA.
   [Scheffler, Immo E.] Univ Calif San Diego, San Diego, CA 92103 USA.
C3 University of California System; University of California Irvine; University of Zaragoza; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of Zaragoza; Ben Gurion University; Ben Gurion University; University of California System; University of California Irvine; University of California System; University of California San Diego
RP Procaccio, V (corresponding author), Univ Calif Irvine, Ctr Mol & Mitochondrial Med & Genet, 2034 Hewitt Hall, Irvine, CA 92697 USA.
EM vproca@uci.edu
FU NIH [RO1 NS21328, NS41850, AG24373, FIS-PI08/0264]
CR Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   Au HC, 1999, P NATL ACAD SCI USA, V96, P4354, DOI 10.1073/pnas.96.8.4354
   Baranova EA, 2007, J MOL BIOL, V366, P140, DOI 10.1016/j.jmb.2006.11.026
   Barrientos A, 1998, J BIOL CHEM, V273, P14210, DOI 10.1074/jbc.273.23.14210
   Bayona-Bafaluy MP, 2003, NUCLEIC ACIDS RES, V31, P0, DOI 10.1093/nar/gng100
   Blok MJ, 2007, J MED GENET, V44, P0, DOI 10.1136/jmg.2006.045716
   Brown MD, 1997, AM J HUM GENET, V60, P381
   BUNN CL, 1974, P NATL ACAD SCI USA, V71, P1681, DOI 10.1073/pnas.71.5.1681
   Carroll J, 2006, J BIOL CHEM, V281, P32724, DOI 10.1074/jbc.M607135200
   Chen RM, 2004, J BIOL CHEM, V279, P26036, DOI 10.1074/jbc.M402710200
   Chomyn A, 2001, J BIOENERG BIOMEMBR, V33, P251, DOI 10.1023/A:1010791204961
   Fernandez-Moreira D, 2007, ANN NEUROL, V61, P73, DOI 10.1002/ana.21036
   GILES RE, 1980, P NATL ACAD SCI-BIOL, V77, P6715, DOI 10.1073/pnas.77.11.6715
   Gropman A, 2004, AM J MED GENET A, V124A, P377, DOI 10.1002/ajmg.a.20456
   Hirst J, 2003, BBA-BIOENERGETICS, V1604, P135, DOI 10.1016/S0005-2728(03)00059-8
   Ingman M, 2006, NUCLEIC ACIDS RES, V34, PD749, DOI 10.1093/nar/gkj010
   Janssen RJRJ, 2006, J INHERIT METAB DIS, V29, P499, DOI 10.1007/s10545-006-0362-4
   Lazarou M, 2009, BBA-MOL CELL RES, V1793, P78, DOI 10.1016/j.bbamcr.2008.04.015
   McKenzie M, 2000, J BIOL CHEM, V275, P31514, DOI 10.1074/jbc.M004070200
   McKenzie M, 2007, J BIOL CHEM, V282, P36845, DOI 10.1074/jbc.M704158200
   Mishmar D, 2006, GENE, V378, P11, DOI 10.1016/j.gene.2006.03.015
   Munakata K, 2004, GENOMICS, V84, P1041, DOI 10.1016/j.ygeno.2004.08.015
   Procaccio V, 2004, NEUROLOGY, V62, P1899, DOI 10.1212/01.WNL.0000125251.56131.65
   Ruiz-Pesini E, 2004, SCIENCE, V303, P223, DOI 10.1126/science.1088434
   Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, PD823, DOI 10.1093/nar/gkl927
   Sazanov LA, 2000, BIOCHEMISTRY-US, V39, P7229, DOI 10.1021/bi000335t
   Scheffler IE, 2004, BBA-BIOENERGETICS, V1659, P160, DOI 10.1016/j.bbabio.2004.08.002
   Scheffler IE, 2001, J BIOENERG BIOMEMBR, V33, P243, DOI 10.1023/A:1010739120891
   Seo BB, 1998, P NATL ACAD SCI USA, V95, P9167, DOI 10.1073/pnas.95.16.9167
   Trounce I A, 1996, METHODS ENZYMOL, V264, P484, DOI 10.1016/S0076-6879(96)64044-0
   Wallace DC, 2007, EMERY AND RIMOINS PRINCIPLES AND PRACTICE OF MEDICAL GENETICS, V5th, P194
   WALLACE DC, 1987, CURR GENET, V12, P81, DOI 10.1007/BF00434661
   WALLACE DC, 1975, J CELL BIOL, V67, P174, DOI 10.1083/jcb.67.1.174
   WALLACE DC, 1979, SOM CELL GENET, V5, P396
   Wissinger B, 1997, BIOCHEM BIOPH RES CO, V234, P511, DOI 10.1006/bbrc.1997.6660
   Wittig I, 2007, MOL CELL PROTEOMICS, V6, P1215, DOI 10.1074/mcp.M700076-MCP200
   Yadava N, 2008, INT J BIOCHEM CELL B, V40, P447, DOI 10.1016/j.biocel.2007.08.015
   Yadava N, 2002, J BIOL CHEM, V277, P21221, DOI 10.1074/jbc.M202016200
   Zhuchenko O, 1996, GENOMICS, V37, P281, DOI 10.1006/geno.1996.0561
NR 39
TC 73
Z9 78
U1 0
U2 16
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1096-7192
EI 1096-7206
J9 MOL GENET METAB
JI Mol. Genet. Metab.
PD APR 15
PY 2009
VL 96
IS 4
BP 189
EP 195
DI 10.1016/j.ymgme.2008.12.004
PG 7
WC Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research & Experimental
SC Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental Medicine
GA 426VZ
UT WOS:000264737700007
PM 19185523
DA 2024-11-01
ER

PT J
AU Kierdaszuk, B
   Jamrozik, Z
   Tonska, K
   Bartnik, E
   Kaliszewska, M
   Kaminska, A
   Kwiecinski, H
AF Kierdaszuk, Biruta
   Jamrozik, Zygmunt
   Tonska, Katarzyna
   Bartnik, Ewa
   Kaliszewska, Magdalena
   Kaminska, Anna
   Kwiecinski, Hubert
TI Mitochondrial cytopathies: clinical, morphological and genetic characteristics
SO NEUROLOGIA I NEUROCHIRURGIA POLSKA
LA English
DT Article
DE mitochondrial cytopathies; skeletal muscle biopsy; ragged-red fibres; mitochondrial DNA
ID disorders; mutations; diseases
AB Background and purpose: Mitochondrial cytopathies are heterogeneous disorders affecting multiple systems but most commonly involving the skeletal muscle and central nervous system. The variety of symptoms and signs requires biochemical, morphological and genetic evaluation. The results of genetic studies indicate that there is no direct correlation between genotype and phenotype in mitochondrial cytopathies. This study is the first such analysis of a group of Polish patients with mitochondrial cytopathies. Its aim is to define the clinical features of mitochondrial cytopathies in relation to their genetic defects. Material and methods: In a retrospective study, 46 patients with final diagnosis of mitochondrial cytopathy were evaluated clinically and electrophysiologically. Each patient underwent electromyography, electroneurography, and some patients were also assessed using electroencephalography. Clinical diagnoses were confirmed through the histopathological evaluation of muscle biopsies. In 36 cases mitochondrial DNA (mtDNA) testing was performed. Results: Eight different clinical syndromes were diagnosed among the evaluated patients. In the skeletal muscle biopsy, ragged-red fibres, which are a significant symptom for these disorders, were present in the majority of cases (93%). The presence of specific gene mutations was confirmed in 9 out of the 36 cases in which mtDNA was examined. Conclusions: The results of our study confirm the remarkable clinical heterogeneity of mitochondrial cytopathies. Final diagnosis in many cases Could only be confirmed by detection of the genetic defects. Molecular diagnosis may in the future have a significant impact on new therapeutic approaches.
C1 [Kierdaszuk, Biruta; Jamrozik, Zygmunt; Kaminska, Anna; Kwiecinski, Hubert] Warszawski Uniwersytet Med, Neurol Klin, PL-02097 Warsaw, Poland.
   [Tonska, Katarzyna; Bartnik, Ewa; Kaliszewska, Magdalena] Uniwersytet Warszawski, Inst Genet & Biotechnol, PL-02097 Warsaw, Poland.
C3 University of Warsaw
RP Kierdaszuk, B (corresponding author), Warszawski Uniwersytet Med, Neurol Klin, Ul Banacha 1A, PL-02097 Warsaw, Poland.
EM bi_ruta@vp.pl
CR Agostino A, 2003, NEUROLOGY, V60, P1354, DOI 10.1212/01.WNL.0000056088.09408.3C
   Bourgeois JM, 2004, MITOCHONDRION, V4, P441, DOI 10.1016/j.mito.2004.07.036
   Chinnery PF, 1999, J MED GENET, V36, P425
   Di Donato S, 2009, J NEUROL, V256, P693, DOI 10.1007/s00415-009-5028-3
   DiMauro S, 2004, BBA-BIOENERGETICS, V1658, P80, DOI 10.1016/j.bbabio.2004.03.014
   DUBOWITZ V, 2007, MUSCLE BIOPSY PRACTI, V0, P481
   Lacomis D, 2002, NEUROL CLIN, V20, P587, DOI 10.1016/S0733-8619(01)00013-5
   Leonard JV, 2000, LANCET, V355, P299, DOI 10.1016/S0140-6736(99)05225-3
   Maceluch Jaros Aw, 2006, PEDIATR ENDOCRINOL REV, V4, P117
   Mancuso M, 2007, BIOSCIENCE REP, V27, P31, DOI 10.1007/s10540-007-9035-2
   McFarland R, 2002, LANCET NEUROL, V1, P343, DOI 10.1016/S1474-4422(02)00159-X
   Naviaux RK, 2004, MITOCHONDRION, V4, P351, DOI 10.1016/j.mito.2004.07.002
   ROWLAND LP, 2005, MERRITTS NEUROLOGY, V0, P695
   Schmiedel J, 2003, J NEUROL, V250, P267, DOI 10.1007/s00415-003-0978-3
   Sciacco M, 2001, J NEUROL, V248, P778, DOI 10.1007/s004150170094
   Soong N W, 1996, METHODS ENZYMOL, V264, P421, DOI 10.1016/S0076-6879(96)64038-5
   WALLACE DC, 1994, J BIOENERG BIOMEMBR, V26, P241, DOI 10.1007/BF00763096
NR 19
TC 7
Z9 7
U1 0
U2 3
PU TERMEDIA PUBLISHING HOUSE LTD
PI POZNAN
PA WENEDOW ST 9-1, POZNAN, 61-614, POLAND
SN 0028-3843
EI 
J9 NEUROL NEUROCHIR POL
JI Neurol. Neurochir. Pol.
PD MAY-JUN 15
PY 2009
VL 43
IS 3
BP 216
EP 227
DI 
PG 12
WC Clinical Neurology
SC Neurosciences & Neurology
GA 549FG
UT WOS:000274031300002
PM 19618304
DA 2024-11-01
ER

PT J
AU Hofer, T
   Servais, S
   Seo, AY
   Marzetti, E
   Hiona, A
   Upadhyay, SJ
   Wohlgemuth, SE
   Leeuwenburgh, C
AF Hofer, Tim
   Servais, Stephane
   Seo, Arnold Young
   Marzetti, Emanuele
   Hiona, Asimina
   Upadhyay, Shashank Jagdish
   Wohlgemuth, Stephanie Eva
   Leeuwenburgh, Christiaan
TI Bioenergetics and permeability transition pore opening in heart subsarcolemmal and interfibrillar mitochondria: Effects of aging and lifelong calorie restriction
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE Heart disease; Ischemia-reperfusion; Senescence; Hypertrophy
ID ischemia-reperfusion injury; cytochrome-c release; rat cardiac-muscle; oxidative stress; cell-death; hydrogen-peroxide; diastolic function; h2o2 production; dna mutations; brown-norway
AB Loss of cardiac mitochondrial function with age may cause increased cardiomyocyte death through mitochondria-mediated release of apoptogenic factors. We investigated ventricular subsarcolemmal (SSM) and interfibrillar (IFM) mitochondrial bioenergetics and susceptibility towards Ca2+-induced permeability transition pore (mPTP) opening with aging and lifelong calorie restriction (CR). Cardiac mitochondria were isolated from 8-, 18-, 29- and 37-month-old male Fischer 344 x Brown Norway rats fed either ad libitum (AL) or 40% calorie restricted diets. With age, H2O2 generation did not increase and oxygen consumption did not significantly decrease in either SSM or IFM. Strikingly, IFM displayed an increased susceptibility towards mPTP opening during senescence. In contrast, Ca2+ retention capacity of SSM was not affected by age, but SSM tolerated much less Ca2+ than IFM. Only modest age-dependent increases in cytosolic caspase activities and cytochrome c levels were observed and were not affected by CR. Levels of putative mPTP-modulating components: cyclophilin-D, the adenine nucleotide translocase (ANT), and the voltage-dependent ion channel (VDAC) were not affected by aging or CR. In summary, the age-related reduction of Ca2+ retention capacity in IFM may explain the increased susceptibility to stress-induced cell death in the aged myocardium. (C) 2009 Elsevier Ireland Ltd. All rights reserved.
C1 [Hofer, Tim; Servais, Stephane; Seo, Arnold Young; Marzetti, Emanuele; Hiona, Asimina; Upadhyay, Shashank Jagdish; Wohlgemuth, Stephanie Eva; Leeuwenburgh, Christiaan] Univ Florida, Dept Aging & Geriatr Res, Coll Med, Inst Aging,Div Biol Aging, Gainesville, FL 32610 USA.
   [Marzetti, Emanuele] Univ Cattolica Sacro Cuore, Dept Gerontol Geriatr & Physiatr, I-00168 Rome, Italy.
C3 State University System of Florida; University of Florida; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli
RP Hofer, T (corresponding author), Univ Tromso, MabCent SFI, Sykehusvegen 21, N-9019 Tromso, Norway.
EM tim.hofer@comhem.se; cleeuwen@aging.ufl.edu
FU National Institute on Aging [AG17994, AG21042]; American Heart Postdoctoral Fellowship [0525346B, 0615256B]; Claude D. Pepper Older Americans Independence Center (OAIC) [1 P30 AG028740-01]; American Heart Association (AHA) [0525346B, 0615256B] Funding Source: American Heart Association (AHA)
CR Baines CP, 2007, NAT CELL BIOL, V9, P550, DOI 10.1038/ncb1575
   Barazzoni R, 2000, J BIOL CHEM, V275, P3343, DOI 10.1074/jbc.275.5.3343
   Barja G, 2002, J BIOENERG BIOMEMBR, V34, P227, DOI 10.1023/A:1016039604958
   Bianchi K, 2004, BBA-MOL CELL RES, V1742, P119, DOI 10.1016/j.bbamcr.2004.09.015
   BOVERIS A, 1973, BIOCHEM J, V134, P707, DOI 10.1042/bj1340707
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Brustovetsky N, 1996, BIOCHEMISTRY-US, V35, P8483, DOI 10.1021/bi960833v
   CHEMNITIUS JM, 1993, INT J BIOCHEM, V25, P589, DOI 10.1016/0020-711X(93)90668-5
   Cocco T, 2005, FREE RADICAL BIO MED, V38, P796, DOI 10.1016/j.freeradbiomed.2004.11.034
   Colom B, 2007, CARDIOVASC RES, V74, P456, DOI 10.1016/j.cardiores.2007.02.001
   Crompton M, 2004, AGING CELL, V3, P3, DOI 10.1046/j.1474-9728.2003.00073.x
   Crow MT, 2004, CIRC RES, V95, P957, DOI 10.1161/01.RES.0000148632.35500.d9
   DI LF, 2005, CARDIOVASC RES, V66, P222
   Di Lisa F, 2006, CARDIOVASC RES, V70, P191, DOI 10.1016/j.cardiores.2006.01.016
   Drew B, 2003, AM J PHYSIOL-REG I, V284, PR474, DOI 10.1152/ajpregu.00455.2002
   Ellison Georgina M, 2007, NAT CLIN PRACT CARDIOVASC MED, V4 Suppl 1, PS52, DOI 10.1038/ncpcardio0773
   Fannin SW, 1999, ARCH BIOCHEM BIOPHYS, V372, P399, DOI 10.1006/abbi.1999.1508
   Fontana L, 2004, P NATL ACAD SCI USA, V101, P6659, DOI 10.1073/pnas.0308291101
   Gill C, 2002, FASEB J, V16, P135, DOI 10.1096/fj.01-0629com
   Gredilla R, 2002, MICROSC RES TECHNIQ, V59, P273, DOI 10.1002/jemt.10204
   Gredilla R, 2001, FASEB J, V15, P1589, DOI 10.1096/fj.00-0764fje
   Grimm S, 2007, APOPTOSIS, V12, P841, DOI 10.1007/s10495-007-0747-3
   Hacker TA, 2006, AM J PHYSIOL-HEART C, V290, PH304, DOI 10.1152/ajpheart.00290.2005
   Halestrap AP, 2006, BIOCHEM SOC T, V34, P232, DOI 10.1042/BST0340232
   Hansford RG, 1997, J BIOENERG BIOMEMBR, V29, P89, DOI 10.1023/A:1022420007908
   Hansford RG, 1998, MOL CELL BIOCHEM, V184, P359, DOI 10.1023/A:1006893903113
   Harman D, 2003, ANTIOXID REDOX SIGN, V5, P557, DOI 10.1089/152308603770310202
   Hausenloy DJ, 2003, CARDIOVASC RES, V60, P617, DOI 10.1016/j.cardiores.2003.09.025
   Hayflick L, 2007, ANN NY ACAD SCI, V1100, P1, DOI 10.1196/annals.1395.001
   Hiona A, 2008, EXP GERONTOL, V43, P24, DOI 10.1016/j.exger.2007.10.001
   Ichas F, 1997, CELL, V89, P1145, DOI 10.1016/S0092-8674(00)80301-3
   Jahangir A, 2001, MECH AGEING DEV, V122, P1073, DOI 10.1016/S0047-6374(01)00242-1
   Jekabsone A, 2003, BIOCHEM PHARMACOL, V66, P1513, DOI 10.1016/S0006-2952(03)00506-9
   Judge S, 2005, AM J PHYSIOL-REG I, V289, PR1564, DOI 10.1152/ajpregu.00396.2005
   Judge S, 2005, FASEB J, V19, P419, DOI 10.1096/fj.04-2622fje
   Judge S, 2004, AM J PHYSIOL-REG I, V286, PR254, DOI 10.1152/ajpregu.00502.2003
   Judge S, 2007, AM J PHYSIOL-CELL PH, V292, PC1983, DOI 10.1152/ajpcell.00285.2006
   Kajstura J, 1996, AM J PHYSIOL-HEART C, V271, PH1215, DOI 10.1152/ajpheart.1996.271.3.H1215
   Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Lesnefsky EJ, 2001, J MOL CELL CARDIOL, V33, P37, DOI 10.1006/jmcc.2000.1273
   Lesnefsky EJ, 2001, J MOL CELL CARDIOL, V33, P1065, DOI 10.1006/jmcc.2001.1378
   Leung AWC, 2008, BBA-BIOENERGETICS, V1777, P946, DOI 10.1016/j.bbabio.2008.03.009
   Lipman RD, 1996, J GERONTOL A-BIOL, V51, PB54, DOI 10.1093/gerona/51A.1.B54
   MANZELMANN MS, 1987, MECH AGEING DEV, V39, P281, DOI 10.1016/0047-6374(87)90067-4
   MCDOWELL EM, 1976, ARCH PATHOL LAB MED, V100, P405
   MENZIES RA, 1971, J BIOL CHEM, V246, P2425
   Meyer TE, 2006, J AM COLL CARDIOL, V47, P398, DOI 10.1016/j.jacc.2005.08.069
   Miró O, 2000, CARDIOVASC RES, V47, P624, DOI 10.1016/S0008-6363(00)00122-X
   MISARE BD, 1992, J THORAC CARDIOV SUR, V103, P60
   Moghaddas S, 2002, J GERONTOL A-BIOL, V57, PB22, DOI 10.1093/gerona/57.1.B22
   MULLERHOCKER J, 1989, AM J PATHOL, V134, P1167
   MUSCARI C, 1990, BASIC RES CARDIOL, V85, P172, DOI 10.1007/BF01906970
   NOHL H, 1978, EUR J BIOCHEM, V82, P563, DOI 10.1111/j.1432-1033.1978.tb12051.x
   Olivetti G, 2000, CARDIOVASC RES, V45, P68, DOI 10.1016/S0008-6363(99)00298-9
   PALMER JW, 1977, J BIOL CHEM, V252, P8731
   PALMER JW, 1986, AM J PHYSIOL, V250, PH741, DOI 10.1152/ajpheart.1986.250.5.H741
   PALMER JW, 1985, ARCH BIOCHEM BIOPHYS, V236, P691, DOI 10.1016/0003-9861(85)90675-7
   Pepe S, 1999, AM J PHYSIOL-HEART C, V276, PH149, DOI 10.1152/ajpheart.1999.276.1.H149
   Pepe S, 2000, CLIN EXP PHARMACOL P, V27, P745, DOI 10.1046/j.1440-1681.2000.03326.x
   Petrosillo G, 2001, FEBS LETT, V509, P435, DOI 10.1016/S0014-5793(01)03206-9
   Phaneuf S, 2002, AM J PHYSIOL-REG I, V282, PR423, DOI 10.1152/ajpregu.00296.2001
   Pugh KG, 2001, DRUG AGING, V18, P263, DOI 10.2165/00002512-200118040-00004
   Riva A, 2005, AM J PHYSIOL-HEART C, V289, PH868, DOI 10.1152/ajpheart.00866.2004
   SOHAL RS, 1994, MECH AGEING DEV, V74, P121, DOI 10.1016/0047-6374(94)90104-X
   Sprott Richard L, 1996, P3, V0, P0
   Suh JH, 2003, FREE RADICAL BIO MED, V35, P1064, DOI 10.1016/S0891-5849(03)00468-4
   Taffet GE, 1997, J GERONTOL A-BIOL, V52, PB285, DOI 10.1093/gerona/52A.6.B285
   Tanveer A, 1996, EUR J BIOCHEM, V238, P166, DOI 10.1111/j.1432-1033.1996.0166q.x
   Wohlgemuth SE, 2007, REJUV RES, V10, P281, DOI 10.1089/rej.2006.0535
NR 70
TC 75
Z9 82
U1 0
U2 7
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND
SN 0047-6374
EI 
J9 MECH AGEING DEV
JI Mech. Ageing Dev.
PD MAY 15
PY 2009
VL 130
IS 5
BP 297
EP 307
DI 10.1016/j.mad.2009.01.004
PG 11
WC Cell Biology; Geriatrics & Gerontology
SC Cell Biology; Geriatrics & Gerontology
GA 442AO
UT WOS:000265812300003
PM 19428447
DA 2024-11-01
ER

PT J
AU Al-Dosary, M
   Whittaker, RG
   Haughton, J
   McFarland, R
   Goodship, J
   Turnbull, DM
   Taylor, RW
AF Al-Dosary, Mazhor
   Whittaker, Roger G.
   Haughton, Joanna
   McFarland, Robert
   Goodship, Judith
   Turnbull, Douglass M.
   Taylor, Robert W.
TI Neuromuscular disease presentation with three genetic defects involving two genomes
SO NEUROMUSCULAR DISORDERS
LA English
DT Article
DE PEO; Mitochondrial DNA; tRNA mutation; Single fibre analysis; Segregation
ID mitochondrial-dna mutations; depletion myopathy; ophthalmoplegia; deficiency; cells
AB An extensive range of molecular defects have been identified in the human mitochondrial genome (mtDNA), many associated with well-characterised, progressive neurological syndromes. We describe a patient who presented to a mitochondrial clinic with progressive bilateral ptosis, external opthalmoplegia and increasing difficulty with walking. He had previously been diagnosed with a dominant, demyelinating polyneuropathy due to PMP22 gene duplication and had also developed gout, presenting in acute renal failure, due to an X-linked recessive HPRT gene mutation. Muscle biopsy revealed many COX-deficient fibres which we show contain high levels of a third genetic defect - a novel, mitochondrial tRNA(Leu(CUN)) (MTTL2) gene mutation. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Taylor, Robert W.] Univ Newcastle, Mitochondrial Res Grp, Inst Ageing & Hlth, Sch Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Al-Dosary, Mazhor; Whittaker, Roger G.; McFarland, Robert; Turnbull, Douglass M.; Taylor, Robert W.] Univ Newcastle, NCG Rare Mitochondrial Disorders Adults & Childre, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Haughton, Joanna] Newcastle Gen Hosp, Reg Neurosci Ctr, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England.
   [Goodship, Judith] Univ Newcastle, Inst Human Genet, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
C3 Newcastle University - UK; Newcastle University - UK; Newcastle General Hospital; Newcastle University - UK
RP Taylor, RW (corresponding author), Univ Newcastle, Mitochondrial Res Grp, Inst Ageing & Hlth, Sch Med, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM r.w.taylor@ncl.ac.uk
FU Wellcome Trust; UK National Commissioning Group; MRC [G0800674] Funding Source: UKRI
CR Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   Battersby BJ, 2003, NAT GENET, V33, P183, DOI 10.1038/ng1073
   Blakely E, 2008, NEUROMUSCULAR DISORD, V18, P557, DOI 10.1016/j.nmd.2008.04.014
   Blakely EL, 2009, ARCH NEUROL-CHICAGO, V66, P399, DOI 10.1001/archneurol.2008.576
   Cardaioli E, 2005, BIOCHEM BIOPH RES CO, V327, P675, DOI 10.1016/j.bbrc.2004.11.170
   Carrozzo R, 2003, HUM MUTAT, V21, P0, DOI 10.1002/humu.9135
   DAVIDSON BL, 1989, J CLIN INVEST, V84, P342, DOI 10.1172/JCI114160
   Deschauer M, 2006, ARCH NEUROL-CHICAGO, V63, P902, DOI 10.1001/archneur.63.6.902
   GIBBS RA, 1989, P NATL ACAD SCI USA, V86, P1919, DOI 10.1073/pnas.86.6.1919
   Ingman M, 2006, NUCLEIC ACIDS RES, V34, PD749, DOI 10.1093/nar/gkj010
   Jacobs HT, 2003, HUM MOL GENET, V12, PR293, DOI 10.1093/hmg/ddg285
   Krishnan KJ, 2007, ANAL BIOCHEM, V370, P127, DOI 10.1016/j.ab.2007.06.024
   McFarland R, 2008, NEUROMUSCULAR DISORD, V18, P63, DOI 10.1016/j.nmd.2007.07.007
   Puig JG, 2001, MEDICINE, V80, P102, DOI 10.1097/00005792-200103000-00003
   Rotig A, 2009, BIOCH BIOPHYS ACTA, V0, P0
   Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, PD823, DOI 10.1093/nar/gkl927
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Sacconi S, 2008, HUM MOL GENET, V17, P1814, DOI 10.1093/hmg/ddn073
   Schaefer AM, 2005, MUSCLE NERVE, V32, P104, DOI 10.1002/mus.20319
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   Schouten JP, 2002, NUCLEIC ACIDS RES, V30, P0, DOI 10.1093/nar/gnf056
   Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
NR 23
TC 7
Z9 7
U1 0
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8966
EI 1873-2364
J9 NEUROMUSCULAR DISORD
JI Neuromusc. Disord.
PD DEC 15
PY 2009
VL 19
IS 12
BP 841
EP 844
DI 10.1016/j.nmd.2009.10.001
PG 4
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 534DB
UT WOS:000272874600009
PM 19853445
DA 2024-11-01
ER

PT J
AU López-Gallardo, E
   Solano, A
   Herrero-Martín, MD
   Martínez-Romero, I
   Castaño-Pérez, MD
   Andreu, AL
   Herrera, A
   López-Pérez, MJ
   Ruiz-Pesini, E
   Montoya, J
AF Lopez-Gallardo, E.
   Solano, A.
   Herrero-Martin, M. D.
   Martinez-Romero, I.
   Castano-Perez, M. D.
   Andreu, A. L.
   Herrera, A.
   Lopez-Perez, M. J.
   Ruiz-Pesini, E.
   Montoya, J.
TI NARP syndrome in a patient harbouring an insertion in the <i>MT-ATP6</i> gene that results in a truncated protein
SO JOURNAL OF MEDICAL GENETICS
LA English
DT Article
ID polyacrylamide-gel electrophoresis; atp synthase; mutation; mitochondria; separation; phenotype; diseases; mtdna
AB Background: Neurogenic muscle weakness, ataxia and retinitis pigmentosa (NARP) syndrome have been associated to m.8993T>G/C mutations in the subunit 6 of the ATP synthase (p.MT-ATP6). Methods: We have performed a mutational screening of the mitochondrial DNA gene encoding for this protein in 62 patients with the disease, that do not carry any of the common mutations described to date. Results: We report clinical and molecular data in one patient who harbours a de novo insertion in the MT-ATP6 gene that results in a truncated subunit. The mutation was heteroplasmic (85%) in muscle DNA and the BN-PAGE analysis showed a clear decrease in the amount of ATP synthase. Conclusion: Molecular analysis of NARP patients cannot be limited to the search of the m.8993T>G/C and either the ATP6 or the whole mtDNA should be sequenced.
C1 [Lopez-Gallardo, E.; Solano, A.; Herrero-Martin, M. D.; Martinez-Romero, I.; Lopez-Perez, M. J.; Ruiz-Pesini, E.; Montoya, J.] Univ Zaragoza, Dept Bioquim Biol Mol & Celular, E-50013 Zaragoza, Spain.
   [Castano-Perez, M. D.] Hosp Virgen Lirios, Serv Neurol, Alicante, Spain.
   [Andreu, A. L.] Hosp Valle De Hebron, Barcelona, Spain.
   [Herrera, A.] Hosp Miguel Servet, Serv Cirugia Ortoped & Traumatol, Zaragoza, Spain.
C3 University of Zaragoza; Hospital Universitari Vall d'Hebron; Miguel Servet University Hospital
RP Montoya, J (corresponding author), Univ Zaragoza, Dept Bioquim Biol Mol & Celular, Miguel Servet 177, E-50013 Zaragoza, Spain.
EM jmontoya@unizar.es
FU Instituto de Salud Carlos III-FIS [PI07-0045, PI07/90512]; Diputacion General de Aragon; FIS [FI05/00501, FI0700184]; The CIBER de Enfermedades Raras; ISCIII
CR Carrozzo R, 2006, ANN NEUROL, V59, P265, DOI 10.1002/ana.20729
   Childs AM, 2007, NEUROPEDIATRICS, V38, P313, DOI 10.1055/s-2008-1065355
   DEVIVO DC, 1993, BRAIN DEV-JPN, V15, P1, DOI 10.1016/0387-7604(93)90002-P
   DEVRIES DD, 1993, ANN NEUROL, V34, P410, DOI 10.1002/ana.410340319
   GANGULY A, 1993, P NATL ACAD SCI USA, V90, P10325, DOI 10.1073/pnas.90.21.10325
   GrandierVazeille X, 1996, ANAL BIOCHEM, V242, P248, DOI 10.1006/abio.1996.0460
   Herrero-Martin Maria D, 2008, HUM MUTAT, V29, PE112, DOI 10.1002/humu.20800
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   JOHN UP, 1986, NUCLEIC ACIDS RES, V14, P7437, DOI 10.1093/nar/14.18.7437
   Jonckheere AI, 2008, J MED GENET, V45, P129, DOI 10.1136/jmg.2007.052084
   Marotta R, 2004, INTERN MED J, V34, P10, DOI 10.1111/j.1444-0903.2004.t01-3-.x
   Mishmar D, 2004, HUM MUTAT, V23, P125, DOI 10.1002/humu.10304
   MORADIAMELI M, 1983, P NATL ACAD SCI-BIOL, V80, P6167, DOI 10.1073/pnas.80.20.6167
   Ono S, 2004, J BIOL CHEM, V279, P33409, DOI 10.1074/jbc.M404993200
   Rak M, 2007, J BIOL CHEM, V282, P10853, DOI 10.1074/jbc.M608692200
   Ruiz-Pesini E, 2006, REV NEUROLOGIA, V43, P416, DOI 10.33588/rn.4307.2005508
   SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2
   Sciacco M, 2003, J NEUROL, V250, P1498, DOI 10.1007/s00415-003-0246-6
   SHOFFNER JM, 1992, NEUROLOGY, V42, P2168, DOI 10.1212/WNL.42.11.2168
   TATUCH Y, 1992, AM J HUM GENET, V50, P852
NR 20
TC 36
Z9 39
U1 0
U2 6
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0022-2593
EI 1468-6244
J9 J MED GENET
JI J. Med. Genet.
PD JAN 15
PY 2009
VL 46
IS 1
BP 64
EP 67
DI 10.1136/jmg.2008.060616
PG 4
WC Genetics & Heredity
SC Genetics & Heredity
GA 390XW
UT WOS:000262198000009
PM 19124644
DA 2024-11-01
ER

PT J
AU Liu, CY
   Lee, CF
   Wei, YH
AF Liu, Chun-Yi
   Lee, Cheng-Feng
   Wei, Yau-Huei
TI Activation of PKCδ and ERK1/2 in the sensitivity to UV-induced apoptosis of human cells harboring 4977 bp deletion of mitochondrial DNA
SO BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
LA English
DT Article
DE Apoptosis; ERK1/2; Mitochondrial DNA; Oxidative stress; PKC delta
ID kinase-c-delta; hereditary optic neuropathy; substantia-nigra neurons; signal-regulated kinase; oxidative stress; protein-kinases; proteolytic activation; parkinson-disease; epithelial-cells; death
AB This work was supported by grants (NSC 96-2320-B-010-006 and NSC 97-2320-B-010-013-MY3) from the National Science Council, Executive Yuan, Taiwan.The 4977 bp deletion of mitochondrial DNA (mtDNA), often found in patients with chronic progressive external ophthalmoplegia (CPEO), has been demonstrated to increase the susceptibility to apoptosis of human cells. We investigated the mechanism underlying the apoptotic susceptibility of the Delta 4977 cybrid harboring about 80% 4977 bp-deleted mtDNA. The production of hydrogen peroxide (H2O2) and phosphorylation of PKC delta and ERK1/2 were increased in the Delta 4977 cybrid, which was more susceptible to UV-induced apoptosis. Moreover, treatment with N-acetyl-L-cysteine (NAC) or blocking of activation of PKC delta by rottlerin or PKC delta-siRNA, and inhibition of ERK1/2 by PD98059 or ERK1/2-siRNA significantly attenuated the susceptibility of the Delta 4977 cybrid to apoptosis. Furthermore, the increase of PKC delta expression in the Delta 4977 cybrid also amplified the apoptotic signal through caspase 3-mediated proteolytic activation of PKC delta. In addition, PKC delta and ERK1/2 were hyperphosphorylated in skin fibroblasts of CPEO patients harboring Delta 4977 bp-deleted mtDNA. We suggest that the activation of PKC delta and ERK1/2 elicited by 4977 bp-deleted mtDNA-induced oxidative stress plays a role in the susceptibility of the mutant cells to apoptosis. This may explain, at least in part, the degenerative manifestation of brain and muscle in patients with mitochondrial encephalomyopathies such as CPEO syndrome. (C) 2009 Published by Elsevier B.V.
C1 [Liu, Chun-Yi; Lee, Cheng-Feng; Wei, Yau-Huei] Natl Yang Ming Univ, Sch Life Sci, Inst Biochem & Mol Biol, Taipei 112, Taiwan.
C3 National Yang Ming Chiao Tung University
RP Wei, YH (corresponding author), Natl Yang Ming Univ, Sch Life Sci, Inst Biochem & Mol Biol, 155 Li Nong St,Sec 2, Taipei 112, Taiwan.
EM joeman@ym.edu.tw
FU National Science Council, Executive Yuan, Taiwan [NSC 96-2320-B-010-006, NSC 97-2320-B-010-013-MY3]
CR Auré K, 2006, BRAIN, V129, P1249, DOI 10.1093/brain/awl061
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Bhat NR, 1999, J NEUROCHEM, V72, P112, DOI 10.1046/j.1471-4159.1999.0720112.x
   Brodie C, 2003, APOPTOSIS, V8, P19, DOI 10.1023/A:1021640817208
   CHEUNG EC, 2004, SCI STKE, V0, PE45
   Chu CT, 2004, EUR J BIOCHEM, V271, P2060, DOI 10.1111/j.1432-1033.2004.04132.x
   DCosta AM, 2005, CELL DEATH DIFFER, V12, P224, DOI 10.1038/sj.cdd.4401558
   Danielson SR, 2002, J BIOL CHEM, V277, P5810, DOI 10.1074/jbc.M110119200
   Dave KR, 2005, NEUROBIOL DIS, V18, P126, DOI 10.1016/j.nbd.2004.08.017
   Dong J, 2004, AM J PHYSIOL-RENAL, V287, PF1049, DOI 10.1152/ajprenal.00132.2004
   Ghayur T, 1996, J EXP MED, V184, P2399, DOI 10.1084/jem.184.6.2399
   Ghelli A, 2003, J BIOL CHEM, V278, P4145, DOI 10.1074/jbc.M210285200
   Ghelli A, 2008, INVEST OPHTH VIS SCI, V49, P671, DOI 10.1167/iovs.07-0880
   Ikezoe K, 2002, ACTA NEUROPATHOL, V103, P531, DOI 10.1007/s00401-001-0502-8
   Kanthasamy AG, 2003, ANTIOXID REDOX SIGN, V5, P609, DOI 10.1089/152308603770310275
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Lee CF, 2005, ANN NY ACAD SCI, V1042, P429, DOI 10.1196/annals.1338.036
   Lee CF, 2006, FREE RADICAL BIO MED, V40, P2136, DOI 10.1016/j.freeradbiomed.2006.02.008
   Li LW, 1999, MOL CELL BIOL, V19, P8547
   Liu CY, 2007, MITOCHONDRION, V7, P89, DOI 10.1016/j.mito.2006.11.020
   Liu CY, 2004, ANN NY ACAD SCI, V1011, P133, DOI 10.1196/annals.1293.014
   Lu CY, 2003, MOL GENET METAB, V80, P321, DOI 10.1016/j.ymgme.2003.08.005
   Majumder PK, 2001, CELL GROWTH DIFFER, V12, P465
   Matassa AA, 2001, J BIOL CHEM, V276, P29719, DOI 10.1074/jbc.M100273200
   Mawrin C, 2004, NEUROSCI LETT, V357, P111, DOI 10.1016/j.neulet.2003.11.073
   Peng TI, 2006, BBA-MOL BASIS DIS, V1762, P241, DOI 10.1016/j.bbadis.2005.10.008
   Ramachandiran S, 2002, CHEM RES TOXICOL, V15, P1635, DOI 10.1021/tx0200663
   Reyland ME, 1999, J BIOL CHEM, V274, P19115, DOI 10.1074/jbc.274.27.19115
   Ricci C, 2008, AM J PHYSIOL-CELL PH, V294, PC413, DOI 10.1152/ajpcell.00362.2007
   Sayre LM, 2008, CHEM RES TOXICOL, V21, P172, DOI 10.1021/tx700210j
   Schmiedel J, 2003, J NEUROL, V250, P267, DOI 10.1007/s00415-003-0978-3
   Sitailo LA, 2004, J INVEST DERMATOL, V123, P434, DOI 10.1111/j.0022-202X.2004.23403.x
   Steinberg SF, 2004, BIOCHEM J, V384, P449, DOI 10.1042/BJ20040704
   Ueda Y, 1996, J BIOL CHEM, V271, P23512, DOI 10.1074/jbc.271.38.23512
   Wada T, 2004, ONCOGENE, V23, P2838, DOI 10.1038/sj.onc.1207556
   Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751
   Wei YH, 2001, ANN NY ACAD SCI, V928, P97
   Yoshida K, 2007, CELL SIGNAL, V19, P892, DOI 10.1016/j.cellsig.2007.01.027
   Zhang DH, 2007, J PHARMACOL EXP THER, V322, P913, DOI 10.1124/jpet.107.124669
   Zhou MJ, 1997, ANAL BIOCHEM, V253, P162, DOI 10.1006/abio.1997.2391
   Zhuang SG, 2006, J PHARMACOL EXP THER, V319, P991, DOI 10.1124/jpet.106.107367
NR 41
TC 14
Z9 14
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0925-4439
EI 
J9 BBA-MOL BASIS DIS
JI Biochim. Biophys. Acta-Mol. Basis Dis.
PD AUG 15
PY 2009
VL 1792
IS 8
BP 783
EP 790
DI 10.1016/j.bbadis.2009.05.005
PG 8
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 485HT
UT WOS:000269112500006
PM 19477272
DA 2024-11-01
ER

PT J
AU Horvath, R
   Bender, A
   Abicht, A
   Holinski-Feder, E
   Czermin, B
   Trips, T
   Schneiderat, P
   Lochmüller, H
   Klopstock, T
AF Horvath, Rita
   Bender, Andreas
   Abicht, Angela
   Holinski-Feder, Elke
   Czermin, Birgit
   Trips, Tobias
   Schneiderat, Peter
   Lochmueller, Hanns
   Klopstock, Thomas
TI Heteroplasmic mutation in the anticodon-stem of mitochondrial tRNA<SUP>Val</SUP> causing MNGIE-like gastrointestinal dysmotility and cachexia
SO JOURNAL OF NEUROLOGY
LA English
DT Article
DE Mitochondrial encephalomyopathy; MNGIE-like gastrointestinal dysmotility and cachexia; tRNA(Val)
ID stroke-like episodes; transfer-rna genes; neurogastrointestinal encephalomyopathy; lactic-acidosis; neurological presentation; point mutation; dna deletions; melas; features; disease
AB While mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) is typically associated with mutations in the nuclear gene encoding for thymidine phosphorylase (ECGF1, TYMP), a similar clinical phenotype was described in patients carrying mutations in the nuclear-encoded polymerase gamma (POLG1) as well as a few mitochondrial tRNA genes. Here we report a novel mutation in the mitochondrial tRNA(Val) (MTTV) gene in a girl presenting with clinical symptoms of MNGIE-like gastrointestinal dysmotility and cachexia. Clinical, histological, biochemical and single cell investigations were performed. The heteroplasmic m.1630A > G mutation was detected in the mitochondrial tRNA(Val) (MTTV) gene in the patient's muscle, blood leukocytes and myoblasts, as well as in blood DNA of the unaffected mother. We provide clinical, biochemical, histological, and molecular genetic evidence on the single cell level for the pathogenicity of this mutation. Our finding adds to the genetic heterogeneity of MNGIE-like gastrointestinal symptoms and highlights the importance of a thorough genetic workup in case of suspected mitochondrial disease.
C1 [Horvath, Rita] Newcastle Univ, Mitochondrial Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Horvath, Rita; Schneiderat, Peter; Lochmueller, Hanns; Klopstock, Thomas] Univ Munich, Dept Neurol, Friedrich Baur Inst, D-80336 Munich, Germany.
   [Bender, Andreas] Univ Munich, Dept Neurol, D-81377 Munich, Germany.
   [Horvath, Rita; Abicht, Angela; Holinski-Feder, Elke; Czermin, Birgit] Ctr Med Genet, D-80335 Munich, Germany.
   [Trips, Tobias] Hosp Traunstein, Dept Pediat, D-83278 Traunstein, Germany.
   [Lochmueller, Hanns] Newcastle Univ, Inst Human Genet, Int Ctr Life, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England.
C3 Newcastle University - UK; University of Munich; University of Munich; Newcastle University - UK
RP Horvath, R (corresponding author), Newcastle Univ, Mitochondrial Res Grp, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM Rita.Horvath@ncl.ac.uk
FU Deutsche Forschungsgemeinschaft [HO 2505/2-1]
CR Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Blakely EL, 2004, J NEUROL SCI, V225, P99, DOI 10.1016/j.jns.2004.07.007
   BOULET L, 1992, AM J HUM GENET, V51, P1187
   Chalmers RM, 1997, NEUROLOGY, V49, P589, DOI 10.1212/WNL.49.2.589
   Chang TM, 2004, PEDIATR NEUROL, V31, P374, DOI 10.1016/j.pediatrneurol.2004.05.009
   CHOMYN A, 1992, P NATL ACAD SCI USA, V89, P4221, DOI 10.1073/pnas.89.10.4221
   de Coo IFM, 1998, NEUROLOGY, V50, P293, DOI 10.1212/WNL.50.1.293
   DOUGHERTY FE, 1994, J PEDIATR-US, V125, P758, DOI 10.1016/S0022-3476(94)70073-7
   FISCHER JC, 1986, EUR J PEDIATR, V144, P441, DOI 10.1007/BF00441735
   García-Velasco A, 2003, J INTERN MED, V253, P381, DOI 10.1046/j.1365-2796.2003.01095.x
   Helm M, 2000, RNA, V6, P1356, DOI 10.1017/S1355838200001047
   Inoue K, 2003, DIABETES CARE, V26, P2219, DOI 10.2337/diacare.26.7.2219
   LAUBER J, 1991, NUCLEIC ACIDS RES, V19, P1393, DOI 10.1093/nar/19.7.1393
   Lehnhardt FG, 2008, ARCH NEUROL-CHICAGO, V65, P407, DOI 10.1001/archneur.65.3.407
   Maniura-Weber K, 2004, EUR J HUM GENET, V12, P509, DOI 10.1038/sj.ejhg.5201185
   Martí R, 2004, CLIN CHEM, V50, P120, DOI 10.1373/clinchem.2003.026179
   Marti R, 2002, MITOCHONDRION, V2, P143, DOI 10.1016/S1567-7249(02)00036-3
   McFarland R, 2002, NAT GENET, V30, P145, DOI 10.1038/ng819
   MUNSCHER C, 1993, BIOL CHEM H-S, V374, P1099, DOI 10.1515/bchm3.1993.374.7-12.1099
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Reichenbach J, 2006, PEDIATR RES, V60, P321, DOI 10.1203/01.pdr.0000233252.60457.cf
   Sacconi S, 2002, ARCH NEUROL-CHICAGO, V59, P1013, DOI 10.1001/archneur.59.6.1013
   SCIACCO M, 1994, HUM MOL GENET, V3, P13, DOI 10.1093/hmg/3.1.13
   Shimotake T, 1998, J PEDIATR SURG, V33, P1837, DOI 10.1016/S0022-3468(98)90301-3
   Taylor RW, 1996, ANN NEUROL, V40, P459, DOI 10.1002/ana.410400318
   Tiranti V, 1998, ANN NEUROL, V43, P98, DOI 10.1002/ana.410430116
   Van Goethem G, 2003, EUR J HUM GENET, V11, P547, DOI 10.1038/sj.ejhg.5201002
   Verma A, 1997, PEDIATR RES, V42, P448, DOI 10.1203/00006450-199710000-00005
   Vissing J, 2002, NEUROLOGY, V59, P926, DOI 10.1212/WNL.59.6.926
NR 29
TC 27
Z9 27
U1 0
U2 3
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0340-5354
EI 
J9 J NEUROL
JI J. Neurol.
PD MAY 15
PY 2009
VL 256
IS 5
BP 810
EP 815
DI 10.1007/s00415-009-5023-8
PG 6
WC Clinical Neurology
SC Neurosciences & Neurology
GA 447AX
UT WOS:000266165100016
PM 19252805
DA 2024-11-01
ER

PT J
AU Katayama, Y
   Maeda, K
   Iizuka, T
   Hayashi, M
   Hashizume, Y
   Sanada, M
   Kawai, H
   Kashiwagi, A
AF Katayama, Yuri
   Maeda, Kengo
   Iizuka, Takahiro
   Hayashi, Masaharu
   Hashizume, Yoshio
   Sanada, Mitsuru
   Kawai, Hiromichi
   Kashiwagi, Atsunori
TI Accumulation of oxidative stress around the stroke-like lesions of MELAS patients
SO MITOCHONDRION
LA English
DT Article
DE MELAS; Stroke-like episode; Oxidative stress; Edaravone; 8-hydroxy-2 '-deoxyguanosine; Manganese superoxide dismutase
ID free-radical scavenger; amyotrophic-lateral-sclerosis; transient cerebral-ischemia; mitochondrial-dna; lactic-acidosis; episodes melas; l-arginine; superoxide dismutases; reductase deficiency; antioxidant enzymes
AB To investigate the relationship between oxidative stress and progressive spread of the stroke-like lesions in mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) with 3243A>G mutation, we retrospectively analyzed the spread frequency in patients with and without treatment with the radical scavenger edaravone. Oxidative damage and defensive enzymes were histologically evaluated. Spread was significantly less frequent in the patients treated with edaravone. Although 8-hydroxy-2'-deoxyguanosine, a marker for oxidative damage of DNA, was obviously accumulated in peri-lesional surviving neurons, manganese superoxide dismutase and 8-oxoguanine glycosylase 1 were not up-regulated in those neurons. Increased oxidative stress and insufficient defense could be involved in the pathogenesis of the spreading lesions in MELAS. (C) 2009 Elsevier B. V. and Mitochondria Research Society. All rights reserved.
C1 [Katayama, Yuri; Maeda, Kengo; Sanada, Mitsuru; Kawai, Hiromichi] Shiga Univ Med Sci, Dept Internal Med, Div Neurol, Shiga 5202192, Japan.
   [Iizuka, Takahiro] Kitasato Univ, Sch Med, Dept Neurol, Kanagawa 2288555, Japan.
   [Hayashi, Masaharu] Tokyo Metropolitan Inst Neurosci, Dept Clin Neuropathol, Tokyo 1838526, Japan.
   [Hashizume, Yoshio] Aichi Med Univ, Inst Med Sci Aging, Aichi 4801195, Japan.
   [Kashiwagi, Atsunori] Shiga Univ Med Sci, Dept Internal Med, Div Endocrinol & Metab, Shiga 5202192, Japan.
C3 Shiga University of Medical Science; Kitasato University; Tokyo Metropolitan Institute for Neuroscience; Tokyo Metropolitan Institute of Medical Science; Aichi Medical University; Shiga University of Medical Science
RP Maeda, K (corresponding author), Shiga Hosp, Dept Neurol, Natl Hosp Org, 255 Gochi, Shiga 5278505, Japan.
EM iky05@shiga-hp.jp
CR ABE K, 1988, STROKE, V19, P480, DOI 10.1161/01.STR.19.4.480
   Aguirre N, 2005, FREE RADICAL RES, V39, P383, DOI 10.1080/10715760400027979
   Bogdanov MB, 2001, J NEUROCHEM, V79, P1246, DOI 10.1046/j.1471-4159.2001.00689.x
   Candelario-Jalil E, 2001, NEUROSCI RES, V41, P233, DOI 10.1016/S0168-0102(01)00282-6
   Chan PH, 1996, STROKE, V27, P1124, DOI 10.1161/01.STR.27.6.1124
   Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713
   Clark JM, 1996, NEUROLOGY, V46, P223, DOI 10.1212/WNL.46.1.223
   COYLE JT, 1993, SCIENCE, V262, P689, DOI 10.1126/science.7901908
   Culotta VC, 2006, BBA-MOL CELL RES, V1763, P747, DOI 10.1016/j.bbamcr.2006.05.003
   DiMauro S, 2004, ANN NY ACAD SCI, V1011, P232, DOI 10.1196/annals.1293.023
   DiMauro S, 2000, NEUROL SCI, V21, P0
   DiMauro S, 2007, BIOSCIENCE REP, V27, P125, DOI 10.1007/s10540-007-9041-4
   DiMauro S, 2006, MUSCLE NERVE, V34, P265, DOI 10.1002/mus.20598
   Ferrante RJ, 1997, J NEUROCHEM, V69, P2064
   Finsterer J, 2006, ACTA NEUROL SCAND, V114, P217, DOI 10.1111/j.1600-0404.2006.00671.x
   Folkerth RD, 2004, J NEUROPATH EXP NEUR, V63, P990, DOI 10.1093/jnen/63.9.990
   FRAGA CG, 1990, P NATL ACAD SCI USA, V87, P4533, DOI 10.1073/pnas.87.12.4533
   Gilchrist JM, 1996, STROKE, V27, P1420, DOI 10.1161/01.STR.27.8.1420
   GOTO Y, 1991, BIOCHIM BIOPHYS ACTA, V1097, P238, DOI 10.1016/0925-4439(91)90042-8
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Hersch SM, 2006, NEUROLOGY, V66, P250, DOI 10.1212/01.wnl.0000194318.74946.b6
   HIRANO M, 1994, J CHILD NEUROL, V9, P4, DOI 10.1177/088307389400900102
   ICHIKI T, 1988, ANN NEUROL, V23, P287, DOI 10.1002/ana.410230312
   Iizuka T, 2005, CURR NEUROVASC RES, V2, P29, DOI 10.2174/1567202052773544
   Iizuka T, 2003, NEUROLOGY, V61, P1238, DOI 10.1212/01.WNL.0000091888.26232.FE
   Iizuka T, 2002, NEUROLOGY, V59, P816, DOI 10.1212/WNL.59.6.816
   Iizuka T, 2007, J NEUROL SCI, V257, P126, DOI 10.1016/j.jns.2007.01.040
   Jarrett SG, 2008, NEUROBIOL DIS, V30, P130, DOI 10.1016/j.nbd.2007.12.009
   Kaufmann P, 2004, NEUROLOGY, V62, P1297, DOI 10.1212/01.WNL.0000120557.83907.A8
   Kawai H, 1997, J PHARMACOL EXP THER, V281, P921
   Kim GW, 2002, STROKE, V33, P809, DOI 10.1161/hs0302.103745
   KING MP, 1992, MOL CELL BIOL, V12, P480, DOI 10.1128/MCB.12.2.480
   KOBAYASHI M, 1987, J PEDIATR-US, V110, P223, DOI 10.1016/S0022-3476(87)80158-0
   KOBAYASHI M, 1986, J INHERIT METAB DIS, V9, P301, DOI 10.1007/BF01799670
   Koga Y, 2006, NEUROLOGY, V66, P1766, DOI 10.1212/01.wnl.0000220197.36849.1e
   Koga Y, 2005, NEUROLOGY, V64, P710, DOI 10.1212/01.WNL.0000151976.60624.01
   Koga Y, 2002, NEUROLOGY, V58, P827, DOI 10.1212/WNL.58.5.827
   Koga Y, 2007, MITOCHONDRION, V7, P133, DOI 10.1016/j.mito.2006.11.006
   Kovács R, 2002, J NEUROPHYSIOL, V88, P2909, DOI 10.1152/jn.00149.2002
   Liang LP, 2004, FREE RADICAL BIO MED, V36, P542, DOI 10.1016/j.freeradbiomed.2003.11.029
   Liang LP, 2000, NEUROSCIENCE, V101, P563, DOI 10.1016/S0306-4522(00)00397-3
   MAEDA K, 2005, CLIN NEUROL, V45, P416
   Mecocci P, 1997, MOL CHEM NEUROPATHOL, V31, P53, DOI 10.1007/BF02815160
   Morgan-Hughes JA, 1999, BBA-BIOENERGETICS, V1410, P125, DOI 10.1016/S0005-2728(98)00162-5
   Nagayama T, 2000, J NEUROCHEM, V75, P1716, DOI 10.1046/j.1471-4159.2000.0751716.x
   NISHI H, 1989, STROKE, V20, P1236, DOI 10.1161/01.STR.20.9.1236
   Nunomura A, 1999, J NEUROSCI, V19, P1959
   OHAMA E, 1987, ACTA NEUROPATHOL, V74, P226, DOI 10.1007/BF00688185
   Ohtaki H, 2007, NEUROSCI RES, V58, P349, DOI 10.1016/j.neures.2007.04.005
   Otomo E, 2003, CEREBROVASC DIS, V15, P222, DOI 10.1159/000069318
   Pang CY, 2001, DIABETES RES CLIN PR, V54, PS45, DOI 10.1016/S0168-8227(01)00335-7
   Patel M, 2004, FREE RADICAL BIO MED, V37, P1951, DOI 10.1016/j.freeradbiomed.2004.08.021
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Rusanen H, 2000, BBA-MOL BASIS DIS, V1500, P10, DOI 10.1016/S0925-4439(99)00081-2
   SAKUTA R, 1989, ANN NEUROL, V25, P594, DOI 10.1002/ana.410250611
   Sandhu JK, 2005, BIOCHEM J, V391, P191, DOI 10.1042/BJ20050272
   Sato S, 2005, NEUROLOGY, V64, P1081, DOI 10.1212/01.WNL.0000154597.24838.6B
   Scaglia F, 2006, CNS DRUGS, V20, P443, DOI 10.2165/00023210-200620060-00002
   Seki S, 2003, HISTOPATHOLOGY, V42, P365, DOI 10.1046/j.1365-2559.2003.01599.x
   SPARACO M, 1993, J NEUROPATH EXP NEUR, V52, P1, DOI 10.1097/00005072-199301000-00001
   Sugimoto K, 1997, DIABETOLOGIA, V40, P1380, DOI 10.1007/s001250050839
   Takamatsu Y, 1997, JPN PHARM THER S, V25, P0
   Tanahashi C, 2000, ACTA NEUROPATHOL, V99, P31, DOI 10.1007/PL00007403
   Terauchi A, 1996, BRAIN DEV-JPN, V18, P224, DOI 10.1016/0387-7604(96)00015-0
   Vives-Bauza C, 2006, NEUROSCI LETT, V391, P136, DOI 10.1016/j.neulet.2005.08.049
   Vladimirova O, 1998, MULT SCLER, V4, P413, DOI 10.1177/135245859800400503
   Wang AL, 2008, NEUROBIOL AGING, V0, P0
   WATANABE T, 1994, J PHARMACOL EXP THER, V268, P1597
   WATANABE T, 1994, J PHARMACOL EXP THER, V271, P1624
   Wei YH, 2001, CHINESE J PHYSIOL, V44, P1
   Yamamoto T, 1997, BRAIN RES, V762, P240, DOI 10.1016/S0006-8993(97)00490-3
   Yamamoto Y, 1996, REDOX REP, V2, P333, DOI 10.1080/13510002.1996.11747069
   Yoneda M, 1999, NEUROLOGY, V53, P2182, DOI 10.1212/WNL.53.9.2182
   Yoshida H, 2006, CNS DRUG REV, V12, P9, DOI 10.1111/j.1527-3458.2006.00009.x
   Zhang N, 2005, STROKE, V36, P2220, DOI 10.1161/01.STR.0000182241.07096.06
NR 75
TC 29
Z9 35
U1 1
U2 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD SEP 15
PY 2009
VL 9
IS 5
BP 306
EP 313
DI 10.1016/j.mito.2009.04.002
PG 8
WC Cell Biology; Genetics & Heredity
SC Cell Biology; Genetics & Heredity
GA 541LC
UT WOS:000273416200003
PM 19393775
DA 2024-11-01
ER

PT J
AU O'Rourke, K
   Buddles, MR
   Farrell, M
   Howley, R
   Sukuraman, S
   Connolly, S
   Turnbull, DM
   Hutchinson, M
   Taylor, RW
AF O'Rourke, Killian
   Buddles, Mark R.
   Farrell, Michael
   Howley, Rachel
   Sukuraman, Sunita
   Connolly, Sean
   Turnbull, Douglass M.
   Hutchinson, Michael
   Taylor, Robert W.
TI PHENOTYPIC DIVERSITY ASSOCIATED WITH THE MITOCHONDRIAL m.8313G&gt;A POINT MUTATION
SO MUSCLE & NERVE
LA English
DT Article
DE mitochondrial myopathy; mitochondrial DNA; tRNA mutation; cytochrome c oxidase; single muscle fiber mutation analysis
ID sporadic patient; dna disease; myopathy
AB We report the clinical, histochemical, and molecular genetic findings in a patient with progressive mitochondrial cytopathy due to the m.8313G>A point mutation in the mitochondrial tRNA(Lys)(MTTK) gene. The clinical features in this case are severe, including short stature, myopathy, peripheral neuropathy, and osteoporosis, while extensive analysis of maternal relatives indicate that the mutation has arisen de novo and was not maternally inherited. This report of a second case, together with single muscle fiber mutation analysis that shows clear segregation of mutation load with cytochrome c oxidase deficiency, confirms that the mutation is pathologic. Muscle Nerve 40: 648-651, 2009
C1 [O'Rourke, Killian; Sukuraman, Sunita; Connolly, Sean; Hutchinson, Michael] St Vincents Univ Hosp, Dept Neurol, Dublin 4, Ireland.
   [Buddles, Mark R.; Turnbull, Douglass M.; Taylor, Robert W.] Univ Newcastle, Sch Med, Inst Ageing & Hlth, Mitochondrial Res Grp, Newcastle Upon Tyne, Tyne & Wear, England.
   [Farrell, Michael; Howley, Rachel] Beaumont Hosp, Dept Neuropathol, Dublin 9, Ireland.
C3 University College Dublin; Saint Vincent's University Hospital; Newcastle University - UK
RP O'Rourke, K (corresponding author), St Vincents Univ Hosp, Dept Neurol, Dublin 4, Ireland.
EM killian.orourke@gmail.com
FU Wellcome Trust [074454] Funding Source: Medline
CR Bacman SR, 2003, BIOCHEM J, V374, P131, DOI 10.1042/BJ20030222
   Blakely EL, 2007, J NEUROL, V254, P1283, DOI 10.1007/s00415-006-0490-7
   Fu K, 1996, HUM MOL GENET, V5, P1835, DOI 10.1093/hmg/5.11.1835
   Johnson K, 2000, ARTHRITIS RHEUM-US, V43, P1560, DOI 10.1002/1529-0131(200007)43:7<1560::AID-ANR21>3.0.CO;2-S
   Karadimas CL, 2002, NEUROMUSCULAR DISORD, V12, P865, DOI 10.1016/S0960-8966(02)00072-X
   McFarland R, 2002, LANCET NEUROL, V1, P343, DOI 10.1016/S1474-4422(02)00159-X
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   SHIANG R, 1994, CELL, V78, P335, DOI 10.1016/0092-8674(94)90302-6
   SILVESTRI G, 1993, NEUROLOGY, V43, P1200, DOI 10.1212/WNL.43.6.1200
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Verma A, 1997, PEDIATR RES, V42, P448, DOI 10.1203/00006450-199710000-00005
NR 11
TC 2
Z9 2
U1 0
U2 0
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0148-639X
EI 
J9 MUSCLE NERVE
JI Muscle Nerve
PD OCT 15
PY 2009
VL 40
IS 4
BP 648
EP 651
DI 10.1002/mus.21342
PG 4
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 506SA
UT WOS:000270794900020
PM 19618438
DA 2024-11-01
ER

PT J
AU Wang, J
   Brautbar, A
   Chan, AK
   Dzwiniel, T
   Fang-Yuan, L
   Waters, PJ
   Graham, BH
   Wong, LJ
AF Wang, Jing
   Brautbar, Ariel
   Chan, Alicia K.
   Dzwiniel, Tara
   Fang-Yuan, Li
   Waters, Paula J.
   Graham, Brett H.
   Wong, Lee-Jun
TI Two mtDNA mutations 14487T&gt;C (M63V, ND6) and 12297T&gt;C (tRNA Leu) in a Leigh syndrome family
SO MOLECULAR GENETICS AND METABOLISM
LA English
DT Article
DE Mitochondrial disease; Leigh syndrome; mtDNA; 1448TF > C; 12297T > C
ID mitochondrial-dna mutations; complex-i deficiency; dilated cardiomyopathy; a12308g polymorphism; disease; gene; risk
AB Mitochondrial cytopathies are characterized by a large variability of clinical phenotypes and severity. The 14487T>C mutation in mtDNA has been recently described to be associated with Leigh syndrome. The 12297T>C mutation has been described in isolated dilated cardiomyopathy patients. Here, we report a family with multiple members who harbor both mutations, with only a few individuals who are affected with Leigh syndrome. Mitochondrial whole genome sequencing analysis in the proband's muscle specimen detected two nearly homoplasmic mutations: 14487T>C (M63V in ND6) and 12297T>C in the tRNA 11 (CUN) gene. These two mutations were also detected in the blood, urine sediments, hair follicles, and buccal swab samples of all matrilineal relatives tested. All individuals tested were nearly homoplasmic for the 12297T>C mutation, but had variable degrees of heteroplasmy for 14487T>C. We also screened for the frequency of these two mutations. Of 268 patients with Leigh or Leigh-like disease, one case was found to harbor the 14487T>C mutation (0.3%), and one had the 12297T>C mutation (0.3%). Neither mutation was detected in the 88 patients meeting MELAS syndrome criteria nor in the 56 patients with respiratory chain complex I or I + III deficiency. In conclusion, the 14487T>C mutation appears as the primary etiology of Leigh syndrome in this family, demonstrating the high level of heteroplasmy needed for a clinically significant phenotype with this mutation. The 12297T>C mutation was not associated with dilated cardiomyopathy for the family members who were clinically evaluated and who were shown by testing to be nearly homoplasmic for that mutation. (C) 2008 Elsevier Inc. All rights reserved.
C1 [Wang, Jing; Brautbar, Ariel; Fang-Yuan, Li; Graham, Brett H.; Wong, Lee-Jun] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.
   [Chan, Alicia K.; Dzwiniel, Tara] Univ Alberta, Dept Med Genet, Edmonton, AB, Canada.
   [Waters, Paula J.] Childrens & Womens Hlth Ctr, Dept Pathol & Lab Med, Vancouver, BC, Canada.
C3 Baylor College of Medicine; University of Alberta
RP Wong, LJ (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, 1 Baylor Plaza,NAB 2015, Houston, TX 77030 USA.
EM ljwong@bcm.edu
CR Bai RK, 2008, CANCER RES, V68, P624, DOI 10.1158/0008-5472.CAN-07-5706
   Bai RK, 2004, CLIN CHEM, V50, P996, DOI 10.1373/clinchem.2004.031153
   Bugiani M, 2004, BBA-BIOENERGETICS, V1659, P136, DOI 10.1016/j.bbabio.2004.09.006
   Covarrubias D, 2008, J HUM GENET, V53, P924, DOI 10.1007/s10038-008-0331-x
   Crimi M, 2003, EUR J HUM GENET, V11, P896, DOI 10.1038/sj.ejhg.5201056
   DAVIS PC, 1987, AM J NEURORADIOL, V8, P71
   DEMARCHI JM, 1994, HUM MUTAT, V4, P281, DOI 10.1002/humu.1380040409
   Dimauro S, 2001, AM J MED GENET, V106, P18, DOI 10.1002/ajmg.1392
   Gonzalo R, 2005, FEBS LETT, V579, P6909, DOI 10.1016/j.febslet.2005.11.034
   Grasso M, 2001, EUR J HUM GENET, V9, P311, DOI 10.1038/sj.ejhg.5200622
   Huntsman RJ, 2005, PEDIATR NEUROL, V32, P334, DOI 10.1016/j.pediatrneurol.2004.12.009
   Kirby DM, 2000, ANN NEUROL, V48, P102, DOI 10.1002/1531-8249(200007)48:1<102::AID-ANA15>3.3.CO;2-D
   Liang MH, 1998, AM J MED GENET, V77, P395, DOI 10.1002/(SICI)1096-8628(19980605)77:5<395::AID-AJMG8>3.0.CO;2-M
   Malfatti E, 2007, BRAIN, V130, P1894, DOI 10.1093/brain/awm114
   Nishioka T, 2004, J HUM GENET, V49, P701, DOI 10.1007/s10038-004-0209-5
   Pulkes T, 2000, LANCET, V356, P2068, DOI 10.1016/S0140-6736(00)03408-5
   Ravn K, 2001, EUR J HUM GENET, V9, P805, DOI 10.1038/sj.ejhg.5200712
   SANTORELLI FM, 1993, ANN NEUROL, V34, P827, DOI 10.1002/ana.410340612
   Shanske S, 2004, MITOCHONDRION, V4, P403, DOI 10.1016/j.mito.2004.07.026
   Solano A, 2003, ANN NEUROL, V54, P527, DOI 10.1002/ana.10682
   Tessa A, 1999, EUR J HUM GENET, V7, P847, DOI 10.1038/sj.ejhg.5200380
   Ugalde C, 2003, ANN NEUROL, V54, P665, DOI 10.1002/ana.10734
   Wong LJC, 2007, MUSCLE NERVE, V36, P279, DOI 10.1002/mus.20807
   Wong LJC, 1997, CLIN CHEM, V43, P1857
   Wong LJC, 2005, CLIN CHIM ACTA, V354, P1, DOI 10.1016/j.cccn.2004.11.003
NR 25
TC 16
Z9 17
U1 0
U2 4
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1096-7192
EI 1096-7206
J9 MOL GENET METAB
JI Mol. Genet. Metab.
PD FEB 15
PY 2009
VL 96
IS 2
BP 59
EP 65
DI 10.1016/j.ymgme.2008.10.006
PG 7
WC Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research & Experimental
SC Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental Medicine
GA 399QG
UT WOS:000262813800003
PM 19062322
DA 2024-11-01
ER

PT J
AU Spinazzola, A
   Invernizzi, F
   Carrara, F
   Lamantea, E
   Donati, A
   DiRocco, M
   Giordano, I
   Meznaric-Petrusa, M
   Baruffini, E
   Ferrero, I
   Zeviani, M
AF Spinazzola, A.
   Invernizzi, F.
   Carrara, F.
   Lamantea, E.
   Donati, A.
   DiRocco, M.
   Giordano, I.
   Meznaric-Petrusa, M.
   Baruffini, E.
   Ferrero, I.
   Zeviani, M.
TI Clinical and molecular features of mitochondrial DNA depletion syndromes
SO JOURNAL OF INHERITED METABOLIC DISEASE
LA English
DT Article; Proceedings Paper
ID progressive external ophthalmoplegia; deoxyguanosine kinase; mtdna depletion; thymidine kinase; polg mutations; ataxic neuropathy; sucla2 mutations; alpers-syndrome; gene; deficiency
AB Mitochondrial DNA depletion syndromes (MDSs) form a group of autosomal recessive disorders characterized by profoundly decreased mitochondrial DNA copy numbers in affected tissues. Three main clinical presentations are known: myopathic, encephalomyopathic and hepatocerebral. The first is associated with mutations in thymidine kinase 2 (TK2) and p53-induced ribonucleotide reductase B subunit (RRM2B); the second with mutations in succinate synthase A (SUCLA2) and B (SUCLG1); the third with mutations in Twinkle (PEO1), pol-gamma A (POLG1), deoxyguanosine kinase (DGUOK) and MPV17 (MPV17). In this work, we review the MDS-associated phenotypes and present our own experience of 32 MDS patients, with the aim of defining the mutation frequency of the known genes, the clinical spectrum of the diseases, and the genotype-phenotype correlations. Five of our patients carried previously unreported mutations in one of the eight MDS genes.
C1 [Spinazzola, A.; Invernizzi, F.; Carrara, F.; Lamantea, E.; Zeviani, M.] IRCCS Fdn Neurol Inst C Besta, Unit Mol Neurogenet, I-20126 Milan, Italy.
   [Donati, A.] AOU Meyer, Clin Pediat Neurol, Metab & Muscular Unit, Florence, Italy.
   [DiRocco, M.] Inst G Gaslini, Genoa, Italy.
   [Giordano, I.] Spedali Civil Brescia, Dept Child & Adolescent Neuropsychiat, I-25125 Brescia, Italy.
   [Meznaric-Petrusa, M.] Univ Ljubljana, Fac Med, Inst Anat, Ljubljana, Slovenia.
   [Baruffini, E.; Ferrero, I.] Univ Parma, Dept Genet Biol Microrganisms Anthropol & Evolut, I-43100 Parma, Italy.
C3 University of Florence; Azienda Ospedaliera Universitaria (AOU) MEYER; University of Genoa; IRCCS Istituto Giannina Gaslini; Hospital Spedali Civili Brescia; University of Ljubljana; University of Parma
RP Zeviani, M (corresponding author), IRCCS Fdn Neurol Inst C Besta, Unit Mol Neurogenet, Via Temolo 4, I-20126 Milan, Italy.
EM zeviani@istituto-besta.it
FU Telethon [GGP07019] Funding Source: Medline
CR Akman HO, 2008, HUM MOL GENET, V17, P2433, DOI 10.1093/hmg/ddn143
   Alberio S, 2007, MITOCHONDRION, V7, P6, DOI 10.1016/j.mito.2006.11.010
   Ashley N, 2007, HUM MOL GENET, V16, P1400, DOI 10.1093/hmg/ddm090
   Baruffini E, 2006, HUM MOL GENET, V15, P2846, DOI 10.1093/hmg/ddl219
   Bornstein B, 2008, NEUROMUSCULAR DISORD, V18, P453, DOI 10.1016/j.nmd.2008.04.006
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   Bugiani M, 2004, BBA-BIOENERGETICS, V1659, P136, DOI 10.1016/j.bbabio.2004.09.006
   Carrozzo R, 2007, BRAIN, V130, P862, DOI 10.1093/brain/awl389
   Chan SSL, 2005, DNA REPAIR, V4, P1381, DOI 10.1016/j.dnarep.2005.08.010
   Dimmock DP, 2008, HUM MUTAT, V29, P330, DOI 10.1002/humu.9519
   Elpeleg O, 2005, AM J HUM GENET, V76, P1081, DOI 10.1086/430843
   Engelsen BA, 2008, BRAIN, V131, P818, DOI 10.1093/brain/awn007
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   Freisinger P, 2006, ARCH NEUROL-CHICAGO, V63, P1129, DOI 10.1001/archneur.63.8.1129
   Galbiati S, 2006, PEDIATR NEUROL, V34, P177, DOI 10.1016/j.pediatrneurol.2005.07.013
   Hakonen AH, 2007, BRAIN, V130, P3032, DOI 10.1093/brain/awm242
   He LP, 2002, NUCLEIC ACIDS RES, V30, P0, DOI 10.1093/nar/gnf067
   HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2
   Kimura T, 2003, NAT GENET, V34, P440, DOI 10.1038/ng1212
   Mancuso M, 2002, NEUROLOGY, V59, P1197, DOI 10.1212/01.WNL.0000028689.93049.9A
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   MARIOTTI C, 1995, J NEUROL, V242, P547, DOI 10.1007/BF00868806
   Milone M, 2008, NEUROMUSCULAR DISORD, V18, P626, DOI 10.1016/j.nmd.2008.05.009
   MORAES CT, 1991, AM J HUM GENET, V48, P492
   Naïmi M, 2006, EUR J HUM GENET, V14, P917, DOI 10.1038/sj.ejhg.5201627
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443
   Oskoui M, 2006, ARCH NEUROL-CHICAGO, V63, P1122, DOI 10.1001/archneur.63.8.1122
   Ostergaard E, 2007, AM J HUM GENET, V81, P383, DOI 10.1086/519222
   Ostergaard E, 2007, BRAIN, V130, P853, DOI 10.1093/brain/awl383
   Poggi GM, 2000, J INHERIT METAB DIS, V23, P755, DOI 10.1023/A:1005663804214
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Salviati L, 2002, ANN NEUROL, V52, P311, DOI 10.1002/ana.10284
   Sarzi E, 2007, ANN NEUROL, V62, P579, DOI 10.1002/ana.21207
   SLONIMSKI PP, 1976, EUR J BIOCHEM, V61, P27, DOI 10.1111/j.1432-1033.1976.tb09994.x
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Spinazzola A, 2008, ARCH NEUROL-CHICAGO, V65, P1108, DOI 10.1001/archneur.65.8.1108
   Spinazzola A, 2008, NEUROMUSCULAR DISORD, V18, P315, DOI 10.1016/j.nmd.2007.12.007
   Tanaka H, 2000, NATURE, V404, P42, DOI 10.1038/35003506
   Tanji K, 2001, METHOD CELL BIOL, V65, P311, DOI 10.1016/S0091-679X(01)65019-2
   TRITSCHLER HJ, 1992, NEUROLOGY, V42, P209, DOI 10.1212/WNL.42.1.209
   Trott A, 2004, EUKARYOT CELL, V3, P620, DOI 10.1128/EC.3.3.620-631.2004
   Tzoulis C, 2006, BRAIN, V129, P1685, DOI 10.1093/brain/awl097
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2003, NEUROMUSCULAR DISORD, V13, P133, DOI 10.1016/S0960-8966(02)00216-X
   Vilà MR, 2003, NEUROLOGY, V60, P1203, DOI 10.1212/01.WNL.0000055928.58122.47
   Viscomi C, 2009, HUM MOL GENET, V18, P12, DOI 10.1093/hmg/ddn309
   Vu TH, 2001, HEPATOLOGY, V34, P116, DOI 10.1053/jhep.2001.25921
   Wang LY, 2005, MOL GENET METAB, V84, P75, DOI 10.1016/j.ymgme.2004.09.005
   Winterthun S, 2005, NEUROLOGY, V64, P1204, DOI 10.1212/01.WNL.0000156516.77696.5A
   Wong LJC, 2008, HUM MUTAT, V29, PE150, DOI 10.1002/humu.20824
   Zhou XS, 2008, HUM MOL GENET, V17, P2329, DOI 10.1093/hmg/ddn133
   zum Gottesberge AMM, 2005, HISTOCHEM CELL BIOL, V124, P507, DOI 10.1007/s00418-005-0027-7
NR 53
TC 143
Z9 162
U1 0
U2 21
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0141-8955
EI 1573-2665
J9 J INHERIT METAB DIS
JI J. Inherit. Metab. Dis.
PD APR 15
PY 2009
VL 32
IS 2
BP 143
EP 158
DI 10.1007/s10545-008-1038-z
PG 16
WC Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research & Experimental
SC Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental Medicine
GA 428NX
UT WOS:000264856300002
PM 19125351
DA 2024-11-01
ER

PT J
AU Huang, CC
   Lin, TJ
   Chen, CC
   Lin, WT
AF Huang, Chi-Chang
   Lin, Tien-Jen
   Chen, Chun-Chieh
   Lin, Wan-Teng
TI Endurance training accelerates exhaustive exercise-induced mitochondrial DNA deletion and apoptosis of left ventricle myocardium in rats
SO EUROPEAN JOURNAL OF APPLIED PHYSIOLOGY
LA English
DT Article
DE Endurance training; Exhaustive exercise; Left ventricular; Mitochondrial DNA deletion; Apotosis
ID skeletal-muscle; myeloperoxidase activity; matrix metalloproteinases; cardiac-hypertrophy; xanthine-oxidase; copy number; l-arginine; stress; heat-shock-protein-70; tissue
AB Even though exhaustive exercise-induced oxidative stress increases the risk of tissue damage, regular endurance training is widely assumed to improve cardiac function and protects against heart disease. We tested the hypothesis that an endurance training program prevents exhaustive exercise-induced increases in cardiac dysfunction and apoptosis in left ventricle (LV). Thirty-two male Sprague-Dawley rats were randomly divided into four groups: sedentary control (C), trained (T), exhaustively exercised (E), and trained plus exhaustively exercised (TE). Rats in T and TE groups ran on a motorized treadmill for 12 weeks. Rats in groups E and TE performed an exhaustive running test on a treadmill. The main effects of training were indicated by increased running time to exhaustion (80 +/- A 5 and 151 +/- A 13 min for groups E and TE, respectively, P = 0.0001), myocardial hypertrophy (0.38% and 0.47% for untrained and trained rats, respectively, P = 0.0002), decreased LV ejection fraction (88% and 71% for untrained and trained rats, respectively, P < 0.0001), accelerated mitochondrial DNA 4834-bp large deletion (mtDNA(4834) deletion), and up-regulated protein levels of heat shock protein-70, cytochrome C, cleaved capsase-3, and cleaved PARP in LV following a bout of exhaustive exercise. Contrary to our hypothesis, these results suggest that endurance training induced significant impairment of regional systolic and diastolic LV myocardial function and ejection fraction in rats. Our findings show that endurance training accelerates exhaustive exercise-induced mtDNA(4834) deletion and apoptosis in the LV.
C1 [Lin, Wan-Teng] Tunghai Univ, Coll Agr, Dept Hosp Management, Taichung 40704, Taiwan.
   [Huang, Chi-Chang; Chen, Chun-Chieh] Acad Sinica, Agr Biotechnol Res Ctr, Taipei 11529, Taiwan.
   [Lin, Tien-Jen] Municipal Fang Hosp, Div Neurosurg, Dept Surg, Taipei 11031, Taiwan.
   [Lin, Tien-Jen] Taipei Med Univ, Grad Inst Injury Prevent, Taipei 11031, Taiwan.
C3 Tunghai University; Academia Sinica - Taiwan; Taipei Medical University
RP Lin, WT (corresponding author), Tunghai Univ, Coll Agr, Dept Hosp Management, 181,Sec 3,Taichung Port Rd, Taichung 40704, Taiwan.
EM 040770@thu.edu.tw
FU National Science Council of Taiwan [NSC-96-2413-H-029-003, NSC-972-410-H029-037-MY2]
CR Antunes-Neto JMF, 2006, STRESS, V9, P107, DOI 10.1080/10253890600772211
   BEDFORD TG, 1979, J APPL PHYSIOL, V47, P1278, DOI 10.1152/jappl.1979.47.6.1278
   Beere HM, 2000, NAT CELL BIOL, V2, P469, DOI 10.1038/35019501
   Branda RF, 2002, MUTAT RES-FUND MOL M, V501, P29, DOI 10.1016/S0027-5107(02)00014-3
   Callejas NA, 2001, HEPATOLOGY, V33, P860, DOI 10.1053/jhep.2001.23002
   Chou YF, 2007, J NUTR, V137, P2036, DOI 10.1093/jn/137.9.2036
   Clarkson PM, 2000, AM J CLIN NUTR, V72, P637S, DOI 10.1093/ajcn/72.2.637S
   CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370
   Demirel HA, 2003, AM J PHYSIOL-HEART C, V285, PH1609, DOI 10.1152/ajpheart.00982.2002
   FrankiewiczJozko A, 1996, EUR J APPL PHYSIOL, V74, P470
   GADALETA MN, 1992, MUTAT RES, V275, P181, DOI 10.1016/0921-8734(92)90022-H
   Hamilton KL, 2003, FREE RADICAL BIO MED, V34, P800, DOI 10.1016/S0891-5849(02)01431-4
   Huang CC, 2008, EXP GERONTOL, V43, P571, DOI 10.1016/j.exger.2008.03.002
   Ji LL, 2008, FREE RADICAL BIO MED, V44, P142, DOI 10.1016/j.freeradbiomed.2007.02.031
   Kavazis AN, 2008, AM J PHYSIOL-HEART C, V294, PH928, DOI 10.1152/ajpheart.01231.2007
   Kim SH, 1997, MOL CELLS, V7, P726
   Le Page C, 2009, EXP GERONTOL, V44, P177, DOI 10.1016/j.exger.2008.10.003
   LEE HC, 1994, BBA-MOL BASIS DIS, V1226, P37, DOI 10.1016/0925-4439(94)90056-6
   Lee SD, 2008, J APPL PHYSIOL, V104, P1144, DOI 10.1152/japplphysiol.00152.2007
   Lee YI, 2006, EUR J APPL PHYSIOL, V97, P216, DOI 10.1007/s00421-006-0161-5
   Lin WT, 2006, BRIT J NUTR, V95, P67, DOI 10.1079/BJN20051602
   Linnane AW, 1998, ANN NY ACAD SCI, V854, P202, DOI 10.1111/j.1749-6632.1998.tb09903.x
   Liu CC, 2005, BRIT J NUTR, V94, P595, DOI 10.1079/BJN20051541
   Mansouri A, 1997, GASTROENTEROLOGY, V113, P599, DOI 10.1053/gast.1997.v113.pm9247482
   Marini M, 2007, EUR J APPL PHYSIOL, V99, P503, DOI 10.1007/s00421-006-0369-4
   Mikami T, 2004, J APPL PHYSIOL, V96, P1776, DOI 10.1152/japplphysiol.00795.2002
   Mooren FC, 2002, J APPL PHYSIOL, V93, P147, DOI 10.1152/japplphysiol.01262.2001
   Pagenstecher A, 2000, AM J PATHOL, V157, P197, DOI 10.1016/S0002-9440(10)64531-2
   Powers SK, 2004, ANN NY ACAD SCI, V1019, P462, DOI 10.1196/annals.1297.084
   Powers SK, 2001, MED SCI SPORT EXER, V33, P386, DOI 10.1097/00005768-200103000-00009
   Ravagnan L, 2001, NAT CELL BIOL, V3, P839, DOI 10.1038/ncb0901-839
   Roldán V, 2008, AM HEART J, V156, P85, DOI 10.1016/j.ahj.2008.01.035
   Rullman E, 2009, J APPL PHYSIOL, V106, P804, DOI 10.1152/japplphysiol.90872.2008
   Sakai Y, 1999, MUSCLE NERVE, V22, P258, DOI 10.1002/(SICI)1097-4598(199902)22:2<258::AID-MUS15>3.0.CO;2-1
   Shyur LF, 2008, PHYTOCHEMISTRY, V69, P1348, DOI 10.1016/j.phytochem.2008.01.017
   Siu PM, 2004, FASEB J, V18, P1150, DOI 10.1096/fj.03-1291fje
   Smolka MB, 2000, AM J PHYSIOL-REG I, V279, PR1539, DOI 10.1152/ajpregu.2000.279.5.R1539
   Tanimura Y, 2008, MED SCI SPORT EXER, V40, P1455, DOI 10.1249/MSS.0b013e31817242cf
   Taylor RP, 1999, AM J PHYSIOL-HEART C, V276, PH1098, DOI 10.1152/ajpheart.1999.276.3.H1098
   Thorp DB, 2007, AM J PHYSIOL-REG I, V293, PR363, DOI 10.1152/ajpregu.00363.2006
   Tsai K, 2001, FREE RADICAL BIO MED, V31, P1465, DOI 10.1016/S0891-5849(01)00729-8
   Tupling AR, 2008, APPL PHYSIOL NUTR ME, V33, P1023, DOI 10.1139/H08-067
   Wang S, 2008, EUR J APPL PHYSIOL, V104, P549, DOI 10.1007/s00421-008-0803-x
   Watson PA, 2007, AM J PHYSIOL-HEART C, V293, PH246, DOI 10.1152/ajpheart.00734.2006
   Wu HJ, 2004, WORLD J GASTROENTERO, V10, P2711, DOI 10.3748/wjg.v10.i18.2711
NR 45
TC 44
Z9 55
U1 0
U2 13
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1439-6319
EI 1439-6327
J9 EUR J APPL PHYSIOL
JI Eur. J. Appl. Physiol.
PD DEC 15
PY 2009
VL 107
IS 6
BP 697
EP 706
DI 10.1007/s00421-009-1177-4
PG 10
WC Physiology; Sport Sciences
SC Physiology; Sport Sciences
GA 519KB
UT WOS:000271764100008
PM 19730878
DA 2024-11-01
ER

PT J
AU Khrapko, K
   Vijg, J
AF Khrapko, Konstantin
   Vijg, Jan
TI Mitochondrial DNA mutations and aging: devils in the details?
SO TRENDS IN GENETICS
LA English
DT Review
ID cause dilated cardiomyopathy; substantia-nigra neurons; mtdna point mutations; degenerative diseases; deletion mutations; oxidative stress; stem-cells; mammalian mitochondria; skeletal-muscle; high-frequency
AB Although several lines of evidence support a role for accumulating somatic mitochondrial DNA (mtDNA) mutations in the etiology of aging, it remains unclear if they are a major cause of age-related deterioration and death. Mouse models that harbor elevated mtDNA mutation frequencies age prematurely; these findings were thought to provide conclusive evidence for a causal role of such mutations in aging. Yet, the presence of several conflicting reports has sparked controversy in the field and this is further aggravated by discrepancies in the estimates of mtDNA mutant fractions, which disagree by orders of magnitude. Here, we briefly review the evidence and some of the unresolved questions surrounding a causative role for accumulating mtDNA mutations in aging.
C1 [Khrapko, Konstantin] Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA.
   [Khrapko, Konstantin] Harvard Univ, Sch Med, Boston, MA 02115 USA.
   [Vijg, Jan] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10461 USA.
C3 Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Yeshiva University; Montefiore Medical Center; Albert Einstein College of Medicine
RP Khrapko, K (corresponding author), Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA.
EM khrapko@hms.harvard.edu; jvijg@aecom.yu.edu
FU NIH [AG17242, AG20438, NS058988, AG19787]; Ellison Medical Foundation; United Mitochondrial Disease Foundation
CR Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Bensch KG, 2007, DIABETES OBES METAB, V9, P74, DOI 10.1111/j.1463-1326.2007.00776.x
   Bielas JH, 2005, NAT METHODS, V2, P285, DOI 10.1038/NMETH751
   Bua EA, 2004, FASEB J, V18, P582, DOI 10.1096/fj.03-0668fje
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Cantuti-Castelvetria I, 2005, NEUROBIOL AGING, V26, P1343, DOI 10.1016/j.neurobiolaging.2004.11.008
   Coller HA, 2005, MUTAT RES-FUND MOL M, V578, P256, DOI 10.1016/j.mrfmmm.2005.05.014
   Coller HA, 2001, NAT GENET, V28, P147, DOI 10.1038/88859
   CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927
   Cree LM, 2008, NAT GENET, V40, P249, DOI 10.1038/ng.2007.63
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   Dubec SJ, 2008, REJUV RES, V11, P611, DOI 10.1089/rej.2007.0617
   Dufour E, 2008, HUM MOL GENET, V17, P1418, DOI 10.1093/hmg/ddn030
   Ekstrand MI, 2007, P NATL ACAD SCI USA, V104, P1325, DOI 10.1073/pnas.0605208103
   Elson JL, 2001, AM J HUM GENET, V68, P802, DOI 10.1086/318801
   Falkenberg M, 2007, ANNU REV BIOCHEM, V76, P679, DOI 10.1146/annurev.biochem.76.060305.152028
   Greaves LC, 2006, P NATL ACAD SCI USA, V103, P714, DOI 10.1073/pnas.0505903103
   Hansson A, 2004, P NATL ACAD SCI USA, V101, P3136, DOI 10.1073/pnas.0308710100
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   Herbst A, 2007, J GERONTOL A-BIOL, V62, P235, DOI 10.1093/gerona/62.3.235
   Huang WY, 2000, NAT MED, V6, P482, DOI 10.1038/74914
   Inoue K, 2000, NAT GENET, V26, P176, DOI 10.1038/82826
   Itoh K, 1996, NEUROBIOL AGING, V17, P843, DOI 10.1016/S0197-4580(96)00168-6
   Jacobs HT, 2003, AGING CELL, V2, P11, DOI 10.1046/j.1474-9728.2003.00032.x
   Jacobs L, 2007, MOL HUM REPROD, V13, P149, DOI 10.1093/molehr/gal112
   JOHNSTON W, 1995, ANN NEUROL, V37, P16, DOI 10.1002/ana.410370106
   Kasahara T, 2006, MOL PSYCHIATR, V11, P577, DOI 10.1038/sj.mp.4001824
   Khaidakov A, 2005, EXP GERONTOL, V40, P396, DOI 10.1016/j.exger.2005.02.007
   Khrapko K, 2003, MUTAT RES-FUND MOL M, V522, P13, DOI 10.1016/S0027-5107(02)00306-8
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Legros F, 2004, J CELL SCI, V117, P2653, DOI 10.1242/jcs.01134
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   MONNAT RJ, 1985, P NATL ACAD SCI USA, V82, P2895, DOI 10.1073/pnas.82.9.2895
   Mott JL, 1999, ANN NY ACAD SCI, V893, P353, DOI 10.1111/j.1749-6632.1999.tb07853.x
   Mott JL, 2001, MUTAT RES-FUND MOL M, V474, P35, DOI 10.1016/S0027-5107(00)00159-7
   Nakada K, 2001, NAT MED, V7, P934, DOI 10.1038/90976
   Nekhaeva E, 2002, P NATL ACAD SCI USA, V99, P5521, DOI 10.1073/pnas.072670199
   Niu X, 2007, EXP CELL RES, V313, P3924, DOI 10.1016/j.yexcr.2007.05.029
   Ono T, 2001, NAT GENET, V28, P272, DOI 10.1038/90116
   Orrenius S, 2007, ANNU REV PHARMACOL, V47, P143, DOI 10.1146/annurev.pharmtox.47.120505.105122
   Park CB, 2007, CELL, V130, P273, DOI 10.1016/j.cell.2007.05.046
   Rorbach J, 2007, BIOCHEM SOC T, V35, P1290, DOI 10.1042/BST0351290
   Sato A, 2005, P NATL ACAD SCI USA, V102, P16765, DOI 10.1073/pnas.0506197102
   Sato A, 2005, P NATL ACAD SCI USA, V102, P6057, DOI 10.1073/pnas.0408666102
   Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653
   Silva JP, 2000, NAT GENET, V26, P336, DOI 10.1038/81649
   Simon DK, 2001, GENOMICS, V73, P113, DOI 10.1006/geno.2001.6515
   Smigrodzki R, 2004, NEUROBIOL AGING, V25, P1273, DOI 10.1016/j.neurobiolaging.2004.02.020
   SOONG NW, 1992, NAT GENET, V2, P318
   Sörensen L, 2001, J NEUROSCI, V21, P8082, DOI 10.1523/JNEUROSCI.21-20-08082.2001
   Tanaka M, 1996, ANN NY ACAD SCI, V786, P102, DOI 10.1111/j.1749-6632.1996.tb39055.x
   Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435
   Terman A, 2007, J PATHOL, V211, P134, DOI 10.1002/path.2094
   Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95
   Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988
   Vijg J, 2007, AGING GENOME, V0, P0
   WALLACE DC, 1992, SCIENCE, V256, P628, DOI 10.1126/science.1533953
   Wanagat J, 2001, FASEB J, V15, P322, DOI 10.1096/fj.00-0320com
   Wanrooij S, 2004, NUCLEIC ACIDS RES, V32, P3053, DOI 10.1093/nar/gkh634
   YONEDA M, 1994, MOL CELL BIOL, V14, P2699, DOI 10.1128/MCB.14.4.2699
   Zhang D, 2005, AM J PHYSIOL-HEART C, V288, PH2476, DOI 10.1152/ajpheart.00670.2004
   Zhang D, 2003, CARDIOVASC RES, V57, P147, DOI 10.1016/S0008-6363(02)00695-8
   Zhang DK, 2000, GENOMICS, V69, P151, DOI 10.1006/geno.2000.6333
NR 66
TC 87
Z9 93
U1 0
U2 9
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0168-9525
EI 
J9 TRENDS GENET
JI Trends Genet.
PD FEB 15
PY 2009
VL 25
IS 2
BP 91
EP 98
DI 10.1016/j.tig.2008.11.007
PG 8
WC Genetics & Heredity
SC Genetics & Heredity
GA 415IF
UT WOS:000263926800006
PM 19110336
DA 2024-11-01
ER

PT J
AU Elson, JL
   Swalwell, H
   Blakely, EL
   McFarland, R
   Taylor, RW
   Turnbull, DM
AF Elson, Joanna L.
   Swalwell, Helen
   Blakely, Emma L.
   McFarland, Robert
   Taylor, Robert W.
   Turnbull, Doug M.
TI Pathogenic Mitochondrial tRNA Mutations - Which Mutations Are Inherited and Why?
SO HUMAN MUTATION
LA English
DT Article
DE mitochondrial DNA; tRNA mutation; threshold; inheritance; genetic counseling
ID ragged-red fibers; point mutation; dna mutations; sporadic patient; exercise intolerance; trna(lys) gene; myopathy; merrf; melas; prevalence
AB Mitochondrial transfer RNA (mt-tRNA) mutations are the commonest mitochondrial (mtDNA) mutations to cause human disease. The majority of mt-tRNA mutations are heteroplasmic and while some exhibit maternal transmission within families, many others are only seen as sporadic mutations. Using the available clinical, biochemical and genetic data from published pathogenic mt-tRNA mutations, we have explored several different factors thought to influence the transmission of mt-tRNA mutations. Our data show that the most important factor in predicting whether a mutation is transmitted to offspring is whether the mt-tRNA mutation is selected against in a rapidly replicating tissue such as blood. This suggests that those mt-tRNA mutations which exert a major phenotype in dividing cells are unlikely to be inherited. This is entirely compatible with recent observations on the mitochondrial genetic bottleneck in early development and has important implications for families with mt-tRNA disease. (C) 2009 Wiley-Liss, Inc.
C1 [Elson, Joanna L.; Swalwell, Helen; Blakely, Emma L.; McFarland, Robert; Taylor, Robert W.; Turnbull, Doug M.] Newcastle Univ, Sch Med, Mitochondrial Res Grp, Inst Ageing & Hlth, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
C3 Newcastle University - UK
RP Taylor, RW (corresponding author), Newcastle Univ, Sch Med, Mitochondrial Res Grp, Inst Ageing & Hlth, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM r.w.taylor@ncl.ac.uk
FU Research Council UK RCUK; UK National Commissioning Group for Rare Mitochondrial Disorders of Children and Adults; Wellcome Trust [GR074454]; Medical Research Council [G0800674, G0700718]; BBSRC; EPSRC; ESRC; MRC [G0700718, G90/63, G108/539, G0800674] Funding Source: UKRI
CR ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Anitori R, 2005, MOL GENET METAB, V84, P176, DOI 10.1016/j.ymgme.2004.10.003
   Bataillard M, 2001, NEUROLOGY, V56, P405, DOI 10.1212/WNL.56.3.405
   Bidooki S, 2004, NEUROMUSCULAR DISORD, V14, P417, DOI 10.1016/j.nmd.2004.03.004
   Blakely EL, 2007, J NEUROL, V254, P1283, DOI 10.1007/s00415-006-0490-7
   Blakely EL, 2009, ARCH NEUROL-CHICAGO, V66, P399, DOI 10.1001/archneurol.2008.576
   Cao LQ, 2007, NAT GENET, V39, P386, DOI 10.1038/ng1970
   Chinnery PE, 1998, BRAIN, V121, P1889, DOI 10.1093/brain/121.10.1889
   Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713
   Cree LM, 2008, NAT GENET, V40, P249, DOI 10.1038/ng.2007.63
   Crimi M, 2003, NEUROLOGY, V60, P1200, DOI 10.1212/01.WNL.0000055865.30580.39
   Darin N, 2006, NEUROMUSCULAR DISORD, V16, P504, DOI 10.1016/j.nmd.2006.05.010
   Deschauer M, 2006, ARCH NEUROL-CHICAGO, V63, P902, DOI 10.1001/archneur.63.6.902
   Dey R, 2000, NEUROMUSCULAR DISORD, V10, P488, DOI 10.1016/S0960-8966(00)00125-5
   Dimauro S, 2001, AM J MED GENET, V106, P18, DOI 10.1002/ajmg.1392
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   Fu K, 1996, HUM MOL GENET, V5, P1835, DOI 10.1093/hmg/5.11.1835
   Houshmand M, 1999, HUM MUTAT, V13, P203, DOI 10.1002/(SICI)1098-1004(1999)13:3<203::AID-HUMU4>3.0.CO;2-3
   ICHIKI T, 1988, ANN NEUROL, V23, P287, DOI 10.1002/ana.410230312
   Jacobs HT, 2003, HUM MOL GENET, V12, PR293, DOI 10.1093/hmg/ddg285
   Karadimas CL, 2002, NEUROMUSCULAR DISORD, V12, P865, DOI 10.1016/S0960-8966(02)00072-X
   Lynn S, 1998, DIABETES, V47, P1800, DOI 10.2337/diabetes.47.11.1800
   Majamaa K, 1998, AM J HUM GENET, V63, P447, DOI 10.1086/301959
   Mancuso M, 2004, NEUROLOGY, V62, P2119, DOI 10.1212/01.WNL.0000127608.48406.F1
   Maniura-Weber K, 2004, EUR J HUM GENET, V12, P509, DOI 10.1038/sj.ejhg.5201185
   Manwaring N, 2007, MITOCHONDRION, V7, P230, DOI 10.1016/j.mito.2006.12.004
   Mayr JA, 2006, NEUROMUSCULAR DISORD, V16, P874, DOI 10.1016/j.nmd.2006.08.010
   McFarland R, 2004, TRENDS GENET, V20, P591, DOI 10.1016/j.tig.2004.09.014
   McFarland R, 2008, NEUROMUSCULAR DISORD, V18, P63, DOI 10.1016/j.nmd.2007.07.007
   Melone MAB, 2004, ARCH NEUROL-CHICAGO, V61, P269, DOI 10.1001/archneur.61.2.269
   MORAES CT, 1993, NAT GENET, V4, P284, DOI 10.1038/ng0793-284
   MORAES CT, 1993, J CLIN INVEST, V92, P2906, DOI 10.1172/JCI116913
   Moslemi AR, 1998, NEUROMUSCULAR DISORD, V8, P345, DOI 10.1016/S0960-8966(98)00029-7
   Moslemi AR, 2004, NEUROMUSCULAR DISORD, V14, P46, DOI 10.1016/S0960-8966(03)00168-8
   Nishigaki Y, 2003, NEUROMUSCULAR DISORD, V13, P334, DOI 10.1016/S0960-8966(02)00283-3
   Ozawa M, 1997, MUSCLE NERVE, V20, P271, DOI 10.1002/(SICI)1097-4598(199703)20:3<271::AID-MUS2>3.0.CO;2-8
   Pereira C, 2007, BIOCHEM BIOPH RES CO, V354, P937, DOI 10.1016/j.bbrc.2007.01.068
   Rossmanith W, 2003, ANN NEUROL, V54, P820, DOI 10.1002/ana.10753
   Sacconi S, 2008, HUM MOL GENET, V17, P1814, DOI 10.1093/hmg/ddn073
   Santorelli FM, 1996, AM J HUM GENET, V58, P933
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   Stewart JB, 2008, PLOS BIOL, V6, P63, DOI 10.1371/journal.pbio.0060010
   Swalwell H, 2006, NEUROLOGY, V66, P447, DOI 10.1212/01.wnl.0000196490.36349.83
   Swalwell H, 2008, EUR J HUM GENET, V16, P1265, DOI 10.1038/ejhg.2008.65
   Taylor RW, 1998, BIOCHEM BIOPH RES CO, V243, P47, DOI 10.1006/bbrc.1997.8055
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Taylor RW, 2004, NEUROLOGY, V62, P1420, DOI 10.1212/01.WNL.0000120667.77372.46
   Taylor RW, 2002, NEUROMUSCULAR DISORD, V12, P659, DOI 10.1016/S0960-8966(02)00026-3
   Tiranti V, 1998, ANN NEUROL, V43, P98, DOI 10.1002/ana.410430116
   Wai T, 2008, NAT GENET, V40, P1484, DOI 10.1038/ng.258
   Weber K, 1997, AM J HUM GENET, V60, P373
NR 51
TC 44
Z9 44
U1 0
U2 8
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1059-7794
EI 1098-1004
J9 HUM MUTAT
JI Hum. Mutat.
PD NOV 15
PY 2009
VL 30
IS 11
BP E984
EP E992
DI 10.1002/humu.21113
PG 9
WC Genetics & Heredity
SC Genetics & Heredity
GA 626QD
UT WOS:000279980700003
PM 19718780
DA 2024-11-01
ER

PT J
AU Finsterer, J
   Harbo, HF
   Baets, J
   Van Broeckhoven, C
   Di Donato, S
   Fontaine, B
   De Jonghe, P
   Lossos, A
   Lynch, T
   Mariotti, C
   Schöls, L
   Spinazzola, A
   Szolnoki, Z
   Tabrizi, SJ
   Tallaksen, CME
   Zeviani, M
   Burgunder, JM
   Gasser, T
AF Finsterer, J.
   Harbo, H. F.
   Baets, J.
   Van Broeckhoven, C.
   Di Donato, S.
   Fontaine, B.
   De Jonghe, P.
   Lossos, A.
   Lynch, T.
   Mariotti, C.
   Schoels, L.
   Spinazzola, A.
   Szolnoki, Z.
   Tabrizi, S. J.
   Tallaksen, C. M. E.
   Zeviani, M.
   Burgunder, J. -M.
   Gasser, T.
TI EFNS guidelines on the molecular diagnosis of mitochondrial disorders
SO EUROPEAN JOURNAL OF NEUROLOGY
LA English
DT Article
DE encephalomyopathies; hereditary disease; metabolic myopathies; mitochondrial myopathy; molecular genetics
ID progressive external ophthalmoplegia; inherited neurologic diseases; cytochrome-c-oxidase; multiple deletions; gene-mutations; leigh-disease; task-force; 2 parts; dna; deficiency
AB Objectives: These European Federation of Neurological Sciences (EFNS) guidelines are designed to provide practical help for the general neurologist to make appropriate use of molecular genetics for diagnosing mitochondrial disorders (MIDs), which gain increasing attention and are more frequently diagnosed due to improved diagnostic tools. Background: Since the publication of the first EFNS guidelines on the molecular diagnosis of inherited neurological diseases in 2001, rapid progress has been made in this field, necessitating the creation of an updated version. Search strategy: To collect data about the molecular diagnosis of MIDs search for literature in various electronic databases, such as Cochrane library, MEDLINE, OMIM, GENETEST or Embase, were carried out and original papers, meta-analyses, review papers, and guideline recommendations were reviewed. Results: The guidelines summarise the possibilities and limitations of molecular genetic diagnosis of MIDs and provide practical recommendations and diagnostic criteria in accordance with the EFNS Scientific Committee to guide the molecular diagnostic work-up of MIDs. Recommendations: The proposed guidelines suggest an approach to the molecular diagnosis of MIDs in a manner accessible to general neurologists.
C1 [Finsterer, J.] Krankenanstalt Rudolfstiftung Wien, Vienna, Austria.
   [Finsterer, J.] Danube Univ Krems, Krems, Austria.
   [Harbo, H. F.] Oslo Univ Hosp, Dept Neurol, Oslo, Norway.
   [Harbo, H. F.] Univ Oslo, Fac Div Ulleval, Oslo, Norway.
   [Baets, J.; De Jonghe, P.] Univ Antwerp Hosp, Dept Neurol, Antwerp, Belgium.
   [Baets, J.; Van Broeckhoven, C.; De Jonghe, P.] VIB, Dept Mol Genet, Antwerp, Belgium.
   [Baets, J.; Van Broeckhoven, C.; De Jonghe, P.] Univ Antwerp, Inst Born Bunge, Neurogenet Lab, B-2020 Antwerp, Belgium.
   [Mariotti, C.] Ist Neurol Carlo Besta, Fdn IRCCS, Unit Biochem & Genet Neurogenet & Metab Dis, Milan, Italy.
   [Fontaine, B.] Grp Hosp Pitie Salpetriere, AP HP, Ctr Reference Canalopathies Musculaires, F-75634 Paris, France.
   [Lossos, A.] Hadassah Univ Hosp, Dept Neurol, IL-91120 Jerusalem, Israel.
   [Lynch, T.] Mater Misericordiae Univ, Dublin Neurol Inst, Beaumont Hosp, Dublin, Ireland.
   [Lynch, T.] Mater Misericordiae Univ, Dublin Neurol Inst, Mater Private Hosp, Dublin, Ireland.
   [Schoels, L.] Univ Tubingen, Ctr Neurol, Tubingen, Germany.
   [Gasser, T.] Univ Tubingen, Hertie Inst Clin Brain Res, Dept Neurodegenerat Dis, Tubingen, Germany.
   [Spinazzola, A.; Zeviani, M.] Neurol Inst Carlo Besta, IRCCS Fdn, Div Mol Neurogenet, Milan, Italy.
   [Szolnoki, Z.] Pandy Cty Hosp, Dept Neurol & Cerebrovasc Dis, Gyula, Hungary.
   [Tabrizi, S. J.] Inst Neurol, Dept Neurodegenerat Dis, London WC1N 3BG, England.
   [Tabrizi, S. J.] Natl Hosp Neurol & Neurosurg, London WC1N 3BG, England.
   [Tallaksen, C. M. E.] Univ Oslo, Univ Hosp, Fac Div Ulleval, Oslo, Norway.
   [Burgunder, J. -M.] Univ Bern, Dept Neurol, Bern, Switzerland.
C3 Rudolfstiftung Hospital; Danube University Krems; University of Oslo; University of Oslo; University of Antwerp; Flanders Institute for Biotechnology (VIB); University of Antwerp; Fondazione IRCCS Istituto Neurologico Carlo Besta; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Hebrew University of Jerusalem; University College Dublin; Mater Misericordiae University Hospital; University College Dublin; Mater Private Hospital; Mater Misericordiae University Hospital; Eberhard Karls University of Tubingen; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Fondazione IRCCS Istituto Neurologico Carlo Besta; University of London; University College London; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of Oslo; University of Bern
RP Finsterer, J (corresponding author), Postfach 20, A-1180 Vienna, Austria.
EM fifigs1@yahoo.de
CR Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944
   Berger I, 2008, ANN NEUROL, V63, P405, DOI 10.1002/ana.21332
   Blesa JR, 2007, NEUROMOL MED, V9, P285, DOI 10.1007/s12017-007-8000-3
   Boultwood J, 2008, PLOS ONE, V3, P0, DOI 10.1371/journal.pone.0001970
   Brainin M, 2004, EUR J NEUROL, V11, P577, DOI 10.1111/j.1468-1331.2004.00867.x
   Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   Finsterer J, 2001, J INHERIT METAB DIS, V24, P560, DOI 10.1023/A:1012415810881
   Gasser T, 2001, EUR J NEUROL, V8, P299
   Gasser T, 2001, EUR J NEUROL, V8, P407
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   Kaukonen J, 1999, AM J HUM GENET, V65, P256, DOI 10.1086/302445
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   Massa V, 2008, AM J HUM GENET, V82, P1281, DOI 10.1016/j.ajhg.2008.05.002
   Mollet J, 2008, AM J HUM GENET, V82, P623, DOI 10.1016/j.ajhg.2007.12.022
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Oldfors Anders, 2007, HANDB CLIN NEUROL, V86, P125, DOI 10.1016/S0072-9752(07)86006-4
   ROTIG A, 1989, LANCET, V1, P902
   SERVIDEI S, 1991, NEUROLOGY, V41, P1053, DOI 10.1212/WNL.41.7.1053
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Spinazzola A, 2007, BIOSCIENCE REP, V27, P39, DOI 10.1007/s10540-007-9036-1
   SUOMALAINEN A, 1995, NAT GENET, V9, P146, DOI 10.1038/ng0295-146
   TATUCH Y, 1992, AM J HUM GENET, V50, P852
   Tiranti V, 1999, ANN NEUROL, V46, P161, DOI 10.1002/1531-8249(199908)46:2<161::AID-ANA4>3.0.CO;2-O
   Tsao CY, 2003, J CHILD NEUROL, V18, P62, DOI 10.1177/08830738030180011401
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2003, EUR J HUM GENET, V11, P547, DOI 10.1038/sj.ejhg.5201002
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   ZEVIANI M, 1988, NEUROLOGY, V38, P1339
   Zeviani M, 2004, BRAIN, V127, P2153, DOI 10.1093/brain/awh259
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
NR 33
TC 46
Z9 54
U1 0
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1351-5101
EI 1468-1331
J9 EUR J NEUROL
JI Eur. J. Neurol.
PD DEC 15
PY 2009
VL 16
IS 12
BP 1255
EP 1264
DI 10.1111/j.1468-1331.2009.02811.x
PG 10
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 522BT
UT WOS:000271973400003
PM 19950421
DA 2024-11-01
ER

PT J
AU Matsushima, Y
   Kaguni, LS
AF Matsushima, Yuichi
   Kaguni, Laurie S.
TI Functional importance of the conserved N-terminal domain of the mitochondrial replicative DNA helicase
SO BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS
LA English
DT Article; Proceedings Paper
DE Mitochondria; Mitochondrial DNA; Replisome; Primase; Helicase; Autosomal dominant progressive external ophthalmoplegia
ID progressive external ophthalmoplegia; schneider cells; copy number; modular architecture; twinkle helicase; zinc motif; primase; bacteriophage-t7; mutations; binding
AB The mitochondrial replicative DNA helicase is an essential cellular protein that shows high similarity with the bifunctional primase-helicase of bacteriophage 17, the gene 4 protein (T7 gp4). The N-terminal primase domain of T7 gp4 comprises seven conserved sequence motifs, I, II, III, IV, V, VI, and an RNA polymerase basic domain. The putative primase domain of metazoan mitochondrial DNA helicases has diverged from T7 gp4 and in particular, the primase domain of vertebrates lacks motif I, which comprises a zinc binding domain. Interestingly, motif I is conserved in insect mtDNA helicases. Here, we evaluate the effects of overexpression in Drosophila cell culture of variants carrying mutations in conserved amino acids in the N-terminal region, including the zinc binding domain. Overexpression of alanine substitution mutants of conserved amino acids in motifs I, IV, V and VI and the RNA polymerase basic domain results in increased mtDNA copy number as is observed with overexpression of the wild type enzyme. In contrast, overexpression of three N-terminal mutants W282L, R301Q and P302L that are analogous to human autosomal dominant progressive external ophthalmoplegia mutations results in mitochondrial DNA depletion, and in the case of R301Q, a dominant negative cellular phenotype. Thus whereas our data suggest lack of a DNA primase activity in Drosophila mitochondrial DNA helicase, they show that specific N-terminal amino acid residues that map close to the central linker region likely play a physiological role in the C-terminal helicase function of the protein. (C) 2008 Elsevier B.V. All rights reserved.
C1 [Kaguni, Laurie S.] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA.
   Michigan State Univ, Ctr Mitochondrial Sci & Med, E Lansing, MI 48824 USA.
C3 Michigan State University; Michigan State University
RP Kaguni, LS (corresponding author), Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA.
EM lskaguni@msu.edu
FU NIGMS NIH HHS [R01 GM045295-13A1, GM45295, R01 GM045295-14, R01 GM045295-15, R01 GM045295-16, R01 GM045295] Funding Source: Medline
CR Aravind L, 1998, NUCLEIC ACIDS RES, V26, P4205, DOI 10.1093/nar/26.18.4205
   Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646
   Farge G, 2008, NUCLEIC ACIDS RES, V36, P393, DOI 10.1093/nar/gkm1025
   Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455
   Kato M, 2003, MOL CELL, V11, P1349, DOI 10.1016/S1097-2765(03)00195-3
   Korhonen JA, 2008, J MOL BIOL, V377, P691, DOI 10.1016/j.jmb.2008.01.035
   Kusakabe T, 1996, J BIOL CHEM, V271, P19563, DOI 10.1074/jbc.271.32.19563
   Lee SJ, 2005, J BIOL CHEM, V280, P26984, DOI 10.1074/jbc.M504817200
   Lee SJ, 2001, J BIOL CHEM, V276, P49419, DOI 10.1074/jbc.M108443200
   Lee SJ, 2002, P NATL ACAD SCI USA, V99, P12703, DOI 10.1073/pnas.202471499
   Matsushima Y, 2005, J BIOL CHEM, V280, P16815, DOI 10.1074/jbc.M500569200
   Matsushima Y, 2004, J BIOL CHEM, V279, P26900, DOI 10.1074/jbc.M401643200
   Matsushima Y, 2008, J BIOL CHEM, V283, P23964, DOI 10.1074/jbc.M803674200
   Matsushima Y, 2007, J BIOL CHEM, V282, P9436, DOI 10.1074/jbc.M610550200
   MENDELMAN LV, 1994, EMBO J, V13, P3909, DOI 10.1002/j.1460-2075.1994.tb06702.x
   Sarzi E, 2007, ANN NEUROL, V62, P579, DOI 10.1002/ana.21207
   Shutt TE, 2006, J MOL EVOL, V62, P588, DOI 10.1007/s00239-005-0162-8
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spinazzola A, 2005, GENE, V354, P162, DOI 10.1016/j.gene.2005.03.025
   Tyynismaa H, 2004, HUM MOL GENET, V13, P3219, DOI 10.1093/hmg/ddh342
   Virgilio R, 2008, J NEUROL, V255, P1384, DOI 10.1007/s00415-008-0926-3
   Washington MT, 1996, J BIOL CHEM, V271, P26825, DOI 10.1074/jbc.271.43.26825
   Ziebarth TD, 2007, J MOL BIOL, V367, P1382, DOI 10.1016/j.jmb.2007.01.079
NR 23
TC 12
Z9 16
U1 1
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0005-2728
EI 0006-3002
J9 BBA-BIOENERGETICS
JI Biochim. Biophys. Acta-Bioenerg.
PD MAY 15
PY 2009
VL 1787
IS 5
BP 290
EP 293
DI 10.1016/j.bbabio.2008.11.005
PG 4
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 451MX
UT WOS:000266475400002
PM 19063859
DA 2024-11-01
ER

PT J
AU Ophuis, RJAO
   Wijers, M
   Bennink, MB
   de Loo, FAJV
   Fransen, JAM
   Wieringa, B
   Wansink, DG
AF Ophuis, Ralph J. A. Oude
   Wijers, Mietske
   Bennink, Miranda B.
   de Loo, Fons A. J. van
   Fransen, Jack A. M.
   Wieringa, Be
   Wansink, Derick G.
TI A Tail-Anchored Myotonic Dystrophy Protein Kinase Isoform Induces Perinuclear Clustering of Mitochondria, Autophagy, and Apoptosis
SO PLOS ONE
LA English
DT Article
ID mammalian-cells; skeletal-muscle; fission; fusion; localization; morphology; calcium; overexpression; bioenergetics; generation
AB Background: Studies on the myotonic dystrophy protein kinase (DMPK) gene and gene products have thus far mainly concentrated on the fate of length mutation in the (CTG)n repeat at the DNA level and consequences of repeat expansion at the RNA level in DM1 patients and disease models. Surprisingly little is known about the function of DMPK protein products. Methodology/Principal Findings: We demonstrate here that transient expression of one major protein product of the human gene, the hDMPK A isoform with a long tail anchor, results in mitochondrial fragmentation and clustering in the perinuclear region. Clustering occurred in a variety of cell types and was enhanced by an intact tubulin cytoskeleton. In addition to morphomechanical changes, hDMPK A expression induces physiological changes like loss of mitochondrial membrane potential, increased autophagy activity, and leakage of cytochrome c from the mitochondrial intermembrane space accompanied by apoptosis. Truncation analysis using YFP-hDMPK A fusion constructs revealed that the protein's tail domain was necessary and sufficient to evoke mitochondrial clustering behavior. Conclusion/Significance: Our data suggest that the expression level of the DMPK A isoform needs to be tightly controlled in cells where the hDMPK gene is expressed. We speculate that aberrant splice isoform expression might be a codetermining factor in manifestation of specific DM1 features in patients.
C1 [Ophuis, Ralph J. A. Oude; Wijers, Mietske; Fransen, Jack A. M.; Wieringa, Be; Wansink, Derick G.] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Cell Biol, NL-6525 ED Nijmegen, Netherlands.
   [Bennink, Miranda B.; de Loo, Fons A. J. van] Radboud Univ Nijmegen, Med Ctr, NL-6525 ED Nijmegen, Netherlands.
C3 Radboud University Nijmegen; Radboud University Nijmegen
RP Wansink, DG (corresponding author), Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Cell Biol, NL-6525 ED Nijmegen, Netherlands.
EM r.wansink@ncmls.ru.nl
FU Prinses Beatrix Fonds; Association Francaise contre les Myopathies (AFM)
CR Anesti V, 2006, BBA-BIOENERGETICS, V1757, P692, DOI 10.1016/j.bbabio.2006.04.013
   Benard G, 2008, ANTIOXID REDOX SIGN, V10, P1313, DOI 10.1089/ars.2007.2000
   Benders AAGM, 1997, J CLIN INVEST, V100, P1440, DOI 10.1172/JCI119664
   Cai Q, 2009, NEURON, V61, P493, DOI 10.1016/j.neuron.2009.02.003
   Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010
   Chang DTW, 2006, PROG NEUROBIOL, V80, P241, DOI 10.1016/j.pneurobio.2006.09.003
   Chartier C, 1996, J VIROL, V70, P4805, DOI 10.1128/JVI.70.7.4805-4810.1996
   Cho DH, 2005, MOL CELL, V20, P483, DOI 10.1016/j.molcel.2005.09.002
   Chou T, 2001, BIOPHYS J, V80, P1075, DOI 10.1016/S0006-3495(01)76086-9
   Czaplinski K, 2006, TRENDS BIOCHEM SCI, V31, P687, DOI 10.1016/j.tibs.2006.10.007
   Diaz G, 2003, HISTOCHEM CELL BIOL, V120, P319, DOI 10.1007/s00418-003-0566-8
   Distelmaier F, 2008, CYTOM PART A, V73A, P129, DOI 10.1002/cyto.a.20503
   Ferrara N, 2004, ONCOLOGIST, V9, P2, DOI 10.1634/theoncologist.9-suppl_1-2
   Filippova GN, 2001, NAT GENET, V28, P335, DOI 10.1038/ng570
   Fransson A, 2006, BIOCHEM BIOPH RES CO, V344, P500, DOI 10.1016/j.bbrc.2006.03.163
   Frederick RL, 2004, J CELL BIOL, V167, P87, DOI 10.1083/jcb.200405100
   GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59
   Groenen PJTA, 2000, HUM MOL GENET, V9, P605, DOI 10.1093/hmg/9.4.605
   He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509
   Hofmann MW, 2004, P NATL ACAD SCI USA, V101, P14776, DOI 10.1073/pnas.0405175101
   Huang P, 2007, EUR J CELL BIOL, V86, P289, DOI 10.1016/j.ejcb.2007.04.002
   James DI, 2003, J BIOL CHEM, V278, P36373, DOI 10.1074/jbc.M303758200
   KALIMAN P, 2008, CELL SIGNAL, V0, P0
   Karim MR, 2007, AUTOPHAGY, V3, P553, DOI 10.4161/auto.4615
   Kim I, 2007, ARCH BIOCHEM BIOPHYS, V462, P245, DOI 10.1016/j.abb.2007.03.034
   Knott AB, 2008, NAT REV NEUROSCI, V9, P505, DOI 10.1038/nrn2417
   Koopman WJH, 2008, METHODS, V46, P304, DOI 10.1016/j.ymeth.2008.09.018
   Koshiba T, 2004, SCIENCE, V305, P858, DOI 10.1126/science.1099793
   Lee YJ, 2004, MOL BIOL CELL, V15, P5001, DOI 10.1091/mbc.E04-04-0294
   Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9
   Lyamzaev KG, 2004, ACTA BIOCHIM POL, V51, P553
   Mahadevan MS, 2006, NAT GENET, V38, P1066, DOI 10.1038/ng1857
   MAHADEVAN MS, 1993, HUM MOL GENET, V2, P299, DOI 10.1093/hmg/2.3.299
   Marroquin LD, 2007, TOXICOL SCI, V97, P539, DOI 10.1093/toxsci/kfm052
   Mitra K, 2009, P NATL ACAD SCI USA, V106, P11960, DOI 10.1073/pnas.0904875106
   Mounsey JP, 2000, J BIOL CHEM, V275, P23362, DOI 10.1074/jbc.M000899200
   OCochlain DF, 2004, HUM MOL GENET, V13, P2505, DOI 10.1093/hmg/ddh266
   Ollesch J, 2008, EUR BIOPHYS J BIOPHY, V37, P435, DOI 10.1007/s00249-007-0233-4
   Ophuis RJAO, 2009, MUSCLE NERVE, V40, P545, DOI 10.1002/mus.21352
   Reynwar BJ, 2007, NATURE, V447, P461, DOI 10.1038/nature05840
   Rojo M, 2002, J CELL SCI, V115, P1663
   Rossignol R, 2004, CANCER RES, V64, P985, DOI 10.1158/0008-5472.CAN-03-1101
   Santel A, 2003, J CELL SCI, V116, P2763, DOI 10.1242/jcs.00479
   Saraste M, 1999, SCIENCE, V283, P1488, DOI 10.1126/science.283.5407.1488
   Satoh M, 2003, BIOCHEM BIOPH RES CO, V300, P482, DOI 10.1016/S0006-291X(02)02874-7
   Schiedner G, 2000, HUM GENE THER, V11, P2105, DOI 10.1089/104303400750001417
   Siciliano G, 2001, BRAIN RES BULL, V56, P405, DOI 10.1016/S0361-9230(01)00653-0
   Snapp EL, 2003, J CELL BIOL, V163, P257, DOI 10.1083/jcb.200306020
   Spät A, 2008, CELL CALCIUM, V44, P51, DOI 10.1016/j.ceca.2007.11.015
   STADHOUDERS AM, 1994, P NATL ACAD SCI USA, V91, P5089, DOI 10.1073/pnas.91.11.5089
   Tanaka Y, 1998, CELL, V93, P1147, DOI 10.1016/S0092-8674(00)81459-2
   Ueda H, 1999, J NEUROL SCI, V162, P38, DOI 10.1016/S0022-510X(98)00290-1
   van Herpen REMA, 2005, MOL CELL BIOL, V25, P1402, DOI 10.1128/MCB.25.4.1402-1414.2005
   Wansink DG, 2003, MOL CELL BIOL, V23, P5489, DOI 10.1128/MCB.23.16.5489-5501.2003
   WANSINK DG, 2006, GENETIC INSTABILITIE, V0, P79
   Yaffe MP, 1996, P NATL ACAD SCI USA, V93, P11664, DOI 10.1073/pnas.93.21.11664
   Ylä-Anttila P, 2009, METHOD ENZYMOL, V452, P143, DOI 10.1016/S0076-6879(08)03610-0
   Yoon Y, 2003, MOL CELL BIOL, V23, P5409, DOI 10.1128/MCB.23.15.5409-5420.2003
   Youle RJ, 2005, NAT REV MOL CELL BIO, V6, P657, DOI 10.1038/nrm1697
NR 59
TC 16
Z9 16
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
EI 
J9 PLOS ONE
JI PLoS One
PD NOV 25
PY 2009
VL 4
IS 11
BP 
EP 
DI 10.1371/journal.pone.0008024
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 533MK
UT WOS:000272827800015
DA 2024-11-01
ER

PT J
AU Wei, YL
   Yu, CA
   Yang, P
   Li, AL
   Wen, JY
   Zhao, SM
   Liu, HX
   Ke, YN
   Campbell, W
   Zhang, YG
   Li, XH
   Liao, WQ
AF Wei, Yan-Ling
   Yu, Chang-An
   Yang, Peng
   Li, Ai-Li
   Wen, Jian-Yan
   Zhao, Shu-Min
   Liu, Hong-Xing
   Ke, Yuan-Nan
   Campbell, William
   Zhang, Yi-Guan
   Li, Xiao-Hui
   Liao, Wen-Qiang
TI NOVEL MITOCHONDRIAL DNA MUTATIONS ASSOCIATED WITH CHINESE FAMILIAL HYPERTROPHIC CARDIOMYOPATHY
SO CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
LA English
DT Article
DE haplogroup Chinese; hypertrophic cardiomyopathy; mitochondrial DNA mutation
ID genome; haplogroups; myopathy; sequence; patient; acid
AB P>Hypertrophic cardiomyopathy (HCM) is a genetic disorder that has a complex set of symptoms and potentially devastating consequences. Increasing evidence indicates that mitochondrial DNA (mtDNA) mutations are responsible for the development of HCM, but the mtDNA mutations appear to differ considerably among different populations and regions. In the present study, three families with HCM were found and investigated: one in Shandong province and two in the Chongqing region of China. The entire mtDNA genome from the 18 affected and 66 unaffected family members was sequenced directly and the mtDNA mutations were determined. The frequency of haplogroup M10 was significantly higher in family members with HCM (HCM group) than in unaffected family members (normal group). Three mtDNA mutations were found with a significantly higher frequency in affected individuals than in unaffected family individuals, namely G7697A in the cytochrome c oxidase subunit II gene (P < 0.0001; odds ratio (OR) 227.5; 95% confidence interval (CI) 23.6-2194.8) and T12477C (P = 0.0037; OR 5.6; 95% CI 1.8-17.6) and G13135A in the NADH dehydrogenase 5 gene (P < 0.0001; OR 26.0; 95% CI 6.9-98.3), suggesting that these mutations are probably associated with susceptibility to HCM. In addition, mitochondrial Complex I activity was markedly decreased in the HCM group, suggesting that these mutations most likely affect mitochondrial respiratory function. In conclusion, the results of the present study imply that mtDNA mutations G7697A, T12477C and G13135A are genetic factors that indicate a susceptibility to HCM and that could be used for the large-scale screening of genetic markers as well as the early diagnosis of HCM.
C1 [Wei, Yan-Ling; Zhang, Yi-Guan; Li, Xiao-Hui] Third Mil Med Univ, Inst Mat Med, Sch Pharm, Chongqing 400038, Peoples R China.
   [Wei, Yan-Ling; Zhang, Yi-Guan; Li, Xiao-Hui] Third Mil Med Univ, Dept Pharmaceut, Sch Pharm, Chongqing 400038, Peoples R China.
   [Yu, Chang-An; Yang, Peng; Li, Ai-Li; Wen, Jian-Yan; Liu, Hong-Xing; Ke, Yuan-Nan; Liao, Wen-Qiang] China Japan Friendship Hosp, Natl Integrat Med Ctr Cardiovasc Dis, Beijing, Peoples R China.
   [Zhao, Shu-Min] Beijing Genovax Biotechnol Corp, Beijing, Peoples R China.
   [Campbell, William] PepMetr & Pegasus Pharmaceut Grp, Richmond, BC, Canada.
C3 Army Medical University; Army Medical University; China-Japan Friendship Hospital
RP Li, XH (corresponding author), Third Mil Med Univ, Inst Mat Med, Sch Pharm, Chongqing 400038, Peoples R China.
EM caseml@hotmail.com
FU National Natural Science Foundation of China [30 371 768]; Beijing Tai-De Pharmaceuticals (Beijing, China)
CR AMISAGO MK, 2000, NEW ENGL J MED, V343, P1688
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   Casali C, 1999, J AM COLL CARDIOL, V33, P1584, DOI 10.1016/S0735-1097(99)00079-0
   Castro MG, 2006, INT J CARDIOL, V112, P202, DOI 10.1016/j.ijcard.2005.09.008
   Chen J, 2006, DIABETES RES CLIN PR, V74, P148, DOI 10.1016/j.diabres.2006.03.024
   Coats Caroline J, 2008, CURR TREAT OPTIONS CARDIOVASC MED, V10, P496, DOI 10.1007/s11936-008-0042-9
   Crimi M, 2008, INT J NANOMED, V3, P51
   Feigenbaum A, 2006, AM J MED GENET A, V140A, P2216, DOI 10.1002/ajmg.a.31436
   Harada K, 2004, J BIOL CHEM, V279, P14488, DOI 10.1074/jbc.M309355200
   Herrnstadt C, 2002, AM J HUM GENET, V70, P1152, DOI 10.1086/339933
   Janssen AJM, 2006, CLIN CHEM, V52, P860, DOI 10.1373/clinchem.2005.062414
   Jonckheere AI, 2008, J MED GENET, V45, P129, DOI 10.1136/jmg.2007.052084
   Li JY, 2007, J FORMOS MED ASSOC, V106, P528, DOI 10.1016/S0929-6646(07)60003-5
   Liao WQ, 2008, TOHOKU J EXP MED, V215, P377, DOI 10.1620/tjem.215.377
   MarinGarcia J, 1997, PEDIATR CARDIOL, V18, P251, DOI 10.1007/s002469900169
   Menotti Francesca, 2004, ITAL HEART J, V5, P460
   Morita H, 2006, CIRCULATION, V113, P2697, DOI 10.1161/CIRCULATIONAHA.105.593558
   Prasad GN, 2006, INT J CARDIOL, V109, P432, DOI 10.1016/j.ijcard.2005.07.065
   Ruppert V, 2004, BIOCHEM BIOPH RES CO, V318, P535, DOI 10.1016/j.bbrc.2004.04.061
   Santorelli F M, 2001, AM HEART J, V141, PE1, DOI 10.1067/mhj.2001.112088
   Stuart JA, 2006, BBA-BIOENERGETICS, V1757, P79, DOI 10.1016/j.bbabio.2006.01.003
   Takeda N, 1997, MOL CELL BIOCHEM, V176, P287, DOI 10.1023/A:1006869616555
   Tanjore RR, 2008, CAN J CARDIOL, V24, P127, DOI 10.1016/S0828-282X(08)70568-3
   Taylor RW, 2003, J AM COLL CARDIOL, V41, P1786, DOI 10.1016/S0735-1097(03)00300-0
   Toylor MR, 2004, EXPERT REV MOL DIAGN, V4, P99, DOI 10.1586/14737159.4.1.99
   Zifa E, 2008, MITOCHONDRION, V8, P229, DOI 10.1016/j.mito.2008.04.001
NR 27
TC 18
Z9 21
U1 2
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1440-1681
EI 
J9 CLIN EXP PHARMACOL P
JI Clin. Exp. Pharmacol. Physiol.
PD SEP 15
PY 2009
VL 36
IS 9
BP 933
EP 939
DI 10.1111/j.1440-1681.2009.05183.x
PG 7
WC Pharmacology & Pharmacy; Physiology
SC Pharmacology & Pharmacy; Physiology
GA 489WH
UT WOS:000269455600015
PM 19473338
DA 2024-11-01
ER

PT J
AU Blok, MJ
   van den Bosch, BJ
   Jongen, E
   Hendrickx, A
   de Die-Smulders, CE
   Hoogendijk, JE
   Brusse, E
   de Visser, M
   Poll-The, BT
   Bierau, J
   de Coo, IF
   Smeets, HJ
AF Blok, M. J.
   van den Bosch, B. J.
   Jongen, E.
   Hendrickx, A.
   de Die-Smulders, C. E.
   Hoogendijk, J. E.
   Brusse, E.
   de Visser, M.
   Poll-The, B. T.
   Bierau, J.
   de Coo, I. F.
   Smeets, H. J.
TI The unfolding clinical spectrum of <i>POLG</i> mutations
SO JOURNAL OF MEDICAL GENETICS
LA English
DT Article
ID mitochondrial-dna polymerase; progressive external ophthalmoplegia; alpers-syndrome; gamma-a; spacer-region; deletions; disease; disorders; depletion; gene
AB Background: Mutations in the DNA polymerase-gamma (POLG) gene are a major cause of clinically heterogeneous mitochondrial diseases, associated with mtDNA depletion and multiple deletions. Objective: To determine the spectrum of POLG mutations in our Dutch patient cohort, to evaluate the pathogenicity of novel mutations, and to establish genotype-phenotype correlations. Results: The authors identified 64 predominantly recessive mutations in 37 patients from a total of 232 patients, consisting of 23 different mutations. The substitution p.A467T was most frequently observed (n=23), but was as frequent in childhood cases as in adult cases. Five new pathogenic recessive mutations, p.Lys925ArgfsX42, p.R275X, p.G426S, p.A804T and p.R869Q were identified. The known dominant chronic progressive external ophthalmoplegia (CPEO) mutation p.R943H was for the first time associated with premature ovarian failure as well. In 19 patients the authors identified only a single recessive mutation, or a sequence variant with unclear clinical significance. The data substantiate earlier observations that in POLG patients a fatal status epilepticus and liver failure can be triggered by sodium valproate. It is therefore important to exclude POLG mutations before administering this treatment. Conclusion: The clinical features of the patient are the most important features to select putative POLG mutation carriers and not the presence of mtDNA deletions or OXPHOS (oxidative phosphorylation) activity. The authors conclude that POLG mutations are an important cause of heterogeneous mitochondrial pathology and that more accurate genotype-phenotype correlations allow a more rapid genetic diagnosis and improved prognosis for mutation carriers.
C1 [Blok, M. J.; van den Bosch, B. J.; Jongen, E.; Hendrickx, A.; de Die-Smulders, C. E.; Bierau, J.; Smeets, H. J.] Maastricht Univ, Med Ctr, Dept Clin Genet, NL-6202 AZ Maastricht, Netherlands.
   [van den Bosch, B. J.; Smeets, H. J.] Maastricht Univ, Med Ctr, Dept Genet & Cell Biol, NL-6202 AZ Maastricht, Netherlands.
   [Hoogendijk, J. E.] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Neurol, Utrecht, Netherlands.
   [Brusse, E.] Erasmus MC Univ Med Ctr, Dept Neurol, Rotterdam, Netherlands.
   [de Visser, M.] Univ Amsterdam, Acad Med Ctr, Dept Neurol, NL-1012 WX Amsterdam, Netherlands.
   [Poll-The, B. T.] Univ Amsterdam, Emmas Children Hosp, Dept Pediat, Amsterdam, Netherlands.
   [de Coo, I. F.] Erasmus MC Univ Med Ctr, Dept Neurol, Rotterdam, Netherlands.
C3 Maastricht University; Maastricht University; Utrecht University; Utrecht University Medical Center; Erasmus University Rotterdam; Erasmus MC; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Emma Children's Hospital; Erasmus University Rotterdam; Erasmus MC
RP van den Bosch, BJ (corresponding author), Maastricht Univ, Med Ctr, Dept Clin Genet, POB 5800, NL-6202 AZ Maastricht, Netherlands.
EM bianca.vandenbosch@gen.unimaas.nl
CR Agostino A, 2003, NEUROLOGY, V60, P1354, DOI 10.1212/01.WNL.0000056088.09408.3C
   Brierley EJ, 1998, ANN NEUROL, V43, P217, DOI 10.1002/ana.410430212
   Chan SSL, 2006, HUM MOL GENET, V15, P3473, DOI 10.1093/hmg/ddl424
   Chan SSL, 2009, BBA-BIOENERGETICS, V1787, P312, DOI 10.1016/j.bbabio.2008.10.007
   Chan SSL, 2005, J BIOL CHEM, V280, P31341, DOI 10.1074/jbc.M506762200
   CHINNERY PF, 2007, NEUROMUSCULAR DISORD, V18, P259
   CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   de Vries MC, 2007, EUR J PEDIATR, V166, P229, DOI 10.1007/s00431-006-0234-9
   Del Bo R, 2003, NEUROLOGY, V61, P903, DOI 10.1212/01.WNL.0000092303.13864.BE
   Di Fonzo A, 2003, HUM MUTAT, V22, P0, DOI 10.1002/humu.9203
   Eyer F, 2005, J CLIN PSYCHOPHARM, V25, P376, DOI 10.1097/01.jcp.0000168485.76397.5c
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   Gago MF, 2006, NEUROMUSCULAR DISORD, V16, P507, DOI 10.1016/j.nmd.2006.05.016
   González-Vioque E, 2006, ARCH NEUROL-CHICAGO, V63, P107, DOI 10.1001/archneur.63.1.107
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Hudson G, 2006, HUM MOL GENET, V15, PR244, DOI 10.1093/hmg/ddl233
   Lamantea E, 2004, ANN NEUROL, V56, P454, DOI 10.1002/ana.20219
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   Luo NG, 2005, J BIOL CHEM, V280, P2491, DOI 10.1074/jbc.M411447200
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Luoma PT, 2007, NEUROLOGY, V69, P1152, DOI 10.1212/01.wnl.0000276955.23735.eb
   Luoma PT, 2005, HUM MOL GENET, V14, P1907, DOI 10.1093/hmg/ddi196
   Naïmi M, 2006, EUR J HUM GENET, V14, P917, DOI 10.1038/sj.ejhg.5201627
   Naviaux RK, 2005, ANN NEUROL, V58, P491, DOI 10.1002/ana.20544
   Nguyen KV, 2006, J HEPATOL, V45, P108, DOI 10.1016/j.jhep.2005.12.026
   Nguyen KV, 2005, NEUROLOGY, V65, P1493, DOI 10.1212/01.wnl.0000182814.55361.70
   Pagnamenta AT, 2006, HUM REPROD, V21, P2467, DOI 10.1093/humrep/del076
   Rovio AT, 2004, MAMM GENOME, V15, P492, DOI 10.1007/s00335-004-3049-x
   Sarzi E, 2007, J PEDIATR-US, V150, P531, DOI 10.1016/j.jpeds.2007.01.044
   Spelbrink JN, 2000, J BIOL CHEM, V275, P24818, DOI 10.1074/jbc.M000559200
   Stewart JD, 2009, J MED GENET, V46, P209, DOI 10.1136/jmg.2008.058180
   Tzoulis C, 2006, BRAIN, V129, P1685, DOI 10.1093/brain/awl097
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2004, NEUROLOGY, V63, P1251, DOI 10.1212/01.WNL.0000140494.58732.83
   Van Goethem G, 2003, NEUROLOGY, V61, P1811, DOI 10.1212/01.WNL.0000098997.23471.65
   Van Goethem G, 2003, HUM MUTAT, V22, P175, DOI 10.1002/humu.10246
   Van Goethem G, 2003, EUR J HUM GENET, V11, P547, DOI 10.1038/sj.ejhg.5201002
   Winterthun S, 2005, NEUROLOGY, V64, P1204, DOI 10.1212/01.WNL.0000156516.77696.5A
   Wong LJC, 2008, HUM MUTAT, V29, PE150, DOI 10.1002/humu.20824
NR 40
TC 65
Z9 71
U1 0
U2 6
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0022-2593
EI 1468-6244
J9 J MED GENET
JI J. Med. Genet.
PD NOV 15
PY 2009
VL 46
IS 11
BP 776
EP 785
DI 10.1136/jmg.2009.067686
PG 10
WC Genetics & Heredity
SC Genetics & Heredity
GA 514EE
UT WOS:000271376300009
PM 19578034
DA 2024-11-01
ER

PT J
AU Lorenzoni, PJ
   Scola, RH
   Kay, CSK
   Arndt, RC
   Freund, AA
   Bruck, I
   Santos, MLSF
   Werneck, LC
AF Lorenzoni, Paulo Jose
   Scola, Rosana H.
   Kay, Claudia S. Kamoi
   Arndt, Raquel C.
   Freund, Aline A.
   Bruck, Isac
   Santos, Mara Lucia S. F.
   Werneck, Lineu C.
TI MELAS Clinical features, muscle biopsy and molecular genetics
SO ARQUIVOS DE NEURO-PSIQUIATRIA
LA English
DT Article
DE MELAS; mitochondrial myopathies; biopsy; mitochondrial DNA; genetics
ID stroke-like episodes; mitochondrial-dna mutation; ragged-red fibers; lactic-acidosis; blood-vessels; encephalopathy; myopathy; disorders; encephalomyopathy; involvement
AB Objective: The aim of the study was to analyze a series of Brazilian patients suffering from MELAS. Method: Ten patients with MELAS were studied with correlation between clinical findings, laboratorial data, electrophysiology, histochemical and molecular features. Results: Blood lactate was increased in eight patients. Brain image studies revealed a stroke-like pattern in all patients. Muscle biopsy showed ralled-red fibers (RRF) in 90% of patients on modified Gomori-trichrome and in 100% on succinate dehydrogenase stains. Cytochrome c oxidase stain analysis indicated deficient activity in one patient and subsarcolemmal accumulation in seven patients. Strongly succinate dehydrogenase-reactive blood vessels (SSV) occurred in six patients. The molecular analysis of tRNA(Leu(UUR)) gene by PCR/RLFP and direct sequencing showed the A3243G mutation on mtDNA in 4 patients. Conclusion: The muscle biopsy often confirmed the MELAS diagnosis by presence of RRF and SSV. Molecular analysis of tRNA(Leu(UUR)) gene should not be the only diagnostic criteria for MELAS.
C1 [Lorenzoni, Paulo Jose; Scola, Rosana H.; Kay, Claudia S. Kamoi; Arndt, Raquel C.; Freund, Aline A.; Werneck, Lineu C.] Univ Fed Parana, Dept Internal Med, Neurol Neuromuscular Div, BR-80060000 Curitiba, PR, Brazil.
   [Bruck, Isac] Univ Fed Parana, Neuropediat Div, Dept Pediat, BR-80060000 Curitiba, PR, Brazil.
   [Santos, Mara Lucia S. F.] Hosp Pequeno Principe, Pediat Neurol Dept, Curitiba, PR, Brazil.
C3 Universidade Federal do Parana; Universidade Federal do Parana; Hospital Pequeno Principe
RP Scola, RH (corresponding author), UFPR, Hosp Clin, Serv Doencas Neuromusculares, Rua Gen Carneiro 181,3 Andar, BR-80060900 Curitiba, PR, Brazil.
EM scola@hc.ufpr.br
FU Fundacao Araucaria; CAPES; CNPq
CR ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   Bourgeois JM, 2004, MITOCHONDRION, V4, P441, DOI 10.1016/j.mito.2004.07.036
   CIAFALONI E, 1992, ANN NEUROL, V31, P391, DOI 10.1002/ana.410310408
   Conforto AB, 2007, ARQ NEURO-PSIQUIAT, V65, P371, DOI 10.1590/S0004-282X2007000300001
   Finsterer J, 2007, ACTA NEUROL SCAND, V116, P1, DOI 10.1111/j.1600-0404.2007.00836.x
   Finsterer J, 2006, ACTA NEUROL SCAND, V114, P217, DOI 10.1111/j.1600-0404.2006.00671.x
   GOTO Y, 1992, NEUROLOGY, V42, P545, DOI 10.1212/WNL.42.3.545
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   GOTO Y, 1995, MUSCLE NERVE S3, V20, P0
   Haas R, 2004, MITOCHONDRION, V4, P471, DOI 10.1016/j.mito.2004.07.008
   HASEGAWA H, 1991, ANN NEUROL, V29, P601, DOI 10.1002/ana.410290606
   HIRANO M, 1994, J CHILD NEUROL, V9, P4, DOI 10.1177/088307389400900102
   HIRANO M, 1992, NEUROMUSCULAR DISORD, V2, P125, DOI 10.1016/0960-8966(92)90045-8
   Iizuka T, 2003, NEUROLOGY, V61, P1238, DOI 10.1212/01.WNL.0000091888.26232.FE
   Kaufmann P, 2004, NEUROLOGY, V62, P1297, DOI 10.1212/01.WNL.0000120557.83907.A8
   MARIE SKN, 1994, BIOCHEM MED METAB B, V52, P136, DOI 10.1006/bmmb.1994.1045
   Okajima Y, 1998, HEART, V80, P292, DOI 10.1136/hrt.80.3.292
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   PETRUZZELLA V, 1994, HUM MOL GENET, V3, P449, DOI 10.1093/hmg/3.3.449
   Schmiedel J, 2003, J NEUROL, V250, P267, DOI 10.1007/s00415-003-0978-3
   Tanji K, 2008, J NEUROL SCI, V270, P23, DOI 10.1016/j.jns.2008.01.016
   TOKUNAGA M, 1993, ANN NEUROL, V33, P275, DOI 10.1002/ana.410330308
   TOKUNAGA M, 1994, ANN NEUROL, V35, P413, DOI 10.1002/ana.410350407
   Vydt TCG, 2007, AM J CARDIOL, V99, P264, DOI 10.1016/j.amjcard.2006.07.089
   Walker UA, 1996, EUR NEUROL, V36, P260, DOI 10.1159/000117269
   Werneck L C, 1987, ARQ NEUROPSIQUIATR, V45, P288
   Werneck LC, 1981, REV BRAS CLIN TER S, V10, P0
   Zeviani M, 2004, BRAIN, V127, P2153, DOI 10.1093/brain/awh259
NR 29
TC 13
Z9 19
U1 0
U2 0
PU ASSOC ARQUIVOS NEURO- PSIQUIATRIA
PI SAO PAULO SP
PA PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL
SN 0004-282X
EI 1678-4227
J9 ARQ NEURO-PSIQUIAT
JI Arq. Neuro-Psiquiatr.
PD SEP 15
PY 2009
VL 67
IS 3A
BP 668
EP 676
DI 10.1590/S0004-282X2009000400018
PG 9
WC Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA 489YR
UT WOS:000269463500018
PM 19722047
DA 2024-11-01
ER

PT J
AU Burusnukul, P
   de los Reyes, EC
AF Burusnukul, Prinyarat
   de los Reyes, Emily C.
TI Phenotypic Variations in 3 Children With POLG1 Mutations
SO JOURNAL OF CHILD NEUROLOGY
LA English
DT Article
DE mitochondrial disease; DNA polymerase gamma; progressive external ophthalmoplegia; Alpers-Huttenlocher syndrome
ID dna-polymerase-gamma; progressive external ophthalmoplegia; alpers-syndrome; male-infertility; mitochondrial; disorders; gene; childhood
AB Autosomal inherited mitochondrial diseases have been of increasing interest among clinicians and mitochondrial research groups because these diseases are caused through a secondary effect on the mitochondrial DNA. It was thought that the genetic stability of mitochondrial DNA relies on the accuracy of DNA polymerase gamma. Mutations of DNA polymerase gamma 1 gene (MIM# 174763) have been shown to be a cause of mitochondrial disorders associated with Mendelian disorders characterized by multiple mitochondrial DNA deletions or depletions. To date, several clinical phenotypes associated with polymerase gamma mutation have been reported presenting in both adults and children. We present 3 children in whom were found to have reported pathogenic DNA polymerase gamma 1 mutations: heterozygous p.G517V in 2 half siblings and heterozygous p.T251I and p.P587L in the other. The aim of this communication is to report 3 pediatric cases associated with DNA polymerase gamma 1 mutations to augment the expanding clinical phenotype that has been previously reported.
C1 [Burusnukul, Prinyarat; de los Reyes, Emily C.] Ohio State Univ, Dept Pediat & Neurol, Natl Childrens Hosp, Columbus, OH 43210 USA.
C3 University System of Ohio; Ohio State University; Nationwide Childrens Hospital
RP de los Reyes, EC (corresponding author), Ohio State Univ, Dept Pediat & Neurol, Natl Childrens Hosp, 700 Childrens Dr, Columbus, OH 43210 USA.
EM delosReyes@nationwidechildrens.org
CR Davidzon G, 2006, ANN NEUROL, V59, P859, DOI 10.1002/ana.20831
   de Vries MC, 2008, J INHERIT METAB DIS, V31, PS299, DOI 10.1007/s10545-008-0871-4
   de Vries MC, 2007, EUR J PEDIATR, V166, P229, DOI 10.1007/s00431-006-0234-9
   Di Fonzo A, 2003, HUM MUTAT, V22, P0, DOI 10.1002/humu.9203
   DiMauro S, 2008, ANNU REV NEUROSCI, V31, P91, DOI 10.1146/annurev.neuro.30.051606.094302
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   Filosto M, 2003, ARCH NEUROL-CHICAGO, V60, P1279, DOI 10.1001/archneur.60.9.1279
   Graziewicz MA, 2006, CHEM REV, V106, P383, DOI 10.1021/cr040463d
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Kollberg G, 2006, J NEUROPATH EXP NEUR, V65, P758, DOI 10.1097/01.jnen.0000229987.17548.6e
   Krausz C, 2004, J CLIN ENDOCR METAB, V89, P4292, DOI 10.1210/jc.2004-0008
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Nguyen KV, 2005, NEUROLOGY, V65, P1493, DOI 10.1212/01.wnl.0000182814.55361.70
   Rovio AT, 2001, NAT GENET, V29, P261, DOI 10.1038/ng759
   Spinazzola A, 2005, GENE, V354, P162, DOI 10.1016/j.gene.2005.03.025
   Uusimaa J, 2008, EPILEPSIA, V49, P1038, DOI 10.1111/j.1528-1167.2008.01544.x
   Van Goethem G, 2004, NEUROLOGY, V63, P1251, DOI 10.1212/01.WNL.0000140494.58732.83
   Van Goethem G, 2003, NEUROLOGY, V61, P1811, DOI 10.1212/01.WNL.0000098997.23471.65
   Van Goethem G, 2003, NEUROMUSCULAR DISORD, V13, P133, DOI 10.1016/S0960-8966(02)00216-X
   Walker RL, 1997, GENOMICS, V40, P376, DOI 10.1006/geno.1996.4580
   Winterthun S, 2005, NEUROLOGY, V64, P1204, DOI 10.1212/01.WNL.0000156516.77696.5A
NR 22
TC 12
Z9 12
U1 0
U2 3
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0883-0738
EI 
J9 J CHILD NEUROL
JI J. Child Neurol.
PD APR 15
PY 2009
VL 24
IS 4
BP 482
EP 486
DI 10.1177/0883073808324539
PG 5
WC Clinical Neurology; Pediatrics
SC Neurosciences & Neurology; Pediatrics
GA 424UH
UT WOS:000264593300016
PM 19189930
DA 2024-11-01
ER

PT J
AU Amati-Bonneau, P
   Milea, D
   Bonneau, D
   Chevrollier, A
   Ferré, M
   Guillet, V
   Gueguen, N
   Loiseau, D
   de Crescenzo, MAP
   Verny, C
   Procaccio, V
   Lenaers, G
   Reynier, P
AF Amati-Bonneau, Patrizia
   Milea, Dan
   Bonneau, Dominique
   Chevrollier, Arnaud
   Ferre, Marc
   Guillet, Virginie
   Gueguen, Naig
   Loiseau, Dominique
   de Crescenzo, Marie-Anne Pou
   Verny, Christophe
   Procaccio, Vincent
   Lenaers, Guy
   Reynier, Pascal
TI OPA1-associated disorders: Phenotypes and pathophysiology
SO INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
LA English
DT Review
DE Dominant optic atrophy; Mitochondrial diseases; OPA1; Optic nerve; Retinal ganglion cells
ID dominant optic atrophy; sensorineural hearing-loss; cytochrome-c release; chromosome 3q region; opa1 mutations; mitochondrial morphology; external ophthalmoplegia; clinical-features; r445h mutation; ganglion-cells
AB The OPA1 gene, encoding a dynamin-like mitochondrial GTPase, is involved in autosomal dominant optic atrophy (ADOA, OMIM#165500). ADOA, also known as Kjer's optic atrophy, affects retinal ganglion cells and the axons forming the optic nerve, leading to progressive visual loss. OPA1 gene sequencing in patients with hereditary optic neuropathies indicates that the clinical spectrum of ADOA is larger than previously thought. Specific OPA1 mutations are responsible for several distinct clinical presentations, such as ADOA with deafness (ADOAD), and severe multi-systemic syndromes, the so-called "ADOA plus" disorders, which involve neurological and neuromuscular symptoms similar to those due to mitochondrial oxidative phosphorylation defects or mitochondrial DNA instability. The study of the various clinical presentations of ADOA in conjunction with the investigation of OPA1 mutations in fibroblasts from patients with optic atrophy provides new insights into the pathophysiological mechanisms of the disease while underscoring the multiple physiological roles played by OPA1 in energetic metabolism, mitochondrial structure and maintenance, and cell death. Finally, OPA1 represents an important new paradigm for emerging neurodegenerative diseases affecting mitochondrial structure, plasticity and functions. (C) 2009 Elsevier Ltd. All rights reserved.
C1 [Amati-Bonneau, Patrizia; Bonneau, Dominique; Chevrollier, Arnaud; Ferre, Marc; Guillet, Virginie; Gueguen, Naig; Procaccio, Vincent; Reynier, Pascal] CHU Angers, Dept Biochim & Genet, F-49933 Angers, France.
   [Amati-Bonneau, Patrizia; Bonneau, Dominique; Chevrollier, Arnaud; Ferre, Marc; Guillet, Virginie; Gueguen, Naig; Loiseau, Dominique; de Crescenzo, Marie-Anne Pou; Reynier, Pascal] INSERM, U694, Angers, France.
   [Milea, Dan] Copenhagen Univ Hosp, Copenhagen, Denmark.
   [Bonneau, Dominique; Guillet, Virginie; Loiseau, Dominique; de Crescenzo, Marie-Anne Pou; Verny, Christophe; Procaccio, Vincent; Reynier, Pascal] Univ Angers, Angers, France.
   [Verny, Christophe] CHU Angers, Dept Neurol, F-49933 Angers, France.
   [Procaccio, Vincent] INSERM, U771, Angers, France.
   [Procaccio, Vincent] CNRS, UMR 6214, Angers, France.
   [Lenaers, Guy] Univ Montpellier I & II, INSERM, Inst Neurosci Montpellier, U583, Montpellier, France.
C3 Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; University of Copenhagen; Universite d'Angers; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Universite d'Angers; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); Universite d'Angers; Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm)
RP Reynier, P (corresponding author), CHU Angers, Dept Biochim & Genet, 4 Rue Larrey, F-49933 Angers, France.
EM pareynier@chu-angers.fr
FU INSERM; University Hospital of Angers [04-12]; University of Angers, France: Forskningsradet forsundhed og Sygdom, Denmark; "Association contre les Maladies Mitochondilates (AMMi)"; "Ouvrir les Yeux (OLY)"; "Retina France" and "Union Nationale des Aveugles et Deficients Visuels (UNADEV)"
CR Acland GM, 2001, NAT GENET, V28, P92, DOI 10.1038/ng0501-92
   Aijaz S, 2004, INVEST OPHTH VIS SCI, V45, P1667, DOI 10.1167/iovs.03-1093
   Alavi MV, 2007, BRAIN, V130, P1029, DOI 10.1093/brain/awm005
   Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944
   Amati-Bonneau P, 2005, ANN NEUROL, V58, P958, DOI 10.1002/ana.20681
   Amati-Bonneau P, 2003, AM J OPHTHALMOL, V136, P1170, DOI 10.1016/S0002-9394(03)00665-2
   Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   Assink JJM, 1997, AM J HUM GENET, V61, P934, DOI 10.1086/514884
   Barbet F, 2005, J MED GENET, V42, P0, DOI 10.1136/jmg.2004.025502
   Barbet F, 2003, EUR J HUM GENET, V11, P966, DOI 10.1038/sj.ejhg.5201070
   Baris Olivier, 2003, HUM MUTAT, V21, P656, DOI 10.1002/humu.9152
   Batten B, 1896, TRANS OPHTHALMOL SOC UK, V16, P125
   Bette S, 2005, ACTA NEUROPATHOL, V109, P393, DOI 10.1007/s00401-004-0970-8
   Carelli V, 2004, PROG RETIN EYE RES, V23, P53, DOI 10.1016/j.preteyeres.2003.10.003
   Carelli V, 2007, NEUROLOGY, V68, P0
   Chevrollier A, 2008, ANN NEUROL, V63, P794, DOI 10.1002/ana.21385
   Cipolat S, 2006, CELL, V126, P163, DOI 10.1016/j.cell.2006.06.021
   Cohn AC, 2007, AM J OPHTHALMOL, V143, P656, DOI 10.1016/j.ajo.2006.12.038
   Cornille K, 2008, ANN NEUROL, V63, P667, DOI 10.1002/ana.21376
   Davies VJ, 2007, HUM MOL GENET, V16, P1307, DOI 10.1093/hmg/ddm079
   Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936
   Delettre C, 2001, HUM GENET, V109, P584, DOI 10.1007/s00439-001-0633-y
   EIBERG H, 1994, HUM MOL GENET, V3, P977, DOI 10.1093/hmg/3.6.977
   Ferré M, 2005, HUM MUTAT, V25, P423, DOI 10.1002/humu.20161
   FERRE M, 2009, HUM MUTAT, V0, P0
   Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025
   Fuhrmann N, 2009, J MED GENET, V46, P136, DOI 10.1136/jmg.2008.062570
   Guarente L, 2007, COLD SPRING HARB SYM, V72, P483, DOI 10.1101/sqb.2007.72.024
   Han J, 2006, GENET MED, V8, P217, DOI 10.1097/01.gim.0000214299.61930.c0
   HARDING AE, 1992, BRAIN, V115, P979, DOI 10.1093/brain/115.4.979
   HOYT CS, 1980, OPHTHALMOLOGY, V87, P245
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   Huizing M, 2005, MOL GENET METAB, V86, P51, DOI 10.1016/j.ymgme.2005.07.034
   Ito Y, 2007, INVEST OPHTH VIS SCI, V48, P4079, DOI 10.1167/iovs.07-0024
   JOHNSTON PB, 1979, AM J OPHTHALMOL, V88, P868, DOI 10.1016/0002-9394(79)90565-8
   Kamei S, 2005, INVEST OPHTH VIS SCI, V46, P4288, DOI 10.1167/iovs.03-1407
   Ke Tie, 2006, ZHONGHUA YIXUE YICHUANXUE ZAZHI, V23, P481
   Kerrison JB, 1998, AM J OPHTHALMOL, V125, P64, DOI 10.1016/S0002-9394(99)80236-0
   Kijima K, 2005, HUM GENET, V116, P23, DOI 10.1007/s00439-004-1199-2
   Kim JY, 2005, NEUROLOGY, V64, P966, DOI 10.1212/01.WNL.0000157282.76715.B1
   KIVLIN JD, 1983, AM J HUM GENET, V35, P1190
   Kjer B, 1996, ACTA OPHTHALMOL SCAN, V74, P3
   KJER P, 1959, ACTA OPHTHALMOL SUPPL, V164, P1
   KJER P, 1983, ACTA OPHTHALMOL, V61, P300
   KONIGSMARK BW, 1974, ARCH OPHTHALMOL-CHIC, V91, P99, DOI 10.1001/archopht.1974.03900060105003
   Lawson VH, 2005, NEUROLOGY, V65, P197, DOI 10.1212/01.wnl.0000168898.76071.70
   Leber T, 1871, ARCH OPHTHALMOL-CHIC, V17, P249
   Li CM, 2005, AM J MED GENET A, V138A, P208, DOI 10.1002/ajmg.a.30794
   Liguori M, 2008, J NEUROL, V255, P127, DOI 10.1007/s00415-008-0571-x
   Lodi R, 2004, ANN NEUROL, V56, P719, DOI 10.1002/ana.20278
   LUNKES A, 1995, AM J HUM GENET, V57, P968
   LYLE WM, 1990, GENETIC RISK, V0, P0
   Man PYW, 2003, AM J HUM GENET, V72, P333, DOI 10.1016/j.ajhg.2016.05.015
   Marchbank NJ, 2002, J MED GENET, V39, P0, DOI 10.1136/jmg.39.8.e47
   Mayorov Vladimir I, 2008, BMC BIOCHEMISTRY, V9, P9, DOI 10.1186/1471-2091-9-22
   MEIRE F, 1985, OPHTHALMIC PAED GEN, V5, P91, DOI 10.3109/13816818509007861
   METS MB, 1985, OPHTHALMIC PAED GEN, V5, P85, DOI 10.3109/13816818509007860
   MILEA D, 2009, ACTA OPHTHALMOL, V0, P0
   Nochez Y, 2009, MOL VIS, V15, P598
   Olichon A, 2003, J BIOL CHEM, V278, P7743, DOI 10.1074/jbc.C200677200
   Olichow A, 2007, J CELL PHYSIOL, V211, P423, DOI 10.1002/jcp.20950
   Payne M, 2004, AM J OPHTHALMOL, V138, P749, DOI 10.1016/j.ajo.2004.06.011
   Pesch UEA, 2004, INVEST OPHTH VIS SCI, V45, P4217, DOI 10.1167/iovs.03-1261
   Pesch UEA, 2001, HUM MOL GENET, V10, P1359, DOI 10.1093/hmg/10.13.1359
   Poole AC, 2008, P NATL ACAD SCI USA, V105, P1638, DOI 10.1073/pnas.0709336105
   Puomila A, 2005, ACTA OPHTHALMOL SCAN, V83, P337, DOI 10.1111/j.1600-0420.2005.00448.x
   Puomila A, 2007, EUR J HUM GENET, V15, P1079, DOI 10.1038/sj.ejhg.5201828
   Reynier P, 2004, J MED GENET, V41, P0, DOI 10.1136/jmg.2003.016576
   Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, PD823, DOI 10.1093/nar/gkl927
   Schimpf S, 2008, HUM MUTAT, V29, P106, DOI 10.1002/humu.20607
   Shimizu S, 2003, AM J OPHTHALMOL, V135, P256, DOI 10.1016/S0002-9394(02)01929-3
   Snell S, 1897, TRANS OPHTHALMOL SOC UK, V17, P66
   Spinazzi M, 2008, HUM MOL GENET, V17, P3291, DOI 10.1093/hmg/ddn225
   Stewart JD, 2008, NEUROLOGY, V71, P1829, DOI 10.1212/01.wnl.0000335931.54095.0a
   Thiselton DL, 2002, INVEST OPHTH VIS SCI, V43, P1715
   Thiselton DL, 2001, HUM GENET, V109, P498, DOI 10.1007/s004390100600
   Toomes C, 2001, HUM MOL GENET, V10, P1369, DOI 10.1093/hmg/10.13.1369
   Verny C, 2008, NEUROLOGY, V70, P1152, DOI 10.1212/01.wnl.0000289194.89359.a1
   Votruba M, 1998, J MED GENET, V35, P793, DOI 10.1136/jmg.35.10.793
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Wang H, 2008, HUM MOL GENET, V0, P0
   WANG X, 2008, P NATL ACAD SCI US, V0, P0
   Waterham HR, 2007, NEW ENGL J MED, V356, P1736, DOI 10.1056/NEJMoa064436
   Yang YF, 2008, P NATL ACAD SCI USA, V105, P7070, DOI 10.1073/pnas.0711845105
   Yarosh W, 2008, PLOS GENET, V4, P0, DOI 10.1371/journal.pgen.0040006
   Zanna C, 2008, BRAIN, V131, P352, DOI 10.1093/brain/awm335
   Zeviani M, 2008, BRAIN, V131, P314, DOI 10.1093/brain/awm339
   Züchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341
   Züchner S, 2006, ANN NEUROL, V59, P276, DOI 10.1002/ana.20797
NR 89
TC 108
Z9 117
U1 2
U2 18
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 1357-2725
EI 1878-5875
J9 INT J BIOCHEM CELL B
JI Int. J. Biochem. Cell Biol.
PD OCT 15
PY 2009
VL 41
IS 10
BP 1855
EP 1865
DI 10.1016/j.biocel.2009.04.012
PG 11
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 501AZ
UT WOS:000270351100012
PM 19389487
DA 2024-11-01
ER

PT J
AU Sobreira, C
   Marques, W
   Neto, OMP
   Santos, AC
   Neto, JMP
   Barreira, AA
AF Sobreira, Claudia
   Marques, Wilson, Jr.
   Neto, Octavio M. Pontes
   Santos, Antonio Carlos
   Neto, Joao M. Pina
   Barreira, Amilton A.
TI Leigh-like syndrome with the T8993G mutation in the mitochondrial ATPase 6 gene: long-term follow-up discloses a slowly progressive course
SO JOURNAL OF THE NEUROLOGICAL SCIENCES
LA English
DT Article
DE Myopathy; Mitochondrial diseases; Muscle pathology; Respiratory chain; Mitochondrial DNA; Maternally inherited Leigh syndrome (MILS); Neurogenic weakness; Ataxia and retinitis pigmentosa (NARP); T8993G mitochondrial DNA mutation; Mitochondrial ATPase; Mitochondria
ID cytochrome-c-oxidase; mtdna mutation; mutant load; dna; disease; tissue
AB We describe the long-term clinical outcome of a patient with Leigh-like syndrome presenting as an early onset encephalopathy and peripheral neuropathy caused by the T8993G mutation in the mitochondrial DNA (mtDNA). Clinical follow-up for 20 years revealed a peculiar pattern of slow disease progression, characterized by the addition of new minor deficits, while worsening of previous symptoms was mild. Brain MRI revealed cerebellar atrophy, diffuse demyelination of corona radiata and parietal white matter, and bilateral and symmetrical putaminal lesions. The proportion of mutant mtDNAs in blood was 72% (+/- 0.02%) and in skeletal muscle was 81% (+/- 0.4%). Leigh-like syndrome caused by the T8993G mtDNA mutation is a progressive disease, although not necessarily associated with an aggressive clinical course. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Sobreira, Claudia; Marques, Wilson, Jr.; Neto, Octavio M. Pontes; Barreira, Amilton A.] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Neurociencias, Div Neurol, BR-14048900 Ribeirao Preto, Brazil.
   [Santos, Antonio Carlos] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Med, Div Radiol, BR-14048900 Ribeirao Preto, Brazil.
   [Neto, Joao M. Pina] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Genet, BR-14048900 Ribeirao Preto, Brazil.
C3 Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo
RP Sobreira, C (corresponding author), Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Neurociencias & Ciencias Comportamento, Div Neurol, HC 4O Andar,Ave Bandeirantes 3900,Campus Univ Mon, BR-14048900 Ribeirao Preto, Brazil.
EM csobreira@fmrp.usp.br
FU FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [98/14928-3]
CR Carrozzo R, 2001, NEUROLOGY, V56, P687, DOI 10.1212/WNL.56.5.687
   Chalmers RM, 1997, NEUROLOGY, V49, P589, DOI 10.1212/WNL.49.2.589
   Debray FG, 2007, AM J MED GENET A, V143A, P2046, DOI 10.1002/ajmg.a.31880
   Enns GM, 2006, MOL GENET METAB, V88, P364, DOI 10.1016/j.ymgme.2006.02.001
   Finsterer J, 2008, PEDIATR NEUROL, V39, P223, DOI 10.1016/j.pediatrneurol.2008.07.013
   Fujii T, 1998, PEDIATR NEUROL, V18, P275, DOI 10.1016/S0887-8994(97)00187-2
   Goldenberg PC, 2003, NEUROLOGY, V60, P865, DOI 10.1212/01.WNL.0000049460.72439.7F
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   MORAES CT, 1992, AM J HUM GENET, V50, P934
   Morava E, 2006, AM J MED GENET A, V140A, P863, DOI 10.1002/ajmg.a.31194
   Nagashima T, 1999, ACTA NEUROPATHOL, V97, P416, DOI 10.1007/s004010051007
   Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311
   SANTORELLI FM, 1993, ANN NEUROL, V34, P827, DOI 10.1002/ana.410340612
   TATUCH Y, 1992, AM J HUM GENET, V50, P852
   Tiranti V, 2000, HUM MOL GENET, V9, P2733, DOI 10.1093/hmg/9.18.2733
   Uziel G, 1997, J NEUROL NEUROSUR PS, V63, P16, DOI 10.1136/jnnp.63.1.16
   White SL, 1999, J INHERIT METAB DIS, V22, P899, DOI 10.1023/A:1005639407166
NR 17
TC 6
Z9 6
U1 0
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0022-510X
EI 
J9 J NEUROL SCI
JI J. Neurol. Sci.
PD MAR 15
PY 2009
VL 278
IS 1-2
BP 132
EP 134
DI 10.1016/j.jns.2008.11.023
PG 3
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 411ZF
UT WOS:000263692300027
PM 19144360
DA 2024-11-01
ER

PT J
AU Rahman, S
   Hanna, MG
AF Rahman, S.
   Hanna, M. G.
TI Diagnosis and therapy in neuromuscular disorders: diagnosis and new treatments in mitochondrial diseases
SO JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
LA English
DT Review
ID hereditary optic neuropathy; stroke-like episodes; progressive external ophthalmoplegia; cytochrome-c-oxidase; preimplantation genetic diagnosis; ragged-red fibers; coenzyme q(10); cochlear implantation; mtdna mutation; dna depletion
AB Mitochondrial disease enters the differential diagnosis of a wide range of CNS and PNS presentations. Respiratory chain ATP production is under bigenomic genetic control. Adult mitochondrial diseases are mainly caused by mutations in mitochondrial DNA (mtDNA), and nuclear gene defects usually present with more severe childhood phenotypes. Recently, mutations in certain nuclear genes-for example POLG, MFN2 and OPA1, have been associated with an increasing number of adult-onset phenotypes. Achieving an accurate diagnosis can be complex and requires the coordinated interplay of clinical assessment, muscle histochemistry, muscle respiratory chain enzymology and genetics. Factors influencing the transmission and expression of mtDNA defects are not fully defined, presenting difficulties in calculating accurate recurrence risks for patients. Curative therapy exists for primary coenzyme Q(10) deficiency. For certain mtDNA mutations new therapeutic strategies, including resistance training, have the potential to reduce mutant mtDNA load. Allogeneic stem cell transplant may produce benefit in the nuclear recessive mitochondrial disorder mitochondrial neurogastrointestinal encephalomyopathy and should be considered in this nuclear driven multiple mtDNA deletion disorder. Supportive therapies in a multidisciplinary team environment are essential to reduce morbidity and mortality.
C1 [Rahman, S.; Hanna, M. G.] UCL Inst Neurol, Ctr Neuromuscular Dis, MRC, London WC1N 3BG, England.
   [Rahman, S.; Hanna, M. G.] UCL Inst Child Hlth, Mitochondrial Res Grp, London, England.
C3 University of London; University College London; University of London; University College London
RP Rahman, S (corresponding author), UCL Inst Neurol, Ctr Neuromuscular Dis, MRC, Queen Sq, London WC1N 3BG, England.
EM s.rahman@ich.ucl.ac.uk
FU MRC Centre for Neuromuscular Diseases [G0601943]; SPARKS; Great Ormond Street Hospital and Institute of Child Health Science Development Initiative; Department of Health's National Institute for Health Research Biomedical Research Centres; MRC [G0800674, G0200335, G0601943] Funding Source: UKRI
CR ALLEN RJ, 1983, ANN NEUROL, V13, P679, DOI 10.1002/ana.410130620
   Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   Andreu AL, 1999, NEW ENGL J MED, V341, P1037, DOI 10.1056/NEJM199909303411404
   Bastin J, 2008, J CLIN ENDOCR METAB, V93, P1433, DOI 10.1210/jc.2007-1701
   Bitner-Glindzicz M, 2009, NEW ENGL J MED, V360, P640, DOI 10.1056/NEJMc0806396
   Bohlega S, 1996, NEUROLOGY, V46, P1329, DOI 10.1212/WNL.46.5.1329
   Brown DT, 2006, LANCET, V368, P87, DOI 10.1016/S0140-6736(06)68972-1
   Brown DT, 2001, AM J HUM GENET, V68, P533, DOI 10.1086/318190
   Chinnery P, 2006, COCHRANE DB SYST REV, V0, P0, DOI DOI 10.1002/14651858.CD004426.pub2
   Chinnery PF, 2004, LANCET, V364, P592, DOI 10.1016/S0140-6736(04)16851-7
   Chol M, 2003, J MED GENET, V40, P188, DOI 10.1136/jmg.40.3.188
   CIAFALONI E, 1992, ANN NEUROL, V31, P391, DOI 10.1002/ana.410310408
   Clark KM, 1997, NAT GENET, V16, P222, DOI 10.1038/ng0797-222
   Corona P, 2001, ANN NEUROL, V49, P106, DOI 10.1002/1531-8249(200101)49:1<106::AID-ANA16>3.0.CO;2-T
   Cullington HE, 1999, J LARYNGOL OTOL, V113, P353, DOI 10.1017/S0022215100143956
   Dean NL, 2003, MOL HUM REPROD, V9, P631, DOI 10.1093/molehr/gag077
   DiMauro S, 2008, ANNU REV NEUROSCI, V31, P91, DOI 10.1146/annurev.neuro.30.051606.094302
   Dimmock DP, 2008, LIVER TRANSPLANT, V14, P1480, DOI 10.1002/lt.21556
   DOUGADOS M, 1983, ANN NEUROL, V13, P687, DOI 10.1002/ana.410130624
   Duncan AJ, 2005, CLIN CHEM, V51, P2380, DOI 10.1373/clinchem.2005.054643
   Ellouze S, 2008, AM J HUM GENET, V83, P373, DOI 10.1016/j.ajhg.2008.08.013
   Feyereisen E, 2007, FERTIL STERIL, V87, P60, DOI 10.1016/j.fertnstert.2006.05.059
   Finsterer J, 2006, NETH J MED, V64, P61
   Freisinger P, 2004, J INHERIT METAB DIS, V27, P67, DOI 10.1023/B:BOLI.0000016614.47380.2f
   GOTO Y, 1991, BIOCHIM BIOPHYS ACTA, V1097, P238, DOI 10.1016/0925-4439(91)90042-8
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   GOTO YI, 1994, BIOCHEM BIOPH RES CO, V202, P1624, DOI 10.1006/bbrc.1994.2119
   Hanna MG, 1997, CURR OPIN NEUROL, V10, P351, DOI 10.1097/00019052-199708000-00012
   Hanna MG, 1998, J NEUROL NEUROSUR PS, V65, P512, DOI 10.1136/jnnp.65.4.512
   HANNA MG, 1995, AM J HUM GENET, V56, P1026
   HARDING AE, 1992, AM J HUM GENET, V50, P629
   HARDING AE, 1992, BRAIN, V115, P979, DOI 10.1093/brain/115.4.979
   Hirano M, 2006, NEUROLOGY, V67, P1458, DOI 10.1212/01.wnl.0000240853.97716.24
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   JACKSON MJ, 1995, BRAIN, V118, P339, DOI 10.1093/brain/118.2.339
   Jacobs HT, 1997, ANN MED, V29, P483, DOI 10.3109/07853899709007472
   JOHNS DR, 1993, ARCH OPHTHALMOL-CHIC, V111, P495, DOI 10.1001/archopht.1993.01090040087038
   Karadimas CL, 2006, AM J HUM GENET, V79, P544, DOI 10.1086/506913
   Kaufmann P, 2006, NEUROLOGY, V66, P324, DOI 10.1212/01.wnl.0000196641.05913.27
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Kirby DM, 2000, ANN NEUROL, V48, P102, DOI 10.1002/1531-8249(200007)48:1<102::AID-ANA15>3.3.CO;2-D
   Koga Y, 2006, NEUROLOGY, V66, P1766, DOI 10.1212/01.wnl.0000220197.36849.1e
   Koga Y, 2005, NEUROLOGY, V64, P710, DOI 10.1212/01.WNL.0000151976.60624.01
   Koga Y, 2007, MITOCHONDRION, V7, P133, DOI 10.1016/j.mito.2006.11.006
   Kolesnikova OA, 2004, HUM MOL GENET, V13, P2519, DOI 10.1093/hmg/ddh267
   LAFORET P, 1995, NEUROMUSCULAR DISORD, V5, P399, DOI 10.1016/0960-8966(94)00080-S
   Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013
   Lalani SR, 2005, ARCH NEUROL-CHICAGO, V62, P317, DOI 10.1001/archneur.62.2.317
   Lara MC, 2006, NEUROLOGY, V67, P1461, DOI 10.1212/01.wnl.0000239824.95411.52
   LARSSON NG, 1995, MUSCLE NERVE S, V3, P102
   LEIGH D, 1951, J NEUROL NEUROSUR PS, V14, P216, DOI 10.1136/jnnp.14.3.216
   Leshinsky-Silver E, 2003, PRENATAL DIAG, V23, P31, DOI 10.1002/pd.516
   Lev D, 2004, PEDIATR CARDIOL, V25, P443, DOI 10.1007/s00246-003-0490-7
   Mahata B, 2006, SCIENCE, V314, P471, DOI 10.1126/science.1129754
   Majamaa K, 1998, AM J HUM GENET, V63, P447, DOI 10.1086/301959
   Mancuso M, 2004, NEUROLOGY, V62, P316, DOI 10.1212/WNL.62.2.316
   Mancuso M, 2002, NEUROLOGY, V59, P1197, DOI 10.1212/01.WNL.0000028689.93049.9A
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   Manfredi G, 2002, NAT GENET, V30, P394, DOI 10.1038/ng851
   Minczuk M, 2008, NUCLEIC ACIDS RES, V36, P3926, DOI 10.1093/nar/gkn313
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   MORAES CT, 1993, NEUROMUSCULAR DISORD, V3, P43, DOI 10.1016/0960-8966(93)90040-Q
   Moran NF, 2008, NEUROLOGY, V71, P686, DOI 10.1212/01.wnl.0000324602.97205.ab
   Murphy JL, 2008, BRAIN, V131, P2832, DOI 10.1093/brain/awn252
   Murphy MP, 2008, BBA-BIOENERGETICS, V1777, P1028, DOI 10.1016/j.bbabio.2008.03.029
   Murphy R, 2008, DIABETIC MED, V25, P383, DOI 10.1111/j.1464-5491.2008.02359.x
   Musumeci O, 2001, NEUROLOGY, V56, P849, DOI 10.1212/WNL.56.7.849
   NEWMAN NJ, 1991, AM J OPHTHALMOL, V111, P750, DOI 10.1016/S0002-9394(14)76784-4
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   OGASAHARA S, 1989, P NATL ACAD SCI USA, V86, P2379, DOI 10.1073/pnas.86.7.2379
   Pineda M, 2006, ANN NEUROL, V59, P394, DOI 10.1002/ana.20746
   Poulton J, 2001, J MED GENET, V38, P0
   Rahman S, 2001, J PEDIATR-US, V139, P456, DOI 10.1067/mpd.2001.117575
   Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311
   Rahman S, 2001, AM J HUM GENET, V68, P238, DOI 10.1086/316930
   Rahman S, 2009, ARCH DIS CHILD, V94, P3, DOI 10.1136/adc.2008.147983
   Rosenthal EL, 1999, AM J OTOL, V20, P187
   Rötig A, 2000, LANCET, V356, P391, DOI 10.1016/S0140-6736(00)02531-9
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Salviati L, 2002, BIOCHEM J, V363, P321, DOI 10.1042/0264-6021:3630321
   Sanaker PS, 2007, ACTA NEUROL SCAND, V115, P64, DOI 10.1111/j.1600-0404.2007.00850.x
   Santorelli FM, 1997, BIOCHEM BIOPH RES CO, V238, P326, DOI 10.1006/bbrc.1997.7167
   Santra S, 2004, ANN NEUROL, V56, P662, DOI 10.1002/ana.20240
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   SILVESTRI G, 1992, AM J HUM GENET, V51, P1213
   Sinnathuray AR, 2003, OTOL NEUROTOL, V24, P418, DOI 10.1097/00129492-200305000-00012
   Sobreira C, 1997, NEUROLOGY, V48, P1238, DOI 10.1212/WNL.48.5.1238
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Suzuki S, 1998, DIABETOLOGIA, V41, P584, DOI 10.1007/s001250050950
   Taanman JW, 2003, HUM MOL GENET, V12, P1839, DOI 10.1093/hmg/ddg192
   Taivassalo T, 2006, BRAIN, V129, P3391, DOI 10.1093/brain/awl282
   Tanaka M, 2002, J BIOMED SCI, V9, P534, DOI 10.1007/BF02254980
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Taylor RW, 2003, J MED GENET, V40, P0, DOI 10.1136/jmg.40.7.e85
   Taylor RW, 2004, NEUROMUSCULAR DISORD, V14, P237, DOI 10.1016/j.nmd.2003.12.004
   Thorburn DR, 2001, AM J MED GENET, V106, P102, DOI 10.1002/ajmg.1380
   Tiranti V, 1998, AM J HUM GENET, V63, P1609, DOI 10.1086/302150
   Tono T, 1998, AM J OTOL, V19, P754
   TRAFF J, 1995, ACTA NEUROL SCAND, V92, P394
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Maldergem L, 2002, ANN NEUROL, V52, P750, DOI 10.1002/ana.10371
   Vandebona H, 2009, NEW ENGL J MED, V360, P642, DOI 10.1056/NEJMc0806397
   VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368
   Verhoeven K, 2006, BRAIN, V129, P2093, DOI 10.1093/brain/awl126
   WALLACE DC, 1970, BRAIN, V93, P121, DOI 10.1093/brain/93.1.121
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Wenz T, 2008, CELL METAB, V8, P249, DOI 10.1016/j.cmet.2008.07.006
   White SL, 1999, PRENATAL DIAG, V19, P1165, DOI 10.1002/(SICI)1097-0223(199912)19:12<1165::AID-PD719>3.3.CO;2-4
   Whittaker RG, 2009, NEUROLOGY, V72, P568, DOI 10.1212/01.wnl.0000342121.91336.4d
   Yavuz H, 2007, ARCH NEUROL-CHICAGO, V64, P435, DOI 10.1001/archneur.64.3.435
   Zhu ZQ, 1998, NAT GENET, V20, P337, DOI 10.1038/3804
NR 114
TC 59
Z9 63
U1 0
U2 8
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0022-3050
EI 1468-330X
J9 J NEUROL NEUROSUR PS
JI J. Neurol. Neurosurg. Psychiatry
PD SEP 15
PY 2009
VL 80
IS 9
BP 943
EP 953
DI 10.1136/jnnp.2008.158279
PG 11
WC Clinical Neurology; Psychiatry; Surgery
SC Neurosciences & Neurology; Psychiatry; Surgery
GA 483VS
UT WOS:000268997800004
PM 19684231
DA 2024-11-01
ER

PT J
AU Tyynismaa, H
   Ylikallio, E
   Patel, M
   Molnar, MJ
   Haller, RG
   Suomalainen, A
AF Tyynismaa, Henna
   Ylikallio, Emil
   Patel, Mehul
   Molnar, Maria J.
   Haller, Ronald G.
   Suomalainen, Anu
TI A Heterozygous Truncating Mutation in <i>RRM2B</i> Causes Autosomal-Dominant Progressive External Ophthalmoplegia with Multiple mtDNA Deletions
SO AMERICAN JOURNAL OF HUMAN GENETICS
LA English
DT Article
ID mitochondrial-dna depletion; adenine-nucleotide translocator; ribonucleotide reductase gene; in-vitro; twinkle mutations; p53r2 protein; resting cells; dntp pools; damage; ataxia
AB Autosomal-dominant progressive external ophthalmoplegia (adPEO) is a mitochondrial disorder that is characterized by accumulation of multiple mitochondrial DNA (mtDNA) deletions in postmitotic tissues. The disorder is heterogeneous, with five known nuclear disease genes that encode the proteins ANTI, Twinkle, POLG, POLG2, and OPA1. Defects in these proteins affect mtDNA maintenance, probably leading to stalled replication forks, consequent mtDNA deletion formation, and progressive respiratory chain deficiency. Here we present a large adPEO family with Multiple mtDNA deletions, whose disease was not explained by mutations in any of the known adPEO loci. We mapped the disease locus in this family to chromosome 8q22.1-q23.3. The critical linkage region contained the RRM2B gene, which encodes the small subunit of the ribonucleotide reductase p53R2, which has previously been shown to be essential for the maintenance of mtDNA copy number. Mutation screening of RRM2B revealed a heterozygous nonsense mutation in exon 9 (c.979C -> T [p.R327X]) in all affected individuals that was absent in 380 control chromosomes. The same mutation was found to segregate in another adPEO family. The mutant mRNA escaped nonsense-mediated decay and resulted in a protein with truncation of 25 highly conserved C-terminal amino acids essential for the interaction with the ribonucleotide reductase subunit R1. We conclude that dominant-negative or gain-of-function mutations in RRM2B are a cause of multiple mtDNA deletions and adPEO.
C1 [Tyynismaa, Henna; Ylikallio, Emil; Suomalainen, Anu] Univ Helsinki, Biomedicum Helsinki, Res Program Mol Neurol, FIN-00290 Helsinki, Finland.
   [Patel, Mehul; Haller, Ronald G.] Univ Texas SW Med Ctr Dallas, Dept Neurol, Dallas, TX 75390 USA.
   [Molnar, Maria J.] Semmelweis Univ, Clin & Res Ctr Mol Neurol, H-1083 Budapest, Hungary.
   [Haller, Ronald G.] Dallas VA Med Ctr, Dallas, TX 75231 USA.
   [Haller, Ronald G.] Inst Exercise & Environm Med, Neuromuscular Ctr, Dallas, TX 75231 USA.
   [Suomalainen, Anu] Univ Helsinki, Cent Hosp, Dept Neurol, FIN-00290 Helsinki, Finland.
C3 University of Helsinki; University of Texas System; University of Texas Southwestern Medical Center Dallas; Semmelweis University; University of Helsinki; Helsinki University Central Hospital
RP Tyynismaa, H (corresponding author), Univ Helsinki, Biomedicum Helsinki, Res Program Mol Neurol, FIN-00290 Helsinki, Finland.
EM henna.tyynisma@helsinki.fi
FU Academy of Finland; Sigrid Juselius Foundation; University of Helsinki; VA Merit Review grant
CR Bornstein B, 2008, NEUROMUSCULAR DISORD, V18, P453, DOI 10.1016/j.nmd.2008.04.006
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   Byun DS, 2002, INT J CANCER, V98, P718, DOI 10.1002/ijc.10253
   Chang LF, 2008, P NATL ACAD SCI USA, V105, P18519, DOI 10.1073/pnas.0803313105
   Deng ZL, 2005, WORLD J GASTROENTERO, V11, P5169
   FISHER A, 1993, J MED CHEM, V36, P3859, DOI 10.1021/jm00076a015
   Goffart S, 2009, HUM MOL GENET, V18, P328, DOI 10.1093/hmg/ddn359
   Guittet O, 2001, J BIOL CHEM, V276, P40647, DOI 10.1074/jbc.M106088200
   Håkansson P, 2006, J BIOL CHEM, V281, P7834, DOI 10.1074/jbc.M512894200
   Hakonen AH, 2008, HUM MOL GENET, V17, P3822, DOI 10.1093/hmg/ddn280
   Hakonen AH, 2007, BRAIN, V130, P3032, DOI 10.1093/brain/awm242
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Kimura T, 2003, NAT GENET, V34, P440, DOI 10.1038/ng1212
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   KUNZ BA, 1994, MUTAT RES-REV GENET, V318, P1, DOI 10.1016/0165-1110(94)90006-X
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Luoma PT, 2005, HUM MOL GENET, V14, P1907, DOI 10.1093/hmg/ddi196
   Mathews CK, 2006, FASEB J, V20, P1300, DOI 10.1096/fj.06-5730rev
   Melberg A, 1996, MUSCLE NERVE, V19, P751
   Nakano K, 2000, ONCOGENE, V19, P4283, DOI 10.1038/sj.onc.1203774
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443
   Palmieri L, 2005, HUM MOL GENET, V14, P3079, DOI 10.1093/hmg/ddi341
   Pontarin G, 2007, J BIOL CHEM, V282, P16820, DOI 10.1074/jbc.M701310200
   Pontarin G, 2008, P NATL ACAD SCI USA, V105, P17801, DOI 10.1073/pnas.0808198105
   Sarzi E, 2007, ANN NEUROL, V62, P579, DOI 10.1002/ana.21207
   SERVIDEI S, 1991, NEUROLOGY, V41, P1053, DOI 10.1212/WNL.41.7.1053
   Shao JM, 2004, CANCER RES, V64, P1, DOI 10.1158/0008-5472.CAN-03-3048
   Smeds J, 2002, CARCINOGENESIS, V23, P645, DOI 10.1093/carcin/23.4.645
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Suomalainen A, 1997, NEUROLOGY, V48, P1244, DOI 10.1212/WNL.48.5.1244
   SUOMALAINEN A, 1992, J CLIN INVEST, V90, P61, DOI 10.1172/JCI115856
   Tanaka H, 2000, NATURE, V404, P42, DOI 10.1038/35003506
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2004, NEUROLOGY, V63, P1251, DOI 10.1212/01.WNL.0000140494.58732.83
   Wanrooij S, 2004, NUCLEIC ACIDS RES, V32, P3053, DOI 10.1093/nar/gkh634
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
NR 39
TC 95
Z9 104
U1 0
U2 15
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0002-9297
EI 1537-6605
J9 AM J HUM GENET
JI Am. J. Hum. Genet.
PD AUG 14
PY 2009
VL 85
IS 2
BP 290
EP 295
DI 10.1016/j.ajhg.2009.07.009
PG 6
WC Genetics & Heredity
SC Genetics & Heredity
GA 488EV
UT WOS:000269332900018
PM 19664747
DA 2024-11-01
ER

PT J
AU Formichi, P
   Radi, E
   Battisti, C
   Di Maio, G
   Tarquini, E
   Leonini, A
   Di Stefano, A
   Dotti, MT
   Federico, A
AF Formichi, Patrizia
   Radi, Elena
   Battisti, Carla
   Di Maio, Giuseppe
   Tarquini, Ermelinda
   Leonini, Alessandra
   Di Stefano, Anna
   Dotti, Maria Teresa
   Federico, Antonio
TI Apoptosis in CADASIL: An In Vitro Study of Lymphocytes and Fibroblasts From a Cohort of Italian Patients
SO JOURNAL OF CELLULAR PHYSIOLOGY
LA English
DT Article
ID autosomal-dominant arteriopathy; smooth-muscle-cells; dna fragmentation; subcortical infarcts; oxidative stress; ataxia-telangiectasia; flow-cytometry; notch3 gene; leukoencephalopathy; expression
AB Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy(CADASIL) is a hereditary disease affecting vascular smooth muscle cells of nearly all tissues. Clinical manifestations mainly concern the central nervous system with repeated TIA/stroke, migraine, psychiatric disturbances, and cognitive decline. Minor findings have been reported in muscle, nerve,and skin. CADASIL is due to NOTCH3 gene mutations. This gene has been identified as an up-regulator of c-FLIP, an inhibitor of Fas-ligand-induced apoptosis. The aim of this study was to assess the involvement of oxidative stress-induced apoptosis in cells from 16 Italian CADASIL patients. Peripheral blood lymphocytes (PBLs) and fibroblasts from CADASIL patients were exposed to 2-deoxy-D-ribose (dRib), which induces apoptosis by oxidative stress. Apoptosis was analyzed by flow cytometry, agarose gel electrophoresis and fluorescence microscopy for caspase-3 activation, phosphatidylserine exposure and mitochondrial membrane depolarization. PBLs and fibroblasts from CADASIL patients showed a significantly higher response to dRib-induced apoptosis than those of controls. PBLs from CADASIL patients also showed a significantly higher percentage of apoptotic cells than PBLs from controls, even when cultured without dRib. The greater susceptibility of PBLs and fibroblasts from CADASIL patients to dRib-induced apoptosis suggests that NOTCH3 mutations are an important apoptotic trigger. Since PBLs from patients showed higher levels of apoptosis even in the absence of an apoptotic stimulus, cells from CADASIL patients appear to be physiologically prone to apoptotic cell death.
C1 [Formichi, Patrizia; Radi, Elena; Battisti, Carla; Di Maio, Giuseppe; Dotti, Maria Teresa; Federico, Antonio] Univ Siena, Dept Neurol Neurosurg & Behav Sci, I-53100 Siena, Italy.
   [Tarquini, Ermelinda] Azienda Osped, Dept Neurol Neurosurg & Behav Sci, Siena, Italy.
   [Leonini, Alessandra; Di Stefano, Anna] Univ Siena, Dept Mol Biol, I-53100 Siena, Italy.
C3 University of Siena; University of Siena; University Hospital of Siena; University of Siena
RP Federico, A (corresponding author), Policlin Le Scotte, Sez Sci Neurol, Dipartimento Sci Neurol Neurochirurg & Comportame, Vle Bracci 2, I-53100 Siena, Italy.
EM federico@unisi.it
FU Regione Toscana [AOOGRT/2120/125.002.006]; Fondazione Monte dei Paschi di Siena [27489]
CR Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770
   BARBIERI D, 1992, BIOCHEM BIOPH RES CO, V187, P1256, DOI 10.1016/0006-291X(92)90438-Q
   Battisti C, 1996, J NEUROL SCI, V144, P128, DOI 10.1016/S0022-510X(96)00216-X
   BAUDRIMONT M, 1993, STROKE, V24, P122, DOI 10.1161/01.STR.24.1.122
   BOYUM A, 1984, METHOD ENZYMOL, V108, P88
   Campos AH, 2002, CIRC RES, V91, P999, DOI 10.1161/01.RES.0000044944.99984.25
   CHABRIAT H, 1995, NEUROLOGY, V45, P1086, DOI 10.1212/WNL.45.6.1086
   de la Peña P, 2001, NEUROLOGY, V57, P1235, DOI 10.1212/WNL.57.7.1235
   Dotti MT, 2004, ARCH NEUROL-CHICAGO, V61, P942, DOI 10.1001/archneur.61.6.942
   Duru NK, 2001, J ANDROL, V22, P646
   EASTMAN A, 1995, METHOD CELL BIOL, V46, P41
   Ekert PG, 1999, CELL DEATH DIFFER, V6, P1081, DOI 10.1038/sj.cdd.4400594
   Finnilä S, 2001, J MOL MED, V79, P641, DOI 10.1007/s001090100268
   Formichi P, 2006, J CELL PHYSIOL, V208, P289, DOI 10.1002/jcp.20662
   Formichi P, 2000, LIFE SCI, V66, P1893, DOI 10.1016/S0024-3205(00)00515-4
   GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493
   Gibbons GH, 2000, CIRC RES, V86, P1009, DOI 10.1161/01.RES.86.10.1009
   Haruki N, 2005, CANCER RES, V65, P3555, DOI 10.1158/0008-5472.CAN-04-3132
   Ihalainen S, 2007, MOL MED, V13, P305, DOI 10.2119/2006-00069.Ihalainen
   Joutel A, 2000, J CLIN INVEST, V105, P597, DOI 10.1172/JCI8047
   Joutel A, 1996, NATURE, V383, P707, DOI 10.1038/383707a0
   Kalimo H, 2002, BRAIN PATHOL, V12, P371
   Kaneto H, 1996, BIOCHEM J, V320, P855, DOI 10.1042/bj3200855
   Kletsas D, 1998, BIOCHEM BIOPH RES CO, V243, P416, DOI 10.1006/bbrc.1997.7975
   Lieven CJ, 2003, ANTIOXID REDOX SIGN, V5, P641, DOI 10.1089/152308603770310310
   NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O
   Peters N, 2006, NEUROLOGY, V66, P1517, DOI 10.1212/01.wnl.0000216271.96364.50
   RUCHOUX MM, 1994, STROKE, V25, P2291, DOI 10.1161/01.STR.25.11.2291
   Ruchoux MM, 1997, J NEUROPATH EXP NEUR, V56, P947, DOI 10.1097/00005072-199709000-00001
   RUCHOUX MM, 1995, ACTA NEUROPATHOL, V89, P500
   Ruchoux MM, 2000, ANN NY ACAD SCI, V903, P285, DOI 10.1111/j.1749-6632.2000.tb06378.x
   Rufa A, 2005, NEUROL SCI, V26, P271, DOI 10.1007/s10072-005-0470-1
   SCHRODER JM, 1995, ACTA NEUROPATHOL, V89, P116, DOI 10.1007/BF00296354
   TELFORD WG, 1991, CELL PROLIFERAT, V24, P447, DOI 10.1111/j.1365-2184.1991.tb01173.x
   TOURNIERLASSERVE E, 1993, NAT GENET, V3, P256, DOI 10.1038/ng0393-256
   VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I
   Viswanathan A, 2006, STROKE, V37, P2690, DOI 10.1161/01.STR.0000245091.28429.6a
   Wang T, 2008, PROG BIOPHYS MOL BIO, V96, P499, DOI 10.1016/j.pbiomolbio.2007.07.006
   Wang WL, 2003, BIOCHEM BIOPH RES CO, V308, P596, DOI 10.1016/S0006-291X(03)01453-0
   Wang WL, 2002, J BIOL CHEM, V277, P21723, DOI 10.1074/jbc.M202224200
NR 40
TC 28
Z9 30
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0021-9541
EI 1097-4652
J9 J CELL PHYSIOL
JI J. Cell. Physiol.
PD MAY 15
PY 2009
VL 219
IS 2
BP 494
EP 502
DI 10.1002/jcp.21695
PG 9
WC Cell Biology; Physiology
SC Cell Biology; Physiology
GA 425VO
UT WOS:000264666000030
PM 19180562
DA 2024-11-01
ER

PT J
AU Greaves, LC
   Beadle, NE
   Taylor, GA
   Commane, D
   Mathers, JC
   Khrapko, K
   Turnbull, DM
AF Greaves, Laura C.
   Beadle, Nina E.
   Taylor, Geoffrey A.
   Commane, Daniel
   Mathers, John C.
   Khrapko, Konstantin
   Turnbull, Doug M.
TI Quantification of mitochondrial DNA mutation load
SO AGING CELL
LA English
DT Article
DE ageing; cloning; colon; human; mitochondria; mitochondrial DNA; mutation load; polymerase chain reaction
ID human skeletal-muscle; single-molecule pcr; point mutations; stem-cells; organization; deletion; tissue; disease; genome; mice
AB P>Mitochondrial DNA (mtDNA) mutations are an important cause of genetic disease and have been proposed to play a role in the ageing process. Quantification of total mtDNA mutation load in ageing tissues is difficult as mutational events are rare in a background of wild-type molecules, and detection of individual mutated molecules is beyond the sensitivity of most sequencing based techniques. The methods currently most commonly used to document the incidence of mtDNA point mutations in ageing include post-PCR cloning, single-molecule PCR and the random mutation capture assay. The mtDNA mutation load obtained by these different techniques varies by orders of magnitude, but direct comparison of the three techniques on the same ageing human tissue has not been performed. We assess the procedures and practicalities involved in each of these three assays and discuss the results obtained by investigation of mutation loads in colonic mucosal biopsies from ten human subjects.
C1 [Greaves, Laura C.; Beadle, Nina E.; Taylor, Geoffrey A.; Turnbull, Doug M.] Newcastle Univ, Sch Med, Inst Ageing & Hlth, Mitochondrial Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Commane, Daniel; Mathers, John C.] Newcastle Univ, Inst Ageing & Hlth, Human Nutr Res Ctr, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Khrapko, Konstantin] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA.
C3 Newcastle University - UK; Newcastle University - UK; Harvard University; Beth Israel Deaconess Medical Center
RP Greaves, LC (corresponding author), Newcastle Univ, Sch Med, Inst Ageing & Hlth, Mitochondrial Res Grp, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM l.c.greaves@ncl.ac.uk
FU Wellcome Trust, Food Standards Agency (UK) [N12015]; Cancer Research UK; Biotechnology and Biomedical Sciences Research Council (UK); BBSRC; EPSRC; ESRC; MRC; NIH [AG19787, NS058988]; MRC [G0700718] Funding Source: UKRI
CR ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   COOPER JM, 1992, J NEUROL SCI, V113, P91, DOI 10.1016/0022-510X(92)90270-U
   CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927
   Cottrell DA, 2001, NEUROBIOL AGING, V22, P265, DOI 10.1016/S0197-4580(00)00234-7
   Del Bo R, 2002, J NEUROL SCI, V202, P85, DOI 10.1016/S0022-510X(02)00247-2
   Greaves LC, 2006, P NATL ACAD SCI USA, V103, P714, DOI 10.1073/pnas.0505903103
   KHRAPKO K, 1994, PROG NUCLEIC ACID RE, V49, P285
   Kraytsberg Y, 2005, EXPERT REV MOL DIAGN, V5, P809, DOI 10.1586/14737159.5.5.809
   Kraytsberg Y, 2008, METHODS, V46, P269, DOI 10.1016/j.ymeth.2008.10.005
   KRAYTSBERG Y, 2004, ANAL SOMATIC MUTATIO, V0, P0
   Kraytsberg Yevgenya, 2007, EXPERT OPIN MED DIAGN, V1, P109, DOI 10.1517/17530059.1.1.109
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   MIQUEL J, 1980, EXP GERONTOL, V15, P575, DOI 10.1016/0531-5565(80)90010-8
   NASS MMK, 1966, P NATL ACAD SCI USA, V56, P1215, DOI 10.1073/pnas.56.4.1215
   Nekhaeva E, 2002, P NATL ACAD SCI USA, V99, P5521, DOI 10.1073/pnas.072670199
   OLD SL, 1989, HISTOCHEM J, V21, P545, DOI 10.1007/BF01753355
   Simon DK, 2001, GENOMICS, V73, P113, DOI 10.1006/geno.2001.6515
   Smigrodzki R, 2004, NEUROBIOL AGING, V25, P1273, DOI 10.1016/j.neurobiolaging.2004.02.020
   Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988
   Wilding CS, 2006, RADIAT RES, V165, P202, DOI 10.1667/RR3494.1
   Woischnik M, 2002, GENOME RES, V12, P885, DOI 10.1101/gr.227202
NR 24
TC 36
Z9 46
U1 0
U2 11
PU WILEY-BLACKWELL PUBLISHING, INC
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1474-9718
EI 
J9 AGING CELL
JI Aging Cell
PD OCT 15
PY 2009
VL 8
IS 5
BP 566
EP 572
DI 10.1111/j.1474-9726.2009.00505.x
PG 7
WC Cell Biology; Geriatrics & Gerontology
SC Cell Biology; Geriatrics & Gerontology
GA 498FU
UT WOS:000270123400006
PM 19624578
DA 2024-11-01
ER

PT J
AU Ercan, A
   Kulaksiz, G
   Dalmizrak, O
   Muftuoglu, M
   Ogus, H
   Cavdar, L
   Inan, L
   Ozer, N
AF Ercan, Ayse
   Kulaksiz, Gulnihal
   Dalmizrak, Ozlem
   Muftuoglu, Meltem
   Ogus, Hamdi
   Cavdar, Leyla
   Inan, Levent
   Ozer, Nazmi
TI Mitochondrial Respiratory Chain Enzyme Activities, mtDNA Variants and Gene Expression Levels in Idiopathic Parkinson's Disease
SO TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI
LA English
DT Article
DE Idiopathic PD; Complex I; glutathione; ND2; ND4
ID complex-i activity; skeletal-muscle; glutathione depletion; dna; dysfunction; inhibition; mutations; platelets; brain
AB Purpose: Mitochondrial dysfunction has been implicated in the development of idiopathic Parkinson's disease. In this study, it was aimed to investigate the relationship between mitochondrial respiratory chain enzyme deficiency and variants in ND2 and ND4 region of Complex I and expressions of these genes. Complex IV activity and glutathione level were also studied. Methods: Activities of Complex I, Complex IV, citrate synthase and glutathione levels were measured from muscle biopsy samples of 19 idiopathic Parkinson's Disease patients. Entire ND2 and ND4 regions of Complex I were screened by sequencing and expression levels of these regions were also examined by using relative quantitative RT-PCR. Results: A significant decrease in Complex I and IV activities was found in Parkinson's Disease patients (19.73 +/- 8.24 U/mg protein, 11.51 +/- 6.45 U/mg protein) compared with the control group (31.48 +/- 8.28 U/mg protein, 30.02 +/- 14.76 U/mg protein), respectively. Although several sequence variants were detected in ND2 and ND4 genes, they didn't account for the decrease in Complex I activity. ND2 (19 % and 21 %) and ND4 (14 % and 13 %) mRNA expressions were reduced in two of 19 patients. Conclusion: Taken together, Complex I and IV dysfunctions and mitochondrial abnormalities might be the result of oxidative stress contributing to the pathogenesis of idiopathic Parkinson's Disease since we found that reduced glutathione levels were decreased 47 % in these patients.
C1 [Kulaksiz, Gulnihal; Dalmizrak, Ozlem; Muftuoglu, Meltem; Ogus, Hamdi; Ozer, Nazmi] Hacettepe Univ, Fac Med, Dept Biochem, TR-06100 Ankara, Turkey.
   [Ercan, Ayse] Hacettepe Univ, Fac Pharm, Dept Biochem, TR-06100 Ankara, Turkey.
   [Dalmizrak, Ozlem; Ozer, Nazmi] Near East Univ, Fac Med, Dept Basic Med Sci, TR-10 Nicosia, Mersin, Turkey.
   [Cavdar, Leyla; Inan, Levent] Ankara Res & Training Hosp, Dept Neurol, TR-06100 Ankara, Turkey.
C3 Hacettepe University; Hacettepe University; Mersin University; Near East University; Ankara Training & Research Hospital
RP Ozer, N (corresponding author), Hacettepe Univ, Fac Med, Dept Biochem, TR-06100 Ankara, Turkey.
EM naozer@hacettepe.edu.tr
FU Scientific and Technical Research Council of Turkey [SBAG-2596]; Hacettepe University Scientific Research Unit [02G112]
CR Abril J, 2008, PROSTATE, V68, P1086, DOI 10.1002/pros.20771
   ANDERSON JJ, 1993, J NEUROL NEUROSUR PS, V56, P477, DOI 10.1136/jnnp.56.5.477
   BENECKE R, 1993, BRAIN, V116, P1451, DOI 10.1093/brain/116.6.1451
   BINDOFF LA, 1991, J NEUROL SCI, V104, P203, DOI 10.1016/0022-510X(91)90311-T
   BIRCHMACHIN MA, 1994, BIOCHEM MED METAB B, V51, P35, DOI 10.1006/bmmb.1994.1004
   BLIN O, 1994, J NEUROL SCI, V125, P95, DOI 10.1016/0022-510X(94)90248-8
   Bragoszewski P, 2008, BMC CANCER, V8, P0, DOI 10.1186/1471-2407-8-292
   BRAVI D, 1992, MOVEMENT DISORD, V7, P228, DOI 10.1002/mds.870070307
   CARDELLACH F, 1993, NEUROLOGY, V43, P2258, DOI 10.1212/WNL.43.11.2258
   Chinta SJ, 2006, FREE RADICAL BIO MED, V41, P1442, DOI 10.1016/j.freeradbiomed.2006.08.002
   Davis GC, 1979, PSYCHIAT RES, V1, P649
   DIDONATO S, 1993, NEUROLOGY, V43, P2262, DOI 10.1212/WNL.43.11.2262
   Greenamyre JT, 2001, IUBMB LIFE, V52, P135, DOI 10.1080/15216540152845939
   HAAS RH, 1995, ANN NEUROL, V37, P714, DOI 10.1002/ana.410370604
   Huerta C, 2005, J NEUROL SCI, V236, P49, DOI 10.1016/j.jns.2005.04.016
   IKEBE S, 1995, MOL BRAIN RES, V28, P281, DOI 10.1016/0169-328X(94)00209-W
   Jha N, 2000, J BIOL CHEM, V275, P26096, DOI 10.1074/jbc.M000120200
   Kosel S, 1998, NEUROGENETICS, V1, P197, DOI 10.1007/s100480050029
   KOSOWER NS, 1979, P NATL ACAD SCI USA, V76, P3382, DOI 10.1073/pnas.76.7.3382
   LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MANN VM, 1992, BRAIN, V115, P333, DOI 10.1093/brain/115.2.333
   Mizuno Y, 1998, ANN NEUROL, V44, PS99, DOI 10.1002/ana.410440715
   Müftüoglu M, 2004, MOVEMENT DISORD, V19, P544, DOI 10.1002/mds.10695
   NAKAGAWAHATTORI Y, 1992, J NEUROL SCI, V107, P29, DOI 10.1016/0022-510X(92)90205-Y
   Pich MM, 1996, FEBS LETT, V380, P176, DOI 10.1016/0014-5793(96)00037-3
   REICHMANN H, 1994, EUR NEUROL, V34, P263, DOI 10.1159/000117053
   Reichmann H, 2000, J NEUROL, V247, P63
   Riess O, 1998, MOL MED TODAY, V4, P438, DOI 10.1016/S1357-4310(98)01343-4
   Schapira AHV, 2007, CELL DEATH DIFFER, V14, P1261, DOI 10.1038/sj.cdd.4402160
   Shadel GS, 1997, ANNU REV BIOCHEM, V66, P409, DOI 10.1146/annurev.biochem.66.1.409
   SHOFFNER JM, 1991, ANN NEUROL, V30, P332, DOI 10.1002/ana.410300304
   Shoffner JM, 2000, NEUROL CLIN, V18, P105, DOI 10.1016/S0733-8619(05)70180-8
   SHOFFNER JM, 1993, GENOMICS, V17, P171, DOI 10.1006/geno.1993.1299
   SHULTS CW, 1995, NEUROLOGY, V45, P344, DOI 10.1212/WNL.45.2.344
   SIAN J, 1994, ANN NEUROL, V36, P348, DOI 10.1002/ana.410360305
   Simon DK, 2000, NEUROLOGY, V54, P703, DOI 10.1212/WNL.54.3.703
   SOFIC E, 1992, NEUROSCI LETT, V142, P128, DOI 10.1016/0304-3940(92)90355-B
   Sun F, 2007, PHARMACOL THERAPEUT, V114, P327, DOI 10.1016/j.pharmthera.2007.04.001
   Thomas B, 2007, HUM MOL GENET, V16, PR183, DOI 10.1093/hmg/ddm159
   Trounce I A, 1996, METHODS ENZYMOL, V264, P484, DOI 10.1016/S0076-6879(96)64044-0
   Valdivieso AG, 2007, BIOCHEM BIOPH RES CO, V356, P805, DOI 10.1016/j.bbrc.2007.03.057
   Vives-Bauza C, 2002, BIOCHEM BIOPH RES CO, V290, P1593, DOI 10.1006/bbrc.2002.6388
   Winkler-Stuck K, 2005, J NEURAL TRANSM, V112, P499, DOI 10.1007/s00702-004-0195-y
NR 45
TC 2
Z9 2
U1 0
U2 4
PU WALTER DE GRUYTER GMBH
PI BERLIN
PA GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY
SN 0250-4685
EI 1303-829X
J9 TURK J BIOCHEM
JI Turk. J. Biochem.
PD JUN 15
PY 2009
VL 34
IS 2
BP 97
EP 104
DI 
PG 8
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 508MJ
UT WOS:000270935200007
DA 2024-11-01
ER

PT J
AU Da Pozzo, P
   Cardaioli, E
   Malfatti, E
   Gallus, GN
   Malandrini, A
   Gaudiano, C
   Berti, G
   Invernizzi, F
   Zeviani, M
   Federico, A
AF Da Pozzo, Paola
   Cardaioli, Elena
   Malfatti, Edoardo
   Gallus, Gian Nicola
   Malandrini, Alessandro
   Gaudiano, Carmen
   Berti, Gianna
   Invernizzi, Federica
   Zeviani, Massimo
   Federico, Antonio
TI A novel mutation in the mitochondrial <i>tRNA<SUP>Pro</SUP></i> gene associated with late-onset ataxia, retinitis pigmentosa, deafness, leukoencephalopathy and complex I deficiency
SO EUROPEAN JOURNAL OF HUMAN GENETICS
LA English
DT Article
DE mtDNA; transfer RNA(Pro); mitochondrial disease
ID progressive external ophthalmoplegia; point mutation; a3243g mutation; dna; disorders; features; disease; sequence; patient
AB We present a patient with ataxia, retinitis pigmentosa, dysarthria, neurosensorial deafness, nystagmus and leukoencephalopathy. A novel heteroplasmic G to A transition at nucleotide 15 975 was found, affecting the T arm of the mitochondrial (mt) tRNA(Pro) gene. A biochemical analysis of respiratory chain enzymes in muscle revealed isolated complex I deficiency. This is the fourth pathogenic tRNA(Pro) point mutation to be associated with an mt disorder. The result highlights the importance of molecular dissection of mtDNA in patients with defined mt disorder and confirms the clinical and biochemical heterogeneity associated with tRNA(Pro) mutations. European Journal of Human Genetics (2009) 17, 1092-1096; doi:10.1038/ejhg.2009.12; published online 18 February 2009
C1 [Da Pozzo, Paola; Cardaioli, Elena; Malfatti, Edoardo; Gallus, Gian Nicola; Malandrini, Alessandro; Gaudiano, Carmen; Berti, Gianna; Federico, Antonio] Univ Siena, Sch Med, Dept Neurol Neurosurg & Behav Sci, I-53100 Siena, Italy.
   [Invernizzi, Federica; Zeviani, Massimo] C Besta Neurol Inst Fdn IRCCS, Pierfranco & Luisa Mariani Ctr Study Childrens Mi, Unit Mol Neurogenet, Milan, Italy.
C3 University of Siena
RP Federico, A (corresponding author), Univ Siena, Sch Med, Dept Neurol Neurosurg & Behav Sci, Viale Bracci 2, I-53100 Siena, Italy.
EM federico@unisi.it
FU University of Siena; Regione Toscana
CR Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   Bugiani M, 2004, BBA-BIOENERGETICS, V1659, P136, DOI 10.1016/j.bbabio.2004.09.006
   Cardaioli E, 2005, BIOCHEM BIOPH RES CO, V327, P675, DOI 10.1016/j.bbrc.2004.11.170
   Cardaioli E, 2007, NEUROMUSCULAR DISORD, V17, P681, DOI 10.1016/j.nmd.2007.05.001
   Chinnery PF, 2000, ANN NEUROL, V47, P381, DOI 10.1002/1531-8249(200003)47:3<381::AID-ANA17>3.0.CO;2-2
   Da Pozzo P, 2004, BIOCHEM BIOPH RES CO, V324, P360, DOI 10.1016/j.bbrc.2004.09.058
   Giegé R, 1998, NUCLEIC ACIDS RES, V26, P5017, DOI 10.1093/nar/26.22.5017
   Grasbon-Frodl EM, 1999, NEUROGENETICS, V2, P121, DOI 10.1007/s100480050063
   IONASESCU VV, 1994, NEUROLOGY, V44, P975, DOI 10.1212/WNL.44.5.975
   Keränen T, 2006, EPILEPTIC DISORD, V8, P200
   Kirino Y, 2005, P NATL ACAD SCI USA, V102, P7127, DOI 10.1073/pnas.0500563102
   Koga Y, 2000, ACTA NEUROPATHOL, V99, P186, DOI 10.1007/PL00007423
   MITOMAP, 2008, HUM MIT GEN DAT, V0, P0
   Pancrudo J, 2007, J CHILD NEUROL, V22, P858, DOI 10.1177/0883073807304199
   SCHON EA, 1994, J BIOENERG BIOMEMBR, V26, P291, DOI 10.1007/BF00763100
   Seneca S, 2000, J INHERIT METAB DIS, V23, P853, DOI 10.1023/A:1026729223050
   Spagnolo M, 2001, NEUROMUSCULAR DISORD, V11, P481, DOI 10.1016/S0960-8966(01)00195-X
   Wong LJC, 2002, AM J MED GENET, V113, P59, DOI 10.1002/ajmg.10767
   Zeviani M, 1998, MEDICINE, V77, P59, DOI 10.1097/00005792-199801000-00006
   Zeviani M, 2007, CURR OPIN NEUROL, V20, P564, DOI 10.1097/WCO.0b013e3282ef58cd
   Zifa E, 2007, RNA BIOL, V4, P38, DOI 10.4161/rna.4.1.4548
NR 21
TC 23
Z9 24
U1 0
U2 1
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1018-4813
EI 
J9 EUR J HUM GENET
JI Eur. J. Hum. Genet.
PD AUG 15
PY 2009
VL 17
IS 8
BP 1092
EP 1096
DI 10.1038/ejhg.2009.12
PG 5
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA 474DD
UT WOS:000268261700017
PM 19223931
DA 2024-11-01
ER

PT J
AU Tyynismaa, H
   Suomalainen, A
AF Tyynismaa, Henna
   Suomalainen, Anu
TI Mouse models of mitochondrial DNA defects and their relevance for human disease
SO EMBO REPORTS
LA English
DT Review
DE mitochondria; mitochondrial DNA; mouse model
ID transcription factor-a; adenine-nucleotide translocator; multiple mtdna deletions; thymidine kinase; polymerase-gamma; rapid segregation; point mutation; knockout mice; gene; myopathy
AB Qualitative and quantitative changes in mitochondrial DNA (mtDNA) have been shown to be common causes of inherited neurodegenerative and muscular diseases, and have also been implicated in ageing. These diseases can be caused by primary mtDNA mutations, or by defects in nuclear-encoded mtDNA maintenance proteins that cause secondary mtDNA mutagenesis or instability. Furthermore, it has been proposed that mtDNA copy number affects cellular tolerance to environmental stress. However, the mechanisms that regulate mtDNA copy number and the tissue-specific consequences of mtDNA mutations are largely unknown. As post-mitotic tissues differ greatly from proliferating cultured cells in their need for mtDNA maintenance, and as most mitochondrial diseases affect post-mitotic cell types, the mouse is an important model in which to study mtDNA defects. Here, we review recently developed mouse models, and their contribution to our knowledge of mtDNA maintenance and its role in disease.
C1 [Tyynismaa, Henna; Suomalainen, Anu] Univ Helsinki, Biomedicum, Res Programme Mol Neurol, FIN-00290 Helsinki, Finland.
   [Tyynismaa, Henna; Suomalainen, Anu] Univ Helsinki, Cent Hosp, Dept Neurol, FIN-00290 Helsinki, Finland.
C3 University of Helsinki; University of Helsinki; Helsinki University Central Hospital
RP Tyynismaa, H (corresponding author), Univ Helsinki, Biomedicum, Res Programme Mol Neurol, RC523B,Haartmaninkatu 8,POB 63, FIN-00290 Helsinki, Finland.
EM henna.tyynismaa@helsinki.fi
FU European Molecular Biology organization; Sigrid Juselius Foundation; Academy of Finland; University of Helsinki; Helsinki University Central Hospital; Helsinki Biomedical Graduate School
CR Akman HO, 2008, HUM MOL GENET, V17, P2433, DOI 10.1093/hmg/ddn143
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Battersby BJ, 2005, HUM MOL GENET, V14, P2587, DOI 10.1093/hmg/ddi293
   Battersby BJ, 2003, NAT GENET, V33, P183, DOI 10.1038/ng1073
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   Cerritelli SM, 2003, MOL CELL, V11, P807, DOI 10.1016/S1097-2765(03)00088-1
   Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010
   Cree LM, 2008, NAT GENET, V40, P249, DOI 10.1038/ng.2007.63
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   Ekstrand MI, 2007, P NATL ACAD SCI USA, V104, P1325, DOI 10.1073/pnas.0605208103
   Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786
   Finsterer J, 2007, ACTA NEUROL SCAND, V116, P1, DOI 10.1111/j.1600-0404.2007.00836.x
   FISHER RP, 1988, MOL CELL BIOL, V8, P3496, DOI 10.1128/MCB.8.8.3496
   Götz A, 2008, BRAIN, V131, P2841, DOI 10.1093/brain/awn236
   Graham BH, 1997, NAT GENET, V16, P226, DOI 10.1038/ng0797-226
   Graziewicz MA, 2006, CHEM REV, V106, P383, DOI 10.1021/cr040463d
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   Hance N, 2005, HUM MOL GENET, V14, P1775, DOI 10.1093/hmg/ddi184
   Haraguchi M, 2002, MOL CELL BIOL, V22, P5212, DOI 10.1128/MCB.22.14.5212-5221.2002
   Hayashi M, 2006, NAT MED, V12, P128, DOI 10.1038/nm1327
   Hayashi Y, 2008, J NEUROSCI, V28, P8624, DOI 10.1523/JNEUROSCI.1957-08.2008
   Hosseini SH, 2007, AM J PATHOL, V170, P865, DOI 10.2353/ajpath.2007.060655
   Hudson G, 2006, HUM MOL GENET, V15, PR244, DOI 10.1093/hmg/ddl233
   Huo L, 2001, MOL CELL BIOL, V21, P644, DOI 10.1128/MCB.21.2.644-654.2001
   Ikeuchi M, 2005, CIRCULATION, V112, P683, DOI 10.1161/CIRCULATIONAHA.104.524835
   Inoue K, 2000, NAT GENET, V26, P176, DOI 10.1038/82826
   Jenuth JP, 1996, NAT GENET, V14, P146, DOI 10.1038/ng1096-146
   Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455
   Kanki T, 2004, MOL CELL BIOL, V24, P9823, DOI 10.1128/MCB.24.22.9823-9834.2004
   Kasahara T, 2006, MOL PSYCHIATR, V11, P577, DOI 10.1038/sj.mp.4001824
   Kaufman BA, 2007, MOL BIOL CELL, V18, P3225, DOI 10.1091/mbc.E07-05-0404
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Kimura T, 2003, NAT GENET, V34, P440, DOI 10.1038/ng1212
   KOBAYASHI Y, 1991, AM J HUM GENET, V49, P590
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231
   Lewis W, 2007, LAB INVEST, V87, P326, DOI 10.1038/labinvest.3700523
   Li H, 2000, P NATL ACAD SCI USA, V97, P3467, DOI 10.1073/pnas.97.7.3467
   Marchington DR, 1999, NAT MED, V5, P957, DOI 10.1038/11403
   McGregor A, 2001, MOL GENET GENOMICS, V265, P721, DOI 10.1007/s004380100469
   Nakada K, 2004, BIOCHEM BIOPH RES CO, V323, P175, DOI 10.1016/j.bbrc.2004.08.073
   Palmieri L, 2005, HUM MOL GENET, V14, P3079, DOI 10.1093/hmg/ddi341
   REID FM, 1994, HUM MUTAT, V3, P243, DOI 10.1002/humu.1380030311
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Sarzi E, 2007, J PEDIATR-US, V150, P531, DOI 10.1016/j.jpeds.2007.01.044
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Shoubridge EA, 2001, HUM MOL GENET, V10, P2277, DOI 10.1093/hmg/10.20.2277
   Silva JP, 2000, NAT GENET, V26, P336, DOI 10.1038/81649
   Silva JP, 2002, BBA-BIOENERGETICS, V1555, P106, DOI 10.1016/S0005-2728(02)00263-3
   Sligh JE, 2000, P NATL ACAD SCI USA, V97, P14461, DOI 10.1073/pnas.250491597
   Sörensen L, 2001, J NEUROSCI, V21, P8082, DOI 10.1523/JNEUROSCI.21-20-08082.2001
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Srivastava S, 2005, HUM MOL GENET, V14, P893, DOI 10.1093/hmg/ddi082
   Stewart JB, 2008, PLOS BIOL, V6, P63, DOI 10.1371/journal.pbio.0060010
   Suomalainen A, 1997, NEUROLOGY, V48, P1244, DOI 10.1212/WNL.48.5.1244
   Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Tyynismaa H, 2004, HUM MOL GENET, V13, P3219, DOI 10.1093/hmg/ddh342
   Viscomi C, 2009, HUM MOL GENET, V18, P12, DOI 10.1093/hmg/ddn309
   Wang JM, 1999, NAT GENET, V21, P133, DOI 10.1038/5089
   WEIHER H, 1990, CELL, V62, P425, DOI 10.1016/0092-8674(90)90008-3
   Wredenberg A, 2002, P NATL ACAD SCI USA, V99, P15066, DOI 10.1073/pnas.232591499
   Zeviani M, 2004, BRAIN, V127, P2153, DOI 10.1093/brain/awh259
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
   Zhang DK, 2000, GENOMICS, V69, P151, DOI 10.1006/geno.2000.6333
   Zhou XS, 2008, HUM MOL GENET, V17, P2329, DOI 10.1093/hmg/ddn133
NR 69
TC 71
Z9 79
U1 0
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1469-221X
EI 1469-3178
J9 EMBO REP
JI EMBO Rep.
PD FEB 15
PY 2009
VL 10
IS 2
BP 137
EP 143
DI 10.1038/embor.2008.242
PG 7
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 403ZE
UT WOS:000263119700010
PM 19148224
DA 2024-11-01
ER

PT J
AU Whittaker, RG
   Turnbull, DM
AF Whittaker, R. G.
   Turnbull, D. M.
TI A diagnostic tattoo
SO CLINICAL GENETICS
LA English
DT Article
DE diagnosis; MERRF; mitochondrial disease
ID ragged-red fibers; mitochondrial trna(lys); myoclonic epilepsy; mutation; merrf; gene
AB The hallmarks of the myoclonic epilepsy with ragged red fibers (MERRF) syndrome are myoclonic epilepsy, ataxia and ragged red fibres detected on muscle biopsy. We present a case of a 25-year-old male who first presented to his general practitioner at the age of 22 years with myoclonic jerks affecting the arms and legs, fatigue and mild ataxia. He was found to carry an A > G transition at nucleotide 8344 in mitochondrial DNA. This mutation is the most common cause of the MERRF syndrome, found in more than 80% of affected patients. Our patient had the diagnosis tattooed on his arm, both out of frustration at how few people had heard of it, and as a way of accepting that his condition was a part of who he was. Although the MERRF syndrome is one of the more common forms of mitochondrial encephalomyopathy, with a prevalence estimated at between 0.25 and 0.39 per 100,000, it is still a rare disorder. We are always striving to increase the public's understanding of these important conditions. Our patient has perhaps helped more than most towards this aspiration.
C1 [Whittaker, R. G.; Turnbull, D. M.] Royal Victoria Infirm, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England.
   [Whittaker, R. G.; Turnbull, D. M.] Royal Victoria Infirm, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England.
C3 Newcastle University - UK; Newcastle University - UK
RP Whittaker, RG (corresponding author), Newcastle Univ, Sch Med, Mitochondrial Res Grp, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM r.whittaker@ncl.ac.uk
FU Wellcome Trust [074454] Funding Source: Medline
CR Chinnery PF, 2000, ANN NEUROL, V48, P188, DOI 10.1002/1531-8249(200008)48:2<188::AID-ANA8>3.3.CO;2-G
   Ozawa M, 1997, MUSCLE NERVE, V20, P271, DOI 10.1002/(SICI)1097-4598(199703)20:3<271::AID-MUS2>3.0.CO;2-8
   Rossmanith W, 2003, ANN NEUROL, V54, P820, DOI 10.1002/ana.10753
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   SILVESTRI G, 1992, AM J HUM GENET, V51, P1213
NR 5
TC 5
Z9 5
U1 0
U2 9
PU WILEY-BLACKWELL PUBLISHING, INC
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0009-9163
EI 
J9 CLIN GENET
JI Clin. Genet.
PD JAN 15
PY 2009
VL 75
IS 1
BP 37
EP 38
DI 10.1111/j.1399-0004.2008.01103.x
PG 2
WC Genetics & Heredity
SC Genetics & Heredity
GA 389XP
UT WOS:000262129200004
PM 19128396
DA 2024-11-01
ER

PT J
AU Kim, JT
   Lee, YJ
   Lee, YM
   Kang, HC
   Lee, JS
   Kim, HD
AF Kim, Jeong Tae
   Lee, Yun Jin
   Lee, Young Mock
   Kang, Hoon Chul
   Lee, Joon Soo
   Kim, Heung Dong
TI Clinical characteristics of patients with non-specific and non-categorized mitochondrial diseases
SO ACTA PAEDIATRICA
LA English
DT Article
DE Magnetic resonance imaging; Mitochondria; Neuromuscular system; Respiratory chain complex
ID pediatric-patients; disorders; children; dna; manifestations; diagnosis; deletions; spectrum
AB Aim: Mitochondrial disease is a heterogeneous disorder entity induced by defects in mitochondrial respiratory chain complex (MRC). A significant portion of patients with MRC defect will not conform to a specific, known syndrome. We have analysed the clinical features of 108 Korean paediatric patients with non-specific and non-categorized mitochondrial disease. Methods: We retrospectively reviewed the clinical and laboratory features of 108 paediatrics patients with non-specific and non-categorized mitochondrial diseases who showed defects in MRC activity, confirmed by spectrophotometric biochemical enzyme assay of their muscles. Results: Neuromuscular involvement was noted in all patients, with developmental delay and seizure accounting for 92.6% and 77.8% of total patients respectively. Various extraneurological symptoms were observed. Most patients exhibited MRC I defect, accounting for 100 (92.6%) patients. The most common brain magnetic resonance imaging (MRI) finding was diffuse cerebral atrophy. However, in 23.1% of patients, no notable changes were visible on MRI. Conclusions: Mitochondrial respiratory chain complex I defect was the most common finding in this study. Though neuromuscular symptoms predominated, with presence of numerous extraneurological findings, we could not find any novel symptoms that might be unique to this category of mitochondrial disease. But, comparatively, more patients presented with unremarkable birth histories and normal brain MRI findings.
C1 [Kim, Jeong Tae; Lee, Yun Jin; Lee, Young Mock; Kang, Hoon Chul; Lee, Joon Soo; Kim, Heung Dong] Yonsei Univ, Severance Childrens Hosp, Gangnam Severance Hosp, Dept Pediat,Coll Med, Seoul 135720, South Korea.
C3 Yonsei University; Yonsei University Health System
RP Lee, YM (corresponding author), Yonsei Univ, Severance Childrens Hosp, Gangnam Severance Hosp, Dept Pediat,Coll Med, POB 1217,712 Eonjuro,146-92 Dogok Dong, Seoul 135720, South Korea.
EM ymleemd@yuhs.ac
FU Korean Government (MEST) [KRF-2008-331-E00154]
CR Barragán-Campos HM, 2005, ARCH NEUROL-CHICAGO, V62, P737, DOI 10.1001/archneur.62.5.737
   Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   Debray FG, 2007, PEDIATRICS, V119, P722, DOI 10.1542/peds.2006-1866
   Finsterer J, 2004, EUR J NEUROL, V11, P163, DOI 10.1046/j.1351-5101.2003.00728.x
   García-Cazorla A, 2005, PEDIATRICS, V116, P1170, DOI 10.1542/peds.2004-2407
   Gibson K, 2008, PEDIATRICS, V122, P1003, DOI 10.1542/peds.2007-3502
   Gillis L, 2002, PEDIATR CLIN N AM, V49, P203, DOI 10.1016/S0031-3955(03)00115-9
   Haas RH, 2007, PEDIATRICS, V120, P1326, DOI 10.1542/peds.2007-0391
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Kang HC, 2007, CHILD NERV SYST, V23, P1301, DOI 10.1007/s00381-007-0369-7
   Kim J, 2008, EUR RADIOL, V18, P1741, DOI 10.1007/s00330-008-0921-1
   Kirby DM, 1999, NEUROLOGY, V52, P1255, DOI 10.1212/WNL.52.6.1255
   Lee YM, 2008, EPILEPSIA, V49, P685, DOI 10.1111/j.1528-1167.2007.01522.x
   LUFT R, 1962, J CLIN INVEST, V41, P1776, DOI 10.1172/JCI104637
   Martín-Hernández E, 2005, PEDIATR NEPHROL, V20, P1299, DOI 10.1007/s00467-005-1948-z
   McFarland R, 2007, CURR TOP DEV BIOL, V77, P113, DOI 10.1016/S0070-2153(06)77005-3
   Munnich A, 1996, J INHERIT METAB DIS, V19, P521, DOI 10.1007/BF01799112
   RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8
   Scaglia F, 2004, PEDIATRICS, V114, P925, DOI 10.1542/peds.2004-0718
   Sperl W, 1997, WIEN KLIN WOCHENSCHR, V109, P93
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   von Kleist-Retzow JC, 2003, J PEDIATR-US, V143, P208, DOI 10.1067/S0022-3476(03)00130-6
   ZEVIANI M, 1988, NEUROLOGY, V38, P1339
NR 23
TC 14
Z9 15
U1 1
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0803-5253
EI 1651-2227
J9 ACTA PAEDIATR
JI Acta Paediatr.
PD NOV 15
PY 2009
VL 98
IS 11
BP 1825
EP 1829
DI 10.1111/j.1651-2227.2009.01428.x
PG 5
WC Pediatrics
SC Pediatrics
GA 503PI
UT WOS:000270549700025
PM 19659453
DA 2024-11-01
ER

PT J
AU Alavi, MV
   Fuhrmann, N
   Nguyen, HP
   Yu-Wai-Man, P
   Heiduschka, P
   Chinnery, PF
   Wissinger, B
AF Alavi, Marcel V.
   Fuhrmann, Nico
   Nguyen, Huu Phuc
   Yu-Wai-Man, Patrick
   Heiduschka, Peter
   Chinnery, Patrick F.
   Wissinger, Bernd
TI Subtle neurological and metabolic abnormalities in an <i>Opa1</i> mouse model of autosomal dominant optic atrophy
SO EXPERIMENTAL NEUROLOGY
LA English
DT Article
DE Opa1; ADOA; Mouse; mtDNA; Rotarod; Accelerod; Neuromuscular abnormalities; Subclinical; Life expectancy; SHIRPA; Tremor; Limb grasping
ID dynamin-related protein; cytochrome-c release; mitochondrial morphology; external ophthalmoplegia; gene; mutations; fusion; deletions; defects; disease
AB The ubiquitously expressed gene OPA1 is the main disease causing gene for autosomal dominant optic atrophy (ADOA). These patients present with bilateral reduction in visual acuity, central visual field defects and impaired color vision, secondary to the progressive loss of retinal ganglion cells (RGCs) and subsequent degeneration of the optic nerve. Up to now, it is not clear why a mutation in a ubiquitously expressed gene affects only RGCs and the optic nerve. Twenty-two-month-old Opa1 animals underwent a full examination following the Shirpa protocol. Weight, food intake and life span were monitored. Rotarod treadmill experiments were performed to assess neuromuscular function. Limb skeletal muscle was evaluated morphologically, mitochondrial cytochrome c oxidase (COX) activity was studied histochemically and mtDNA integrity was determined by long-range PCR. The Shirpa test showed that 33% of the Opa1 mice suffered from tremor and 52% of the Opa1 animals showed an abnormal clutching reflex. Control animals performed well in the accelerating Rotarod treadmill experiment whereas the Opa1 mice performed significantly worse. Skeletal muscle fibers were morphologically normal, had normal COX activity and showed no evidence of secondary mtDNA damage in contrast to patients with syndromic ADOA. We also found a highly significant difference in body weight. Our results demonstrate that OPA1 mutations affect not only RGCs but also other tissues and cell types, though to a lesser extent. In particular we found deficits in both neuromuscular and metabolic function. We therefore want to encourage clinicians to be vigilant about to extra-ocular manifestations in ADOA patients. (C) 2009 Elsevier Inc. All rights reserved.
C1 [Alavi, Marcel V.; Fuhrmann, Nico; Wissinger, Bernd] Univ Tubingen, Ctr Ophthalmol, Inst Ophthalm Res, Mol Genet Lab, D-72076 Tubingen, Germany.
   [Nguyen, Huu Phuc] Univ Tubingen, Dept Med Genet, D-72076 Tubingen, Germany.
   [Yu-Wai-Man, Patrick; Chinnery, Patrick F.] Newcastle Univ, Sch Med, Inst Ageing & Hlth, Mitochondrial Res Grp, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
   [Yu-Wai-Man, Patrick] Royal Victoria Infirm, Dept Ophthalmol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England.
C3 Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Newcastle University - UK; Newcastle University - UK
RP Alavi, MV (corresponding author), Univ Tubingen, Ctr Ophthalmol, Inst Ophthalm Res, Mol Genet Lab, Rontgenweg 11, D-72076 Tubingen, Germany.
EM marcel.alavi@googlemail.com
FU MRC Clinical Research Fellow; Wellcome Trust Senior Fellow in Clinical Science; MRC [G0701386] Funding Source: UKRI
CR Alavi MV, 2007, BRAIN, V130, P1029, DOI 10.1093/brain/awm005
   Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944
   Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   Barbet F, 2005, J MED GENET, V42, P0, DOI 10.1136/jmg.2004.025502
   Bette S, 2005, ACTA NEUROPATHOL, V109, P393, DOI 10.1007/s00401-004-0970-8
   CALDWELL JB, 1971, ARCH OPHTHALMOL-CHIC, V85, P133, DOI 10.1001/archopht.1971.00990050135004
   Cipolat S, 2004, P NATL ACAD SCI USA, V101, P15927, DOI 10.1073/pnas.0407043101
   Cipolat S, 2006, CELL, V126, P163, DOI 10.1016/j.cell.2006.06.021
   Davies VJ, 2007, HUM MOL GENET, V16, P1307, DOI 10.1093/hmg/ddm079
   Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936
   Ferraris S, 2008, ARCH NEUROL-CHICAGO, V65, P125, DOI 10.1001/archneurol.2007.9
   Ferré M, 2005, HUM MUTAT, V25, P423, DOI 10.1002/humu.20161
   Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025
   Friedman MJ, 2007, NAT NEUROSCI, V10, P1519, DOI 10.1038/nn2011
   Fuhrmann N, 2009, J MED GENET, V46, P136, DOI 10.1136/jmg.2008.062570
   Hales KG, 1997, CELL, V90, P121, DOI 10.1016/S0092-8674(00)80319-0
   HAYASAKI H, 2001, CELL MOL BIOL, V47, P0
   Heiduschka P, 2010, INVEST OPHTH VIS SCI, V51, P1424, DOI 10.1167/iovs.09-3606
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   JAEGER W, 1966, J GENET HUM, V15, P312
   Kerrison JB, 1999, ARCH OPHTHALMOL-CHIC, V117, P805
   KIVLIN JD, 1983, AM J HUM GENET, V35, P1190
   Kjer B, 1996, ACTA OPHTHALMOL SCAN, V74, P3
   KLEIN R, 1994, NATURE, V368, P249, DOI 10.1038/368249a0
   KLINE LB, 1979, ARCH OPHTHALMOL-CHIC, V97, P1680, DOI 10.1001/archopht.1979.01020020248013
   Lorenz B, 1994, OPHTHALMOLOGE, V91, P831
   Man CYYW, 2005, MED HYPOTHESES, V65, P1038, DOI 10.1016/j.mehy.2004.10.021
   Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0
   Manttari Satu, 2005, BMC PHYSIOL, V5, P4, DOI 10.1186/1472-6793-5-4
   MARCHBANK NJ, 2002, J MED GENET E, V47, P39
   Nguyen HP, 2006, HUM MOL GENET, V15, P3177, DOI 10.1093/hmg/ddl394
   Olichon A, 2007, CELL DEATH DIFFER, V14, P682, DOI 10.1038/sj.cdd.4402048
   Olichon A, 2003, J BIOL CHEM, V278, P7743, DOI 10.1074/jbc.C200677200
   Olichon A, 2002, FEBS LETT, V523, P171, DOI 10.1016/S0014-5793(02)02985-X
   Reynolds B, 2004, J COMMUN NETW-UK, V3, P1
   ROGGEVEEN HCJ, 1985, OPHTHALMIC PAED GEN, V5, P103, DOI 10.3109/13816818509007863
   ROWLATT C, 1976, LABORATORY ANIMALS (LONDON), V10, P419, DOI 10.1258/002367776780956917
   Spinazzi M, 2008, HUM MOL GENET, V17, P3291, DOI 10.1093/hmg/ddn225
   Taylor RW, 2004, NEUROMUSCULAR DISORD, V14, P237, DOI 10.1016/j.nmd.2003.12.004
   Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Yu-Wai-Man P, 2009, INVEST OPHTH VIS SCI, V50, P4561, DOI 10.1167/iovs.09-3634
   Zeviani M, 2008, BRAIN, V131, P314, DOI 10.1093/brain/awm339
NR 43
TC 41
Z9 46
U1 1
U2 7
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0014-4886
EI 1090-2430
J9 EXP NEUROL
JI Exp. Neurol.
PD DEC 15
PY 2009
VL 220
IS 2
BP 404
EP 409
DI 10.1016/j.expneurol.2009.09.026
PG 6
WC Neurosciences
SC Neurosciences & Neurology
GA 528FV
UT WOS:000272428700026
PM 19815013
DA 2024-11-01
ER

PT J
AU Tzoulis, C
   Papingji, M
   Fiskestrand, T
   Roste, LS
   Bindoff, LA
AF Tzoulis, C.
   Papingji, M.
   Fiskestrand, T.
   Roste, L. S.
   Bindoff, L. A.
TI Mitochondrial DNA depletion in progressive external ophthalmoplegia caused by <i>POLG1</i> mutations
SO ACTA NEUROLOGICA SCANDINAVICA
LA English
DT Article
DE progressive external ophthalmoplegia; POLG; mtDNA; depletion
ID polymerase-gamma mutations; deletions; disease; parkinsonism; spectrum
AB Objectives - To investigate two patients with late onset, progressive external ophthalmoplegia (PEO) and sensory peripheral neuropathy. Materials & Methods - The patients aged 86 and 50 years were investigated clinically including magnetic resonance imaging of the brain, electrophysiological studies and, in one, skeletal muscle biopsy. Molecular studies included sequencing of the whole coding region of the POLG1 gene and mitochondrial DNA (mtDNA) analysis for deletions and depletion. Results - Both patients were compound heterozygous for gene encoding the catalytic subunit of the DNA-polymerase gamma (POLG1) mutations. One had the p.737R and p.W748S mutations while the other carried the p.T251I, p.P587L and p.W748S mutations. While these mutations have been previously described, these combinations are novel. mtDNA studies in skeletal muscle showed evidence of multiple deletions and approximately 64% depletion of the mitochondrial genome. Conclusion - Our findings broaden the genotypic spectrum of POLG-associated PEO and show that in addition to multiple deletions, mtDNA depletion occurs and may contribute to the pathogenesis of this disorder.
C1 [Tzoulis, C.; Papingji, M.; Bindoff, L. A.] Haukeland Hosp, Dept Neurol, N-5021 Bergen, Norway.
   [Tzoulis, C.; Bindoff, L. A.] Univ Bergen, Dept Clin Med, Bergen, Norway.
   [Fiskestrand, T.] Haukeland Hosp, Ctr Med Genet & Mol Med, N-5021 Bergen, Norway.
   [Roste, L. S.] Univ Hosp, Dept Neurol, Div Clin Neurosci, Rikshosp, Oslo, Norway.
C3 University of Bergen; Haukeland University Hospital; University of Bergen; University of Bergen; Haukeland University Hospital; University of Oslo; National Hospital Norway
RP Bindoff, LA (corresponding author), Haukeland Hosp, Dept Neurol, N-5021 Bergen, Norway.
EM laurence.bindoff@nevro.uib.no
CR Agostino A, 2003, NEUROLOGY, V60, P1354, DOI 10.1212/01.WNL.0000056088.09408.3C
   Ashley N, 2008, HUM MOL GENET, V17, P2496, DOI 10.1093/hmg/ddn150
   Davidzon G, 2006, ANN NEUROL, V59, P859, DOI 10.1002/ana.20831
   Di Fonzo A, 2003, HUM MUTAT, V22, P0, DOI 10.1002/humu.9203
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   Filosto M, 2003, ARCH NEUROL-CHICAGO, V60, P1279, DOI 10.1001/archneur.60.9.1279
   González-Vioque E, 2006, ARCH NEUROL-CHICAGO, V63, P107, DOI 10.1001/archneur.63.1.107
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   Hakonen AH, 2007, EUR J HUM GENET, V15, P779, DOI 10.1038/sj.ejhg.5201831
   Harrower T, 2008, ARCH NEUROL-CHICAGO, V65, P133, DOI 10.1001/archneurol.2007.4
   He LP, 2002, NUCLEIC ACIDS RES, V30, P0, DOI 10.1093/nar/gnf067
   Hirano M, 2001, SEMIN CELL DEV BIOL, V12, P417, DOI 10.1006/scdb.2001.0279
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Kollberg G, 2006, J NEUROPATH EXP NEUR, V65, P758, DOI 10.1097/01.jnen.0000229987.17548.6e
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Pagnamenta AT, 2006, HUM REPROD, V21, P2467, DOI 10.1093/humrep/del076
   Tzoulis C, 2006, BRAIN, V129, P1685, DOI 10.1093/brain/awl097
   Winterthun S, 2005, NEUROLOGY, V64, P1204, DOI 10.1212/01.WNL.0000156516.77696.5A
   Wong LJC, 2008, HUM MUTAT, V29, PE150, DOI 10.1002/humu.20824
NR 19
TC 13
Z9 13
U1 0
U2 2
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0001-6314
EI 
J9 ACTA NEUROL SCAND
JI Acta Neurol. Scand.
PD AUG 15
PY 2009
VL 120
IS 
BP 38
EP 41
DI 10.1111/j.1600-0404.2009.01212.x
PG 4
WC Clinical Neurology
SC Neurosciences & Neurology
GA 463IK
UT WOS:000267425400008
PM 19566497
DA 2024-11-01
ER

PT J
AU Sikorska, M
   Sandhu, JK
   Simon, DK
   Pathiraja, V
   Sodja, C
   Li, Y
   Ribecco-Lutkiewicz, M
   Lanthier, P
   Borowy-Borowski, H
   Upton, A
   Raha, S
   Pulst, SM
   Tarnopolsky, MA
AF Sikorska, Marianna
   Sandhu, Jagdeep K.
   Simon, David K.
   Pathiraja, Vimukthi
   Sodja, Caroline
   Li, Yan
   Ribecco-Lutkiewicz, Maria
   Lanthier, Patricia
   Borowy-Borowski, Henryk
   Upton, Adrian
   Raha, Sandeep
   Pulst, Stefan M.
   Tarnopolsky, Mark A.
TI IDENTIFICATION OF ATAXIA-ASSOCIATED mtDNA MUTATIONS (m.4052T&gt;C and m.9035T&gt;C) AND EVALUATION OF THEIR PATHOGENICITY IN TRANSMITOCHONDRIAL CYBRIDS
SO MUSCLE & NERVE
LA English
DT Article
DE antioxidant; homoplasmic mutations; mitochondrial; oxidative stress; therapy
ID mitochondrial-dna mutations; leigh-syndrome; atp synthase; myoclonic epilepsy; lactic-acidosis; coenzyme q(10); transfer-rnas; disease; expression; disorders
AB The potential pathogenicity of two homoplasmic mtDNA point mutations, 9035T>C and 4452T>C, found in a family afflicted with maternally transmitted cognitive developmental delay, learning disability, and progressive ataxia was evaluated using transmitochondrial cybrids. We confirmed that the 4452T>C transition in tRNA(Met) represented a polymorphism; however, 9035T>C conversion in the ATP6 gene was responsible for a defective F(0)-ATPase. Accordingly, mutant cybrids had a reduced oligomycin-sensitive ATP hydrolyzing activity. They had less than half of the steady-state content of ATP and nearly an 8-fold higher basal level of reactive oxygen species (ROS). Mutant cybrids were unable to cope with additional insults, i.e., glucose deprivation or tertiary-butyl hydroperoxide, and they succumbed to either apoptotic or necrotic cell death. Both of these outcomes were prevented by the antioxidants CoQ(10) and vitamin E, suggesting that the abnormally high levels of ROS were the triggers of cell death. In conclusion, the principal metabolic defects, i.e., energy deficiency and ROS burden, resulted from the 9035T>C mutation and could be responsible for the development of clinical symptoms in this family. Furthermore, antioxidant therapy might prove helpful in the management of this disease. Muscle Nerve 40: 381-394, 2009
C1 [Sikorska, Marianna; Sandhu, Jagdeep K.; Sodja, Caroline; Li, Yan; Ribecco-Lutkiewicz, Maria; Lanthier, Patricia; Borowy-Borowski, Henryk] Natl Res Council Canada, Neurogenesis & Brain Repair Grp M54, Inst Biol Sci, Ottawa, ON K1A 0R6, Canada.
   [Simon, David K.; Pathiraja, Vimukthi] Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA.
   [Simon, David K.; Pathiraja, Vimukthi] Harvard Univ, Sch Med, Boston, MA USA.
   [Upton, Adrian; Tarnopolsky, Mark A.] McMaster Univ, Dept Med Neurol, Hamilton, ON L8N 3Z5, Canada.
   [Raha, Sandeep; Tarnopolsky, Mark A.] McMaster Univ, Dept Pediat Neuromuscular & Neurometab Disorders, Hamilton, ON L8N 3Z5, Canada.
   [Pulst, Stefan M.] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA.
C3 National Research Council Canada; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; McMaster University; McMaster University; Cedars Sinai Medical Center
RP Sikorska, M (corresponding author), Natl Res Council Canada, Neurogenesis & Brain Repair Grp M54, Inst Biol Sci, 1200 Montreal Rd, Ottawa, ON K1A 0R6, Canada.
EM marianna.sikorska@nrc.ca; tarnopol@mcmaster.ca
CR Aksenov MY, 1998, J MOL NEUROSCI, V11, P151, DOI 10.1385/JMN:11:2:151
   Borowy-Borowski H, 2004, J DRUG TARGET, V12, P415, DOI 10.1080/10611860412331285233
   Boyer PD, 2002, J BIOL CHEM, V277, P39045, DOI 10.1074/jbc.X200001200
   Carelli V, 2003, TRENDS GENET, V19, P257, DOI 10.1016/S0168-9525(03)00072-6
   Chen XL, 2004, CURR PHARM DESIGN, V10, P879, DOI 10.2174/1381612043452901
   Chomyn A, 1998, AM J HUM GENET, V62, P745, DOI 10.1086/301813
   CIAFALONI E, 1993, J PEDIATR-US, V122, P419, DOI 10.1016/S0022-3476(05)83431-6
   CIAFALONI E, 1992, ANN NEUROL, V31, P391, DOI 10.1002/ana.410310408
   Debray FG, 2007, AM J MED GENET A, V143A, P2046, DOI 10.1002/ajmg.a.31880
   DIMAURO S, 1993, ARCH NEUROL-CHICAGO, V50, P1197, DOI 10.1001/archneur.1993.00540110075008
   Finsterer J, 2004, EUR J NEUROL, V11, P163, DOI 10.1046/j.1351-5101.2003.00728.x
   Florentz C, 2003, CELL MOL LIFE SCI, V60, P1356, DOI 10.1007/s00018-003-2343-1
   Florholmen G, 2004, J MOL CELL CARDIOL, V37, P1183, DOI 10.1016/j.yjmcc.2004.09.008
   Graves S, 1998, METHODS MOL BIOL, V108, P353
   HAMMANS SR, 1993, BRAIN, V116, P617, DOI 10.1093/brain/116.3.617
   Han D, 2001, BIOCHEM J, V353, P411, DOI 10.1042/0264-6021:3530411
   Helm M, 2000, RNA, V6, P1356, DOI 10.1017/S1355838200001047
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   ISSARTEL JP, 1992, EXPERIENTIA, V48, P351, DOI 10.1007/BF01923429
   Jayaraman S, 2005, J IMMUNOL METHODS, V306, P68, DOI 10.1016/j.jim.2005.07.024
   Lee JI, 2006, BIOCHEM J, V393, P181, DOI 10.1042/BJ20051111
   McFarland R, 2007, NEUROLOGY, V69, P911, DOI 10.1212/01.wnl.0000267843.10977.4a
   MEISTER A, 1988, J BIOL CHEM, V263, P17205
   Miquel J, 2002, ANN NY ACAD SCI, V959, P508, DOI 10.1111/j.1749-6632.2002.tb02120.x
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   Morgan-Hughes JA, 1999, BBA-BIOENERGETICS, V1410, P125, DOI 10.1016/S0005-2728(98)00162-5
   Muller FL, 2004, J BIOL CHEM, V279, P49064, DOI 10.1074/jbc.M407715200
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Qu J, 2006, INVEST OPHTH VIS SCI, V47, P475, DOI 10.1167/iovs.05-0665
   Rastogi VK, 1999, NATURE, V402, P263, DOI 10.1038/46224
   Sandhu JK, 2005, BIOCHEM J, V391, P191, DOI 10.1042/BJ20050272
   Schon EA, 2000, TRENDS BIOCHEM SCI, V25, P555, DOI 10.1016/S0968-0004(00)01688-1
   Schon EA, 1997, J BIOENERG BIOMEMBR, V29, P131, DOI 10.1023/A:1022685929755
   Schon EA, 2001, SEMIN CELL DEV BIOL, V12, P441, DOI 10.1006/scdb.2001.0281
   Sgarbi G, 2006, BIOCHEM J, V395, P493, DOI 10.1042/BJ20051748
   Shults CW, 2002, ARCH NEUROL-CHICAGO, V59, P1541, DOI 10.1001/archneur.59.10.1541
   Sikorska M, 2003, BIOFACTORS, V18, P173, DOI 10.1002/biof.5520180220
   Simon DK, 1999, ANNU REV MED, V50, P111
   St-Pierre J, 2002, J BIOL CHEM, V277, P44784, DOI 10.1074/jbc.M207217200
   Sternberg D, 1998, HUM MOL GENET, V7, P33, DOI 10.1093/hmg/7.1.33
   Sternberg D, 2001, BRAIN, V124, P984, DOI 10.1093/brain/124.5.984
   Tarnopolsky MA, 2004, MUSCLE NERVE, V29, P537, DOI 10.1002/mus.20020
   Tipnis SR, 1999, BIOCHEM J, V337, P559, DOI 10.1042/0264-6021:3370559
   Vissing J, 1998, NEUROLOGY, V50, P1875, DOI 10.1212/WNL.50.6.1875
   Wallace DC, 2001, MENT RETARD DEV D R, V7, P158, DOI 10.1002/mrdd.1023
   Weber K, 2002, BIOL CHEM, V383, P283, DOI 10.1515/BC.2002.030
   White SL, 1999, AM J HUM GENET, V65, P474, DOI 10.1086/302488
   Young AJ, 2007, CNS SPECTRUMS, V12, P62, DOI 10.1017/S1092852900020538
   Zeviani M, 2004, BRAIN, V127, P2153, DOI 10.1093/brain/awh259
NR 49
TC 21
Z9 22
U1 0
U2 3
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0148-639X
EI 
J9 MUSCLE NERVE
JI Muscle Nerve
PD SEP 15
PY 2009
VL 40
IS 3
BP 381
EP 394
DI 10.1002/mus.21355
PG 14
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 492ZH
UT WOS:000269701500008
PM 19626676
DA 2024-11-01
ER

PT J
AU Baqri, RM
   Turner, BA
   Rheuben, MB
   Hammond, BD
   Kaguni, LS
   Miller, KE
AF Baqri, Rehan M.
   Turner, Brittany A.
   Rheuben, Mary B.
   Hammond, Bradley D.
   Kaguni, Laurie S.
   Miller, Kyle E.
TI Disruption of Mitochondrial DNA Replication in <i>Drosophila</i> Increases Mitochondrial Fast Axonal Transport <i>In Vivo</i>
SO PLOS ONE
LA English
DT Article
ID marie-tooth-disease; polymerase-gamma; oxidative-phosphorylation; catalytic subunit; accessory subunit; alpers-syndrome; polg mutations; kinesin; neurons; melanogaster
AB Mutations in mitochondrial DNA polymerase (pol gamma) cause several progressive human diseases including Parkinson's disease, Alper's syndrome, and progressive external ophthalmoplegia. At the cellular level, disruption of pol gamma leads to depletion of mtDNA, disrupts the mitochondrial respiratory chain, and increases susceptibility to oxidative stress. Although recent studies have intensified focus on the role of mtDNA in neuronal diseases, the changes that take place in mitochondrial biogenesis and mitochondrial axonal transport when mtDNA replication is disrupted are unknown. Using high-speed confocal microscopy, electron microscopy and biochemical approaches, we report that mutations in pol gamma deplete mtDNA levels and lead to an increase in mitochondrial density in Drosophila proximal nerves and muscles, without a noticeable increase in mitochondrial fragmentation. Furthermore, there is a rise in flux of bidirectional mitochondrial axonal transport, albeit with slower kinesin-based anterograde transport. In contrast, flux of synaptic vesicle precursors was modestly decreased in pol gamma-alpha mutants. Our data indicate that disruption of mtDNA replication does not hinder mitochondrial biogenesis, increases mitochondrial axonal transport, and raises the question of whether high levels of circulating mtDNA-deficient mitochondria are beneficial or deleterious in mtDNA diseases.
RP Baqri, RM (corresponding author), Michigan State Univ, Dept Zool, E Lansing, MI 48824 USA.
EM kmiller@msu.edu
FU NIGMS NIH HHS [R01 GM045295, GM45295] Funding Source: Medline
CR Adán C, 2008, J BIOL CHEM, V283, P12333, DOI 10.1074/jbc.M801342200
   Amiri M, 2008, DEV NEUROBIOL, V68, P1348, DOI 10.1002/dneu.20668
   Ashley N, 2005, EXP CELL RES, V303, P432, DOI 10.1016/j.yexcr.2004.10.013
   Atlante A, 2005, BBA-BIOENERGETICS, V1708, P50, DOI 10.1016/j.bbabio.2005.01.009
   Baloh RH, 2007, J NEUROSCI, V27, P422, DOI 10.1523/JNEUROSCI.4798-06.2007
   Beal MF, 2005, ANN NEUROL, V58, P495, DOI 10.1002/ana.20624
   Betts J, 2004, NEUROCHEM RES, V29, P505, DOI 10.1023/B:NERE.0000014821.07269.8d
   BRADY ST, 1985, NATURE, V317, P73, DOI 10.1038/317073a0
   Chang DTW, 2006, NEUROBIOL DIS, V22, P388, DOI 10.1016/j.nbd.2005.12.007
   Davidzon G, 2006, ANN NEUROL, V59, P859, DOI 10.1002/ana.20831
   Davis AF, 1996, J CELL BIOL, V135, P883, DOI 10.1083/jcb.135.4.883
   De Vos KJ, 2007, HUM MOL GENET, V16, P2720, DOI 10.1093/hmg/ddm226
   DIMAURO S, 1987, J INHERIT METAB DIS, V10, P113, DOI 10.1007/BF01812852
   Ebneth A, 1998, J CELL BIOL, V143, P777, DOI 10.1083/jcb.143.3.777
   Escobar-Khondiker M, 2007, J NEUROSCI, V27, P7827, DOI 10.1523/JNEUROSCI.1644-07.2007
   Ferreirinha F, 2004, J CLIN INVEST, V113, P231, DOI 10.1172/JCI200420138
   Fisher ME, 2001, P NATL ACAD SCI USA, V98, P7748, DOI 10.1073/pnas.141080498
   FRIEDE RL, 1977, J PHYSIOL-LONDON, V265, P507, DOI 10.1113/jphysiol.1977.sp011727
   Gajewski CD, 2003, MOL BIOL CELL, V14, P3628, DOI 10.1091/mbc.E02-12-0796
   GODDARD JM, 1978, P NATL ACAD SCI USA, V75, P3886, DOI 10.1073/pnas.75.8.3886
   Goldstein AYN, 2008, CURR OPIN NEUROBIOL, V18, P495, DOI 10.1016/j.conb.2008.10.003
   Goldstein LSB, 2003, NEURON, V40, P415, DOI 10.1016/S0896-6273(03)00630-5
   GOTT AL, 1990, HUM REPROD, V5, P104, DOI 10.1093/oxfordjournals.humrep.a137028
   Hansson A, 2004, P NATL ACAD SCI USA, V101, P3136, DOI 10.1073/pnas.0308710100
   Harrower T, 2008, ARCH NEUROL-CHICAGO, V65, P133, DOI 10.1001/archneurol.2007.4
   Heddi A, 1999, J BIOL CHEM, V274, P22968, DOI 10.1074/jbc.274.33.22968
   Hirokawa N, 2008, PHYSIOL REV, V88, P1089, DOI 10.1152/physrev.00023.2007
   HOLLENBECK PJ, 1985, CELL BIOL INT REP, V9, P193, DOI 10.1016/0309-1651(85)90094-3
   Iyengar B, 1999, GENETICS, V153, P1809
   Iyengar B, 2002, P NATL ACAD SCI USA, V99, P4483, DOI 10.1073/pnas.072664899
   Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455
   Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717
   Klopfenstein DR, 2004, MOL BIOL CELL, V15, P3729, DOI 10.1091/mbc.E04-04-0326
   Knott AB, 2008, NAT REV NEUROSCI, V9, P505, DOI 10.1038/nrn2417
   Kundu M, 2005, CELL DEATH DIFFER, V12, P1484, DOI 10.1038/sj.cdd.4401780
   Legros F, 2004, J CELL SCI, V117, P2653, DOI 10.1242/jcs.01134
   Lewis DL, 1996, J BIOL CHEM, V271, P23389, DOI 10.1074/jbc.271.38.23389
   Lewis W, 2003, NAT REV DRUG DISCOV, V2, P812, DOI 10.1038/nrd1201
   Liu D, 2006, NEUROMOL MED, V8, P389, DOI 10.1385/NMM:8:3:389
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Luoma PT, 2007, NEUROLOGY, V69, P1152, DOI 10.1212/01.wnl.0000276955.23735.eb
   Mansouri A, 2003, HEPATOLOGY, V38, P715, DOI 10.1053/jhep.2003.50353
   MARTINEZAZORIN F, 2007, J NEUROCHEM, V0, P0
   McKenzie M, 2007, J BIOL CHEM, V282, P36845, DOI 10.1074/jbc.M704158200
   Miller KE, 2004, J CELL SCI, V117, P2791, DOI 10.1242/jcs.01130
   Miller KE, 2005, CURR BIOL, V15, P684, DOI 10.1016/j.cub.2005.02.061
   Mironov SL, 2007, BIOPHYS J, V92, P2944, DOI 10.1529/biophysj.106.092981
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Naviaux RK, 1999, ANN NEUROL, V45, P54, DOI 10.1002/1531-8249(199901)45:1<54::AID-ART10>3.0.CO;2-B
   OCHS S, 1971, J NEUROCHEM, V18, P107, DOI 10.1111/j.1471-4159.1971.tb00172.x
   PASCHAL BM, 1987, J CELL BIOL, V105, P1273, DOI 10.1083/jcb.105.3.1273
   Piccioni F, 2002, FASEB J, V16, P1418, DOI 10.1096/fj.01-1035fje
   PILLING AD, 2006, MOL BIOL CELL, V0, P0
   Samuels DC, 2006, IUBMB LIFE, V58, P403, DOI 10.1080/15216540600791571
   Sanyal S, 2009, GENE EXPR PATTERNS, V9, P371, DOI 10.1016/j.gep.2009.01.002
   SENIOR AE, 1988, PHYSIOL REV, V68, P177, DOI 10.1152/physrev.1988.68.1.177
   SHOFFNER JM, 1994, ANNU REV NUTR, V14, P535, DOI 10.1146/annurev.nu.14.070194.002535
   Smeitink JA, 2006, CELL METAB, V3, P9, DOI 10.1016/j.cmet.2005.12.001
   Sweeney ST, 2002, NEURON, V36, P403, DOI 10.1016/S0896-6273(02)01014-0
   VALE RD, 1985, CELL, V42, P39, DOI 10.1016/S0092-8674(85)80099-4
   Verburg J, 2008, J NEUROSCI, V28, P8306, DOI 10.1523/JNEUROSCI.2614-08.2008
   Wang YX, 1997, J BIOL CHEM, V272, P13640, DOI 10.1074/jbc.272.21.13640
NR 63
TC 31
Z9 33
U1 0
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA
SN 1932-6203
EI 
J9 PLOS ONE
JI PLoS One
PD NOV 17
PY 2009
VL 4
IS 11
BP 
EP 
DI 10.1371/journal.pone.0007874
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 520OG
UT WOS:000271854200020
PM 19924234
DA 2024-11-01
ER

PT J
AU Wong, J
   McLennan, SV
   Molyneaux, L
   Min, D
   Twigg, SM
   Yue, DK
AF Wong, J.
   McLennan, S. V.
   Molyneaux, L.
   Min, D.
   Twigg, S. M.
   Yue, D. K.
TI Mitochondrial DNA content in peripheral blood monocytes: relationship with age of diabetes onsetand diabetic complications
SO DIABETOLOGIA
LA English
DT Article
DE Age of onset; Diabetic complications; DNA; Macrophage; Mitochondria; Monocyte; Type 2 diabetes
ID of-onset; insulin-secretion; skeletal-muscle; increased risk; gene variation; nitric-oxide; mellitus; inflammation; nephropathy; sensitivity
AB We examined whether age of type 2 diabetes onset is related to mitochondrial DNA content in peripheral blood monocytes (PBMCs). PBMCs were isolated from 65 patients with type 2 diabetes. To minimise age as a confounder, only patients aged a parts per thousand yen50 years were studied. Sample mitochondrial DNA (mtDNA) content was determined by amplification of the mitochondrial gene CYT-B (also known as MT-CYB) and adjusted for single-copy nuclear control genes (36B4 [also known as RPLPO] and GAPDH). Age of diabetes onset ranged from 25 to 69 years. There was a significant positive relationship between age of diabetes onset in quartiles and mtDNA content for the whole group (p = 0.02 for trend). When stratified by the presence of diabetes complications, a strong positive relationship was observed between age of diagnosis and mtDNA content for participants without diabetic complications (r = 0.7; p = 0.0002), but not for those with complications (r = -0.04; p = 0.8). Multivariate analysis confirmed age of onset and complication status as independent determinants. There was co-linearity between age of onset and disease duration, with similar relationships also seen between duration and mtDNA content. An earlier age of type 2 diabetes onset is associated with a lower PBMC mtDNA content, but only in patients without diabetes complications. This may reflect a differing biology of PBMC mtDNA in those with early-onset diabetes and those who are prone to complications. PBMC mtDNA depletion may accelerate diabetes onset; however the independent effect of diabetes duration remains to be evaluated.
C1 [Wong, J.; Molyneaux, L.; Twigg, S. M.; Yue, D. K.] Royal Prince Alfred Hosp, Ctr Diabet, Sydney, NSW 2050, Australia.
   [Wong, J.; McLennan, S. V.; Molyneaux, L.; Twigg, S. M.; Yue, D. K.] Univ Sydney, Discipline Med, Sydney, NSW 2006, Australia.
   [Wong, J.; McLennan, S. V.; Min, D.; Twigg, S. M.; Yue, D. K.] Royal Prince Alfred Hosp, Dept Endocrinol, Sydney, NSW 2050, Australia.
C3 NSW Health; Royal Prince Alfred Hospital; University of Sydney; University of Sydney; University of Sydney; NSW Health; Royal Prince Alfred Hospital
RP Wong, J (corresponding author), Royal Prince Alfred Hosp, Ctr Diabet, Level 6,Missenden Rd, Sydney, NSW 2050, Australia.
EM jencia.wong@email.cs.nsw.gov.au
CR Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S
   [Anonymous], 1991, OPHTHALMOLOGY, V98, P786
   ANTONETTI DA, 1995, J CLIN INVEST, V95, P1383, DOI 10.1172/JCI117790
   Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185
   Baughman JM, 2006, NAT GENET, V38, P1232, DOI 10.1038/ng1106-1232
   Bogacka I, 2005, DIABETES, V54, P1392, DOI 10.2337/diabetes.54.5.1392
   Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615
   Curran JE, 2007, HUM MOL GENET, V16, P1504, DOI 10.1093/hmg/ddm101
   Ehses JA, 2007, DIABETES, V56, P2356, DOI 10.2337/db06-1650
   Flavell DM, 2005, DIABETES, V54, P582, DOI 10.2337/diabetes.54.2.582
   Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733
   Gourlain K, 2003, HIV MED, V4, P287, DOI 10.1046/j.1468-1293.2003.00158.x
   Guo Y, 2006, DIABETES, V55, P3625, DOI 10.2337/db06-0379
   Hanson RL, 2007, DIABETES, V56, P3045, DOI 10.2337/db07-0462
   Heine GH, 2008, KIDNEY INT, V73, P622, DOI 10.1038/sj.ki.5002744
   Hevener AL, 2007, J CLIN INVEST, V117, P1658, DOI 10.1172/JCI31561
   Hillier TA, 2003, DIABETES CARE, V26, P2999, DOI 10.2337/diacare.26.11.2999
   Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485
   Jaakkola U, 2006, EXP CLIN ENDOCR DIAB, V114, P147, DOI 10.1055/s-2006-924079
   Ji LN, 2001, CHINESE MED J-PEKING, V114, P1205
   Lee HK, 1998, DIABETES RES CLIN PR, V42, P161, DOI 10.1016/S0168-8227(98)00110-7
   Lehman DM, 2007, DIABETES, V56, P389, DOI 10.2337/db06-0860
   MCGILL M, 1993, DIABETIC MED, V10, P366, DOI 10.1111/j.1464-5491.1993.tb00082.x
   Moreno-Loshuertos R, 2006, NAT GENET, V38, P1261, DOI 10.1038/ng1897
   Nisoli E, 2006, J CELL SCI, V119, P2855, DOI 10.1242/jcs.03062
   Ochi M, 2007, DIABETES, V56, P2834, DOI 10.2337/db06-1157
   Oliva R, 2004, ENDOCRINE, V24, P111, DOI 10.1385/ENDO:24:2:111
   Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314
   Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, P0, DOI 10.1093/nar/29.9.e45
   Schick BA, 2007, CLIN PHARMACOL THER, V81, P650, DOI 10.1038/sj.clpt.6100124
   SERRADAS P, 1995, ENDOCRINOLOGY, V136, P5623, DOI 10.1210/en.136.12.5623
   Silva JP, 2000, NAT GENET, V26, P336, DOI 10.1038/81649
   Singh R, 2007, DIABETIC MED, V24, P784, DOI 10.1111/j.1464-5491.2007.02164.x
   Song J, 2001, DIABETES CARE, V24, P865, DOI 10.2337/diacare.24.5.865
   Sukhorukov VS, 2000, ARKHIV PATOLOGII, V62, P19
   Tedesco L, 2008, DIABETES, V57, P2028, DOI 10.2337/db07-1623
   Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751
   Wang H, 1999, EUR J APPL PHYSIOL O, V80, P22, DOI 10.1007/s004210050553
   Wiederkehr A, 2006, ENDOCRINOLOGY, V147, P2643, DOI 10.1210/en.2006-0057
   Wiltshire S, 2004, DIABETES, V53, P855, DOI 10.2337/diabetes.53.3.855
   Wong J, 2008, DIABETES CARE, V31, P1985, DOI 10.2337/dc08-0580
   YOSHIHARU T, 2008, METAB CLIN EXP, V57, P453
   Yu TZ, 2006, P NATL ACAD SCI USA, V103, P2653, DOI 10.1073/pnas.0511154103
   Zeggini E, 2004, DIABETES, V53, P3319, DOI 10.2337/diabetes.53.12.3319
NR 44
TC 46
Z9 48
U1 0
U2 3
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0012-186X
EI 1432-0428
J9 DIABETOLOGIA
JI Diabetologia
PD SEP 15
PY 2009
VL 52
IS 9
BP 1953
EP 1961
DI 10.1007/s00125-009-1424-6
PG 9
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 480ZN
UT WOS:000268776100030
PM 19629432
DA 2024-11-01
ER

PT J
AU Spinazzola, A
   Zeviani, M
AF Spinazzola, Antonella
   Zeviani, Massimo
TI Mitochondrial Diseases: A Cross-Talk Between Mitochondrial and Nuclear Genomes
SO INHERITED NEUROMUSCULAR DISEASES: TRANSLATION FROM PATHMECHANISMS TO THERAPIES
LA English
DT Article; Proceedings Paper
DE Mitochondrial disease; Mitochondrial DNA; mtDNA depletion; mtDNA multiple deletions; Nucleus; Mitochondrion cross-talk
ID progressive external ophthalmoplegia; nucleoside-diphosphate kinase; adenine-nucleotide translocator; dna depletion syndrome; autosomal-dominant; neurogastrointestinal encephalomyopathy; multiple deletions; polg mutations; navajo neurohepatopathy; mtdna depletion
AB More than one billion years ago, mitochondria were free-living prokaryotic organisms with their own DNA. However, during the evolution, ancestral genes have been transferred from the mitochondrial to the nuclear genome so that mtDNA became dependent on numerous nucleus-encoded factors for its integrity, replication and expression. Mutations in any of these factors may alter the cross-talk between the two genomes and cause Mendelian diseases that affect mtDNA integrity or expression.
C1 [Spinazzola, Antonella; Zeviani, Massimo] Fdn IRCCS Neurol Inst C Besta, Unit Mol Neurogenet, I-20126 Milan, Italy.
RP Zeviani, M (corresponding author), Fdn IRCCS Neurol Inst C Besta, Unit Mol Neurogenet, Via LiberoTemolo 4, I-20126 Milan, Italy.
EM zeviani@istituto-besta.it
CR Agostino A, 2003, NEUROLOGY, V60, P1354, DOI 10.1212/01.WNL.0000056088.09408.3C
   Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944
   Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   Bornstein B, 2008, NEUROMUSCULAR DISORD, V18, P453, DOI 10.1016/j.nmd.2008.04.006
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   Calvo S, 2006, NAT GENET, V38, P576, DOI 10.1038/ng1776
   Carrozzo R, 2007, BRAIN, V130, P862, DOI 10.1093/brain/awl389
   Clayton DA, 2000, EXP CELL RES, V255, P4, DOI 10.1006/excr.1999.4763
   Contamine V, 2000, MICROBIOL MOL BIOL R, V64, P281, DOI 10.1128/MMBR.64.2.281-315.2000
   Davidzon G, 2005, ANN NEUROL, V57, P921, DOI 10.1002/ana.20498
   Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936
   Deschauer M, 2003, NEUROMUSCULAR DISORD, V13, P568, DOI 10.1016/S0960-8966(03)00071-3
   Duvezin-Caubet S, 2006, J BIOL CHEM, V281, P37972, DOI 10.1074/jbc.M606059200
   Elpeleg O, 2005, AM J HUM GENET, V76, P1081, DOI 10.1086/430843
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   Ferraro P, 2005, J BIOL CHEM, V280, P24472, DOI 10.1074/jbc.M502869200
   Filosto M, 2003, ARCH NEUROL-CHICAGO, V60, P1279, DOI 10.1001/archneur.60.9.1279
   Galassi G, 2008, NEUROMUSCULAR DISORD, V18, P465, DOI 10.1016/j.nmd.2008.03.013
   Galbiati S, 2006, PEDIATR NEUROL, V34, P177, DOI 10.1016/j.pediatrneurol.2005.07.013
   Graziewicz MA, 2004, NAT STRUCT MOL BIOL, V11, P770, DOI 10.1038/nsmb805
   HAKONEN AH, 2008, HUM MOL GENET 0905, V0, P0
   Hakonen AH, 2007, BRAIN, V130, P3032, DOI 10.1093/brain/awm242
   Hirano M, 2006, NEUROLOGY, V67, P1458, DOI 10.1212/01.wnl.0000240853.97716.24
   Hirano M, 2001, SEMIN CELL DEV BIOL, V12, P417, DOI 10.1006/scdb.2001.0279
   HIRANO M, 1994, NEUROLOGY, V44, P721, DOI 10.1212/WNL.44.4.721
   Holt IJ, 2000, CELL, V100, P515, DOI 10.1016/S0092-8674(00)80688-1
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   Invernizzi F, 2008, NEUROMUSCULAR DISORD, V18, P460, DOI 10.1016/j.nmd.2008.04.005
   KADRMAS EF, 1991, BIOCHIM BIOPHYS ACTA, V1074, P339, DOI 10.1016/0304-4165(91)90083-S
   Kajander OA, 2000, HUM MOL GENET, V9, P2821, DOI 10.1093/hmg/9.19.2821
   Karadimas CL, 2006, AM J HUM GENET, V79, P544, DOI 10.1086/506913
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   KAVANAUGHBLACK A, 1994, P NATL ACAD SCI USA, V91, P5883, DOI 10.1073/pnas.91.13.5883
   KJER P, 1959, ACTA OPHTHALMOL S54, V37, P1
   Kowluru A, 2002, ARCH BIOCHEM BIOPHYS, V398, P160, DOI 10.1006/abbi.2001.2710
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   Lara MC, 2006, NEUROLOGY, V67, P1461, DOI 10.1212/01.wnl.0000239824.95411.52
   Lee YJ, 2004, MOL BIOL CELL, V15, P5001, DOI 10.1091/mbc.E04-04-0294
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   Martí R, 2004, CLIN CHEM, V50, P120, DOI 10.1373/clinchem.2003.026179
   MIZUSAWA H, 1988, J NEUROL SCI, V86, P171, DOI 10.1016/0022-510X(88)90096-2
   MORAES CT, 1991, AM J HUM GENET, V48, P492
   Moslemi AR, 1996, ANN NEUROL, V40, P707, DOI 10.1002/ana.410400506
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Nikali K, 2005, HUM MOL GENET, V14, P2981, DOI 10.1093/hmg/ddi328
   Nishigaki Y, 2003, J CLIN INVEST, V111, P1913, DOI 10.1172/JCI200317828
   Nishino I, 2000, ANN NEUROL, V47, P792
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Oskoui M, 2006, ARCH NEUROL-CHICAGO, V63, P1122, DOI 10.1001/archneur.63.8.1122
   Ostergaard E, 2007, AM J HUM GENET, V81, P383, DOI 10.1086/519222
   Ostergaard E, 2007, BRAIN, V130, P853, DOI 10.1093/brain/awl383
   Palmieri L, 2005, HUM MOL GENET, V14, P3079, DOI 10.1093/hmg/ddi341
   PARKS RE, 1973, COMP BIOCHEM PHYSIOL, V45, P355, DOI 10.1016/0305-0491(73)90070-9
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Salviati L, 2002, ANN NEUROL, V52, P311, DOI 10.1002/ana.10284
   Sarzi E, 2007, ANN NEUROL, V62, P579, DOI 10.1002/ana.21207
   SERVIDEI S, 1991, NEUROLOGY, V41, P1053, DOI 10.1212/WNL.41.7.1053
   Song SW, 2003, J BIOL CHEM, V278, P43893, DOI 10.1074/jbc.C300401200
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Spinazzola A, 2005, GENE, V354, P162, DOI 10.1016/j.gene.2005.03.025
   Spinazzola A, 2002, J BIOL CHEM, V277, P4128, DOI 10.1074/jbc.M111028200
   Spinazzola A, 2008, ARCH NEUROL-CHICAGO, V65, P1108, DOI 10.1001/archneur.65.8.1108
   Spinazzola A, 2008, NEUROMUSCULAR DISORD, V18, P315, DOI 10.1016/j.nmd.2007.12.007
   Tadiboyina VT, 2005, AM J MED GENET A, V135A, P289, DOI 10.1002/ajmg.a.30748
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   TRITSCHLER HJ, 1992, NEUROLOGY, V42, P209, DOI 10.1212/WNL.42.1.209
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2004, NEUROLOGY, V63, P1251, DOI 10.1212/01.WNL.0000140494.58732.83
   Van Goethem G, 2003, NEUROMUSCULAR DISORD, V13, P133, DOI 10.1016/S0960-8966(02)00216-X
   Vu TH, 2001, HEPATOLOGY, V34, P116, DOI 10.1053/jhep.2001.25921
   WANG X, 2008, HUM MOL GENET, V0, P0
   Winterthun S, 2005, NEUROLOGY, V64, P1204, DOI 10.1212/01.WNL.0000156516.77696.5A
   Wong LJC, 2007, HEPATOLOGY, V46, P1218, DOI 10.1002/hep.21799
   Yavuz H, 2007, ARCH NEUROL-CHICAGO, V64, P435, DOI 10.1001/archneur.64.3.435
   YUZAKI M, 1989, BIOCHEM BIOPH RES CO, V164, P1352, DOI 10.1016/0006-291X(89)91818-4
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
NR 80
TC 25
Z9 25
U1 0
U2 3
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 0065-2598
EI 2214-8019
J9 ADV EXP MED BIOL
JI Adv.Exp.Med.Biol.
PD JUN 15
PY 2009
VL 652
IS 
BP 69
EP 84
DI 10.1007/978-90-481-2813-6_6
PG 16
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA BOT76
UT WOS:000277561400006
PM 20225020
DA 2024-11-01
ER

PT J
AU Zecic, A
   Smet, JE
   De Praeter, CM
   Vanhaesebrouck, P
   Viscomi, C
   Van Den Broecke, C
   De Paepe, B
   Lohse, P
   Martin, JJ
   Jackson, JG
   Campbell, CR
   De Meirleir, LJ
   Zeviani, M
   Seneca, SH
   Lissens, W
   Van Coster, RN
AF Zecic, Alexandra
   Smet, Joel E.
   De Praeter, Claudine M.
   Vanhaesebrouck, Piet
   Viscomi, Carlo
   Van Den Broecke, Caroline
   De Paepe, Boel
   Lohse, Peter
   Martin, Jean-Jacques
   Jackson, Joshua G.
   Campbell, Colin R.
   De Meirleir, Linda J.
   Zeviani, Massimo
   Seneca, Sara H.
   Lissens, Willy
   Van Coster, Rudy N.
TI Lactic Acidosis in a Newborn With Adrenal Calcifications
SO PEDIATRIC RESEARCH
LA English
DT Article
ID respiratory-chain; mutation; translation; deficiency; siblings; defects; disease; infancy
AB A patient is reported who presented in the newborn period with an unusual combination of congenital lactic acidosis and bilateral calcifications in the adrenal medulla, visible on standard abdominal x-ray and ultrasound examination. At birth, the proband was hypotonic and dystrophic. She developed respiratory insufficiency, cardiomegaly, and hepatomegaly and died at the age of 38 d. Examination of postmortem heart muscle revealed multiple areas of myocardial infarction with dystrophic calcifications. In the medulla of the adrenal glands, foci of necrosis and calcifications, and in the liver, multiple zones of necrosis and iron deposition were detected. Biochemical-analysis in heart muscle revealed a decreased activity of complex IV of the oxidative phosphorylation (OXPHOS) and in liver a combined deficiency involving the complexes I, III, IV, and V. The findings were suggestive of a defect in biosynthesis of the mitochondrially encoded subunits of the OXPHOS complexes. Extensive analysis of the proband's mitochondrial DNA revealed neither pathogenic deletions and point mutations nor copy number alterations. Relative amounts of mitochondrial transcripts for the ribosomal mitochondrial 12S rRNA (12S) and mitochondrial 16S rRNA (16S) were significantly increased suggesting a compensatory mechanism involving the transcription machinery to low levels of translation. The underlying molecular defect has not been identified yet. (Pediatr Res 66: 317-322, 2009)
C1 [Zecic, Alexandra; De Praeter, Claudine M.; Vanhaesebrouck, Piet] Ghent Univ Hosp, Dept Neonatol, B-9000 Ghent, Belgium.
   [Smet, Joel E.; De Paepe, Boel; Van Coster, Rudy N.] Ghent Univ Hosp, Dept Pediat Neurol & Metab, B-9000 Ghent, Belgium.
   [Van Den Broecke, Caroline] Ghent Univ Hosp, Dept Pathol, B-9000 Ghent, Belgium.
   [Viscomi, Carlo; Zeviani, Massimo] Ist Nazl Neurol Carlo Besta, Dept Mol Neurogenet, I-20126 Milan, Italy.
   [Lohse, Peter] Univ Munich, Dept Clin Chem, D-81377 Munich, Germany.
   [Martin, Jean-Jacques] Univ Antwerp, Dept Neuropathol, B-2610 Antwerp, Belgium.
   [Jackson, Joshua G.; Campbell, Colin R.] Univ Minnesota, Sch Med, Dept Pharmacol, Minneapolis, MN 55455 USA.
   [De Meirleir, Linda J.; Seneca, Sara H.; Lissens, Willy] Univ Hosp Brussels, Dept Med Genet, B-1090 Brussels, Belgium.
C3 Ghent University; Ghent University Hospital; Ghent University; Ghent University Hospital; Ghent University; Ghent University Hospital; Fondazione IRCCS Istituto Neurologico Carlo Besta; University of Munich; University of Antwerp; University of Minnesota System; University of Minnesota Twin Cities; University Hospital Brussels
RP Van Coster, RN (corresponding author), Ghent Univ Hosp, Dept Pediat, Div Pediat Neurol & Metab, Pintelaan 185, B-9000 Ghent, Belgium.
EM rudy.vancoster@ugent.be
FU Fund for Scientific Research (FWO) Belgium [G.0666.06]; Kid-AuQuai foundation
CR BIRCHMACHIN MA, 1989, PEDIATR RES, V25, P553, DOI 10.1203/00006450-198905000-00025
   Carrozzo R, 2006, ANN NEUROL, V59, P265, DOI 10.1002/ana.20729
   Coenen MJH, 2004, NEW ENGL J MED, V351, P2080, DOI 10.1056/NEJMoa041878
   De A, 2007, BIOCHEM J, V402, P175, DOI 10.1042/BJ20061004
   De Paepe B, 2006, PEDIATR RES, V59, P2, DOI 10.1203/01.pdr.0000191294.34122.ab
   DIMAURO S, 1987, ANN NEUROL, V22, P498, DOI 10.1002/ana.410220409
   FISCHER JC, 1986, EUR J PEDIATR, V144, P441, DOI 10.1007/BF00441735
   Indumathi CK, 2005, INDIAN JOURNAL OF PEDIATRICS, V72, P1049, DOI 10.1007/BF02724410
   Lohse P, 2000, J LIPID RES, V41, P23
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MAGNIN D, 1973, HELV PAEDIATR ACTA, V28, P135
   Miller C, 2004, ANN NEUROL, V56, P734, DOI 10.1002/ana.20282
   MORRISON SC, 1988, PEDIATR RADIOL, V18, P240, DOI 10.1007/BF02390405
   Nijtmans LGJ, 2001, J BIOL CHEM, V276, P6755, DOI 10.1074/jbc.M008114200
   ROBINSON BH, 1992, EUR J PEDIATR, V151, P347, DOI 10.1007/BF02113256
   RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8
   Saada A, 2007, J MED GENET, V44, P784, DOI 10.1136/jmg.2007.053116
   Smeitink JAM, 2006, AM J HUM GENET, V79, P869, DOI 10.1086/508434
   SOTTOCASA GL, 1967, J CELL BIOL, V32, P415, DOI 10.1083/jcb.32.2.415
   Srere PA, 1969, METHODS IN ENZYMOLOGY, V13, P3
   Valente L, 2007, AM J HUM GENET, V80, P44, DOI 10.1086/510559
   Van Coster R, 2001, PEDIATR RES, V50, P658, DOI 10.1203/00006450-200111000-00020
   van Straaten HLM, 2005, NEUROPEDIATRICS, V36, P193, DOI 10.1055/s-2005-865713
   WOLMAN M, 1961, PEDIATRICS, V28, P742
NR 24
TC 4
Z9 4
U1 0
U2 4
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
SN 0031-3998
EI 1530-0447
J9 PEDIATR RES
JI Pediatr. Res.
PD SEP 15
PY 2009
VL 66
IS 3
BP 317
EP 322
DI 10.1203/PDR.0b013e3181b40a80
PG 6
WC Pediatrics
SC Pediatrics
GA 488HK
UT WOS:000269339800014
PM 19581830
DA 2024-11-01
ER

PT J
AU Gasser, RB
   Campbell, BE
   Jex, AR
AF Gasser, Robin B.
   Campbell, Bronwyn E.
   Jex, Aaron R.
TI Mutation scanning-coupled tools for the analysis of genetic variation in <i>Taenia</i> and diagnosis - Status and prospects
SO INFECTION GENETICS AND EVOLUTION
LA English
DT Review
DE Taenia; Mutation scanning; Specific identification; Systematics; Epidemiology; Population genetics
ID strand conformation polymorphism; polymerase-chain-reaction; dna differential-diagnosis; real-time pcr; ribosomal dna; mitochondrial genm; capillary-electrophoresis; saginata cysticercosis; parasitic nematodes; echinococcus-multilocularis
AB Cestodes of the genus Taenia occur as adult tapeworms in the small intestine of carnivorous definitive hosts and are transmitted to particular mammalian intermediate hosts, in which they develop as fluid-filled larvae in tissues, causing the disease cysticercosis or coenuriasis. A number of species are of medical importance and/or cause losses to the meat and livestock industry mainly due to the condemnation of infected muscle and offal. The control of taeniid cestodes relies upon epidemiological data, including the precise identification and characterization of the causative agents. Traditional, phenetic techniques have limitations for specific diagnosis. Although there has been progress in the establishment of molecular tools, there has been relatively limited application of mutation scanning approaches to species of Taenia. In the present article, we briefly review key genetic markers used for the specific identification of taeniids and tools for the analysis of genetic variation within and among populations and the diagnosis of taeniasis and cysticercosis/coenuriasis. We also discuss the advantages and disadvantages of selected techniques and emphasize the benefits of utilizing mutation scanning-based approaches in achieving detailed insights into the population genetics and epidemiology of Taenia species. (C) 2009 Published by Elsevier B.V.
C1 [Gasser, Robin B.; Campbell, Bronwyn E.; Jex, Aaron R.] Univ Melbourne, Dept Vet Sci, Werribee, Vic 3030, Australia.
C3 University of Melbourne
RP Gasser, RB (corresponding author), Univ Melbourne, Dept Vet Sci, 250 Princes Highway, Werribee, Vic 3030, Australia.
EM robinbg@unimelb.edu.au
FU Australian Research Council (ARC); Melbourne Water Corporation, and Meat and Livestock Australia (MLA); American-Australian Fulbright Commission
CR Abuladze K, 1970, ESSENTIALS OF CESTODOLOGY, VIV, P0
   Abuseir S, 2006, PARASITOL RES, V99, P405, DOI 10.1007/s00436-006-0158-3
   Aguilar-Díaz H, 2006, PARASITOL INT, V55, PS127, DOI 10.1016/j.parint.2005.11.020
   ALLSOPP BA, 1987, PARASITOLOGY, V95, P593, DOI 10.1017/S0031182000058017
   [Anonymous], 2008, GEORGIS PARASITOLOGY FOR VETERINARIANS-E-BOOK, V0, P0
   Arnheim N, 1983, P38, V0, P0
   Avise JC, 2000, PHYLOGEOGRAPHY HIST, V0, P0, DOI DOI 10.2307/J.CTV1NZFGJ7
   Avise John C, 1994, PI, V0, P0
   Badaraco JL, 2008, EXP PARASITOL, V119, P453, DOI 10.1016/j.exppara.2008.02.004
   Bart JM, 2006, INFECT GENET EVOL, V6, P390, DOI 10.1016/j.meegid.2006.01.006
   Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517
   BEVERIDGE I, 1976, AUST VET J, V52, P369, DOI 10.1111/j.1751-0813.1976.tb09491.x
   BOWLES J, 1993, MOL BIOCHEM PARASIT, V57, P231, DOI 10.1016/0166-6851(93)90199-8
   BOWLES J, 1994, AM J TROP MED HYG, V50, P33, DOI 10.4269/ajtmh.1994.50.1.TM0500010033
   BOWLES J, 1993, INT J PARASITOL, V23, P969, DOI 10.1016/0020-7519(93)90065-7
   BOWLES J, 1992, MOL BIOCHEM PARASIT, V54, P165, DOI 10.1016/0166-6851(92)90109-W
   Campbell G, 2006, PARASITOL INT, V55, PS121, DOI 10.1016/j.parint.2005.11.019
   Carabin H, 2005, TRENDS PARASITOL, V21, P327, DOI 10.1016/j.pt.2005.05.009
   Casulli A, 2009, INT J PARASITOL, V39, P837, DOI 10.1016/j.ijpara.2008.12.001
   Chervy L, 2002, SYST PARASITOL, V52, P1, DOI 10.1023/A:1015086301717
   Chilton NB, 1999, INT J PARASITOL, V29, P1971, DOI 10.1016/S0020-7519(99)00148-4
   CHILTON NB, 1995, INT J PARASITOL, V25, P647, DOI 10.1016/0020-7519(94)00171-J
   Chung JH, 2007, ELECTROPHORESIS, V28, P2416, DOI 10.1002/elps.200600570
   Constantine CC, 2003, TRENDS PARASITOL, V19, P346, DOI 10.1016/S1471-4922(03)00167-3
   DINNIK JA, 1972, Z TROPENMED PARASIT, V23, P197
   Doi K, 2004, ELECTROPHORESIS, V25, P833, DOI 10.1002/elps.200305721
   DOVER GA, 1989, GENETICS, V122, P249
   EDWARDS GT, 1981, J HELMINTHOL, V55, P1, DOI 10.1017/S0022149X00025384
   ELDER JF, 1995, Q REV BIOL, V70, P297, DOI 10.1086/419073
   ELLSWORTH DL, 1993, BIOTECHNIQUES, V14, P214
   EORN KS, 2006, PARASITOL INT, V55, P0
   Flisser A, 2006, VET PARASITOL, V139, P283, DOI 10.1016/j.vetpar.2006.04.019
   Foronda P, 2005, J HELMINTHOL, V79, P139, DOI 10.1079/JOH2005280
   Gasser RB, 1999, VET PARASITOL, V84, P229, DOI 10.1016/S0304-4017(99)00036-9
   Gasser RB, 1998, INT J PARASITOL, V28, P1775, DOI 10.1016/S0020-7519(98)00126-X
   Gasser RB, 1998, ELECTROPHORESIS, V19, P2391, DOI 10.1002/elps.1150191405
   GASSER RB, 1995, ACTA TROP, V59, P31, DOI 10.1016/0001-706X(94)00085-F
   Gasser RB, 1997, INT J PARASITOL, V27, P1449, DOI 10.1016/S0020-7519(97)00131-8
   Gasser RB, 2006, VET PARASITOL, V136, P69, DOI 10.1016/j.vetpar.2005.12.002
   Gasser RB, 1999, ELECTROPHORESIS, V20, P2834, DOI 10.1002/(SICI)1522-2683(19991001)20:14<2834::AID-ELPS2834>3.0.CO;2-F
   Gasser RB, 2006, NAT PROTOC, V1, P3121, DOI 10.1038/nprot.2006.485
   Geysen D, 2007, J FOOD PROTECT, V70, P236, DOI 10.4315/0362-028X-70.1.236
   González LM, 2006, VET PARASITOL, V142, P95, DOI 10.1016/j.vetpar.2006.06.009
   González LM, 2004, DIAGN MICR INFEC DIS, V49, P183, DOI 10.1016/j.diagmicrobio.2004.03.013
   González LM, 2002, DIAGN MICR INFEC DIS, V42, P243
   González LM, 2000, J CLIN MICROBIOL, V38, P737
   Gonzalez Luis Miguel, 2002, TRANS R SOC TROP MED HYG, V96 Suppl 1, PS243, DOI 10.1016/S0035-9203(02)90083-0
   Gudewar J, 2009, MOL BIOL REP, V36, P1381, DOI 10.1007/s11033-008-9324-2
   Gupta PK, 2008, TRENDS BIOTECHNOL, V26, P602, DOI 10.1016/j.tibtech.2008.07.003
   Haag KL, 1999, PARASITOLOGY, V118, P63, DOI 10.1017/S0031182098003485
   Haag KL, 1998, MEM I OSWALDO CRUZ, V93, P695, DOI 10.1590/S0074-02761998000500024
   Haag KL, 1997, PARASITOLOGY, V115, P521, DOI 10.1017/S0031182097001649
   HALL BG, 2007, PHYLOGENETIC TREES M, V0, P302
   HANCOCK JM, 1988, MOL BIOL EVOL, V5, P393
   HANCOCK JM, 1990, NUCLEIC ACIDS RES, V18, P5949, DOI 10.1093/nar/18.20.5949
   Harris TD, 2008, SCIENCE, V320, P106, DOI 10.1126/science.1150427
   Harrison LJS, 2005, TROP ANIM HEALTH PRO, V37, P103, DOI 10.1023/B:TROP.0000048459.98067.99
   Hawkins GA, 1997, NAT BIOTECHNOL, V15, P803, DOI 10.1038/nbt0897-803
   Hernández M, 2008, ANN TROP MED PARASIT, V102, P317, DOI 10.1179/136485908X278856
   Hoberg EP, 2006, PARASITOL INT, V55, PS23, DOI 10.1016/j.parint.2005.11.049
   Hoberg EP, 2001, P ROY SOC B-BIOL SCI, V268, P781, DOI 10.1098/rspb.2000.1579
   Hoberg EP, 2000, J PARASITOL, V86, P89, DOI 10.1645/0022-3395(2000)086[0089:APHFSO]2.0.CO;2
   Hu M, 2006, TRENDS PARASITOL, V22, P78, DOI 10.1016/j.pt.2005.12.003
   Hu M, 2004, ADV PARASIT, V56, P133, DOI 10.1016/S0065-308X(03)56003-1
   Ito A, 2003, LANCET, V362, P1918, DOI 10.1016/S0140-6736(03)14965-3
   Ito A, 2003, ACTA TROP, V87, P95, DOI 10.1016/S0001-706X(03)00024-X
   Jeon HK, 2005, PARASITOLOGY, V130, P717, DOI 10.1017/S0031182004007164
   Jeon HK, 2009, EXP PARASITOL, V121, P151, DOI 10.1016/j.exppara.2008.10.014
   Jespersgaard C, 2006, ELECTROPHORESIS, V27, P3816, DOI 10.1002/elps.200600095
   Jex AR, 2009, BMC GENOMICS, V10, P0, DOI 10.1186/1471-2164-10-79
   Jex AR, 2008, BMC GENOMICS, V9, P0, DOI 10.1186/1471-2164-9-11
   JONES A, 1988, SYST PARASITOL, V11, P31, DOI 10.1007/BF00006974
   Jones Arlene, 2001, P150, V0, P0, DOI DOI 10.1002/9780470377000.ch7
   Kedra AH, 2001, PARASITOL INT, V50, P145, DOI 10.1016/S1383-5769(01)00064-2
   Dias AKK, 2007, EXP PARASITOL, V117, P9, DOI 10.1016/j.exppara.2007.03.005
   King S, 2005, J MICROBIOL METH, V60, P83, DOI 10.1016/j.mimet.2004.08.014
   Kirkpatrick NC, 2009, AVIAN PATHOL, V38, P13, DOI 10.1080/03079450802596053
   Knapp J, 2008, INFECT GENET EVOL, V8, P367, DOI 10.1016/j.meegid.2008.02.010
   Lavikainen A, 2008, PARASITOLOGY, V135, P1457, DOI 10.1017/S003118200800499X
   Lavikainen A, 2006, PARASITOLOGY, V133, P565, DOI 10.1017/S0031182006000667
   Le TH, 2000, ACTA TROP, V77, P243, DOI 10.1016/S0001-706X(00)00157-1
   Le TH, 2002, TRENDS PARASITOL, V18, P206, DOI 10.1016/S1471-4922(02)02252-3
   Loos-Frank B, 2000, SYST PARASITOL, V45, P155, DOI 10.1023/A:1006219625792
   MACPHERSON JM, 1993, MOL CELL PROBE, V7, P293, DOI 10.1006/mcpr.1993.1043
   Maravilla P, 2003, J PARASITOL, V89, P1250, DOI 10.1645/GE-2786RN
   Maravilla P, 2008, INFECT GENET EVOL, V8, P213, DOI 10.1016/j.meegid.2007.11.006
   Mardis ER, 2008, ANNU REV GENOM HUM G, V9, P387, DOI 10.1146/annurev.genom.9.081307.164359
   Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959
   Mathis A, 2006, PARASITOL INT, V55, PS87, DOI 10.1016/j.parint.2005.11.012
   Mayta H, 2000, J CLIN MICROBIOL, V38, P133
   Mayta H, 2008, J CLIN MICROBIOL, V46, P286, DOI 10.1128/JCM.01172-07
   McManus DP, 1990, REVUE SCIENTIFIQUE ET TECHNIQUE OFFICE INTERNATIONAL DES EPIZOOTIES, V9, P489
   MCMANUS D P, 1990, SOUTHEAST ASIAN JOURNAL OF TROPICAL MEDICINE AND PUBLIC HEALTH, V21, P161
   McManus DP, 2006, PARASITOL INT, V55, PS31, DOI 10.1016/j.parint.2005.11.004
   McManus DP, 1996, INT J PARASITOL, V26, P687, DOI 10.1016/0020-7519(96)82612-9
   Mitchelson KR, 2003, MOL BIOTECHNOL, V24, P41, DOI 10.1385/MB:24:1:41
   Mitreva M, 2007, VET PARASITOL, V148, P31, DOI 10.1016/j.vetpar.2007.05.008
   Morozova O, 2008, GENOMICS, V92, P255, DOI 10.1016/j.ygeno.2008.07.001
   Nakao M, 2007, PARASITOLOGY, V134, P713, DOI 10.1017/S0031182006001934
   Nakao M, 2002, PARASITOLOGY, V124, P657, DOI 10.1017/S0031182002001725
   Nkouawa A, 2009, J CLIN MICROBIOL, V47, P168, DOI 10.1128/JCM.01573-08
   Nunes CM, 2005, EXP PARASITOL, V110, P412, DOI 10.1016/j.exppara.2005.03.008
   Nunes CRM, 2003, EXP PARASITOL, V104, P67, DOI 10.1016/S0014-4894(03)00111-5
   OKAMOTO M, 1995, PARASITOL RES, V81, P451, DOI 10.1007/BF00931785
   ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8
   Oudni-MRad M, 2006, PARASITE, V13, P131, DOI 10.1051/parasite/2006132131
   Pandey V, 2008, APPLIED BIOSYSTEMS SOLID SYSTEM: LIGATION-BASED SEQUENCING. NEXT GENERATION GENOME SEQUENCING: TOWARDS PERSONALIZED MEDICINE, V0, P29
   Pangasa A, 2009, MOL CELL PROBE, V23, P10, DOI 10.1016/j.mcp.2008.10.003
   Rasmussen JP, 2007, BMC BIOINFORMATICS, V8, P0, DOI 10.1186/1471-2105-8-107
   Rausch RL, 1994, P665, V0, P0
   Rausch RL, 2003, COMP PARASITOL, V70, P1, DOI 10.1654/1525-2647(2003)070[0001:TPNSFT]2.0.CO;2
   Righetti PG, 2002, ELECTROPHORESIS, V23, P1361, DOI 10.1002/1522-2683(200205)23:10<1361::AID-ELPS1361>3.0.CO;2-J
   Robinson BS, 2006, APPL ENVIRON MICROB, V72, P5857, DOI 10.1128/AEM.00113-06
   SACHS R, 1968, BULLETIN OF EPIZOOTIC DISEASES OF AFRICA, V16, P455
   SACHS R, 1970, JOURNAL OF THE SOUTH AFRICAN VETERINARY MEDICAL ASSOCIATION, V41, P79
   SACHS R, 1969, BULLETIN OF EPIZOOTIC DISEASES OF AFRICA, V17, P337
   SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875
   Sato MO, 2006, AM J TROP MED HYG, V75, P933, DOI 10.4269/ajtmh.2006.75.933
   Schantz PM, 2006, PARASITOL INT, V55, PS7, DOI 10.1016/j.parint.2005.11.050
   SCHLOTTERER C, 1994, CURR BIOL, V4, P777, DOI 10.1016/S0960-9822(00)00175-5
   Shin GW, 2008, ANAL BIOCHEM, V383, P31, DOI 10.1016/j.ab.2008.08.021
   Somers R, 2006, TROP MED INT HEALTH, V11, P65, DOI 10.1111/j.1365-3156.2005.01537.x
   Somers R, 2007, T ROY SOC TROP MED H, V101, P275, DOI 10.1016/j.trstmh.2006.04.007
   Stefanic S, 2004, PARASITOL RES, V92, P347, DOI 10.1007/s00436-003-1043-y
   TAUTZ D, 1989, NUCLEIC ACIDS RES, V17, P6463, DOI 10.1093/nar/17.16.6463
   TAUTZ D, 1993, EXS, V67, P21
   ten Bosch JR, 2008, J MOL DIAGN, V10, P484, DOI 10.2353/jmoldx.2008.080027
   Theis JH, 1996, AM J TROP MED HYG, V55, P456, DOI 10.4269/ajtmh.1996.55.456
   Trachsel D, 2007, PARASITOLOGY, V134, P911, DOI 10.1017/S0031182007002235
   van Herwerden L, 2000, INT J PARASITOL, V30, P157, DOI 10.1016/S0020-7519(00)00002-3
   Varcasia A, 2006, PARASITOL RES, V99, P622, DOI 10.1007/s00436-006-0179-y
   Vega R, 2003, INT J PARASITOL, V33, P1479, DOI 10.1016/S0020-7519(03)00206-6
   Verster A, 1969, J VET RES, V36, P3
   WELSH J, 1990, NUCLEIC ACIDS RES, V18, P7213, DOI 10.1093/nar/18.24.7213
   WILLIAMS JGK, 1990, NUCLEIC ACIDS RES, V18, P6531, DOI 10.1093/nar/18.22.6531
   Yamasaki H, 2006, PARASITOL INT, V55, PS81, DOI 10.1016/j.parint.2005.11.013
   Yamasaki H, 2004, J CLIN MICROBIOL, V42, P548, DOI 10.1128/JCM.42.2.548-553.2004
   Yamasaki H, 2002, J CLIN MICROBIOL, V40, P3818, DOI 10.1128/JCM.40.10.3818-3821.2002
   YAMASAKI H, 2005, SE ASIAN J TROP MED, V36, P0
   Yamasaki H, 2006, PARASITOL INT, V55, P127, DOI 10.1016/j.parint.2005.11.057
   ZARLENGA DS, 1991, EXP PARASITOL, V72, P174, DOI 10.1016/0014-4894(91)90135-J
   ZARLENGA DS, 1991, SE ASIAN J TROP MED, V22, P0
   Zhang L, 2007, MOL CELL PROBE, V21, P379, DOI 10.1016/j.mcp.2007.05.003
   Zhu XQ, 1998, ELECTROPHORESIS, V19, P1366, DOI 10.1002/elps.1150190828
   Zinger L, 2008, J MICROBIOL METH, V73, P209, DOI 10.1016/j.mimet.2008.03.001
   Zinger L, 2008, J MICROBIOL METH, V72, P42, DOI 10.1016/j.mimet.2007.10.005
   Zinger L, 2007, MICROB ECOL, V54, P203, DOI 10.1007/s00248-006-9151-8
NR 147
TC 7
Z9 7
U1 0
U2 2
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1567-1348
EI 1567-7257
J9 INFECT GENET EVOL
JI Infect. Genet. Evol.
PD SEP 15
PY 2009
VL 9
IS 5
BP 740
EP 747
DI 10.1016/j.meegid.2009.05.005
PG 8
WC Infectious Diseases
SC Infectious Diseases
GA 487KD
UT WOS:000269271400002
PM 19454324
DA 2024-11-01
ER

PT J
AU Chan, SSL
   Copeland, WC
AF Chan, Sherine S. L.
   Copeland, William C.
TI Functional Analysis of Mutant Mitochondrial DNA Polymerase Proteins Involved in Human Disease
SO MITOCHONDRIAL DNA: METHODS AND PROTOCOLS
LA English
DT Article; Book Chapter
DE DNA polymerase gamma; mitochondrial DNA polymerase; DNA replication; DNA repair; mitochondrial disease; enzyme assays; POLG; POLG2
ID progressive external ophthalmoplegia; accessory subunit; gamma; mutation; identification; toxicity; defects
AB DNA polymerase gamma (pol gamma) is the only DNA polymerase within the mitochondrion and is thus essential for replication and repair of mtDNA. POLG, the gene encoding the catalytic subunit of pol gamma, is a major locus for a wide spectrum of mitochondrial diseases with more than 100 known disease mutations. Thus, we need to understand how and why pol gamma defects lead to disease. By using an extensive array of methods, we are developing a clearer understanding of how defects in pol gamma contribute to disease. Furthermore, crucial knowledge concerning the role of pol gamma in mtDNA replication and repair can be acquired. Here we present the protocols to characterize mutant DNA pol gamma proteins, namely, assays for processivc DNA synthesis, exonuclease activity, DNA binding, subunit interaction, and protein stability.
C1 [Chan, Sherine S. L.; Copeland, William C.] Natl Inst Environm Hlth Sci, Mol Genet Lab, Mitochondrial DNA Replicat Grp, NIH, Res Triangle Pk, NC 27709 USA.
C3 National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)
RP Chan, SSL (corresponding author), Natl Inst Environm Hlth Sci, Mol Genet Lab, Mitochondrial DNA Replicat Grp, NIH, Res Triangle Pk, NC 27709 USA.
FU Intramural NIH HHS [Z01 ES065078-14] Funding Source: Medline; NIEHS NIH HHS [1K99-ES015555-01, K99 ES015555, R00 ES015555, K99 ES015555-01] Funding Source: Medline
CR Chan SSL, 2006, HUM MOL GENET, V15, P3473, DOI 10.1093/hmg/ddl424
   Chan SSL, 2005, DNA REPAIR, V4, P1381, DOI 10.1016/j.dnarep.2005.08.010
   Chan SSL, 2005, J BIOL CHEM, V280, P31341, DOI 10.1074/jbc.M506762200
   DeRose EF, 2003, BIOCHEMISTRY-US, V42, P9564, DOI 10.1021/bi034298s
   Dimauro S, 2005, ANN MED, V37, P222, DOI 10.1080/07853890510007368
   Graziewicz MA, 2004, NAT STRUCT MOL BIOL, V11, P770, DOI 10.1038/nsmb805
   Graziewicz MA, 2006, CHEM REV, V106, P383, DOI 10.1021/cr040463d
   Lim SE, 2003, J MOL BIOL, V329, P45, DOI 10.1016/S0022-2836(03)00405-4
   Lim SE, 2001, J BIOL CHEM, V276, P23616, DOI 10.1074/jbc.M101114200
   Lim SE, 1999, J BIOL CHEM, V274, P38197, DOI 10.1074/jbc.274.53.38197
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   Longley Matthew J, 2002, METHODS MOL BIOL, V197, P245, DOI 10.1385/1-59259-284-8:245
   Longley MJ, 1998, BIOCHEMISTRY-US, V37, P10529, DOI 10.1021/bi980772w
   Luoma PT, 2005, HUM MOL GENET, V14, P1907, DOI 10.1093/hmg/ddi196
   Naviaux RK, 2004, MITOCHONDRION, V4, P351, DOI 10.1016/j.mito.2004.07.002
   Ponamarev MV, 2002, J BIOL CHEM, V277, P15225, DOI 10.1074/jbc.C200100200
   Yakubovskaya E, 2006, J BIOL CHEM, V281, P374, DOI 10.1074/jbc.M509730200
   Yamanaka H, 2007, J INFECT DIS, V195, P1419, DOI 10.1086/513872
NR 18
TC 4
Z9 4
U1 1
U2 1
PU HUMANA PRESS INC
PI TOTOWA
PA 999 RIVERVIEW DR, STE 208, TOTOWA, NJ 07512-1165 USA
SN 1064-3745
EI 
J9 METHODS MOL BIOL
JI Methods Mol. Biol.
PD JUN 15
PY 2009
VL 554
IS 
BP 59
EP 72
DI 10.1007/978-1-59745-521-3_4
PG 14
WC Biochemical Research Methods
SC Biochemistry & Molecular Biology
GA BKY51
UT WOS:000269615700004
PM 19513667
DA 2024-11-01
ER

PT J
AU Sacconi, S
   Salviati, L
   Trevisson, E
AF Sacconi, Sabrina
   Salviati, Leonardo
   Trevisson, Eva
TI Mutation analysis of <i>COX18</i> in 29 patients with isolated cytochrome <i>c</i> oxidase deficiency
SO JOURNAL OF HUMAN GENETICS
LA English
DT Article
DE Cytochrome c oxidase; cytochrome c oxidase deficiency; COX18; mitochondrial encephalomyopathy
ID leigh-syndrome; saccharomyces-cerevisiae; gene-mutations; surf1; biogenesis; defects; yeast
AB Isolated cytochrome c oxidase (COX) deficiency (MIM#220110) is a relatively common biochemical finding in pediatric patients with mitochondrial disorder. It has been associated with different clinical phenotypes ranging from isolated myopathy to severe multisystem disorder. It is a genetically heterogeneous trait, and the most frequent genetic defects affect SURF1 and SCO2, two genes required for COX assembly. However, a significant proportion of patients lacks mutation in these genes and in other known genes that require COX biogenesis. COX18 is a novel COX assembly gene required for membrane insertion of the C-terminal portion of COX subunit II. We have studied 29 pediatric patients with isolated COX deficiency in the skeletal muscle associated with different clinical phenotypes. Mutations in SURF1, SC02, SC01, COX10, COX15 and in mitochondrial DNA, had been ruled out earlier. The COX18 gene was analyzed using a PCR-single-stranded conformation polymorphism (PCR-SSCP) protocol, and in 15 patients, the analysis was repeated by direct sequencing. No pathogenic mutations were detected in our cohort of patients indicating that COX18 mutations may be very rare or associated with other phenotypes than isolated COX deficiency in infancy. Journal of Human Genetics (2009) 54, 419-421; doi: 10.1038/jhg.2009.36; published online 17 April 2009
C1 [Salviati, Leonardo] Univ Padua, Pediat Clin Genet Unit, Dept Pediat, Hematol Oncol Lab, I-35128 Padua, Italy.
   [Salviati, Leonardo; Trevisson, Eva] Univ Padua, Clin Genet Unit, I-35128 Padua, Italy.
   [Sacconi, Sabrina] Univ Nice, Fac Med, Ctr Reference Malad Neuromusculaires, Nice, France.
   [Sacconi, Sabrina] Univ Nice, Fac Med, CNRS, UMR 6543, Nice, France.
C3 University of Padua; University of Padua; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); Universite Cote d'Azur
RP Salviati, L (corresponding author), Univ Padua, Pediat Clin Genet Unit, Dept Pediat, Hematol Oncol Lab, Via Giustiniani 3, I-35128 Padua, Italy.
EM leonardo.salviati@unipd.it
FU Telethon Italy Grant [GGP06256]; Association Francaise Contre les Myopathies
CR Antonicka H, 2003, HUM MOL GENET, V12, P2693, DOI 10.1093/hmg/ddg284
   Barrientos A, 2009, BBA-MOL CELL RES, V1793, P97, DOI 10.1016/j.bbamcr.2008.05.003
   Böhm M, 2006, PEDIATR RES, V59, P21, DOI 10.1203/01.pdr.0000190572.68191.13
   Bugiani M, 2005, J MED GENET, V42, P0, DOI 10.1136/jmg.2004.029926
   Coenen MJH, 2006, J CHILD NEUROL, V21, P508, DOI 10.1177/08830738060210062501
   Gaisne M, 2006, FEMS YEAST RES, V6, P869, DOI 10.1111/j.1567-1364.2006.00083.x
   Kuhn A, 2003, TRENDS CELL BIOL, V13, P510, DOI 10.1016/j.tcb.2003.08.005
   Massa V, 2008, AM J HUM GENET, V82, P1281, DOI 10.1016/j.ajhg.2008.05.002
   Michel H, 1998, P NATL ACAD SCI USA, V95, P12819, DOI 10.1073/pnas.95.22.12819
   Mootha VK, 2003, P NATL ACAD SCI USA, V100, P605, DOI 10.1073/pnas.242716699
   Sacconi S, 2005, BIOCHEM BIOPH RES CO, V337, P832, DOI 10.1016/j.bbrc.2005.09.127
   Sacconi S, 2003, PEDIATR RES, V53, P224, DOI 10.1203/01.PDR.0000048100.91730.6A
   Salviati L, 2004, AM J MED GENET A, V128A, P195, DOI 10.1002/ajmg.a.30073
   Salviati L, 2002, ANN NEUROL, V52, P311, DOI 10.1002/ana.10284
   Shoubridge EA, 2001, AM J MED GENET, V106, P46, DOI 10.1002/ajmg.1378
   Souza RL, 2000, J BIOL CHEM, V275, P14898, DOI 10.1074/jbc.275.20.14898
   Tay SKH, 2005, J CHILD NEUROL, V20, P670, DOI 10.1177/08830738050200080701
   TZAGOLOFF A, 1990, MICROBIOL REV, V54, P211, DOI 10.1128/MMBR.54.3.211-225.1990
   Vempati UD, 2007, MOL CELL BIOL, V27, P1771, DOI 10.1128/MCB.00287-06
   Zhu ZQ, 1998, NAT GENET, V20, P337, DOI 10.1038/3804
NR 20
TC 7
Z9 9
U1 0
U2 2
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1434-5161
EI 1435-232X
J9 J HUM GENET
JI J. Hum. Genet.
PD JUL 15
PY 2009
VL 54
IS 7
BP 419
EP 421
DI 10.1038/jhg.2009.36
PG 3
WC Genetics & Heredity
SC Genetics & Heredity
GA 474WD
UT WOS:000268314100009
PM 19373256
DA 2024-11-01
ER

PT J
AU Kucharczyk, R
   Rak, M
   di Rago, JP
AF Kucharczyk, Roza
   Rak, Malgorzata
   di Rago, Jean-Paul
TI Biochemical consequences in yeast of the human mitochondrial DNA 8993T&gt;C mutation in the ATPase6 gene found in NARP/MILS patients
SO BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
LA English
DT Article
DE ATP6; F1F0 ATP synthase, NARP/MILS disease; Mitochondrial DNA; Yeast
ID atp-synthase; saccharomyces-cerevisiae; leigh-syndrome; t8993g mutation; oxidative-phosphorylation; narp mutation; mtdna; expression; cells; fibroblasts
AB We have created and analyzed the properties of a yeast model of the human mitochondrial DNA T8993C mutation that has been associated with maternally-inherited Leigh syndrome and/or with neurogenic muscle weakness, ataxia and retinitis pigmentosa. This mutation changes a highly conserved leucine to proline in the Atp6p subunit of the ATP synthase, at position 156 in the human protein, position 183 in yeast. In vitro the yeast T8993C mitochondria showed a 40-50% decrease in the rate of ATP synthesis. The ATP-driven translocation of protons across the inner mitochondrial membrane was normal in the mutant and fully sensitive to oligomycin, an inhibitor of the ATP synthase proton channel. However under conditions of maximal ATP hydrolytic activity, using non-osmotically protected mitochondria, the mutant ATPase activity was poorly inhibited by oligomycin (by 40% versus 85% in wild type cells). These anomalies were attributed by BN-PAGE and mitochondrial protein synthesis analyses to a less efficient incorporation of Atp6p within the ATP synthase. Interestingly,the cytochrome c oxidase content was selectively decreased by 40-50% in T8993C yeast, apparently due to a reduced synthesis of its mitochondrially encoded Cox1p subunit. This observation further supports the existence of a control of cytochrome c oxidase expression by the ATP synthase in yeast mitochondria. Despite the ATPase deficiency, growth of the atp6-L183P mutant on respiratory substrates and the efficiency of oxidative phosphorylation were similar to that of wild type, indicating that the mutation did not affect the proton permeability of the mitochondrial inner membrane. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Kucharczyk, Roza; Rak, Malgorzata; di Rago, Jean-Paul] Univ Bordeaux 2, CNRS, Inst Biochim & Genet Cellulaires, F-33076 Bordeaux, France.
   [Kucharczyk, Roza] Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland.
C3 Centre National de la Recherche Scientifique (CNRS); Universite de Bordeaux; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences
RP di Rago, JP (corresponding author), Univ Bordeaux 2, CNRS, Inst Biochim & Genet Cellulaires, F-33076 Bordeaux, France.
EM jp.dirago@ibgc.u-bordeaux2.fr
FU French Ministry of Research; Agence Nationale de la Recherche (ANR); Association Francaise contre les Myopathies (AFM); GIS-Maladies rares; ANR; Conseil de la Region Aquitaine
CR Ackerman SH, 2005, PROG NUCLEIC ACID RE, V80, P95, DOI 10.1016/S0079-6603(05)80003-0
   Ackerman SH, 2002, BBA-BIOENERGETICS, V1555, P101, DOI 10.1016/S0005-2728(02)00262-1
   Arselin G, 1996, J BIOL CHEM, V271, P20284, DOI 10.1074/jbc.271.34.20284
   Baracca A, 2000, J BIOL CHEM, V275, P4177, DOI 10.1074/jbc.275.6.4177
   Baracca A, 2007, BBA-BIOENERGETICS, V1767, P913, DOI 10.1016/j.bbabio.2007.05.005
   Barrientos A, 2002, GENE, V286, P53, DOI 10.1016/S0378-1119(01)00803-4
   Barrientos A, 2004, EMBO J, V23, P3472, DOI 10.1038/sj.emboj.7600358
   Bonnefoy N, 2001, METHOD CELL BIOL, V65, P381, DOI 10.1016/S0091-679X(01)65022-2
   Ciesla M, 2007, MOL CELL BIOL, V27, P7693, DOI 10.1128/MCB.01051-07
   Cizková A, 2008, NAT GENET, V40, P1288, DOI 10.1038/ng.246
   CLAISSE ML, 1974, EUR J BIOCHEM, V49, P49, DOI 10.1111/j.1432-1033.1974.tb03810.x
   Contamine V, 2000, MICROBIOL MOL BIOL R, V64, P281, DOI 10.1128/MMBR.64.2.281-315.2000
   Cortés-Hernández P, 2007, J BIOL CHEM, V282, P1051, DOI 10.1074/jbc.M606828200
   DEVRIES DD, 1993, ANN NEUROL, V34, P410, DOI 10.1002/ana.410340319
   EMAUS RK, 1986, BIOCHIM BIOPHYS ACTA, V850, P436, DOI 10.1016/0005-2728(86)90112-X
   Fillingame RH, 2003, FEBS LETT, V555, P29, DOI 10.1016/S0014-5793(03)01101-3
   García JJ, 2000, J BIOL CHEM, V275, P11075, DOI 10.1074/jbc.275.15.11075
   Geromel V, 2001, HUM MOL GENET, V10, P1221, DOI 10.1093/hmg/10.11.1221
   Guerin B, 1979, METHODS ENZYMOL, V55, P149
   HOUSTEK J, 1995, BBA-MOL BASIS DIS, V1271, P349, DOI 10.1016/0925-4439(95)00063-A
   Houstek J, 2006, BBA-BIOENERGETICS, V1757, P1400, DOI 10.1016/j.bbabio.2006.04.006
   KUCHARCZYK R, 2009, BIOCHIM BIOPHYS ACTA, V1739, P186
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Lefebvre-Legendre L, 2001, J BIOL CHEM, V276, P6789, DOI 10.1074/jbc.M009557200
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Manfred G, 1999, J BIOL CHEM, V274, P9386, DOI 10.1074/jbc.274.14.9386
   Mattiazzi M, 2004, HUM MOL GENET, V13, P869, DOI 10.1093/hmg/ddh103
   Morava E, 2006, AM J MED GENET A, V140A, P863, DOI 10.1002/ajmg.a.31194
   MUKHOPADHYAY A, 1994, FEBS LETT, V343, P160, DOI 10.1016/0014-5793(94)80310-2
   Perez-Martinez X, 2003, EMBO J, V22, P5951, DOI 10.1093/emboj/cdg566
   Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, P0, DOI 10.1093/nar/30.9.e36
   Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, P0, DOI 10.1093/nar/29.9.e45
   Rak M, 2007, J BIOL CHEM, V282, P34039, DOI 10.1074/jbc.M703053200
   Rak M, 2007, J BIOL CHEM, V282, P10853, DOI 10.1074/jbc.M608692200
   RIGOULET M, 1979, FEBS LETT, V102, P18, DOI 10.1016/0014-5793(79)80919-9
   SANTORELLI FM, 1994, NEUROLOGY, V44, P972, DOI 10.1212/WNL.44.5.972
   Saraste M, 1999, SCIENCE, V283, P1488, DOI 10.1126/science.283.5407.1488
   Schon EA, 2001, SEMIN CELL DEV BIOL, V12, P441, DOI 10.1006/scdb.2001.0281
   Sgarbi G, 2006, BIOCHEM J, V395, P493, DOI 10.1042/BJ20051748
   SOMLO M, 1968, EUR J BIOCHEM, V5, P276, DOI 10.1111/j.1432-1033.1968.tb00368.x
   Steele DF, 1996, P NATL ACAD SCI USA, V93, P5253, DOI 10.1073/pnas.93.11.5253
   TATUCH Y, 1992, AM J HUM GENET, V50, P852
   TROUNCE I, 1994, P NATL ACAD SCI USA, V91, P8334, DOI 10.1073/pnas.91.18.8334
   Tzagoloff A, 2004, J BIOL CHEM, V279, P19775, DOI 10.1074/jbc.M401506200
   VazquezMemije ME, 1996, J INHERIT METAB DIS, V19, P43, DOI 10.1007/BF01799347
   Velours J, 2000, J BIOENERG BIOMEMBR, V32, P383, DOI 10.1023/A:1005580020547
   Venard R, 2003, BIOCHEMISTRY-US, V42, P7626, DOI 10.1021/bi034394t
   Wittig I, 2007, METHOD CELL BIOL, V80, P723, DOI 10.1016/S0091-679X(06)80033-6
   Zeng XM, 2007, J BIOL CHEM, V282, P36167, DOI 10.1074/jbc.M705436200
   Zeng XM, 2007, MOL BIOL CELL, V18, P617, DOI 10.1091/mbc.E06-09-0801
NR 50
TC 54
Z9 57
U1 0
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-4889
EI 0006-3002
J9 BBA-MOL CELL RES
JI Biochim. Biophys. Acta-Mol. Cell Res.
PD MAY 15
PY 2009
VL 1793
IS 5
BP 817
EP 824
DI 10.1016/j.bbamcr.2009.02.011
PG 8
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 453YZ
UT WOS:000266650100008
PM 19269308
DA 2024-11-01
ER

PT J
AU Kaufmann, P
   Engelstad, K
   Wei, Y
   Kulikova, R
   Oskoui, M
   Battista, V
   Koenigsberger, DY
   Pascual, JM
   Sano, M
   Hirano, M
   DiMauro, S
   Shungu, DC
   Mao, XL
   De Vivo, DC
AF Kaufmann, Petra
   Engelstad, Kristin
   Wei, Ying
   Kulikova, Romana
   Oskoui, Maryam
   Battista, Vanessa
   Koenigsberger, Dorcas Y.
   Pascual, Juan M.
   Sano, Mary
   Hirano, Michio
   DiMauro, Salvatore
   Shungu, Dikoma C.
   Mao, Xiangling
   De Vivo, Darryl C.
TI Protean Phenotypic Features of the A3243G Mitochondrial DNA Mutation
SO ARCHIVES OF NEUROLOGY
LA English
DT Article
ID lactic-acidosis; clinical spectrum; episodes melas; load; encephalopathy; myopathy; brain; merrf
AB Objective: To describe the spectrum of clinical symptoms, signs, and laboratory features associated with A3243G, a mitochondrial DNA point mutation that affects multiple organs with varying severity, making the diagnosis and treatment of these patients complex. Design: Cohort study. Setting: Columbia University Medical Center. Participants: A cohort of 123 matrilineal relatives from 45 families, including 45 fully symptomatic patients with mitochondrial myopathy, encephalomyopathy, lactic acidosis, and stroke-like episodes ( syndrome), 78 carrier relatives, and 30 controls. Main Outcome Measures: Data gathered from standardized medical history questionnaires, neurological and ophthalmological examination forms, and laboratory tests. We compared data between 3 groups. Results: Mutation carriers' clinical and laboratory results frequently had many abnormalities. In addition to neurological symptoms, they often had cardiac, endocrine, gastrointestinal, and psychiatric symptoms. Conclusions: The A3243G mutation carriers have multiple medical problems, suggesting that the A3243G mutation should be considered as an etiological factor in patients with multisystem clinical presentations or a family history compatible with matrilineal inheritance. Because some medical problems affecting A3243G mutation carriers are treatable, early detection and proactive management may mitigate the burden of morbidity.
C1 [Kaufmann, Petra] Columbia Univ, Neurol Inst, Dept Neurol, Med Ctr, New York, NY 10032 USA.
   [Kulikova, Romana; De Vivo, Darryl C.] Columbia Univ, Med Ctr, Dept Pediat, New York, NY 10032 USA.
   [Wei, Ying] Columbia Univ, Med Ctr, Dept Biostat, New York, NY 10032 USA.
   [Sano, Mary] Cornell Univ, Dept Psychiat, Mt Sinai Sch Med, New York, NY 10021 USA.
   [Shungu, Dikoma C.] Cornell Univ, Dept Radiol, New York, NY 10021 USA.
   [Oskoui, Maryam] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada.
   [Pascual, Juan M.] Univ Texas SW, Dept Neurol, Dallas, TX USA.
   [Pascual, Juan M.] Univ Texas SW, Dept Physiol, Dallas, TX USA.
   [Pascual, Juan M.] Univ Texas SW, Dept Pediat, Dallas, TX USA.
C3 Columbia University; Columbia University; Columbia University; Icahn School of Medicine at Mount Sinai; Cornell University; Cornell University; McGill University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas
RP Kaufmann, P (corresponding author), Columbia Univ, Neurol Inst, Dept Neurol, Med Ctr, 710 W 168Th St, New York, NY 10032 USA.
EM pk88@columbia.edu
FU National Institute of Child Health and Human Development [PO1-HD32062]; Clinical and Translational Science Award [RR024156]; Colleen Giblin Foundation; Marriott Mitochondrial Disorder Clinical Research Fund
CR Chinnery PE, 1998, BRAIN, V121, P1889, DOI 10.1093/brain/121.10.1889
   Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713
   CIAFALONI E, 1991, NEUROLOGY, V41, P1663, DOI 10.1212/WNL.41.10.1663
   CIAFALONI E, 1992, ANN NEUROL, V31, P391, DOI 10.1002/ana.410310408
   DAMIAN MS, 1995, ACTA NEUROL SCAND, V92, P409
   DEVIVO DC, 1990, BIOL NEONATE, V58, P54
   DEVIVO DC, 1993, BRAIN DEV-JPN, V15, P1, DOI 10.1016/0387-7604(93)90002-P
   DUYN JH, 1993, RADIOLOGY, V188, P277, DOI 10.1148/radiology.188.1.8511313
   FOLSTEIN MF, 1975, J PSYCHIATR RES, V12, P198
   GOTO Y, 1991, BIOCHIM BIOPHYS ACTA, V1097, P238, DOI 10.1016/0925-4439(91)90042-8
   HIRANO M, 1994, J CHILD NEUROL, V9, P4, DOI 10.1177/088307389400900102
   Huang CC, 2002, J BIOMED SCI, V9, P527, DOI 10.1007/BF02254979
   KARNOFSKY KA, 1949, EVALUATION CHEMOTHER, V0, P196
   Kaufmann P, 2004, NEUROLOGY, V62, P1297, DOI 10.1212/01.WNL.0000120557.83907.A8
   Kaufmann P, 1996, ANN NEUROL, V40, P172, DOI 10.1002/ana.410400208
   KRUSKAL WILLIAM H, 1952, JOUR AMER STATIST ASSOC, V47, P583, DOI 10.2307/2280779
   MacKenzie DM, 1996, PSYCHOL MED, V26, P427, DOI 10.1017/S0033291700034826
   Majamaa-Voltti KAM, 2006, NEUROLOGY, V66, P1470, DOI 10.1212/01.wnl.0000216136.61640.79
   MANTEL N, 1959, JNCI-J NATL CANCER I, V22, P719
   Manwaring N, 2007, MITOCHONDRION, V7, P230, DOI 10.1016/j.mito.2006.12.004
   Morovvati S, 2002, ACTA NEUROL SCAND, V106, P104, DOI 10.1034/j.1600-0404.2002.01172.x
NR 21
TC 52
Z9 59
U1 0
U2 2
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 0003-9942
EI 1538-3687
J9 ARCH NEUROL-CHICAGO
JI Arch. Neurol.
PD JAN 15
PY 2009
VL 66
IS 1
BP 85
EP 91
DI 
PG 7
WC Clinical Neurology
SC Neurosciences & Neurology
GA 393UM
UT WOS:000262398900011
PM 19139304
DA 2024-11-01
ER

PT J
AU Torraco, A
   Diaz, F
   Vempati, UD
   Moraes, CT
AF Torraco, Alessandra
   Diaz, Francisca
   Vempati, Uma D.
   Moraes, Carlos T.
TI Mouse models of oxidative phosphorylation defects: Powerful tools to study the pathobiology of mitochondrial diseases
SO BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
LA English
DT Review
DE Mitochondria; Mitochondrial disease; Knockout mouse; Knock-in mouse; Conditional knockout mouse
ID cytochrome-c-oxidase; transcription-factor-a; dna-polymerase-gamma; adenine-nucleotide translocator; progressive external ophthalmoplegia; embryonic stem-cells; mtdna copy number; diabetes-mellitus; alzheimers-disease; termination factor
AB Defects in the oxidative phosphorylation system (OXPHOS) are responsible for a group of extremely heterogeneous and pleiotropic pathologies commonly known as mitochondrial diseases. Although many mutations have been found to be responsible for OXPHOS defects, their pathogenetic mechanisms are still poorly understood. An important contribution to investigate the in vivo function of several mitochondrial proteins and their role in mitochondrial dysfunction, has been provided by mouse models. Thanks to their genetic and physiologic similarity to humans, mouse models represent a powerful tool to investigate the impact of pathological mutations on metabolic pathways. In this review we discuss the main mouse models of mitochondrial disease developed, focusing on the ones that directly affect the OXPHOS system. (C) 2008 Elsevier B.V. All rights reserved.
C1 [Torraco, Alessandra; Diaz, Francisca; Vempati, Uma D.; Moraes, Carlos T.] Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA.
   [Moraes, Carlos T.] Univ Miami, Miller Sch Med, Dept Cell Biol & Anat, Miami, FL 33136 USA.
C3 University of Miami; University of Miami
RP Moraes, CT (corresponding author), Univ Miami, Miller Sch Med, Dept Neurol, 1095 NW 14th Terrace, Miami, FL 33136 USA.
EM cmoraes@med.miami.edu
FU Public Health Service [NS041777, CA85700, EY10804]; Muscular Dystrophy Association
CR AGNATI LF, 1995, PROG NEUROBIOL, V46, P561, DOI 10.1016/0301-0082(95)00017-P
   Agostino A, 2003, HUM MOL GENET, V12, P399, DOI 10.1093/hmg/ddg038
   Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   Antonicka H, 2003, HUM MOL GENET, V12, P2693, DOI 10.1093/hmg/ddg284
   Antonicka H, 2003, AM J HUM GENET, V72, P101, DOI 10.1086/345489
   Bacman SR, 2007, GENE THER, V14, P1309, DOI 10.1038/sj.gt.3302981
   Bano D, 2005, CELL, V120, P275, DOI 10.1016/j.cell.2004.11.049
   Barrientos A, 2002, EMBO J, V21, P43, DOI 10.1093/emboj/21.1.43
   Bayona-Bafaluy MP, 2005, P NATL ACAD SCI USA, V102, P14392, DOI 10.1073/pnas.0502896102
   Bensch KG, 2007, DIABETES OBES METAB, V9, P74, DOI 10.1111/j.1463-1326.2007.00776.x
   Blesa JR, 2007, NEUROMOL MED, V9, P285, DOI 10.1007/s12017-007-8000-3
   Bothe GWM, 2000, GENESIS, V26, P165, DOI 10.1002/(SICI)1526-968X(200002)26:2<165::AID-GENE22>3.0.CO;2-F
   Cardaioli E, 1999, J SUBMICR CYTOL PATH, V31, P301
   Carrodeguas JA, 2002, J BIOL CHEM, V277, P50008, DOI 10.1074/jbc.M207030200
   CARRY MR, 1986, ANAT RECORD, V214, P8, DOI 10.1002/ar.1092140103
   Chen XJ, 2005, NAT REV GENET, V6, P815, DOI 10.1038/nrg1708
   Cho YM, 2006, BIOCHEM BIOPH RES CO, V348, P1472, DOI 10.1016/j.bbrc.2006.08.020
   CLAYTON DA, 1991, ANNU REV CELL BIOL, V7, P453, DOI 10.1146/annurev.cb.07.110191.002321
   Coenen MJH, 2004, ANN NEUROL, V56, P560, DOI 10.1002/ana.20229
   Coulbault L, 2007, BIOCHEM BIOPH RES CO, V362, P601, DOI 10.1016/j.bbrc.2007.08.040
   Cree LM, 2008, NAT GENET, V40, P249, DOI 10.1038/ng.2007.63
   DAGA A, 1993, J BIOL CHEM, V268, P8123
   DellAgnello C, 2007, HUM MOL GENET, V16, P431, DOI 10.1093/hmg/ddl477
   Deschauer M, 2007, NEUROLOGY, V68, P1741, DOI 10.1212/01.wnl.0000261929.92478.3e
   Deschauer M, 2005, NEUROMUSCULAR DISORD, V15, P311, DOI 10.1016/j.nmd.2004.12.004
   Diaz F, 2008, GUT, V57, P232, DOI 10.1136/gut.2006.119180
   Diaz F, 2005, HUM MOL GENET, V14, P2737, DOI 10.1093/hmg/ddi307
   DiMauro S, 2007, BIOSCIENCE REP, V27, P5, DOI 10.1007/s10540-007-9032-5
   Dobie KW, 1996, P NATL ACAD SCI USA, V93, P6659, DOI 10.1073/pnas.93.13.6659
   DONOVAN DM, 1995, MOL BRAIN RES, V30, P327, DOI 10.1016/0169-328X(95)00018-N
   DUNBAR DR, 1993, HUM MOL GENET, V2, P1619, DOI 10.1093/hmg/2.10.1619
   Ekstrand MI, 2007, P NATL ACAD SCI USA, V104, P1325, DOI 10.1073/pnas.0605208103
   Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109
   Elston T, 1998, NATURE, V391, P510, DOI 10.1038/35185
   Esposito LA, 1999, P NATL ACAD SCI USA, V96, P4820, DOI 10.1073/pnas.96.9.4820
   Facucho-Oliveira JM, 2007, J CELL SCI, V120, P4025, DOI 10.1242/jcs.016972
   Falkenberg M, 2002, NAT GENET, V31, P289, DOI 10.1038/ng909
   Falkenberg M, 2007, ANNU REV BIOCHEM, V76, P679, DOI 10.1146/annurev.biochem.76.060305.152028
   Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786
   Farge G, 2008, NUCLEIC ACIDS RES, V36, P393, DOI 10.1093/nar/gkm1025
   Ferraris S, 2008, ARCH NEUROL-CHICAGO, V65, P125, DOI 10.1001/archneurol.2007.9
   Fontanesi F, 2004, HUM MOL GENET, V13, P923, DOI 10.1093/hmg/ddh108
   Fontanesi F, 2006, AM J PHYSIOL-CELL PH, V291, PC1129, DOI 10.1152/ajpcell.00233.2006
   Fukui H, 2008, TRENDS NEUROSCI, V31, P251, DOI 10.1016/j.tins.2008.02.008
   Fukui H, 2007, P NATL ACAD SCI USA, V104, P14163, DOI 10.1073/pnas.0705738104
   Fukushima H, 2006, ARCH OTOLARYNGOL, V132, P934, DOI 10.1001/archotol.132.9.934
   Garstka HL, 2003, NUCLEIC ACIDS RES, V31, P5039, DOI 10.1093/nar/gkg717
   Golden TR, 2007, WORMBOOK, V0, PP1, DOI 10.I895/W0RMB00K.I.127.2
   Goto A, 2001, BIOCHEM J, V354, P243, DOI 10.1042/0264-6021:3540243
   Graham BH, 1997, NAT GENET, V16, P226, DOI 10.1038/ng0797-226
   Hakonen AH, 2007, BRAIN, V130, P3032, DOI 10.1093/brain/awm242
   Hance N, 2005, HUM MOL GENET, V14, P1775, DOI 10.1093/hmg/ddi184
   Hao ZY, 2005, CELL, V121, P579, DOI 10.1016/j.cell.2005.03.016
   Hardy J, 2006, J ALZHEIMERS DIS, V9, P151
   Harrower T, 2008, ARCH NEUROL-CHICAGO, V65, P133, DOI 10.1001/archneurol.2007.4
   Holt IJ, 2007, MITOCHONDRION, V7, P311, DOI 10.1016/j.mito.2007.06.004
   Hsieh RH, 2001, J BIOMED SCI, V8, P328, DOI 10.1159/000054051
   Hudson G, 2005, AM J HUM GENET, V77, P1086, DOI 10.1086/498176
   Hudson G, 2006, HUM MOL GENET, V15, PR244, DOI 10.1093/hmg/ddl233
   Hunsberger JG, 2005, MOL BRAIN RES, V141, P95, DOI 10.1016/j.molbrainres.2005.08.005
   Hyvärinen AK, 2007, NUCLEIC ACIDS RES, V35, P6458, DOI 10.1093/nar/gkm676
   Inoue K, 2001, TANPAKUSHITSU KAKUSAN KOSO, V46, P829
   Irwin RW, 2008, ENDOCRINOLOGY, V0, P0
   Jankowsky JL, 2001, BIOMOL ENG, V17, P157, DOI 10.1016/S1389-0344(01)00067-3
   Kadenbach B, 2000, FREE RADICAL BIO MED, V29, P211, DOI 10.1016/S0891-5849(00)00305-1
   Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455
   Kang D, 2007, MITOCHONDRION, V7, P39, DOI 10.1016/j.mito.2006.11.017
   Kariya S, 2007, OTOL NEUROTOL, V28, P1063, DOI 10.1097/MAO.0b013e31815a8433
   Kasahara A, 2006, HUM MOL GENET, V15, P871, DOI 10.1093/hmg/ddl005
   Kasashima K, 2008, EXP CELL RES, V314, P988, DOI 10.1016/j.yexcr.2008.01.005
   Kaufman BA, 2007, MOL BIOL CELL, V18, P3225, DOI 10.1091/mbc.E07-05-0404
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   KLINGENBERG M, 1992, BIOCHEM SOC T, V20, P547, DOI 10.1042/bst0200547
   Kokoszka JE, 2004, NATURE, V427, P461, DOI 10.1038/nature02229
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231
   LARSSON NG, 1992, AM J HUM GENET, V50, P360
   Laurent G, 2008, CELL METAB, V7, P113, DOI 10.1016/j.cmet.2007.12.010
   LeDoux SP, 2007, NEUROSCIENCE, V145, P1249, DOI 10.1016/j.neuroscience.2006.10.002
   Levy SE, 1999, TRANSGENIC RES, V8, P137, DOI 10.1023/A:1008967412955
   Lewis W, 2007, LAB INVEST, V87, P326, DOI 10.1038/labinvest.3700523
   Li H, 2000, P NATL ACAD SCI USA, V97, P3467, DOI 10.1073/pnas.97.7.3467
   Li JY, 2007, J FORMOS MED ASSOC, V106, P528, DOI 10.1016/S0929-6646(07)60003-5
   Li K, 2000, CELL, V101, P389, DOI 10.1016/S0092-8674(00)80849-1
   Li M, 2007, PROG NEUROBIOL, V83, P131, DOI 10.1016/j.pneurobio.2007.08.002
   Lim SE, 1999, J BIOL CHEM, V274, P38197, DOI 10.1074/jbc.274.53.38197
   Linder T, 2005, CURR GENET, V48, P265, DOI 10.1007/s00294-005-0022-5
   Luoma PT, 2007, NEUROLOGY, V69, P1152, DOI 10.1212/01.wnl.0000276955.23735.eb
   Majamaa-Voltti KAM, 2006, NEUROLOGY, V66, P1470, DOI 10.1212/01.wnl.0000216136.61640.79
   Malka F, 2006, BBA-MOL CELL RES, V1763, P463, DOI 10.1016/j.bbamcr.2006.04.001
   Maniura-Weber K, 2004, NUCLEIC ACIDS RES, V32, P6015, DOI 10.1093/nar/gkh921
   Marchington DR, 1999, NAT MED, V5, P957, DOI 10.1038/11403
   Martin M, 2005, CELL, V123, P1227, DOI 10.1016/j.cell.2005.09.040
   Marzo I, 1998, SCIENCE, V281, P2027, DOI 10.1126/science.281.5385.2027
   Matsushima Y, 2003, J BIOL CHEM, V278, P31149, DOI 10.1074/jbc.M303842200
   Mick DU, 2007, EMBO J, V26, P4347, DOI 10.1038/sj.emboj.7601862
   MIQUEL J, 1980, EXP GERONTOL, V15, P575, DOI 10.1016/0531-5565(80)90010-8
   Miyakawa I, 1994, TANPAKUSHITSU KAKUSAN KOSO, V39, P601
   Moslemi AR, 2007, MITOCHONDRION, V7, P241, DOI 10.1016/j.mito.2007.02.002
   Munnich A, 1996, EUR J PEDIATR, V155, P262
   Murakami T, 1997, GENOMICS, V42, P161, DOI 10.1006/geno.1997.4711
   Narisawa S, 2002, MOL CELL BIOL, V22, P5554, DOI 10.1128/MCB.22.15.5554-5562.2002
   Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409
   Nijtmans LGJ, 2001, FEBS LETT, V498, P46, DOI 10.1016/S0014-5793(01)02447-4
   Nikali K, 2005, HUM MOL GENET, V14, P2981, DOI 10.1093/hmg/ddi328
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   OLIVO PD, 1983, NATURE, V306, P400, DOI 10.1038/306400a0
   Pancrudo J, 2007, NEUROMUSCULAR DISORD, V17, P651, DOI 10.1016/j.nmd.2007.04.005
   Papadopoulou LC, 1999, NAT GENET, V23, P333
   Park CB, 2007, CELL, V130, P273, DOI 10.1016/j.cell.2007.05.046
   PARK KS, 2008, DIABETOLOGIA, V0, P0
   Parsons WJ, 1996, AM J PHYSIOL-HEART C, V270, PH567, DOI 10.1152/ajpheart.1996.270.2.H567
   PIATTO VB, 2007, NEUROBIOL AGING, V0, P0
   Pohjoismäki JLO, 2006, NUCLEIC ACIDS RES, V34, P5815, DOI 10.1093/nar/gkl703
   Pu JZ, 2008, P NATL ACAD SCI USA, V105, P1192, DOI 10.1073/pnas.0708746105
   Radford NB, 2002, AM J PHYSIOL-HEART C, V282, PH726, DOI 10.1152/ajpheart.00308.2001
   Rajasimha HK, 2008, AM J HUM GENET, V82, P333, DOI 10.1016/j.ajhg.2007.10.007
   Reed JC, 1997, CELL, V91, P559, DOI 10.1016/S0092-8674(00)80442-0
   Rorbach J, 2007, BIOCHEM SOC T, V35, P1290, DOI 10.1042/BST0351290
   ROTIG A, 1992, AM J HUM GENET, V50, P364
   Ryan MT, 2007, ANNU REV BIOCHEM, V76, P701, DOI 10.1146/annurev.biochem.76.052305.091720
   SAUER B, 1989, NUCLEIC ACIDS RES, V17, P147, DOI 10.1093/nar/17.1.147
   Schaefer AM, 2004, BBA-BIOENERGETICS, V1659, P115, DOI 10.1016/j.bbabio.2004.09.005
   Schon EA, 2004, J CLIN INVEST, V114, P760, DOI 10.1172/JCI200422942
   Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653
   Schultz RA, 1998, J BIOL CHEM, V273, P3447, DOI 10.1074/jbc.273.6.3447
   Schulz TJ, 2007, PLOS ONE, V2, P0, DOI 10.1371/journal.pone.0001013
   SHANG J, 1994, J BIOL CHEM, V269, P29112
   Shibata Noriyuki, 2008, BRAIN AND NERVE (TOKYO), V60, P157
   Silva JP, 2000, NAT GENET, V26, P336, DOI 10.1038/81649
   Skladal D, 2003, BRAIN, V126, P1905, DOI 10.1093/brain/awg170
   Sligh JE, 2000, P NATL ACAD SCI USA, V97, P14461, DOI 10.1073/pnas.250491597
   SOMEYA S, 2007, NEUROBIOL AGING, V0, P0
   Sörensen L, 2001, J NEUROSCI, V21, P8082, DOI 10.1523/JNEUROSCI.21-20-08082.2001
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469
   Sproule DM, 2007, ARCH NEUROL-CHICAGO, V64, P1625, DOI 10.1001/archneur.64.11.1625
   STEPIEN G, 1992, J BIOL CHEM, V267, P14592
   Stewart JB, 2008, PLOS BIOL, V6, P63, DOI 10.1371/journal.pbio.0060010
   STUBBS L, 1990, GENOMICS, V6, P645, DOI 10.1016/0888-7543(90)90499-K
   Sun JT, 2002, GENETICS, V161, P661
   TAANMAN JW, 1993, BIOCHIM BIOPHYS ACTA, V1225, P95, DOI 10.1016/0925-4439(93)90128-N
   Thornberry NA, 1998, CHEM BIOL, V5, PR97, DOI 10.1016/S1074-5521(98)90615-9
   Tiranti V, 1999, ANN NEUROL, V46, P161, DOI 10.1002/1531-8249(199908)46:2<161::AID-ANA4>3.0.CO;2-O
   Tiranti V, 1998, AM J HUM GENET, V63, P1609, DOI 10.1086/302150
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Tsien JZ, 1996, CELL, V87, P1317, DOI 10.1016/S0092-8674(00)81826-7
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   UPHOLT WB, 1977, CELL, V11, P571, DOI 10.1016/0092-8674(77)90075-7
   Valnot I, 2000, AM J HUM GENET, V67, P1104
   Valnot I, 2000, HUM MOL GENET, V9, P1245, DOI 10.1093/hmg/9.8.1245
   Vempati UD, 2007, MOL CELL BIOL, V27, P1771, DOI 10.1128/MCB.00287-06
   Viña J, 2007, J ALZHEIMERS DIS, V11, P175
   Wang JM, 1999, NAT GENET, V21, P133, DOI 10.1038/5089
   WATANABE T, 1978, P NATL ACAD SCI USA, V75, P5113, DOI 10.1073/pnas.75.10.5113
   Williams SL, 2001, LAB INVEST, V81, P1069, DOI 10.1038/labinvest.3780319
   Wredenberg A, 2002, P NATL ACAD SCI USA, V99, P15066, DOI 10.1073/pnas.232591499
   Xu FH, 2004, BIOCHEM J, V382, P331, DOI 10.1042/BJ20040469
   Yamasoba T, 2007, HEARING RES, V226, P185, DOI 10.1016/j.heares.2006.06.004
   Yin H, 2005, INVEST OPHTH VIS SCI, V46, P4555, DOI 10.1167/iovs.05-0695
   YOUNG P, 1994, BIOCHEM BIOPH RES CO, V203, P46, DOI 10.1006/bbrc.1994.2146
   Zeviani M, 2003, CURR OPIN GENET DEV, V13, P262, DOI 10.1016/S0959-437X(03)00052-2
   Zhu ZQ, 1998, NAT GENET, V20, P337, DOI 10.1038/3804
   ZORATTI M, 1995, BBA-REV BIOMEMBRANES, V1241, P139, DOI 10.1016/0304-4157(95)00003-A
   Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2
NR 165
TC 28
Z9 31
U1 0
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-4889
EI 0006-3002
J9 BBA-MOL CELL RES
JI Biochim. Biophys. Acta-Mol. Cell Res.
PD JAN 15
PY 2009
VL 1793
IS 1
BP 171
EP 180
DI 10.1016/j.bbamcr.2008.06.003
PG 10
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 398NH
UT WOS:000262738300020
PM 18601959
DA 2024-11-01
ER

PT J
AU Smet, J
   Seneca, S
   De Paepe, B
   Meulemans, A
   Verhelst, H
   Leroy, J
   De Meirleir, L
   Lissens, W
   Van Coster, R
AF Smet, Joel
   Seneca, Sara
   De Paepe, Boel
   Meulemans, Ann
   Verhelst, Helene
   Leroy, Jules
   De Meirleir, Linda
   Lissens, Willy
   Van Coster, Rudy
TI Subcomplexes of mitochondrial complex V reveal mutations in mitochondrial DNA
SO ELECTROPHORESIS
LA English
DT Article
DE Blue Native PAGE; Complex V subcomplexes; mtDNA depletion; mtDNA point mutation; Oxidative phosphorylation
ID atp-synthase; respiratory-chain; lactic-acidosis; gene mutation; translation; muscle; deficiency; myopathy; patient; defect
AB Complex V, site of the final step in oxidative phosphorylation, uses the proton gradient across the inner mitochondrial membrane for the production of ATP. It is a multi-subunit complex composed of a catalytic domain (F-1) and a membrane domain (F-0) linked by two stalks. Subcomplexes of complex V containing the F, domain have previously been reported in small series of patients. We report the results in tissue samples and/or cultured skin fibroblasts studied by blue native PAGE followed by activity staining in the gel. Catalytically active subcomplexes of complex V were detected in 66 tissues originating from 53 patients. In 29 of the latter (55%), a mitochondrial DNA (mtDNA) defect was identified. Twelve patients had a pathogenic point mutation in a mitochondrial tRNA, one a large mtDNA deletion, 12 showed mtDNA depletion and four had a mutation in the MT-ATP6 gene. We conclude that the presence of subcomplexes of complex V is a valuable indicator in the detection of mtDNA defects.
C1 [Smet, Joel; De Paepe, Boel; Verhelst, Helene; Leroy, Jules; Van Coster, Rudy] Ghent Univ Hosp, Dept Pediat, Div Pediat Neurol & Metab, B-9000 Ghent, Belgium.
   [Seneca, Sara; Meulemans, Ann; De Meirleir, Linda; Lissens, Willy] Free Univ Brussels, Div Paediat Neurol & Metab, Brussels, Belgium.
   [Seneca, Sara; Meulemans, Ann; De Meirleir, Linda; Lissens, Willy] Free Univ Brussels, Ctr Med Genet, UZ Brussel Hosp, Brussels, Belgium.
C3 Ghent University; Ghent University Hospital; Universite Libre de Bruxelles; Universite Libre de Bruxelles
RP Van Coster, R (corresponding author), Ghent Univ Hosp, Dept Pediat, Div Pediat Neurol & Metab, Pintelaan 185, B-9000 Ghent, Belgium.
EM rudy.vancoster@ugent.be
FU Fund for Scientific Research Belgium (FWO) [G.0666.06]
CR BIRCHMACHIN MA, 1989, PEDIATR RES, V25, P553, DOI 10.1203/00006450-198905000-00025
   Bozdogan B, 2004, INT J ANTIMICROB AG, V23, P113, DOI 10.1016/j.ijantimicag.2003.11.003
   Carrozzo R, 2006, ANN NEUROL, V59, P265, DOI 10.1002/ana.20729
   Coenen MJH, 2004, NEW ENGL J MED, V351, P2080, DOI 10.1056/NEJMoa041878
   De Vriese AS, 2006, CLIN INFECT DIS, V42, P1111, DOI 10.1086/501356
   DIMAURO S, 1987, ANN NEUROL, V22, P498, DOI 10.1002/ana.410220409
   FISCHER JC, 1986, EUR J PEDIATR, V144, P441, DOI 10.1007/BF00441735
   HOUSTEK J, 1995, BBA-MOL BASIS DIS, V1271, P349, DOI 10.1016/0925-4439(95)00063-A
   Jonckheere AI, 2008, J MED GENET, V45, P129, DOI 10.1136/jmg.2007.052084
   King M P, 1996, METHODS ENZYMOL, V264, P304, DOI 10.1016/S0076-6879(96)64029-4
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   Meulemans A, 2007, ARCH NEUROL-CHICAGO, V64, P1339, DOI 10.1001/archneur.64.9.1339
   Meulemans A, 2007, EUR J PAEDIATR NEURO, V11, P17, DOI 10.1016/j.ejpn.2006.10.004
   Meulemans A, 2006, ARCH NEUROL-CHICAGO, V63, P1194, DOI 10.1001/archneur.63.8.1194
   Miller C, 2004, ANN NEUROL, V56, P734, DOI 10.1002/ana.20282
   RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8
   Saada A, 2007, J MED GENET, V44, P784, DOI 10.1136/jmg.2007.053116
   Scalais E, 2007, EUR J NEUROL, V14, Pe3, DOI 10.1111/j.1468-1331.2007.01926.x
   SCHOLTE HR, 1992, J INHERIT METAB DIS, V15, P347, DOI 10.1007/BF02435973
   Seneca S, 2005, AM J MED GENET A, V137A, P170, DOI 10.1002/ajmg.a.30854
   Seneca S, 1996, J INHERIT METAB DIS, V19, P115, DOI 10.1007/BF01799407
   Smeitink JAM, 2006, AM J HUM GENET, V79, P869, DOI 10.1086/508434
   SOTTOCASA GL, 1967, J CELL BIOL, V32, P415, DOI 10.1083/jcb.32.2.415
   Srere PA, 1969, METHODS IN ENZYMOLOGY, V13, P3
   Valente L, 2007, AM J HUM GENET, V80, P44, DOI 10.1086/510559
   Van Coster R, 2001, PEDIATR RES, V50, P658, DOI 10.1203/00006450-200111000-00020
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Walker JE, 2006, BBA-BIOENERGETICS, V1757, P286, DOI 10.1016/j.bbabio.2006.01.001
   Zerbetto E, 1997, ELECTROPHORESIS, V18, P2059, DOI 10.1002/elps.1150181131
NR 29
TC 26
Z9 27
U1 0
U2 17
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0173-0835
EI 1522-2683
J9 ELECTROPHORESIS
JI Electrophoresis
PD OCT 15
PY 2009
VL 30
IS 20
BP 3565
EP 3572
DI 10.1002/elps.200900213
PG 8
WC Biochemical Research Methods; Chemistry, Analytical
SC Biochemistry & Molecular Biology; Chemistry
GA 516WG
UT WOS:000271573400010
PM 19862739
DA 2024-11-01
ER

PT J
AU Kudin, AP
   Zsurka, G
   Elger, CE
   Kunz, WS
AF Kudin, Alexei P.
   Zsurka, Gabor
   Elger, Christian E.
   Kunz, Wolfram S.
TI Mitochondrial involvement in temporal lobe epilepsy
SO EXPERIMENTAL NEUROLOGY
LA English
DT Review
DE Temporal lobe epilepsy; Mitochondria; Mitochondrial diseases
ID stroke-like episodes; progressive external ophthalmoplegia; hippocampal slice cultures; n-acetyl aspartate; lactic-acidosis; point mutation; oxidative-phosphorylation; missense mutation; dna mutations; regional hypometabolism
AB Mitochondrial dysfunction has been identified as a potential cause of epileptic seizures and therapy-resistant forms of severe epilepsy, Thus, a broad variety of mutation in mitochondrial DNA or nuclear genes leading to the impairment of mitochondrial respiratory chain or of mitochondrial ATP synthesis has been associated with epileptic phenotypes. Additionally, with a variety of different methods impaired mitochondrial function has been reported for the seizure focus of patients with temporal lobe epilepsy and Ammon's horn sclerosis and of animal models of temporal lobe epilepsy. Since mitochondrial oxidative phosphorylation provides the major source of ATP in neurons and mitochondria participate in cellular Ca2+ homeostasis, their dysfunction strongly affects neuronal excitability and synaptic transmission, which is proposed to be highly relevant for seizure generation. Additionally, mitochondrial dysfunction is known to trigger neuronal cell death, which is a prominent feature of therapy-resistant temporal lobe epilepsy. Therefore, mitochondria have to be considered as promising targets for neuroprotective strategies in epilepsy. (C) 2009 Elsevier Inc. All rights reserved.
C1 [Kudin, Alexei P.; Zsurka, Gabor; Elger, Christian E.; Kunz, Wolfram S.] Univ Bonn, Div Neurochem, Dept Epileptol, Med Ctr, D-53105 Bonn, Germany.
C3 University of Bonn
RP Kunz, WS (corresponding author), Univ Bonn, Div Neurochem, Dept Epileptol, Med Ctr, Sigmund Freud Str 25, D-53105 Bonn, Germany.
EM wolfram.kunz@ukb.uni-bonn.de
FU Deutsche Forschungsgemeinschaft [KU-911/15-1, TR3-A11, TR3-D12]; BMBF [01GZ0704]
CR ASTRUP J, 1981, STROKE, V12, P726, DOI 10.1161/01.STR.12.6.726
   Baron M, 2007, BIOCHEM SOC T, V35, P1228, DOI 10.1042/BST0351228
   Bataillard M, 2001, NEUROLOGY, V56, P405, DOI 10.1212/WNL.56.3.405
   Bengzon J, 1997, P NATL ACAD SCI USA, V94, P10432, DOI 10.1073/pnas.94.19.10432
   Bindokas VP, 1998, J NEUROSCI, V18, P4570
   Blümcke I, 1999, J COMP NEUROL, V414, P437, DOI 10.1002/(SICI)1096-9861(19991129)414:4<437::AID-CNE2>3.0.CO;2-3
   Brini M, 1999, NAT MED, V5, P951, DOI 10.1038/11396
   Brown MD, 2001, HUM GENET, V109, P33, DOI 10.1007/s004390100538
   Campos Y, 2000, NEUROMUSCULAR DISORD, V10, P493, DOI 10.1016/S0960-8966(00)00107-3
   Canafoglia L, 2001, NEUROLOGY, V56, P1340, DOI 10.1212/WNL.56.10.1340
   Chaturvedi RK, 2008, ANN NY ACAD SCI, V1147, P395, DOI 10.1196/annals.1427.027
   Cock H, 1999, EPILEPSIA, V40, P33, DOI 10.1111/j.1528-1157.1999.tb00897.x
   De Coo IFM, 1999, ANN NEUROL, V45, P130, DOI 10.1002/1531-8249(199901)45:1<130::AID-ART21>3.0.CO;2-Z
   DEVRIES DD, 1993, ANN NEUROL, V34, P410, DOI 10.1002/ana.410340319
   DiMauro S, 1999, ADV NEUROL, V79, P411
   Ferrante RJ, 2000, J NEUROSCI, V20, P4389, DOI 10.1523/JNEUROSCI.20-12-04389.2000
   Frantseva MV, 2000, EUR J NEUROSCI, V12, P1431, DOI 10.1046/j.1460-9568.2000.00016.x
   GOTO Y, 1991, BIOCHIM BIOPHYS ACTA, V1097, P238, DOI 10.1016/0925-4439(91)90042-8
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   GOTO YI, 1994, BIOCHEM BIOPH RES CO, V202, P1624, DOI 10.1006/bbrc.1994.2119
   Hanna MG, 1998, J NEUROL NEUROSUR PS, V65, P512, DOI 10.1136/jnnp.65.4.512
   HENRY TR, 1994, ANN NEUROL, V36, P925, DOI 10.1002/ana.410360620
   HIRANO M, 2008, EPILEPSY COMPREHENSI, V3, P2621
   Holtzman D, 1999, J NEUROCHEM, V73, P2477, DOI 10.1046/j.1471-4159.1999.0732477.x
   Jaksch M, 1998, ANN NEUROL, V44, P635, DOI 10.1002/ana.410440409
   Jarrett SG, 2008, J NEUROCHEM, V106, P1044, DOI 10.1111/j.1471-4159.2008.05460.x
   Kann O, 2005, BRAIN, V128, P2396, DOI 10.1093/brain/awh568
   Kann O, 2003, NEUROSCIENCE, V119, P87, DOI 10.1016/S0306-4522(03)00026-5
   Klivenyi P, 1999, NAT MED, V5, P347, DOI 10.1038/6568
   Kovács R, 2002, J NEUROPHYSIOL, V88, P2909, DOI 10.1152/jn.00149.2002
   Krajewski S, 1999, P NATL ACAD SCI USA, V96, P5752, DOI 10.1073/pnas.96.10.5752
   Kudin AP, 2008, BBA-BIOENERGETICS, V1777, P689, DOI 10.1016/j.bbabio.2008.05.010
   Kudin AP, 2005, BIOMED PHARMACOTHER, V59, P163, DOI 10.1016/j.biopha.2005.03.012
   Kudin AP, 2004, EPILEPSIA, V45, P1478, DOI 10.1111/j.0013-9580.2004.13504.x
   Kudin AP, 2004, J BIOL CHEM, V279, P4127, DOI 10.1074/jbc.M310341200
   Kudin AP, 2002, EUR J NEUROSCI, V15, P1105, DOI 10.1046/j.1460-9568.2002.01947.x
   Kunz WS, 2000, ANN NEUROL, V48, P766, DOI 10.1002/1531-8249(200011)48:5<766::AID-ANA10>3.0.CO;2-M
   Kunz WS, 1999, BRAIN RES, V826, P236, DOI 10.1016/S0006-8993(99)01279-2
   Kunz WS, 2002, CURR OPIN NEUROL, V15, P179, DOI 10.1097/00019052-200204000-00009
   Liang LP, 2000, NEUROSCIENCE, V101, P563, DOI 10.1016/S0306-4522(00)00397-3
   Mancuso M, 2004, NEUROLOGY, V62, P2119, DOI 10.1212/01.WNL.0000127608.48406.F1
   MANFREDI G, 1995, NEUROMUSCULAR DISORD, V5, P391, DOI 10.1016/0960-8966(94)00079-O
   Manfredi G, 1996, HUM MUTAT, V7, P158
   MARGERISON JH, 1966, BRAIN, V89, P499, DOI 10.1093/brain/89.3.499
   MELDRUM BS, 1993, BRAIN PATHOL, V3, P405, DOI 10.1111/j.1750-3639.1993.tb00768.x
   MORAES CT, 1993, J CLIN INVEST, V92, P2906, DOI 10.1172/JCI116913
   MORTEN KJ, 1993, HUM MOL GENET, V2, P2081, DOI 10.1093/hmg/2.12.2081
   Naini AB, 2005, ARCH NEUROL-CHICAGO, V62, P473, DOI 10.1001/archneur.62.3.473
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Nishigaki Y, 2003, NEUROMUSCULAR DISORD, V13, P334, DOI 10.1016/S0960-8966(02)00283-3
   Nishino I, 1996, MUSCLE NERVE, V19, P1603, DOI 10.1002/(SICI)1097-4598(199612)19:12<1603::AID-MUS10>3.0.CO;2-S
   OBrien TJ, 1997, EPILEPSIA, V38, P74, DOI 10.1111/j.1528-1157.1997.tb01080.x
   Pulkes T, 2005, NEUROMUSCULAR DISORD, V15, P364, DOI 10.1016/j.nmd.2005.01.006
   Ravn K, 2001, EUR J HUM GENET, V9, P805, DOI 10.1038/sj.ejhg.5200712
   SAKUTA R, 1989, ANN NEUROL, V25, P594, DOI 10.1002/ana.410250611
   SANTORELLI FM, 1995, BIOCHEM BIOPH RES CO, V216, P835, DOI 10.1006/bbrc.1995.2697
   Santorelli FM, 1997, BIOCHEM BIOPH RES CO, V238, P326, DOI 10.1006/bbrc.1997.7167
   Santra S, 2004, ANN NEUROL, V56, P662, DOI 10.1002/ana.20240
   SATO W, 1994, BIOCHEM MOL BIOL INT, V33, P1055
   Schröder R, 2000, J NEUROPATH EXP NEUR, V59, P353, DOI 10.1093/jnen/59.5.353
   Schuchmann S, 2002, NEUROBIOL DIS, V11, P96, DOI 10.1006/nbdi.2002.0533
   Schuelke M, 1998, ANN NEUROL, V44, P700, DOI 10.1002/ana.410440420
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Shtilbans A, 2000, J CHILD NEUROL, V15, P759, DOI 10.1177/088307380001501109
   Shtilbans A, 1999, J CHILD NEUROL, V14, P610, DOI 10.1177/088307389901400910
   Skulachev VP, 1996, Q REV BIOPHYS, V29, P169, DOI 10.1017/S0033583500005795
   Sullivan PG, 2000, ANN NEUROL, V48, P723, DOI 10.1002/1531-8249(200011)48:5<723::AID-ANA5>3.0.CO;2-W
   Suomalainen A, 1997, NEUROLOGY, V48, P1244, DOI 10.1212/WNL.48.5.1244
   Tang YG, 1997, NEURON, V18, P483, DOI 10.1016/S0896-6273(00)81248-9
   TANIIKE M, 1992, BIOCHEM BIOPH RES CO, V186, P47, DOI 10.1016/S0006-291X(05)80773-9
   Taylor RW, 2004, NEUROLOGY, V62, P1420, DOI 10.1212/01.WNL.0000120667.77372.46
   Taylor RW, 2001, ANN NEUROL, V50, P104, DOI 10.1002/ana.1084
   Taylor RW, 1996, ANN NEUROL, V40, P459, DOI 10.1002/ana.410400318
   Tiranti V, 1999, NEUROMUSCULAR DISORD, V9, P66, DOI 10.1016/S0960-8966(98)00103-5
   TURSKI WA, 1983, EXPERIENTIA, V39, P1408, DOI 10.1007/BF01990130
   Urbanska EM, 1998, EUR J PHARMACOL, V359, P55, DOI 10.1016/S0014-2999(98)00648-7
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Varlamov DA, 2002, HUM MOL GENET, V11, P1797, DOI 10.1093/hmg/11.16.1797
   Vielhaber S, 2003, EUR J NEUROSCI, V18, P2292, DOI 10.1046/j.1460-9568.2003.02954.x
   Vielhaber S, 2003, EPILEPSIA, V44, P193, DOI 10.1046/j.1528-1157.2003.38102.x
   Vielhaber S, 2008, EPILEPSIA, V49, P40, DOI 10.1111/j.1528-1167.2007.01280.x
   Willmore LJ, 2005, EPILEPSY BEHAV, V7, PS25, DOI 10.1016/j.yebeh.2005.08.006
   Winterthun S, 2005, NEUROLOGY, V64, P1204, DOI 10.1212/01.WNL.0000156516.77696.5A
   Yamamoto HA, 1996, NEUROSCI LETT, V207, P89, DOI 10.1016/0304-3940(96)12493-9
   Zeviani Massimo, 1993, EUROPEAN JOURNAL OF HUMAN GENETICS, V1, P80
   Zsurka G, 2008, J NEUROPATH EXP NEUR, V67, P857, DOI 10.1097/NEN.0b013e3181839b2d
NR 86
TC 97
Z9 108
U1 0
U2 10
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0014-4886
EI 1090-2430
J9 EXP NEUROL
JI Exp. Neurol.
PD AUG 15
PY 2009
VL 218
IS 2
BP 326
EP 332
DI 10.1016/j.expneurol.2009.02.014
PG 7
WC Neurosciences
SC Neurosciences & Neurology
GA 472GE
UT WOS:000268117400019
PM 19268667
DA 2024-11-01
ER

PT J
AU Taanman, JW
   Rahman, S
   Pagnamenta, AT
   Morris, AAM
   Bitner-Glindzicz, M
   Wolf, NI
   Leonard, JV
   Clayton, PT
   Schapira, AHV
AF Taanman, Jan-Willem
   Rahman, Shamima
   Pagnamenta, Alistair T.
   Morris, Andrew A. M.
   Bitner-Glindzicz, Maria
   Wolf, Nicole I.
   Leonard, James V.
   Clayton, Peter T.
   Schapira, Anthony H. V.
TI Analysis of Mutant DNA Polymerase γ in Patients With Mitochondrial DNA Depletion
SO HUMAN MUTATION
LA English
DT Article
DE POLG; mitochondrial DNA; mtDNA; DNA polymerase gamma; Leigh syndrome; mitochondrial DNA depletion syndrome; Alpers-Huttenlocher syndrome
ID progressive external ophthalmoplegia; saccharomyces-cerevisiae; accessory subunit; human-cells; mutations; defects; replication; mtdna; polg; identification
AB We studied six unrelated children with depletion of mitochondrial DNA (mtDNA). They presented with Leigh syndrome, infantile hepatocerebral mtDNA depletion syndrome, or Alpers-Huttenlocher syndrome. Several genes have been implicated in mtDNA depletion. Screening of candidate genes indicated that all six patients were compound heterozygous for missense mutations in the gene for the catalytic subunit of DNA polymerase I (POLG). Three of the identified mutations, c.3328C>T (p.H1110Y), c.3401A>G (p.H1134R) and c.3406G>A (p.E1136K), have not been reported earlier. To investigate the functional consequences of the mutations, we carried out a series of biochemical assays in cultured fibroblasts. These studies revealed that fibroblast cultures from the patients with infantile hepatocerebral mtDNA depletion syndrome progressively lost their mtDNA during culturing, whereas fibroblast cultures from patients presenting with Leigh syndrome or Alpers-Huttenlocher syndrome had reduced but stable levels of mtDNA. DNA polymerase gamma activity was below the normal range in all patient cultures, except for one; however, this culture showed low levels of the heterodimeric enzyme and poor DNA polymerase gamma processivity. Parental fibroblast cultures had normal catalytic efficiency of DNA polymerase gamma, consistent with the observation that all carriers are asymptomatic. Thus, we report the first patient with Leigh syndrome caused by POLG mutations. The cell culture experiments established the pathogenicity of the identified POLQ mutations and helped to define the molecular mechanisms responsible for mtDNA depletion in the patients tissues. The assays may facilitate the identification of those patients in whom screening for POLG mutations would be most appropriate.
C1 [Taanman, Jan-Willem; Schapira, Anthony H. V.] UCL, Inst Neurol, Dept Clin Neurosci, London NW3 2PF, England.
   [Rahman, Shamima; Pagnamenta, Alistair T.; Bitner-Glindzicz, Maria; Leonard, James V.] UCL, Inst Child Hlth, Clin & Mol Genet Unit, London NW3 2PF, England.
   [Morris, Andrew A. M.] Royal Manchester Childrens Hosp, Willink Biochem Genet Unit, Manchester M27 1HA, Lancs, England.
   [Wolf, Nicole I.] Univ Childrens Hosp Heidelberg, Dept Pediat Neurol, Heidelberg, Germany.
   [Clayton, Peter T.] UCL, Inst Child Hlth, Biochem Res Grp, London NW3 2PF, England.
   [Clayton, Peter T.] UCL, Inst Child Hlth, Endocrinol Res Grp, London NW3 2PF, England.
C3 University of London; University College London; University of London; University College London; Royal Manchester Children's Hospital; Ruprecht Karls University Heidelberg; University of London; University College London; University of London; University College London
RP Taanman, JW (corresponding author), UCL, Inst Neurol, Dept Clin Neurosci, Rowland Hill St, London NW3 2PF, England.
EM j.taanman@medsch.ucl.ac.uk
FU Children Living with Inherited Metabolic Diseases; Child Health Research Appeal Trust; Medical Research Council; National Health Service Executive; The Wellcome Trust [048410]; MRC [G0601943, G0200335] Funding Source: UKRI
CR Baruffini E, 2007, BBA-MOL BASIS DIS, V1772, P1225, DOI 10.1016/j.bbadis.2007.10.002
   Baruffini E, 2006, HUM MOL GENET, V15, P2846, DOI 10.1093/hmg/ddl219
   Blake JC, 1999, AM J PATHOL, V155, P67, DOI 10.1016/S0002-9440(10)65100-0
   BODNAR AG, 1995, BIOCHEM J, V305, P817, DOI 10.1042/bj3050817
   Chan SSL, 2006, HUM MOL GENET, V15, P3473, DOI 10.1093/hmg/ddl424
   Chan SSL, 2005, J BIOL CHEM, V280, P31341, DOI 10.1074/jbc.M506762200
   Elpeleg O, 2005, AM J HUM GENET, V76, P1081, DOI 10.1086/430843
   Fan L, 2006, J MOL BIOL, V358, P1229, DOI 10.1016/j.jmb.2006.02.073
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   FOURY F, 1992, EMBO J, V11, P2717, DOI 10.1002/j.1460-2075.1992.tb05337.x
   GRAY H, 1992, J BIOL CHEM, V267, P5835
   Graziewicz MA, 2004, NAT STRUCT MOL BIOL, V11, P770, DOI 10.1038/nsmb805
   Graziewicz MA, 2006, CHEM REV, V106, P383, DOI 10.1021/cr040463d
   Graziewicz MA, 2007, HUM MOL GENET, V16, P2729, DOI 10.1093/hmg/ddm227
   Kapsa RMI, 1998, NUCLEIC ACIDS RES, V26, P4365, DOI 10.1093/nar/26.19.4365
   KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477
   Lim SE, 1999, J BIOL CHEM, V274, P38197, DOI 10.1074/jbc.274.53.38197
   Longley MJ, 1998, BIOCHEMISTRY-US, V37, P10529, DOI 10.1021/bi980772w
   Luoma PT, 2005, HUM MOL GENET, V14, P1907, DOI 10.1093/hmg/ddi196
   Magnusson J, 2003, EXP CELL RES, V289, P133, DOI 10.1016/S0014-4827(03)00249-0
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Naviaux RK, 1999, CLIN CHEM, V45, P1725
   Nijtmans LGJ, 2002, METHODS, V26, P327, DOI 10.1016/S1046-2023(02)00038-5
   Pagnamenta AT, 2006, HUM REPROD, V21, P2467, DOI 10.1093/humrep/del076
   Rickwood D, 1987, MITOCHONDRIA: A PRATICAL APPROACH, V0, P1
   Sarzi E, 2007, ANN NEUROL, V62, P579, DOI 10.1002/ana.21207
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Stuart GR, 2006, HUM MOL GENET, V15, P363, DOI 10.1093/hmg/ddi454
   TASHIRO F, 1978, J BIOCHEM, V84, P385, DOI 10.1093/oxfordjournals.jbchem.a132139
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   WANG TSF, 1991, ANNU REV BIOCHEM, V60, P513, DOI 10.1146/annurev.biochem.60.1.513
   Yakubovskaya E, 2006, J BIOL CHEM, V281, P374, DOI 10.1074/jbc.M509730200
   Yakubovskaya E, 2007, EMBO J, V26, P4283, DOI 10.1038/sj.emboj.7601843
NR 34
TC 41
Z9 43
U1 0
U2 6
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1059-7794
EI 
J9 HUM MUTAT
JI Hum. Mutat.
PD FEB 15
PY 2009
VL 30
IS 2
BP 248
EP 254
DI 10.1002/humu.20852
PG 7
WC Genetics & Heredity
SC Genetics & Heredity
GA 405WF
UT WOS:000263254200015
PM 18828154
DA 2024-11-01
ER

PT J
AU Chou, YF
   Huang, RFS
AF Chou, Yi-Fang
   Huang, Rwei-Fen S.
TI Mitochondrial DNA deletions of blood lymphocytes as genetic markers of low folate-related mitochondrial genotoxicity in peripheral tissues
SO EUROPEAN JOURNAL OF NUTRITION
LA English
DT Article
DE Folate deficiency; mtDNA deletions; Lymphocytes; Genetic marker; Peripheral tissues
ID kearns-sayre syndrome; oxidative stress; copy number; hepatocellular-carcinoma; transcription factor; bp deletion; mutations; rats; age; disease
AB A low folate status and mitochondrial DNA (mtDNA) mutations are risk factors for various cancers and degenerative diseases. It is not known if lymphocytic mtDNA deletions can be used as genetic "markers" to reflect global mtDNA damage during folate deficiency. The aim of this study was to characterize folate-related mtDNA deletions in lymphocytes and their associations with mt genotoxicity in peripheral tissues. Weaning Wistar rats were fed folate-deficient and folate-replete (control) diets for 2 and 4 weeks. Folate levels of blood lymphocytes and various tissues were assayed by the Lactobacillus casei method. mtDNA deletions were measured by a real-time polymerase chain reaction analysis of whole DNA extracts. Compared to the control counterparts, mtDNA deletions of lymphocytes increased by 3.5-fold (P < 0.05) after 4 weeks of folate deficiency. Lymphocytic mtDNA deletions were inversely associated with plasma (r = -0.619, P = 0.018), red blood cell (r = -0.668, P = 0.009), and lymphocytic folate levels (r = -0.536, P = 0.048). Frequencies of lymphatic mtDNA deletions were positively correlated with mtDNA deletions in tissues including the lungs (r = 0.803, P = 0.0005), muscles (r = 0.755, P = 0.001), heart (r = 0.633, P = 0.015), liver (r = 0.722, P = 0.003), kidneys (r = 0.737, P = 0.006), pancreas (r = 0.666, P = 0.009), and brain (r = 0.917, P < 0.0001). Conclusions: Our data demonstrate that accumulated mtDNA deletions of lymphocytes depended upon dietary folate deprivation. The accumulated mt deletions in lymphocytes closely reflected the mt genotoxicity in the peripheral tissues during folate deficiency.
C1 [Chou, Yi-Fang; Huang, Rwei-Fen S.] Fu Jen Catholic Univ, Dept Nutr Sci, Hsinchuang 242, Taipei County, Taiwan.
C3 Fu Jen Catholic University
RP Huang, RFS (corresponding author), Fu Jen Catholic Univ, Dept Nutr Sci, Hsinchuang 242, Taipei County, Taiwan.
EM 034825@mail.fju.edu.tw
FU National Science Council, Taiwan [NSC96-2320-B-002]
CR Biagini G, 1998, MECH AGEING DEV, V101, P269, DOI 10.1016/S0047-6374(97)00181-4
   Branda RF, 2002, MUTAT RES-FUND MOL M, V501, P29, DOI 10.1016/S0027-5107(02)00014-3
   Chang CM, 2007, BRIT J NUTR, V97, P855, DOI 10.1017/S0007114507666410
   Choi SW, 2000, J NUTR, V130, P129, DOI 10.1093/jn/130.2.129
   CHOU YF, 2007, J NUTR, V100, P596
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370
   Crott JW, 2005, MUTAT RES-FUND MOL M, V570, P63, DOI 10.1016/j.mrfmmm.2004.09.009
   Doria G, 2001, MECH AGEING DEV, V122, P985, DOI 10.1016/S0047-6374(01)00251-2
   Duthie SJ, 2000, BRIT J CANCER, V83, P1532, DOI 10.1054/bjoc.2000.1481
   Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109
   Fenech M, 2001, MUTAT RES-FUND MOL M, V480, P51, DOI 10.1016/S0027-5107(01)00168-3
   Fliss MS, 2000, SCIENCE, V287, P2017, DOI 10.1126/science.287.5460.2017
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   HORNE DW, 1988, CLIN CHEM, V34, P2357
   Huang RFS, 2001, J NUTR, V131, P33, DOI 10.1093/jn/131.1.33
   Jerónimo C, 2001, ONCOGENE, V20, P5195, DOI 10.1038/sj.onc.1204646
   Kim UK, 2000, BASIC RES CARDIOL, V95, P163, DOI 10.1007/s003950050178
   KOPXIDAS G, 2000, ANN NY ACAD SCI, V908, P226
   Kuo CS, 2008, BRIT J NUTR, V100, P596, DOI 10.1017/S0007114508911557
   LEE HC, 1994, BBA-MOL BASIS DIS, V1226, P37, DOI 10.1016/0925-4439(94)90056-6
   LESTIENNE P, 1988, LANCET, V1, P885
   Loscalzo J, 1996, J CLIN INVEST, V98, P5, DOI 10.1172/JCI118776
   Luchsinger JA, 2007, ARCH NEUROL-CHICAGO, V64, P86, DOI 10.1001/archneur.64.1.86
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   Meissner C, 2000, FORENSIC SCI INT, V113, P109, DOI 10.1016/S0379-0738(00)00249-8
   Melberg A, 2005, ACTA NEUROPATHOL, V110, P315, DOI 10.1007/s00401-005-1047-z
   Mohamed SA, 2004, EXP GERONTOL, V39, P181, DOI 10.1016/j.exger.2003.10.011
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   Raha S, 2000, TRENDS BIOCHEM SCI, V25, P502, DOI 10.1016/S0968-0004(00)01674-1
   Rampersaud GC, 2000, AM J CLIN NUTR, V72, P998
   Ravagnan L, 2002, J CELL PHYSIOL, V192, P131, DOI 10.1002/jcp.10111
   Ross OA, 2002, EXP GERONTOL, V37, P329, DOI 10.1016/S0531-5565(01)00200-5
   VARELAMOREIRAS G, 1992, J NUTR, V122, P986, DOI 10.1093/jn/122.4.986
   VIRBASIUS JV, 1994, P NATL ACAD SCI USA, V91, P1309, DOI 10.1073/pnas.91.4.1309
   von Wurmb N, 1998, MUTAT RES-FUND MOL M, V422, P247, DOI 10.1016/S0027-5107(98)00205-X
   WALZEM RL, 1988, J NUTR, V118, P1089, DOI 10.1093/jn/118.9.1089
   Wang Y, 2001, P NATL ACAD SCI USA, V98, P4022, DOI 10.1073/pnas.061013598
   Wei YH, 1998, P SOC EXP BIOL MED, V217, P53
   Wei YH, 2002, EXP BIOL MED, V227, P671, DOI 10.1177/153537020222700901
   WEI YH, 1992, MUTAT RES, V275, P145, DOI 10.1016/0921-8734(92)90019-L
   Wei YH, 1998, CURR SCI INDIA, V74, P887
   Yin PH, 2004, BRIT J CANCER, V90, P2390, DOI 10.1038/sj.bjc.6601838
NR 43
TC 28
Z9 28
U1 0
U2 6
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1436-6207
EI 1436-6215
J9 EUR J NUTR
JI Eur. J. Nutr.
PD OCT 15
PY 2009
VL 48
IS 7
BP 429
EP 436
DI 10.1007/s00394-009-0031-0
PG 8
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA 495TH
UT WOS:000269917400006
PM 19437061
DA 2024-11-01
ER

PT J
AU Negro, R
   Zoccolella, S
   Dell'Aglio, R
   Amati, A
   Artuso, L
   Bisceglia, L
   Lavolpe, V
   Papa, S
   Serlenga, L
   Petruzzella, V
AF Negro, Roberto
   Zoccolella, Stefano
   Dell'Aglio, Rosa
   Amati, Angela
   Artuso, Lucia
   Bisceglia, Luigi
   Lavolpe, Vito
   Papa, Sergio
   Serlenga, Luigi
   Petruzzella, Vittoria
TI Molecular analysis in a family presenting with a mild form of late-onset autosomal dominant chronic progressive external ophthalmoplegia
SO NEUROMUSCULAR DISORDERS
LA English
DT Article
DE mtDNA multiple deletions; mtDNA copy number; Progressive external ophthalmoplegia
ID mitochondrial-dna deletions; twinkle; mutations; helicase; disease
AB Nuclear genes affecting mitochondrial genome stability were screened in an Italian family presenting with autosomal dominant progressive external ophthalmoplegia (adPEO) associated with multiple mitochondrial DNA (mtDNA) deletions. We report on a heterozygous c.907C>T (p.R303W) mutation found in the N-terminal domain of the human mitochondrial DNA helicase, Twinkle protein, in six members of a family, in which two individuals manifested late-onset PEO and morphological and molecular signs of mitochondrial dysfunction along with two carriers who are presently free of disease manifestation. We also investigated if the p.R303W mutation in PEO1 gene affected the relative copy number of mitochondrial DNA genomes. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Negro, Roberto; Dell'Aglio, Rosa; Artuso, Lucia; Papa, Sergio; Petruzzella, Vittoria] Univ Bari, Dept Med Biochem Med Biol & Med Phys, I-70124 Bari, Italy.
   [Zoccolella, Stefano] Osped Riuniti Foggia, Clin Nervous Syst Dis, Foggia, Italy.
   [Amati, Angela; Lavolpe, Vito] Univ Bari, Dept Neurol & Psychiat Sci, I-70124 Bari, Italy.
   [Bisceglia, Luigi] IRCCS Casa Sollievo Sofferenza, Foggia, Italy.
   [Papa, Sergio; Petruzzella, Vittoria] CNR, Inst Biomembranes & Bioenerget, Bari, Italy.
   [Serlenga, Luigi] L Bonomo Hosp, Operat Unit Neurol, Bari, Italy.
C3 Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro; IRCCS Casa Sollievo Della Sofferenza; Consiglio Nazionale delle Ricerche (CNR)
RP Petruzzella, V (corresponding author), Univ Bari, Dept Med Biochem Med Biol & Med Phys, Piazza Giulio Cesare 11, I-70124 Bari, Italy.
EM v.petruzzella@biochem.uniba.it
FU Italian Ministry of Health (Ricerca Corrente e Finalizzata); MIUR-PRIN [2005052128001]; Research Foundation Cassa di Risparmio di Puglia
CR Agostino A, 2003, NEUROLOGY, V60, P1354, DOI 10.1212/01.WNL.0000056088.09408.3C
   Goffart S, 2009, HUM MOL GENET, V18, P328, DOI 10.1093/hmg/ddn359
   He LP, 2002, NUCLEIC ACIDS RES, V30, P0, DOI 10.1093/nar/gnf067
   Hudson G, 2005, NEUROLOGY, V64, P371, DOI 10.1212/01.WNL.0000149767.51152.83
   Lee Andrew G, 2002, CURR NEUROL NEUROSCI REP, V2, P413, DOI 10.1007/s11910-002-0067-5
   Matsushima Y, 2008, J BIOL CHEM, V283, P23964, DOI 10.1074/jbc.M803674200
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Suomalainen A, 1997, NEUROLOGY, V48, P1244, DOI 10.1212/WNL.48.5.1244
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Virgilio R, 2008, J NEUROL, V255, P1384, DOI 10.1007/s00415-008-0926-3
NR 10
TC 7
Z9 9
U1 0
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8966
EI 1873-2364
J9 NEUROMUSCULAR DISORD
JI Neuromusc. Disord.
PD JUN 15
PY 2009
VL 19
IS 6
BP 423
EP 426
DI 10.1016/j.nmd.2009.04.008
PG 4
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 474SV
UT WOS:000268305200008
PM 19428252
DA 2024-11-01
ER

PT J
AU Viscomi, C
   Spinazzola, A
   Maggioni, M
   Fernandez-Vizarra, E
   Massa, V
   Pagano, C
   Vettor, R
   Mora, M
   Zeviani, M
AF Viscomi, Carlo
   Spinazzola, Antonella
   Maggioni, Marco
   Fernandez-Vizarra, Erika
   Massa, Valeria
   Pagano, Claudio
   Vettor, Roberto
   Mora, Marina
   Zeviani, Massimo
TI Early-onset liver mtDNA depletion and late-onset proteinuric nephropathy in <i>Mpv17 knockout</i> mice
SO HUMAN MOLECULAR GENETICS
LA English
DT Article
ID mitochondrial-dna depletion; melanocyte stem-cell; mpv17 gene; inner-ear; basement-membrane; transgenic mouse; thymidine kinase; initiation sites; copy number; mutations
AB In humans, MPV17 mutations are responsible for severe mitochondrial depletion syndrome, mainly affecting the liver and the nervous system. To gain insight into physiopathology of MPV17-related disease, we investigated an available Mpv17 knockout animal model. We found severe mtDNA depletion in liver and, albeit to a lesser extent, in skeletal muscle, whereas hardly any depletion was detected in brain and kidney, up to 1 year after birth. Mouse embryonic fibroblasts did show mtDNA depletion, but only after several culturing passages, or in a serumless culturing medium. In spite of severe mtDNA depletion, only moderate decrease in respiratory chain enzymatic activities, and mild cytoarchitectural alterations, were observed in the Mpv17(-/-) livers, but neither cirrhosis nor failure ever occurred in this organ at any age. The mtDNA transcription rate was markedly increased in liver, which could contribute to compensate the severe mtDNA depletion. This phenomenon was associated with specific downregulation of Mterf1, a negative modulator of mtDNA transcription. The most relevant clinical features involved skin, inner ear and kidney. The coat of the Mpv17(-/-) mice turned gray early in adulthood, and 18-month or older mice developed focal segmental glomerulosclerosis (FSGS) with massive proteinuria. Concomitant degeneration of cochlear sensory epithelia was reported as well. These symptoms were associated with significantly shorter lifespan. Coincidental with the onset of FSGS, there was hardly any mtDNA left in the glomerular tufts. These results demonstrate that Mpv17 controls mtDNA copy number by a highly tissue- and possibly cytotype-specific mechanism.
C1 [Viscomi, Carlo; Spinazzola, Antonella; Fernandez-Vizarra, Erika; Massa, Valeria; Zeviani, Massimo] IRCCS Fdn Neurol Inst C Besta, Unit Mol Neurogenet, Pierfranco & Luisa Mariani Ctr Study Mitochondria, I-20126 Milan, Italy.
   [Mora, Marina] IRCCS Fdn Neurol Inst C Besta, Unit Neuromuscular Dis, I-20126 Milan, Italy.
   [Maggioni, Marco] San Paolo Univ Hosp, Serv Pathol, Milan, Italy.
   [Pagano, Claudio; Vettor, Roberto] Univ Padua, Sch Med, Dept Med & Surg Sci, Padua, Italy.
C3 University of Padua
RP Zeviani, M (corresponding author), IRCCS Fdn Neurol Inst C Besta, Unit Mol Neurogenet, Pierfranco & Luisa Mariani Ctr Study Mitochondria, Via Temolo 4, I-20126 Milan, Italy.
EM zeviani@istituto-besta.it
FU Pierfranco and Luisa Mariani Foundation; Telethon-Italy Foundation [GGP07019]; Italian Ministry of University and Research [RBLA038RMA]; Italian Ministry of Health [RF2006 ex 56/05/21]; MITOCIRCLE; EUMITOCOMBAT [LSHM-CT-2004-503116]; European Union; Marie Curie intra-European fellowship [FP6-2005-Mobility5]
CR Akman HO, 2008, HUM MOL GENET, V17, P2433, DOI 10.1093/hmg/ddn143
   Angelin A, 2007, P NATL ACAD SCI USA, V104, P991, DOI 10.1073/pnas.0610270104
   APPENZELLER O, 1976, ARCH NEUROL-CHICAGO, V33, P733, DOI 10.1001/archneur.1976.00500110001001
   Barthélémy C, 2001, ANN NEUROL, V49, P607, DOI 10.1002/ana.1002.abs
   Binder CJ, 1999, AM J PATHOL, V154, P1067, DOI 10.1016/S0002-9440(10)65359-X
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   Bugiani M, 2005, J MED GENET, V42, P0, DOI 10.1136/jmg.2004.029926
   Clozel M, 1999, EXP GERONTOL, V34, P1007, DOI 10.1016/S0531-5565(99)00074-1
   Cree LM, 2008, DIABETOLOGIA, V51, P1440, DOI 10.1007/s00125-008-1054-4
   Elpeleg O, 2005, AM J HUM GENET, V76, P1081, DOI 10.1086/430843
   Fernández-Vizarra E, 2002, METHODS, V26, P292, DOI 10.1016/S1046-2023(02)00034-8
   Fernández-Vizarra E, 2008, CURR GENET, V54, P13, DOI 10.1007/s00294-008-0194-x
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   Gleyzer N, 2005, MOL CELL BIOL, V25, P1354, DOI 10.1128/MCB.25.4.1354-1366.2005
   Gubler MC, 2008, NAT CLIN PRACT NEPHR, V4, P24, DOI 10.1038/ncpneph0671
   Hagiwara M, 2006, KIDNEY INT, V69, P1146, DOI 10.1038/sj.ki.5000207
   Hakonen AH, 2007, BRAIN, V130, P3032, DOI 10.1093/brain/awm242
   Heath KE, 2001, AM J HUM GENET, V69, P1033, DOI 10.1086/324267
   Inoue K, 2000, NAT GENET, V26, P176, DOI 10.1038/82826
   Irwin WA, 2003, NAT GENET, V35, P367, DOI 10.1038/ng1270
   Karadimas CL, 2006, AM J HUM GENET, V79, P544, DOI 10.1086/506913
   Kimura T, 2003, NAT GENET, V34, P440, DOI 10.1038/ng1212
   Lalwani AK, 2008, BRAIN RES, V1197, P13, DOI 10.1016/j.brainres.2007.12.058
   Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231
   Mak SS, 2006, DEV BIOL, V291, P144, DOI 10.1016/j.ydbio.2005.12.025
   Mandel H, 2001, HEPATOLOGY, V34, P776, DOI 10.1053/jhep.2001.27664
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   Martin M, 2005, CELL, V123, P1227, DOI 10.1016/j.cell.2005.09.040
   Masuyama M, 2005, BBA-GEN SUBJECTS, V1723, P302, DOI 10.1016/j.bbagen.2005.03.001
   Merlini L, 2008, P NATL ACAD SCI USA, V105, P5225, DOI 10.1073/pnas.0800962105
   MONTOYA J, 1983, CELL, V34, P151, DOI 10.1016/0092-8674(83)90145-9
   MONTOYA J, 1982, P NATL ACAD SCI-BIOL, V79, P7195, DOI 10.1073/pnas.79.23.7195
   Navarro-Sastre A, 2008, MOL GENET METAB, V94, P234, DOI 10.1016/j.ymgme.2008.01.012
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Nishimura EK, 2005, SCIENCE, V307, P720, DOI 10.1126/science.1099593
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   OBryan T, 2000, J AM SOC NEPHROL, V11, P1067, DOI 10.1681/ASN.V1161067
   Ostergaard E, 2007, AM J HUM GENET, V81, P383, DOI 10.1086/519222
   Park CB, 2007, CELL, V130, P273, DOI 10.1016/j.cell.2007.05.046
   Reuter A, 1998, MOL BIOL CELL, V9, P1675, DOI 10.1091/mbc.9.7.1675
   Rötig A, 2003, J NEPHROL, V16, P286
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Sarzi E, 2007, ANN NEUROL, V62, P579, DOI 10.1002/ana.21207
   Sarzi E, 2007, J PEDIATR-US, V150, P531, DOI 10.1016/j.jpeds.2007.01.044
   Scarpulla RC, 2006, J CELL BIOCHEM, V97, P673, DOI 10.1002/jcb.20743
   Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007
   Sciacco M, 1996, METHODS ENZYMOL, V264, P509, DOI 10.1016/S0076-6879(96)64045-2
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   SPINAZZOLA A, 2008, ARCH NEUROL-CHICAGO, V65, P1
   Spinazzola A, 2008, NEUROMUSCULAR DISORD, V18, P315, DOI 10.1016/j.nmd.2007.12.007
   Spinazzola A, 2007, BIOSCIENCE REP, V27, P39, DOI 10.1007/s10540-007-9036-1
   Tobin DJ, 2001, EXP GERONTOL, V36, P29, DOI 10.1016/S0531-5565(00)00210-2
   WEIHER H, 1990, CELL, V62, P425, DOI 10.1016/0092-8674(90)90008-3
   Wong LJC, 2007, HEPATOLOGY, V46, P1218, DOI 10.1002/hep.21799
   Zhou XS, 2008, HUM MOL GENET, V17, P2329, DOI 10.1093/hmg/ddn133
   zum Gottesberge AMM, 2005, HISTOCHEM CELL BIOL, V124, P507, DOI 10.1007/s00418-005-0027-7
   zumGottesberge AMM, 1996, EUR ARCH OTO-RHINO-L, V253, P470, DOI 10.1007/BF00179952
   ZWACKA RM, 1994, EMBO J, V13, P5129, DOI 10.1002/j.1460-2075.1994.tb06842.x
NR 58
TC 73
Z9 75
U1 0
U2 4
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0964-6906
EI 1460-2083
J9 HUM MOL GENET
JI Hum. Mol. Genet.
PD JAN 1
PY 2009
VL 18
IS 1
BP 12
EP 26
DI 10.1093/hmg/ddn309
PG 15
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA 383NM
UT WOS:000261680300002
PM 18818194
DA 2024-11-01
ER

PT J
AU Frederiksen, AL
   Jeppesen, TD
   Vissing, J
   Schwartz, M
   Kyvik, KO
   Schmitz, O
   Poulsen, PL
   Andersen, PH
AF Frederiksen, Anja Lisbeth
   Jeppesen, Tina Dysgaard
   Vissing, John
   Schwartz, Marianne
   Kyvik, Kirsten Ohm
   Schmitz, Ole
   Poulsen, Per Logstrup
   Andersen, Per Heden
TI High Prevalence of Impaired Glucose Homeostasis and Myopathy in Asymptomatic and Oligosymptomatic 3243A&gt;G Mitochondrial DNA Mutation-Positive Subjects
SO JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
LA English
DT Article
ID stroke-like episodes; diabetes-mellitus; trna(leu(uur)) mutation; insulin-resistance; lactic-acidosis; gene; phenotype; deafness; melas; spectrum
AB Introduction: The point mutation of 3243A>G mtDNA is the most frequent cause of mitochondrial diabetes, often presenting as the syndrome maternally inherited diabetes and deafness (MIDD). The mutation may also cause myopathy, ataxia, strokes, ophthalmoplegia, epilepsy, and cardiomyopathy in various combinations. Consequently, it is difficult to predict the "phenotypic risk profile" of 3243A>G mutation-positive subjects. The 3243A>G mutation coexists in cells with wild-type mtDNA, a phenomenon called heteroplasmy. The marked variability in mutation loads in different tissues is the main explanation for the different phenotypes associated with this mutation. Aim: The aim of the study was to screen asymptomatic and oligosymptomatic 3243A>G mtDNA carriers for diabetes and myopathy. Methods: The study is a case-control study. Nineteen adult 3243A>G carriers presumed to be normoglycemic and matched healthy controls were subjected to an oral glucose tolerance test. Twenty-six adult 3243A>G carriers with unknown myopathy status and 17 healthy controls had a maximal cycle test and a muscle biopsy performed. The mutation loads were quantified in blood and muscle biopsies and correlated to the clinical manifestations of the mutation. Results: In the presumed normoglycemic 3243A>G-positive subjects, one subject had overt diabetes, and 10 subjects had impaired glucose tolerance. Sixteen of the 26 subjects with unknown oxidative capacity fulfilled criteria for myopathy. The mutation load in blood and muscle correlated with the age for diagnosis of impaired glucose homeostasis and hearing impairment (rho = -0.71 to -0.78; P < 0.0001). Conclusion: The findings suggest that 3243A>G mutation carriers should be screened for diabetes and myopathy. (J Clin Endocrinol Metab 94: 2872-2879, 2009)
C1 [Frederiksen, Anja Lisbeth; Andersen, Per Heden] Ribe Cty Hosp, Dept Endocrinol, DK-6700 Esbjerg, Denmark.
   [Frederiksen, Anja Lisbeth] Odense Univ Hosp, Dept Endocrinol, DK-5000 Odense, Denmark.
   [Jeppesen, Tina Dysgaard; Vissing, John] Univ Copenhagen, Rigshosp, Neuromuscular Res Unit, Dept Neurol, DK-2100 Copenhagen, Denmark.
   [Schwartz, Marianne] Univ Copenhagen, Rigshosp, Dept Clin Genet, DK-2100 Copenhagen, Denmark.
   [Kyvik, Kirsten Ohm] Univ So Denmark, Inst Publ Hlth, Danish Twin Registry, DK-5230 Odense, Denmark.
   [Schmitz, Ole; Poulsen, Per Logstrup] Aarhus Univ Hosp, Dept Endocrinol M, Res Lab, DK-8200 Aarhus, Denmark.
C3 University of Southern Denmark; Odense University Hospital; Rigshospitalet; University of Copenhagen; University of Copenhagen; Rigshospitalet; University of Southern Denmark; Aarhus University
RP Frederiksen, AL (corresponding author), Ribe Cty Hosp, Dept Endocrinol, Finsensgade 35, DK-6700 Esbjerg, Denmark.
EM anja.frederiksen@ouh.regionsyddanmark.dk
CR [Anonymous], 2008, MITOMAP: A HUMAN MITOCHONDRIAL GENOME DATABASE, V0, P0
   Becker R, 2002, EXP CLIN ENDOCR DIAB, V110, P291, DOI 10.1055/s-2002-34592
   Blake DR, 2004, DIABETES, V53, P2095, DOI 10.2337/diabetes.53.8.2095
   Brändle M, 2001, DIABETES CARE, V24, P1253, DOI 10.2337/diacare.24.7.1253
   Chinnery PF, 2000, ANN NEUROL, V48, P188, DOI 10.1002/1531-8249(200008)48:2<188::AID-ANA8>3.3.CO;2-G
   Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713
   Chinnery PF, 2000, BRAIN, V123, P82, DOI 10.1093/brain/123.1.82
   DAMIAN MS, 1995, ACTA NEUROL SCAND, V92, P409
   DeSouza RA, 2004, SOUTH MED J, V97, P528, DOI 10.1097/00007611-200405000-00023
   Frederiksen AL, 2006, J MED GENET, V43, P0, DOI 10.1136/jmg.2005.039339
   Gavin JR, 1997, DIABETES CARE, V20, P1183
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Guéry B, 2003, J AM SOC NEPHROL, V14, P2099, DOI 10.1097/01.ASN.0000080180.51098.02
   Guillausseau PJ, 2004, DIABETES METAB, V30, P181, DOI 10.1016/S1262-3636(07)70105-2
   Hotta O, 2001, KIDNEY INT, V59, P1236, DOI 10.1046/j.1523-1755.2001.0590041236.x
   Jansen JJ, 1997, J AM SOC NEPHROL, V8, P1118
   Jeppesen TD, 2003, ANN NEUROL, V54, P86, DOI 10.1002/ana.10594
   Jeppesen TD, 2006, ARCH NEUROL-CHICAGO, V63, P1701, DOI 10.1001/archneur.63.12.1701
   Jones DL, 2004, INTERN MED J, V34, P517, DOI 10.1111/j.1444-0903.2004.00659.x
   Kärppä M, 2004, J NEUROL, V251, P556, DOI 10.1007/s00415-004-0363-x
   Löwik MM, 2005, NEPHROL DIAL TRANSPL, V20, P336, DOI 10.1093/ndt/gfh546
   Maassen JA, 2004, DIABETES, V53, PS103, DOI 10.2337/diabetes.53.2007.S103
   Maassen JA, 2002, J ENDOCRINOL INVEST, V25, P477, DOI 10.1007/BF03344042
   Majamaa K, 1998, AM J HUM GENET, V63, P447, DOI 10.1086/301959
   MANOUVRIER S, 1995, J MED GENET, V32, P654, DOI 10.1136/jmg.32.8.654
   MARIOTTI C, 1995, J NEUROL, V242, P304, DOI 10.1007/BF00878873
   Olsson C, 1998, HUM MUTAT, V12, P52, DOI 10.1002/(SICI)1098-1004(1998)12:1<52::AID-HUMU8>3.0.CO;2-K
   Schwartz M, 2002, NEW ENGL J MED, V347, P576, DOI 10.1056/NEJMoa020350
   Sparaco M, 2003, ACTA NEUROPATHOL, V106, P202, DOI 10.1007/s00401-003-0716-z
   Suomalainen A, 2000, MOL BIOTECHNOL, V15, P123, DOI 10.1385/MB:15:2:123
   Suzuki S, 2003, DIABETES RES CLIN PR, V59, P207, DOI 10.1016/S0168-8227(02)00246-2
   Szendroedi J, 2009, DIABETES CARE, V32, P677, DOI 10.2337/dc08-2078
   Taivassalo T, 2003, BRAIN, V126, P413, DOI 10.1093/brain/awg028
   Torroni A, 2003, AM J HUM GENET, V72, P1005, DOI 10.1086/373936
   Uimonen S, 2001, HUM GENET, V108, P284, DOI 10.1007/s004390100475
   Unwin N, 2002, DIABETIC MED, V19, P708, DOI 10.1046/j.1464-5491.2002.00835.x
   van den Ouweland JMW, 1999, DIABETOLOGIA, V42, P485, DOI 10.1007/s001250051183
   VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368
   Velho G, 1996, DIABETES, V45, P478, DOI 10.2337/diabetes.45.4.478
NR 39
TC 18
Z9 19
U1 0
U2 1
PU ENDOCRINE SOC
PI WASHINGTON
PA 2055 L ST NW, SUITE 600, WASHINGTON, DC 20036 USA
SN 0021-972X
EI 1945-7197
J9 J CLIN ENDOCR METAB
JI J. Clin. Endocrinol. Metab.
PD AUG 15
PY 2009
VL 94
IS 8
BP 2872
EP 2879
DI 10.1210/jc.2009-0235
PG 8
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 479UW
UT WOS:000268687700029
PM 19470628
DA 2024-11-01
ER

PT J
AU Greaves, LC
   Turnbull, DM
AF Greaves, Laura C.
   Turnbull, Doug M.
TI Mitochondrial DNA mutations and ageing
SO BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
LA English
DT Review
DE Mitochondria; Mitochondrial DNA; Ageing; Mutation; Respiratory chain dysfunction
ID somatic mtdna mutations; point mutations; skeletal-muscle; life-span; dilated cardiomyopathy; deoxyribonucleic-acid; radical production; choroid-plexus; control-region; hearing-loss
AB The mechanism by which we age has sparked a huge number of theories, and is an area of intense debate. As the elderly population rises, the importance of elucidating these mechanisms is becoming more apparent as age is the single biggest risk factor for a number of diseases such as cancer, diabetes and neurodegenerative disease. Mitochondrial DNA (MtDNA) mutations have been shown to accumulate in cells and tissues during the ageing process; however the question as to whether these mutations have a causal role in the ageing process remains an area of uncertainty. Here we review the current literature, and discuss the evidence for and against a causal role of mtDNA mutations in ageing and in the pathogenesis of age-related disease. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Greaves, Laura C.; Turnbull, Doug M.] Univ Newcastle, Sch Med, Mitochondrial Res Grp, Inst Ageing & Hlth, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
C3 Newcastle University - UK
RP Turnbull, DM (corresponding author), Univ Newcastle, Sch Med, Mitochondrial Res Grp, Inst Ageing & Hlth, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM D.M.Turnbull@ncl.ac.uk
FU Wellcome Trust; Food Standards Agency (UK) [N12015]; Newcastle University Centre for Brain Ageing Vitality; BBSRC; EPSRC; ESRC; MRC; crosscouncil Lifelong Health and Wellbeing Initiative; MRC [G0700718] Funding Source: UKRI
CR Agarwal S, 1996, EXP GERONTOL, V31, P365, DOI 10.1016/0531-5565(95)02039-X
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Barreau E, 1996, INVEST OPHTH VIS SCI, V37, P384
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   BENDER A, 2008, J NEUROL, V0, P0
   Birket MJ, 2007, AGING CELL, V6, P557, DOI 10.1111/j.1474-9726.2007.00310.x
   BOULET L, 1992, AM J HUM GENET, V51, P1187
   BROWN WM, 1979, P NATL ACAD SCI USA, V76, P1967, DOI 10.1073/pnas.76.4.1967
   Bua EA, 2004, FASEB J, V18, P582, DOI 10.1096/fj.03-0668fje
   CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527
   Chinnery PF, 1999, LANCET, V354, P0
   CHOMYN A, 1992, P NATL ACAD SCI USA, V89, P4221, DOI 10.1073/pnas.89.10.4221
   COOPER JM, 1992, J NEUROL SCI, V113, P91, DOI 10.1016/0022-510X(92)90270-U
   CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370
   CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927
   Coskun PE, 2004, P NATL ACAD SCI USA, V101, P10726, DOI 10.1073/pnas.0403649101
   Cottrell DA, 2001, NEUROPATH APPL NEURO, V27, P206, DOI 10.1046/j.1365-2990.2001.00315.x
   Cottrell DA, 2001, NEUROBIOL AGING, V22, P265, DOI 10.1016/S0197-4580(00)00234-7
   deGrey ADNJ, 1997, BIOESSAYS, V19, P161, DOI 10.1002/bies.950190211
   Ekstrand MI, 2007, P NATL ACAD SCI USA, V104, P1325, DOI 10.1073/pnas.0605208103
   FELLOUS TG, 2008, HEPATOLOGY, V0, P0
   FUKUI H, 2008, HUM MOL GENET, V0, P0
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   HAYASHI JI, 1991, P NATL ACAD SCI USA, V88, P10614, DOI 10.1073/pnas.88.23.10614
   Herbst A, 2007, J GERONTOL A-BIOL, V62, P235, DOI 10.1093/gerona/62.3.235
   Herrero A, 1997, MECH AGEING DEV, V98, P95, DOI 10.1016/S0047-6374(97)00076-6
   Huang TT, 2001, FREE RADICAL BIO MED, V31, P1101, DOI 10.1016/S0891-5849(01)00694-3
   KAO SH, 1995, BIOL REPROD, V52, P729, DOI 10.1095/biolreprod52.4.729
   KITAGAWA T, 1993, BIOL REPROD, V49, P730, DOI 10.1095/biolreprod49.4.730
   Kowald A, 1999, EXP GERONTOL, V34, P605, DOI 10.1016/S0531-5565(99)00011-X
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Krishnan KJ, 2007, NUCLEIC ACIDS RES, V35, P7399, DOI 10.1093/nar/gkm635
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Kukat A, 2009, EXP GERONTOL, V44, P101, DOI 10.1016/j.exger.2008.05.006
   LARSSON NG, 1995, MOL GENETIC ASPECTS, V0, P151
   LEE CM, 1993, J GERONTOL, V48, PB201, DOI 10.1093/geronj/48.6.B201
   LI YB, 1995, NAT GENET, V11, P376, DOI 10.1038/ng1295-376
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   Mcdonald SAC, 2008, GASTROENTEROLOGY, V134, P500, DOI 10.1053/j.gastro.2007.11.035
   Melov S, 1999, P NATL ACAD SCI USA, V96, P846, DOI 10.1073/pnas.96.3.846
   Michikawa Y, 1999, SCIENCE, V286, P774, DOI 10.1126/science.286.5440.774
   MIQUEL J, 1980, EXP GERONTOL, V15, P575, DOI 10.1016/0531-5565(80)90010-8
   MITA S, 1990, NUCLEIC ACIDS RES, V18, P561, DOI 10.1093/nar/18.3.561
   MORAES CT, 1992, NAT GENET, V1, P359, DOI 10.1038/ng0892-359
   Mott JL, 1999, ANN NY ACAD SCI, V893, P353, DOI 10.1111/j.1749-6632.1999.tb07853.x
   MULLERHOCKER J, 1990, J NEUROL SCI, V100, P14, DOI 10.1016/0022-510x(90)90006-9
   MULLERHOCKER J, 1989, AM J PATHOL, V134, P1167
   MUNSCHER C, 1993, FEBS LETT, V317, P27, DOI 10.1016/0014-5793(93)81484-H
   NASS MMK, 1966, P NATL ACAD SCI USA, V56, P1215, DOI 10.1073/pnas.56.4.1215
   Nekhaeva E, 2002, P NATL ACAD SCI USA, V99, P5521, DOI 10.1073/pnas.072670199
   Niu X, 2007, EXP CELL RES, V313, P3924, DOI 10.1016/j.yexcr.2007.05.029
   PANG CY, 1994, ARCH BIOCHEM BIOPHYS, V312, P534, DOI 10.1006/abbi.1994.1342
   PRYOR WA, 1973, FED PROC, V32, P1862
   RAO KS, 1992, MUTAT RES, V275, P317
   Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653
   SHADEL GS, 1997, MITOCHONDRIAL DNA MA, V0, P409
   SHOUBRIDGE EA, 1994, J BIOENERG BIOMEMBR, V26, P301, DOI 10.1007/BF00763101
   Silva JP, 2000, NAT GENET, V26, P336, DOI 10.1038/81649
   SIMONETTI S, 1992, BIOCHIM BIOPHYS ACTA, V1180, P113, DOI 10.1016/0925-4439(92)90059-V
   SOHAL RS, 1989, MECH AGEING DEV, V49, P129, DOI 10.1016/0047-6374(89)90096-1
   Someya S, 2008, NEUROBIOL AGING, V29, P1080, DOI 10.1016/j.neurobiolaging.2007.01.014
   Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435
   Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Troen BR, 2003, MT SINAI J MED, V70, P3
   Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95
   Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988
   WALLACE DC, 1989, TRENDS GENET, V5, P9, DOI 10.1016/0168-9525(89)90005-X
   Wang Y, 2001, P NATL ACAD SCI USA, V98, P4022, DOI 10.1073/pnas.061013598
   Williams MD, 1998, J BIOL CHEM, V273, P28510, DOI 10.1074/jbc.273.43.28510
   YONEDA M, 1992, P NATL ACAD SCI USA, V89, P11164, DOI 10.1073/pnas.89.23.11164
   ZEVIANI M, 1988, NEUROLOGY, V38, P1339
   ZHANG CF, 1993, BIOCHEM BIOPH RES CO, V195, P1104, DOI 10.1006/bbrc.1993.2158
   Zhang DK, 2000, GENOMICS, V69, P151, DOI 10.1006/geno.2000.6333
NR 76
TC 40
Z9 45
U1 0
U2 13
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0304-4165
EI 1872-8006
J9 BBA-GEN SUBJECTS
JI Biochim. Biophys. Acta-Gen. Subj.
PD OCT 15
PY 2009
VL 1790
IS 10
BP 1015
EP 1020
DI 10.1016/j.bbagen.2009.04.018
PG 6
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 503EO
UT WOS:000270516100008
PM 19409965
DA 2024-11-01
ER

PT J
AU Kohler, JJ
   Hosseini, SH
   Cucoranu, I
   Hoying-Brandt, A
   Green, E
   Johnson, D
   Wittich, B
   Srivastava, J
   Ivey, K
   Fields, E
   Russ, R
   Raper, CM
   Santoianni, R
   Lewis, W
AF Kohler, James J.
   Hosseini, Seyed H.
   Cucoranu, Ioan
   Hoying-Brandt, Amy
   Green, Elgin
   Johnson, David
   Wittich, Bree
   Srivastava, Jaya
   Ivey, Kristopher
   Fields, Earl
   Russ, Rodney
   Raper, C. Michael
   Santoianni, Robert
   Lewis, William
TI Murine cardiac mtDNA: effects of transgenic manipulation of nucleoside phosphorylation
SO LABORATORY INVESTIGATION
LA English
DT Article
DE mtDNA; NRTI; cardiomyopathy; transgenic; murine
ID mitochondrial thymidine kinase; dna-polymerase gamma; overexpression; cardiomyopathy; replication; expression; depletion; toxicity; diseases; muscle
AB Mitochondrial toxicity results from pyrimidine nucleoside reverse transcriptase inhibitors (NRTIs) for HIV/AIDS. In the heart, this can deplete mitochondrial (mt) DNA and cause cardiac dysfunction (eg, left ventricle hypertrophy, LVH). Four unique transgenic, cardiac-targeted overexpressors (TGs) were generated to determine their individual impact on native mitochondrial biogenesis and effects of NRTI administration on development of mitochondrial toxicity. TGs included cardiac-specific overexpression of native thymidine kinase 2 (TK2), two pathogenic TK2 mutants (H121N and I212N), and a mutant of mtDNA polymerase, pol-gamma (Y955C). Each was treated with antiretrovirals (AZT-HAART, 3 or 10 weeks, zidovudine (AZT) + lamivudine (3TC) + indinavir, or vehicle control). Parameters included left ventricle (LV) performance (echocardiography), LV mtDNA abundance (real-time PCR), and mitochondrial fine structure ( electron microscopy, EM) as a function of duration of treatment and presence of TG. mtDNA abundance significantly decreased in Y955C TG, increased in TK2 native and I212N TGs, and was unchanged in H121N TGs at 10 weeks regardless of treatment. Y955C and I212N TGs exhibited LVH during growth irrespective of treatment. Y955C TGs exhibited cardiomyopathy ( CM) at 3 and 10 weeks irrespective of treatment, whereas H121N and I212N TGs exhibited CM only after 10 weeks AZT-HAART. EM features were consistent with cardiac dysfunction. mtDNA abundance and cardiac functional changes were related to TG expression of mitochondrially related genes, mutations thereof, and NRTIs. Laboratory Investigation (2009) 89, 122-130; doi: 10.1038/labinvest.2008.121; published online 15 December 2008
C1 [Kohler, James J.; Hosseini, Seyed H.; Cucoranu, Ioan; Hoying-Brandt, Amy; Green, Elgin; Johnson, David; Wittich, Bree; Srivastava, Jaya; Ivey, Kristopher; Fields, Earl; Russ, Rodney; Raper, C. Michael; Santoianni, Robert; Lewis, William] Emory Univ, Sch Med, Dept Pathol, Atlanta, GA 30322 USA.
C3 Emory University
RP Kohler, JJ (corresponding author), Emory Univ, Sch Med, Dept Pathol, 7126 Woodruff Mem Bldg,101 Woodruff Circle, Atlanta, GA 30322 USA.
EM jjkohle@emory.edu
FU NIH NHLBI [R01 HL059798, HL079867]; NIDDK [K01 DK078513]
CR BARTH E, 1992, J MOL CELL CARDIOL, V24, P669, DOI 10.1016/0022-2828(92)93381-S
   Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646
   Côté HCF, 2003, J INFECT DIS, V187, P1972, DOI 10.1086/375353
   DALAKAS MC, 1990, NEW ENGL J MED, V322, P1098, DOI 10.1056/NEJM199004193221602
   Davies Stella M, 2006, HEMATOLOGY AM SOC HEMATOL EDUC PROGRAM, V0, P111
   ERIKSSON S, 1991, ADV EXP MED BIOL, V309, P239
   Eriksson S, 2002, CELL MOL LIFE SCI, V59, P1327, DOI 10.1007/s00018-002-8511-x
   Ferraro P, 2006, P NATL ACAD SCI USA, V103, P18586, DOI 10.1073/pnas.0609020103
   Graziewicz MA, 2006, CHEM REV, V106, P383, DOI 10.1021/cr040463d
   Hoit BD, 2002, GENOMICS, V79, P679, DOI 10.1006/geno.2002.6754
   Hosseini SH, 2007, AM J PATHOL, V170, P865, DOI 10.2353/ajpath.2007.060655
   Huang WY, 2000, NAT MED, V6, P482, DOI 10.1038/74914
   Katz Arnold M, 1998, CARDIOLOGY CLINICS, V16, P633, DOI 10.1016/S0733-8651(05)70040-0
   Kohler JJ, 2008, CARDIOVASC TOXICOL, V8, P57, DOI 10.1007/s12012-008-9015-1
   Lefai E, 2000, MOL GEN GENET, V264, P37, DOI 10.1007/s004380000301
   Lewis W, 2000, LAB INVEST, V80, P187, DOI 10.1038/labinvest.3780022
   LEWIS W, 1995, NAT MED, V1, P417, DOI 10.1038/nm0595-417
   Lewis W, 2001, LAB INVEST, V81, P1527, DOI 10.1038/labinvest.3780366
   Lewis W, 2007, LAB INVEST, V87, P326, DOI 10.1038/labinvest.3700523
   McLeod CJ, 2005, TRENDS CARDIOVAS MED, V15, P118, DOI 10.1016/j.tcm.2005.05.001
   Moyes CD, 2003, ANNU REV PHYSIOL, V65, P177, DOI 10.1146/annurev.physiol.65.092101.142705
   Nebert DW, 2008, DRUG METAB REV, V40, P187, DOI 10.1080/03602530801952864
   Pakendorf B, 2005, ANNU REV GENOM HUM G, V6, P165, DOI 10.1146/annurev.genom.6.080604.162249
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Song SW, 2005, P NATL ACAD SCI USA, V102, P4990, DOI 10.1073/pnas.0500253102
   Thomopoulos S, 2007, J ORTHOP RES, V25, P1154, DOI 10.1002/jor.20418
   WALLACE DC, 1992, ANNU REV BIOCHEM, V61, P1175, DOI 10.1146/annurev.bi.61.070192.005523
   Wang JH, 2000, BIOCHEM PHARMACOL, V59, P1583, DOI 10.1016/S0006-2952(00)00285-9
NR 28
TC 16
Z9 18
U1 0
U2 0
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 0023-6837
EI 1530-0307
J9 LAB INVEST
JI Lab. Invest.
PD FEB 15
PY 2009
VL 89
IS 2
BP 122
EP 130
DI 10.1038/labinvest.2008.121
PG 9
WC Medicine, Research & Experimental; Pathology
SC Research & Experimental Medicine; Pathology
GA 400KO
UT WOS:000262866700002
PM 19079325
DA 2024-11-01
ER

PT J
AU Mahad, DJ
   Ziabreva, I
   Campbell, G
   Laulund, F
   Murphy, JL
   Reeve, AK
   Greaves, L
   Smith, KJ
   Turnbull, DM
AF Mahad, D. J.
   Ziabreva, I.
   Campbell, G.
   Laulund, F.
   Murphy, J. L.
   Reeve, A. K.
   Greaves, L.
   Smith, K. J.
   Turnbull, D. M.
TI Detection of cytochrome c oxidase activity and mitochondrial proteins in single cells
SO JOURNAL OF NEUROSCIENCE METHODS
LA English
DT Article
DE Mitochondria; Cytochrome c oxidase; Neurodegeneration; Immunohistochemistry and histochemistry
ID amyotrophic-lateral-sclerosis; substantia-nigra neurons; dna mutations; muscle-fibers; nitric-oxide; stem-cells; rat-brain; disease; mechanisms; deletions
AB Cytochrome c oxidase or mitochondrial respiratory chain complex IV is where over 90% of oxygen is consumed. The relationship between complex IV activity and mitochondrial proteins, which provides a guide to understanding the mechanisms in primary mitochondrial disorders, has been determined by histochemistry (activity) and immunohistochemistry in serial sections. In the central nervous system (CNS), mitochondrial activity and immunoreactivity have been determined in populations of cells in serial sections as capturing cells in more than one section is difficult. In this report we describe a method to determine complex IV activity in relation to mitochondrial proteins at a single cell level in the CNS. We performed complex IV histochemistry and immunohistochemistry consecutively in snap frozen sections. Although the product of complex IV histochemistry reduces the sensitivity of standard immunohistochemistry (secondary antibody and ABC method) the biotin-free Menapath polymer detection system (A. Menarini Diagnostics, Wokingham, UK) enables mitochondrial proteins to be detected following complex IV histochemistry. The co-occurring chromogens may then be separately visualised and analysed using multi-spectral imaging (Nuance system CRI, Woburn, MA). Our technique is applicable for exploring mitochondrial defects within single cells in a variety of CNS disorders and animal models of those diseases. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Mahad, D. J.; Ziabreva, I.; Campbell, G.; Murphy, J. L.; Reeve, A. K.; Greaves, L.; Turnbull, D. M.] Univ Newcastle, Inst Ageing & Hlth, Mitochondrial Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Laulund, F.; Smith, K. J.] Inst Neurol, Dept Neuroinflammat, London WC1N 3BG, England.
C3 Newcastle University - UK; University of London; University College London
RP Mahad, DJ (corresponding author), Univ Newcastle, Inst Ageing & Hlth, Mitochondrial Res Grp, Framlington Rd, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM mahadd@doctors.org.uk
FU Wellcome Trust; Medical Research Council; European Union; Multiple Sclerosis Society of Great Britain and Northern Ireland; MRC [G0500814, G0800954, G0700718] Funding Source: UKRI
CR Aboul-Enein F, 2005, ACTA NEUROPATHOL, V109, P49, DOI 10.1007/s00401-004-0954-8
   Beal MF, 2005, ANN NEUROL, V58, P495, DOI 10.1002/ana.20624
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Betts J, 2004, NEUROCHEM RES, V29, P505, DOI 10.1023/B:NERE.0000014821.07269.8d
   Borthwick GM, 1999, ANN NEUROL, V46, P787, DOI 10.1002/1531-8249(199911)46:5<787::AID-ANA17>3.0.CO;2-8
   Cooper CE, 2008, J BIOENERG BIOMEMBR, V40, P533, DOI 10.1007/s10863-008-9166-6
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   DIMLICH RVW, 1990, BRAIN RES, V516, P181, DOI 10.1016/0006-8993(90)90917-Z
   Dutta R, 2006, ANN NEUROL, V59, P478, DOI 10.1002/ana.20736
   Elfering SL, 2004, AM J PHYSIOL-HEART C, V286, PH22, DOI 10.1152/ajpheart.00766.2003
   Fontanesi F, 2008, IUBMB LIFE, V60, P557, DOI 10.1002/iub.86
   Greaves LC, 2006, P NATL ACAD SCI USA, V103, P714, DOI 10.1073/pnas.0505903103
   HEVNER RF, 1995, NEUROSCIENCE, V65, P313, DOI 10.1016/0306-4522(94)00514-6
   JOHNSON MA, 1993, ANN NEUROL, V33, P28, DOI 10.1002/ana.410330106
   JOHNSON MA, 1988, J NEUROL SCI, V87, P75, DOI 10.1016/0022-510X(88)90056-1
   KEILIN D, 1945, BIOCHEM J, V39, P148, DOI 10.1042/bj0390148
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Mannella CA, 1998, J STRUCT BIOL, V121, P207, DOI 10.1006/jsbi.1997.3954
   Mansfield James R, 2008, CURR PROTOC MOL BIOL, VChapter 14, P0, DOI 10.1002/0471142727.mb1419s84
   Martin LJ, 2007, J COMP NEUROL, V500, P20, DOI 10.1002/cne.21160
   Pye D, 2006, NUCLEIC ACIDS RES, V34, P0, DOI 10.1093/nar/gkl516
   Rahman S, 2000, BRAIN, V123, P591, DOI 10.1093/brain/123.3.591
   Reeve AK, 2008, AM J HUM GENET, V82, P228, DOI 10.1016/j.ajhg.2007.09.018
   Reeve AK, 2008, ANN NY ACAD SCI, V1147, P21, DOI 10.1196/annals.1427.016
   SCIACCO M, 1994, HUM MOL GENET, V3, P13, DOI 10.1093/hmg/3.1.13
   SELIGMAN AM, 1968, J CELL BIOL, V38, P1, DOI 10.1083/jcb.38.1.1
   Shoubridge EA, 2001, HUM MOL GENET, V10, P2277, DOI 10.1093/hmg/10.20.2277
   Taanman JW, 2001, BIOCHEM SOC T, V29, P446, DOI 10.1042/BST0290446
   Tanji K, 2001, SEMIN CELL DEV BIOL, V12, P429, DOI 10.1006/scdb.2001.0280
   Tanji K, 2000, BRAIN PATHOL, V10, P422
   Tanji K, 2008, METHODS, V46, P274, DOI 10.1016/j.ymeth.2008.09.027
   Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
NR 33
TC 26
Z9 28
U1 0
U2 7
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0165-0270
EI 
J9 J NEUROSCI METH
JI J. Neurosci. Methods
PD NOV 15
PY 2009
VL 184
IS 2
BP 310
EP 319
DI 10.1016/j.jneumeth.2009.08.020
PG 10
WC Biochemical Research Methods; Neurosciences
SC Biochemistry & Molecular Biology; Neurosciences & Neurology
GA 521IN
UT WOS:000271914400015
PM 19723540
DA 2024-11-01
ER

PT J
AU Melberg, A
   Moslemi, AR
   Palm, O
   Raininko, R
   Stålberg, E
   Oldfors, A
AF Melberg, Atle
   Moslemi, Ali-Reza
   Palm, Oscar
   Raininko, Raili
   Stalberg, Erik
   Oldfors, Anders
TI A patient with two mitochondrial DNA mutations causing PEO and LHON
SO EUROPEAN JOURNAL OF MEDICAL GENETICS
LA English
DT Article
DE Progressive external ophthalmoplegia (PEO); Leber hereditary optic neuropathy (LHON); Point mutation; Deletion; Mitochondrial DNA
ID hereditary optic neuropathy; progressive external ophthalmoplegia; deletions; atrophy
AB We report a 22-year-old man with PEO and optic atrophy. PEO developed before the onset of optic atrophy. The patient showed mitochondrial myopathy with cytochrome c oxidase deficient fibers. In skeletal muscle the patient was homoplasmic for the mtDNA G11778A Leber hereditary optic neuropathy (LHON) mutation and heteroplasmic for the mtDNA 5 kb "common" deletion mutation. In blood only the homoplasmic LHON mutation was identified. The occurrence of two pathogenic mtDNA mutations is exceedingly rare. The clinical findings in this patient indicate that the combination of the two mtDNA mutations resulted in the expected combined phenotype since the mtDNA deletion mutation accounted for the PEO and the mtDNA G11778A point mutation for the optic atrophy. (C) 2008 Elsevier Masson SAS. All rights reserved.
C1 [Moslemi, Ali-Reza; Oldfors, Anders] Sahlgrens Univ Hosp, Dept Pathol, SE-41345 Gothenburg, Sweden.
   [Melberg, Atle; Stalberg, Erik] Univ Uppsala Hosp, Dept Neurosci, Uppsala, Sweden.
   [Raininko, Raili] Univ Uppsala Hosp, Dept Radiol, Uppsala, Sweden.
   [Palm, Oscar] Karlstad Hosp, Dept Ophthalmol, Karlstad, Sweden.
C3 Sahlgrenska University Hospital; Uppsala University; Uppsala University Hospital; Uppsala University; Uppsala University Hospital
RP Oldfors, A (corresponding author), Sahlgrens Univ Hosp, Dept Pathol, SE-41345 Gothenburg, Sweden.
EM anders.oldfors@gu.se
FU Selander Foundation; Swedish Association of the Neurologically Disabled; Swedish Medical Research Council [7122]
CR Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   Kovács GG, 2005, BRAIN, V128, P35, DOI 10.1093/brain/awh310
   LARSSON NG, 1991, ANN NEUROL, V30, P701, DOI 10.1002/ana.410300511
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   Moslemi AR, 2000, CARDIOLOGY, V94, P68, DOI 10.1159/000007049
   Moslemi AR, 1999, NEUROLOGY, V53, P79, DOI 10.1212/WNL.53.1.79
   Ohno K, 1996, ANN NEUROL, V39, P761, DOI 10.1002/ana.410390612
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
NR 9
TC 4
Z9 5
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1769-7212
EI 1878-0849
J9 EUR J MED GENET
JI Eur. J. Med. Genet.
PD JAN-FEB 15
PY 2009
VL 52
IS 1
BP 47
EP 48
DI 10.1016/j.ejmg.2008.10.004
PG 2
WC Genetics & Heredity
SC Genetics & Heredity
GA 403ND
UT WOS:000263088400010
PM 19015050
DA 2024-11-01
ER

PT J
AU Wortmann, SB
   Rodenburg, RJT
   Jonckheere, A
   de Vries, MC
   Huizing, M
   Heldt, K
   van den Heuvel, LP
   Wendel, U
   Kluijtmans, LA
   Engelke, UF
   Wevers, RA
   Smeitink, JAM
   Morava, E
AF Wortmann, Saskia B.
   Rodenburg, Richard J. T.
   Jonckheere, An
   de Vries, Maaike C.
   Huizing, Marjan
   Heldt, Katrin
   van den Heuvel, Lambert P.
   Wendel, Udo
   Kluijtmans, Leo A.
   Engelke, Udo F.
   Wevers, Ron A.
   Smeitink, Jan A. M.
   Morava, Eva
TI Biochemical and genetic analysis of 3-methylglutaconic aciduria type IV: a diagnostic strategy
SO BRAIN
LA English
DT Article
ID mitochondrial-dna depletion; hypertrophic cardiomyopathy; barth-syndrome; oxidative-phosphorylation; congenital cataract; lactic-acidosis; myopathy; deficiency; mutations; disorder
AB The heterogeneous group of 3-methylglutaconic aciduria type IV consists of patients with various organ involvement and mostly progressive neurological impairment in combination with 3-methylglutaconic aciduria and biochemical features of dysfunctional oxidative phosphorylation. Here we describe the clinical and biochemical phenotype in 18 children and define 4 clinical subgroups (encephalomyopathic, hepatocerebral, cardiomyopathic, myopathic). In the encephalomyopathic group with neurodegenerative symptoms and respiratory chain complex I deficiency, two of the children, presenting with mild Methylmalonic aciduria, Leigh-like encephalomyopathy, dystonia and deafness, harboured SUCLA2 mutations. In children with a hepatocerebral phenotype most patients presented with complex I deficiency and mtDNA-depletion, three of which carried POLG1-mutations. In the cardiomyopathic subgroup most patients had complex V deficiency and an overlapping phenotype with that previously described in isolated complex V deficiency, in three patients a TMEM70 mutation was confirmed. In one male with a pure myopathic form and severe combined respiratory chain disorder, based on the pathogenomic histology of central core disease, RYR1 mutations were detected. In our patient group the presence of the biochemical marker 3-methylglutaconic acid was indicative for nuclear coded respiratory chain disorders. By delineating patient-groups we elucidated the genetic defect in 10 out of 18 children. Depending on the clinical and biochemical phenotype we suggest POLG1, SUCLA2, TMEM70 and RYR1 sequence analysis and mtDNA-depletion studies in children with 3-methylglutaconic aciduria type IV.
C1 [Wortmann, Saskia B.; Rodenburg, Richard J. T.; de Vries, Maaike C.; Smeitink, Jan A. M.; Morava, Eva] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mitochondrial Disorders, Dept Paediat, NL-6500 HB Nijmegen, Netherlands.
   [Jonckheere, An; van den Heuvel, Lambert P.; Kluijtmans, Leo A.; Engelke, Udo F.; Wevers, Ron A.] Radboud Univ Nijmegen, Med Ctr, Lab Paediat & Neurol, NL-6500 HB Nijmegen, Netherlands.
   [Huizing, Marjan] NHGRI, NIH, Bethesda, MD 20892 USA.
   [Heldt, Katrin; Wendel, Udo] Univ Childrens Hosp, Dept Gen Paediat, Dusseldorf, Germany.
C3 Radboud University Nijmegen; Radboud University Nijmegen; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)
RP Morava, E (corresponding author), Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mitochondrial Disorders, Dept Paediat, POB 9101, NL-6500 HB Nijmegen, Netherlands.
EM e.morava@cukz.umcn.nl
CR Anikster Y, 2001, AM J HUM GENET, V69, P1218, DOI 10.1086/324651
   Bene J, 2003, EUR J HUM GENET, V11, P375, DOI 10.1038/sj.ejhg.5200975
   BESLEY GTN, 1995, J INHERIT METAB DIS, V18, P221, DOI 10.1007/BF00711772
   Cantlay AM, 1999, J PEDIATR-US, V135, P311, DOI 10.1016/S0022-3476(99)70126-5
   Carrozzo R, 2007, BRAIN, V130, P862, DOI 10.1093/brain/awl389
   CHRISTODOULOU J, 1994, AM J MED GENET, V50, P255, DOI 10.1002/ajmg.1320500309
   CIZKOVA A, 2008, ABSTRACTBOOK EUROM A, V7, P137
   Davey KM, 2006, J MED GENET, V43, P385, DOI 10.1136/jmg.2005.036657
   De Kremer RD, 2001, AM J MED GENET, V99, P83, DOI 10.1002/1096-8628(2001)9999:9999<::AID-AJMG1136>3.0.CO;2-X
   de Vries MC, 2007, EUR J PEDIATR, V166, P229, DOI 10.1007/s00431-006-0234-9
   Di Rosa G, 2006, J INHERIT METAB DIS, V29, P546, DOI 10.1007/s10545-006-0279-y
   ELPELEG ON, 1994, DEV MED CHILD NEUROL, V36, P167
   Engelke UFH, 2006, NMR BIOMED, V19, P271, DOI 10.1002/nbm.1018
   Engelke UFH, 2004, CLIN CHEM, V50, P58, DOI 10.1373/clinchem.2003.020214
   FIGARELLABRANGER D, 1992, J NEUROL SCI, V108, P105, DOI 10.1016/0022-510X(92)90195-Q
   GIBSON KM, 1991, J PEDIATR-US, V118, P885, DOI 10.1016/S0022-3476(05)82199-7
   GIBSON KM, 1992, J PEDIATR-US, V121, P940, DOI 10.1016/S0022-3476(05)80348-8
   Gunay-Aygun M, 2005, MOL GENET METAB, V84, P1, DOI 10.1016/j.ymgme.2004.12.003
   IBEL H, 1993, EUR J PEDIATR, V152, P665, DOI 10.1007/BF01955244
   JAKOBS C, 1991, EUR J PEDIATR, V150, P684, DOI 10.1007/BF02072635
   Janssen AJM, 2006, CLIN CHEM, V52, P860, DOI 10.1373/clinchem.2005.062414
   KELLEY RI, 1995, PEDIATR RES, V37, P671, DOI 10.1203/00006450-199505000-00020
   Law LK, 2003, J INHERIT METAB DIS, V26, P705, DOI 10.1023/B:BOLI.0000005603.04633.21
   LICHTERKONECKI U, 1993, EUR J PEDIATR, V152, P378, DOI 10.1007/BF01956761
   McFarland R, 2008, ARCH DIS CHILD, V93, P151, DOI 10.1136/adc.2007.122911
   Monnier N, 2008, HUM MUTAT, V29, P670, DOI 10.1002/humu.20696
   Morava E, 2006, NEUROLOGY, V67, P1823, DOI 10.1212/01.wnl.0000244435.27645.54
   Morava E, 2004, EUR J PEDIATR, V163, P467, DOI 10.1007/s00431-004-1465-2
   MULLERHOCKER J, 1991, VIRCHOWS ARCH A, V419, P355, DOI 10.1007/BF01606527
   Nijtmans LGJ, 2002, METHODS, V26, P327, DOI 10.1016/S1046-2023(02)00038-5
   Ruesch S, 1996, ENZYME PROTEIN, V49, P321, DOI 10.1159/000468642
   Sarzi E, 2007, J PEDIATR-US, V150, P531, DOI 10.1016/j.jpeds.2007.01.044
   Scaglia F, 2001, J CHILD NEUROL, V16, P136, DOI 10.1177/088307380101600214
   SENGERS RCA, 1975, J PEDIATR-US, V86, P873, DOI 10.1016/S0022-3476(75)80217-4
   Sperl W, 2006, NEUROMUSCULAR DISORD, V16, P821, DOI 10.1016/j.nmd.2006.08.008
   Valianpour F, 2002, J PEDIATR-US, V141, P729, DOI 10.1067/mpd.2002.129174
   Woods CG, 2006, AM J HUM GENET, V78, P889, DOI 10.1086/503875
   Wortmann S, 2006, MOL GENET METAB, V88, P47, DOI 10.1016/j.ymgme.2006.01.013
NR 38
TC 65
Z9 69
U1 1
U2 4
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0006-8950
EI 1460-2156
J9 BRAIN
JI Brain
PD JAN 15
PY 2009
VL 132
IS 
BP 136
EP 146
DI 10.1093/brain/awn296
PG 11
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 398FN
UT WOS:000262718100015
PM 19015156
DA 2024-11-01
ER

PT J
AU Agier, V
   Auré, K
   Lombès, A
AF Agier, V.
   Aure, K.
   Lombes, A.
TI MELAS SYNDROME
SO DRUGS OF THE FUTURE
LA English
DT Article
ID stroke-like episodes; transfer rnaleu(uur) gene; mitochondrial-dna; lactic-acidosis; a3243g mutation; 3243a-greater-than-g mutation; transfer rna(leu(uur)); clinical-features; diabetes-mellitus; protein-synthesis
AB MELAS syndrome, on acronym for Mitochondrial myopathy, Encephalopathy, Lactic Acidosis, and Strokelike episodes, is a very severe form of mitochondrial encephalopathy It has several genetic causes, the most frequent of which is the m 3243A>C mutation in the MT-TL1 gene on the mitochondrial DNA (mtDNA), often called the "MELAS mutation" This mutation is the most recurrent deleterious mtDNA point mutation It is always heteroplasmic and responsible for very diverse clinical presentations in addition to MELAS syndrome D Diseases associated with the m 3243A>C mutation ore thought to be due to oxidative phospharylation defects They display complex genotype/phenotype relationships and pathophysiological mechanisms, as well as difficulties for the set tip of controlled therapeutic trials
C1 [Agier, V.; Aure, K.; Lombes, A.] Univ Paris 06, INSERM, UMRS 975, Hop La Salpetriere,AP HP, F-75013 Paris, France.
C3 Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm)
RP Lombès, A (corresponding author), Univ Paris 06, INSERM, UMRS 975, Hop La Salpetriere,AP HP, F-75013 Paris, France.
FU AFM (Association Francaise contre les Myopathies)
CR Auré K, 2006, BRAIN, V129, P1249, DOI 10.1093/brain/awl061
   Betts J, 2008, NEUROLOGY, V70, P1290, DOI 10.1212/01.wnl.0000308940.38092.74
   CHINNERY P, 2006, COCHRANE DB SYST REV, V0, P1426
   Chinnery PF, 1999, AM J MED GENET, V85, P498
   Chinnery PF, 2001, NEUROLOGY, V56, P1101, DOI 10.1212/WNL.56.8.1101
   Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713
   CHOMYN A, 1992, P NATL ACAD SCI USA, V89, P4221, DOI 10.1073/pnas.89.10.4221
   CIAFALONI E, 1992, ANN NEUROL, V31, P391, DOI 10.1002/ana.410310408
   Deschauer M, 2007, NEUROLOGY, V68, P1741, DOI 10.1212/01.wnl.0000261929.92478.3e
   Dubeau F, 2000, ANN NEUROL, V47, P179, DOI 10.1002/1531-8249(200002)47:2<179::AID-ANA7>3.0.CO;2-Z
   Dunbar DR, 1996, HUM MOL GENET, V5, P123, DOI 10.1093/hmg/5.1.123
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   GOTO Y, 1992, NEUROLOGY, V42, P545, DOI 10.1212/WNL.42.3.545
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Guillausseau PJ, 2001, ANN INTERN MED, V134, P721, DOI 10.7326/0003-4819-134-9_Part_1-200105010-00008
   HAMMANS SR, 1995, BRAIN, V118, P721, DOI 10.1093/brain/118.3.721
   HIRANO M, 1994, J CHILD NEUROL, V9, P4, DOI 10.1177/088307389400900102
   James AM, 1996, BIOCHEM J, V318, P401, DOI 10.1042/bj3180401
   Janssen AJM, 2008, ANN NEUROL, V63, P473, DOI 10.1002/ana.21328
   Jeppesen TD, 2006, ARCH NEUROL-CHICAGO, V63, P1701, DOI 10.1001/archneur.63.12.1701
   Kärppä M, 2005, BRAIN, V128, P1861, DOI 10.1093/brain/awh515
   Kaufmann P, 2006, NEUROLOGY, V66, P324, DOI 10.1212/01.wnl.0000196641.05913.27
   KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477
   KING MP, 1992, MOL CELL BIOL, V12, P480, DOI 10.1128/MCB.12.2.480
   KOBAYASHI Y, 1990, BIOCHEM BIOPH RES CO, V173, P816, DOI 10.1016/S0006-291X(05)80860-5
   LAFORET P, 1995, NEUROMUSCULAR DISORD, V5, P399, DOI 10.1016/0960-8966(94)00080-S
   MACMILLAN C, 1993, NEUROLOGY, V43, P1586, DOI 10.1212/WNL.43.8.1586
   Majamaa K, 1998, AM J HUM GENET, V63, P447, DOI 10.1086/301959
   Majamaa-Voltti KAM, 2006, NEUROLOGY, V66, P1470, DOI 10.1212/01.wnl.0000216136.61640.79
   MANOUVRIER S, 1995, J MED GENET, V32, P654, DOI 10.1136/jmg.32.8.654
   Manwaring N, 2007, MITOCHONDRION, V7, P230, DOI 10.1016/j.mito.2006.12.004
   MARIOTTI C, 1995, J NEUROL, V242, P304, DOI 10.1007/BF00878873
   MORAES CT, 1992, AM J HUM GENET, V50, P934
   OHAMA E, 1987, ACTA NEUROPATHOL, V74, P226, DOI 10.1007/BF00688185
   Okajima Y, 1998, HEART, V80, P292, DOI 10.1136/hrt.80.3.292
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Rahman S, 2001, AM J HUM GENET, V68, P238, DOI 10.1086/316930
   Rodriguez MC, 2007, MUSCLE NERVE, V35, P235, DOI 10.1002/mus.20688
   Sasarman F, 2008, HUM MOL GENET, V17, P3697, DOI 10.1093/hmg/ddn265
   Schaefer AM, 2006, NEUROLOGY, V66, P1932, DOI 10.1212/01.wnl.0000219759.72195.41
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   Shanske S, 2004, AM J MED GENET A, V130A, P134, DOI 10.1002/ajmg.a.30220
   Sproule DM, 2008, ANN NY ACAD SCI, V1142, P133, DOI 10.1196/annals.1444.011
   Tanji K, 2000, BRAIN PATHOL, V10, P422
   tHart LM, 1996, HUM MUTAT, V7, P193
   Touati G, 1997, ARCH DIS CHILD, V76, P16, DOI 10.1136/adc.76.1.16
   Uimonen S, 2001, HUM GENET, V108, P284, DOI 10.1007/s004390100475
   Uusimaa J, 2007, ANN NEUROL, V62, P278, DOI 10.1002/ana.21196
   van den Ouweland JMW, 1999, DIABETOLOGIA, V42, P485, DOI 10.1007/s001250051183
   VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368
   Whittaker RG, 2009, NEUROLOGY, V72, P568, DOI 10.1212/01.wnl.0000342121.91336.4d
   Yasukawa T, 2000, J BIOL CHEM, V275, P4251, DOI 10.1074/jbc.275.6.4251
NR 52
TC 0
Z9 0
U1 0
U2 2
PU PROUS SCIENCE, SAU-THOMSON REUTERS
PI BARCELONA
PA 398 PROVENCA, 08025 BARCELONA, SPAIN
SN 0377-8282
EI 2013-0368
J9 DRUG FUTURE
JI Drug Future
PD MAR 15
PY 2009
VL 34
IS 3
BP 237
EP 241
DI 10.1358/dof.2009.034.03.1340065
PG 5
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 561MT
UT WOS:000274982400008
DA 2024-11-01
ER

PT J
AU Ikawa, M
   Okazawa, H
   Arakawa, K
   Kudo, T
   Kimura, H
   Fujibayashi, Y
   Kuriyama, M
   Yoneda, M
AF Ikawa, Masamichi
   Okazawa, Hidehiko
   Arakawa, Kenichiro
   Kudo, Takashi
   Kimura, Hirohiko
   Fujibayashi, Yasuhisa
   Kuriyama, Masaru
   Yoneda, Makoto
TI PET imaging of redox and energy states in stroke-like episodes of MELAS
SO MITOCHONDRION
LA English
DT Article
DE MELAS; Stroke-like episodes; Oxidative stress; Over-reduction state; PET; Functional imaging
ID mitochondrial-dna; oxidative stress; a3243g mutation; hypoxia; cells; damage; encephalomyopathy; prevalence; angiopathy; agent
AB In stroke-like episodes of patients with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS), changes in oxidative stress and glucose metabolism and their sequence remain obscure. We developed a novel double imaging method using positron emission tomography (PET) with [Cu-62]-diacetyl-bis(N4-methylthiosemicarbazone) ((CU)-C-62-ATSM) and [F-18]-fluorodeoxyglucose ((18)FDG) to visualize the regional oxidative stress, glucose metabolism and blood flow in brain lesions of stroke-like episodes non-invasively and rapidly. These PET imagings were performed on a MELAS patient with stroke-like lesions, and clearly demonstrated that oxidative stress following hyperemia along with increased glucose metabolism plays crucial roles in the pathogenesis of MELAS stroke-like episodes. (C) 2009 Elsevier B.V. and Mitochondria Research Society. All rights reserved.
C1 [Ikawa, Masamichi; Kuriyama, Masaru; Yoneda, Makoto] Univ Fukui, Fac Med Sci, Dept Internal Med Neurol 2, Fukui 9101193, Japan.
   [Okazawa, Hidehiko; Kudo, Takashi; Fujibayashi, Yasuhisa] Univ Fukui, Biomed Imaging Res Ctr, Fukui 9101193, Japan.
   [Arakawa, Kenichiro] Univ Fukui, Fac Med Sci, Dept Internal Med Cardiol 3, Fukui 9101193, Japan.
   [Kimura, Hirohiko] Univ Fukui, Fac Med Sci, Dept Radiol, Fukui 9101193, Japan.
C3 University of Fukui; University of Fukui; University of Fukui; University of Fukui
RP Yoneda, M (corresponding author), Univ Fukui, Fac Med Sci, Dept Internal Med Neurol 2, 23-3 Shimoaiduki,Eiheiji Cho, Fukui 9101193, Japan.
EM myoneda@u-fukui.ac.jp
FU National Institute of Radiological Sciences, Chiba, Japan; Japan Society for the Promotion of Science [17209040]; 21st Century COE Program (Medical Science); Grants-in-Aid for Scientific Research [17209040] Funding Source: KAKEN
CR BANDY B, 1990, FREE RADICAL BIO MED, V8, P523, DOI 10.1016/0891-5849(90)90152-9
   BUETTNER GR, 1987, FREE RADICAL BIO MED, V3, P259, DOI 10.1016/S0891-5849(87)80033-3
   Dearling JLJ, 2002, J BIOL INORG CHEM, V7, P249, DOI 10.1007/s007750100291
   Fowler JS, 2002, SEMIN NUCL MED, V32, P6, DOI 10.1053/snuc.2002.29270
   Fujibayashi Y, 1999, NUCL MED BIOL, V26, P117, DOI 10.1016/S0969-8051(98)00049-3
   Fujibayashi Y, 1997, J NUCL MED, V38, P1155
   FUJII T, 1991, J NEUROL SCI, V103, P37, DOI 10.1016/0022-510X(91)90280-K
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Iizuka T, 2002, NEUROLOGY, V59, P816, DOI 10.1212/WNL.59.6.816
   Indo HP, 2007, MITOCHONDRION, V7, P106, DOI 10.1016/j.mito.2006.11.026
   Ishikawa K, 2005, CIRC J, V 69, P617, DOI 10.1253/circj.69.617
   Koga Y, 2005, NEUROLOGY, V64, P710, DOI 10.1212/01.WNL.0000151976.60624.01
   Lewis JS, 2001, J NUCL MED, V42, P655
   Lewis JS, 2002, J NUCL MED, V43, P1557
   Manwaring N, 2007, MITOCHONDRION, V7, P230, DOI 10.1016/j.mito.2006.12.004
   McKenzie M, 2004, NEUROCHEM RES, V29, P589, DOI 10.1023/B:NERE.0000014829.42364.dd
   Molnár MJ, 2000, NEUROLOGY, V55, P544, DOI 10.1212/WNL.55.4.544
   Nishioka J, 2008, BRAIN DEV-JPN, V30, P100, DOI 10.1016/j.braindev.2007.06.008
   Obata A, 2001, ANN NUCL MED, V15, P499, DOI 10.1007/BF02988502
   OHAMA E, 1987, ACTA NEUROPATHOL, V74, P226, DOI 10.1007/BF00688185
   Pang CY, 2001, DIABETES RES CLIN PR, V54, PS45, DOI 10.1016/S0168-8227(01)00335-7
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Rusanen H, 2000, BBA-MOL BASIS DIS, V1500, P10, DOI 10.1016/S0925-4439(99)00081-2
   Shelly MJ, 2007, CLIN NUCL MED, V32, P479, DOI 10.1097/RLU.0b013e3180537852
   SHIGENAGA MK, 1989, P NATL ACAD SCI USA, V86, P9697, DOI 10.1073/pnas.86.24.9697
   Uusimaa J, 2007, ANN NEUROL, V62, P278, DOI 10.1002/ana.21196
   Yoneda M, 1999, NEUROLOGY, V53, P2182, DOI 10.1212/WNL.53.9.2182
   Zhang J, 1998, BIOCHEM MOL BIOL INT, V46, P71
NR 28
TC 72
Z9 78
U1 0
U2 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD APR 15
PY 2009
VL 9
IS 2
BP 144
EP 148
DI 10.1016/j.mito.2009.01.011
PG 5
WC Cell Biology; Genetics & Heredity
SC Cell Biology; Genetics & Heredity
GA 428PO
UT WOS:000264861400009
PM 19460295
DA 2024-11-01
ER

PT J
AU Stewart, JD
   Tennant, S
   Powell, H
   Pyle, A
   Blakely, EL
   He, L
   Hudson, G
   Roberts, M
   du Plessis, D
   Gow, D
   Mewasingh, LD
   Hanna, MG
   Omer, S
   Morris, AA
   Roxburgh, R
   Livingston, JH
   McFarland, R
   Turnbull, DM
   Chinnery, PF
   Taylor, RW
AF Stewart, J. D.
   Tennant, S.
   Powell, H.
   Pyle, A.
   Blakely, E. L.
   He, L.
   Hudson, G.
   Roberts, M.
   du Plessis, D.
   Gow, D.
   Mewasingh, L. D.
   Hanna, M. G.
   Omer, S.
   Morris, A. A.
   Roxburgh, R.
   Livingston, J. H.
   McFarland, R.
   Turnbull, D. M.
   Chinnery, P. F.
   Taylor, R. W.
TI Novel <i>POLG1</i> mutations associated with neuromuscular and liver phenotypes in adults and children
SO JOURNAL OF MEDICAL GENETICS
LA English
DT Article
ID dna-polymerase-gamma; progressive external ophthalmoplegia; mitochondrial-dna; alpers-syndrome; w748s mutation; deletions; disorders; diagnosis; depletion; disease
AB Background: The POLG1 gene encodes the catalytic subunit of DNA polymerase gamma, essential for mitochondrial DNA replication and repair. Mutations in POLG1 have been linked to a spectrum of clinical phenotypes, and may account for up to 25% of all adult presentations of mitochondrial disease. Methods and results: We present 14 patients, with characteristic features of mitochondrial disease including progressive external ophthalmoplegia (PEO) and Alpers-Huttenlocher syndrome and laboratory findings indicative of mitochondrial dysfunction, including cytochrome c oxidase (COX) deficiency and multiple deletions or depletion of the mitochondrial DNA. Four novel POLG1 missense substitutions (p.R597W, p.L605R, p.G746S, p.A862T), are described, together with the first adult patient with a recently described polymerase domain mutation (p.R1047W). All novel changes were rare in a control population and affected highly conserved amino acids. Conclusion: The addition of these substitutions including the first report of a dinucleotide mutation (c.1814_1815TT>GC)-to the growing list of defects further confirms the importance of POLG1 mutations as the underlying abnormality in a range of neurological presentations.
C1 [Stewart, J. D.; Pyle, A.; Blakely, E. L.; He, L.; Hudson, G.; McFarland, R.; Turnbull, D. M.; Chinnery, P. F.; Taylor, R. W.] Univ Newcastle, Mitochondrial Res Grp, Sch Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Tennant, S.; Powell, H.; Turnbull, D. M.; Chinnery, P. F.; Taylor, R. W.] Univ Newcastle, Inst Hlth & Aging, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Roberts, M.; du Plessis, D.; Gow, D.] Hope Hosp, Dept Neurol, Salford M6 8HD, Lancs, England.
   [Roberts, M.; du Plessis, D.; Gow, D.] Hope Hosp, Dept Neuropathol, Salford M6 8HD, Lancs, England.
   [Mewasingh, L. D.] Imperial Coll Healthcare NHS Trust, St Marys Hosp, Dept Paediat Neurol, London, England.
   [Hanna, M. G.] Inst Neurol, Dept Mol Neurosci, London WC1N 3BG, England.
   [Omer, S.] Univ London St Georges Hosp, Dept Neurol, London, England.
   [Morris, A. A.] Royal Manchester Childrens Hosp, Willink Unit, Manchester M27 1HA, Lancs, England.
   [Livingston, J. H.] Leeds Teaching Hosp NHS Trust, Dept Paediat Neurol, Leeds, W Yorkshire, England.
   [Tennant, S.; Powell, H.; Turnbull, D. M.; Chinnery, P. F.; Taylor, R. W.] Univ Newcastle, Inst Human Genet, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Roxburgh, R.] Auckland City Hosp, Auckland, New Zealand.
C3 Newcastle University - UK; Newcastle University - UK; Imperial College London; University of London; University College London; City St Georges, University of London; Royal Manchester Children's Hospital; University of Leeds; Newcastle University - UK; Auckland City Hospital
RP Taylor, RW (corresponding author), Univ Newcastle, Mitochondrial Res Grp, Sch Med, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM w.taylor@ncl.ac.uk
FU United Mitochondrial Diseases Foundation; US Army; Parkinson's Disease Society; EU [FP6]; MITOCIRCLE; Wellcome Trust; Muscular Dystrophy Campaign; NHS Trust; Department of Health; MRC [G0800674, G0601943] Funding Source: UKRI
CR Chan SSL, 2006, HUM MOL GENET, V15, P3473, DOI 10.1093/hmg/ddl424
   Chan SSL, 2005, DNA REPAIR, V4, P1381, DOI 10.1016/j.dnarep.2005.08.010
   CHINNERY PF, 2007, NEUROMUSCULAR DISORD, V18, P259
   CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6
   Davidzon G, 2005, ANN NEUROL, V57, P921, DOI 10.1002/ana.20498
   Deschauer M, 2007, NEUROLOGY, V68, P1741, DOI 10.1212/01.wnl.0000261929.92478.3e
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   Fratter C, 2006, J MED GENET, V43, P0
   González-Vioque E, 2006, ARCH NEUROL-CHICAGO, V63, P107, DOI 10.1001/archneur.63.1.107
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   Harrower T, 2008, ARCH NEUROL-CHICAGO, V65, P133, DOI 10.1001/archneurol.2007.4
   He LP, 2002, NUCLEIC ACIDS RES, V30, P0, DOI 10.1093/nar/gnf067
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455
   Kirby DM, 2007, METHOD CELL BIOL, V80, P93, DOI 10.1016/S0091-679X(06)80004-X
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   Longley MJ, 2005, GENE, V354, P125, DOI 10.1016/j.gene.2005.03.029
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Nguyen KV, 2006, J HEPATOL, V45, P108, DOI 10.1016/j.jhep.2005.12.026
   Nguyen KV, 2005, NEUROLOGY, V65, P1493, DOI 10.1212/01.wnl.0000182814.55361.70
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2004, NEUROLOGY, V63, P1251, DOI 10.1212/01.WNL.0000140494.58732.83
   Van Goethem G, 2003, EUR J HUM GENET, V11, P547, DOI 10.1038/sj.ejhg.5201002
   Van Goethem G, 2003, NEUROMUSCULAR DISORD, V13, P133, DOI 10.1016/S0960-8966(02)00216-X
   Wiltshire E, 2008, ARCH NEUROL-CHICAGO, V65, P121, DOI 10.1001/archneurol.2007.14
   Winterthun S, 2005, NEUROLOGY, V64, P1204, DOI 10.1212/01.WNL.0000156516.77696.5A
NR 27
TC 38
Z9 43
U1 0
U2 3
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0022-2593
EI 1468-6244
J9 J MED GENET
JI J. Med. Genet.
PD MAR 15
PY 2009
VL 46
IS 3
BP 209
EP 214
DI 10.1136/jmg.2008.058180
PG 6
WC Genetics & Heredity
SC Genetics & Heredity
GA 412JY
UT WOS:000263722300009
PM 19251978
DA 2024-11-01
ER

PT J
AU Mehrazin, M
   Shanske, S
   Kaufmann, P
   Wei, Y
   Coku, J
   Engelstad, K
   Naini, A
   De Vivo, DC
   DiMauro, S
AF Mehrazin, Mahsa
   Shanske, Sara
   Kaufmann, Petra
   Wei, Ying
   Coku, Jorida
   Engelstad, Kristin
   Naini, Ali
   De Vivo, Darryl C.
   DiMauro, Salvatore
TI Longitudinal Changes of mtDNA A3243G Mutation Load and Level of Functioning in MELAS
SO AMERICAN JOURNAL OF MEDICAL GENETICS PART A
LA English
DT Article
DE mitochondrial DNA mutation; MELAS; A3243G; heteroplasmy; mutant load
ID stroke-like episodes; mitochondrial-dna mutation; lactic-acidosis; point mutation; protein-synthesis; myopathy; gene; encephalomyopathy; encephalopathy; prevalence
AB Mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes (MELAS), one of the most common mitochondrial multisystemic diseases, is most commonly associated with an A-to-G transition at nucleotide position 3243 (A3243G) in mitochondrial DNA. We studied 34 individuals harboring the A3243G mutation for up to 7 years; 17 had the full MELAS phenotype and 17 who were classified as "carrier relatives" because they were either asymptomatic or had some symptoms suggestive of mitochondrial disease but no seizures or strokes. Using the sensitive real-time polymerase chain reaction to quantify the A3243G mutation, we confirmed that the percent mutation decreases progressively in DNA isolated from blood: the average percent decrease was 0.5% per year for fully symptomatic patients and 0.2% per year for oligosymptomatic carrier relatives. We also correlated mutant loads with functional status estimated by the Karnofksky score: even though the mutation load decreases, the level of functioning worsens in fully symptomatic patients, whereas the level of functioning of carrier relatives remains largely unchanged. This study suggests that A3243G mutant load in DNA isolated from blood is neither useful for prognosis nor for functional assessment. (C) 2009 Wiley-Liss, Inc.
C1 [Mehrazin, Mahsa; Shanske, Sara; Kaufmann, Petra; Coku, Jorida; Engelstad, Kristin; Naini, Ali; De Vivo, Darryl C.; DiMauro, Salvatore] Columbia Univ Coll Phys & Surg, Dept Neurol, New York, NY 10032 USA.
   [Wei, Ying] Columbia Univ, Mailman Sch Publ Hlth, Dept Biostat, New York, NY USA.
C3 Columbia University; Columbia University
RP DiMauro, S (corresponding author), Russ Berrie Med Sci Pavil,Room 313,1150 St Nichol, New York, NY 10032 USA.
EM sd12@columbia.edu
FU NIH [HD32062]; Marriott Mitochondrial Disorders Clinical Research Fund (MMD- CRF)
CR CAMPOS Y, 1995, ACTA NEUROL SCAND, V91, P62
   Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713
   CHOMYN A, 1991, MOL CELL BIOL, V11, P2236, DOI 10.1128/MCB.11.4.2236
   CIAFALONI E, 1991, NEUROLOGY, V41, P1663, DOI 10.1212/WNL.41.10.1663
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   DIMAURO S, 1993, ARCH NEUROL-CHICAGO, V50, P1197, DOI 10.1001/archneur.1993.00540110075008
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   Jeppesen TD, 2006, ARCH NEUROL-CHICAGO, V63, P1701, DOI 10.1001/archneur.63.12.1701
   Karnofsky DA, 1949, EVALUATION CHEMOTHER, V0, P196
   KING MP, 1992, MOL CELL BIOL, V12, P480, DOI 10.1128/MCB.12.2.480
   Kirby DM, 2004, J CLIN INVEST, V114, P837, DOI 10.1172/JCI200420683
   KOBAYASHI Y, 1991, AM J HUM GENET, V49, P590
   KOBAYASHI Y, 1992, J INHERIT METAB DIS, V15, P803, DOI 10.1007/BF01800025
   LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876
   Liolitsa D, 2003, ANN NEUROL, V53, P128, DOI 10.1002/ana.10435
   LIOU CW, 1994, ACTA NEUROL SCAND, V90, P354
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   MACMILLAN C, 1993, NEUROLOGY, V43, P1586, DOI 10.1212/WNL.43.8.1586
   Majamaa K, 1998, AM J HUM GENET, V63, P447, DOI 10.1086/301959
   Manwaring N, 2007, MITOCHONDRION, V7, P230, DOI 10.1016/j.mito.2006.12.004
   MARTINUZZI A, 1992, J NEUROL SCI, V113, P222, DOI 10.1016/0022-510X(92)90250-O
   McDonnell MT, 2004, EUR J HUM GENET, V12, P778, DOI 10.1038/sj.ejhg.5201216
   NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691
   Pyle A, 2007, J MED GENET, V44, P69, DOI 10.1136/jmg.2006.043109
   Rahman S, 2001, AM J HUM GENET, V68, P238, DOI 10.1086/316930
   Ravn K, 2001, EUR J HUM GENET, V9, P805, DOI 10.1038/sj.ejhg.5200712
   Shanske S, 2004, AM J MED GENET A, V130A, P134, DOI 10.1002/ajmg.a.30220
   SHIRAIWA N, 1993, J NEUROL SCI, V120, P174, DOI 10.1016/0022-510X(93)90270-9
   Singh R, 2006, J MOL DIAGN, V8, P225, DOI 10.2353/jmoldx.2006.050067
   Sue CM, 1998, J NEUROL SCI, V161, P36, DOI 10.1016/S0022-510X(98)00179-8
   THART LM, 1994, DIABETOLOGIA, V37, P1169
   WALLACE DC, 1992, ANNU REV BIOCHEM, V61, P1175, DOI 10.1146/annurev.bi.61.070192.005523
NR 33
TC 37
Z9 46
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4825
EI 1552-4833
J9 AM J MED GENET A
JI Am. J. Med. Genet. A
PD APR 15
PY 2009
VL 149A
IS 4
BP 584
EP 587
DI 10.1002/ajmg.a.32703
PG 4
WC Genetics & Heredity
SC Genetics & Heredity
GA 430IN
UT WOS:000264982900006
PM 19253345
DA 2024-11-01
ER

PT J
AU Chan, SSL
   Naviaux, RK
   Basinger, AA
   Casas, KA
   Copeland, WC
AF Chan, Sherine S. L.
   Naviaux, Robert K.
   Basinger, Alice A.
   Casas, Kari A.
   Copeland, William C.
TI <i>De novo</i> mutation in <i>POLG</i> leads to haplotype insufficiency and Alpers syndrome
SO MITOCHONDRION
LA English
DT Article
DE Mitochondrial disease; Mitochondrial DNA replication; Alpers syndrome; Nonsense-mediated decay; De novo mutation; Haplotype insufficiency
ID dna-polymerase-gamma; progressive external ophthalmoplegia; mitochondrial-dna; accessory subunit; messenger-rna; depletion; disease; ant1; degeneration; consequence
AB Mutations in POLG are a major contributor to pediatric and adult mitochondrial diseases. However, the consequences of many POLG mutations are not well understood. We investigated the molecular cause of Alpers syndome in a patient harboring the POLG mutations A467T in trans with c.2157+5_+6 gc-->ag in intron 12. Analysis of transcripts arising from the c.2157+5_+ 6 gc-->ag allele revealed alternative splicing with an insertion of 30 intronic nucleotides leading to a premature termination codon. These transcripts were subsequently removed through nonsense-mediated decay, leading to haplotype insufficiency due to expression of the A467T allele and decreased expression of the c.2157+5_+ 6 gc-->ag allele, which is likely responsible for the Alpers syndrome phenotype. Published by Elsevier B. V. on behalf of Mitochondrion Research Society.
C1 [Chan, Sherine S. L.; Copeland, William C.] NIEHS, Mol Genet Lab, NIH, Res Triangle Pk, NC 27709 USA.
   [Basinger, Alice A.] Cook Childrens Phys Network, Div Genet, Ft Worth, TX 76102 USA.
   [Casas, Kari A.] Trinity Mother Frances Hosp & Clin, Tyler, TX 75702 USA.
   [Naviaux, Robert K.] Univ Calif San Diego, Mitochondrial & Metab Dis Ctr, Dept Med, San Diego, CA 92103 USA.
   [Naviaux, Robert K.] Univ Calif San Diego, Mitochondrial & Metab Dis Ctr, Dept Pediat, San Diego, CA 92103 USA.
C3 National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Cook Children's Medical Center; University of California System; University of California San Diego; University of California System; University of California San Diego
RP Copeland, WC (corresponding author), NIEHS, Mol Genet Lab, NIH, 111 TW Alexander Dr, Res Triangle Pk, NC 27709 USA.
EM copelan1@niehs.nih.gov
FU National Institutes of Health Career Development Award [1K99-ES015555-01]; National Institute of Environmental Health Sciences, NIH [Z01ES065078]
CR Agostino A, 2003, NEUROLOGY, V60, P1354, DOI 10.1212/01.WNL.0000056088.09408.3C
   Alpers BJ, 1931, ARCH NEURO PSYCHIATR, V25, P469, DOI 10.1001/archneurpsyc.1931.02230030027002
   Ashley N, 2008, HUM MOL GENET, V17, P2496, DOI 10.1093/hmg/ddn150
   BRUNAK S, 1991, J MOL BIOL, V220, P49, DOI 10.1016/0022-2836(91)90380-O
   Chan SSL, 2009, BBA-BIOENERGETICS, V1787, P312, DOI 10.1016/j.bbabio.2008.10.007
   Chan SSL, 2005, DNA REPAIR, V4, P1381, DOI 10.1016/j.dnarep.2005.08.010
   Chan SSL, 2005, J BIOL CHEM, V280, P31341, DOI 10.1074/jbc.M506762200
   Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646
   de Vries MC, 2007, EUR J PEDIATR, V166, P229, DOI 10.1007/s00431-006-0234-9
   Del Bo R, 2003, NEUROLOGY, V61, P903, DOI 10.1212/01.WNL.0000092303.13864.BE
   Di Fonzo A, 2003, HUM MUTAT, V22, P0, DOI 10.1002/humu.9203
   Dimauro S, 2005, ANN MED, V37, P222, DOI 10.1080/07853890510007368
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   HARDING BN, 1995, J NEUROL NEUROSUR PS, V58, P320, DOI 10.1136/jnnp.58.3.320
   Hebsgaard SM, 1996, NUCLEIC ACIDS RES, V24, P3439, DOI 10.1093/nar/24.17.3439
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Hudson G, 2006, NEUROLOGY, V66, P1439, DOI 10.1212/01.wnl.0000210486.32196.24
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   Lim SE, 1999, J BIOL CHEM, V274, P38197, DOI 10.1074/jbc.274.53.38197
   LUTZ RE, 2009, J PEDIAT GASTROENTER, V0, P0
   Naïmi M, 2006, EUR J HUM GENET, V14, P917, DOI 10.1038/sj.ejhg.5201627
   Naviaux RK, 2005, ANN NEUROL, V58, P491, DOI 10.1002/ana.20544
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Naviaux RK, 1999, ANN NEUROL, V45, P54, DOI 10.1002/1531-8249(199901)45:1<54::AID-ART10>3.0.CO;2-B
   Nguyen KV, 2006, J HEPATOL, V45, P108, DOI 10.1016/j.jhep.2005.12.026
   Nguyen KV, 2005, NEUROLOGY, V65, P1493, DOI 10.1212/01.wnl.0000182814.55361.70
   Spinazzola A, 2009, J INTERN MED, V265, P174, DOI 10.1111/j.1365-2796.2008.02059.x
   Tzoulis C, 2006, BRAIN, V129, P1685, DOI 10.1093/brain/awl097
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
   Wong LJC, 2008, HUM MUTAT, V29, PE150, DOI 10.1002/humu.20824
NR 30
TC 8
Z9 10
U1 0
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD SEP 15
PY 2009
VL 9
IS 5
BP 340
EP 345
DI 10.1016/j.mito.2009.05.002
PG 6
WC Cell Biology; Genetics & Heredity
SC Cell Biology; Genetics & Heredity
GA 541LC
UT WOS:000273416200008
PM 19501198
DA 2024-11-01
ER

PT J
AU Wallace, DC
   Fan, WW
AF Wallace, Douglas C.
   Fan, WeiWei
TI The pathophysiology of mitochondrial disease as modeled in the mouse
SO GENES & DEVELOPMENT
LA English
DT Review
DE Mitochondrion; mtDNA; OXPHOS dysfunction; mitochondrial disease; mouse model
ID cytochrome-c-oxidase; hereditary optic neuropathy; progressive external ophthalmoplegia; adenine-nucleotide translocator; follicle-stimulating-hormone; dynamin-related protein; brown adipose-tissue; mtdna control-region; dna deletion levels; chloramphenicol resistance
AB It is now clear that mitochondrial defects are associated with a plethora of clinical phenotypes in man and mouse. This is the result of the mitochondria's central role in energy production, reactive oxygen species (ROS) biology, and apoptosis, and because the mitochondrial genome consists of roughly 1500 genes distributed across the maternal mitochondrial DNA (mtDNA) and the Mendelian nuclear DNA (nDNA). While numerous pathogenic mutations in both mtDNA and nDNA mitochondrial genes have been identified in the past 21 years, the causal role of mitochondrial dysfunction in the common metabolic and degenerative diseases, cancer, and aging is still debated. However, the development of mice harboring mitochondrial gene mutations is permitting demonstration of the direct cause-and-effect relationship between mitochondrial dysfunction and disease. Mutations in nDNA-encoded mitochondrial genes involved in energy metabolism, antioxidant defenses, apoptosis via the mitochondrial permeability transition pore (mtPTP), mitochondrial fusion, and mtDNA biogenesis have already demonstrated the phenotypic importance of mitochondrial defects. These studies are being expanded by the recent development of procedures for introducing mtDNA mutations into the mouse. These studies are providing direct proof that mtDNA mutations are sufficient by themselves to generate major clinical phenotypes. As more different mtDNA types and mtDNA gene mutations are introduced into various mouse nDNA backgrounds, the potential functional role of mtDNA variation in permitting humans and mammals to adapt to different environments and in determining their predisposition to a wide array of diseases should be definitively demonstrated.
C1 [Wallace, Douglas C.; Fan, WeiWei] Univ Calif Irvine, Org Res Unit Mol & Mitochondrial Med & Genet, Irvine, CA 92697 USA.
C3 University of California System; University of California Irvine
RP Wallace, DC (corresponding author), Univ Calif Irvine, Org Res Unit Mol & Mitochondrial Med & Genet, Irvine, CA 92697 USA.
EM dwallace@uci.edu
FU NIH [NS21328, AG24373, DK73691, AG13154, AG16573]; CIRM Comprehensive [RC1-00353-1]; Doris Duke Clinical Interfaces Award 2005
CR Acín-Pérez R, 2004, MOL CELL, V13, P805, DOI 10.1016/S1097-2765(04)00124-8
   Acín-Pérez R, 2003, HUM MOL GENET, V12, P329, DOI 10.1093/hmg/ddg021
   Agostino A, 2003, HUM MOL GENET, V12, P399, DOI 10.1093/hmg/ddg038
   Alavi MV, 2007, BRAIN, V130, P1029, DOI 10.1093/brain/awm005
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Anflous K, 2001, J BIOL CHEM, V276, P1954, DOI 10.1074/jbc.M006587200
   Antonicka H, 2003, HUM MOL GENET, V12, P2693, DOI 10.1093/hmg/ddg284
   Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565
   AVISE JC, 1979, GENETICS, V92, P279
   Bai RK, 2007, CANCER RES, V67, P4687, DOI 10.1158/0008-5472.CAN-06-3554
   Bai YD, 1998, EMBO J, V17, P4848, DOI 10.1093/emboj/17.16.4848
   Bai YD, 2000, MOL CELL BIOL, V20, P805, DOI 10.1128/MCB.20.3.805-815.2000
   Baines CP, 2007, NAT CELL BIOL, V9, P550, DOI 10.1038/ncb1575
   Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434
   BALLINGER SW, 1992, NAT GENET, V1, P11, DOI 10.1038/ng0492-11
   BALLINGER SW, 1994, NAT GENET, V7, P458, DOI 10.1038/ng0894-458
   Basso E, 2005, J BIOL CHEM, V280, P18558, DOI 10.1074/jbc.C500089200
   Baudouin SV, 2005, LANCET, V366, P2118, DOI 10.1016/S0140-6736(05)67890-7
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   BLANC H, 1981, P NATL ACAD SCI-BIOL, V78, P3789, DOI 10.1073/pnas.78.6.3789
   BLANC H, 1981, NUCLEIC ACIDS RES, V9, P5785, DOI 10.1093/nar/9.21.5785
   Booker LM, 2006, J UROLOGY, V175, P468, DOI 10.1016/S0022-5347(05)00163-1
   Brandon M, 2006, ONCOGENE, V25, P4647, DOI 10.1038/sj.onc.1209607
   Brower JV, 2007, J BIOL CHEM, V282, P29658, DOI 10.1074/jbc.M704386200
   Brown MD, 2002, HUM GENET, V110, P130, DOI 10.1007/s00439-001-0660-8
   Brown MD, 1997, AM J HUM GENET, V60, P381
   BROWN MD, 1995, HUM MUTAT, V6, P311, DOI 10.1002/humu.1380060405
   BUNN CL, 1977, SOMAT CELL GENET, V3, P71, DOI 10.1007/BF01550988
   BUNN CL, 1974, P NATL ACAD SCI USA, V71, P1681, DOI 10.1073/pnas.71.5.1681
   Cai JY, 2000, FREE RADICAL BIO MED, V29, P334, DOI 10.1016/S0891-5849(00)00312-9
   Carrieri G, 2001, HUM GENET, V108, P194, DOI 10.1007/s004390100463
   Carrozzo R, 2007, BRAIN, V130, P862, DOI 10.1093/brain/awl389
   Chagnon P, 1999, AM J MED GENET, V85, P20, DOI 10.1002/(SICI)1096-8628(19990702)85:1<20::AID-AJMG6>3.0.CO;2-K
   Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200
   Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046
   Chen HC, 2007, CELL, V130, P548, DOI 10.1016/j.cell.2007.06.026
   Cheng EHY, 2003, SCIENCE, V301, P513, DOI 10.1126/science.1083995
   CHOMYN A, 1986, SCIENCE, V234, P614, DOI 10.1126/science.3764430
   CHOMYN A, 1985, NATURE, V314, P592, DOI 10.1038/314592a0
   Cipolat S, 2004, P NATL ACAD SCI USA, V101, P15927, DOI 10.1073/pnas.0407043101
   Clayton DA, 2003, IUBMB LIFE, V55, P213, DOI 10.1080/1521654031000134824
   CORRALDEBRINSKI M, 1991, JAMA-J AM MED ASSOC, V266, P1812, DOI 10.1001/jama.266.13.1812
   CORRALDEBRINSKI M, 1994, GENOMICS, V23, P471, DOI 10.1006/geno.1994.1525
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927
   Coskun PE, 2004, P NATL ACAD SCI USA, V101, P10726, DOI 10.1073/pnas.0403649101
   Crispim D, 2006, ANN HUM GENET, V70, P488, DOI 10.1111/j.1469-1809.2005.00249.x
   DAIRAGHI DJ, 1995, J MOL BIOL, V249, P11, DOI 10.1006/jmbi.1995.9889
   Darvishi K, 2007, CANCER LETT, V249, P249, DOI 10.1016/j.canlet.2006.09.005
   Davies VJ, 2007, HUM MOL GENET, V16, P1307, DOI 10.1093/hmg/ddm079
   De Benedictis G, 1999, FASEB J, V13, P1532, DOI 10.1096/fasebj.13.12.1532
   Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936
   DellAgnello C, 2007, HUM MOL GENET, V16, P431, DOI 10.1093/hmg/ddl477
   DENARO M, 1981, P NATL ACAD SCI-BIOL, V78, P5768, DOI 10.1073/pnas.78.9.5768
   Diaz F, 2008, GUT, V57, P232, DOI 10.1136/gut.2006.119180
   Diaz F, 2005, HUM MOL GENET, V14, P2737, DOI 10.1093/hmg/ddi307
   DiMauro S, 1993, MOL GENETIC BASIS NE, V0, P665
   Ekstrand MI, 2007, P NATL ACAD SCI USA, V104, P1325, DOI 10.1073/pnas.0605208103
   Elchuri S, 2005, ONCOGENE, V24, P367, DOI 10.1038/sj.onc.1208207
   Enerback S, 1997, NATURE, V387, P90, DOI 10.1038/387090a0
   Esposito LA, 1999, P NATL ACAD SCI USA, V96, P4820, DOI 10.1073/pnas.96.9.4820
   Esposito LA, 2000, FREE RADICAL BIO MED, V28, P754, DOI 10.1016/S0891-5849(00)00161-1
   Evans AR, 2000, MUTAT RES-DNA REPAIR, V461, P83, DOI 10.1016/S0921-8777(00)00046-X
   Falkenberg M, 2002, NAT GENET, V31, P289, DOI 10.1038/ng909
   Falkenberg M, 2007, ANNU REV BIOCHEM, V76, P679, DOI 10.1146/annurev.biochem.76.060305.152028
   Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786
   FERRIS SD, 1982, NATURE, V295, P163, DOI 10.1038/295163a0
   FISHER RP, 1992, J BIOL CHEM, V267, P3358
   Freeman HC, 2006, DIABETES, V55, P2153, DOI 10.2337/db06-0358
   Fuku N, 2007, AM J HUM GENET, V80, P407, DOI 10.1086/512202
   Fukui H, 2007, P NATL ACAD SCI USA, V104, P14163, DOI 10.1073/pnas.0705738104
   Gandre-Babbe S, 2008, MOL BIOL CELL, V19, P2402, DOI 10.1091/mbc.E07-12-1287
   Ghezzi D, 2005, EUR J HUM GENET, V13, P748, DOI 10.1038/sj.ejhg.5201425
   GILES RE, 1980, P NATL ACAD SCI-BIOL, V77, P6715, DOI 10.1073/pnas.77.11.6715
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Gottlieb E, 2005, NAT REV CANCER, V5, P857, DOI 10.1038/nrc1737
   Graham BH, 1997, NAT GENET, V16, P226, DOI 10.1038/ng0797-226
   Hansen JM, 2006, ANNU REV PHARMACOL, V46, P215, DOI 10.1146/annurev.pharmtox.46.120604.141122
   Hashimoto Y, 2001, P NATL ACAD SCI USA, V98, P6336, DOI 10.1073/pnas.101133498
   Hashizume K, 2008, AM J PATHOL, V172, P1325, DOI 10.2353/ajpath.2008.070730
   Heddi A, 1999, J BIOL CHEM, V274, P22968, DOI 10.1074/jbc.274.33.22968
   Hendrickson SL, 2009, JAIDS-J ACQ IMM DEF, V51, P111, DOI 10.1097/QAI.0b013e3181a324d6
   Hendrickson SL, 2008, AIDS, V22, P2429, DOI 10.1097/QAD.0b013e32831940bb
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   HORTON TM, 1995, NEUROLOGY, V45, P1879, DOI 10.1212/WNL.45.10.1879
   HOWELL N, 1988, J MOL BIOL, V203, P607, DOI 10.1016/0022-2836(88)90195-7
   HOWELL N, 1990, BIOCHEMISTRY-US, V29, P8970, DOI 10.1021/bi00490a013
   HOWELL N, 1987, J BIOL CHEM, V262, P2411
   Huang TT, 2006, HUM MOL GENET, V15, P1187, DOI 10.1093/hmg/ddl034
   Hussein MR, 2005, HUM REPROD UPDATE, V11, P162, DOI 10.1093/humupd/dmi001
   Imamura Y, 2006, P NATL ACAD SCI USA, V103, P11282, DOI 10.1073/pnas.0602131103
   Inoue K, 2000, NAT GENET, V26, P176, DOI 10.1038/82826
   Ishikawa K, 2008, SCIENCE, V320, P661, DOI 10.1126/science.1156906
   Ivanova R, 1998, GERONTOLOGY, V44, P349, DOI 10.1159/000022041
   JACOBSSON A, 1985, J BIOL CHEM, V260, P6250
   James DI, 2003, J BIOL CHEM, V278, P36373, DOI 10.1074/jbc.M303758200
   Jenuth JP, 1996, NAT GENET, V14, P146, DOI 10.1038/ng1096-146
   Jones DP, 2006, CHEM-BIOL INTERACT, V163, P38, DOI 10.1016/j.cbi.2006.07.008
   Jones MM, 2007, ARCH OPHTHALMOL-CHIC, V125, P1235, DOI 10.1001/archopht.125.9.1235
   KAPSA R, 1994, J INHERIT METAB DIS, V17, P521, DOI 10.1007/BF00711584
   Kasahara A, 2006, HUM MOL GENET, V15, P871, DOI 10.1093/hmg/ddl005
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   KAUKONEN J, 1995, AM J HUM GENET, V57, P1246
   Kelley MR, 2001, ANTIOXID REDOX SIGN, V3, P671, DOI 10.1089/15230860152543014
   KHUSNUTDINOVA E, 2008, ANN NY ACAD IN PRESS, V0, P0
   KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477
   Kokoszka JE, 2001, P NATL ACAD SCI USA, V98, P2278, DOI 10.1073/pnas.051627098
   Kokoszka JE, 2004, NATURE, V427, P461, DOI 10.1038/nature02229
   KOZAK LP, 1988, J BIOL CHEM, V263, P12274
   Krauskopf A, 2006, BBA-BIOENERGETICS, V1757, P590, DOI 10.1016/j.bbabio.2006.02.007
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Kruse SE, 2008, CELL METAB, V7, P312, DOI 10.1016/j.cmet.2008.02.004
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231
   Lebovitz RM, 1996, P NATL ACAD SCI USA, V93, P9782, DOI 10.1073/pnas.93.18.9782
   Levy SE, 2000, GENE, V254, P57, DOI 10.1016/S0378-1119(00)00252-3
   Li K, 2000, CELL, V101, P389, DOI 10.1016/S0092-8674(00)80849-1
   LI YB, 1995, NAT GENET, V11, P376, DOI 10.1038/ng1295-376
   Linder T, 2005, CURR GENET, V48, P265, DOI 10.1007/s00294-005-0022-5
   LUFT R, 1962, J CLIN INVEST, V41, P1776, DOI 10.1172/JCI104637
   LUFT R, 1994, P NATL ACAD SCI USA, V91, P8731, DOI 10.1073/pnas.91.19.8731
   MacGregor GR, 2006, EMBRYONIC STEM CELLS, V0, P72
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   Martin M, 2005, CELL, V123, P1227, DOI 10.1016/j.cell.2005.09.040
   McCord JM, 2000, AM J MED, V108, P652, DOI 10.1016/S0002-9343(00)00412-5
   McCulloch V, 2003, MOL CELL BIOL, V23, P5816, DOI 10.1128/MCB.23.16.5816-5824.2003
   McKenzie M, 2004, P NATL ACAD SCI USA, V101, P1685, DOI 10.1073/pnas.0303184101
   Melov S, 1999, P NATL ACAD SCI USA, V96, P846, DOI 10.1073/pnas.96.3.846
   Michikawa Y, 1999, SCIENCE, V286, P774, DOI 10.1126/science.286.5440.774
   Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100
   MITA S, 1989, P NATL ACAD SCI USA, V86, P9509, DOI 10.1073/pnas.86.23.9509
   Mohlke KL, 2005, HUM GENET, V118, P245, DOI 10.1007/s00439-005-0046-4
   MONTOYA J, 1981, NATURE, V290, P465, DOI 10.1038/290465a0
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   Murdock DG, 2000, NUCLEIC ACIDS RES, V28, P4350, DOI 10.1093/nar/28.21.4350
   Murdock DG, 1999, J BIOL CHEM, V274, P14429, DOI 10.1074/jbc.274.20.14429
   Nachman MW, 1996, GENETICS, V142, P953
   Nakada K, 2006, P NATL ACAD SCI USA, V103, P15148, DOI 10.1073/pnas.0604641103
   Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317
   NICHOLLS DG, 1984, PHYSIOL REV, V64, P1, DOI 10.1152/physrev.1984.64.1.1
   Niemi AK, 2003, HUM GENET, V112, P29, DOI 10.1007/s00439-002-0843-y
   Nishigaki Y, 2007, HUM GENET, V120, P827, DOI 10.1007/s00439-006-0269-z
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0
   OLIVER NA, 1982, MOL CELL BIOL, V2, P30, DOI 10.1128/MCB.2.1.30
   Palmieri L, 2005, HUM MOL GENET, V14, P3079, DOI 10.1093/hmg/ddi341
   Park CB, 2007, CELL, V130, P273, DOI 10.1016/j.cell.2007.05.046
   Petros JA, 2005, P NATL ACAD SCI USA, V102, P719, DOI 10.1073/pnas.0408894102
   Potluri P, 2009, MOL GENET METAB, V96, P189, DOI 10.1016/j.ymgme.2008.12.004
   Procaccio V, 2004, NEUROLOGY, V62, P1899, DOI 10.1212/01.WNL.0000125251.56131.65
   Raby BA, 2007, J ALLERGY CLIN IMMUN, V120, P351, DOI 10.1016/j.jaci.2007.05.029
   RADI R, 1991, J BIOL CHEM, V266, P22028
   RADI R, 1993, FREE RADICAL BIO MED, V15, P653, DOI 10.1016/0891-5849(93)90169-U
   RADI R, 1993, ARCH BIOCHEM BIOPHYS, V300, P409, DOI 10.1006/abbi.1993.1055
   Reaume AG, 1996, NAT GENET, V13, P43, DOI 10.1038/ng0596-43
   REICHLING S, 1987, BIOCHEM BIOPH RES CO, V142, P696, DOI 10.1016/0006-291X(87)91470-7
   RIDLEY RG, 1986, NUCLEIC ACIDS RES, V14, P4025, DOI 10.1093/nar/14.10.4025
   Rodic N, 2005, STEM CELLS, V23, P1314, DOI 10.1634/stemcells.2005-0119
   Rose G, 2001, EUR J HUM GENET, V9, P701, DOI 10.1038/sj.ejhg.5200703
   ROTIG A, 1995, HUM MOL GENET, V4, P1327, DOI 10.1093/hmg/4.8.1327
   ROTIG A, 1988, LANCET, V2, P567
   Ruiz-Pesini E, 2004, SCIENCE, V303, P223, DOI 10.1126/science.1088434
   Ruiz-Pesini E, 2006, HUM MUTAT, V27, P1072, DOI 10.1002/humu.20378
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Sampson MJ, 2001, J BIOL CHEM, V276, P39206, DOI 10.1074/jbc.M104724200
   Sato A, 2007, GENETICS, V177, P2031, DOI 10.1534/genetics.107.081026
   Saxena R, 2006, AM J HUM GENET, V79, P54, DOI 10.1086/504926
   Schriner SE, 2000, FREE RADICAL BIO MED, V29, P664, DOI 10.1016/S0891-5849(00)00352-X
   Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653
   Schwartz M, 2002, NEW ENGL J MED, V347, P576, DOI 10.1056/NEJMoa020350
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   SHOFFNER JM, 1993, GENOMICS, V17, P171, DOI 10.1006/geno.1993.1299
   Silva JP, 2000, NAT GENET, V26, P336, DOI 10.1038/81649
   Sligh JE, 2000, P NATL ACAD SCI USA, V97, P14461, DOI 10.1073/pnas.250491597
   Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245
   SOONG NW, 1992, NAT GENET, V2, P318
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spiegelman BM, 2004, CELL, V119, P157, DOI 10.1016/j.cell.2004.09.037
   Stewart JB, 2008, PLOS BIOL, V6, P63, DOI 10.1371/journal.pbio.0060010
   Subrarnaniam V, 2008, BBA-BIOENERGETICS, V1777, P666, DOI 10.1016/j.bbabio.2008.03.015
   Tanaka M, 1998, LANCET, V351, P185, DOI 10.1016/S0140-6736(05)78211-8
   Tanaka M, 2000, MECH AGEING DEV, V116, P65, DOI 10.1016/S0047-6374(00)00149-4
   TILLY JL, 1995, ENDOCRINOLOGY, V136, P242, DOI 10.1210/en.136.1.242
   Tiranti V, 1998, AM J HUM GENET, V63, P1609, DOI 10.1086/302150
   Torroni A, 1997, AM J HUM GENET, V60, P1107
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Trounce I, 2000, NUCLEIC ACIDS RES, V28, P2164, DOI 10.1093/nar/28.10.2164
   Tsai-Turton M, 2006, ENDOCRINOLOGY, V147, P1224, DOI 10.1210/en.2005-1281
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Udar N, 2009, INVEST OPHTH VIS SCI, V50, P2966, DOI 10.1167/iovs.08-2646
   van der Walt JM, 2004, NEUROSCI LETT, V365, P28, DOI 10.1016/j.neulet.2004.04.051
   van der Walt JM, 2003, AM J HUM GENET, V72, P804, DOI 10.1086/373937
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95
   Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988
   Vermulst M, 2008, METHODS, V46, P263, DOI 10.1016/j.ymeth.2008.10.008
   Vidal-Puig AJ, 2000, J BIOL CHEM, V275, P16258, DOI 10.1074/jbc.M910179199
   Wallace DC, 2005, COLD SH Q B, V70, P363, DOI 10.1101/sqb.2005.70.035
   Wallace DC, 2007, EMERY AND RIMOINS PRINCIPLES AND PRACTICE OF MEDICAL GENETICS, V5th, P194
   Wallace DC, 2002, EMERY AND RIMOINS PRINCIPLES AND PRACTICE OF MEDICAL GENETICS, V0, P299
   Wallace DC, 2001, THE METABOLIC AND MOLECULAR BASIS OF INHERITED DISEASE, V0, P2425
   WALLACE DC, 1977, SOMAT CELL GENET, V3, P93, DOI 10.1007/BF01550989
   Wallace DC, 2005, GENE, V354, P169, DOI 10.1016/j.gene.2005.05.001
   Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751
   Wallace DC, 2003, COLD SPRING HARB SYM, V68, P479
   WALLACE DC, 1981, MOL CELL BIOL, V1, P697, DOI 10.1128/MCB.1.8.697
   Wallace DC, 1999, GENE, V238, P211, DOI 10.1016/S0378-1119(99)00295-4
   WALLACE DC, 1979, SOMAT CELL GENET, V5, P373, DOI 10.1007/BF01538849
   WALLACE DC, 1988, CELL, V55, P601, DOI 10.1016/0092-8674(88)90218-8
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   WALLACE DC, 1992, SCIENCE, V256, P628, DOI 10.1126/science.1533953
   WALLACE DC, 1975, J CELL BIOL, V67, P174, DOI 10.1083/jcb.67.1.174
   WALLACE DC, 2007, AM J HUM GENET, V0, P0
   Wallace DC, 2008, GENETICS, V179, P727, DOI 10.1534/genetics.104.91769
   Wallace DC, 2007, ANNU REV BIOCHEM, V76, P781, DOI 10.1146/annurev.biochem.76.081205.150955
   Wang JM, 1999, NAT GENET, V21, P133, DOI 10.1038/5089
   Wredenberg A, 2002, P NATL ACAD SCI USA, V99, P15066, DOI 10.1073/pnas.232591499
   Yoon Y, 2003, MOL CELL BIOL, V23, P5409, DOI 10.1128/MCB.23.15.5409-5420.2003
   Zamzami N, 2001, NAT REV MOL CELL BIO, V2, P67, DOI 10.1038/35048073
   Zhu ZQ, 1998, NAT GENET, V20, P337, DOI 10.1038/3804
   Züchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341
NR 222
TC 156
Z9 182
U1 0
U2 22
PU COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT
PI COLD SPRING HARBOR
PA 1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA
SN 0890-9369
EI 1549-5477
J9 GENE DEV
JI Genes Dev.
PD AUG 15
PY 2009
VL 23
IS 15
BP 1714
EP 1736
DI 10.1101/gad.1784909
PG 23
WC Cell Biology; Developmental Biology; Genetics & Heredity
SC Cell Biology; Developmental Biology; Genetics & Heredity
GA 478OW
UT WOS:000268598600004
PM 19651984
DA 2024-11-01
ER

PT J
AU Iyer, S
   Thomas, RR
   Portell, FR
   Dunham, LD
   Quigley, CK
   Bennett, JP
AF Iyer, Shilpa
   Thomas, Ravindar R.
   Portell, Francisco R.
   Dunham, Lisa D.
   Quigley, Caitlin K.
   Bennett, James P., Jr.
TI Recombinant mitochondrial transcription factor A with N-terminal mitochondrial transduction domain increases respiration and mitochondrial gene expression
SO MITOCHONDRION
LA English
DT Article
DE TFAM; Respiration; Mitochondrial gene expression; Respiratory proteins
ID factor-a tfam; hereditary optic neuropathy; mtdna copy number; dna nucleoids; replication; disease; overexpression; maintenance; biogenesis; chaperones
AB We developed a scalable procedure to produce human mitochondrial transcription factor A (TFAM) modified with an N-terminal protein transduction domain (PTD) and mitochondrial localization signal (MLS) that allow it to cross membranes and enter mitochondria through its "mitochondrial transduction domain" (MTD = PTD + MLS). Alexa488-labeled MTD-TFAM rapidly entered the mitochondrial compartment of cybrid cells carrying the G11778A LHON mutation. MTD-TFAM reversibly increased respiration and levels of respiratory proteins. In vivo treatment of mice with MTD-TFAM increased motor endurance and complex I-driven respiration in mitochondria from brain and skeletal muscle. MTD-TFAM increases mitochondrial bioenergetics and holds promise for treatment of mitochondrial diseases involving deficiencies of energy production. (C) 2009 Elsevier B.V. and Mitochondria Research Society. All rights reserved.
C1 [Iyer, Shilpa; Thomas, Ravindar R.; Dunham, Lisa D.; Quigley, Caitlin K.; Bennett, James P., Jr.] Univ Virginia, Ctr Study Neurodegenerat Dis, Charlottesville, VA 22908 USA.
   [Iyer, Shilpa; Thomas, Ravindar R.; Dunham, Lisa D.; Quigley, Caitlin K.; Bennett, James P., Jr.] Univ Virginia, Morris K Udall Parkinsons Dis Res Ctr Excellence, Charlottesville, VA 22908 USA.
   [Portell, Francisco R.] Gencia Corp, Charlottesville, VA USA.
C3 University of Virginia; University of Virginia
RP Bennett, JP (corresponding author), Univ Virginia, Ctr Study Neurodegenerat Dis, POB 800394, Charlottesville, VA 22908 USA.
EM bennett@virginia.edu
FU National Institute of Health [NS39788, AG023443]; American Parkinson's Disease Association (Iyer); Parkinson's Disease Foundation (Iyer)
CR Bogenhagen DF, 2008, J BIOL CHEM, V283, P3665, DOI 10.1074/jbc.M708444200
   Brown TA, 2005, GENE DEV, V19, P2466, DOI 10.1101/gad.1352105
   Cotney J, 2007, NUCLEIC ACIDS RES, V35, P4042, DOI 10.1093/nar/gkm424
   DIMAURO S, 2008, ANN REV NEUROSCI, V0, P0
   Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109
   Fernández-Silva P, 2003, EXP PHYSIOL, V88, P41, DOI 10.1113/eph8802514
   Garstka HL, 2003, NUCLEIC ACIDS RES, V31, P5039, DOI 10.1093/nar/gkg717
   Holt IJ, 2007, MITOCHONDRION, V7, P311, DOI 10.1016/j.mito.2007.06.004
   Hütter E, 2006, EXP GERONTOL, V41, P103, DOI 10.1016/j.exger.2005.09.011
   Ikeuchi M, 2005, CIRCULATION, V112, P683, DOI 10.1161/CIRCULATIONAHA.104.524835
   Kang D, 2007, MITOCHONDRION, V7, P39, DOI 10.1016/j.mito.2006.11.017
   Khan SM, 2004, J BIOENERG BIOMEMBR, V36, P387, DOI 10.1023/B:JOBB.0000041773.20072.9e
   Kucej M, 2007, TRENDS CELL BIOL, V17, P586, DOI 10.1016/j.tcb.2007.08.007
   Kutik S, 2007, J CELL BIOL, V179, P585, DOI 10.1083/jcb.200708199
   Leidhold C, 2007, ANN NY ACAD SCI, V1113, P72, DOI 10.1196/annals.1391.011
   Maniura-Weber K, 2004, NUCLEIC ACIDS RES, V32, P6015, DOI 10.1093/nar/gkh921
   Pohjoismäki JLO, 2006, NUCLEIC ACIDS RES, V34, P5815, DOI 10.1093/nar/gkl703
   Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007
   Shadel GS, 2008, AM J PATHOL, V172, P1445, DOI 10.2353/ajpath.2008.071163
   Szabadkai G, 2007, ADV EXP MED BIOL, V594, P64
   Wadia JS, 2004, NAT MED, V10, P310, DOI 10.1038/nm996
   Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Wallace Douglas C, 2002, METHODS MOL BIOL, V197, P3, DOI 10.1385/1-59259-284-8:003
   Wang YS, 2006, J BIOL CHEM, V281, P25791, DOI 10.1074/jbc.M604501200
   Yen MY, 2006, PROG RETIN EYE RES, V25, P381, DOI 10.1016/j.preteyeres.2006.05.002
NR 26
TC 46
Z9 54
U1 1
U2 13
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD JUN 15
PY 2009
VL 9
IS 3
BP 196
EP 203
DI 10.1016/j.mito.2009.01.012
PG 8
WC Cell Biology; Genetics & Heredity
SC Cell Biology; Genetics & Heredity
GA 443YI
UT WOS:000265946300004
PM 19460293
DA 2024-11-01
ER

PT J
AU Johnston, DS
   Su, YA
   Alesci, S
AF Johnston, Daniel S.
   Su, Yan A.
   Alesci, Salvatore
TI Mitochondrial gene profiling: translational perspectives
SO PHARMACOGENOMICS
LA English
DT Review
DE gene expression; microarray; mitochondria; translational medicine
ID focused cdna microarray; skeletal-muscle; oligonucleotide microarray; dna microarrays; apoptotic genes; expression; dysfunction; mutations; mitochip; genome
AB The last decade has witnessed the development of multiple microarray platforms designed to study, in a comprehensive fashion, the expression and sequence of both mitochondrial and nuclear genes that encode mitochondrial proteins. Mitochondrial dysfunction has been implicated in a number of severe medical conditions including cancer, metabolic diseases (i.e., cardiovascular, diabetes and obesity) and neurodegenerative disorders and it is responsible for the adverse effects of numerous drugs. Profiling of the genetic and genomic status of mitochondria with focused microarrays offers the promise of rapidly and robustly identifying novel biomarkers for early disease diagnoses and prognoses, predicting of drug safety, liability, and selecting and stratifying of patients in clinical trials.
C1 [Johnston, Daniel S.; Alesci, Salvatore] Wyeth Ayerst Res, Discovery Translat Med, Collegeville, PA 19426 USA.
   [Su, Yan A.] George Washington Univ, Sch Med & Hlth Sci, Washington, DC 20052 USA.
   [Su, Yan A.] GenProMarkers Inc, Rockville, MD USA.
C3 Pfizer; George Washington University
RP Alesci, S (corresponding author), Wyeth Ayerst Res, Discovery Translat Med, 500 Arcola Rd,S2323, Collegeville, PA 19426 USA.
EM alescis@wyeth.com
CR Alesci S, 2006, PHARMACOGENOMICS J, V6, P333, DOI 10.1038/sj.tpj.6500377
   Alesci S, 2004, 17TH IEEE SYMPOSIUM ON COMPUTER-BASED MEDICAL SYSTEMS, V0, P329, DOI 10.1109/CBMS.2004.1311736
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Bai XY, 2007, BIOTECHNIQUES, V42, P365, DOI 10.2144/000112388
   Chee M, 1996, SCIENCE, V274, P610, DOI 10.1126/science.274.5287.610
   Chinnery PF, 2003, TRENDS GENET, V19, P60, DOI 10.1016/S0168-9525(02)00030-6
   Cízková A, 2008, BMC GENOMICS, V9, P0, DOI 10.1186/1471-2164-9-38
   CLAYTON DA, 1991, ANNU REV CELL BIOL, V7, P453, DOI 10.1146/annurev.cb.07.110191.002321
   Coe KJ, 2007, CHEM RES TOXICOL, V20, P1277, DOI 10.1021/tx7001349
   Dakubo Gabriel D, 2008, EXPERT OPIN MED DIAGN, V2, P263, DOI 10.1517/17530059.2.3.263
   DAKUBO GD, 2008, GEN METHODS OVERVIEW, V0, P441
   de Longueville F, 2004, COMB CHEM HIGH T SCR, V7, P207
   Desai VG, 2008, MITOCHONDRION, V8, P181, DOI 10.1016/j.mito.2008.01.002
   Desai VG, 2007, MITOCHONDRION, V7, P322, DOI 10.1016/j.mito.2007.02.004
   Desai VG, 2007, MUTAT RES-FUND MOL M, V616, P210, DOI 10.1016/j.mrfmmm.2006.11.011
   Di Lorenzo C, 2009, NEUROLOGY, V72, P1588, DOI 10.1212/WNL.0b013e3181a41269
   DiMauro S, 2002, MUSCLE NERVE, V26, P597, DOI 10.1002/mus.10194
   Divne AM, 2005, FORENSIC SCI INT, V154, P111, DOI 10.1016/j.forsciint.2004.09.134
   Duke DC, 2006, NEUROGENETICS, V7, P139, DOI 10.1007/s10048-006-0033-5
   Enns GM, 2003, MOL GENET METAB, V80, P11, DOI 10.1016/j.ymgme.2003.08.009
   FEUERSTEIN GZ, 2006, AM DRUG DISCOVERY, V2, P23
   Graff C, 1999, J INTERN MED, V246, P11, DOI 10.1046/j.1365-2796.1999.00514.x
   Hasselgren P O, 1999, CURR OPIN CLIN NUTR METAB CARE, V2, P201, DOI 10.1097/00075197-199905000-00002
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Jakupciak JP, 2008, BMC CANCER, V8, P0, DOI 10.1186/1471-2407-8-95
   Jelinsky SA, 2007, BIOL REPROD, V76, P561, DOI 10.1095/biolreprod.106.057323
   Johnston DS, 2008, P NATL ACAD SCI USA, V105, P8315, DOI 10.1073/pnas.0709854105
   JOHNSTON DS, 2008, AM DRUG DISCOVERY, V3, P54
   Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944
   Leighton JX, 2006, ENVIRON HEALTH PERSP, V114, P573, DOI 10.1289/ehp.8318
   Maitra A, 2004, GENOME RES, V14, P812, DOI 10.1101/gr.2228504
   Mithani SK, 2007, CLIN CANCER RES, V13, P7335, DOI 10.1158/1078-0432.CCR-07-0220
   Mitsui T, 2002, J NEUROL, V249, P1004, DOI 10.1007/s00415-002-0774-5
   NASS MMK, 1963, J CELL BIOL, V19, P593, DOI 10.1083/jcb.19.3.593
   NEWGARD CB, 1995, ANNU REV BIOCHEM, V64, P689, DOI 10.1146/annurev.biochem.64.1.689
   Osiewacz HD, 2002, GENE, V286, P65, DOI 10.1016/S0378-1119(01)00804-6
   Reddy PH, 2004, HUM MOL GENET, V13, P1225, DOI 10.1093/hmg/ddh140
   Rego-Pérez I, 2008, ARTHRITIS RHEUM-US, V58, P2387, DOI 10.1002/art.23659
   RICHTER C, 1988, P NATL ACAD SCI USA, V85, P6465, DOI 10.1073/pnas.85.17.6465
   Rutkowski JL, 2007, AM DRUG DISCOVERY, V2, P36
   Schapira AHV, 1999, EUR J CLIN INVEST, V29, P886
   Schapira AHV, 1998, BBA-BIOENERGETICS, V1366, P225, DOI 10.1016/S0005-2728(98)00115-7
   Scheffler IE, 2001, MITOCHONDRION, V1, P3, DOI 10.1016/S1567-7249(00)00002-7
   Servidei S, 2001, NEUROMUSCUL DISORD, V11, P690
   SHOFFNER JM, 1990, ADV HUM GENET, V19, P267
   Sigurdsson S, 2006, GENOMICS, V87, P534, DOI 10.1016/j.ygeno.2005.11.022
   Su YA, 2008, INT J BIOL SCI, V4, P223
   Subrarnaniam V, 2008, BBA-BIOENERGETICS, V1777, P666, DOI 10.1016/j.bbabio.2008.03.015
   Sui GP, 2006, MOL CANCER, V5, P0, DOI 10.1186/1476-4598-5-73
   Szewczyk A, 2002, PHARMACOL REV, V54, P101, DOI 10.1124/pr.54.1.101
   Tanaka TS, 2000, P NATL ACAD SCI USA, V97, P9127, DOI 10.1073/pnas.97.16.9127
   van der Westhuizen FH, 2003, NEUROPEDIATRICS, V34, P14, DOI 10.1055/s-2003-38618
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Voss JG, 2008, BIOL RES NURS, V9, P272, DOI 10.1177/1099800408315160
   Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751
   WALLACE DC, 1987, CURR GENET, V12, P81, DOI 10.1007/BF00434661
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Wang B-D, 2008, CELLSCIENCE, V4, P57
   Wang QX, 2004, AM J MED GENET A, V131A, P50, DOI 10.1002/ajmg.a.30323
   Waring Jeffrey F, 2003, ENVIRONMENTAL HEALTH PERSPECTIVES, V111, P53
   Waring JF, 2002, TOXICOLOGY, V181, P537, DOI 10.1016/S0300-483X(02)00477-8
   Washizuka S, 2003, INT J NEUROPSYCHOPH, V6, P421, DOI 10.1017/S1461145703003778
   Yang Y, 2006, PHARMACOGENOMICS, V7, P177, DOI 10.2217/14622416.7.2.177
   Yang Y, 2004, CHEM-BIOL INTERACT, V150, P71, DOI 10.1016/j.cbi.2004.09.013
   Zeviani M, 1999, ITAL J NEUROL SCI, V20, P401
   Zhou SY, 2007, P NATL ACAD SCI USA, V104, P7540, DOI 10.1073/pnas.0610818104
   Zhou SY, 2006, J MOL DIAGN, V8, P476, DOI 10.2353/jmoldx.2006.060008
NR 67
TC 8
Z9 9
U1 0
U2 2
PU FUTURE MEDICINE LTD
PI LONDON
PA UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3 1QB, ENGLAND
SN 1462-2416
EI 1744-8042
J9 PHARMACOGENOMICS
JI Pharmacogenomics
PD OCT 15
PY 2009
VL 10
IS 10
BP 1645
EP 1655
DI 10.2217/PGS.09.112
PG 11
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 513YD
UT WOS:000271359200010
PM 19842937
DA 2024-11-01
ER

PT J
AU Shaibani, A
   Shchelochkov, OA
   Zhang, SL
   Katsonis, P
   Lichtarge, O
   Wong, LJ
   Shinawi, M
AF Shaibani, Aziz
   Shchelochkov, Oleg A.
   Zhang, Shulin
   Katsonis, Panagiotis
   Lichtarge, Olivier
   Wong, Lee-Jun
   Shinawi, Marwan
TI Mitochondrial Neurogastrointestinal Encephalopathy Due to Mutations in <i>RRM2B</i>
SO ARCHIVES OF NEUROLOGY
LA English
DT Article
ID dna depletion; gene; encephalomyopathy; features; replication; disorder; failure; p53r2; mngie
AB Background: Mitochondrial neurogastrointestinal encephalopathy (MNGIE) is a progressive neurodegenerative disorder associated with thymidine phosphorylase deficiency resulting in high levels of plasma thymidine and a characteristic clinical phenotype. Objective: To investigate the molecular basis of MNGIE in a patient with a normal plasma thymidine level. Design: Clinical, neurophysiological, and histopathological examinations as well as molecular and genetic analyses. Setting: Nerve and muscle center and genetic clinic. Patient: A 42-year-old woman with clinical findings strongly suggestive for MNGIE. Main Outcome Measures: Clinical description of the disease and its novel genetic cause. Results: Identification of mitochondrial DNA depletion in muscle samples (approximately 12% of the control mean content) prompted us to look for other causes of our patient's condition. Sequencing of genes associated with mitochondrial DNA depletion-POLG, PEO1, ANT1, SUCLG1, and SUCLA2-did not reveal deleterious mutations. Results of sequencing and array comparative genomic hybridization of the mitochondrial DNA for point mutations and deletions in blood and muscle were negative. Sequencing of RRM2B, a gene encoding cytosolic p53-inducible ribonucleoside reductase small subunit (RIR2B), revealed 2 pathogenic mutations, c.329G>A (p. R110H) and c.362G >A (p.R121H). These mutations are predicted to affect the docking interface of the RIR2B homodimer and likely result in impaired enzyme activity. Conclusions: This study expands the clinical spectrum of impaired RIR2B function, challenges the notion of locus homogeneity of MNGIE, and sheds light on the pathogenesis of conditions involved in the homeostasis of the mitochondrial nucleotide pool. Our findings suggest that patients with MNGIE who have normal thymidine levels should be tested for RRM2B mutations.
C1 [Shchelochkov, Oleg A.; Zhang, Shulin; Katsonis, Panagiotis; Lichtarge, Olivier; Wong, Lee-Jun; Shinawi, Marwan] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.
   [Shaibani, Aziz] Nerve & Muscle Ctr Texas, Houston, TX USA.
   [Shaibani, Aziz] Baylor Coll Med, Dept Med, Houston, TX 77030 USA.
   [Lichtarge, Olivier] Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA.
   [Lichtarge, Olivier] Baylor Coll Med, Dept Pharmacol, Houston, TX 77030 USA.
   [Zhang, Shulin; Wong, Lee-Jun] Baylor Coll Med, Med Genet Labs, Houston, TX 77030 USA.
   [Shchelochkov, Oleg A.; Shinawi, Marwan] Texas Childrens Hosp, Houston, TX 77030 USA.
C3 Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine
RP Shinawi, M (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, 1 Baylor Plaza,Room T619, Houston, TX 77030 USA.
EM mshinawi@bcm.tmc.edu
FU NIDDK NIH HHS [5 R90 DK071505-03, 5 R90 DK071505-04, R90 DK071505] Funding Source: Medline; NIGMS NIH HHS [R01-GM066099, R01-GM079656, R01 GM066099, R01 GM079656-02, R01 GM079656, R01 GM079656-03] Funding Source: Medline
CR Bai RK, 2005, J MOL DIAGN, V7, P613, DOI 10.1016/S1525-1578(10)60595-8
   Bornstein B, 2008, NEUROMUSCULAR DISORD, V18, P453, DOI 10.1016/j.nmd.2008.04.006
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646
   Kimura T, 2003, NAT GENET, V34, P440, DOI 10.1038/ng1212
   Kollberg G, 2009, NEUROMUSCULAR DISORD, V19, P147, DOI 10.1016/j.nmd.2008.11.014
   Lehnhardt FG, 2008, ARCH NEUROL-CHICAGO, V65, P407, DOI 10.1001/archneur.65.3.407
   Nishino I, 2000, ANN NEUROL, V47, P792
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Nishino I, 2001, NEUROMUSCULAR DISORD, V11, P7, DOI 10.1016/S0960-8966(00)00159-0
   Spinazzola A, 2009, J INHERIT METAB DIS, V32, P143, DOI 10.1007/s10545-008-1038-z
   Tanaka H, 2000, NATURE, V404, P42, DOI 10.1038/35003506
   Van Goethem G, 2003, EUR J HUM GENET, V11, P547, DOI 10.1038/sj.ejhg.5201002
   Ward RM, 2008, PLOS ONE, V3, P0, DOI 10.1371/journal.pone.0002136
   Wong LJC, 2007, HEPATOLOGY, V46, P1218, DOI 10.1002/hep.21799
NR 15
TC 85
Z9 90
U1 0
U2 2
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 0003-9942
EI 1538-3687
J9 ARCH NEUROL-CHICAGO
JI Arch. Neurol.
PD AUG 15
PY 2009
VL 66
IS 8
BP 1028
EP 1032
DI 10.1001/archneurol.2009.139
PG 5
WC Clinical Neurology
SC Neurosciences & Neurology
GA 481YA
UT WOS:000268848100017
PM 19667227
DA 2024-11-01
ER

PT J
AU Werner, KGE
   Morel, CF
   Kirton, A
   Benseler, SM
   Shoffner, JM
   Addis, JBL
   Robinson, BH
   Burrowes, DM
   Blaser, SI
   Epstein, LG
   Feigenbaum, ASJ
AF Werner, Klaus G. E.
   Morel, Chantal F.
   Kirton, Adam
   Benseler, Susanne M.
   Shoffner, John M.
   Addis, Jane B. L.
   Robinson, Brian H.
   Burrowes, Delilah M.
   Blaser, Susan I.
   Epstein, Leon G.
   Feigenbaum, Annette S. J.
TI Rolandic Mitochondrial Encephalomyelopathy and <i>MT</i>-<i>ND3</i> Mutations
SO PEDIATRIC NEUROLOGY
LA English
DT Article
ID complex-i deficiency; nd3 gene; leigh-syndrome; dna mutation; missense mutation; lactic-acidosis; encephalopathy; children; myopathy; features
AB Mitochondrial encephalopathies may be caused by mutations in the respiratory chain complex I subunit genes. Described here are the cases of two pediatric patients who presented with MELAS-like calcarine lesions in addition to novel, bilateral rolandic lesions and epilepsia partialis continua, secondary to MT-ND3 mutations. Data were collected included neurologic symptoms, serial brain imaging, metabolic evaluations, skeletal muscle biopsies, mitochondrial biochemical and molecular testing. Permission for publication was given by the families. Muscle histology revealed nonspecific changes, with no ragged red or blue or COX-negative fibers. Sequencing of the mitochondrial DNA indicated patient 2 to be homoplasmic in muscle for the mt.10158T>C mutation in the ND3 subunit and Patient 1 to be 75% heteroplasmic for the mt.10191T>C mutation, also in ND3. Bilateral rolandic lesions and epilepsia partialis continua accompanied by suspicion of mitochondrial disease are indications to search for an underlying mutation in the MT-ND3 gene. (C) 2009 by Elsevier Inc. All rights reserved.
C1 [Morel, Chantal F.; Feigenbaum, Annette S. J.] Hosp Sick Children, Div Clin & Metab Genet, Toronto, ON M5G 1X8, Canada.
   [Werner, Klaus G. E.] Hosp Sick Children, Div Neurol & Pediat Emergency Med, Toronto, ON M5G 1X8, Canada.
   [Benseler, Susanne M.] Hosp Sick Children, Div Rheumatol & Pediat Emergency Med, Inst Res, Toronto, ON M5G 1X8, Canada.
   [Blaser, Susan I.] Hosp Sick Children, Dept Diagnost Imaging, Div Neuroradiol, Toronto, ON M5G 1X8, Canada.
   [Addis, Jane B. L.; Robinson, Brian H.] Hosp Sick Children, Metab Res Program, Res Inst, Dept Biochem, Toronto, ON M5G 1X8, Canada.
   [Kirton, Adam] Alberta Childrens Prov Gen Hosp, Div Neurol, Calgary, AB T2T 5C7, Canada.
   [Shoffner, John M.] Med Neurogenet, Atlanta, GA USA.
   [Burrowes, Delilah M.] Northwestern Univ, Feinberg Sch Med, Dept Radiol, Chicago, IL 60611 USA.
   [Epstein, Leon G.] Northwestern Univ, Feinberg Sch Med, Dept Pediat, Chicago, IL 60611 USA.
   [Epstein, Leon G.] Northwestern Univ, Feinberg Sch Med, Dept Neurol, Chicago, IL 60611 USA.
C3 University of Toronto; Hospital for Sick Children (SickKids); University of Toronto; Hospital for Sick Children (SickKids); University of Toronto; Hospital for Sick Children (SickKids); University of Toronto; Hospital for Sick Children (SickKids); University of Toronto; Hospital for Sick Children (SickKids); University of Calgary; Alberta Childrens Hospital; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine
RP Feigenbaum, ASJ (corresponding author), Hosp Sick Children, Div Clin & Metab Genet, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.
EM Annette.feigenbaum@sickkids.ca
CR Bénit P, 2001, AM J HUM GENET, V68, P1344, DOI 10.1086/320603
   Chae JH, 2007, PEDIATR RES, V61, P622, DOI 10.1203/pdr.0b013e3180459f2d
   Cockerell OC, 1996, BRAIN, V119, P393, DOI 10.1093/brain/119.2.393
   Crimi M, 2004, PEDIATR RES, V55, P842, DOI 10.1203/01.PDR.0000117844.73436.68
   Finsterer J, 2004, EUR J NEUROL, V11, P163, DOI 10.1046/j.1351-5101.2003.00728.x
   Galkin A, 2008, J BIOL CHEM, V283, P20907, DOI 10.1074/jbc.M803190200
   GOTO Y, 1991, BIOCHIM BIOPHYS ACTA, V1097, P238, DOI 10.1016/0925-4439(91)90042-8
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Ingman M, 2006, NUCLEIC ACIDS RES, V34, PD749, DOI 10.1093/nar/gkj010
   Kirby DM, 1999, NEUROLOGY, V52, P1255, DOI 10.1212/WNL.52.6.1255
   Lebon S, 2003, J MED GENET, V40, P896, DOI 10.1136/jmg.40.12.896
   Leshinsky-Silver E, 2005, BIOCHEM BIOPH RES CO, V334, P582, DOI 10.1016/j.bbrc.2005.06.134
   Loeffen JLCM, 2000, HUM MUTAT, V15, P123, DOI 10.1002/(SICI)1098-1004(200002)15:2<123::AID-HUMU1>3.3.CO;2-G
   McFarland R, 2004, ANN NEUROL, V55, P58, DOI 10.1002/ana.10787
   MORTEN KJ, 1993, HUM MOL GENET, V2, P2081, DOI 10.1093/hmg/2.12.2081
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Pitkanen S, 1996, J INHERIT METAB DIS, V19, P675, DOI 10.1007/BF01799845
   Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311
   ROBINSON BH, 1990, PEDIATR RES, V28, P549, DOI 10.1203/00006450-199011000-00027
   Robinson BH, 1998, BBA-BIOENERGETICS, V1364, P271, DOI 10.1016/S0005-2728(98)00033-4
   ROBINSON DS, 1993, CLIN EXP ALLERGY, V23, P1, DOI 10.1111/j.1365-2222.1993.tb02475.x
   Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, PD823, DOI 10.1093/nar/gkl927
   Sarzi E, 2007, AM J MED GENET A, V143A, P33, DOI 10.1002/ajmg.a.31565
   Taylor RW, 2001, ANN NEUROL, V50, P104, DOI 10.1002/ana.1084
NR 24
TC 27
Z9 29
U1 0
U2 5
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0887-8994
EI 1873-5150
J9 PEDIATR NEUROL
JI Pediatr. Neurol.
PD JUL 15
PY 2009
VL 41
IS 1
BP 27
EP 33
DI 10.1016/j.pediatrneurol.2009.02.010
PG 7
WC Clinical Neurology; Pediatrics
SC Neurosciences & Neurology; Pediatrics
GA 460OF
UT WOS:000267196300005
PM 19520270
DA 2024-11-01
ER

PT J
AU Walter, JH
AF Walter, J. H.
TI Genes, patients, families, doctors-Mutation analysis in clinical practice
SO JOURNAL OF INHERITED METABOLIC DISEASE
LA English
DT Article; Proceedings Paper
ID mitochondrial-dna depletion; tk2 gene; alpers-syndrome; polg mutations; myopathy; synthase; disease
AB Developments in mutation analysis have led to significant benefits for patients with inherited metabolic disorders and their families. This is particularly the case where new methodologies have prevented the need for invasive tissue biopsies or have allowed carrier detection or first trimester prenatal testing to be undertaken. Whereas in the past it may have only been possible to identify specific 'common' mutations, the availability of techniques, such as automated sequencing, and novel technologies including mutation scanning techniques, multiplex ligation dependent probe amplification, and array technologies, have vastly improved the diagnostic efficiency of molecular testing.
C1 Royal Manchester Childrens Hosp, Willink Biochem Genet Unit, Manchester M27 4HA, Lancs, England.
C3 Royal Manchester Children's Hospital
RP Walter, JH (corresponding author), Royal Manchester Childrens Hosp, Willink Biochem Genet Unit, Manchester M27 4HA, Lancs, England.
EM john.walter@cmft.nhs.uk
CR Bandmann O, 1998, ANN NEUROL, V44, P649, DOI 10.1002/ana.410440411
   Besley GTN, 1999, J INHERIT METAB DIS, V22, P263, DOI 10.1023/A:1005534105933
   Blakely E, 2008, NEUROMUSCULAR DISORD, V18, P557, DOI 10.1016/j.nmd.2008.04.014
   Bornstein B, 2008, NEUROMUSCULAR DISORD, V18, P453, DOI 10.1016/j.nmd.2008.04.006
   Carrozzo R, 2003, HUM MUTAT, V21, P0, DOI 10.1002/humu.9135
   Davidzon G, 2005, ANN NEUROL, V57, P921, DOI 10.1002/ana.20498
   Elsas LJ, 1998, GENET MED, V1, P40
   Freisinger P, 2006, ARCH NEUROL-CHICAGO, V63, P1129, DOI 10.1001/archneur.63.8.1129
   Galbiati S, 2006, PEDIATR NEUROL, V34, P177, DOI 10.1016/j.pediatrneurol.2005.07.013
   Götz A, 2008, BRAIN, V131, P2841, DOI 10.1093/brain/awn236
   Mancuso M, 2005, ARCH NEUROL-CHICAGO, V62, P745, DOI 10.1001/archneur.62.5.745
   Mancuso M, 2003, ARCH NEUROL-CHICAGO, V60, P1007, DOI 10.1001/archneur.60.7.1007
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Orho M, 1998, J CLIN INVEST, V102, P507, DOI 10.1172/JCI2890
   Rabinowitz SS, 2004, J PEDIATR GASTR NUTR, V38, P216, DOI 10.1097/00005176-200402000-00022
   Ridout CK, 2008, HUM GENET, V124, P187, DOI 10.1007/s00439-008-0538-0
   Thöny B, 2006, HUM MUTAT, V27, P870, DOI 10.1002/humu.20366
   Tulinius M, 2005, NEUROMUSCULAR DISORD, V15, P412, DOI 10.1016/j.nmd.2005.03.010
   Yamaguchi S, 2006, HUM MUTAT, V27, P626, DOI 10.1002/humu.20339
   Zschocke J, 2008, J INHERIT METAB DIS, V31, P697, DOI 10.1007/s10545-008-1052-1
NR 20
TC 1
Z9 1
U1 0
U2 2
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0141-8955
EI 
J9 J INHERIT METAB DIS
JI J. Inherit. Metab. Dis.
PD JUN 15
PY 2009
VL 32
IS 3
BP 441
EP 446
DI 10.1007/s10545-009-1085-0
PG 6
WC Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research & Experimental
SC Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental Medicine
GA 451EF
UT WOS:000266452800016
PM 19306072
DA 2024-11-01
ER

PT J
AU Iizuka, T
   Goto, Y
   Miyakawa, S
   Sato, M
   Wang, ZX
   Suzuki, K
   Hamada, J
   Kurata, A
   Sakai, F
AF Iizuka, Takahiro
   Goto, Yu-ichi
   Miyakawa, Saori
   Sato, Mayumi
   Wang, Zhaoxia
   Suzuki, Kosuke
   Hamada, Junichi
   Kurata, Akira
   Sakai, Fumihiko
TI Progressive carotid artery stenosis with a novel tRNA phenylalanine mitochondrial DNA mutation
SO JOURNAL OF THE NEUROLOGICAL SCIENCES
LA English
DT Article; Proceedings Paper
DE Carotid stenosis; Brain infarction; Mitochondrial encephalopathy; Carotid stenting; Gene mutation
ID stroke-like episodes; lactic-acidosis; melas; disease; encephalopathy; mechanisms; myopathy; patient
AB Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS) is a distinct clinical syndrome caused by Mutations in the mitochondrial DNA. The pathogenesis of stroke-like episodes remains unknown but major vessels stenosis is not a cause of stroke-like episodes, We describe a novel heteroplasmic G617A transition in the mitochondrial transfer RNA phenylalanine gene in a patient with encephalomyopathy who presented with recurrent embolic ischemic strokes accompanied by transient occlusion of middle cerebral, anterior cerebral and internal carotid arteries. These ischemic strokes were presumed to be artery-to artery embolisms associated with carotid artery stenosis. Single muscle fiber analysis revealed the pathogenicity of the mutation although its causative role on carotid artery stenosis remains to be elucidated. This case expands phenotypic spectrum of mitochondrial disorders in terms of macroangiopathy, but niacroangiopathy-related ischemic strokes should be distinguished from classic stroke-like episodes of MELAS that are speculated to be microangioapthy-related or non-ischemic neurovascular events. (c) 2008 Elsevier B.V. All rights reserved.
C1 [Iizuka, Takahiro; Miyakawa, Saori; Sato, Mayumi; Suzuki, Kosuke; Hamada, Junichi; Sakai, Fumihiko] Kitasato Univ, Sch Med, Dept Neurol, Kanagawa 2288555, Japan.
   [Kurata, Akira] Kitasato Univ, Sch Med, Dept Neurosurg, Kanagawa 2288555, Japan.
C3 Kitasato University; Kitasato University
RP Iizuka, T (corresponding author), Kitasato Univ, Sch Med, Dept Neurol, 1-15-1 Kitasato, Kanagawa 2288555, Japan.
EM takahiro@med.kitasato-u.ac.jp
CR Chinnery PF, 1997, ANN NEUROL, V41, P408, DOI 10.1002/ana.410410319
   Deschauer M, 2006, ARCH NEUROL-CHICAGO, V63, P902, DOI 10.1001/archneur.63.6.902
   DESTEE A, 1989, REV NEUROL, V145, P37
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   Hanna MG, 1998, J NEUROL NEUROSUR PS, V65, P512, DOI 10.1136/jnnp.65.4.512
   HIRANO M, 1992, NEUROMUSCULAR DISORD, V2, P125, DOI 10.1016/0960-8966(92)90045-8
   Iizuka T, 2005, CURR NEUROVASC RES, V2, P29, DOI 10.2174/1567202052773544
   Iizuka T, 2003, NEUROLOGY, V61, P1238, DOI 10.1212/01.WNL.0000091888.26232.FE
   Iizuka T, 2002, NEUROLOGY, V59, P816, DOI 10.1212/WNL.59.6.816
   ITO J, 1995, J CHILD NEUROL, V10, P337, DOI 10.1177/088307389501000422
   Kleinle S, 1998, BIOCHEM BIOPH RES CO, V247, P112, DOI 10.1006/bbrc.1998.8729
   Komaki H, 2003, MITOCHONDRION, V2, P293, DOI 10.1016/S1567-7249(03)00003-5
   Ling JQ, 2007, P NATL ACAD SCI USA, V104, P15299, DOI 10.1073/pnas.0704441104
   Longo N, 2008, AM J MED GENET A, V146A, P361, DOI 10.1002/ajmg.a.31841
   Mancuso M, 2004, NEUROLOGY, V62, P2119, DOI 10.1212/01.WNL.0000127608.48406.F1
   Martínez-Fernández E, 2001, STROKE, V32, P2507, DOI 10.1161/hs1101.098328
   Moslemi AR, 2004, NEUROMUSCULAR DISORD, V14, P46, DOI 10.1016/S0960-8966(03)00168-8
   Noguchi A, 2005, PEDIATR NEUROL, V33, P70, DOI 10.1016/j.pediatrneurol.2005.01.013
   Tay SHK, 2006, ARCH NEUROL-CHICAGO, V63, P281, DOI 10.1001/archneur.63.2.281
   Tzen CY, 2001, KIDNEY INT, V59, P846, DOI 10.1046/j.1523-1755.2001.00567.x
   VALENTE L, 2008, BIOCH BIOPHYS A 1015, V0, P0
NR 21
TC 28
Z9 29
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0022-510X
EI 1878-5883
J9 J NEUROL SCI
JI J. Neurol. Sci.
PD MAR 15
PY 2009
VL 278
IS 1-2
BP 35
EP 40
DI 10.1016/j.jns.2008.11.016
PG 6
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 411ZF
UT WOS:000263692300007
PM 19091329
DA 2024-11-01
ER

PT J
AU López-Gallardo, E
   López-Pèrez, MJ
   Montoya, J
   Ruiz-Pesini, E
AF Lopez-Gallardo, Ester
   Lopez-Perez, Manuel J.
   Montoya, Julio
   Ruiz-Pesini, Eduardo
TI CPEO and KSS differ in the percentage and location of the mtDNA deletion
SO MITOCHONDRION
LA English
DT Article
DE mtDNA; Deletion; CPEO; KSS; PS
ID mitochondrial-dna deletions; progressive external ophthalmoplegia; human-cells; replication; patient
AB Disorders caused by single mtDNA deletions are quite rare in the general population. To understand the molecular mechanism by which they come about and try to correlate the type of deletion with the phenotype of the patients, a very large cohort of affected individuals needs to be studied. We have performed a meta-analysis of 313 deletions found in CPEO, KSS and PS patients. Our results indicate that the percentage and location of the deletion show differences between these syndromes. Thus, the moment when the deletion is produced probably not only determines the affected tissues and the phenotype, but also the percentage and location of the deletion. (C) 2009 Elsevier B. V. and Mitochondria Research Society. All rights reserved.
C1 [Lopez-Gallardo, Ester; Lopez-Perez, Manuel J.; Montoya, Julio; Ruiz-Pesini, Eduardo] Univ Zaragoza, Dept Bioquim Biol Mol & Celular, E-50013 Zaragoza, Spain.
   [Ruiz-Pesini, Eduardo] Fdn ARAID, Zaragoza 50013, Spain.
   [Montoya, Julio; Ruiz-Pesini, Eduardo] Inst Aragones Ciencias Salud, Zaragoza 50013, Spain.
   [Lopez-Gallardo, Ester; Lopez-Perez, Manuel J.; Montoya, Julio; Ruiz-Pesini, Eduardo] CIBERER, Zaragoza 50013, Spain.
C3 University of Zaragoza; CIBER - Centro de Investigacion Biomedica en Red; CIBERER
RP Montoya, J (corresponding author), Univ Zaragoza, Dept Bioquim Biol Mol & Celular, Miguel Servet 177, E-50013 Zaragoza, Spain.
EM esterlop@unizar.es; lopezper@unizar.es; jmontoya@unizar.es; eduruiz@unizar.es
FU Instituto de Salud Carlos III-FIS [PI07-0045]; Diputacion General de Aragon [B33]
CR Anderson EJ, 2006, AM J PHYSIOL-CELL PH, V290, PC844, DOI 10.1152/ajpcell.00402.2005
   Auré K, 2007, BRAIN, V130, P1516, DOI 10.1093/brain/awm067
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Brown TA, 2006, CELL CYCLE, V5, P917, DOI 10.4161/cc.5.9.2710
   Carod-Artal FJ, 2003, REV NEUROLOGIA, V37, P1029, DOI 10.33588/rn.3711.2003547
   Chinnery PF, 2000, ANN NEUROL, V48, P188, DOI 10.1002/1531-8249(200008)48:2<188::AID-ANA8>3.3.CO;2-G
   Chinnery PF, 2004, LANCET, V364, P592, DOI 10.1016/S0140-6736(04)16851-7
   Cree LM, 2008, NAT GENET, V40, P249, DOI 10.1038/ng.2007.63
   Facucho-Oliveira JM, 2007, J CELL SCI, V120, P4025, DOI 10.1242/jcs.016972
   HARDING AE, 1992, J INHERIT METAB DIS, V15, P480, DOI 10.1007/BF01799606
   Hyvärinen AK, 2007, NUCLEIC ACIDS RES, V35, P6458, DOI 10.1093/nar/gkm676
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   LARSSON NG, 1990, PEDIATR RES, V28, P131, DOI 10.1203/00006450-199028020-00011
   Pineda M, 2006, ANN NEUROL, V59, P394, DOI 10.1002/ana.20746
   Pineda M, 2004, REV NEUROLOGIA, V38, P1023, DOI 10.33588/rn.3811.2004019
   Pohjoismäki JLO, 2006, NUCLEIC ACIDS RES, V34, P5815, DOI 10.1093/nar/gkl703
   Remes AM, 2005, NEUROLOGY, V64, P976, DOI 10.1212/01.WNL.0000154518.31302.ED
   Samuels DC, 2004, TRENDS GENET, V20, P393, DOI 10.1016/j.tig.2004.07.003
   SHOFFNER JM, 1989, P NATL ACAD SCI USA, V86, P7952, DOI 10.1073/pnas.86.20.7952
   Solano A, 2004, PEDIATR NEPHROL, V19, P790, DOI 10.1007/s00467-004-1473-5
   Solano A, 2003, J MED GENET, V40, P0, DOI 10.1136/jmg.40.7.e86
   Tessa A, 2000, FUNCT NEUROL, V15, P211
   Yamashita S, 2008, J HUM GENET, V53, P598, DOI 10.1007/s10038-008-0289-8
NR 23
TC 46
Z9 53
U1 0
U2 9
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD SEP 15
PY 2009
VL 9
IS 5
BP 314
EP 317
DI 10.1016/j.mito.2009.04.005
PG 4
WC Cell Biology; Genetics & Heredity
SC Cell Biology; Genetics & Heredity
GA 541LC
UT WOS:000273416200004
PM 19410662
DA 2024-11-01
ER

PT J
AU Bohlega, S
   Van Goethem, G
   Al Semari, A
   Löfgren, A
   Al Hamed, M
   Van Broeckhoven, C
   Kambouris, M
AF Bohlega, S.
   Van Goethem, G.
   Al Semari, A.
   Loefgren, A.
   Al Hamed, M.
   Van Broeckhoven, C.
   Kambouris, M.
TI Novel Twinkle gene mutation in autosomal dominant progressive external ophthalmoplegia and multisystem failure
SO NEUROMUSCULAR DISORDERS
LA English
DT Article
DE mtDNA; PEO; PEO1; Twinkle gene; Mutation; adPEO
ID mitochondrial-dna; deletions; helicase
AB A Saudi Arabian family presented with adult onset autosomal dominant progressive external ophthalmoplegia (adPEO) complicated by late onset reversible failure of the CNS, respiratory, hepatic, and endocrine systems. Clinical findings were suggestive of mitochondrial dysfunction and multiple mitochondrial DNA deletions were demonstrated on long range and real time polymerase chain reaction assays but not on Southern blotting. The disorder is caused by a novel heterozygous PEO1 mutation predicting a Leu360Gly substitution in the twinkle protein. The peculiar clinical presentation expands the variable phenotype observed in adPEO and Twinkle gene mutations. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Bohlega, S.] King Faisal Specialist Hosp & Res Ctr, Dept Neurosci, Neurol Sect, Riyadh 11211, Saudi Arabia.
   [Van Goethem, G.] Univ Antwerp Hosp, Dept Neurol, Antwerp, Belgium.
   [Van Goethem, G.; Loefgren, A.; Van Broeckhoven, C.] Inst Born Bunge, Neurogenet Lab, Antwerp, Belgium.
   [Van Goethem, G.; Loefgren, A.; Van Broeckhoven, C.] VIB, Dept Mol Genet, Antwerp, Belgium.
   [Loefgren, A.; Van Broeckhoven, C.] Univ Antwerp, Dept Med Genet, B-2020 Antwerp, Belgium.
   [Al Hamed, M.; Kambouris, M.] King Faisal Specialist Hosp & Res Ctr, Res Ctr, Riyadh 11211, Saudi Arabia.
C3 King Faisal Specialist Hospital & Research Center; University of Antwerp; Flanders Institute for Biotechnology (VIB); University of Antwerp; King Faisal Specialist Hospital & Research Center
RP Bohlega, S (corresponding author), King Faisal Specialist Hosp & Res Ctr, Dept Neurosci, Neurol Sect, POB 3354, Riyadh 11211, Saudi Arabia.
EM boholega@kfshrc.edu.sa
CR Deschauer M, 2003, NEUROMUSCULAR DISORD, V13, P568, DOI 10.1016/S0960-8966(03)00071-3
   Goffart S, 2009, HUM MOL GENET, V18, P328, DOI 10.1093/hmg/ddn359
   Jeppesen TD, 2008, NEUROMUSCULAR DISORD, V18, P306, DOI 10.1016/j.nmd.2007.10.007
   Korhonen JA, 2008, J MOL BIOL, V377, P691, DOI 10.1016/j.jmb.2008.01.035
   Lewis S, 2002, J NEUROL SCI, V201, P39, DOI 10.1016/S0022-510X(02)00190-9
   Rivera H, 2007, NEUROMUSCULAR DISORD, V17, P677, DOI 10.1016/j.nmd.2007.05.006
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spinazzola A, 2005, GENE, V354, P162, DOI 10.1016/j.gene.2005.03.025
   Van Goethem G, 2003, NEUROMOL MED, V3, P129, DOI 10.1385/NMM:3:3:129
   Vandenberghe W, 2009, MOVEMENT DISORD, V24, P308, DOI 10.1002/mds.22198
NR 10
TC 6
Z9 9
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8966
EI 
J9 NEUROMUSCULAR DISORD
JI Neuromusc. Disord.
PD DEC 15
PY 2009
VL 19
IS 12
BP 845
EP 848
DI 10.1016/j.nmd.2009.10.002
PG 4
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 534DB
UT WOS:000272874600010
PM 19853444
DA 2024-11-01
ER

PT J
AU Broccolini, A
   Gidaro, T
   Morosetti, R
   Mirabella, M
AF Broccolini, Aldobrando
   Gidaro, Teresa
   Morosetti, Roberta
   Mirabella, Massimiliano
TI HEREDITARY INCLUSION-BODY MYOPATHY: CLUES ON PATHOGENESIS AND POSSIBLE THERAPY
SO MUSCLE & NERVE
LA English
DT Review
DE hereditary inclusion-body myopathy; distal myopathy with rimmed vacuoles; h-IBM; DMRV; GNE
ID acetylglucosamine 2-epimerase/n-acetylmannosamine kinase; sialic-acid biosynthesis; mitochondrial-dna deletions; n-acetylneuraminic acid; precursor protein gene; rimmed vacuoles; distal myopathy; gne gene; human muscle; udp-n-acetylglucosamine-2-epimerase/n-acetylmannosamine kinase
AB Hereditary inclusion-body myopathy (h-IBM), or distal myopathy with rimmed vacuoles (DMRV), is an autosomal recessive disorder with onset in early adult life and a progressive course leading to severe disability. h-IBM/DMRV is due to mutations of a gene (GNE) that codes for a rate-limiting enzyme in the sialic acid biosynthetic pathway. Despite the identification of the causative gene defect, it has not been unambiguously clarified how GNE gene mutations impair muscle metabolism. Although numerous studies have indicated a key role of hyposialylation of glycoproteins in h-IBM/DMRV pathogenesis, others have demonstrated new and unpredicted functions of the GNE gene, outside the sialic acid biosynthetic pathway, that may also be relevant. This review illustrates the clinical and pathologic characteristics of h-IBM/DMRV and the main clues available to date concerning the possible pathogenic mechanisms and therapeutic perspectives of this disorder. Muscle Nerve 40: 340-349, 2009
C1 [Broccolini, Aldobrando; Gidaro, Teresa; Morosetti, Roberta; Mirabella, Massimiliano] Catholic Univ, Dept Neurosci, I-00168 Rome, Italy.
C3 Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli
RP Mirabella, M (corresponding author), Catholic Univ, Dept Neurosci, Lgo Gemelli 8, I-00168 Rome, Italy.
EM mirabella@rm.unicatt.it
FU Fondazione Don Gnocchi, Catholic University; Istituto Superiore di Sanita
CR Amouri R, 2005, NEUROMUSCULAR DISORD, V15, P361, DOI 10.1016/j.nmd.2005.01.012
   Amsili S, 2007, CELL DEATH DIFFER, V14, P1916, DOI 10.1038/sj.cdd.4402208
   Arai A, 2002, ANN NEUROL, V52, P516, DOI 10.1002/ana.10341
   Argov Z, 2003, NEUROLOGY, V60, P1519, DOI 10.1212/01.WNL.0000061617.71839.42
   ARGOV Z, 1984, J NEUROL SCI, V64, P33, DOI 10.1016/0022-510X(84)90053-4
   ASKANAS V, 1992, AM J PATHOL, V141, P31
   Askanas V, 1996, P NATL ACAD SCI USA, V93, P1314, DOI 10.1073/pnas.93.3.1314
   ASKANAS V, 1993, ANN NEUROL, V34, P551, DOI 10.1002/ana.410340408
   Askanas V, 1997, NEUROREPORT, V8, P2155, DOI 10.1097/00001756-199707070-00012
   ASKANAS V, 1994, AM J PATHOL, V144, P177
   Askanas Valerie, 1998, CURRENT OPINION IN RHEUMATOLOGY, V10, P530, DOI 10.1097/00002281-199811000-00005
   Broccolini A, 2005, NEUROMUSCULAR DISORD, V15, P177, DOI 10.1016/j.nmd.2004.10.001
   Broccolini A, 2002, NEUROLOGY, V59, P1808, DOI 10.1212/01.WNL.0000031808.04545.E0
   Broccolini A, 2008, J NEUROCHEM, V105, P971, DOI 10.1111/j.1471-4159.2007.05208.x
   Broccolini A, 2004, HUM MUTAT, V23, P0, DOI 10.1002/humu.9252
   COLE AJ, 1988, BRAIN, V111, P1025, DOI 10.1093/brain/111.5.1025
   Darvish D, 2002, MOL GENET METAB, V77, P252, DOI 10.1016/S1096-7192(02)00141-5
   Del Bo R, 2003, MUSCLE NERVE, V28, P113, DOI 10.1002/mus.10391
   Ding WX, 2007, AM J PATHOL, V171, P513, DOI 10.2353/ajpath.2007.070188
   Eisenberg I, 2001, NAT GENET, V29, P83, DOI 10.1038/ng718
   Eisenberg I, 2008, HUM MOL GENET, V17, P3663, DOI 10.1093/hmg/ddn261
   Eisenberg Iris, 2003, HUM MUTAT, V21, P99, DOI 10.1002/humu.9100
   Galeano B, 2007, J CLIN INVEST, V117, P1585, DOI 10.1172/JCI30954
   García-Ruiz C, 2000, FASEB J, V14, P847, DOI 10.1096/fasebj.14.7.847
   Hinderlich S, 1997, J BIOL CHEM, V272, P24313, DOI 10.1074/jbc.272.39.24313
   Hinderlich S, 2001, BIOL CHEM, V382, P291, DOI 10.1515/BC.2001.036
   Hong YJ, 2003, J BIOL CHEM, V278, P53045, DOI 10.1074/jbc.M309967200
   Horstkorte R, 1999, EUR J BIOCHEM, V260, P923, DOI 10.1046/j.1432-1327.1999.00253.x
   HOWELL S, 1995, PEPTIDES, V16, P647, DOI 10.1016/0196-9781(95)00021-B
   Huizing M, 2004, MOL GENET METAB, V81, P196, DOI 10.1016/j.ymgme.2003.11.012
   Iwata N, 2001, SCIENCE, V292, P1550, DOI 10.1126/science.1059946
   Kayashima T, 2002, J HUM GENET, V47, P77, DOI 10.1007/s100380200004
   Keppler OT, 1999, SCIENCE, V284, P1372, DOI 10.1126/science.284.5418.1372
   Kim BJ, 2006, J HUM GENET, V51, P137, DOI 10.1007/s10038-005-0338-5
   Krause S, 2007, NEUROLOGY, V69, P655, DOI 10.1212/01.wnl.0000267426.97138.fd
   Krause S, 2003, NEUROMUSCULAR DISORD, V13, P830, DOI 10.1016/S0960-8966(03)00140-8
   LAFRANCE MH, 1994, BIOCHEM J, V302, P451, DOI 10.1042/bj3020451
   Liewluck T, 2006, MUSCLE NERVE, V34, P775, DOI 10.1002/mus.20583
   Malicdan MCV, 2007, HUM MOL GENET, V16, P2669, DOI 10.1093/hmg/ddm220
   Malicdan MCV, 2007, AUTOPHAGY, V3, P396, DOI 10.4161/auto.4270
   Malicdan MCV, 2009, NAT MED, V15, P690, DOI 10.1038/nm.1956
   Malisan F, 2005, IUBMB LIFE, V57, P477, DOI 10.1080/15216540500167179
   MASSA R, 1991, ARCH NEUROL-CHICAGO, V48, P519, DOI 10.1001/archneur.1991.00530170083024
   McFerrin J, 1998, NEUROREPORT, V9, P3201, DOI 10.1097/00001756-199810050-00013
   Michele DE, 2002, NATURE, V418, P417, DOI 10.1038/nature00837
   Mirabella M, 1996, J NEUROPATH EXP NEUR, V55, P774, DOI 10.1097/00005072-199607000-00003
   MONTREUIJ, 1968, CLIN CHIM ACTA, V21, P61, DOI 10.1016/0009-8981(68)90011-9
   Moslemi AR, 1997, HUM MUTAT, V10, P381, DOI 10.1002/(SICI)1098-1004(1997)10:5<381::AID-HUMU8>3.0.CO;2-I
   Motozaki Y, 2007, EUR J NEUROL, V14, PE14, DOI 10.1111/j.1468-1331.2007.01905.x
   Ni M, 2007, FEBS LETT, V581, P3641, DOI 10.1016/j.febslet.2007.04.045
   Nishino I, 2002, NEUROLOGY, V59, P1689, DOI 10.1212/01.WNL.0000041631.28557.C6
   Noguchi S, 2004, J BIOL CHEM, V279, P11402, DOI 10.1074/jbc.M313171200
   OLDFORS A, 1993, BRAIN, V116, P325, DOI 10.1093/brain/116.2.325
   Pilkington GJ, 2005, CELL PROLIFERAT, V38, P423, DOI 10.1111/j.1365-2184.2005.00358.x
   Rafuse VF, 1996, J CELL BIOL, V132, P969, DOI 10.1083/jcb.132.5.969
   Rafuse VF, 2000, J NEUROSCI, V20, P6529, DOI 10.1523/JNEUROSCI.20-17-06529.2000
   Ricci E, 2006, NEUROLOGY, V66, P755, DOI 10.1212/01.wnl.0000200956.76449.3f
   SADEH M, 1993, BRAIN, V116, P217, DOI 10.1093/brain/116.1.217
   Saito F, 2004, NEUROMUSCULAR DISORD, V14, P158, DOI 10.1016/j.nmd.2003.09.006
   SARKOZI E, 1994, EXP NEUROL, V128, P27, DOI 10.1006/exnr.1994.1109
   SARKOZI E, 1993, NEUROREPORT, V4, P815, DOI 10.1097/00001756-199306000-00055
   Seppala R, 1999, AM J HUM GENET, V64, P1563, DOI 10.1086/302411
   Sparks S, 2007, BMC NEUROL, V7, P0, DOI 10.1186/1471-2377-7-3
   Tajima Y, 2005, AM J PATHOL, V166, P1121, DOI 10.1016/S0002-9440(10)62332-2
   Tessitore A, 2004, MOL CELL, V15, P753, DOI 10.1016/j.molcel.2004.08.029
   Vasconcelos OM, 2002, NEUROLOGY, V59, P1776, DOI 10.1212/01.WNL.0000039780.13681.AD
   Wang ZY, 2006, J BIOL CHEM, V281, P27016, DOI 10.1074/jbc.M604903200
   Weidemann W, 2006, FEBS LETT, V580, P6649, DOI 10.1016/j.febslet.2006.11.015
   Yan CZ, 2001, ACTA NEUROPATHOL, V101, P9
   Yang CC, 1996, NEUROREPORT, V8, P153, DOI 10.1097/00001756-199612200-00031
NR 70
TC 21
Z9 27
U1 0
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0148-639X
EI 1097-4598
J9 MUSCLE NERVE
JI Muscle Nerve
PD SEP 15
PY 2009
VL 40
IS 3
BP 340
EP 349
DI 10.1002/mus.21385
PG 10
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 492ZH
UT WOS:000269701500002
PM 19618441
DA 2024-11-01
ER

PT J
AU Rahman, S
   Poulton, J
AF Rahman, Shamima
   Poulton, Joanna
TI Diagnosis of mitochondrial DNA depletion syndromes
SO ARCHIVES OF DISEASE IN CHILDHOOD
LA English
DT Article
ID comparative genomic hybridization; dgk gene-mutations; deoxyguanosine kinase; respiratory-chain; sucla2 mutations; mtdna depletion; deficiency; encephalomyopathy; features; myopathy
C1 [Rahman, Shamima] UCL Inst Child Hlth, Mitochondrial Res Grp, London, England.
   [Rahman, Shamima] Natl Hosp Neurol, MRC Ctr Neuromuscular Dis, London, England.
   [Rahman, Shamima] Great Ormond St Hosp Sick Children, Metab Unit, London WC1N 3JH, England.
   [Poulton, Joanna] Univ Oxford, Nuffield Dept Obstet & Gynaecol, Oxford, England.
   [Poulton, Joanna] Great Ormond St Hosp Sick Children, Dubowitz Neuromuscular Ctr, London WC1N 3JH, England.
C3 University of London; University College London; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of Oxford; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust
RP Poulton, J (corresponding author), John Radcliffe Hosp, Nuffield Dept Obstet & Gynaecol, Womens Ctr, Level 3, Oxford OX3 9DU, England.
EM Joanna.Poulton@obs-gyn.ox.ac.uk
FU MRC [G0200335, G0500695] Funding Source: UKRI; Medical Research Council [G0500695, G0200335] Funding Source: Medline; Wellcome Trust Funding Source: Medline
CR Ashley N, 2008, HUM MOL GENET, V17, P2496, DOI 10.1093/hmg/ddn150
   Ashley N, 2007, HUM MOL GENET, V16, P1400, DOI 10.1093/hmg/ddm090
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   Carrozzo R, 2007, BRAIN, V130, P862, DOI 10.1093/brain/awl389
   DEMOUSSON CB, 2007, BIOCHEM J, V402, P377
   Dimmock DP, 2008, HUM MUTAT, V29, P330, DOI 10.1002/humu.9519
   Elpeleg O, 2005, AM J HUM GENET, V76, P1081, DOI 10.1086/430843
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   Freisinger P, 2006, ARCH NEUROL-CHICAGO, V63, P1129, DOI 10.1001/archneur.63.8.1129
   Hakonen AH, 2007, BRAIN, V130, P3032, DOI 10.1093/brain/awm242
   Hargreaves IP, 2002, J INHERIT METAB DIS, V25, P7, DOI 10.1023/A:1015104910239
   Labarthe F, 2005, J HEPATOL, V43, P333, DOI 10.1016/j.jhep.2005.03.023
   Lee NC, 2009, ARCH DIS CHILD, V94, P55, DOI 10.1136/adc.2008.139584
   Mancuso M, 2005, ARCH NEUROL-CHICAGO, V62, P745, DOI 10.1001/archneur.62.5.745
   Mancuso M, 2003, ARCH NEUROL-CHICAGO, V60, P1445, DOI 10.1001/archneur.60.10.1445
   MANDERBACKA K, 2001, SCANDINAVIAN J P S55, V29, P41
   Martí R, 2004, CLIN CHEM, V50, P120, DOI 10.1373/clinchem.2003.026179
   Morten KJ, 2007, MITOCHONDRION, V7, P386, DOI 10.1016/j.mito.2007.09.001
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Ostergaard E, 2007, AM J HUM GENET, V81, P383, DOI 10.1086/519222
   Ostergaard E, 2007, BRAIN, V130, P853, DOI 10.1093/brain/awl383
   Pinkel D, 1998, NAT GENET, V20, P207, DOI 10.1038/2524
   POULTON J, 1995, J INHERIT METAB DIS, V18, P4, DOI 10.1007/BF00711367
   Rabinowitz SS, 2004, J PEDIATR GASTR NUTR, V38, P216, DOI 10.1097/00005176-200402000-00022
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Salviati L, 2002, ANN NEUROL, V52, P311, DOI 10.1002/ana.10284
   Salviati L, 2002, ARCH NEUROL-CHICAGO, V59, P862, DOI 10.1001/archneur.59.5.862
   Sarzi E, 2007, J PEDIATR-US, V150, P531, DOI 10.1016/j.jpeds.2007.01.044
   Slama A, 2005, MOL GENET METAB, V86, P462, DOI 10.1016/j.ymgme.2005.09.006
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Taanman JW, 2003, HUM MOL GENET, V12, P1839, DOI 10.1093/hmg/ddg192
   Taanman JW, 2002, ANN NEUROL, V52, P237, DOI 10.1002/ana.10247
   Tadiboyina VT, 2005, AM J MED GENET A, V135A, P289, DOI 10.1002/ajmg.a.30748
   Vu TH, 1998, NEUROLOGY, V50, P1783, DOI 10.1212/WNL.50.6.1783
   Wang LY, 2005, MOL GENET METAB, V84, P75, DOI 10.1016/j.ymgme.2004.09.005
NR 36
TC 48
Z9 53
U1 0
U2 3
PU B M J PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0003-9888
EI 
J9 ARCH DIS CHILD
JI Arch. Dis. Child.
PD JAN 15
PY 2009
VL 94
IS 1
BP 3
EP 5
DI 10.1136/adc.2008.147983
PG 3
WC Pediatrics
SC Pediatrics
GA 387CP
UT WOS:000261929600002
PM 19103785
DA 2024-11-01
ER

PT J
AU Rohrbach, M
   Chitayat, D
   Maegawa, G
   Shanske, S
   Davidzon, G
   Chong, K
   Clarke, JTR
   Toi, A
   Tarnopolsky, M
   Robinson, B
   Blaser, S
AF Rohrbach, M.
   Chitayat, D.
   Maegawa, G.
   Shanske, S.
   Davidzon, G.
   Chong, K.
   Clarke, J. T. R.
   Toi, A.
   Tarnopolsky, M.
   Robinson, B.
   Blaser, S.
TI Intracerebral Periventricular Pseudocysts in a Fetus with Mitochondrial Depletion Syndrome: An Association or Coincidence
SO FETAL DIAGNOSIS AND THERAPY
LA English
DT Article
DE Mitochondrial depletion; Prenatal ultrasound; Fetal magnetic resonance imaging; Brain pseudocyst
ID deoxyguanosine kinase gene; dna depletion; respiratory-chain; subependymal cysts; mtdna depletion; alpers-syndrome; thymidine kinase; polg mutations; deficiency; myopathy
AB We report the prenatal ultrasound and magnetic resonance imaging finding of periventricular, large subependymal pseudocysts (SEPCs) in a patient who was later diagnosed as having mitochondrial depletion syndrome (MDS). To our knowledge, this is the first report of fetal SEPCs in a patient with MDS. These findings may provide an important diagnostic tool for prenatal diagnosis of MDS in at risk pregnancies when the gene mutation causing the condition has not been delineated. It may also direct the neonatologist in the postnatal care of the newborn detected prenatally with SEPCs in view of the association of this finding with infection, chromosome abnormalities, metabolic disorders and other abnormalities, when such findings are identified serendipitously. Further research is needed to find if the SEPCs detected in our patient is an association or a coincidental finding. Copyright (C) 2009 S. Karger AG, Basel
C1 [Rohrbach, M.; Chitayat, D.; Maegawa, G.; Chong, K.; Clarke, J. T. R.] Hosp Sick Children, Dept Pediat, Div Clin & Metab Genet, Toronto, ON M5G 1X8, Canada.
   [Robinson, B.] Hosp Sick Children, Dept Biochem & Paediat, Toronto, ON M5G 1X8, Canada.
   [Blaser, S.] Hosp Sick Children, Div Diagnost Imaging & Neuroradiol, Toronto, ON M5G 1X8, Canada.
   [Chitayat, D.; Chong, K.] Univ Toronto, Dept Obstet & Gynecol, Prenatal Diag & Med Genet Program, Mt Sinai Hosp, Toronto, ON M5G 1Z5, Canada.
   [Toi, A.] Univ Toronto, Mt Sinai Hosp, Dept Diagnost Imaging, Toronto, ON M5G 1Z5, Canada.
   [Tarnopolsky, M.] McMaster Univ, Med Ctr, Neuromuscular & Neurometab Unit, Hamilton, ON, Canada.
   [Shanske, S.; Davidzon, G.] Columbia Univ, Coll Phys & Surg, Dept Neurol, New York, NY USA.
C3 University of Toronto; Hospital for Sick Children (SickKids); University of Toronto; Hospital for Sick Children (SickKids); University of Toronto; Hospital for Sick Children (SickKids); University of Toronto; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; Sinai Health System Toronto; McMaster University; Columbia University
RP Chitayat, D (corresponding author), Univ Toronto, Dept Obstet & Gynecol, Prenatal Diag & Med Genet Program, Mt Sinai Hosp, 700 Univ Ave,3rd Floor,Room 3292, Toronto, ON M5G 1Z5, Canada.
EM dchitayat@mtsinai.on.ca
CR Carrozzo R, 2003, HUM MUTAT, V21, P0, DOI 10.1002/humu.9135
   CUILLIER F, 2004, J GYNECOL OBST BIO R, V28, P325
   Davidzon G, 2005, ANN NEUROL, V57, P921, DOI 10.1002/ana.20498
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   DiMauro S, 2005, NEUROMUSCULAR DISORD, V15, P276, DOI 10.1016/j.nmd.2004.12.008
   Elpeleg O, 2005, AM J HUM GENET, V76, P1081, DOI 10.1086/430843
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   FIGARELLABRANGER D, 1992, J NEUROL SCI, V108, P105, DOI 10.1016/0022-510X(92)90195-Q
   HEIBEL M, 1993, NEURORADIOLOGY, V35, P85, DOI 10.1007/BF00593960
   Hirano M, 2000, BRAIN PATHOL, V10, P451
   Labarthe F, 2005, J HEPATOL, V43, P333, DOI 10.1016/j.jhep.2005.03.023
   Macmillan CJ, 1996, PEDIATR NEUROL, V14, P203, DOI 10.1016/0887-8994(96)00018-5
   Makhoul IR, 2001, ISRAEL MED ASSOC J, V3, P178
   Mancuso M, 2005, ARCH NEUROL-CHICAGO, V62, P745, DOI 10.1001/archneur.62.5.745
   Mancuso M, 2003, ARCH NEUROL-CHICAGO, V60, P1007, DOI 10.1001/archneur.60.7.1007
   Mancuso M, 2002, NEUROLOGY, V59, P1197, DOI 10.1212/01.WNL.0000028689.93049.9A
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   MORAES CT, 1991, AM J HUM GENET, V48, P492
   Morris AAM, 1998, J HEPATOL, V28, P556, DOI 10.1016/S0168-8278(98)80278-X
   Naïmi M, 2006, EUR J HUM GENET, V14, P917, DOI 10.1038/sj.ejhg.5201627
   Naini A, 2007, METHOD CELL BIOL, V80, P437, DOI 10.1016/S0091-679X(06)80022-1
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Naviaux RK, 1999, ANN NEUROL, V45, P54, DOI 10.1002/1531-8249(199901)45:1<54::AID-ART10>3.0.CO;2-B
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Rabinowitz SS, 2004, J PEDIATR GASTR NUTR, V38, P216, DOI 10.1097/00005176-200402000-00022
   RUSSEL IMB, 1995, PEDIATR RADIOL, V25, P254, DOI 10.1007/BF02011090
   RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Salviati L, 2002, ANN NEUROL, V52, P311, DOI 10.1002/ana.10284
   Scaglia F, 2001, J CHILD NEUROL, V16, P136, DOI 10.1177/088307380101600214
   SHAW CM, 1974, ARCH NEUROL-CHICAGO, V31, P374, DOI 10.1001/archneur.1974.00490420040003
   SHEN EY, 1985, ARCH DIS CHILD, V60, P1072, DOI 10.1136/adc.60.11.1072
   Slama A, 2005, MOL GENET METAB, V86, P462, DOI 10.1016/j.ymgme.2005.09.006
   Spinazzola A, 2005, GENE, V354, P162, DOI 10.1016/j.gene.2005.03.025
   Squires L, 1997, DEV MED CHILD NEUROL, V39, P267
   Taanman JW, 2002, ANN NEUROL, V52, P237, DOI 10.1002/ana.10247
   Tadiboyina VT, 2005, AM J MED GENET A, V135A, P289, DOI 10.1002/ajmg.a.30748
   Vu TH, 1998, NEUROLOGY, V50, P1783, DOI 10.1212/WNL.50.6.1783
   Wang LY, 2005, MOL GENET METAB, V84, P75, DOI 10.1016/j.ymgme.2004.09.005
   YAMASHITA Y, 1990, PEDIATR NEUROL, V6, P375, DOI 10.1016/0887-8994(90)90003-J
   Yano S, 2003, J INHERIT METAB DIS, V26, P481, DOI 10.1023/A:1025125427868
NR 41
TC 15
Z9 18
U1 0
U2 4
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 1015-3837
EI 1421-9964
J9 FETAL DIAGN THER
JI Fetal Diagn. Ther.
PD JUN 15
PY 2009
VL 25
IS 2
BP 177
EP 182
DI 10.1159/000209385
PG 6
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA 482OG
UT WOS:000268898000001
PM 19321960
DA 2024-11-01
ER

PT J
AU McFarland, R
   Turnbull, DM
AF McFarland, R.
   Turnbull, D. M.
TI Batteries not included: diagnosis and management of mitochondrial disease
SO JOURNAL OF INTERNAL MEDICINE
LA English
DT Review
DE mitochondrial disease; neurogenetics; respiratory chain disorders
ID hereditary optic neuropathy; cytochrome-c-oxidase; progressive external ophthalmoplegia; kearns-sayre-syndrome; respiratory-chain disorders; membrane-protein complexes; ribosomal-rna mutation; inherited hearing-loss; non-syndromic deafness; stroke-like episodes
AB In 1998, Wallace et al. (Science 1988; 242: 1427-30) published evidence that the mutation m.11778G > A was responsible for causing Leber's hereditary optic neuropathy. This was the first account of a mitochondrial DNA mutation being irrefutably linked with a human disease and was swiftly followed by a report from Holt et al. (Nature 1988; 331: 717-9) identifying deletions in mitochondrial DNA as a cause for myopathy. During the subsequent 20 years there has been an exponential growth in 'mitochondrial medicine', with clinical, biochemical and genetic characterizations of a wide range of mitochondrial diseases and evidence implicating mitochondria in a host of many other clinical conditions including ageing, neurodegenerative illness and cancer. In this review we shall focus on the diagnosis and management of mitochondrial diseases that lead directly or indirectly to disruption of the process of oxidative phosphorylation.
C1 [McFarland, R.] Newcastle Univ, Sch Med, Sch Neurol Neurobiol & Psychiat, Mitochondrial Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
C3 Newcastle University - UK
RP McFarland, R (corresponding author), Newcastle Univ, Sch Med, Sch Neurol Neurobiol & Psychiat, Mitochondrial Res Grp, 4th Floor,Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM robert.mcfarland@ncl.ac.uk
FU Medical Research Council [G0700718, G0800674, G0601943] Funding Source: Medline; MRC [G0700718, G0800674, G0601943] Funding Source: UKRI
CR Agostino A, 2003, NEUROLOGY, V60, P1354, DOI 10.1212/01.WNL.0000056088.09408.3C
   Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   BALLINGER SW, 1992, NAT GENET, V1, P11, DOI 10.1038/ng0492-11
   Bataillard M, 2001, NEUROLOGY, V56, P405, DOI 10.1212/WNL.56.3.405
   Battersby BJ, 2003, NAT GENET, V33, P183, DOI 10.1038/ng1073
   Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   Biggin A, 2005, MOL GENET METAB, V84, P61, DOI 10.1016/j.ymgme.2004.09.011
   Bohlega S, 1996, NEUROLOGY, V46, P1329, DOI 10.1212/WNL.46.5.1329
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   Brierley EJ, 1998, ANN NEUROL, V43, P217, DOI 10.1002/ana.410430212
   Bykhovskaya Y, 2004, MOL GENET METAB, V83, P199, DOI 10.1016/j.ymgme.2004.07.009
   Carrozzo R, 2001, NEUROLOGY, V56, P687, DOI 10.1212/WNL.56.5.687
   Chinnery PF, 2000, ANN NEUROL, V48, P188, DOI 10.1002/1531-8249(200008)48:2<188::AID-ANA8>3.3.CO;2-G
   DAMIAN MS, 1995, ACTA NEUROL SCAND, V92, P409
   de Coo IFM, 1998, NEUROLOGY, V50, P293, DOI 10.1212/WNL.50.1.293
   de Lonlay P, 2001, NAT GENET, V29, P57, DOI 10.1038/ng706
   De Meirleir L, 2003, AM J MED GENET A, V121A, P126, DOI 10.1002/ajmg.a.20171
   DEBRAEKELEER M, 1993, GENET EPIDEMIOL, V10, P17, DOI 10.1002/gepi.1370100103
   Deschauer M, 1999, NEUROMUSCULAR DISORD, V9, P305, DOI 10.1016/S0960-8966(99)00019-X
   DEVRIES DD, 1993, ANN NEUROL, V34, P410, DOI 10.1002/ana.410340319
   Dimauro S, 2001, AM J MED GENET, V106, P18, DOI 10.1002/ajmg.1392
   Elpeleg O, 2005, AM J HUM GENET, V76, P1081, DOI 10.1086/430843
   Estivill X, 1998, AM J HUM GENET, V62, P27, DOI 10.1086/301676
   Filosto M, 2003, ANN NEUROL, V54, P524, DOI 10.1002/ana.10709
   Gabaldón T, 2004, BBA-BIOENERGETICS, V1659, P212, DOI 10.1016/j.bbabio.2004.07.011
   GERBITZ KD, 1995, BBA-MOL BASIS DIS, V1271, P253, DOI 10.1016/0925-4439(95)00036-4
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Griggs RC, 1999, NEW ENGL J MED, V341, P1077, DOI 10.1056/NEJM199909303411411
   Guan MX, 2001, HUM MOL GENET, V10, P573, DOI 10.1093/hmg/10.6.573
   HAMMANS SR, 1995, BRAIN, V118, P721, DOI 10.1093/brain/118.3.721
   HARDING AE, 1995, MUSCLE NERVE, V0, PS82
   He LP, 2002, NUCLEIC ACIDS RES, V30, P0, DOI 10.1093/nar/gnf067
   Hirano M, 2006, NEUROLOGY, V67, P1458, DOI 10.1212/01.wnl.0000240853.97716.24
   HIRANO M, 1994, NEUROLOGY, V44, P721, DOI 10.1212/WNL.44.4.721
   Hobbie SN, 2008, P NATL ACAD SCI USA, V105, P3244, DOI 10.1073/pnas.0707265105
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   Hudson G, 2005, AM J HUM GENET, V77, P1086, DOI 10.1086/498176
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   Huoponen K, 2001, NEUROGENETICS, V3, P119, DOI 10.1007/s100480100115
   HUTCHIN T, 1993, NUCLEIC ACIDS RES, V21, P4174, DOI 10.1093/nar/21.18.4174
   HUTTENLOCHER PR, 1976, ARCH NEUROL-CHICAGO, V33, P186, DOI 10.1001/archneur.1976.00500030042009
   JACKSON MJ, 1995, BRAIN, V118, P339, DOI 10.1093/brain/118.2.339
   Jin H, 1996, NAT GENET, V14, P177, DOI 10.1038/ng1096-177
   JUN AS, 1994, P NATL ACAD SCI USA, V91, P6206, DOI 10.1073/pnas.91.13.6206
   Karanikis P, 2005, INT J CARDIOL, V101, P147, DOI 10.1016/j.ijcard.2004.01.027
   Kirby DM, 2004, J MED GENET, V41, P784, DOI 10.1136/jmg.2004.020537
   Kleiner L, 1996, OPTOM CLIN, V5, P77
   LEIGH D, 1951, J NEUROL NEUROSUR PS, V14, P216, DOI 10.1136/jnnp.14.3.216
   Lightowlers RN, 1997, TRENDS GENET, V13, P450, DOI 10.1016/S0168-9525(97)01266-3
   Liolitsa D, 2003, ANN NEUROL, V53, P128, DOI 10.1002/ana.10435
   Lister R, 2005, MOL MEMBR BIOL, V22, P87, DOI 10.1080/09687860500041247
   Loeffen JLCM, 2000, HUM MUTAT, V15, P123, DOI 10.1002/(SICI)1098-1004(200002)15:2<123::AID-HUMU1>3.3.CO;2-G
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   Maassen JA, 2004, DIABETES, V53, PS103, DOI 10.2337/diabetes.53.2007.S103
   MACKEY DA, 1992, AUST NZ J OPHTHALMOL, V20, P177, DOI 10.1111/j.1442-9071.1992.tb00937.x
   Majamaa K, 1998, AM J HUM GENET, V63, P447, DOI 10.1086/301959
   Man PYW, 2003, AM J HUM GENET, V72, P333, DOI 10.1016/j.ajhg.2016.05.015
   MANDERBACKA K, 2001, SCANDINAVIAN J P S55, V29, P41
   Manwaring N, 2007, MITOCHONDRION, V7, P230, DOI 10.1016/j.mito.2006.12.004
   Margineantu DH, 2002, MITOCHONDRION, V1, P425, DOI 10.1016/S1567-7249(02)00006-5
   MARGULIS L, 1976, EXP PARASITOL, V39, P277, DOI 10.1016/0014-4894(76)90127-2
   MARTINUZZI A, 1992, J NEUROL SCI, V113, P222, DOI 10.1016/0022-510X(92)90250-O
   McFarland R, 2002, LANCET NEUROL, V1, P343, DOI 10.1016/S1474-4422(02)00159-X
   McFarland R, 2004, TRENDS GENET, V20, P591, DOI 10.1016/j.tig.2004.09.014
   McFarland R, 2004, NEUROMUSCULAR DISORD, V14, P162, DOI 10.1016/j.nmd.2003.10.011
   McFarland R, 2004, ANN NEUROL, V55, P58, DOI 10.1002/ana.10787
   McFarland R, 2002, NAT GENET, V30, P145, DOI 10.1038/ng819
   MITOMAP, 2008, HUM MIT GEN DAT, V0, P0
   Mootha VK, 2003, P NATL ACAD SCI USA, V100, P605, DOI 10.1073/pnas.242716699
   MORIKAWA Y, 1993, VIRCHOWS ARCH A, V423, P227, DOI 10.1007/BF01614775
   Morten KJ, 2007, MITOCHONDRION, V7, P386, DOI 10.1016/j.mito.2007.09.001
   MORTEN KJ, 1995, HUM MOL GENET, V4, P1689
   Nagashima T, 1999, ACTA NEUROPATHOL, V97, P416, DOI 10.1007/s004010051007
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   OLDFORS A, 1995, ACTA NEUROPATHOL, V90, P328
   Ostergaard E, 2007, AM J HUM GENET, V81, P383, DOI 10.1086/519222
   POULTON J, 1995, MUSCLE NERVE, V0, PS154
   PREZANT TR, 1993, NAT GENET, V4, P289, DOI 10.1038/ng0793-289
   Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311
   Rahman S, 2001, AM J HUM GENET, V68, P238, DOI 10.1086/316930
   REID FM, 1994, HUM MUTAT, V3, P243, DOI 10.1002/humu.1380030311
   Rigoli L, 2001, DIABETIC MED, V18, P334, DOI 10.1046/j.1464-5491.2001.00429-2.x
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   SANTORELLI FM, 1994, NEUROLOGY, V44, P972, DOI 10.1212/WNL.44.5.972
   SAUNIER P, 1995, NEUROMUSCULAR DISORD, V5, P285, DOI 10.1016/0960-8966(94)00071-G
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A
   Schwartz M, 2002, NEW ENGL J MED, V347, P576, DOI 10.1056/NEJMoa020350
   Skladal D, 2003, BRAIN, V126, P1905, DOI 10.1093/brain/awg170
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Spinazzola A, 2002, J BIOL CHEM, V277, P4128, DOI 10.1074/jbc.M111028200
   Sproule DM, 2007, ARCH NEUROL-CHICAGO, V64, P1625, DOI 10.1001/archneur.64.11.1625
   Sternberg D, 2001, BRAIN, V124, P984, DOI 10.1093/brain/124.5.984
   STONE EM, 1992, J CLIN NEURO-OPHTHAL, V12, P10
   Subbiah RN, 2007, PACE, V30, P137
   Sue CM, 1999, NEUROLOGY, V52, P1905, DOI 10.1212/WNL.52.9.1905
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Taylor RW, 2003, J AM COLL CARDIOL, V41, P1786, DOI 10.1016/S0735-1097(03)00300-0
   Taylor RW, 2004, NEUROMUSCULAR DISORD, V14, P237, DOI 10.1016/j.nmd.2003.12.004
   THYAGARAJAN D, 1995, ANN NEUROL, V38, P468, DOI 10.1002/ana.410380321
   TIRANTI V, 1995, HUM MOL GENET, V4, P1421, DOI 10.1093/hmg/4.8.1421
   Uusimaa J, 2000, PEDIATRICS, V105, P598, DOI 10.1542/peds.105.3.598
   van den Bosch BJC, 2000, NUCLEIC ACIDS RES, V28, P0, DOI 10.1093/nar/28.20.e89
   Van Goethem G, 2003, EUR J HUM GENET, V11, P547, DOI 10.1038/sj.ejhg.5201002
   VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368
   Vialettes BH, 1997, DIABETES CARE, V20, P1731, DOI 10.2337/diacare.20.11.1731
   Walker M, 2005, DIABETIC MED, V22, P18, DOI 10.1111/j.1464-5491.2005.1761f.x
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   WELZING L, 2008, EUR J PEDIAT 0924, V0, P0
   Whittaker RG, 2007, DIABETOLOGIA, V50, P2085, DOI 10.1007/s00125-007-0779-9
   Whittaker RG, 2007, DIABETES CARE, V30, P2238, DOI 10.2337/dc07-0466
   Wittig I, 2007, ELECTROPHORESIS, V28, P3811, DOI 10.1002/elps.200700367
   Wittig I, 2007, MOL CELL PROTEOMICS, V6, P1215, DOI 10.1074/mcp.M700076-MCP200
   Yavuz H, 2007, ARCH NEUROL-CHICAGO, V64, P435, DOI 10.1001/archneur.64.3.435
   ZEVIANI M, 1988, NEUROLOGY, V38, P1339
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
   Zhu ZQ, 1998, NAT GENET, V20, P337, DOI 10.1038/3804
   ZUPANC ML, 1991, ANN NEUROL, V29, P680, DOI 10.1002/ana.410290619
NR 121
TC 58
Z9 70
U1 0
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0954-6820
EI 1365-2796
J9 J INTERN MED
JI J. Intern. Med.
PD FEB 15
PY 2009
VL 265
IS 2
BP 210
EP 228
DI 10.1111/j.1365-2796.2008.02066.x
PG 19
WC Medicine, General & Internal
SC General & Internal Medicine
GA 393CK
UT WOS:000262348300005
PM 19192037
DA 2024-11-01
ER

PT J
AU Goffart, S
   Cooper, HM
   Tyynismaa, H
   Wanrooij, S
   Suomalainen, A
   Spelbrink, JN
AF Goffart, Steffi
   Cooper, Helen M.
   Tyynismaa, Henna
   Wanrooij, Sjoerd
   Suomalainen, Anu
   Spelbrink, Johannes N.
TI Twinkle mutations associated with autosomal dominant progressive external ophthalmoplegia lead to impaired helicase function and <i>in vivo</i> mtDNA replication stalling
SO HUMAN MOLECULAR GENETICS
LA English
DT Article
ID human mitochondrial-dna; cultured human-cells; multiple deletions; linker region; polg; protein; depletion; disease; prevalence; expression
AB Mutations in the mitochondrial helicase Twinkle underlie autosomal dominant progressive external ophthalmoplegia (PEO), as well as recessively inherited infantile-onset spinocerebellar ataxia and rare forms of mitochondrial DNA (mtDNA) depletion syndrome. Familial PEO is typically associated with the occurrence of multiple mtDNA deletions, but the mechanism by which Twinkle dysfunction induces deletion formation has been under debate. Here we looked at the effects of Twinkle adPEO mutations in human cell culture and studied the mtDNA replication in the Deletor mouse model, which expresses a dominant PEO mutation in Twinkle and accumulates multiple mtDNA deletions during life. We show that expression of dominant Twinkle mutations results in the accumulation of mtDNA replication intermediates in cell culture. This indicated severe replication pausing or stalling and caused mtDNA depletion. A strongly enhanced accumulation of replication intermediates was evident also in six-week-old Deletor mice compared with wild-type littermates, even though mtDNA deletions accumulate in a late-onset fashion in this model. In addition, our results in cell culture pointed to a problem of transcription that preceded the mtDNA depletion phenotype and might be of relevance in adPEO pathophysiology. Finally, in vitro assays showed functional defects in the various Twinkle mutants and broadly agreed with the cell culture phenotypes such as the level of mtDNA depletion and the level of accumulation of replication intermediates. On the basis of our results we suggest that mtDNA replication pausing or stalling is the common consequence of Twinkle PEO mutations that predisposes to multiple deletion formation.
C1 [Goffart, Steffi; Cooper, Helen M.; Wanrooij, Sjoerd; Spelbrink, Johannes N.] Inst Med Technol, Tampere 33014, Finland.
   [Goffart, Steffi; Cooper, Helen M.; Wanrooij, Sjoerd; Spelbrink, Johannes N.] Tampere Univ Hosp, Tampere 33014, Finland.
   [Tyynismaa, Henna; Suomalainen, Anu] Univ Helsinki, Res Program Mol Neurol, Biomedicum, Helsinki, Finland.
   [Tyynismaa, Henna; Suomalainen, Anu] Univ Helsinki, Cent Hosp, Dept Neurol, Helsinki, Finland.
C3 Tampere University; Tampere University Hospital; University of Helsinki; University of Helsinki; Helsinki University Central Hospital
RP Spelbrink, JN (corresponding author), Inst Med Technol, Biokatu 6, Tampere 33014, Finland.
EM hans.spelbrink@uta.fi
FU Academy of Finland [110689, 103213]; CoE; Sigrid Juselius Foundation; University of Helsinki; EU [LSHM-CT-2004-503116]; Tampere University [9G072, 9H079, 9H102]; Academy of Finland (AKA) [103213, 110689] Funding Source: Academy of Finland (AKA)
CR Agostino A, 2003, NEUROLOGY, V60, P1354, DOI 10.1212/01.WNL.0000056088.09408.3C
   BREWER BJ, 1987, CELL, V51, P463, DOI 10.1016/0092-8674(87)90642-8
   CHINNERY PF, 2007, NEUROMUSCULAR DISORD, V18, P259
   CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991
   Cooper HM, 2008, BIOCHEM J, V411, P279, DOI 10.1042/BJ20071624
   Donmez I, 2006, NUCLEIC ACIDS RES, V34, P4216, DOI 10.1093/nar/gkl508
   Farge G, 2008, NUCLEIC ACIDS RES, V36, P393, DOI 10.1093/nar/gkm1025
   Friedman KL, 1995, METHOD ENZYMOL, V262, P613
   Garrido N, 2003, MOL BIOL CELL, V14, P1583, DOI 10.1091/mbc.E02-07-0399
   Guo SY, 1999, J BIOL CHEM, V274, P30303, DOI 10.1074/jbc.274.42.30303
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   Hakonen AH, 2007, BRAIN, V130, P3032, DOI 10.1093/brain/awm242
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   Korhonen JA, 2003, J BIOL CHEM, V278, P48627, DOI 10.1074/jbc.M306981200
   Korhonen JA, 2008, J MOL BIOL, V377, P691, DOI 10.1016/j.jmb.2008.01.035
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   Leipe DD, 2000, GENOME RES, V10, P5
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   Majamaa K, 1998, AM J HUM GENET, V63, P447, DOI 10.1086/301959
   Matsushima Y, 2007, J BIOL CHEM, V282, P9436, DOI 10.1074/jbc.M610550200
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Pohjoismäki JLO, 2006, NUCLEIC ACIDS RES, V34, P5815, DOI 10.1093/nar/gkl703
   Sarzi E, 2007, ANN NEUROL, V62, P579, DOI 10.1002/ana.21207
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spelbrink JN, 2000, J BIOL CHEM, V275, P24818, DOI 10.1074/jbc.M000559200
   Suomalainen A, 1997, NEUROLOGY, V48, P1244, DOI 10.1212/WNL.48.5.1244
   SUOMALAINEN A, 1992, J CLIN INVEST, V90, P61, DOI 10.1172/JCI115856
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Tyynismaa H, 2004, HUM MOL GENET, V13, P3219, DOI 10.1093/hmg/ddh342
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2003, NEUROMUSCULAR DISORD, V13, P133, DOI 10.1016/S0960-8966(02)00216-X
   Virgilio R, 2008, J NEUROL, V255, P1384, DOI 10.1007/s00415-008-0926-3
   Wanrooij S, 2007, NUCLEIC ACIDS RES, V35, P3238, DOI 10.1093/nar/gkm215
   Winterthun S, 2005, NEUROLOGY, V64, P1204, DOI 10.1212/01.WNL.0000156516.77696.5A
   Yakubovskaya E, 2006, J BIOL CHEM, V281, P374, DOI 10.1074/jbc.M509730200
   Yakubovskaya E, 2007, EMBO J, V26, P4283, DOI 10.1038/sj.emboj.7601843
   Yasukawa T, 2005, MOL CELL, V18, P651, DOI 10.1016/j.molcel.2005.05.002
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
NR 40
TC 115
Z9 125
U1 0
U2 6
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0964-6906
EI 1460-2083
J9 HUM MOL GENET
JI Hum. Mol. Genet.
PD JAN 15
PY 2009
VL 18
IS 2
BP 328
EP 340
DI 10.1093/hmg/ddn359
PG 13
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA 386QK
UT WOS:000261897500011
PM 18971204
DA 2024-11-01
ER

PT J
AU Bortot, B
   Barbi, E
   Biffi, S
   Lunazzi, G
   Bussani, R
   Burlina, A
   Norbedo, S
   Ventura, A
   Carrozzi, M
   Severini, GM
AF Bortot, B.
   Barbi, E.
   Biffi, S.
   Lunazzi, G.
   Bussani, R.
   Burlina, A.
   Norbedo, S.
   Ventura, A.
   Carrozzi, M.
   Severini, G. M.
TI Two novel POLG mutations causing hepatic mitochondrial DNA depletion with recurrent hypoketotic hypoglycaemia and fatal liver dysfunction
SO DIGESTIVE AND LIVER DISEASE
LA English
DT Article
DE DNA polymerase gamma; Late onset; Liver failure; mtDNA depletion syndrome
ID polymerase-gamma; alpers-syndrome; oxidative-phosphorylation; spacer-region; disorders; disease; deficiency; childhood; diagnosis; myopathy
AB Background. Inherited mtDNA depletion syndromes (MDS) are a group of severe mitochondrial disorders resulting from defects in nucleus-encoded factors and often associated with severe or fatal liver failure. Patient. In this article, we describe the case of all 18-month-old patient with recurrent hypoketolic hypoglycaemia and fatal hepatic dysfunction with liver mtDNA depletion. Methods. The assessment of mtDNA copy number was performed on leucocytes, liver and muscle biopsy by Quantitative Real Time PCR and total RNA from liver biopsy was used as a template to amplify the cDNA of the POLG I gene. Results. Sequence analysis identified two previously undescribed mutations (1868T>G and 2263A>G) located in the gene coding the catalytic subunit of mitochondrial DNA polymerase gamma (POLG), predicting all L623W and K755E amino acid change, respectively. Both mutations were located in the highly conserved linker region of the protein and were absent in more than 200 healthy unrelated control Subjects. The identification of these two mutations allowed us to perform genetic counselling and prenatal diagnosis. Conclusion. Our data further expand the spectrum of POLG I gene mutations and the unique phenotype reported (late onset isolated liver disease without lactic acidosis) increase the variability of clinical presentations associated with mutations in this gene. (C) 2008 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.
C1 [Bortot, B.; Biffi, S.; Lunazzi, G.; Carrozzi, M.; Severini, G. M.] Inst Child Hlth IRCCS, Child Neurol & Psychiat Unit, Neuromuscular Disorders Lab, Trieste, Italy.
   [Barbi, E.; Norbedo, S.; Ventura, A.] Univ Trieste, Inst Child Hlth IRCCS, Dept Pediat, Trieste, Italy.
   [Severini, G. M.] Inst Child Hlth IRCCS, Med Genet Unit, Trieste, Italy.
   [Biffi, S.] CBM Scrl, Opt Imaging Lab, Trieste, Italy.
   [Bussani, R.] Osped Cattinara, Dept Pathol Anat, Trieste, Italy.
   [Burlina, A.] Univ Hosp, Dept Pediat, Div Metab Disorders, Padua, Italy.
C3 University of Trieste; University of Padua; Azienda Ospedaliera - Universita di Padova
RP Severini, GM (corresponding author), Inst Child Hlth IRCCS, Child Neurol & Psychiat Unit, Neuromuscular Disorders Lab, Via Istria, Trieste, Italy.
EM severini@burlo.trieste.it
CR Alberio S, 2007, MITOCHONDRION, V7, P6, DOI 10.1016/j.mito.2006.11.010
   Bai RK, 2004, CLIN CHEM, V50, P996, DOI 10.1373/clinchem.2004.031153
   Blake JC, 1999, AM J PATHOL, V155, P67, DOI 10.1016/S0002-9440(10)65100-0
   Calvo S, 2006, NAT GENET, V38, P576, DOI 10.1038/ng1776
   CHINNERY PF, 2007, NEUROMUSCULAR DISORD, V18, P259
   CormierDaire V, 1997, J PEDIATR-US, V130, P817, DOI 10.1016/S0022-3476(97)80027-3
   Davidzon G, 2005, ANN NEUROL, V57, P921, DOI 10.1002/ana.20498
   de Vries MC, 2007, EUR J PEDIATR, V166, P229, DOI 10.1007/s00431-006-0234-9
   Dubern B, 2001, TRANSPLANTATION, V71, P633, DOI 10.1097/00007890-200103150-00009
   Elpeleg O, 2003, PEDIATR RES, V54, P153, DOI 10.1203/01.PDR.0000072796.25097.A5
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   Freisinger P, 2006, ARCH NEUROL-CHICAGO, V63, P1129, DOI 10.1001/archneur.63.8.1129
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Hudson G, 2006, HUM MOL GENET, V15, PR244, DOI 10.1093/hmg/ddl233
   Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455
   Lee WS, 2007, SEMIN LIVER DIS, V27, P259, DOI 10.1055/s-2007-985071
   Longley MJ, 2005, GENE, V354, P125, DOI 10.1016/j.gene.2005.03.029
   Luo NG, 2005, J BIOL CHEM, V280, P2491, DOI 10.1074/jbc.M411447200
   Luoma PT, 2005, HUM MOL GENET, V14, P1907, DOI 10.1093/hmg/ddi196
   MANDERBACKA K, 2001, SCANDINAVIAN J P S55, V29, P41
   Morten KJ, 2007, MITOCHONDRION, V7, P386, DOI 10.1016/j.mito.2007.09.001
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Nguyen KV, 2006, J HEPATOL, V45, P108, DOI 10.1016/j.jhep.2005.12.026
   Nguyen KV, 2005, NEUROLOGY, V65, P1493, DOI 10.1212/01.wnl.0000182814.55361.70
   *NIEHS, 2008, HUM DNA POL GAMM MUT, V0, P0
   Rabinowitz SS, 2004, J PEDIATR GASTR NUTR, V38, P216, DOI 10.1097/00005176-200402000-00022
   Remes AM, 2005, NEUROLOGY, V64, P976, DOI 10.1212/01.WNL.0000154518.31302.ED
   RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Sambrook J, 1989, MOLECULAR CLONING, V0, P0
   Sarzi E, 2007, J PEDIATR-US, V150, P531, DOI 10.1016/j.jpeds.2007.01.044
   Van Goethem G, 2003, NEUROLOGY, V61, P1811, DOI 10.1212/01.WNL.0000098997.23471.65
NR 32
TC 6
Z9 6
U1 0
U2 4
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1590-8658
EI 1878-3562
J9 DIGEST LIVER DIS
JI Dig. Liver Dis.
PD JUL 15
PY 2009
VL 41
IS 7
BP 494
EP 499
DI 10.1016/j.dld.2008.11.013
PG 6
WC Gastroenterology & Hepatology
SC Gastroenterology & Hepatology
GA 467YU
UT WOS:000267780600008
PM 19195941
DA 2024-11-01
ER

PT J
AU Valente, L
   Piga, D
   Lamantea, E
   Carrara, F
   Uziel, G
   Cudia, P
   Zani, A
   Farina, L
   Morandi, L
   Mora, M
   Spinazzola, A
   Zeviani, M
   Tiranti, V
AF Valente, Lucia
   Piga, Daniela
   Lamantea, Eleonora
   Carrara, Franco
   Uziel, Graziella
   Cudia, Paola
   Zani, Anna
   Farina, Laura
   Morandi, Lucia
   Mora, Marina
   Spinazzola, Antonella
   Zeviani, Massimo
   Tiranti, Valeria
TI Identification of novel mutations in five patients with mitochondrial encephalomyopathy
SO BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS
LA English
DT Article; Proceedings Paper
DE Mitochondrial DNA; Respiratory chain complex deficiency; mtDNA Sequence analysis; mtDNA mutation
ID cytochrome-c-oxidase; complex-i deficiency; mtdna point mutation; nonsense mutation; sporadic patient; skeletal-muscle; trna(trp) gene; dna mutation; subunit-i; exercise intolerance
AB MELAS, MERRF, LHON and NARP, are well-established mitochondrial syndromes associated with specific point mutations of mitochondrial DNA (mtDNA). However, these recurrent mtDNA mutations account for only a minority of mitochondrial disease cases. To evaluate the impact of novel mtDNA mutations, we performed mtDNA sequence analysis in muscle and other tissues of 240 patients with different mitochondrial neuromuscular syndromes. We identified a total of 33 subjects with novel, private or uncommon mutations. Among these, five novel mutations were found in both paediatric and adult cases. We here report on the clinical description of these patients, as well as the biochemical and molecular genetic characterization of the corresponding mutations. Patients 1 and 2 showed changes in ND genes, patient 3 carried a heteroplasmic deletion in the COI gene, patients 4 and 5 carried heteroplasmic mutations in tRNA(Trp) and tRNA(Phe), respectively. Altogether, these data indicate that mtDNA analysis must become part of the routine screening for mitochondrial disorders. (C) 2008 Elsevier B.V. All rights reserved.
C1 [Valente, Lucia; Piga, Daniela; Lamantea, Eleonora; Carrara, Franco; Zani, Anna; Spinazzola, Antonella; Zeviani, Massimo; Tiranti, Valeria] IRCCS, Fdn Neurol Inst C Besta, Unit Mol Neurogenet, Pierfranco & Luisa Mariani Ctr Study Mitochondria, I-20126 Milan, Italy.
   [Uziel, Graziella] IRCCS, Fdn Neurol Inst C Besta, Unit Child Neurol, I-20126 Milan, Italy.
   [Cudia, Paola; Morandi, Lucia; Mora, Marina] IRCCS, Fdn Neurol Inst C Besta, Unit Neuromuscular Dis, I-20126 Milan, Italy.
   [Farina, Laura] IRCCS, Fdn Neurol Inst C Besta, Unit Neuroradiol, I-20126 Milan, Italy.
RP Tiranti, V (corresponding author), IRCCS, Fdn Neurol Inst C Besta, Unit Mol Neurogenet, Pierfranco & Luisa Mariani Ctr Study Mitochondria, Via Temolo 4, I-20126 Milan, Italy.
EM tiranti@istituto-besta.it
FU Telethon [GGP07019] Funding Source: Medline
CR Andreu AL, 1999, NEW ENGL J MED, V341, P1037, DOI 10.1056/NEJM199909303411404
   Anitori R, 2005, MOL GENET METAB, V84, P176, DOI 10.1016/j.ymgme.2004.10.003
   Antonicka H, 2003, J BIOL CHEM, V278, P43081, DOI 10.1074/jbc.M304998200
   Bourges I, 2004, BIOCHEM J, V383, P491, DOI 10.1042/BJ20040256
   Bruno C, 1999, AM J HUM GENET, V65, P611, DOI 10.1086/302546
   Bugiani M, 2004, BBA-BIOENERGETICS, V1659, P136, DOI 10.1016/j.bbabio.2004.09.006
   Chinnery PF, 1997, ANN NEUROL, V41, P408, DOI 10.1002/ana.410410319
   Chomyn A, 2001, J BIOENERG BIOMEMBR, V33, P251, DOI 10.1023/A:1010791204961
   Clark KM, 1997, NAT GENET, V16, P222, DOI 10.1038/ng0797-222
   Comi GP, 1998, ANN NEUROL, V43, P110, DOI 10.1002/ana.410430119
   Corona P, 2002, ANN NEUROL, V51, P118, DOI 10.1002/ana.10059
   Corona P, 2001, ANN NEUROL, V49, P106, DOI 10.1002/1531-8249(200101)49:1<106::AID-ANA16>3.0.CO;2-T
   Darin N, 2006, NEUROMUSCULAR DISORD, V16, P504, DOI 10.1016/j.nmd.2006.05.010
   Deschauer M, 2006, ARCH NEUROL-CHICAGO, V63, P902, DOI 10.1001/archneur.63.6.902
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   Fetoni V, 2004, NEUROMUSCULAR DISORD, V14, P723, DOI 10.1016/j.nmd.2004.07.002
   Fu K, 1996, HUM MOL GENET, V5, P1835, DOI 10.1093/hmg/5.11.1835
   Gattermann N, 1997, BLOOD, V90, P4961, DOI 10.1182/blood.V90.12.4961.4961_4961_4972
   Hanna MG, 1998, AM J HUM GENET, V63, P29, DOI 10.1086/301910
   Hanna MG, 1998, J NEUROL NEUROSUR PS, V65, P512, DOI 10.1136/jnnp.65.4.512
   Karadimas CL, 2000, NEUROLOGY, V55, P644, DOI 10.1212/WNL.55.5.644
   KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477
   Kirby DM, 2004, J MED GENET, V41, P784, DOI 10.1136/jmg.2004.020537
   Kleinle S, 1998, BIOCHEM BIOPH RES CO, V247, P112, DOI 10.1006/bbrc.1998.8729
   Kollberg G, 2005, J NEUROPATH EXP NEUR, V64, P123, DOI 10.1093/jnen/64.2.123
   Lamantea E, 2002, NEUROMUSCULAR DISORD, V12, P49, DOI 10.1016/S0960-8966(01)00244-9
   Limongelli A, 2004, J MED GENET, V41, P342, DOI 10.1136/jmg.2003.016048
   Lucioli S, 2006, NEUROGENETICS, V7, P51, DOI 10.1007/s10048-005-0015-z
   Malfatti E, 2007, BRAIN, V130, P1894, DOI 10.1093/brain/awm114
   Mancuso M, 2004, NEUROLOGY, V62, P2119, DOI 10.1212/01.WNL.0000127608.48406.F1
   Maniura-Weber K, 2004, EUR J HUM GENET, V12, P509, DOI 10.1038/sj.ejhg.5201185
   MARIOTTI C, 1994, J CLIN INVEST, V93, P1102, DOI 10.1172/JCI117061
   McFarland R, 2004, ANN NEUROL, V55, P58, DOI 10.1002/ana.10787
   Moslemi AR, 2004, NEUROMUSCULAR DISORD, V14, P46, DOI 10.1016/S0960-8966(03)00168-8
   Munaro M, 1997, HUM MOL GENET, V6, P221, DOI 10.1093/hmg/6.2.221
   Murray J, 2003, J BIOL CHEM, V278, P13619, DOI 10.1074/jbc.C300064200
   NELSON I, 1995, ANN NEUROL, V37, P400, DOI 10.1002/ana.410370317
   Nijtmans LGJ, 2002, METHODS, V26, P327, DOI 10.1016/S1046-2023(02)00038-5
   Santorelli FM, 1997, ANN NEUROL, V42, P256, DOI 10.1002/ana.410420220
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   SCIACCO M, 1994, HUM MOL GENET, V3, P13, DOI 10.1093/hmg/3.1.13
   Silvestri G, 1998, NEUROMUSCULAR DISORD, V8, P291, DOI 10.1016/S0960-8966(98)00037-6
   Silvestri G, 2000, NEUROLOGY, V54, P1693, DOI 10.1212/WNL.54.8.1693
   Spinazzola A, 2004, NEUROMUSCULAR DISORD, V14, P815, DOI 10.1016/j.nmd.2004.09.002
   Taivassalo T, 1999, HUM MOL GENET, V8, P1047, DOI 10.1093/hmg/8.6.1047
   Tiranti V, 2000, HUM MOL GENET, V9, P2733, DOI 10.1093/hmg/9.18.2733
   TIRANTI V, 1995, HUM MOL GENET, V4, P2017, DOI 10.1093/hmg/4.11.2017
   Tzen CY, 2001, KIDNEY INT, V59, P846, DOI 10.1046/j.1523-1755.2001.00567.x
   Ugalde C, 2007, MOL GENET METAB, V90, P10, DOI 10.1016/j.ymgme.2006.08.003
   Uziel G, 2000, NEUROMUSCULAR DISORD, V10, P415, DOI 10.1016/S0960-8966(99)00115-7
   Varlamov DA, 2002, HUM MOL GENET, V11, P1797, DOI 10.1093/hmg/11.16.1797
   Weber K, 1997, AM J HUM GENET, V60, P373
   Zerbetto E, 1997, ELECTROPHORESIS, V18, P2059, DOI 10.1002/elps.1150181131
   Zifa E, 2007, RNA BIOL, V4, P38, DOI 10.4161/rna.4.1.4548
NR 54
TC 75
Z9 83
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0005-2728
EI 0006-3002
J9 BBA-BIOENERGETICS
JI Biochim. Biophys. Acta-Bioenerg.
PD MAY 15
PY 2009
VL 1787
IS 5
BP 491
EP 501
DI 10.1016/j.bbabio.2008.10.001
PG 11
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 451MX
UT WOS:000266475400025
PM 18977334
DA 2024-11-01
ER

PT J
AU Yu-Wai-Man, P
   Davies, VJ
   Piechota, MJ
   Cree, LM
   Votruba, M
   Chinnery, PF
AF Yu-Wai-Man, Patrick
   Davies, Vanessa J.
   Piechota, Malgorzata J.
   Cree, Lynsey M.
   Votruba, Marcela
   Chinnery, Patrick F.
TI Secondary mtDNA Defects Do Not Cause Optic Nerve Dysfunction in a Mouse Model of Dominant Optic Atrophy
SO INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
LA English
DT Article
ID mitochondrial-dna deletions; substantia-nigra neurons; opa1 mutations; external ophthalmoplegia; deficiency; morphology; phenotype; molecules; disease; cells
AB PURPOSE. The majority of patients with autosomal dominant optic atrophy (DOA) harbor pathogenic OPA1 mutations and certain missense mutations, mostly within the GTPase domain, have recently been shown to cause multiple mitochondrial DNA (mtDNA) deletions in skeletal muscle. This raises the possibility that the optic neuropathy could be the result of secondary mtDNA defects accumulating within retinal ganglion cells (RGCs). To explore this hypothesis, the authors looked for evidence of mitochondrial dysfunction in a mouse model of DOA and documented the visual and neurologic progression in aging mutant mice. METHODS. Visual function was assessed with a rotating optokinetic (OKN) drum at ages 13 and 18 months and neurologic phenotyping was performed using the primary SHIRPA screen at age 13 months, comparing mutant Opa1(+/-) mice with wild-type C57B1/6 mice. The presence of cytochrome c oxidase (COX) deficiency and multiple mtDNA deletions was investigated in gastrocnemius muscle and eye specimens harvested from 2- and 11-month-old Opa1(+/+) and Opa1(+/-) mice. RESULTS. At age 13 months, Opa1(+/-) mice had a statistically significant reduction in OKN responses compared to C57B1/6 controls with both 2 degrees and 8 degrees gratings (P < 0.001). At age 18 months, the difference between the two groups was significant for the 8 degrees grating (P = 0.003) but not for the 2 degrees grating (P = 0.082). Opa1(+/-) mice did not exhibit any significant neuromuscular deficits and no COX deficient areas or secondary mtDNA deletions were identified in skeletal muscle or the RGC layer. There was also no evidence of significant mtDNA depletion or proliferation in skeletal muscle from Opa1(+/-) mice. CONCLUSIONS. COX deficiency and mtDNA abnormalities do not contribute to optic nerve dysfunction in pure DOA. (Invest Ophthalmol Vis Sci. 2009; 50: 4561-4566) DOI:10.1167/iovs.093634
C1 [Yu-Wai-Man, Patrick; Cree, Lynsey M.; Chinnery, Patrick F.] Univ Newcastle, Sch Med, Inst Ageing & Hlth, Mitochondrial Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Yu-Wai-Man, Patrick] Royal Victoria Infirm, Dept Ophthalmol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England.
   [Davies, Vanessa J.] Cardiff Univ, Cardiff Neurosci Ctr, Cardiff, S Glam, Wales.
   [Davies, Vanessa J.; Piechota, Malgorzata J.; Votruba, Marcela] Cardiff Univ, Sch Optometry & Vis Sci, Cardiff, S Glam, Wales.
   [Votruba, Marcela] Univ Wales Hosp, Cardiff Eye Unit, Cardiff CF4 4XW, S Glam, Wales.
C3 Newcastle University - UK; Newcastle University - UK; Cardiff University; Cardiff University; Cardiff University
RP Yu-Wai-Man, P (corresponding author), Univ Newcastle, Sch Med, Inst Ageing & Hlth, Mitochondrial Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM patrick.yu-wai-man@ncl.ac.uk
FU Medical Research Council, UK; MRC [G0700949, G0701386] Funding Source: UKRI
CR Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Carpenter S, 2001, PATHOLOGY SKELETAL M, V0, P8
   COHN AC, 2008, BR J OPHTHALMOL, V24, P24
   Cree LM, 2008, DIABETOLOGIA, V51, P1440, DOI 10.1007/s00125-008-1054-4
   Cree LM, 2008, NAT GENET, V40, P249, DOI 10.1038/ng.2007.63
   Davies V, 2006, EXP EYE RES, V83, P1003, DOI 10.1016/j.exer.2005.11.021
   Davies VJ, 2007, HUM MOL GENET, V16, P1307, DOI 10.1093/hmg/ddm079
   Ferraris S, 2008, ARCH NEUROL-CHICAGO, V65, P125, DOI 10.1001/archneurol.2007.9
   Ferré M, 2005, HUM MUTAT, V25, P423, DOI 10.1002/humu.20161
   Hart AW, 2005, INVEST OPHTH VIS SCI, V46, P3443, DOI 10.1167/iovs.05-0254
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   JOHNSON MA, 1996, HDB MUSCLE DIS, V0, P61
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   Lightowlers RH, 1999, TRENDS GENET, V15, P91, DOI 10.1016/S0168-9525(98)01684-9
   Lodi R, 2004, ANN NEUROL, V56, P719, DOI 10.1002/ana.20278
   Newman NJ, 2004, EYE, V18, P1144, DOI 10.1038/sj.eye.6701591
   Puomila A, 2005, ACTA OPHTHALMOL SCAN, V83, P337, DOI 10.1111/j.1600-0420.2005.00448.x
   Rogers DC, 1997, MAMM GENOME, V8, P711, DOI 10.1007/s003359900551
   Spinazzi M, 2008, HUM MOL GENET, V17, P3291, DOI 10.1093/hmg/ddn225
   Stewart JD, 2008, NEUROLOGY, V71, P1829, DOI 10.1212/01.wnl.0000335931.54095.0a
   Taylor RW, 2004, NEUROMUSCULAR DISORD, V14, P237, DOI 10.1016/j.nmd.2003.12.004
   Thaung C, 2002, NEUROSCI LETT, V325, P21, DOI 10.1016/S0304-3940(02)00223-9
   Votruba M, 1998, J MED GENET, V35, P793, DOI 10.1136/jmg.35.10.793
   White KE, 2009, INVEST OPHTH VIS SCI, V50, P2567, DOI 10.1167/iovs.08-2913
   Yu-Wai-Man P, 2009, J MED GENET, V46, P145, DOI 10.1136/jmg.2007.054270
   Zanna C, 2008, BRAIN, V131, P352, DOI 10.1093/brain/awm335
   Zeviani M, 2008, BRAIN, V131, P314, DOI 10.1093/brain/awm339
NR 30
TC 19
Z9 20
U1 0
U2 5
PU ASSOC RESEARCH VISION OPHTHALMOLOGY INC
PI ROCKVILLE
PA 12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA
SN 0146-0404
EI 
J9 INVEST OPHTH VIS SCI
JI Invest. Ophthalmol. Vis. Sci.
PD OCT 15
PY 2009
VL 50
IS 10
BP 4561
EP 4566
DI 10.1167/iovs.09-3634
PG 6
WC Ophthalmology
SC Ophthalmology
GA 497XE
UT WOS:000270097200007
PM 19443720
DA 2024-11-01
ER

PT J
AU Banerjee, R
   Starkov, AA
   Beal, MF
   Thomas, B
AF Banerjee, Rebecca
   Starkov, Anatoly A.
   Beal, M. Flint
   Thomas, Bobby
TI Mitochondrial dysfunction in the limelight of Parkinson's disease pathogenesis
SO BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
LA English
DT Review
DE Mitochondrial dysfunction; Mitochondrial DNA; Electron transport chain; Permeability transition pore; alpha-synuclein; Parkin; PINK1; DJ-1; LRRK2
ID permeability transition pore; complex-i deficiency; early-onset parkinsonism; progressive external ophthalmoplegia; adenine-nucleotide translocase; environmental risk-factors; respiratory-chain activity; synuclein transgenic mice; electron-transport chain; substantia-nigra neurons
AB Parkinson's disease (PD) is a progressive neurodegenerative movement disorder with unknown etiology. It is marked by widespread neurodegeneration in the brain with profound loss of A9 midbrain dopaminergic neurons in substantia nigra pars compacta. Several theories of biochemical abnormalities have been linked to pathogenesis of PD of which mitochondrial dysfunction due to an impairment of mitochondrial complex I and subsequent oxidative stress seems to take the center stage in experimental models of PD and in postmortem tissues of sporadic forms of illness. Recent identification of specific gene mutations and their influence on mitochondrial functions has further reinforced the relevance of mitochondrial abnormalities in disease pathogenesis. In both sporadic and familial forms of PD abnormal mitochondrial paradigms associated with disease include impaired functioning of the mitochondrial electron transport chain, aging associated damage to mitochondrial DNA, impaired calcium buffering, and anomalies in mitochondrial morphology and dynamics. Here we provide an overview of specific mitochondrial functions affected in sporadic and familial PD that play a role in disease pathogenesis. We propose to utilize these gained insights to further streamline and focus the research to better understand mitochondria's role in disease development and exploit potential mitochondrial targets for therapeutic interventions in PD pathogenesis. Published by Elsevier B.V.
C1 [Banerjee, Rebecca; Starkov, Anatoly A.; Beal, M. Flint; Thomas, Bobby] Cornell Univ, Weill Med Coll, Dept Neurol & Neurosci, New York, NY 10065 USA.
C3 Cornell University; Weill Cornell Medicine
RP Thomas, B (corresponding author), Cornell Univ, Weill Med Coll, Dept Neurol & Neurosci, 525 E 68th St,A-501, New York, NY 10065 USA.
EM bot2003@med.cornell.edu
FU National Institutes of Health [NS060885, AG01493]; Parkinson's disease Foundation, Department of Defense; Michael J Fox Foundation
CR Abou-Sleiman PM, 2006, NAT REV NEUROSCI, V7, P207, DOI 10.1038/nrn1868
   Alam M, 2002, BEHAV BRAIN RES, V136, P317, DOI 10.1016/S0166-4328(02)00180-8
   Alvarez V, 2008, NEUROSCI LETT, V432, P79, DOI 10.1016/j.neulet.2007.12.010
   Anderson MF, 2002, J NEUROCHEM, V81, P541, DOI 10.1046/j.1471-4159.2002.00836.x
   Andres-Mateos E, 2007, P NATL ACAD SCI USA, V104, P14807, DOI 10.1073/pnas.0703219104
   Andreyev AI, 2005, BIOCHEMISTRY-MOSCOW+, V70, P200, DOI 10.1007/s10541-005-0102-7
   Aomi Y, 2001, BIOCHEM BIOPH RES CO, V280, P265, DOI 10.1006/bbrc.2000.4113
   Autere J, 2004, HUM GENET, V115, P29, DOI 10.1007/s00439-004-1123-9
   Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434
   Basso E, 2005, J BIOL CHEM, V280, P18558, DOI 10.1074/jbc.C500089200
   Beal MF, 2005, ANN NEUROL, V58, P495, DOI 10.1002/ana.20624
   Belin AC, 2007, NEUROSCI LETT, V420, P257, DOI 10.1016/j.neulet.2007.05.010
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   BENECKE R, 1993, BRAIN, V116, P1451, DOI 10.1093/brain/116.6.1451
   Bernardi P, 2006, FEBS J, V273, P2077, DOI 10.1111/j.1742-4658.2006.05213.x
   Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834
   BINDOFF LA, 1991, J NEUROL SCI, V104, P203, DOI 10.1016/0022-510X(91)90311-T
   Biskup S, 2006, ANN NEUROL, V60, P557, DOI 10.1002/ana.21019
   Blake CI, 1997, MOVEMENT DISORD, V12, P3, DOI 10.1002/mds.870120103
   BLIN O, 1994, J NEUROL SCI, V125, P95, DOI 10.1016/0022-510X(94)90248-8
   Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209
   Bonneh-Barkay D, 2005, MOL BRAIN RES, V134, P52, DOI 10.1016/j.molbrainres.2004.11.005
   BRAVI D, 1992, MOVEMENT DISORD, V7, P228, DOI 10.1002/mds.870070307
   Brown TP, 2006, ENVIRON HEALTH PERSP, V114, P156, DOI 10.1289/ehp.8095
   BUCKMAN TD, 1988, BIOCHEM BIOPH RES CO, V151, P897, DOI 10.1016/S0006-291X(88)80366-8
   BURKHARDT C, 1993, ANN NEUROL, V33, P512, DOI 10.1002/ana.410330516
   BURNS RS, 1983, P NATL ACAD SCI-BIOL, V80, P4546, DOI 10.1073/pnas.80.14.4546
   Canet-Avilés RM, 2004, P NATL ACAD SCI USA, V101, P9103, DOI 10.1073/pnas.0402959101
   CARDELLACH F, 1993, NEUROLOGY, V43, P2258, DOI 10.1212/WNL.43.11.2258
   Casarejos MJ, 2006, J NEUROCHEM, V97, P934, DOI 10.1111/j.1471-4159.2006.03777.x
   Cassarino DS, 1999, BBA-MOL BASIS DIS, V1453, P49, DOI 10.1016/S0925-4439(98)00083-0
   Castello PR, 2007, J BIOL CHEM, V282, P14186, DOI 10.1074/jbc.M700827200
   Cha GH, 2005, P NATL ACAD SCI USA, V102, P10345, DOI 10.1073/pnas.0500346102
   Chalmers S, 2003, J BIOL CHEM, V278, P19062, DOI 10.1074/jbc.M212661200
   CHIBA K, 1984, BIOCHEM BIOPH RES CO, V120, P574, DOI 10.1016/0006-291X(84)91293-2
   Choi WS, 2008, P NATL ACAD SCI USA, V105, P15136, DOI 10.1073/pnas.0807581105
   Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779
   Cleren C, 2005, NEUROBIOL DIS, V20, P701, DOI 10.1016/j.nbd.2005.05.022
   Cole NB, 2008, EXP CELL RES, V314, P2076, DOI 10.1016/j.yexcr.2008.03.012
   Darios F, 2003, HUM MOL GENET, V12, P517, DOI 10.1093/hmg/ddg044
   Davidzon G, 2006, ANN NEUROL, V59, P859, DOI 10.1002/ana.20831
   Dawson TM, 2006, J NEURAL TRANSM-SUPP, V0, P209
   Deng HS, 2008, P NATL ACAD SCI USA, V105, P14503, DOI 10.1073/pnas.0803998105
   Devi L, 2008, J BIOL CHEM, V283, P9089, DOI 10.1074/jbc.M710012200
   Di Lisa F, 2001, J BIOL CHEM, V276, P2571, DOI 10.1074/jbc.M006825200
   DIDONATO S, 1993, NEUROLOGY, V43, P2262, DOI 10.1212/WNL.43.11.2262
   Dodson MW, 2007, CURR OPIN NEUROBIOL, V17, P331, DOI 10.1016/j.conb.2007.04.010
   Ekstrand MI, 2007, P NATL ACAD SCI USA, V104, P1325, DOI 10.1073/pnas.0605208103
   Elbaz A, 2007, J NEUROL SCI, V262, P37, DOI 10.1016/j.jns.2007.06.024
   Exner N, 2007, J NEUROSCI, V27, P12413, DOI 10.1523/JNEUROSCI.0719-07.2007
   Fallon L, 2006, NAT CELL BIOL, V8, P834, DOI 10.1038/ncb1441
   Farrer M, 2001, ANN NEUROL, V50, P293, DOI 10.1002/ana.1132
   Fei QY, 2008, J NEUROCHEM, V105, P2091, DOI 10.1111/j.1471-4159.2008.05293.x
   Fei Q, 2008, J BIOL CHEM, V283, P3357, DOI 10.1074/jbc.M708451200
   FERRAZ HB, 1988, NEUROLOGY, V38, P550, DOI 10.1212/WNL.38.4.550
   Filosto M, 2003, ARCH NEUROL-CHICAGO, V60, P1279, DOI 10.1001/archneur.60.9.1279
   Fitsanakis VA, 2002, FREE RADICAL BIO MED, V33, P1714, DOI 10.1016/S0891-5849(02)01169-3
   Fontaine E, 1999, J BIOENERG BIOMEMBR, V31, P335, DOI 10.1023/A:1005475802350
   Fornai F, 2005, P NATL ACAD SCI USA, V102, P3413, DOI 10.1073/pnas.0409713102
   Forno LS, 1996, J NEUROPATH EXP NEUR, V55, P259, DOI 10.1097/00005072-199603000-00001
   Frankhauser P, 2006, NEUROSCI LETT, V399, P197, DOI 10.1016/j.neulet.2006.01.062
   Frantseva MV, 2001, FREE RADICAL BIO MED, V31, P1216, DOI 10.1016/S0891-5849(01)00705-5
   FREI B, 1986, FEBS LETT, V198, P99, DOI 10.1016/0014-5793(86)81192-9
   Friberg H, 2002, BIOCHIMIE, V84, P241, DOI 10.1016/S0300-9084(02)01381-0
   Fung HC, 2006, LANCET NEUROL, V5, P911, DOI 10.1016/S1474-4422(06)70578-6
   Gainetdinov RR, 1997, J NEUROCHEM, V69, P1322
   Gandhi S, 2006, BRAIN, V129, P1720, DOI 10.1093/brain/awl114
   Gautier CA, 2008, P NATL ACAD SCI USA, V105, P11364, DOI 10.1073/pnas.0802076105
   Gloeckner CJ, 2006, HUM MOL GENET, V15, P223, DOI 10.1093/hmg/ddi439
   Gomez-Lazaro M, 2008, FREE RADICAL BIO MED, V44, P1960, DOI 10.1016/j.freeradbiomed.2008.03.009
   Gu M, 1998, ANN NEUROL, V44, P177, DOI 10.1002/ana.410440207
   HAAS RH, 1995, ANN NEUROL, V37, P714, DOI 10.1002/ana.410370604
   Halestrap AP, 2003, CURR MED CHEM, V10, P1507, DOI 10.2174/0929867033457278
   Hanagasi HA, 2005, INT J NEUROSCI, V115, P479, DOI 10.1080/00207450590523017
   Haque ME, 2008, P NATL ACAD SCI USA, V105, P1716, DOI 10.1073/pnas.0705363105
   Hasegawa T, 2008, J NEUROCHEM, V105, P1700, DOI 10.1111/j.1471-4159.2008.05277.x
   Hatano Y, 2004, NEUROLOGY, V63, P1482, DOI 10.1212/01.WNL.0000142258.29304.FE
   Hatcher JM, 2008, TRENDS PHARMACOL SCI, V29, P322, DOI 10.1016/j.tips.2008.03.007
   Hattori N, 1998, GENOMICS, V49, P52, DOI 10.1006/geno.1997.5192
   HAWORTH RA, 1979, ARCH BIOCHEM BIOPHYS, V195, P460, DOI 10.1016/0003-9861(79)90372-2
   HEIKKILA RE, 1985, NEUROSCI LETT, V58, P133, DOI 10.1016/0304-3940(85)90342-8
   HEIKKILA RE, 1984, NATURE, V311, P467, DOI 10.1038/311467a0
   HERTZMAN C, 1990, AM J IND MED, V17, P349, DOI 10.1002/ajim.4700170307
   Hoepken HH, 2007, NEUROBIOL DIS, V25, P401, DOI 10.1016/j.nbd.2006.10.007
   Hudson G, 2007, ARCH NEUROL-CHICAGO, V64, P553, DOI 10.1001/archneur.64.4.553
   Hüser J, 1998, BIOPHYS J, V74, P2129, DOI 10.1016/S0006-3495(98)77920-2
   JANETZKY B, 1994, NEUROSCI LETT, V169, P126, DOI 10.1016/0304-3940(94)90372-7
   JAVITCH JA, 1985, P NATL ACAD SCI USA, V82, P2173, DOI 10.1073/pnas.82.7.2173
   Junn E, 2009, J NEUROSCI RES, V87, P123, DOI 10.1002/jnr.21831
   Keeney PM, 2006, J NEUROSCI, V26, P5256, DOI 10.1523/JNEUROSCI.0984-06.2006
   Kim RH, 2005, P NATL ACAD SCI USA, V102, P5215, DOI 10.1073/pnas.0501282102
   Kinumi T, 2004, BIOCHEM BIOPH RES CO, V317, P722, DOI 10.1016/j.bbrc.2004.03.110
   Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416
   Kitada T, 2007, P NATL ACAD SCI USA, V104, P11441, DOI 10.1073/pnas.0702717104
   Klivenyi P, 2006, NEUROBIOL DIS, V21, P541, DOI 10.1016/j.nbd.2005.08.018
   Kokoszka JE, 2004, NATURE, V427, P461, DOI 10.1038/nature02229
   KOPIN IJ, 1988, ANNU REV NEUROSCI, V11, P81, DOI 10.1146/annurev.ne.11.030188.000501
   Kowaltowski AJ, 1998, ARCH BIOCHEM BIOPHYS, V359, P77, DOI 10.1006/abbi.1998.0870
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   KRIGE D, 1992, ANN NEUROL, V32, P782, DOI 10.1002/ana.410320612
   Kristal BS, 2001, FREE RADICAL BIO MED, V30, P924, DOI 10.1016/S0891-5849(01)00484-1
   Krüger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106
   Kujoth GC, 2007, PLOS GENET, V3, P161, DOI 10.1371/journal.pgen.0030024
   Kuroda Y, 2006, HUM MOL GENET, V15, P883, DOI 10.1093/hmg/ddl006
   Lang AE, 1998, NEW ENGL J MED, V339, P1130, DOI 10.1056/NEJM199810153391607
   Lang AE, 1998, NEW ENGL J MED, V339, P1044, DOI 10.1056/NEJM199810083391506
   LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561
   Lavara-Culebras E, 2007, GENE, V400, P158, DOI 10.1016/j.gene.2007.06.013
   Lee HJ, 2002, J BIOL CHEM, V277, P5411, DOI 10.1074/jbc.M105326200
   Lemasters JJ, 1998, BBA-BIOENERGETICS, V1366, P177, DOI 10.1016/S0005-2728(98)00112-1
   Leung AWC, 2008, BBA-BIOENERGETICS, V1777, P946, DOI 10.1016/j.bbabio.2008.03.009
   Lev N, 2008, NEUROTOXICOLOGY, V29, P397, DOI 10.1016/j.neuro.2008.01.007
   Liou HH, 1997, NEUROLOGY, V48, P1583, DOI 10.1212/WNL.48.6.1583
   Lücking CB, 2000, NEW ENGL J MED, V342, P1560, DOI 10.1056/NEJM200005253422103
   Luoma PT, 2007, NEUROLOGY, V69, P1152, DOI 10.1212/01.wnl.0000276955.23735.eb
   Ma X, 2007, ONCOGENE, V26, P4842, DOI 10.1038/sj.onc.1210287
   Mancuso M, 2004, NEUROLOGY, V62, P316, DOI 10.1212/WNL.62.2.316
   MANN VM, 1992, BRAIN, V115, P333, DOI 10.1093/brain/115.2.333
   Manning-Bog AB, 2002, J BIOL CHEM, V277, P1641, DOI 10.1074/jbc.C100560200
   Marella M, 2008, PLOS ONE, V3, P0, DOI 10.1371/journal.pone.0001433
   MARKEY SP, 1984, NATURE, V311, P464, DOI 10.1038/311464a0
   Martin LJ, 2006, J NEUROSCI, V26, P41, DOI 10.1523/JNEUROSCI.4308-05.2006
   Martin MA, 1996, NEUROLOGY, V46, P1343, DOI 10.1212/WNL.46.5.1343
   Martins LM, 2004, MOL CELL BIOL, V24, P9848, DOI 10.1128/MCB.24.22.9848-9862.2004
   MECO G, 1994, SCAND J WORK ENV HEA, V20, P301, DOI 10.5271/sjweh.1394
   Meuer K, 2007, CELL DEATH DIFFER, V14, P651, DOI 10.1038/sj.cdd.4402087
   Meulener M, 2005, CURR BIOL, V15, P1572, DOI 10.1016/j.cub.2005.07.064
   Minamikawa T, 1999, EXP CELL RES, V246, P26, DOI 10.1006/excr.1998.4290
   MIZUNO Y, 1989, BIOCHEM BIOPH RES CO, V163, P1450, DOI 10.1016/0006-291X(89)91141-8
   MIZUNO Y, 1988, J NEUROL SCI, V86, P97, DOI 10.1016/0022-510X(88)90010-X
   MIZUNO Y, 1988, NEUROSCI LETT, V91, P349, DOI 10.1016/0304-3940(88)90705-7
   Moore DJ, 2006, BIOCHEM SOC T, V34, P749, DOI 10.1042/BST0340749
   Moore DJ, 2008, CURR NEUROL NEUROSCI, V8, P288, DOI 10.1007/s11910-008-0045-7
   Moore DJ, 2005, HUM MOL GENET, V14, P71, DOI 10.1093/hmg/ddi007
   Müftüoglu M, 2004, MOVEMENT DISORD, V19, P544, DOI 10.1002/mds.10695
   Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085
   Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317
   NICKLAS WJ, 1985, LIFE SCI, V36, P2503, DOI 10.1016/0024-3205(85)90146-8
   Norenberg MD, 2007, NEUROCHEM INT, V50, P983, DOI 10.1016/j.neuint.2007.02.008
   Norris EH, 2007, AM J PATHOL, V170, P658, DOI 10.2353/ajpath.2007.060359
   Ozawa T, 1997, BIOSCIENCE REP, V17, P237, DOI 10.1023/A:1027324410022
   Packer MA, 1996, BIOCHEM PHARMACOL, V51, P267, DOI 10.1016/0006-2952(95)02165-5
   Paisán-Ruíz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023
   Palacino JJ, 2004, J BIOL CHEM, V279, P18614, DOI 10.1074/jbc.M401135200
   Panov A, 2007, AM J PHYSIOL-CELL PH, V292, PC708, DOI 10.1152/ajpcell.00202.2006
   Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788
   Parker WD, 2008, BRAIN RES, V1189, P215, DOI 10.1016/j.brainres.2007.10.061
   Parker WD, 2005, BIOCHEM BIOPH RES CO, V326, P667, DOI 10.1016/j.bbrc.2004.11.093
   PARKER WD, 1989, ANN NEUROL, V26, P719, DOI 10.1002/ana.410260606
   Perier C, 2007, P NATL ACAD SCI USA, V104, P8161, DOI 10.1073/pnas.0609874104
   Pesah Y, 2004, DEVELOPMENT, V131, P2183, DOI 10.1242/dev.01095
   Petit A, 2005, J BIOL CHEM, V280, P34025, DOI 10.1074/jbc.M505143200
   Piccoli C, 2008, NEUROCHEM RES, V33, P2565, DOI 10.1007/s11064-008-9729-2
   Plun-Favreau H, 2007, NAT CELL BIOL, V9, P1243, DOI 10.1038/ncb1644
   Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045
   Poole AC, 2008, P NATL ACAD SCI USA, V105, P1638, DOI 10.1073/pnas.0709336105
   Poon HF, 2005, NEUROBIOL DIS, V18, P492, DOI 10.1016/j.nbd.2004.12.009
   Pridgeon JW, 2007, PLOS BIOL, V5, P1494, DOI 10.1371/journal.pbio.0050172
   PRZEDBORSKI S, 1993, ANN NEUROL, V34, P715, DOI 10.1002/ana.410340515
   Pyle A, 2005, ANN NEUROL, V57, P564, DOI 10.1002/ana.20417
   Ramachandiran S, 2007, TOXICOL SCI, V95, P163, DOI 10.1093/toxsci/kfl125
   RAMSAY RR, 1986, BIOCHEM BIOPH RES CO, V134, P743, DOI 10.1016/S0006-291X(86)80483-1
   RAMSAY RR, 1986, BIOCHEM BIOPH RES CO, V135, P269, DOI 10.1016/0006-291X(86)90972-1
   REICHMANN H, 1994, EUR NEUROL, V34, P263, DOI 10.1159/000117053
   Richardson JR, 2005, TOXICOL SCI, V88, P193, DOI 10.1093/toxsci/kfi304
   RICHTER C, 1988, P NATL ACAD SCI USA, V85, P6465, DOI 10.1073/pnas.85.17.6465
   Rosen KM, 2006, J BIOL CHEM, V281, P12809, DOI 10.1074/jbc.M512649200
   Ruiz-Pesini E, 2004, SCIENCE, V303, P223, DOI 10.1126/science.1088434
   Savitt JM, 2006, J CLIN INVEST, V116, P1744, DOI 10.1172/JCI29178
   SCHAPIRA AHV, 1989, LANCET, V1, P1269, DOI 10.1016/S0140-6736(89)92366-0
   SCHAPIRA AHV, 1990, J NEUROCHEM, V55, P2142, DOI 10.1111/j.1471-4159.1990.tb05809.x
   SCHAPIRA AHV, 1990, J NEUROCHEM, V54, P823, DOI 10.1111/j.1471-4159.1990.tb02325.x
   Schinzel AC, 2005, P NATL ACAD SCI USA, V102, P12005, DOI 10.1073/pnas.0505294102
   SECHI GP, 1992, NEUROLOGY, V42, P261, DOI 10.1212/WNL.42.1.261
   Sheehan JP, 1997, J NEUROCHEM, V68, P1221
   Sherer TB, 2003, EXP NEUROL, V179, P9, DOI 10.1006/exnr.2002.8072
   Sherer TB, 2003, J NEUROSCI, V23, P10756, DOI 10.1523/jneurosci.23-34-10756.2003
   Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060
   Shinde S, 2006, NEUROL INDIA, V54, P390, DOI 10.4103/0028-3886.28112
   Silvestri L, 2005, HUM MOL GENET, V14, P3477, DOI 10.1093/hmg/ddi377
   Simon DK, 1999, NEUROLOGY, V53, P1787, DOI 10.1212/WNL.53.8.1787
   Simon DK, 2000, NEUROLOGY, V54, P703, DOI 10.1212/WNL.54.3.703
   Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278
   Soane L, 2007, J NEUROSCI RES, V85, P3407, DOI 10.1002/jnr.21498
   Stavrovskaya IG, 2004, J EXP MED, V200, P211, DOI 10.1084/jem.20032053
   Stichel CC, 2000, EUR J NEUROSCI, V12, P4181, DOI 10.1046/j.1460-9568.2000.01314.x
   Stichel CC, 2007, HUM MOL GENET, V16, P2377, DOI 10.1093/hmg/ddm083
   Swerdlow RH, 2001, EXP NEUROL, V169, P479, DOI 10.1006/exnr.2001.7674
   Swerdlow RH, 1998, ANN NEUROL, V44, P873, DOI 10.1002/ana.410440605
   Swerdlow RH, 1996, ANN NEUROL, V40, P663, DOI 10.1002/ana.410400417
   Taanman JW, 2005, NEUROSCI LETT, V376, P56, DOI 10.1016/j.neulet.2004.11.023
   Tanaka Masashi, 2002, JOURNAL OF NEUROLOGY, V249, P11
   Tanaka Y, 2001, HUM MOL GENET, V10, P919, DOI 10.1093/hmg/10.9.919
   Tang BS, 2006, HUM MOL GENET, V15, P1816, DOI 10.1093/hmg/ddl104
   Tanner C M, 1999, ADV NEUROL, V80, P153
   Thiruchelvam M, 2003, EUR J NEUROSCI, V18, P589, DOI 10.1046/j.1460-9568.2003.02781.x
   Thiruchelvam M, 2002, NEUROTOXICOLOGY, V23, P621, DOI 10.1016/S0161-813X(02)00092-X
   Thiruchelvam M, 2000, J NEUROSCI, V20, P9207
   Thomas B, 2007, HUM MOL GENET, V16, PR183, DOI 10.1093/hmg/ddm159
   Thomas B, 2007, NEUROBIOL DIS, V26, P312, DOI 10.1016/j.nbd.2006.12.021
   Thyagarajan D, 2000, ANN NEUROL, V48, P730, DOI 10.1002/1531-8249(200011)48:5<730::AID-ANA6>3.0.CO;2-0
   Tiangyou W, 2006, NEUROLOGY, V67, P1698, DOI 10.1212/01.wnl.0000238963.07425.d5
   Trinh K, 2008, J NEUROSCI, V28, P465, DOI 10.1523/JNEUROSCI.4778-07.2008
   Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284
   Valente EM, 2004, ANN NEUROL, V56, P336, DOI 10.1002/ana.20256
   van der Brug MP, 2008, P NATL ACAD SCI USA, V105, P10244, DOI 10.1073/pnas.0708518105
   van der Walt JM, 2003, AM J HUM GENET, V72, P804, DOI 10.1086/373937
   Vives-Bauza C, 2002, BIOCHEM BIOPH RES CO, V290, P1593, DOI 10.1006/bbrc.2002.6388
   Wang DL, 2006, P NATL ACAD SCI USA, V103, P13520, DOI 10.1073/pnas.0604661103
   Wang HL, 2007, NEUROBIOL DIS, V28, P216, DOI 10.1016/j.nbd.2007.07.010
   West AB, 2005, P NATL ACAD SCI USA, V102, P16842, DOI 10.1073/pnas.0507360102
   Whitworth AJ, 2006, DRUG DISCOV TODAY, V11, P119, DOI 10.1016/S1359-6446(05)03693-7
   Whitworth AJ, 2005, P NATL ACAD SCI USA, V102, P8024, DOI 10.1073/pnas.0501078102
   WINTERBOURN CC, 1984, ARCH BIOCHEM BIOPHYS, V235, P116, DOI 10.1016/0003-9861(84)90260-1
   Woodfield K, 1998, BIOCHEM J, V336, P287, DOI 10.1042/bj3360287
   Wooten GF, 1997, ANN NEUROL, V41, P265, DOI 10.1002/ana.410410218
   Xun ZY, 2008, MOL CELL PROTEOMICS, V7, P1191, DOI 10.1074/mcp.M700467-MCP200
   Yang H, 2007, J NEUROIMMUNE PHARM, V2, P276, DOI 10.1007/s11481-007-9082-2
   Yang W, 2007, HUM MOL GENET, V16, P2900, DOI 10.1093/hmg/ddm249
   Yang YF, 2008, P NATL ACAD SCI USA, V105, P7070, DOI 10.1073/pnas.0711845105
   Yang YF, 2006, P NATL ACAD SCI USA, V103, P10793, DOI 10.1073/pnas.0602493103
   YOSHINO H, 1992, J NEURAL TRANSM-PARK, V4, P27, DOI 10.1007/BF02257619
   Youdim MBH, 2005, J NEUROSCI RES, V79, P172, DOI 10.1002/jnr.20350
   Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795
   Zhang L, 2005, HUM MOL GENET, V14, P2063, DOI 10.1093/hmg/ddi211
   Zhou C, 2008, P NATL ACAD SCI USA, V105, P12022, DOI 10.1073/pnas.0802814105
   Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005
   ZORATTI M, 1995, BBA-REV BIOMEMBRANES, V1241, P139, DOI 10.1016/0304-4157(95)00003-A
NR 228
TC 192
Z9 223
U1 0
U2 26
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0925-4439
EI 
J9 BBA-MOL BASIS DIS
JI Biochim. Biophys. Acta-Mol. Basis Dis.
PD JUL 15
PY 2009
VL 1792
IS 7
BP 651
EP 663
DI 10.1016/j.bbadis.2008.11.007
PG 13
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 470FI
UT WOS:000267960200009
PM 19059336
DA 2024-11-01
ER

PT J
AU Van Hove, JLK
   Cunningham, V
   Rice, C
   Ringel, SP
   Zhang, Q
   Chou, PC
   Truong, CK
   Wong, LJC
AF Van Hove, Johan L. K.
   Cunningham, Vicki
   Rice, Cathlin
   Ringel, Steven P.
   Zhang, Qing
   Chou, Ping-Chieh
   Truong, Cavatina K.
   Wong, Lee-Jun C.
TI Finding <i>Twinkle</i> in the Eyes of a 71-Year-Old Lady: A Case Report and Review of the Genotypic and Phenotypic Spectrum of <i>TWINKLE</i>-Related Dominant Disease
SO AMERICAN JOURNAL OF MEDICAL GENETICS PART A
LA English
DT Article
DE twinkle; helicase; opthalmoplegia; genotype; mitochondrial DNA; deletions; depletion; phenotypic spectrum
ID progressive external ophthalmoplegia; dna-polymerase-gamma; mitochondrial-dna; multiple deletions; gene mutation; helicase twinkle; mtdna deletions; polg; replication; depletion
AB Progressive external ophthalmoplegia (PEO) call be caused by a disorder characterized by multiple mitochondrial DNA (mtDNA) deletions due to mutations in the TWINKLE gene, encoding a mtDNA helicase. We describe a 71-year-old woman who had developed PEO at age 55 years. She had cataracts, diabetes, paresthesias, cognitive defects, memory problems, hearing loss, and sensory ataxia. She had muscle weakness with ragged red fibers oil biopsy. MRI showed static white matter changes. A c.908G > A substitution (p.R303Q) in the TWINKLE gene was identified. Multiple mtDNA deletions were detected ill muscle but not blood by a PCR-based method, but not by Southern blot analysis. MtDNA copy number was maintained ill blood and muscle. A systematic literature search was used to identify the genotypic and phenotypic spectrum of dominant disease. Patients were adults with PEO and symptoms including myopathy, neuropathy, dysarthria or dysphagia, sensory ataxia, and parkinsonism. Diabetes, cataract, memory loss, hearing loss, and cardiac problems were infrequent. All reported mutations clustered between amino acids 303 and 508 with no mutations at the N-terminal half of the gene. The TWINKLE gene should be analyzed in adults with PEO even in the absence of mtDNA deletions in muscle oil Southern blot analysis, and of a family history for PEO. The pathogenic mutations identified 5' beyond the linker region suggest a functional role for this part of the protein despite the absence of a primase function in humans. In our patient,the pathogenesis involved multiple mtDNA deletions without reduction in mtDNA copy number. (c) 2009 Wiley-Liss, hic.
C1 [Van Hove, Johan L. K.; Cunningham, Vicki; Rice, Cathlin] Univ Colorado, Dept Pediat, Denver, CO 80202 USA.
   [Ringel, Steven P.] Univ Colorado, Dept Neurol, Denver, CO 80202 USA.
   [Zhang, Qing; Chou, Ping-Chieh; Truong, Cavatina K.; Wong, Lee-Jun C.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.
C3 University of Colorado System; University of Colorado Denver; University of Colorado System; University of Colorado Denver; Baylor College of Medicine
RP Van Hove, JLK (corresponding author), Univ Colorado Denver Fitzsimmons, Dept Pediat, Sect Clin Genet & Metab, Mail Stop 8313,RC-1 N,12800 E 19th Ave,Room P18-4, Aurora, CO 80045 USA.
EM johan.vanhove@ucdenver.edu
FU United Mitochondrial Disease Foundation
CR Agostino A, 2003, NEUROLOGY, V60, P1354, DOI 10.1212/01.WNL.0000056088.09408.3C
   Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   Angst J, 1999, J CLIN PSYCHIAT, V60, P5
   Arenas J, 2003, ANN NEUROL, V53, P278, DOI 10.1002/ana.10430
   Bai RK, 2005, J MOL DIAGN, V7, P613, DOI 10.1016/S1525-1578(10)60595-8
   Baloh RH, 2007, ARCH NEUROL-CHICAGO, V64, P998, DOI 10.1001/archneur.64.7.998
   Deschauer M, 2003, NEUROMUSCULAR DISORD, V13, P568, DOI 10.1016/S0960-8966(03)00071-3
   Farge G, 2007, NUCLEIC ACIDS RES, V35, P902, DOI 10.1093/nar/gkl1116
   Garrido N, 2003, MOL BIOL CELL, V14, P1583, DOI 10.1091/mbc.E02-07-0399
   Hakonen AH, 2007, BRAIN, V130, P3032, DOI 10.1093/brain/awm242
   Hirano M, 2001, NEUROLOGY, V57, P2163, DOI 10.1212/WNL.57.12.2163
   Houshmand M, 2006, NEUROL INDIA, V54, P182
   Hudson G, 2005, NEUROLOGY, V64, P371, DOI 10.1212/01.WNL.0000149767.51152.83
   Jeppesen TD, 2008, NEUROMUSCULAR DISORD, V18, P306, DOI 10.1016/j.nmd.2007.10.007
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095
   Kiechl S, 2004, J NEUROL NEUROSUR PS, V75, P1125, DOI 10.1136/jnnp.2003.025890
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   Korhonen JA, 2003, J BIOL CHEM, V278, P48627, DOI 10.1074/jbc.M306981200
   Lewis S, 2002, J NEUROL SCI, V201, P39, DOI 10.1016/S0022-510X(02)00190-9
   Li FY, 1999, NEUROLOGY, V53, P1265, DOI 10.1212/WNL.53.6.1265
   Liang MH, 1998, AM J MED GENET, V77, P395, DOI 10.1002/(SICI)1096-8628(19980605)77:5<395::AID-AJMG8>3.0.CO;2-M
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   Naïmi M, 2006, EUR J HUM GENET, V14, P917, DOI 10.1038/sj.ejhg.5201627
   Nikali K, 2005, HUM MOL GENET, V14, P2981, DOI 10.1093/hmg/ddi328
   Rivera H, 2007, NEUROMUSCULAR DISORD, V17, P677, DOI 10.1016/j.nmd.2007.05.006
   Sarzi E, 2007, ANN NEUROL, V62, P579, DOI 10.1002/ana.21207
   Shutt TE, 2006, J MOL EVOL, V62, P588, DOI 10.1007/s00239-005-0162-8
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Suomalainen A, 1997, NEUROLOGY, V48, P1244, DOI 10.1212/WNL.48.5.1244
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Tyynismaa H, 2004, HUM MOL GENET, V13, P3219, DOI 10.1093/hmg/ddh342
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2003, HUM MUTAT, V22, P175, DOI 10.1002/humu.10246
   Virgilio R, 2008, J NEUROL, V255, P1384, DOI 10.1007/s00415-008-0926-3
   Wanrooij S, 2004, NUCLEIC ACIDS RES, V32, P3053, DOI 10.1093/nar/gkh634
   Wanrooij S, 2007, NUCLEIC ACIDS RES, V35, P3238, DOI 10.1093/nar/gkm215
   Wong LJC, 2007, HEPATOLOGY, V46, P1218, DOI 10.1002/hep.21799
   Wong LJC, 2008, HUM MUTAT, V29, PE150, DOI 10.1002/humu.20824
   Wong LJC, 1997, CLIN CHEM, V43, P1857
   Wong LJC, 2005, CLIN CHIM ACTA, V354, P1, DOI 10.1016/j.cccn.2004.11.003
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
NR 42
TC 44
Z9 46
U1 0
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4825
EI 1552-4833
J9 AM J MED GENET A
JI Am. J. Med. Genet. A
PD MAY 15
PY 2009
VL 149A
IS 5
BP 861
EP 867
DI 10.1002/ajmg.a.32731
PG 7
WC Genetics & Heredity
SC Genetics & Heredity
GA 441YG
UT WOS:000265805900008
PM 19353676
DA 2024-11-01
ER

PT J
AU Bortot, B
   Barbi, E
   Biffi, S
   Angelini, C
   Faleschini, E
   Severini, GM
   Carrozzi, M
AF Bortot, B.
   Barbi, E.
   Biffi, S.
   Angelini, C.
   Faleschini, E.
   Severini, G. M.
   Carrozzi, M.
TI Two novel cosegregating mutations in tRNA<SUP>Met</SUP> and COX III, in a patient with exercise intolerance and autoimmune polyendocrinopathy
SO MITOCHONDRION
LA English
DT Article
DE Met-tRNA and Cox III cosegregating mutations; Exercise intolerance; Autoimmune polyendocrinopathy
ID cytochrome-c-oxidase; mitochondrial-dna mutations; lactic-acidosis; chinese family; rna gene; a1555g mutation; hearing-loss; myopathy; deficiency; mtdna
AB We report a 12-year-old patient with growth retardation, exercise intolerance, lactic acidosis (increasing after exercise) and autoimmune polyendocrinopathy type 2. Muscle biopsy shows abundant COX-negative fibers, subsarcolemmal mitochondrial aggregates and markedly reduced activities of all respiratory chain complexes. Genetic analysis identified two new cosegregating mutations in Met-tRNA (m.4415A > G) and Cox III (m.9922A > C), located in highly conserved regions of MtDNA. Both the mutations are heteroplasmics in multiple patients' tissues. Single-muscle fiber analysis showed significantly higher levels of both the mutations in COX-negative than in normal fibers. in addition, a possible link between the mitochondrial dysfunction and the autoimmune disease is suggested. (C) 2009 Elsevier B.V. and Mitochondria Research Society. All rights reserved.
C1 [Bortot, B.; Biffi, S.; Severini, G. M.; Carrozzi, M.] IRCCS, Inst Child Hlth, Child Neurol & Psychiat Unit, I-34137 Trieste, Italy.
   [Barbi, E.; Faleschini, E.] Univ Trieste, Inst Child Hlth, IRCCS, Dept Pediat, I-34137 Trieste, Italy.
   [Bortot, B.; Severini, G. M.] IRCCS, Inst Child Hlth, Med Genet Unit, I-34137 Trieste, Italy.
   [Angelini, C.] Univ Padua, Dept Neurosci, Padua, Italy.
   [Biffi, S.] CBM Scrl, Opt Imaging Lab, Trieste, Italy.
C3 University of Trieste; University of Padua
RP Carrozzi, M (corresponding author), IRCCS, Inst Child Hlth, Child Neurol & Psychiat Unit, Via Istria 65-1, I-34137 Trieste, Italy.
EM carrozzi@burlo.trieste.it
FU Italian Ministry of Health [Ricerca Finalizzata N ICS 73/04]; Institute of Child Health IRCCS Burlo Garofolo [R.C. 43/03]; Eurobiobank project; Telethon Bank n [GUP05003]
CR ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   Arenas J, 1999, NEUROLOGY, V52, P377, DOI 10.1212/WNL.52.2.377
   Bai RK, 2004, CLIN CHEM, V50, P996, DOI 10.1373/clinchem.2004.031153
   Bidooki SK, 1997, AM J HUM GENET, V60, P1430, DOI 10.1086/515460
   Böhm M, 2006, PEDIATR RES, V59, P21, DOI 10.1203/01.pdr.0000190572.68191.13
   BONILLA E, 1992, BRAIN PATHOL, V2, P113, DOI 10.1111/j.1750-3639.1992.tb00679.x
   Bonin S, 2003, J CLIN PATHOL-MOL PA, V56, P184, DOI 10.1136/mp.56.3.184
   Brandon MC, 2005, NUCLEIC ACIDS RES, V33, P0
   BRUNORI M, 1987, EUR J BIOCHEM, V169, P1, DOI 10.1111/j.1432-1033.1987.tb13572.x
   Campos Y, 2002, MUSCLE NERVE, V25, P185, DOI 10.1002/mus.10012.abs
   CAPALDI RA, 1990, ARCH BIOCHEM BIOPHYS, V280, P252, DOI 10.1016/0003-9861(90)90327-U
   Chabi B, 2003, CLIN CHEM, V49, P1309, DOI 10.1373/49.8.1309
   DiMauro S, 2000, BRAIN PATHOL, V10, P431
   DiMauro S, 2004, BBA-BIOENERGETICS, V1658, P80, DOI 10.1016/j.bbabio.2004.03.014
   DiMauro S, 2001, SEMIN CELL DEV BIOL, V12, P397, DOI 10.1006/scdb.2001.0277
   Dimauro S, 2001, AM J MED GENET, V106, P18, DOI 10.1002/ajmg.1392
   Eystathioy T, 2003, J MOL MED, V81, P811, DOI 10.1007/s00109-003-0495-y
   Finsterer J, 2006, NETH J MED, V64, P61
   HALTIA T, 1989, EMBO J, V8, P3571, DOI 10.1002/j.1460-2075.1989.tb08529.x
   Hammond SM, 2005, FEBS LETT, V579, P5822, DOI 10.1016/j.febslet.2005.08.079
   Hanna MG, 1998, AM J HUM GENET, V63, P29, DOI 10.1086/301910
   Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378
   Horváth R, 2005, NEUROMUSCULAR DISORD, V15, P851, DOI 10.1016/j.nmd.2005.09.005
   Horváth R, 2002, J MED GENET, V39, P812, DOI 10.1136/jmg.39.11.812
   Jakymiw A, 2006, ARTHRITIS RES THER, V8, P0, DOI 10.1186/ar1959
   JAUME JC, 2004, BASIC CLIN ENDOCRINO, V0, P0
   Keightley JA, 1996, NAT GENET, V12, P410, DOI 10.1038/ng0496-410
   Li RH, 2004, AM J MED GENET A, V124A, P113, DOI 10.1002/ajmg.a.20305
   Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513
   Lombes A, 1998, HUM MUTAT, V0, PS175
   Lu T, 2006, BBA-MOL BASIS DIS, V1762, P719, DOI 10.1016/j.bbadis.2006.06.007
   Maniataki E, 2005, RNA, V11, P849, DOI 10.1261/rna.2210805
   McFarland R, 2004, TRENDS GENET, V20, P591, DOI 10.1016/j.tig.2004.09.014
   Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007
   Meulemans A, 2007, ARCH NEUROL-CHICAGO, V64, P1339, DOI 10.1001/archneur.64.9.1339
   Mimaki M, 2003, J HUM GENET, V48, P47, DOI 10.1007/s100380300005
   MORAES CT, 1992, AM J HUM GENET, V50, P934
   Ohno K, 1996, ANN NEUROL, V39, P761, DOI 10.1002/ana.410390612
   Qu J, 2006, INVEST OPHTH VIS SCI, V47, P475, DOI 10.1167/iovs.05-0665
   Qu J, 2007, MITOCHONDRION, V7, P140, DOI 10.1016/j.mito.2006.11.015
   Remes AM, 2005, NEUROLOGY, V64, P976, DOI 10.1212/01.WNL.0000154518.31302.ED
   Ronghua L, 2006, GENE, V376, P79, DOI 10.1016/j.gene.2006.02.014
   Sambrook J, 1989, MOLECULAR CLONING, V0, P0
   Schon EA, 1997, J BIOENERG BIOMEMBR, V29, P131, DOI 10.1023/A:1022685929755
   Seneca S, 2005, AM J MED GENET A, V137A, P170, DOI 10.1002/ajmg.a.30854
   Shoubridge EA, 2001, AM J MED GENET, V106, P46, DOI 10.1002/ajmg.1378
   Spruijt L, 2006, AM J MED GENET A, V140A, P1478, DOI 10.1002/ajmg.a.31324
   Sternberg D, 2001, BRAIN, V124, P984, DOI 10.1093/brain/124.5.984
   Tanji K, 2000, BRAIN PATHOL, V10, P422
   Tiranti V, 2000, HUM MOL GENET, V9, P2733, DOI 10.1093/hmg/9.18.2733
   Trounce I A, 1996, METHODS ENZYMOL, V264, P484, DOI 10.1016/S0076-6879(96)64044-0
   Ueki I, 2006, MITOCHONDRION, V6, P29, DOI 10.1016/j.mito.2005.10.003
   Vissing J, 1998, NEUROLOGY, V50, P1875, DOI 10.1212/WNL.50.6.1875
   Waterhouse PM, 2001, NATURE, V411, P834, DOI 10.1038/35081168
   WILSON KS, 1990, ARCH BIOCHEM BIOPHYS, V282, P413, DOI 10.1016/0003-9861(90)90137-N
   Wittenhagen LM, 2003, TRENDS BIOCHEM SCI, V28, P605, DOI 10.1016/j.tibs.2003.09.006
   Yuan HJ, 2005, AM J MED GENET A, V138A, P133, DOI 10.1002/ajmg.a.30952
   Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444
NR 60
TC 17
Z9 17
U1 0
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD APR 15
PY 2009
VL 9
IS 2
BP 123
EP 129
DI 10.1016/j.mito.2009.01.006
PG 7
WC Cell Biology; Genetics & Heredity
SC Cell Biology; Genetics & Heredity
GA 428PO
UT WOS:000264861400006
PM 19460300
DA 2024-11-01
ER

PT J
AU Di Fonzo, A
   Ronchi, D
   Lodi, T
   Fassone, E
   Tigano, M
   Lamperti, C
   Corti, S
   Bordoni, A
   Fortunato, F
   Nizzardo, M
   Napoli, L
   Donadoni, C
   Salani, S
   Saladino, F
   Moggio, M
   Bresolin, N
   Ferrero, I
   Comi, GP
AF Di Fonzo, Alessio
   Ronchi, Dario
   Lodi, Tiziana
   Fassone, Elisa
   Tigano, Marco
   Lamperti, Costanza
   Corti, Stefania
   Bordoni, Andreina
   Fortunato, Francesco
   Nizzardo, Monica
   Napoli, Laura
   Donadoni, Chiara
   Salani, Sabrina
   Saladino, Francesca
   Moggio, Maurizio
   Bresolin, Nereo
   Ferrero, Iliana
   Comi, Giacomo P.
TI The Mitochondrial Disulfide Relay System Protein GFER Is Mutated in Autosomal-Recessive Myopathy with Cataract and Combined Respiratory-Chain Deficiency
SO AMERICAN JOURNAL OF HUMAN GENETICS
LA English
DT Article
ID cytochrome-c-oxidase; intermembrane space; liver-regeneration; saccharomyces-cerevisiae; sulfhydryl oxidase; skeletal-muscle; augmentor; identification; disorders; mutations
AB A disulfide relay system (DRS) was recently identified in the yeast mitochondrial intermembrane space (IMS) that consists of two essential components: the sulfhydryl oxidase Erv1 and the redox-regulated import receptor Mia40. The DRS drives the import of cysteine-rich proteins into the IMS via an oxidative folding mechanism. Erv1p is reoxidized within this system, transferring its electrons to molecular oxygen through interactions with cytochrome c and cytochrome c oxidase (COX), thereby linking the DRS to the respiratory chain. The role of the human Erv1 ortholog, GFER, in the DRS has been poorly explored. Using homozygosity mapping, we discovered that a mutation in the GFER gene causes an infantile mitochondrial disorder. Three children born to healthy consanguineous parents presented with progressive myopathy and partial combined respiratory-chain deficiency, congenital cataract, sensorineural hearing loss, and developmental delay. The consequences of the mutation at the level of the patient's muscle tissue and fibroblasts were 1) a reduction in complex I, II, and IV activity; 2) a lower cysteine-rich protein content; 3) abnormal ultrastructural morphology of the mitochondria, with enlargement of the IMS space; and 4) accelerated time-dependent accumulation of multiple mtDNA deletions. Moreover, the Saccharomyces cerevisiae erv1(R182H) mutant strain reproduced the complex IV activity defect and exhibited genetic instability of the mtDNA and mitochondrial morphological defects. These findings shed light on the mechanisms of mitochondrial biogenesis, establish the role of GFER in the human DRS, and promote an understanding of the pathogenesis of a new mitochondrial disease.
C1 [Di Fonzo, Alessio; Ronchi, Dario; Fassone, Elisa; Lamperti, Costanza; Corti, Stefania; Bordoni, Andreina; Fortunato, Francesco; Nizzardo, Monica; Napoli, Laura; Donadoni, Chiara; Salani, Sabrina; Saladino, Francesca; Moggio, Maurizio; Bresolin, Nereo; Comi, Giacomo P.] Univ Milan, Dino Ferrari Ctr, Dept Neurol Sci, I-20122 Milan, Italy.
   [Di Fonzo, Alessio; Ronchi, Dario; Fassone, Elisa; Lamperti, Costanza; Corti, Stefania; Bordoni, Andreina; Fortunato, Francesco; Nizzardo, Monica; Napoli, Laura; Donadoni, Chiara; Salani, Sabrina; Saladino, Francesca; Moggio, Maurizio; Bresolin, Nereo; Comi, Giacomo P.] Osped Maggiore Policlin, Fdn IRCCS, I-20122 Milan, Italy.
   [Lodi, Tiziana; Tigano, Marco; Ferrero, Iliana] Univ Parma, Dept Genet Anthropol & Evolut, I-43100 Parma, Italy.
   [Bresolin, Nereo; Comi, Giacomo P.] Univ Milan, Ctr Excellence Neurodegenerat Dis, I-20133 Milan, Italy.
   [Bresolin, Nereo] IRCCS Eugenio Medea, I-23842 Bosisio Parini, Lecco, Italy.
C3 University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Parma; University of Milan; IRCCS Eugenio Medea
RP Comi, GP (corresponding author), Univ Milan, Dino Ferrari Ctr, Dept Neurol Sci, I-20122 Milan, Italy.
EM giacomo.comi@unimi.it
FU Italian Ministry of University [PRIN 2006 2006069034]; Italian Ministry of Health; Telethon Network of Genetics Biobanks [GTB 07001E]; Eurobiobank [QLTR-2001-02769]
CR Baruffini E, 2007, BBA-MOL BASIS DIS, V1772, P1225, DOI 10.1016/j.bbadis.2007.10.002
   Becher D, 1999, YEAST, V15, P1171, DOI 10.1002/(SICI)1097-0061(19990915)15:12<1171::AID-YEA443>3.0.CO;2-T
   Bihlmaier K, 2007, J CELL BIOL, V179, P389, DOI 10.1083/jcb.200707123
   BRESOLIN N, 1985, NEUROLOGY, V35, P802, DOI 10.1212/WNL.35.6.802
   Calvo S, 2006, NAT GENET, V38, P576, DOI 10.1038/ng1776
   Chacinska A, 2004, EMBO J, V23, P3735, DOI 10.1038/sj.emboj.7600389
   DiMauro S, 2008, ANNU REV NEUROSCI, V31, P91, DOI 10.1146/annurev.neuro.30.051606.094302
   Dubowitz V, 1985, MUSCLE BIOPSY PRACTI, V2nd, P0
   Fontanesi F, 2004, HUM MOL GENET, V13, P923, DOI 10.1093/hmg/ddh108
   FRANCAVILLA A, 1994, HEPATOLOGY, V20, P747, DOI 10.1002/hep.1840200328
   Gatzidou E, 2006, WORLD J GASTROENTERO, V12, P4951, DOI 10.3748/wjg.v12.i31.4951
   HECKMATT JZ, 1984, MUSCLE NERVE, V7, P594
   Hell K, 2008, BBA-MOL CELL RES, V1783, P601, DOI 10.1016/j.bbamcr.2007.12.005
   HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2
   Hoffmann K, 2005, BIOINFORMATICS, V21, P3565, DOI 10.1093/bioinformatics/bti571
   Koehler CM, 2004, TRENDS BIOCHEM SCI, V29, P1, DOI 10.1016/j.tibs.2003.11.003
   Leary SC, 2004, HUM MOL GENET, V13, P1839, DOI 10.1093/hmg/ddh197
   Li Y, 2002, EUR J BIOCHEM, V269, P3888, DOI 10.1046/j.1432-1033.2002.03054.x
   Lisowsky T, 2001, DIGEST LIVER DIS, V33, P173, DOI 10.1016/S1590-8658(01)80074-8
   Massa V, 2008, AM J HUM GENET, V82, P1281, DOI 10.1016/j.ajhg.2008.05.002
   Mesecke N, 2005, CELL, V121, P1059, DOI 10.1016/j.cell.2005.04.011
   Okado-Matsumoto A, 2001, J BIOL CHEM, V276, P38388, DOI 10.1074/jbc.M105395200
   Périé S, 2006, NEUROMUSCULAR DISORD, V16, P770, DOI 10.1016/j.nmd.2006.07.022
   Salani S, 2004, MUSCLE NERVE, V30, P366, DOI 10.1002/mus.20106
   Sciacco M, 1996, METHODS ENZYMOL, V264, P509, DOI 10.1016/S0076-6879(96)64045-2
   Terziyska N, 2007, FEBS LETT, V581, P1098, DOI 10.1016/j.febslet.2007.02.014
   Tokatlidis K, 2005, CELL, V121, P965, DOI 10.1016/j.cell.2005.06.019
   VANEKEREN GJ, 1993, EUR J PEDIATR, V152, P255, DOI 10.1007/BF01956157
   Wharton DC, 1967, METHODS ENZYMOL, V10, P245, DOI 10.1016/0076-6879(67)10048-7
   Wright R, 2000, MICROSC RES TECHNIQ, V51, P496, DOI 10.1002/1097-0029(20001215)51:6<496::AID-JEMT2>3.3.CO;2-0
   Zeviani M, 2007, CURR OPIN NEUROL, V20, P564, DOI 10.1097/WCO.0b013e3282ef58cd
NR 31
TC 108
Z9 120
U1 0
U2 9
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0002-9297
EI 1537-6605
J9 AM J HUM GENET
JI Am. J. Hum. Genet.
PD MAY 15
PY 2009
VL 84
IS 5
BP 594
EP 604
DI 10.1016/j.ajhg.2009.04.004
PG 11
WC Genetics & Heredity
SC Genetics & Heredity
GA 449OB
UT WOS:000266338800004
PM 19409522
DA 2024-11-01
ER

PT J
AU Camilleri, M
   Carlson, P
   Zinsmeister, AR
   McKinzie, S
   Busciglio, I
   Burton, D
   Zaki, EA
   Boles, RG
AF Camilleri, Michael
   Carlson, Paula
   Zinsmeister, Alan R.
   McKinzie, Sanna
   Busciglio, Irene
   Burton, Duane
   Zaki, Essam A.
   Boles, Richard G.
TI Mitochondrial DNA and gastrointestinal motor and sensory functions in health and functional gastrointestinal disorders
SO AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
LA English
DT Article
DE 16519T; 3010A; 7028C; irritable bowel syndrome; dyspepsia; haplogroup H; genotype; constipation; nonspecific abdominal pain; gastric emptying; accommodation; satiation; somatic symptoms
ID irritable-bowel-syndrome; cyclic vomiting syndrome; body-mass index; us community; dyspepsia; disease; mutations; symptoms; polymorphisms; protein
AB Camilleri M, Carlson P, Zinsmeister AR, McKinzie S, Busciglio I, Burton D, Zaki EA, Boles RG. Mitochondrial DNA and gastrointestinal motor and sensory functions in health and functional gastrointestinal disorders. Am J Physiol Gastrointest Liver Physiol 296: G510-G516, 2009. First published January 15, 2009; doi:10.1152/ajpgi.90650.2008.-Nerve, muscle, and inflammatory cells involved in gastrointestinal (GI) function have high-energy requirements and are affected in mitochondrial disorders. Familial aggregation of irritable bowel syndrome (IBS) frequently involves mothers and their children. Since mitochondrial DNA (mtDNA) is maternally inherited, mtDNA single nucleotide polymorphisms (SNPs) could confer risk to the development of IBS. The mtDNA SNPs, 16519C>T and 3010G>A, are associated with migraine and childhood cyclic vomiting syndrome. Our hypothesis is that these mtDNA SNPs are associated with functional GI disorders (FGIDs) and GI functions. The mt genome was first tested for the 7028C polymorphism (defining haplogroup H) in 699 patients or controls, and those with 7028C were further genotyped at 16519 and 3010. Phenotypes were based on symptoms (validated questionnaires and criteria) and GI physiology using validated motor and sensory studies. Constipation-predominant IBS and alternating constipation and diarrhea IBS are less prevalent in individuals with the 7028C mtDNA polymorphism than in individuals with 7028T. Conversely, 7028C is associated with higher maximum tolerated volume (lower satiation) compared with 7028T. Among those with 7028C, nonspecific abdominal pain (chronic abdominal pain or dyspepsia) was significantly associated with 3010A compared with 3010G (odds ratio 3.3, P = 0.02), and slower gastric emptying was statistically associated with 3010G. There were no significant associations of mtDNA genotypes tested and stomach volumes, small bowel or colonic transit, rectal compliance, and motor or sensory functions. Thus variation in mtDNA may be associated with satiation, gastric emptying, and possibly pain; further studies of mtDNA in appetite regulation and larger numbers of patients with FGIDs are warranted.
C1 [Camilleri, Michael; Carlson, Paula; McKinzie, Sanna; Busciglio, Irene; Burton, Duane] Mayo Clin, CENTER, Rochester, MN 55905 USA.
   [Zinsmeister, Alan R.] Mayo Clin, Coll Med, Div Biostat, Dept Hlth Sci Res, Rochester, MN 55905 USA.
   [Zaki, Essam A.; Boles, Richard G.] Childrens Hosp Los Angeles, Div Med Genet, Los Angeles, CA 90027 USA.
   [Zaki, Essam A.; Boles, Richard G.] Childrens Hosp Los Angeles, Saban Res Inst, Los Angeles, CA 90027 USA.
   [Boles, Richard G.] Univ So Calif, Keck Sch Med, Div Pediat, Los Angeles, CA 90033 USA.
C3 Mayo Clinic; Mayo Clinic; Children's Hospital Los Angeles; Children's Hospital Los Angeles; University of Southern California
RP Camilleri, M (corresponding author), Mayo Clin, CENTER, Charlton 8-110,200 1st St SW, Rochester, MN 55905 USA.
EM rboles@chla.usc.edu; rboles@chla.usc.edu
CR Andresen V, 2006, GASTROENTEROLOGY, V130, P1985, DOI 10.1053/j.gastro.2006.03.017
   Boles RG, 1997, LANCET, V350, P1299, DOI 10.1016/S0140-6736(05)62477-4
   Boles RG, 2005, AM J MED GENET A, V133A, P71, DOI 10.1002/ajmg.a.30524
   Bouras EP, 2002, GUT, V51, P781, DOI 10.1136/gut.51.6.781
   Burnett BB, 2005, J AFFECT DISORDERS, V88, P109, DOI 10.1016/j.jad.2005.05.009
   Camilleri CE, 2006, AM J GASTROENTEROL, V101, P581, DOI 10.1111/j.1572-0241.2006.00481.x
   Camilleri M, 2005, NEUROGASTROENT MOTIL, V17, P311, DOI 10.1111/j.1365-2982.2004.00632.x
   Camilleri M, 2002, GASTROENTEROLOGY, V123, P425, DOI 10.1053/gast.2002.34780
   Camilleri M, 2008, CLIN GASTROENTEROL H, V6, P772, DOI 10.1016/j.cgh.2008.02.060
   Castillo EJ, 2004, CLIN GASTROENTEROL H, V2, P985, DOI 10.1016/S1542-3565(04)00454-9
   Chial HJ, 2002, NEUROGASTROENT MOTIL, V14, P249, DOI 10.1046/j.1365-2982.2002.00326.x
   Coble MD, 2004, INT J LEGAL MED, V118, P137, DOI 10.1007/s00414-004-0427-6
   Cremonini F, 2002, ALIMENT PHARM THER, V16, P1781, DOI 10.1046/j.1365-2036.2002.01344.x
   Cremonini F, 2005, NEUROGASTROENT MOTIL, V17, P810, DOI 10.1111/j.1365-2982.2005.00709.x
   Delgado-Aros S, 2004, AM J GASTROENTEROL, V99, P1801, DOI 10.1111/j.1572-0241.2004.30887.x
   Delgado-Aros S, 2004, GASTROENTEROLOGY, V127, P1685, DOI 10.1053/j.gastro.2004.09.006
   FAJARDO NR, 2006, NEUROGASTROENT MOTIL, V18, P728
   Gardner A, 2008, BIOPSYCHOSOC MED, V2, P0, DOI 10.1186/1751-0759-2-7
   Gardner A, 2008, PSYCHOTHER PSYCHOSOM, V77, P127, DOI 10.1159/000112891
   Halder SLS, 2007, GASTROENTEROLOGY, V133, P799, DOI 10.1053/j.gastro.2007.06.010
   Hammer HF, 1998, AM J PHYSIOL-GASTR L, V274, PG584, DOI 10.1152/ajpgi.1998.274.3.G584
   Holtmann G, 2004, GASTROENTEROLOGY, V126, P971, DOI 10.1053/j.gastro.2004.01.006
   Ito M, 2001, MITOCHONDRION, V1, P269, DOI 10.1016/S1567-7249(01)00028-9
   JOHNS DR, 1995, NEW ENGL J MED, V333, P638, DOI 10.1056/NEJM199509073331007
   Kalantar JS, 2003, GUT, V52, P1703, DOI 10.1136/gut.52.12.1703
   Kim HJ, 2004, GUT, V53, P829, DOI 10.1136/gut.2003.030882
   Locke GR, 2005, NEUROGASTROENT MOTIL, V17, P29, DOI 10.1111/j.1365-2982.2004.00581.x
   Mayer EA, 2008, GASTROENTEROLOGY, V134, P1826, DOI 10.1053/j.gastro.2008.05.003
   Murakami H, 2002, JPN J PHYSIOL, V52, P247, DOI 10.2170/jjphysiol.52.247
   Navaglia F, 2006, AM J CLIN PATHOL, V126, P593, DOI 10.1309/GQFCCJMH5KHNVX73
   Rose G, 2001, EUR J HUM GENET, V9, P701, DOI 10.1038/sj.ejhg.5200703
   Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, PD823, DOI 10.1093/nar/gkl927
   Saito YA, 2008, NEUROGASTROENT MOTIL, V20, P790, DOI 10.1111/j.1365-2982.2007.1077.x
   SHOFFNER JM, 1994, ANNU REV NUTR, V14, P535, DOI 10.1146/annurev.nu.14.070194.002535
   Tahara T, 2008, DIGEST DIS SCI, V53, P642, DOI 10.1007/s10620-007-9923-0
   TALLEY NJ, 1990, MAYO CLIN PROC, V65, P1456, DOI 10.1016/S0025-6196(12)62169-7
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Van Kerkhoven LAS, 2007, ALIMENT PHARM THER, V26, P979, DOI 10.1111/j.1365-2036.2007.03453.x
   Van Lelyveld N, 2008, NEUROGASTROENT MOTIL, V20, P767, DOI 10.1111/j.1365-2982.2008.01102.x
   Wallace DC, 1999, GENE, V238, P211, DOI 10.1016/S0378-1119(99)00295-4
   Wang QX, 2004, AM J MED GENET A, V131A, P50, DOI 10.1002/ajmg.a.30323
   Wong LJC, 2005, CLIN CHIM ACTA, V354, P1, DOI 10.1016/j.cccn.2004.11.003
NR 44
TC 36
Z9 40
U1 0
U2 4
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0193-1857
EI 1522-1547
J9 AM J PHYSIOL-GASTR L
JI Am. J. Physiol.-Gastroint. Liver Physiol.
PD MAR 15
PY 2009
VL 296
IS 3
BP G510
EP G516
DI 10.1152/ajpgi.90650.2008
PG 7
WC Gastroenterology & Hepatology; Physiology
SC Gastroenterology & Hepatology; Physiology
GA 414YJ
UT WOS:000263900800007
PM 19147801
DA 2024-11-01
ER

PT J
AU Finsterer, J
AF Finsterer, Josef
TI Cardiogenetics, Neurogenetics, and Pathogenetics of Left Ventricular Hypertrabeculation/Noncompaction
SO PEDIATRIC CARDIOLOGY
LA English
DT Article; Proceedings Paper
DE Cardiac disease; Genetics; Hypertrophic cardiomyopathy; Mutation; Myocardium; Neuromuscular disorder
ID apical hypertrophic cardiomyopathy; myoadenylate deaminase deficiency; non-compaction cardiomyopathy; nail-patella syndrome; acute metabolic decompensation; congenital heart-defects; parkinson-white-syndrome; sarcomere protein genes; distal 1q monosomy; barth-syndrome
AB Left ventricular hypertrabeculation (LVHT), also known as noncompaction or spongy myocardium, is a cardiac abnormality of unknown etiology and pathogenesis frequently associated with genetic cardiac and noncardiac disorders, particularly genetic neuromuscular disease. This study aimed to review the current knowledge about the genetic or pathogenetic background of LVHT. A literature review of all human studies dealing with the association of LVHT with genetic cardiac and noncardiac disorders, particularly neuromuscular disorders, was conducted. Most frequently, LVHT is associated with mitochondrial disorders (mtDNA, nDNA mutations), Barth syndrome (G4.5, TAZ mutations), hypertrophic cardiomyopathy (MYH7, ACTC mutations), zaspopathy (ZASP/LDB3 mutations), myotonic dystrophy 1 (DMPK mutations), and dystrobrevinopathy (DTNA mutations). More rarely, LVHT is associated with mutations in the DMD, SCNA5, MYBPC3, FNLA1, PTPN11, LMNA, ZNF9, AMPD1, PMP22, TNNT2, fibrillin2, SHP2, MMACHC, LMX1B, HCCS, or NR0B1 genes. Additionally, LVHT occurs with a number of chromosomal disorders, polymorphisms, and not yet identified genes, as well in a familial context. The broad heterogeneity of LVHT's genetic background suggests that the uniform morphology of LVHT not only is attributable to embryonic noncompaction but also may result from induction of hypertrabeculation as a compensatory reaction of an impaired myocardium. Most frequently, LVHT is associated with mutations in genes causing muscle or cardiac disease, or with chromosomal disorders. These associations require comprehensive cardiac, neurologic, and cytogenetic investigations.
C1 Krankenanstalt Rudolfstiftung Wien, A-1180 Vienna, Austria.
C3 Rudolfstiftung Hospital
RP Finsterer, J (corresponding author), Krankenanstalt Rudolfstiftung Wien, Postfach 20, A-1180 Vienna, Austria.
EM fifigs1@yahoo.de
CR Abe M, 2000, NEUROMUSCULAR DISORD, V10, P472, DOI 10.1016/S0960-8966(00)00127-9
   Adwani SS, 1997, PEDIATR CARDIOL, V18, P143, DOI 10.1007/s002469900135
   ALTENBERGER H, 2008, ACTA CARDIO IN PRESS, V0, P0
   AMANN G, 1992, PEDIATR PATHOL, V12, P83, DOI 10.3109/15513819209023283
   Anderson RH, 2008, EUR HEART J, V29, P10, DOI 10.1093/eurheartj/ehm536
   Arimura T, 2004, J BIOL CHEM, V279, P6746, DOI 10.1074/jbc.M311849200
   Barth PG, 2004, AM J MED GENET A, V126A, P349, DOI 10.1002/ajmg.a.20660
   Battaglia A, 2008, PEDIATRICS, V121, P404, DOI 10.1542/peds.2007-0929
   Belanger AR, 2008, AM J CARDIOL, V102, P92, DOI 10.1016/j.amjcard.2008.02.107
   Benedetti S, 2005, J NEUROL NEUROSUR PS, V76, P1019, DOI 10.1136/jnnp.2004.046110
   Benson DW, 1999, J CLIN INVEST, V104, P1567, DOI 10.1172/JCI8154
   Bleyl SB, 1997, AM J MED GENET, V72, P257, DOI 10.1002/(SICI)1096-8628(19971031)72:3<257::AID-AJMG2>3.0.CO;2-O
   Bleyl SB, 1997, AM J HUM GENET, V61, P868, DOI 10.1086/514879
   Bohrer Thomas, 2006, HEART LUNG CIRC, V15, P269, DOI 10.1016/j.hlc.2006.02.007
   Bongers EMHF, 2008, EUR J HUM GENET, V16, P1240, DOI 10.1038/ejhg.2008.83
   BRAILEY LL, 2006, AM COLL MED GENET, V0, P0
   Breckenridge RA, 2007, CARDIOL YOUNG, V17, P124, DOI 10.1017/S1047951107000273
   Budde BS, 2007, PLOS ONE, V2, P0, DOI 10.1371/journal.pone.0001362
   Burke A, 2005, HUM PATHOL, V36, P403, DOI 10.1016/j.humpath.2005.02.004
   Chen R, 2002, MOL GENET METAB, V77, P319, DOI 10.1016/S1096-7192(02)00195-6
   CHIN TK, 1990, CIRCULATION, V82, P507, DOI 10.1161/01.CIR.82.2.507
   Corrado G, 2006, CARDIOLOGY, V105, P142, DOI 10.1159/000091152
   Davili Z, 2007, EUR J PEDIATR, V166, P867, DOI 10.1007/s00431-006-0310-1
   De Rosa G, 2005, EUR J PEDIATR, V164, P255, DOI 10.1007/s00431-005-1620-4
   de Vries PJ, 2006, J INTELL DISABIL RES, V50, P690, DOI 10.1111/j.1365-2788.2006.00817.x
   Donati MA, 2006, J INHERIT METAB DIS, V29, P684, DOI 10.1007/s10545-006-0388-7
   DUSEK J, 1975, ARCH PATHOL, V99, P312
   EDSTON E, 2008, INT J LEGAL IN PRESS, V0, P0
   ENGBERDING R, 1984, AM J CARDIOL, V53, P1733, DOI 10.1016/0002-9149(84)90618-0
   EURLINGS LW, 2008, INT J CARDI IN PRESS, V0, P0
   Fazio G, 2007, J CARDIOVASC MED, V8, P904, DOI 10.2459/JCM.0b013e32801462b0
   Fichet J, 2007, PACE, V30, P444, DOI 10.1111/j.1540-8159.2007.00690.x
   Filesi I, 2005, PHYSIOL GENOMICS, V23, P150, DOI 10.1152/physiolgenomics.00060.2005
   Finsterer J, 1998, HEART, V80, P632, DOI 10.1136/hrt.80.6.632
   Finsterer J, 2000, EUR NEUROL, V44, P37, DOI 10.1159/000008190
   Finsterer J, 2006, INT J CARDIOL, V106, P420, DOI 10.1016/j.ijcard.2005.01.018
   Finsterer J, 2005, CARDIOLOGY, V103, P167, DOI 10.1159/000084588
   Finsterer J, 2004, CARDIOLOGY, V102, P228, DOI 10.1159/000081015
   Finsterer J, 2004, ACTA CARDIOL, V59, P453, DOI 10.2143/AC.59.4.2005215
   Finsterer J, 2001, EUR NEUROL, V46, P92, DOI 10.1159/000050770
   Finsterer J, 2001, CAN J CARDIOL, V17, P464
   Finsterer J, 2001, HERZ, V26, P477, DOI 10.1007/PL00002051
   FINSTERER J, 2008, INT J CARDI IN PRESS, V0, P0
   FINSTERER J, 2008, HEART VESSE IN PRESS, V0, P0
   Finsterer J, 2008, CLIN CARDIOL, V31, P225, DOI 10.1002/clc.20224
   Finsterer J, 2008, SCAND CARDIOVASC J, V42, P25, DOI 10.1080/14017430701744451
   Finsterer J, 2008, INT J CARDIOL, V123, PE45, DOI 10.1016/j.ijcard.2006.11.120
   Finsterer J, 2007, J CARDIOVASC MED, V8, P1069, DOI 10.2459/JCM.0b013e3280bad892
   Finsterer J, 2007, CARDIOVASC PATHOL, V16, P310, DOI 10.1016/j.carpath.2006.12.005
   Finsterer J, 2007, J ELECTROCARDIOL, V40, P352, DOI 10.1016/j.jelectrocard.2006.11.008
   Finsterer J, 2006, SOUTH MED J, V99, P1304, DOI 10.1097/01.smj.0000247264.90880.d1
   Fishbein WN, 1999, ANN NEUROL, V45, P547, DOI 10.1002/1531-8249(199904)45:4<547::AID-ANA25>3.0.CO;2-L
   Gasser T, 2001, EUR J NEUROL, V8, P407
   Grady RM, 1999, NAT CELL BIOL, V1, P215, DOI 10.1038/12034
   HAPPLE R, 1993, AM J MED GENET, V47, P710, DOI 10.1002/ajmg.1320470525
   Hermida-Prieto M, 2004, AM J CARDIOL, V94, P50, DOI 10.1016/j.amjcard.2004.03.029
   Hoedemaekers YM, 2007, EUR HEART J, V28, P2732, DOI 10.1093/eurheartj/ehm429
   Hofer M, 2007, INT J CARDIOL, V121, P296, DOI 10.1016/j.ijcard.2006.08.065
   Hook S, 1996, PEDIATR CARDIOL, V17, P43, DOI 10.1007/s002469900008
   Hussein A, 1999, KLIN PADIATR, V211, P175, DOI 10.1055/s-2008-1043782
   Ichida F, 1999, J AM COLL CARDIOL, V34, P233, DOI 10.1016/S0735-1097(99)00170-9
   Ichida F, 2001, CIRCULATION, V103, P1256
   Iglesias LM, 2008, REV ESP CARDIOL, V61, P112, DOI 10.1016/S1885-5857(08)60085-7
   Ilercil A, 2006, ECHOCARDIOGR-J CARD, V23, P432, DOI 10.1111/j.1540-8175.2006.00232.x
   Jenni R, 2007, HEART, V93, P11, DOI 10.1136/hrt.2005.082271
   Jenni R, 2002, J AM COLL CARDIOL, V39, P450, DOI 10.1016/S0735-1097(01)01765-X
   Johnson MT, 2006, AM HEART J, V151, P0, DOI 10.1016/j.ahj.2006.01.021
   Jones KJ, 2003, NEUROMUSCULAR DISORD, V13, P456, DOI 10.1016/S0960-8966(03)00066-X
   Junga G, 1999, EUR HEART J, V20, P910, DOI 10.1053/euhj.1998.1398
   Kaneda T, 2005, CIRCULATION, V112, PE96, DOI 10.1161/CIRCULATIONAHA.104.500256
   Kanemoto N, 2006, EUR J MED GENET, V49, P247, DOI 10.1016/j.ejmg.2005.06.004
   Kaski JP, 2008, HEART, V94, P1478, DOI 10.1136/hrt.2007.134684
   Kawasaki T, 2005, INT J CARDIOL, V99, P147, DOI 10.1016/j.ijcard.2003.11.029
   Kenton AB, 2004, MOL GENET METAB, V82, P162, DOI 10.1016/j.ymgme.2004.02.009
   KHALID SK, 2004, J AM SOC ECHOCARDIOG, V17, P87
   Kherbaoui-Redouani L, 2003, ARCH PEDIATRIE, V10, P224, DOI 10.1016/S0929-693X(03)00014-9
   Kirsch Jacobo, 2007, INT J CARDIOL, V118, Pe46, DOI 10.1016/j.ijcard.2006.12.056
   Klaassen S, 2008, CIRCULATION, V117, P2893, DOI 10.1161/CIRCULATIONAHA.107.746164
   Kline AD, 2007, AM J MED GENET A, V143A, P1287, DOI 10.1002/ajmg.a.31757
   Kobza R, 2008, PACE, V31, P461, DOI 10.1111/j.1540-8159.2008.01015.x
   Korcyk D, 2004, J CARDIOVASC MAGN R, V6, P569, DOI 10.1081/JCMR-120030586
   Kuijpers TW, 2004, BLOOD, V103, P3915, DOI 10.1182/blood-2003-11-3940
   Limongelli G, 2007, AM J CARDIOL, V100, P736, DOI 10.1016/j.amjcard.2007.03.093
   Lofiego C, 2006, AM J CARDIOL, V97, P738, DOI 10.1016/j.amjcard.2005.09.109
   MAKITA N, 2006, AM HEART ASS SCI SES, V0, P0
   Mandel K, 2001, CARDIOL YOUNG, V11, P240, DOI 10.1017/S1047951101000208
   Marino B, 1999, J PEDIATR-US, V135, P703, DOI 10.1016/S0022-3476(99)70088-0
   Marziliano N, 2007, AM J MED GENET A, V143A, P907, DOI 10.1002/ajmg.a.31653
   Matsumoto Tae, 2006, JOURNAL OF NIPPON MEDICAL SCHOOL, V73, P285, DOI 10.1272/jnms.73.285
   Mazzocco MMM, 2001, AM J MED GENET, V102, P372, DOI 10.1002/ajmg.1487
   McMahon CJ, 2007, HEART, V93, P676, DOI 10.1136/hrt.2006.093880
   Miner JH, 2008, MICROSC RES TECHNIQ, V71, P349, DOI 10.1002/jemt.20563
   Monserrat L, 2007, EUR HEART J, V28, P1953, DOI 10.1093/eurheartj/ehm239
   Moorman AFM, 1999, HEART DEV, V0, P195
   Murphy RT, 2005, EUR HEART J, V26, P187, DOI 10.1093/eurheartj/ehi025
   Nakamura T, 2007, J CLIN INVEST, V117, P2123, DOI 10.1172/JCI30756
   Nemes A, 2008, INT J CARDIOVAS IMAG, V24, P237, DOI 10.1007/s10554-007-9261-5
   Neudorf UE, 2001, CARDIOL YOUNG, V11, P439, DOI 10.1017/S1047951101000567
   Norman B, 1998, J APPL PHYSIOL, V85, P1273, DOI 10.1152/jappl.1998.85.4.1273
   Oechslin EN, 2000, J AM COLL CARDIOL, V36, P493, DOI 10.1016/S0735-1097(00)00755-5
   Olasoji H O, 2007, NIGER POSTGRAD MED J, V14, P140
   Pascal C, 2005, ARCH MAL COEUR VAISS, V98, P443
   Pauli RM, 1999, AM J MED GENET, V85, P419, DOI 10.1002/(SICI)1096-8628(19990806)85:4<419::AID-AJMG21>3.0.CO;2-S
   Petersen SE, 2005, J AM COLL CARDIOL, V46, P101, DOI 10.1016/j.jacc.2005.03.045
   PFAMMATTER JP, 1995, Z KARDIOL, V84, P947
   Phillips HM, 2007, CIRC RES, V101, P137, DOI 10.1161/CIRCRESAHA.106.142406
   Pignatelli RH, 2003, CIRCULATION, V108, P2672, DOI 10.1161/01.CIR.0000100664.10777.B8
   Porciello R, 2008, DERMATOL ONLINE J, V14, P7
   Rankin J, 2008, AM J MED GENET A, V146A, P1530, DOI 10.1002/ajmg.a.32331
   RIBEIRO MCM, 1987, ANN GENET-PARIS, V30, P126
   Rico-Sanz J, 2003, PHYSIOL GENOMICS, V14, P161, DOI 10.1152/physiolgenomics.00165.2002
   Ronghe MD, 2001, ACTA PAEDIATR, V90, P584, DOI 10.1080/080352501750197773
   SA MI, 2007, REV PORT CARDIOL, V27, P829
   Sabina RL, 2000, NEUROL CLIN, V18, P185, DOI 10.1016/S0733-8619(05)70184-5
   Sarkozy A, 2008, ORPHANET J RARE DIS, V3, P0, DOI 10.1186/1750-1172-3-13
   Sasse-Klaassen S, 2004, CIRCULATION, V109, P2720, DOI 10.1161/01.CIR.0000131865.21260.56
   Scaglia F, 2004, PEDIATRICS, V114, P925, DOI 10.1542/peds.2004-0718
   Schott JJ, 1998, SCIENCE, V281, P108, DOI 10.1126/science.281.5373.108
   Sedmera David, 2008, HEART FAIL CLIN, V4, P235, DOI 10.1016/j.hfc.2008.02.007
   Selcen D, 2005, ANN NEUROL, V57, P269, DOI 10.1002/ana.20376
   Sen-Chowdhry S, 2008, CURR OPIN CARDIOL, V23, P171, DOI 10.1097/HCO.0b013e3282fdc939
   Serés L, 2003, CLIN CARDIOL, V26, P46, DOI 10.1002/clc.4960260111
   Shan L, 2008, MOL GENET METAB, V93, P468, DOI 10.1016/j.ymgme.2007.10.009
   SIBERG K, 2008, EUR J MED G IN PRESS, V0, P0
   Soler R, 2002, J COMPUT ASSIST TOMO, V26, P373, DOI 10.1097/00004728-200205000-00011
   Spencer CT, 2006, PEDIATRICS, V118, PE337, DOI 10.1542/peds.2005-2667
   Spirito P, 2007, EUR HEART J, V28, P1923, DOI 10.1093/eurheartj/ehm266
   Steiner I, 1996, CARDIOVASC PATHOL, V5, P47, DOI 10.1016/1054-8807(95)00058-5
   Stöllberger C, 2007, J CARD FAIL, V13, P211, DOI 10.1016/j.cardfail.2006.11.007
   Stollberger C, 1996, HEART, V76, P380, DOI 10.1136/hrt.76.4.380
   Stöllberger C, 2002, AM J CARDIOL, V90, P899, DOI 10.1016/S0002-9149(02)02723-6
   Stöllberger C, 2004, J AM SOC ECHOCARDIOG, V17, P91, DOI 10.1016/S0894-7317(03)00514-5
   STOLLBERGER C, 2008, ACTA CARDIO IN PRESS, V0, P0
   Stöllberger C, 2007, INT J CARDIOL, V121, P189, DOI 10.1016/j.ijcard.2006.11.007
   TANPAIBOON P, 2006, AM SOC HUM GEN ANN M, V0, P0
   Thienpont B, 2007, EUR J MED GENET, V50, P233, DOI 10.1016/j.ejmg.2007.01.002
   Toyono M, 2001, HEART, V86, P0
   TURLEAU C, 1983, ANN GENET-PARIS, V26, P161
   van Heerde M, 2003, CARDIOL YOUNG, V13, P364, DOI 10.1017/S1047951103000738
   Vatta M, 2003, J AM COLL CARDIOL, V42, P2014, DOI 10.1016/j.jacc.2003.10.021
   Vijayvergiya R, 2008, INT J CARDIOL, V123, PE54, DOI 10.1016/j.ijcard.2006.11.147
   Wahbi K, 2008, NEUROMUSCULAR DISORD, V18, P331, DOI 10.1016/j.nmd.2007.11.012
   Wang JC, 2007, AM J MED GENET A, V143A, P2744, DOI 10.1002/ajmg.a.32004
   Watson WJ, 2007, J ULTRAS MED, V26, P1209, DOI 10.7863/jum.2007.26.9.1209
   Wessels MW, 2008, HUM GENET, V122, P595, DOI 10.1007/s00439-007-0436-x
   Wheeler TM, 2007, CURR OPIN NEUROL, V20, P572, DOI 10.1097/WCO.0b013e3282ef6064
   Wong JA, 1997, AM J MED GENET, V71, P72, DOI 10.1002/(SICI)1096-8628(19970711)71:1<72::AID-AJMG13>3.0.CO;2-S
   Xing YL, 2006, MOL GENET METAB, V88, P71, DOI 10.1016/j.ymgme.2005.11.009
   Yaplito-Lee J, 2007, J PEDIATR-US, V150, P407, DOI 10.1016/j.jpeds.2006.12.047
   Yen TY, 2008, EUR J PEDIATR, V167, P941, DOI 10.1007/s00431-007-0592-y
   Zaragoza MV, 2007, CURR OPIN PEDIATR, V19, P619, DOI 10.1097/MOP.0b013e3282f1ecbc
   Zhou Q, 2001, J CELL BIOL, V155, P605, DOI 10.1083/jcb.200107092
   Zimpfer A, 2007, FETAL PEDIATR PATHOL, V26, P169, DOI 10.1080/15513810701696874
NR 153
TC 166
Z9 192
U1 2
U2 18
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0172-0643
EI 1432-1971
J9 PEDIATR CARDIOL
JI Pediatr. Cardiol.
PD JUL 15
PY 2009
VL 30
IS 5
BP 659
EP 681
DI 10.1007/s00246-008-9359-0
PG 23
WC Cardiac & Cardiovascular Systems; Pediatrics
SC Cardiovascular System & Cardiology; Pediatrics
GA 458ON
UT WOS:000267033500012
PM 19184181
DA 2024-11-01
ER

PT J
AU Bulst, S
   Abicht, A
   Holinski-Feder, E
   Müller-Ziermann, S
   Koehler, U
   Thirion, C
   Walter, MC
   Stewart, JD
   Chinnery, PF
   Lochmüller, H
   Horvath, R
AF Bulst, Stefanie
   Abicht, Angela
   Holinski-Feder, Elke
   Mueller-Ziermann, Solvig
   Koehler, Udo
   Thirion, Christian
   Walter, Maggie C.
   Stewart, Joanna D.
   Chinnery, Patrick F.
   Lochmueller, Hanns
   Horvath, Rita
TI <i>In vitro</i> supplementation with dAMP/dGMP leads to partial restoration of mtDNA levels in mitochondrial depletion syndromes
SO HUMAN MOLECULAR GENETICS
LA English
DT Article
ID dna depletion; thymidine kinase; sucla2 mutations; pool sizes; encephalomyopathy; deficiency; gene; myopathy; defects; phosphorylase
AB Mitochondrial DNA depletion syndrome, a frequent cause of childhood (hepato)encephalomyopathies, is defined as a reduction of mitochondrial DNA copy number related to nuclear DNA. It was previously shown that mtDNA depletion can be prevented by dAMP/dGMP supplementation in deoxyguanosine kinase-deficient fibroblasts. We investigated myotubes of patients diagnosed with mtDNA depletion carrying pathogenic mutations in DGUOK, POLG1 (Alpers syndrome) and TYMP. Differentiating myotubes of all patients and controls were supplemented with different doses of dAMP/dGMP or dAMP/dGMP/dCMP in TYMP deficiency, and analysed for mtDNA/nDNA ratio and for cytochrome c oxidase (COX) activity. Serum deprivation and myotube formation triggered a decrease in mtDNA copy number in DGUOK or POLG1 deficient myotubes, but not in TYMP deficiency and healthy controls. Supplementation with dAMP/dGMP leads to a significant and reproducible rescue of mtDNA depletion in DGUOK deficiency. POLG1 deficient myotubes also showed a mild, not significant increase in mtDNA copy number. MtDNA depletion did not result in deficient COX staining in DGUOK and POLG1-deficient myotubes. Treatment with ethidium bromide resulted in very severe depletion and absence of COX staining in all cell types, and no recovery was observed after supplementation with dAMP/dGMP. We show that supplementation with dAMP/dGMP increases mtDNA copy number significantly in DGUOK deficient myotubes and, leads to a mild, non-significant improvement of mtDNA depletion in POLG1 deficiency. No adverse effect on mtDNA copy number was observed on high-dose supplementation in vitro. Further studies are needed to determine possible therapeutic implications of dAMP/dGMP supplementation for DGUOK deficiency in vivo.
C1 [Bulst, Stefanie; Abicht, Angela; Thirion, Christian; Walter, Maggie C.; Horvath, Rita] Univ Munich, Friedrich Baur Inst, Dept Neurol, D-80539 Munich, Germany.
   [Abicht, Angela; Holinski-Feder, Elke; Mueller-Ziermann, Solvig; Koehler, Udo; Horvath, Rita] Ctr Med Genet, Munich, Germany.
   [Stewart, Joanna D.; Chinnery, Patrick F.; Horvath, Rita] Newcastle Univ, Mitochondrial Res Grp, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
   [Lochmueller, Hanns] Newcastle Univ, Inst Human Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
C3 University of Munich; Newcastle University - UK; Newcastle University - UK
RP Horvath, R (corresponding author), Univ Munich, Friedrich Baur Inst, Dept Neurol, D-80539 Munich, Germany.
EM rita.horvath@ncl.ac.uk
FU Deutsche Forschungsgemeinschaft [HO2505/2-1]; German ministry of education and research (BMBF, Bonn, Germany) [01GM0601]; TREAT- NMD [036825]
CR Alberio S, 2007, MITOCHONDRION, V7, P6, DOI 10.1016/j.mito.2006.11.010
   Ashley N, 2008, HUM MOL GENET, V17, P2496, DOI 10.1093/hmg/ddn150
   Ashley N, 2007, HUM MOL GENET, V16, P1400, DOI 10.1093/hmg/ddm090
   Berridge MV, 2005, BIOTECHNOL ANN REV, V11, P127, DOI 10.1016/S1387-2656(05)11004-7
   Blakely EL, 2004, J MED GENET, V41, P0, DOI 10.1136/jmg.2003.011296
   BOGENHAGEN D, 1976, J BIOL CHEM, V251, P2938
   Bornstein B, 2008, NEUROMUSCULAR DISORD, V18, P453, DOI 10.1016/j.nmd.2008.04.006
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   Carrozzo R, 2007, BRAIN, V130, P862, DOI 10.1093/brain/awl389
   Desler C, 2007, MUTAT RES-FUND MOL M, V625, P112, DOI 10.1016/j.mrfmmm.2007.06.002
   Diaz F, 2002, NUCLEIC ACIDS RES, V30, P4626, DOI 10.1093/nar/gkf602
   Durham SE, 2005, NEUROLOGY, V65, P453, DOI 10.1212/01.wnl.0000171861.30277.88
   Elpeleg O, 2005, AM J HUM GENET, V76, P1081, DOI 10.1086/430843
   ENRIQUEZ JA, 1994, NUCLEIC ACIDS RES, V22, P1861, DOI 10.1093/nar/22.10.1861
   Ferraro P, 2006, P NATL ACAD SCI USA, V103, P18586, DOI 10.1073/pnas.0609020103
   FISCHER JC, 1986, EUR J PEDIATR, V144, P441, DOI 10.1007/BF00441735
   Freisinger P, 2006, ARCH NEUROL-CHICAGO, V63, P1129, DOI 10.1001/archneur.63.8.1129
   Gazziola C, 2001, J BIOL CHEM, V276, P6185, DOI 10.1074/jbc.M007623200
   Hirano M, 2000, BRAIN PATHOL, V10, P451
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   KAROL MH, 1968, SCIENCE, V162, P470, DOI 10.1126/science.162.3852.470
   Lascaratos G, 2007, VISION RES, V47, P1191, DOI 10.1016/j.visres.2006.12.014
   Leanza L, 2008, J BIOL CHEM, V283, P16437, DOI 10.1074/jbc.M801572200
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   Mathews CK, 2007, FASEB J, V21, P2294, DOI 10.1096/fj.06-7977rev
   MORAES CT, 1991, AM J HUM GENET, V48, P492
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Ostergaard E, 2007, AM J HUM GENET, V81, P383, DOI 10.1086/519222
   Ostergaard E, 2007, BRAIN, V130, P853, DOI 10.1093/brain/awl383
   Pontarin G, 2003, P NATL ACAD SCI USA, V100, P12159, DOI 10.1073/pnas.1635259100
   Pontarin G, 2006, J BIOL CHEM, V281, P22720, DOI 10.1074/jbc.M604498200
   Rampazzo C, 2004, J BIOL CHEM, V279, P17019, DOI 10.1074/jbc.M313957200
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Saada A, 2008, MOL GENET METAB, V95, P169, DOI 10.1016/j.ymgme.2008.07.007
   Sandrini MPB, 2005, TRENDS BIOCHEM SCI, V30, P225, DOI 10.1016/j.tibs.2005.03.003
   Sarzi E, 2007, J PEDIATR-US, V150, P531, DOI 10.1016/j.jpeds.2007.01.044
   SELIGMAN AM, 1968, J CELL BIOL, V38, P1, DOI 10.1083/jcb.38.1.1
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Spinazzola A, 2005, GENE, V354, P162, DOI 10.1016/j.gene.2005.03.025
   Spinazzola A, 2002, J BIOL CHEM, V277, P4128, DOI 10.1074/jbc.M111028200
   Sumption ND, 2006, MUTAT RES-FUND MOL M, V594, P30, DOI 10.1016/j.mrfmmm.2005.07.007
   Taanman JW, 2003, HUM MOL GENET, V12, P1839, DOI 10.1093/hmg/ddg192
   Torres SM, 2007, ENVIRON MOL MUTAGEN, V48, P224, DOI 10.1002/em.20264
   Wang JH, 2000, BIOCHEM PHARMACOL, V59, P1583, DOI 10.1016/S0006-2952(00)00285-9
   Wang LY, 2003, J BIOL CHEM, V278, P6963, DOI 10.1074/jbc.M206143200
NR 46
TC 41
Z9 45
U1 0
U2 4
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0964-6906
EI 1460-2083
J9 HUM MOL GENET
JI Hum. Mol. Genet.
PD MAY 1
PY 2009
VL 18
IS 9
BP 1590
EP 1599
DI 10.1093/hmg/ddp074
PG 10
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA 431WS
UT WOS:000265096100005
PM 19221117
DA 2024-11-01
ER

PT J
AU Blakely, EL
   Trip, SA
   Swalwell, H
   He, LP
   Wren, DR
   Rich, P
   Turnbull, DM
   Omer, SE
   Taylor, RW
AF Blakely, Emma L.
   Trip, S. Anand
   Swalwell, Helen
   He, Langping
   Wren, Damian R.
   Rich, Philip
   Turnbull, Douglass M.
   Omer, Salah E.
   Taylor, Robert W.
TI A New Mitochondrial Transfer RNA<SUP>Pro</SUP> Gene Mutation Associated With Myoclonic Epilepsy With Ragged-Red Fibers and Other Neurological Features
SO ARCHIVES OF NEUROLOGY
LA English
DT Article
ID transfer-rna; mtdna mutation; skeletal-muscle; point mutation; dna mutations; human-disease; patient; merrf; transmission; trna(lys)
AB Background: Pathogenic mutations of the human mitochondrial genome are associated with well-characterized, progressive neurological syndromes, with mutations in the transfer RNA genes being particularly prominent. Objective: To describe a novel mitochondrial transfer RNA(Pro) gene mutation in a woman with a myoclonic epilepsy with ragged-red fibers-like disease. Design, Setting, and Patient: Case report of a 49-year-old woman presenting with a myoclonic epilepsy with ragged-red fibers-like disease comprising myoclonic jerks, cerebellar ataxia, and proximal muscle weakness. Results: Histochemical analysis of a muscle biopsy revealed numerous cytochrome-c oxidase-deficient, ragged-red fibers, while biochemical studies indicated decreased activity of respiratory chain complex I. Molecular investigation of mitochondrial DNA revealed a new heteroplasmic mutation in the T psi C stem of the mitochondrial transfer RNA(Pro) gene that segregated with cytochrome-c oxidase deficiency in single muscle fibers. Conclusions: Our case serves to illustrate the everevolving phenotypic spectrum of mitochondrial DNA disease and the importance of performing comprehensive mitochondrial genetic studies in the absence of common mitochondrial DNA mutations.
C1 [Blakely, Emma L.; Swalwell, Helen; He, Langping; Turnbull, Douglass M.; Taylor, Robert W.] Univ Newcastle, Sch Med, Mitochondrial Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Trip, S. Anand] Natl Hosp Neurol & Neurosurg, Dept Clin Neurol, London WC1N 3BG, England.
   [Wren, Damian R.; Rich, Philip; Omer, Salah E.] St George Hosp, Dept Neurol, London, England.
   [Wren, Damian R.; Rich, Philip; Omer, Salah E.] St George Hosp, Dept Neuroradiol, London, England.
C3 Newcastle University - UK; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; City St Georges, University of London; City St Georges, University of London
RP Taylor, RW (corresponding author), Univ Newcastle, Sch Med, Mitochondrial Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM r.w.taylor@ncl.ac.uk
FU Wellcome Trust; Newcastle upon Tyne Hospitals NHS Trust; UK National Commissioning Group for Rare Mitochondrial Disorders of Adults and Children
CR Dimauro S, 2001, AM J MED GENET, V106, P18, DOI 10.1002/ajmg.1392
   Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786
   Fu K, 1996, HUM MOL GENET, V5, P1835, DOI 10.1093/hmg/5.11.1835
   Houshmand M, 1999, HUM MUTAT, V13, P203, DOI 10.1002/(SICI)1098-1004(1999)13:3<203::AID-HUMU4>3.0.CO;2-3
   Ingman M, 2006, NUCLEIC ACIDS RES, V34, PD749, DOI 10.1093/nar/gkj010
   Kirby DM, 2007, METHOD CELL BIOL, V80, P93, DOI 10.1016/S0091-679X(06)80004-X
   Mancuso M, 2004, NEUROLOGY, V62, P2119, DOI 10.1212/01.WNL.0000127608.48406.F1
   McFarland R, 2004, TRENDS GENET, V20, P591, DOI 10.1016/j.tig.2004.09.014
   MORAES CT, 1993, NAT GENET, V4, P284, DOI 10.1038/ng0793-284
   Ozawa M, 1997, MUSCLE NERVE, V20, P271, DOI 10.1002/(SICI)1097-4598(199703)20:3<271::AID-MUS2>3.0.CO;2-8
   Pütz J, 2007, RNA, V13, P1184, DOI 10.1261/rna.588407
   Rahman S, 2001, AM J HUM GENET, V68, P238, DOI 10.1086/316930
   Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, PD823, DOI 10.1093/nar/gkl927
   Seneca S, 2000, J INHERIT METAB DIS, V23, P853, DOI 10.1023/A:1026729223050
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   SILVESTRI G, 1992, AM J HUM GENET, V51, P1213
   Stewart JB, 2008, PLOS BIOL, V6, P63, DOI 10.1371/journal.pbio.0060010
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Taylor RW, 2002, NEUROMUSCULAR DISORD, V12, P659, DOI 10.1016/S0960-8966(02)00026-3
   Weber K, 1997, AM J HUM GENET, V60, P373
   Wong LJC, 2002, AM J MED GENET, V113, P59, DOI 10.1002/ajmg.10767
NR 21
TC 33
Z9 34
U1 0
U2 3
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 515 N STATE ST, CHICAGO, IL 60654-0946 USA
SN 0003-9942
EI 
J9 ARCH NEUROL-CHICAGO
JI Arch. Neurol.
PD MAR 15
PY 2009
VL 66
IS 3
BP 399
EP 402
DI 
PG 4
WC Clinical Neurology
SC Neurosciences & Neurology
GA 416EY
UT WOS:000263989600017
PM 19273760
DA 2024-11-01
ER

PT J
AU Dobrowolski, SF
   Gray, J
   Miller, T
   Sears, M
AF Dobrowolski, Steven F.
   Gray, Jesse
   Miller, Trent
   Sears, Mitch
TI Identifying Sequence Variants in the Human Mitochondrial Genome Using High-Resolution Melt (HRM) Profiling
SO HUMAN MUTATION
LA English
DT Article
DE melt profiling; HRM; HRMA; mitochondria; heteroplasmy; MERRF; MELAS
ID single-nucleotide polymorphisms; polymerase-chain-reaction; point mutations; colorectal-cancer; rapid detection; small amplicons; dna mutations; gene; disorders; egfr
AB Identifying mitochondrial DNA (mtDNA) sequence variants in human diseases is complicated. Many pathological mutations are heteroplasmic, with the mutant allele represented at highly variable percentages. High-resolution melt (HRM or HRMA) profiling was applied to comprehensive assessment of the mitochondrial genome and targeted assessment of recognized pathological mutations. The assay panel providing comprehensive coverage of the mitochondrial genome utilizes 36 overlapping fragment (301-658bp) that employ a common PCR protocol. The comprehensive assay identified heteroplasmic mutation in 33 out of 33 patient specimens tested. Allele fraction among the specimens ranged from 1 to 100%. The comprehensive assay panel was also used to assess 125 mtDNA specimens from healthy donors, which identified 431 unique sequence variants. Utilizing the comprehensive mtDNA panel, the mitochondrial genome of a patient specimen may be assessed in less than I day using a single 384-well plate or two 96-well plates. Specific assays were used to identify the myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS) mutation m.3243A>G, myoclonus epilepsy, ragged red fibers (MERRF) mutation m.8344A>G, and m.1555A>G associated with aminoglycoside hearing loss. These assays employ a calibrated, amplicon-based strategy that is exceedingly simple in design, utilization, and interpretation, yet provides sensitivity to detect variants at and below 10% heteroplasmy. Turnaround time for the genotyping tests is about 1 hr. Hum Mutat 30, 891-898, 2009. (C) 2009 Wiley-Liss, Inc.
C1 [Dobrowolski, Steven F.; Gray, Jesse; Miller, Trent] Idaho Technol, Salt Lake City, UT 84108 USA.
   [Sears, Mitch] ARUP Labs, Salt Lake City, UT USA.
C3 Utah System of Higher Education; University of Utah; ARUP Laboratories
RP Dobrowolski, SF (corresponding author), Idaho Technol, 390 Wakara Way, Salt Lake City, UT 84108 USA.
EM steven_dobrowolski@idahotech.com
CR ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Andreu AL, 2003, J NEUROL, V250, P1403, DOI 10.1007/s00415-003-0281-3
   Bastien R, 2008, HUM MUTAT, V29, P757, DOI 10.1002/humu.20726
   De Leeneer K, 2008, CLIN CHEM, V54, P982, DOI 10.1373/clinchem.2007.098764
   Do H, 2008, BMC CANCER, V8, P0, DOI 10.1186/1471-2407-8-142
   Dobrowolski SE, 2005, HUM MUTAT, V25, P306, DOI 10.1002/humu.20137
   Dobrowolski SF, 2007, HUM MUTAT, V28, P1133, DOI 10.1002/humu.20558
   Dobrowolski SF, 2007, MOL GENET METAB, V91, P218, DOI 10.1016/j.ymgme.2007.03.010
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   Erali M, 2008, EXP MOL PATHOL, V85, P50, DOI 10.1016/j.yexmp.2008.03.012
   Fan AXC, 2008, CLIN CHEM LAB MED, V46, P299, DOI 10.1515/CCLM.2008.071
   Fukui T, 2008, CLIN CANCER RES, V14, P4751, DOI 10.1158/1078-0432.CCR-07-5207
   Gundry CN, 2008, NUCLEIC ACIDS RES, V36, P3401, DOI 10.1093/nar/gkn204
   Hatsch D, 2007, J FORENSIC SCI, V52, P891, DOI 10.1111/j.1556-4029.2007.00473.x
   Laurie AD, 2009, CLIN BIOCHEM, V42, P528, DOI 10.1016/j.clinbiochem.2008.11.015
   Liew M, 2004, CLIN CHEM, V50, P1156, DOI 10.1373/clinchem.2004.032136
   MCKINNEY JT, 2007, ANN M AM SOC HUM GEN, V0, P23
   Mithani SK, 2007, CLIN CANCER RES, V13, P7335, DOI 10.1158/1078-0432.CCR-07-0220
   Montgomery J, 2007, NAT PROTOC, V2, P59, DOI 10.1038/nprot.2007.10
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   Palais RA, 2005, ANAL BIOCHEM, V346, P167, DOI 10.1016/j.ab.2005.08.010
   Simi L, 2008, AM J CLIN PATHOL, V130, P247, DOI 10.1309/LWDY1AXHXUULNVHQ
   Sternberg D, 1998, HUM MOL GENET, V7, P33, DOI 10.1093/hmg/7.1.33
   Takano T, 2008, J CLIN ONCOL, V26, P5589, DOI 10.1200/JCO.2008.16.7254
   Tobe SS, 2008, FORENSIC SCI INT-GEN, V2, P249, DOI 10.1016/j.fsigen.2008.03.002
   van den Bosch BJC, 2000, NUCLEIC ACIDS RES, V28, P0, DOI 10.1093/nar/28.20.e89
   van Eijsden RGE, 2006, GENET MED, V8, P620, DOI 10.1097/01.gim.0000237782.94878.05
   Wang JY, 2008, J ZHEJIANG UNIV-SC B, V9, P610, DOI 10.1631/jzus.B0820058
   Wang L, 2008, CANCER EPIDEM BIOMAR, V17, P3558, DOI 10.1158/1055-9965.EPI-08-0434
   Webb E, 2008, BRIT J CANCER, V99, P2088, DOI 10.1038/sj.bjc.6604805
   White HE, 2005, GENET TEST, V9, P190, DOI 10.1089/gte.2005.9.190
   Wittwer CT, 2003, CLIN CHEM, V49, P853, DOI 10.1373/49.6.853
   Wong Lee-Jun C, 2006, V335, V0, P187
   Wong LJC, 2007, MITOCHONDRION, V7, P45, DOI 10.1016/j.mito.2006.11.025
   Wong Lee-Jun C, 2006, V336, V0, P135
   Wong LJC, 1997, CLIN CHEM, V43, P1857
   Wong LJC, 2004, ELECTROPHORESIS, V25, P2602, DOI 10.1002/elps.200406016
   Wong LJC, 2002, CLIN CHEM, V48, P1901
   Zhou LM, 2004, CLIN CHEM, V50, P1328, DOI 10.1373/clinchem.2004.034322
NR 39
TC 60
Z9 65
U1 0
U2 7
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1059-7794
EI 
J9 HUM MUTAT
JI Hum. Mutat.
PD JUN 15
PY 2009
VL 30
IS 6
BP 891
EP 898
DI 10.1002/humu.21003
PG 8
WC Genetics & Heredity
SC Genetics & Heredity
GA 466BJ
UT WOS:000267635100006
PM 19370763
DA 2024-11-01
ER

PT J
AU Kollberg, G
   Darin, N
   Benan, K
   Moslemi, AR
   Lindal, S
   Tulinius, M
   Oldfors, A
   Holme, E
AF Kollberg, Gittan
   Darin, Niklas
   Benan, Karin
   Moslemi, Ali-Reza
   Lindal, Sigurd
   Tulinius, Mar
   Oldfors, Anders
   Holme, Elisabeth
TI A novel homozygous <i>RRM2B</i> missense mutation in association with severe mtDNA depletion
SO NEUROMUSCULAR DISORDERS
LA English
DT Article
DE mtDNA depletion; Mitochondrial myopathy; RRM2B; p53R2; Ribonucleotide reductase; dNTP synthesis
ID mitochondrial-dna; ribonucleotide reductase; damage; p53r2
AB This report describes two brothers, both deceased in infancy, with severe depletion of mitochondrial DNA (mtDNA) in muscle tissue. Both had feeding difficulties, failure to thrive, severe Muscular hypotonia and lactic acidosis. One of the boys developed a renal proximal tubulopathy. A novel homozygous c.686 G -> T missense mutation in the RRM2B gene, encoding the p53-inducible ribonucleotide reductase subunit (p53R2), was identified. This is the third report on mutations in RRM2B associated with severe mtDNA depletion, which further highlights the importance of de novo synthesis of deoxyribonucleotides (dNTPs) for mtDNA maintenance. (C) 2008 Elsevier B.V. All rights reserved.
C1 [Kollberg, Gittan; Holme, Elisabeth] Sahlgrens Univ Hosp, Dept Clin Chem, SE-41345 Gothenburg, Sweden.
   [Darin, Niklas; Tulinius, Mar] Queen Silvia Childrens Hosp, Dept Paediat, Gothenburg, Sweden.
   [Benan, Karin] Ullevaal Univ Hosp, Dept Paediat, Oslo, Norway.
   [Moslemi, Ali-Reza; Oldfors, Anders] Sahlgrens Univ Hosp, Dept Pathol, SE-41345 Gothenburg, Sweden.
   [Lindal, Sigurd] Univ Tromso Hosp, Dept Pathol, N-9012 Tromso, Norway.
C3 Sahlgrenska University Hospital; Queen Silvia Children's Hospital; University of Oslo; Sahlgrenska University Hospital; UiT The Arctic University of Tromso; University Hospital of North Norway
RP Kollberg, G (corresponding author), Sahlgrens Univ Hosp, Dept Clin Chem, Bruna Straket 16, SE-41345 Gothenburg, Sweden.
EM gittan.kollberg@gu.se
CR Alberio S, 2007, MITOCHONDRION, V7, P6, DOI 10.1016/j.mito.2006.11.010
   Andréasson H, 2002, BIOTECHNIQUES, V33, P402, DOI 10.2144/02332rr07
   Bornstein B, 2008, NEUROMUSCULAR DISORD, V18, P453, DOI 10.1016/j.nmd.2008.04.006
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   Guittet O, 2001, J BIOL CHEM, V276, P40647, DOI 10.1074/jbc.M106088200
   Håkansson P, 2006, J BIOL CHEM, V281, P7834, DOI 10.1074/jbc.M512894200
   Jordan A, 1998, ANNU REV BIOCHEM, V67, P71, DOI 10.1146/annurev.biochem.67.1.71
   Pronicki M, 2008, J CLIN PATHOL, V61, P460, DOI 10.1136/jcp.2007.051060
   Tanaka H, 2000, NATURE, V404, P42, DOI 10.1038/35003506
   Thelander L, 2007, NAT GENET, V39, P703, DOI 10.1038/ng0607-703
   Tulinius M, 2005, NEUROMUSCULAR DISORD, V15, P412, DOI 10.1016/j.nmd.2005.03.010
NR 11
TC 52
Z9 59
U1 0
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8966
EI 1873-2364
J9 NEUROMUSCULAR DISORD
JI Neuromusc. Disord.
PD FEB 15
PY 2009
VL 19
IS 2
BP 147
EP 150
DI 10.1016/j.nmd.2008.11.014
PG 4
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 414MA
UT WOS:000263866700010
PM 19138848
DA 2024-11-01
ER

PT J
AU Naess, K
   Freyer, C
   Bruhn, H
   Wibom, R
   Malm, G
   Nennesmo, I
   Döbeln, U
   Larsson, NG
AF Naess, Karin
   Freyer, Christoph
   Bruhn, Helene
   Wibom, Rolf
   Malm, Gunilla
   Nennesmo, Inger
   von Dobeln, Ulrika
   Larsson, Nils-Goran
TI MtDNA mutations are a common cause of severe disease phenotypes in children with Leigh syndrome
SO BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS
LA English
DT Article; Proceedings Paper
DE Leigh syndrome; Encephalopathy; Mitochondrial disorder; Neurologic disease/disorder; Paediatric disease
ID mitochondrial-dna mutation; complex-i deficiency; cytochrome-c-oxidase; hereditary optic neuropathy; missense mutation; oxidative-phosphorylation; clinical-features; alpers-syndrome; polg mutations; atp production
AB Leigh syndrome is a common clinical manifestation in children with mitochondrial disease and other types of inborn errors of metabolism. We characterised clinical symptoms, prognosis, respiratory chain function and performed extensive genetic analysis of 25 Swedish children suffering from Leigh syndrome with the aim to obtain insights into the molecular pathophysiology and to provide a rationale for genetic counselling. We reviewed the clinical history of all patients and used muscle biopsies in order to perform molecular, biochemical and genetic investigations, including sequencing the entire mitochondrial DNA (mtDNA), the mitochondrial DNA polymerase (POLGA) gene and the surfeit locus protein 1 (SURF1) gene. Respiratory chain enzyme activity measurements identified five patients with isolated complex I deficiency and five with combined enzyme deficiencies. No patient presented with isolated complex IV deficiency. Seven patients had a decreased ATP production rate. Extensive sequence analysis identified eight patients with pathogenic mtDNA mutations and one patient with mutations in POLGA. Mutations of mtDNA are a common cause of LS and mtDNA analysis should always be included in the diagnosis of LS patients, whereas SURF1 mutations are not a common cause of LS in Sweden. Unexpectedly, age of onset, clinical symptoms and prognosis did not reveal any clear differences in LS patients with mtDNA or nuclear DNA mutations. (C) 2008 Elsevier B.V. All rights reserved.
C1 [Freyer, Christoph; Larsson, Nils-Goran] Max Planck Inst Biol Ageing, D-50931 Cologne, Germany.
   [Naess, Karin; Freyer, Christoph; Bruhn, Helene; Wibom, Rolf; Nennesmo, Inger; von Dobeln, Ulrika; Larsson, Nils-Goran] Karolinska Inst, Dept Lab Med, S-14186 Huddinge, Sweden.
   [Naess, Karin; Malm, Gunilla] Karolinska Univ Hosp, Dept Clin Sci, S-14186 Huddinge, Sweden.
C3 Max Planck Society; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital
RP Larsson, NG (corresponding author), Max Planck Inst Biol Ageing, Gleueler Str 50A, D-50931 Cologne, Germany.
EM larsson@age.mpg.de
CR Abu-Amero Khaled K, 2005, OPHTHALMIC GENET, V26, P31, DOI 10.1080/13816810590918235
   ALM J, 1978, ANN CLIN BIOCHEM, V15, P245, DOI 10.1177/000456327801500159
   Ashley N, 2008, HUM MOL GENET, V17, P2496, DOI 10.1093/hmg/ddn150
   BARKOVICH AJ, 1993, AM J NEURORADIOL, V14, P1119
   Batandier C, 2000, HUM MUTAT, V16, P532, DOI 10.1002/1098-1004(200012)16:6<532::AID-HUMU19>3.0.CO;2-P
   Böhm M, 2006, PEDIATR RES, V59, P21, DOI 10.1203/01.pdr.0000190572.68191.13
   CAVANAGH JB, 1994, BRAIN, V117, P1357, DOI 10.1093/brain/117.6.1357
   Chae JH, 2007, PEDIATR RES, V61, P622, DOI 10.1203/pdr.0b013e3180459f2d
   CONSTANTINTEODOSIU D, 1991, ANAL BIOCHEM, V198, P347, DOI 10.1016/0003-2697(91)90437-X
   Darin N, 2001, ANN NEUROL, V49, P377, DOI 10.1002/ana.75
   DEVRIES DD, 1993, ANN NEUROL, V34, P410, DOI 10.1002/ana.410340319
   Esteitie N, 2005, ANN NEUROL, V58, P544, DOI 10.1002/ana.20570
   Farina L, 2002, AM J NEURORADIOL, V23, P1095
   Filosto M, 2003, ARCH NEUROL-CHICAGO, V60, P1279, DOI 10.1001/archneur.60.9.1279
   Herrnstadt C, 2002, AM J HUM GENET, V70, P1152, DOI 10.1086/339933
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   Howell N, 2003, AM J HUM GENET, V72, P1460, DOI 10.1086/375537
   Ingman M, 2006, NUCLEIC ACIDS RES, V34, PD749, DOI 10.1093/nar/gkj010
   JUN AS, 1994, P NATL ACAD SCI USA, V91, P6206, DOI 10.1073/pnas.91.13.6206
   Larsson NG, 2001, ACTA PHYSIOL SCAND, V171, P385, DOI 10.1046/j.1365-201x.2001.00842.x
   LEIGH D, 1951, J NEUROL NEUROSUR PS, V14, P216, DOI 10.1136/jnnp.14.3.216
   MANFREDI G, 1995, NEUROMUSCULAR DISORD, V5, P391, DOI 10.1016/0960-8966(94)00079-O
   McFarland R, 2002, NAT GENET, V30, P145, DOI 10.1038/ng819
   Merenda A, 2006, CURR OPIN CRIT CARE, V12, P90, DOI 10.1097/01.ccx.0000216573.26686.27
   Mitchell AL, 2006, J MED GENET, V43, P175, DOI 10.1136/jmg.2005.032474
   Morris AAM, 1996, ANN NEUROL, V40, P25, DOI 10.1002/ana.410400107
   Nguyen KV, 2006, J HEPATOL, V45, P108, DOI 10.1016/j.jhep.2005.12.026
   Nguyen KV, 2005, NEUROLOGY, V65, P1493, DOI 10.1212/01.wnl.0000182814.55361.70
   Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311
   Santorelli FM, 1997, ANN NEUROL, V42, P256, DOI 10.1002/ana.410420220
   Sarzi E, 2007, AM J MED GENET A, V143A, P33, DOI 10.1002/ajmg.a.31565
   Solano A, 2003, ANN NEUROL, V54, P527, DOI 10.1002/ana.10682
   Sörensen L, 2001, J NEUROSCI, V21, P8082, DOI 10.1523/JNEUROSCI.21-20-08082.2001
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Taylor RW, 2001, ANN NEUROL, V50, P104, DOI 10.1002/ana.1084
   Taylor RW, 2001, NUCLEIC ACIDS RES, V29, Part. no., DOI 10.1093/nar/29.15.e74
   Tiranti V, 1998, AM J HUM GENET, V63, P1609, DOI 10.1086/302150
   Ugalde C, 2003, ANN NEUROL, V54, P665, DOI 10.1002/ana.10734
   Van Goethem G, 2004, NEUROLOGY, V63, P1251, DOI 10.1212/01.WNL.0000140494.58732.83
   VONDOBELN U, 1993, ACTA PAEDIATR, V82, P1079, DOI 10.1111/j.1651-2227.1993.tb12818.x
   WIBOM R, 1990, AM J PHYSIOL, V259, PE204, DOI 10.1152/ajpendo.1990.259.2.E204
   Wibom R, 2002, ANAL BIOCHEM, V311, P139, DOI 10.1016/S0003-2697(02)00424-4
   WONG LJC, 2008, HUM MUTAT, V1020, P0
   Wortmann S, 2006, MOL GENET METAB, V88, P47, DOI 10.1016/j.ymgme.2006.01.013
   Zeviani Massimo, 2004, SUPPL CLIN NEUROPHYSIOL, V57, P304
   Zhang Y, 2007, J INHERIT METAB DIS, V30, P265, DOI 10.1007/s10545-006-0481-y
   Zhu ZQ, 1998, NAT GENET, V20, P337, DOI 10.1038/3804
NR 48
TC 39
Z9 46
U1 0
U2 16
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0005-2728
EI 0006-3002
J9 BBA-BIOENERGETICS
JI Biochim. Biophys. Acta-Bioenerg.
PD MAY 15
PY 2009
VL 1787
IS 5
BP 484
EP 490
DI 10.1016/j.bbabio.2008.11.014
PG 7
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 451MX
UT WOS:000266475400024
PM 19103152
DA 2024-11-01
ER

PT J
AU Johannsen, DL
   Ravussin, E
AF Johannsen, Darcy L.
   Ravussin, Eric
TI The role of mitochondria in health and disease
SO CURRENT OPINION IN PHARMACOLOGY
LA English
DT Review
ID type-2 diabetes-mellitus; human skeletal-muscle; cytochrome-c-oxidase; insulin sensitivity; oxidative capacity; proton leak; metabolism; association; dysfunction; exercise
AB Mitochondria play a key role in energy metabolism in many tissues, including skeletal muscle and liver. Inherent disorders of mitochondria such as DNA deletions cause major disruption of metabolism and can result in severe impairment or death. However, the occurrence of such disorders is extremely rare and cannot account for the majority of metabolic disease. Recently, mitochondrial dysfunction of a more subtle nature in skeletal muscle has been implicated in the pathology of chronic metabolic disease characterized by insulin resistance such as obesity, type 2 diabetes mellitus, and aging. This hypothesis has been substantiated by work from Shulman and colleagues, showing that reduced mitochondrial oxidative capacity underlies the accumulation of intramuscular fat causing insulin resistance with aging. However, recent work by Nair and coworkers has demonstrated that mitochondrial activity may actually be higher in persons exposed to high-calorie diet leading to obesity, suggesting that the accumulation of intramuscular fat and associated fatty acid metabolites may be directly responsible for the development of insulin resistance, independent of mitochondrial function. These inconsistent findings have promoted ongoing investigation into mitochondrial function to determine whether impaired function is a cause or consequence of metabolic disorders.
C1 [Johannsen, Darcy L.; Ravussin, Eric] Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA.
C3 Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center
RP Johannsen, DL (corresponding author), Pennington Biomed Res Ctr, 6400 Perkins Rd, Baton Rouge, LA 70808 USA.
EM darcy.johannsen@pbrc.edu; eric.ravussin@pbrc.edu
FU NIDDK NIH HHS [P30 DK072476] Funding Source: Medline
CR Anderson EJ, 2009, J CLIN INVEST, V119, P573, DOI 10.1172/JCI37048
   Barazzoni R, 2000, J BIOL CHEM, V275, P3343, DOI 10.1074/jbc.275.5.3343
   Befroy DE, 2007, DIABETES, V56, P1376, DOI 10.2337/db06-0783
   BOUCHARD C, 1990, NEW ENGL J MED, V322, P1477, DOI 10.1056/NEJM199005243222101
   Boushel R, 2007, DIABETOLOGIA, V50, P790, DOI 10.1007/s00125-007-0594-3
   Brand MD, 2000, EXP GERONTOL, V35, P811, DOI 10.1016/S0531-5565(00)00135-2
   Conley KE, 2000, J PHYSIOL-LONDON, V526, P203, DOI 10.1111/j.1469-7793.2000.t01-1-00203.x
   Harper ME, 2004, ACTA PHYSIOL SCAND, V182, P321, DOI 10.1111/j.1365-201X.2004.01370.x
   Harper ME, 2002, DIABETES, V51, P2459, DOI 10.2337/diabetes.51.8.2459
   Heilbronn LK, 2007, J CLIN ENDOCR METAB, V92, P1467, DOI 10.1210/jc.2006-2210
   Jackman MR, 2008, OBESITY, V16, P363, DOI 10.1038/oby.2007.40
   Kelley DE, 1999, AM J PHYSIOL-ENDOC M, V277, P0
   Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944
   Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013
   Lanza IR, 2008, DIABETES, V57, P2933, DOI 10.2337/db08-0349
   LUFT R, 1962, J CLIN INVEST, V41, P1776, DOI 10.1172/JCI104637
   Menshikova EV, 2006, J GERONTOL A-BIOL, V61, P534, DOI 10.1093/gerona/61.6.534
   Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180
   Morino K, 2005, J CLIN INVEST, V115, P3587, DOI 10.1172/JCI25151
   MULLERHOCKER J, 1992, MUTAT RES, V275, P115, DOI 10.1016/0921-8734(92)90016-I
   Nair KS, 2008, DIABETES, V57, P1166, DOI 10.2337/db07-1556
   Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100
   Petersen KF, 2005, PLOS MED, V2, P879, DOI 10.1371/journal.pmed.0020233
   Petersen KF, 2006, AM J MED, V119, P10S, DOI 10.1016/j.amjmed.2006.01.009
   Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314
   Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889
   Phielix E, 2008, DIABETES, V57, P2943, DOI 10.2337/db08-0391
   Rimbert Virginie, 2004, FASEB J, V18, P737
   Ritov VB, 2005, DIABETES, V54, P8, DOI 10.2337/diabetes.54.1.8
   Rolfe DFS, 1997, BIOSCIENCE REP, V17, P9, DOI 10.1023/A:1027327015957
   Rooyackers OE, 1996, P NATL ACAD SCI USA, V93, P15364, DOI 10.1073/pnas.93.26.15364
   Ruiz-Pesini E, 2006, HUM MUTAT, V27, P1072, DOI 10.1002/humu.20378
   Schrauwen-Hinderling VB, 2007, DIABETOLOGIA, V50, P113, DOI 10.1007/s00125-006-0475-1
   Schrauwen-Hinderling VB, 2008, J CLIN ENDOCR METAB, V93, P2917, DOI 10.1210/jc.2008-0267
   Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102
   Short KR, 2003, DIABETES, V52, P1888, DOI 10.2337/diabetes.52.8.1888
   Speakman JR, 2004, AGING CELL, V3, P87, DOI 10.1111/j.1474-9728.2004.00097.x
   Szendroedi J, 2008, DIABETOLOGIA, V51, P2155, DOI 10.1007/s00125-008-1153-2
   Szendroedi J, 2007, PLOS MED, V4, P858, DOI 10.1371/journal.pmed.0040154
   Tonkonogi M, 2003, PFLUG ARCH EUR J PHY, V446, P261, DOI 10.1007/s00424-003-1044-9
   TROUNCE I, 1989, LANCET, V1, P637, DOI 10.1016/S0140-6736(89)92143-0
   Wallace DC, 2003, COLD SPRING HARB SYM, V68, P479
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
NR 43
TC 174
Z9 198
U1 0
U2 24
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1471-4892
EI 1471-4973
J9 CURR OPIN PHARMACOL
JI Curr. Opin. Pharmacol.
PD DEC 15
PY 2009
VL 9
IS 6
BP 780
EP 786
DI 10.1016/j.coph.2009.09.002
PG 7
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 528KX
UT WOS:000272445300016
PM 19796990
DA 2024-11-01
ER

PT J
AU Kirches, E
AF Kirches, E.
TI Do mtDNA Mutations Participate in the Pathogenesis of Sporadic Parkinson's Disease?
SO CURRENT GENOMICS
LA English
DT Article
ID mitochondrial-dna deletions; substantia-nigra neurons; complex-i; coenzyme q(10); respiratory-chain; oxidative stress; skeletal-muscle; hydrogen-peroxide; skin fibroblasts; point mutations
AB The pathogenesis of sporadic Parkinson's disease (PD) remains enigmatic. Mitochondrial complex-I defects are known to occur in the substantia nigra (SN) of PD patients and are also debated in some extracerebral tissues. Early sequencing efforts of the mitochondrial DNA (mtDNA) did not reveal specific mutations, but a long lasting discussion was devoted to the issue of randomly distributed low level point mutations, caused by oxidative stress. However, a potential functional impact remained a matter of speculation, since heteroplasmy (mutational load) at any base position analyzed, remained far below the relevant functional threshold. A clearly age-dependent increase of the 'common mtDNA deletion' had been demonstrated in most brain regions by several authors since 1992. However, heteroplasmy did hardly exceed 1% of total mtDNA. It became necessary to exploit PCR techniques, which were able to detect any deletion in a few micro-dissected dopaminergic neurons of the SN. In 2006, two groups published biochemically relevant loads of somatic mtDNA deletions in these neurons. They seem to accumulate to relevant levels in the SN dopaminergic neurons of aged individuals in general, but faster in those developing PD. It is reasonable to assume that this accumulation causes mitochondrial dysfunction of the SN, although it cannot be taken as a final proof for an early pathogenetic role of this dysfunction. Recent studies demonstrate a distribution of deletion breakpoints, which does not differ between PD, aging and classical mitochondrial disorders, suggesting a common, but yet unknown mechanism.
C1 Otto Von Guericke Univ, Dept Neuropathol, D-39120 Magdeburg, Germany.
C3 Otto von Guericke University
RP Kirches, E (corresponding author), Otto Von Guericke Univ, Dept Neuropathol, Leipziger Str 44, D-39120 Magdeburg, Germany.
EM elmar.kirches@med.ovgu.de
CR Abe T, 2003, NEUROSCI LETT, V336, P105, DOI 10.1016/S0304-3940(02)01259-4
   Alam ZI, 1997, J NEUROCHEM, V69, P1196, DOI 10.1046/j.1471-4159.1997.69031196.x
   ARUOMA OI, 1989, J BIOL CHEM, V264, P20509
   Bandmann O, 1997, J NEUROL, V244, P262, DOI 10.1007/s004150050082
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Bender A, 2008, J NEUROL, V255, P1231, DOI 10.1007/s00415-008-0892-9
   BINDOFF LA, 1991, J NEUROL SCI, V104, P203, DOI 10.1016/0022-510X(91)90311-T
   BINDOFF LA, 1989, LANCET, V2, P49, DOI 10.1016/S0140-6736(89)90291-2
   Borland MK, 2008, MOL NEURODEGENER, V3, P0, DOI 10.1186/1750-1326-3-21
   Buhmann C, 2004, NEUROBIOL DIS, V15, P160, DOI 10.1016/j.nbd.2003.10.003
   Chinta SJ, 2006, FREE RADICAL BIO MED, V41, P1442, DOI 10.1016/j.freeradbiomed.2006.08.002
   CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3
   DEXTER DT, 1989, J NEUROCHEM, V52, P381, DOI 10.1111/j.1471-4159.1989.tb09133.x
   Esteves ARF, 2008, MITOCHONDRION, V8, P219, DOI 10.1016/j.mito.2008.03.004
   Floor E, 1998, J NEUROCHEM, V70, P268
   Fukui H, 2009, HUM MOL GENET, V18, P1028, DOI 10.1093/hmg/ddn437
   Gesi M, 2001, PHARMACOL TOXICOL, V89, P217, DOI 10.1034/j.1600-0773.2001.d01-151.x
   Giasson BI, 2000, SCIENCE, V290, P985, DOI 10.1126/science.290.5493.985
   Gille G, 2004, ANN NY ACAD SCI, V1018, P533, DOI 10.1196/annals.1296.066
   GRAHAM DG, 1978, MOL PHARMACOL, V14, P633
   Gu M, 1998, ANN NEUROL, V44, P177, DOI 10.1002/ana.410440207
   HAAS RH, 1995, ANN NEUROL, V37, P714, DOI 10.1002/ana.410370604
   HALLIWELL B, 1992, FREE RADICAL RES COM, V16, P75, DOI 10.3109/10715769209049161
   HASTINGS TG, 1995, J NEUROCHEM, V64, P919
   Holt IJ, 2000, CELL, V100, P515, DOI 10.1016/S0092-8674(00)80688-1
   Hornykiewicz O, 1987, ADV NEUROL, V45, P19
   Hsu M, 2005, J NEUROCHEM, V92, P1091, DOI 10.1111/j.1471-4159.2004.02929.x
   Keeney PM, 2006, J NEUROSCI, V26, P5256, DOI 10.1523/JNEUROSCI.0984-06.2006
   Kikuchi A, 2002, NEUROBIOL DIS, V9, P244, DOI 10.1006/nbdi.2002.0466
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   Kuznetsov AV, 1997, BBA-MOL BASIS DIS, V1360, P142, DOI 10.1016/S0925-4439(96)00072-5
   LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561
   MADSEN CS, 1993, P NATL ACAD SCI USA, V90, P7671, DOI 10.1073/pnas.90.16.7671
   MAKER HS, 1981, J NEUROCHEM, V36, P589, DOI 10.1111/j.1471-4159.1981.tb01631.x
   MIZUNO Y, 1989, BIOCHEM BIOPH RES CO, V163, P1450, DOI 10.1016/0006-291X(89)91141-8
   Müller T, 2003, NEUROSCI LETT, V341, P201, DOI 10.1016/S0304-3940(03)00185-X
   Nakabeppu Y, 2007, J NEUROSCI RES, V85, P919, DOI 10.1002/jnr.21191
   NICKLAS WJ, 1987, LIFE SCI, V40, P721, DOI 10.1016/0024-3205(87)90299-2
   Pallotti F, 1996, AM J HUM GENET, V59, P591
   Panov A, 2005, J BIOL CHEM, V280, P42026, DOI 10.1074/jbc.M508628200
   Parker WD, 2005, BIOCHEM BIOPH RES CO, V326, P667, DOI 10.1016/j.bbrc.2004.11.093
   PARKER WD, 1989, ANN NEUROL, V26, P719, DOI 10.1002/ana.410260606
   Prigione A, 2006, NEUROBIOL DIS, V23, P36, DOI 10.1016/j.nbd.2006.01.013
   Przedborski S, 2004, J BIOENERG BIOMEMBR, V36, P375, DOI 10.1023/B:JOBB.0000041771.66775.d5
   Przedborski S, 2003, ANN NY ACAD SCI, V991, P189
   Qin ZJ, 2007, J BIOL CHEM, V282, P5862, DOI 10.1074/jbc.M608126200
   Reeve AK, 2008, AM J HUM GENET, V82, P228, DOI 10.1016/j.ajhg.2007.09.018
   Reeve AK, 2009, AGING CELL, V8, P496, DOI 10.1111/j.1474-9726.2009.00492.x
   Richter G, 2002, J NEURAL TRANSM, V109, P721, DOI 10.1007/s007020200060
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   SCHAPIRA AHV, 1989, LANCET, V1, P1269, DOI 10.1016/S0140-6736(89)92366-0
   Schoeler S, 2007, CLIN NEUROPATHOL, V26, P164
   SCHON EA, 1989, SCIENCE, V244, P346, DOI 10.1126/science.2711184
   Selley ML, 1998, FREE RADICAL BIO MED, V25, P169, DOI 10.1016/S0891-5849(98)00021-5
   Shults CW, 2005, BIOFACTORS, V25, P117, DOI 10.1002/biof.5520250113
   Shults CW, 2002, ARCH NEUROL-CHICAGO, V59, P1541, DOI 10.1001/archneur.59.10.1541
   Shults CW, 1998, NEUROLOGY, V50, P793, DOI 10.1212/WNL.50.3.793
   SIAN J, 1994, ANN NEUROL, V36, P348, DOI 10.1002/ana.410360305
   Simon DK, 2000, NEUROLOGY, V54, P703, DOI 10.1212/WNL.54.3.703
   SINGER TP, 1995, BBA-MOL BASIS DIS, V1271, P211, DOI 10.1016/0925-4439(95)00030-8
   Smigrodzki R, 2004, NEUROBIOL AGING, V25, P1273, DOI 10.1016/j.neurobiolaging.2004.02.020
   SOFIC E, 1992, NEUROSCI LETT, V142, P128, DOI 10.1016/0304-3940(92)90355-B
   Sohmiya M, 2004, J NEUROL SCI, V223, P161, DOI 10.1016/j.jns.2004.05.007
   SOONG NW, 1992, NAT GENET, V2, P318
   Spencer JPE, 1996, CHEM RES TOXICOL, V9, P1152, DOI 10.1021/tx960084i
   Srivastava S, 2005, HUM MOL GENET, V14, P893, DOI 10.1093/hmg/ddi082
   Stokes AH, 1999, J NEUROSCI RES, V55, P659, DOI 10.1002/(SICI)1097-4547(19990315)55:6<659::AID-JNR1>3.0.CO;2-C
   Storch A, 2007, ARCH NEUROL-CHICAGO, V64, P938, DOI 10.1001/archneur.64.7.nct60005
   Sulzer D, 1999, NEUROTOX RES, V1, P181, DOI 10.1007/BF03033289
   Swerdlow RH, 1996, ANN NEUROL, V40, P663, DOI 10.1002/ana.410400417
   Thomas B, 2007, HUM MOL GENET, V16, PR183, DOI 10.1093/hmg/ddm159
   Trimmer PA, 2009, EXP NEUROL, V218, P320, DOI 10.1016/j.expneurol.2009.03.016
   TSE DCS, 1976, J MED CHEM, V19, P37, DOI 10.1021/jm00223a008
   Wiedemann FR, 2002, J NEUROCHEM, V80, P616, DOI 10.1046/j.0022-3042.2001.00731.x
   Wiedemann FR, 1999, ANN NY ACAD SCI, V893, P426, DOI 10.1111/j.1749-6632.1999.tb07870.x
   Winkler-Stuck K, 2005, J NEURAL TRANSM, V112, P499, DOI 10.1007/s00702-004-0195-y
   Winkler-Stuck K, 2004, J NEUROL SCI, V220, P41, DOI 10.1016/j.jns.2004.02.003
   Yoritaka A, 1996, P NATL ACAD SCI USA, V93, P2696, DOI 10.1073/pnas.93.7.2696
   Zhou C, 2008, ANN NY ACAD SCI, V1147, P93, DOI 10.1196/annals.1427.023
NR 82
TC 8
Z9 8
U1 0
U2 3
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y26, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES
SN 1389-2029
EI 
J9 CURR GENOMICS
JI Curr. Genomics
PD DEC 15
PY 2009
VL 10
IS 8
BP 585
EP 593
DI 10.2174/138920209789503879
PG 9
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA 514GD
UT WOS:000271381500007
PM 20514220
DA 2024-11-01
ER

PT J
AU Virgilio, R
   Ronchi, D
   Bordoni, A
   Fassone, E
   Bonato, S
   Donadoni, C
   Torgano, G
   Moggio, M
   Corti, S
   Bresolin, N
   Comi, GP
AF Virgilio, Roberta
   Ronchi, Dario
   Bordoni, Andreina
   Fassone, Elisa
   Bonato, Sara
   Donadoni, Chiara
   Torgano, Giuseppe
   Moggio, Maurizio
   Corti, Stefania
   Bresolin, Nereo
   Comi, Giacomo P.
TI Mitochondrial DNA G8363A mutation in the tRNA<SUP>Lys</SUP> gene: Clinical, biochemical and pathological study
SO JOURNAL OF THE NEUROLOGICAL SCIENCES
LA English
DT Article
DE Mitochondrial encephalomyopathy; Mitochondrial DNA tRNA(Lys) gene
ID ragged-red fibers; myoclonus epilepsy; leigh-syndrome; deficiency; children
AB The G8363A is a very rare mtDNA tRNA(Lys) gene mutation that has been associated to MERRF-Iike syndrome, cardiomyopathy or Leigh syndrome. Here, we describe the clinical and molecular features of a new large multigenerational family and we review the literature of cases with this mutation. In our family seven members presented a heterogeneous mitochondrial disease phenotype, from MERRF-Iike syndrome to isolated psychiatric disorder, associated with the G8363A mutation. The two probands are dizygotic twin sisters affected by mental retardation, neural deafness, myopathy, myoclonic epilepsy and ataxia. Twins' muscle biopsies showed a severe cytochrorne coxidase (COX) deficiency and ragged-red fibers. Their mitochondrial respiratory chain was defective in complexes I and IV in muscle. A severe reduction in complex IV activity was also observed in fibroblasts and myoblasts. Molecular analysis showed a G8363A transition in the mtDNA tRNA(Lys) gene. The Mutation was almost homoplasmic (>90%) in muscle and blood of the twins and heteroplasmic (55 +/- 8%) in blood sample from affected material relatives. Based on our family data and the meta-analysis of the literature, we confirm that mutational load directly correlates with severity of the disease (severe vs mild/moderate phenotype; P = 0.00168) and with disease onset (P<0.00001). However the presence of several exceptions and overlaps among patients with different clinical severity limits the clinical usefulness of this observation. Although the pathogenicity of the G8363A Mutation is well established, counselling is a difficult task for clinicians because of the large phenotypical variability. Our Study contributes further data on the clinical spectrum and its relation with the level of G8363A tRNA(Lys) mtDNA mutation. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Virgilio, Roberta; Ronchi, Dario; Bordoni, Andreina; Fassone, Elisa; Donadoni, Chiara; Torgano, Giuseppe; Moggio, Maurizio; Corti, Stefania; Bresolin, Nereo; Comi, Giacomo P.] Univ Milan, Dept Neurol Sci, Dino Ferrari Ctr, IRCCS Fdn Osped Maggiore Policlin Mangiagalli & R, I-20122 Milan, Italy.
   [Corti, Stefania; Bresolin, Nereo; Comi, Giacomo P.] Univ Milan, Ctr Excellence Neurodegenerat Dis, Milan, Italy.
   [Bonato, Sara; Bresolin, Nereo] IRCCS Eugenio Medea, Lecce, Italy.
   [Torgano, Giuseppe] IRCCS Fdn Osped Maggiore Policlin Mangiagalli & R, Emergency Dept, Milan, Italy.
C3 IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; University of Milan; IRCCS Eugenio Medea; IRCCS Ca Granda Ospedale Maggiore Policlinico
RP Comi, GP (corresponding author), Univ Milan, Dept Neurol Sci, Dino Ferrari Ctr, IRCCS Fdn Osped Maggiore Policlin Mangiagalli & R, Via Francesco Sforza 35, I-20122 Milan, Italy.
EM giacomo.comi@unimi.it
FU Telethon [GTB07001] Funding Source: Medline
CR Arenas J, 1999, NEUROLOGY, V52, P377, DOI 10.1212/WNL.52.2.377
   Böhm M, 2006, PEDIATR RES, V59, P21, DOI 10.1203/01.pdr.0000190572.68191.13
   Bugiani M, 2004, BBA-BIOENERGETICS, V1659, P136, DOI 10.1016/j.bbabio.2004.09.006
   DAmati G, 1999, PATHOLOGICA, V91, P49
   Graf WD, 2000, J CHILD NEUROL, V15, P357, DOI 10.1177/088307380001500601
   HECKMATT JZ, 1984, MUSCLE NERVE, V7, P594
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MORAES CT, 1993, J CLIN INVEST, V92, P2906, DOI 10.1172/JCI116913
   Ozawa M, 1997, MUSCLE NERVE, V20, P271, DOI 10.1002/(SICI)1097-4598(199703)20:3<271::AID-MUS2>3.0.CO;2-8
   Pineda M, 2004, REV NEUROLOGIA, V38, P1023, DOI 10.33588/rn.3811.2004019
   Prelle A, 2002, J NEUROL, V249, P305, DOI 10.1007/s004150200010
   Pronicki M, 2007, FOLIA NEUROPATHOL, V45, P187
   Salani S, 2004, MUSCLE NERVE, V30, P366, DOI 10.1002/mus.20106
   Santorelli FM, 1996, AM J HUM GENET, V58, P933
   Sciacco M, 1996, METHODS ENZYMOL, V264, P509, DOI 10.1016/S0076-6879(96)64045-2
   Shtilbans A, 2000, J CHILD NEUROL, V15, P759, DOI 10.1177/088307380001501109
   Sissler M, 2004, RNA, V10, P841, DOI 10.1261/rna.5267604
   ZEVIANI M, 1990, ANN NEUROL, V28, P94, DOI 10.1002/ana.410280118
   Zeviani M, 2007, CURR OPIN NEUROL, V20, P564, DOI 10.1097/WCO.0b013e3282ef58cd
NR 19
TC 31
Z9 33
U1 0
U2 10
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0022-510X
EI 
J9 J NEUROL SCI
JI J. Neurol. Sci.
PD JUN 15
PY 2009
VL 281
IS 1-2
BP 85
EP 92
DI 10.1016/j.jns.2009.01.025
PG 8
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 455DI
UT WOS:000266736800019
PM 19278689
DA 2024-11-01
ER

PT J
AU Spinazzola, A
   Zeviani, M
AF Spinazzola, A.
   Zeviani, M.
TI Disorders from perturbations of nuclear-mitochondrial intergenomic cross-talk
SO JOURNAL OF INTERNAL MEDICINE
LA English
DT Review
DE mitochondrial disorders; mitochondrial DNA; mtDNA depletion; mtDNA multiple deletions; oxidative phosphorylation
ID dna-polymerase-gamma; progressive external ophthalmoplegia; adenine-nucleotide translocator; onset spinocerebellar ataxia; neurogastrointestinal encephalomyopathy; autosomal-dominant; multiple deletions; saccharomyces-cerevisiae; polg mutations; oxidative-phosphorylation
AB Spinazzola A, Zeviani M ("C. Besta" Neurological Institute, Foundation IRCCS, Milano, Italy). Disorders from perturbations of nuclear-mitochondrial intergenomic cross-talk (Review). J Intern Med 2009; 265: 174-192. In the course of evolution, mitochondria lost their independence, and mitochondrial DNA (mtDNA) became the 'slave' of nuclear DNA, depending on numerous nucleus-encoded factors for its integrity, replication and expression. Mutations in any of these factors may alter the cross-talk between the two genomes and cause Mendelian disorders characterized by qualitative (multiple deletions) or quantitative (depletion) alterations of mtDNA, or by defective translation of mtDNA-encoded respiratory chain components.
C1 [Spinazzola, A.; Zeviani, M.] Fdn IRCCS, C Besta Neurol Inst, Unit Mol Neurogenet, I-20126 Milan, Italy.
RP Zeviani, M (corresponding author), Fdn IRCCS, C Besta Neurol Inst, Unit Mol Neurogenet, Via Libero Temolo 4, I-20126 Milan, Italy.
EM zeviani@istituto-besta.it
FU Pierfranco and Luisa Mariani Foundation; Telethon-Italy Foundation [GGP07019]; Italian Ministry of University and Research [RBLA038RMA]; Italian Ministry of Health [RF2006 ex 56/05/21]; MITOCIRCLE; EUMITOCOMBAT [LSHM-CT-2004-503116]; European Union Framework Program 6
CR Agostino A, 2003, NEUROLOGY, V60, P1354, DOI 10.1212/01.WNL.0000056088.09408.3C
   Akman HO, 2008, HUM MOL GENET, V17, P2433, DOI 10.1093/hmg/ddn143
   Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944
   Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   Antonicka H, 2006, HUM MOL GENET, V15, P1835, DOI 10.1093/hmg/ddl106
   Ashley N, 2007, HUM MOL GENET, V16, P1400, DOI 10.1093/hmg/ddm090
   Baruffini E, 2007, BBA-MOL BASIS DIS, V1772, P1225, DOI 10.1016/j.bbadis.2007.10.002
   Baruffini E, 2006, HUM MOL GENET, V15, P2846, DOI 10.1093/hmg/ddl219
   Bornstein B, 2008, NEUROMUSCULAR DISORD, V18, P453, DOI 10.1016/j.nmd.2008.04.006
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   Bykhovskaya Y, 2004, AM J HUM GENET, V74, P1303, DOI 10.1086/421530
   Calvo S, 2006, NAT GENET, V38, P576, DOI 10.1038/ng1776
   Carrozzo R, 2007, BRAIN, V130, P862, DOI 10.1093/brain/awl389
   Clayton DA, 2000, EXP CELL RES, V255, P4, DOI 10.1006/excr.1999.4763
   Coenen MJH, 2004, NEW ENGL J MED, V351, P2080, DOI 10.1056/NEJMoa041878
   Contamine V, 2000, MICROBIOL MOL BIOL R, V64, P281, DOI 10.1128/MMBR.64.2.281-315.2000
   Davidzon G, 2005, ANN NEUROL, V57, P921, DOI 10.1002/ana.20498
   Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936
   Duvezin-Caubet S, 2006, J BIOL CHEM, V281, P37972, DOI 10.1074/jbc.M606059200
   Edvardson S, 2007, AM J HUM GENET, V81, P857, DOI 10.1086/521227
   Elpeleg O, 2005, AM J HUM GENET, V76, P1081, DOI 10.1086/430843
   Fernandez-Vizarra E, 2007, J MED GENET, V44, P173, DOI 10.1136/jmg.2006.045252
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   Ferraro P, 2005, J BIOL CHEM, V280, P24472, DOI 10.1074/jbc.M502869200
   Filosto M, 2003, ARCH NEUROL-CHICAGO, V60, P1279, DOI 10.1001/archneur.60.9.1279
   Fontanesi F, 2004, HUM MOL GENET, V13, P923, DOI 10.1093/hmg/ddh108
   Galassi G, 2008, NEUROMUSCULAR DISORD, V18, P465, DOI 10.1016/j.nmd.2008.03.013
   Galbiati S, 2006, PEDIATR NEUROL, V34, P177, DOI 10.1016/j.pediatrneurol.2005.07.013
   Gao J, 2001, GENOMICS, V74, P109, DOI 10.1006/geno.2001.6536
   Giordano C, 2006, GASTROENTEROLOGY, V130, P893, DOI 10.1053/j.gastro.2006.01.004
   Graham BH, 1997, NAT GENET, V16, P226, DOI 10.1038/ng0797-226
   Graziewicz MA, 2004, NAT STRUCT MOL BIOL, V11, P770, DOI 10.1038/nsmb805
   Hakonen AH, 2008, HUM MOL GENET, V17, P3822, DOI 10.1093/hmg/ddn280
   Hakonen AH, 2007, BRAIN, V130, P3032, DOI 10.1093/brain/awm242
   Hirano M, 2006, NEUROLOGY, V67, P1458, DOI 10.1212/01.wnl.0000240853.97716.24
   Hirano M, 2001, SEMIN CELL DEV BIOL, V12, P417, DOI 10.1006/scdb.2001.0279
   HIRANO M, 1994, NEUROLOGY, V44, P721, DOI 10.1212/WNL.44.4.721
   Holt IJ, 2000, CELL, V100, P515, DOI 10.1016/S0092-8674(00)80688-1
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   Invernizzi F, 2008, NEUROMUSCULAR DISORD, V18, P460, DOI 10.1016/j.nmd.2008.04.005
   Iyengar B, 1999, GENETICS, V153, P1809
   Iyengar B, 2002, P NATL ACAD SCI USA, V99, P4483, DOI 10.1073/pnas.072664899
   Jacobs HT, 2005, TRENDS GENET, V21, P312, DOI 10.1016/j.tig.2005.04.003
   Kajander OA, 2000, HUM MOL GENET, V9, P2821, DOI 10.1093/hmg/9.19.2821
   Karadimas CL, 2006, AM J HUM GENET, V79, P544, DOI 10.1086/506913
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Kimura T, 2003, NAT GENET, V34, P440, DOI 10.1038/ng1212
   KJER P, 1959, ACTA OPHTHALMOL S54, V37, P1
   Koc EC, 2002, J BIOL CHEM, V277, P35541, DOI 10.1074/jbc.M202498200
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   Lara MC, 2006, NEUROLOGY, V67, P1461, DOI 10.1212/01.wnl.0000239824.95411.52
   Lee YJ, 2004, MOL BIOL CELL, V15, P5001, DOI 10.1091/mbc.E04-04-0294
   Lefai E, 2000, MOL GEN GENET, V264, P37, DOI 10.1007/s004380000301
   Ling MF, 1997, GENE, V197, P325, DOI 10.1016/S0378-1119(97)00279-5
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   MA L, 1995, J BIOL CHEM, V270, P1859, DOI 10.1074/jbc.270.4.1859
   MANDERBACKA K, 2001, SCANDINAVIAN J P S55, V29, P41
   Martí R, 2005, ANN NEUROL, V58, P649, DOI 10.1002/ana.20615
   Martí R, 2004, CLIN CHEM, V50, P120, DOI 10.1373/clinchem.2003.026179
   Miller C, 2004, ANN NEUROL, V56, P734, DOI 10.1002/ana.20282
   MIZUSAWA H, 1988, J NEUROL SCI, V86, P171, DOI 10.1016/0022-510X(88)90096-2
   MORAES CT, 1991, AM J HUM GENET, V48, P492
   Moslemi AR, 1996, ANN NEUROL, V40, P707, DOI 10.1002/ana.410400506
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Nikali K, 2005, HUM MOL GENET, V14, P2981, DOI 10.1093/hmg/ddi328
   Nishigaki Y, 2003, J CLIN INVEST, V111, P1913, DOI 10.1172/JCI200317828
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Oskoui M, 2006, ARCH NEUROL-CHICAGO, V63, P1122, DOI 10.1001/archneur.63.8.1122
   Ostergaard E, 2007, AM J HUM GENET, V81, P383, DOI 10.1086/519222
   Ostergaard E, 2007, BRAIN, V130, P853, DOI 10.1093/brain/awl383
   Palmieri L, 2005, HUM MOL GENET, V14, P3079, DOI 10.1093/hmg/ddi341
   Pontarin G, 2006, J BIOL CHEM, V281, P22720, DOI 10.1074/jbc.M604498200
   Saada A, 2007, J MED GENET, V44, P784, DOI 10.1136/jmg.2007.053116
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Salviati L, 2002, ANN NEUROL, V52, P311, DOI 10.1002/ana.10284
   Sarzi E, 2007, ANN NEUROL, V62, P579, DOI 10.1002/ana.21207
   Scheper GC, 2007, NAT GENET, V39, P534, DOI 10.1038/ng2013
   SERVIDEI S, 1991, NEUROLOGY, V41, P1053, DOI 10.1212/WNL.41.7.1053
   Smeitink JAM, 2006, AM J HUM GENET, V79, P869, DOI 10.1086/508434
   Song SW, 2003, J BIOL CHEM, V278, P43893, DOI 10.1074/jbc.C300401200
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Spinazzola A, 2005, GENE, V354, P162, DOI 10.1016/j.gene.2005.03.025
   Spinazzola A, 2002, J BIOL CHEM, V277, P4128, DOI 10.1074/jbc.M111028200
   Spinazzola A, 2008, ARCH NEUROL-CHICAGO, V65, P1108, DOI 10.1001/archneur.65.8.1108
   Spinazzola A, 2008, NEUROMUSCULAR DISORD, V18, P315, DOI 10.1016/j.nmd.2007.12.007
   Stuart GR, 2006, HUM MOL GENET, V15, P363, DOI 10.1093/hmg/ddi454
   Tadiboyina VT, 2005, AM J MED GENET A, V135A, P289, DOI 10.1002/ajmg.a.30748
   Toivonen JM, 2001, GENETICS, V159, P241
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   TRITSCHLER HJ, 1992, NEUROLOGY, V42, P209, DOI 10.1212/WNL.42.1.209
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Valente L, 2007, AM J HUM GENET, V80, P44, DOI 10.1086/510559
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2004, NEUROLOGY, V63, P1251, DOI 10.1212/01.WNL.0000140494.58732.83
   Van Goethem G, 2003, NEUROMUSCULAR DISORD, V13, P133, DOI 10.1016/S0960-8966(02)00216-X
   VISCOMI C, 2008, HUM MOL GENET SEP, V0, P0
   Vu TH, 2001, HEPATOLOGY, V34, P116, DOI 10.1053/jhep.2001.25921
   Wang XW, 2008, HUM MOL GENET, V17, P4036, DOI 10.1093/hmg/ddn306
   Winterthun S, 2005, NEUROLOGY, V64, P1204, DOI 10.1212/01.WNL.0000156516.77696.5A
   Wong LJC, 2007, HEPATOLOGY, V46, P1218, DOI 10.1002/hep.21799
   XIN H, 1995, J BIOL CHEM, V270, P17243, DOI 10.1074/jbc.270.29.17243
   Yavuz H, 2007, ARCH NEUROL-CHICAGO, V64, P435, DOI 10.1001/archneur.64.3.435
   YUZAKI M, 1989, BIOCHEM BIOPH RES CO, V164, P1352, DOI 10.1016/0006-291X(89)91818-4
   Zeharia A, 2005, J CHILD NEUROL, V20, P449, DOI 10.1177/08830738050200051301
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
   Zeviani M, 2008, BRAIN, V131, P314, DOI 10.1093/brain/awm339
   Zhang YL, 1998, BBA-GENE STRUCT EXPR, V1443, P245, DOI 10.1016/S0167-4781(98)00223-1
   Zhou XS, 2008, HUM MOL GENET, V17, P2329, DOI 10.1093/hmg/ddn133
NR 111
TC 55
Z9 59
U1 0
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0954-6820
EI 1365-2796
J9 J INTERN MED
JI J. Intern. Med.
PD FEB 15
PY 2009
VL 265
IS 2
BP 174
EP 192
DI 10.1111/j.1365-2796.2008.02059.x
PG 19
WC Medicine, General & Internal
SC General & Internal Medicine
GA 393CK
UT WOS:000262348300003
PM 19192035
DA 2024-11-01
ER

PT J
AU Cree, LM
   Samuels, DC
   Chinnery, PF
AF Cree, L. M.
   Samuels, D. C.
   Chinnery, P. F.
TI The inheritance of pathogenic mitochondrial DNA mutations
SO BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
LA English
DT Review
DE mtDNA; Mitochondria; Genetic bottleneck; Inheritance
ID hereditary optic neuropathy; random genetic drift; mtdna mutation; paternal inheritance; rapid segregation; pedigree analysis; skeletal-muscle; nucleotide 8993; mouse embryos; selection
AB Mitochondrial DNA mutations cause disease in > 1 in 5000 of the population, and similar to 1 in 200 of the population are asymptomatic carriers of a pathogenic mtDNA mutation. Many patients with these pathogenic mtDNA mutations present with a progressive, disabling neurological syndrome that leads to major disability and premature death. There is currently no effective treatment for mitochondrial disorders, placing great emphasis on preventing the transmission of these diseases. An empiric approach can be used to guide genetic counseling for common mtDNA mutations, but many families transmit rare or unique molecular defects. There is therefore a pressing need to develop techniques to prevent transmission based on a solid understanding of the biological mechanisms. Several recent studies have cast new light on the genetics and cell biology of mtDNA inheritance, but these studies have also raised new controversies. Here we compare and contrast these findings and discuss their relevance for the transmission of human mtDNA diseases. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Chinnery, P. F.] Newcastle Univ, Sch Med, Mitochondrial Res Grp, Inst Ageing & Hlth, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Samuels, D. C.] Vanderbilt Univ, Med Ctr, Dept Mol Physiol & Biophys, Ctr Human Genet Res, Nashville, TN USA.
C3 Newcastle University - UK; Vanderbilt University
RP Chinnery, PF (corresponding author), Newcastle Univ, Sch Med, Mitochondrial Res Grp, Inst Ageing & Hlth, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM P.F.Chinnery@ncl.ac.uk
FU Ataxia (UK); Parkinson's disease Society (UK); Medical Research Council (UK); UK NIHR Biomedical Research Centre
CR Brown DT, 2006, LANCET, V368, P87, DOI 10.1016/S0140-6736(06)68972-1
   Brown DT, 2001, AM J HUM GENET, V68, P533, DOI 10.1086/318190
   BU XD, 1991, P NATL ACAD SCI USA, V88, P8198, DOI 10.1073/pnas.88.18.8198
   Cao LQ, 2007, NAT GENET, V39, P386, DOI 10.1038/ng1970
   Chinnery PE, 1998, BRAIN, V121, P1889, DOI 10.1093/brain/121.10.1889
   Chinnery PF, 2000, ANN NEUROL, V48, P188, DOI 10.1002/1531-8249(200008)48:2<188::AID-ANA8>3.3.CO;2-G
   Chinnery PF, 2004, LANCET, V364, P592, DOI 10.1016/S0140-6736(04)16851-7
   Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713
   Chinnery PF, 2000, TRENDS GENET, V16, P500, DOI 10.1016/S0168-9525(00)02120-X
   Chinnery PF, 2006, COCHRANE DB SYST REV, V25, P0
   Cree LM, 2008, NAT GENET, V40, P249, DOI 10.1038/ng.2007.63
   DOWNS KM, 1993, DEVELOPMENT, V118, P1255
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786
   Filosto M, 2003, ANN NEUROL, V54, P524, DOI 10.1002/ana.10709
   Fischel-Ghodsian N, 1998, AM J HUM GENET, V62, P15, DOI 10.1086/301695
   Fu K, 1996, HUM MOL GENET, V5, P1835, DOI 10.1093/hmg/5.11.1835
   GILES RE, 1980, P NATL ACAD SCI-BIOL, V77, P6715, DOI 10.1073/pnas.77.11.6715
   Guan MX, 2006, AM J HUM GENET, V79, P291, DOI 10.1086/506389
   HARDING AE, 1995, AM J HUM GENET, V57, P77
   HAUSWIRTH WW, 1982, P NATL ACAD SCI-BIOL, V79, P4686, DOI 10.1073/pnas.79.15.4686
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Horvath R, 2008, NEUROTHERAPEUTICS, V5, P558, DOI 10.1016/j.nurt.2008.07.002
   Hudson G, 2005, AM J HUM GENET, V77, P1086, DOI 10.1086/498176
   Jacobs LJAM, 2006, HUM REPROD UPDATE, V12, P119, DOI 10.1093/humupd/dmi042
   Jenuth JP, 1996, NAT GENET, V14, P146, DOI 10.1038/ng1096-146
   LARSSON NG, 1992, AM J HUM GENET, V51, P1201
   Macmillan C, 1998, NEUROLOGY, V50, P417, DOI 10.1212/WNL.50.2.417
   Man PYW, 2002, J MED GENET, V39, P162, DOI 10.1136/jmg.39.3.162
   McFarland R, 2007, NEUROLOGY, V69, P911, DOI 10.1212/01.wnl.0000267843.10977.4a
   McFarland R, 2002, NAT GENET, V30, P145, DOI 10.1038/ng819
   MORAES CT, 1993, J CLIN INVEST, V92, P2906, DOI 10.1172/JCI116913
   Payer B, 2006, GENESIS, V44, P75, DOI 10.1002/gene.20187
   Poulton J, 2000, NEUROMUSCULAR DISORD, V10, P484, DOI 10.1016/S0960-8966(00)00130-9
   Poulton J, 2006, LANCET, V368, P841, DOI 10.1016/S0140-6736(06)69326-4
   POULTON J, 1993, HUM MOL GENET, V2, P23, DOI 10.1093/hmg/2.1.23
   PREZANT TR, 1993, NAT GENET, V4, P289, DOI 10.1038/ng0793-289
   Pyle A, 2007, J MED GENET, V44, P69, DOI 10.1136/jmg.2006.043109
   Rahman S, 2001, AM J HUM GENET, V68, P238, DOI 10.1086/316930
   Rajasimha HK, 2008, AM J HUM GENET, V82, P333, DOI 10.1016/j.ajhg.2007.10.007
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   Schwartz M, 2002, NEW ENGL J MED, V347, P576, DOI 10.1056/NEJMoa020350
   Shanske S, 2002, AM J HUM GENET, V71, P679, DOI 10.1086/342482
   Stewart JB, 2008, NAT REV GENET, V0, P0
   Stewart JB, 2008, PLOS BIOL, V6, P63, DOI 10.1371/journal.pbio.0060010
   Sutovsky P, 1999, NATURE, V402, P371, DOI 10.1038/46466
   Taylor RW, 2003, ANN NEUROL, V54, P521, DOI 10.1002/ana.10673
   Thundathil J, 2005, MOL REPROD DEV, V71, P405, DOI 10.1002/mrd.20260
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Uusimaa J, 2007, ANN NEUROL, V62, P278, DOI 10.1002/ana.21196
   Wai T, 2008, NAT GENET, V40, P1484, DOI 10.1038/ng.258
   Weber K, 1997, AM J HUM GENET, V60, P373
   White SL, 1999, AM J HUM GENET, V65, P474, DOI 10.1086/302488
   White SL, 1999, J INHERIT METAB DIS, V22, P899, DOI 10.1023/A:1005639407166
   Wonnapinij P, 2008, AM J HUM GENET, V83, P582, DOI 10.1016/j.ajhg.2008.10.007
   Wright S, 1969, EVOLUTION GENETICS P, V0, P0
NR 56
TC 67
Z9 75
U1 0
U2 24
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0925-4439
EI 0006-3002
J9 BBA-MOL BASIS DIS
JI Biochim. Biophys. Acta-Mol. Basis Dis.
PD DEC 15
PY 2009
VL 1792
IS 12
BP 1097
EP 1102
DI 10.1016/j.bbadis.2009.03.002
PG 6
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 530HG
UT WOS:000272579400002
PM 19303927
DA 2024-11-01
ER

PT J
AU Filosto, M
   Mancuso, M
AF Filosto, Massimiliano
   Mancuso, Michelangelo
TI Mitochondrial Diseases
SO CEREBRAL ISCHEMIA IN YOUNG ADULTS: PATHOGENIC AND CLINICAL PERSPECTIVES
LA English
DT Article; Book Chapter
ID stroke-like episodes; progressive external ophthalmoplegia; kearns-sayre syndrome; adenine-nucleotide translocator; wobble modification deficiency; respiratory-chain disorders; hereditary optic neuropathy; a3243g mtdna mutation; cytochrome-c-oxidase; large-scale deletion
AB Mitochondrial diseases (MD) are disorders caused by an impairment of the mitochondrial respiratory chain function. They are usually progressive, isolated or multisystem diseases and have variable times of onset between birth and senescence. Mitochondria have their own DNA called mitochondrial DNA (mtDNA). Therefore MD have the unique characteristic that they can be caused by mutations in both mtDNA and nuclear DNA (nDNA). The complexity of mitochondrial genetics is in part responsible for the intra- and inter-familiar clinical heterogeneity of this class of diseases. MD are currently classified according to the location of the genetic defect either on mtDNA (sporadic or of maternal inheritance) or on nDNA (autosomic inheritance). Among the variety of symptoms and signs caused by respiratory chain deficiency, stroke may be secondary to classical vascular and non-vascular mechanisms. Vascular mechanisms include atherothrombotic and cardioembolic processes linked to classical vascular risk factors which are present in many MD patients. Non-vascular mechanisms are typical of MELAS, which is characterized by stroke-like lesions located in the cortical posterior regions of the brain with a distribution that does not respect vascular territories. Stroke-like episodes are most likely related to the increased hyperexcitability and susceptibility of cortical neurons to excitotoxic injury.
C1 [Filosto, Massimiliano] Univ Brescia, Sch Med, Neurol Clin, Dept Med & Surg Sci, I-25123 Brescia, Italy.
   [Mancuso, Michelangelo] Univ Pisa, Neurol Clin, Dept Neurosci, Pisa, Italy.
C3 University of Brescia; University of Pisa
RP Filosto, M (corresponding author), Pzle Spedali Civili 1, I-25123 Brescia, Italy.
EM filosto@med.unibs.it
CR ANAN R, 1995, CIRCULATION, V91, P955, DOI 10.1161/01.CIR.91.4.955
   Apostolova LG, 2005, ARCH NEUROL-CHICAGO, V62, P1154, DOI 10.1001/archneur.62.7.1154
   Asoh S, 1996, J BIOCHEM-TOKYO, V120, P600
   Baysal BE, 2000, SCIENCE, V287, P848, DOI 10.1126/science.287.5454.848
   Bénit P, 2001, AM J HUM GENET, V68, P1344, DOI 10.1086/320603
   Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   Betts J, 2006, NEUROPATH APPL NEURO, V32, P359, DOI 10.1111/j.1365-2990.2006.00731.x
   Betts J, 2004, NEUROCHEM RES, V29, P505, DOI 10.1023/B:NERE.0000014821.07269.8d
   Bianchi MC, 2007, BIOSCIENCE REP, V27, P69, DOI 10.1007/s10540-007-9046-z
   Birch-Machin MA, 2000, ANN NEUROL, V48, P330, DOI 10.1002/1531-8249(200009)48:3<330::AID-ANA7>3.0.CO;2-A
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   BOURGERON T, 1995, NAT GENET, V11, P144, DOI 10.1038/ng1095-144
   Brown GK, 1996, J INHERIT METAB DIS, V19, P553, DOI 10.1007/BF01799116
   Budde SMS, 2000, BIOCHEM BIOPH RES CO, V275, P63, DOI 10.1006/bbrc.2000.3257
   Campos Y, 1996, MUSCLE NERVE, V19, P187, DOI 10.1002/(SICI)1097-4598(199602)19:2<187::AID-MUS10>3.0.CO;2-S
   Carelli V, 2004, PROG RETIN EYE RES, V23, P53, DOI 10.1016/j.preteyeres.2003.10.003
   Carmi E, 2001, ANN DERMATOL VENER, V128, P1031
   Chabrol B, 1997, NEUROLOGY, V49, P308, DOI 10.1212/WNL.49.1.308-b
   Chae JH, 2004, BRAIN DEV-JPN, V26, P459, DOI 10.1016/j.braindev.2004.01.002
   Chinnery PE, 1998, BRAIN, V121, P1889, DOI 10.1093/brain/121.10.1889
   Chinnery PF, 2000, ANN NEUROL, V48, P188, DOI 10.1002/1531-8249(200008)48:2<188::AID-ANA8>3.3.CO;2-G
   Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713
   CHOMYN A, 1992, P NATL ACAD SCI USA, V89, P4221, DOI 10.1073/pnas.89.10.4221
   Clark JM, 1996, NEUROLOGY, V46, P223, DOI 10.1212/WNL.46.1.223
   Cock H, 1999, EPILEPSIA, V40, P33, DOI 10.1111/j.1528-1157.1999.tb00897.x
   Crimi M, 2005, FASEB J, V19, P866, DOI 10.1096/fj.04-3045fje
   Darin N, 2001, ANN NEUROL, V49, P377, DOI 10.1002/ana.75
   Deschauer M, 2004, J NEUROL NEUROSUR PS, V75, P1204, DOI 10.1136/jnnp.2003.026278
   Deschauer M, 2003, NEUROMUSCULAR DISORD, V13, P568, DOI 10.1016/S0960-8966(03)00071-3
   DiMauro S, 1999, J CHILD NEUROL, V14, PS23, DOI 10.1177/0883073899014001051
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   DiMauro S, 2002, ADV NEUROL, V89, P217
   Dimauro S, 2001, AM J MED GENET, V106, P18, DOI 10.1002/ajmg.1392
   DiMauro S, 2007, BIOSCIENCE REP, V27, P125, DOI 10.1007/s10540-007-9041-4
   Elpeleg O, 2005, AM J HUM GENET, V76, P1081, DOI 10.1086/430843
   Fabrizi GM, 1996, J NEUROL NEUROSUR PS, V61, P47, DOI 10.1136/jnnp.61.1.47
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   Filosto M, 2007, ACTA NEUROL SCAND, V115, P211, DOI 10.1111/j.1600-0404.2006.00777.x
   Filosto M, 2004, ACTA NEUROPATHOL, V108, P168, DOI 10.1007/s00401-004-0872-9
   Filosto M, 2003, ANN NEUROL, V54, P524, DOI 10.1002/ana.10709
   Filosto M, 2003, ARCH NEUROL-CHICAGO, V60, P1279, DOI 10.1001/archneur.60.9.1279
   Filosto M, 2002, ACTA NEUROPATHOL, V103, P215, DOI 10.1007/s004010100455
   Filosto M, 2008, NEUROMUSCULAR DISORD, V18, P204, DOI 10.1016/j.nmd.2007.12.005
   Filosto M, 2007, BIOSCIENCE REP, V27, P23, DOI 10.1007/s10540-007-9034-3
   Finsterer J, 2007, ACTA NEUROL SCAND, V116, P1, DOI 10.1111/j.1600-0404.2007.00836.x
   Finsterer J, 2006, ACTA NEUROL SCAND, V114, P217, DOI 10.1111/j.1600-0404.2006.00671.x
   Finsterer J, 2005, CLIN NEUROL NEUROSUR, V107, P181, DOI 10.1016/j.clineuro.2004.07.001
   Finsterer J, 2004, CARDIOLOGY, V102, P228, DOI 10.1159/000081015
   Gardner JL, 2007, BIOSCIENCE REP, V27, P139, DOI 10.1007/s10540-007-9042-3
   GERBITZ KD, 1995, BBA-MOL BASIS DIS, V1271, P253, DOI 10.1016/0925-4439(95)00036-4
   Gilchrist JM, 1996, STROKE, V27, P1420, DOI 10.1161/01.STR.27.8.1420
   Gillis L, 2002, PEDIATR CLIN N AM, V49, P203, DOI 10.1016/S0031-3955(03)00115-9
   GOTO Y, 1995, MUSCLE NERVE S, V3, P107
   Helm M, 1999, NUCLEIC ACIDS RES, V27, P756, DOI 10.1093/nar/27.3.756
   Hirano M, 2001, SEMIN CELL DEV BIOL, V12, P417, DOI 10.1006/scdb.2001.0279
   HIRANO M, 1992, NEUROMUSCULAR DISORD, V2, P125, DOI 10.1016/0960-8966(92)90045-8
   Hirano M, 1996, HANDBOOK OF MUSCLE DISEASE, V0, P479
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Huang CC, 2002, J BIOMED SCI, V9, P527, DOI 10.1007/BF02254979
   Iizuka T, 2005, CURR NEUROVASC RES, V2, P29, DOI 10.2174/1567202052773544
   Iizuka T, 2003, NEUROLOGY, V61, P1238, DOI 10.1212/01.WNL.0000091888.26232.FE
   Jacobs HT, 2000, HUM MOL GENET, V9, P463, DOI 10.1093/hmg/9.4.463
   Kamada K, 2001, J NEUROL NEUROSUR PS, V70, P675, DOI 10.1136/jnnp.70.5.675
   Kanaumi T, 2006, PEDIATR NEUROL, V34, P235, DOI 10.1016/j.pediatrneurol.2005.08.024
   Kariya S, 2005, NEUROPEPTIDES, V39, P97, DOI 10.1016/j.npep.2004.11.004
   Kaufmann P, 2006, NEUROLOGY, V66, P324, DOI 10.1212/01.wnl.0000196641.05913.27
   Kaufmann P, 2006, ARCH NEUROL-CHICAGO, V63, P746, DOI 10.1001/archneur.63.5.746
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Kharasch ED, 2006, ANESTHESIOLOGY, V105, P737, DOI 10.1097/00000542-200610000-00020
   Kirino Y, 2004, P NATL ACAD SCI USA, V101, P15070, DOI 10.1073/pnas.0405173101
   Koga Y, 2000, ARCH DIS CHILD, V82, P407, DOI 10.1136/adc.82.5.407
   Koga Y, 2007, MITOCHONDRION, V7, P133, DOI 10.1016/j.mito.2006.11.006
   Komura K, 2003, PEDIATR NEUROL, V28, P53, DOI 10.1016/S0887-8994(02)00469-1
   KOSINSKI C, 1995, STROKE, V26, P1950, DOI 10.1161/01.STR.26.10.1950
   Kroemer G, 1997, CELL DEATH DIFFER, V4, P443, DOI 10.1038/sj.cdd.4400266
   KUHL CK, 1994, RADIOLOGY, V192, P223, DOI 10.1148/radiology.192.1.8208943
   Levinger L, 2004, J MOL BIOL, V337, P535, DOI 10.1016/j.jmb.2004.02.008
   Limongelli A, 2004, J MED GENET, V41, P342, DOI 10.1136/jmg.2003.016048
   Lodi R, 2004, BBA-BIOENERGETICS, V1657, P146, DOI 10.1016/j.bbabio.2004.05.003
   Loeffen J, 2001, ANN NEUROL, V49, P195, DOI 10.1002/1531-8249(20010201)49:2<195::AID-ANA39>3.0.CO;2-M
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   Lorenc A, 2003, MITOCHONDRION, V3, P119, DOI 10.1016/S1567-7249(03)00106-5
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Majamaa K, 1998, AM J HUM GENET, V63, P447, DOI 10.1086/301959
   Man PYW, 2003, AM J HUM GENET, V72, P333, DOI 10.1016/j.ajhg.2016.05.015
   Mancuso M, 2004, ARCH NEUROL-CHICAGO, V61, P1777, DOI 10.1001/archneur.61.11.1777
   Mancuso M, 2004, NEUROLOGY, V62, P2119, DOI 10.1212/01.WNL.0000127608.48406.F1
   Mancuso M, 2004, NEUROLOGY, V62, P316, DOI 10.1212/WNL.62.2.316
   Mancuso M, 2007, BIOSCIENCE REP, V27, P31, DOI 10.1007/s10540-007-9035-2
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   Manfredi G, 1997, ANN NEUROL, V42, P180, DOI 10.1002/ana.410420208
   MATTHEWS PM, 1993, NEUROLOGY, V43, P2484, DOI 10.1212/WNL.43.12.2484
   Michelson DJ, 2004, MITOCHONDRION, V4, P665, DOI 10.1016/j.mito.2004.07.019
   Mirabella M, 2000, BRAIN, V123, P93, DOI 10.1093/brain/123.1.93
   *MIT, 2007, HUM MIT GEN DAT, V0, P0
   MITA S, 1990, NUCLEIC ACIDS RES, V18, P561, DOI 10.1093/nar/18.3.561
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   Musumeci O, 2001, NEUROLOGY, V56, P849, DOI 10.1212/WNL.56.7.849
   Niemann S, 2000, NAT GENET, V26, P268, DOI 10.1038/81551
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   OHAMA E, 1987, ACTA NEUROPATHOL, V74, P226, DOI 10.1007/BF00688185
   OHAMA E, 1987, ACTA NEUROPATHOL, V75, P1, DOI 10.1007/BF00686785
   Palmieri L, 2005, HUM MOL GENET, V14, P3079, DOI 10.1093/hmg/ddi341
   Petruzzella V, 1998, GENOMICS, V54, P494, DOI 10.1006/geno.1998.5580
   Provenzale JM, 1996, NEUROLOGY, V46, P826, DOI 10.1212/WNL.46.3.826
   Pulkes T, 2000, LANCET, V356, P2068, DOI 10.1016/S0140-6736(00)03408-5
   Quinzii C, 2006, AM J HUM GENET, V78, P345, DOI 10.1086/500092
   Rahman S, 2001, AM J HUM GENET, V68, P238, DOI 10.1086/316930
   ROTIG A, 1992, AM J HUM GENET, V50, P364
   Roy MD, 2005, RNA, V11, P254, DOI 10.1261/rna.7143305
   Saada A, 2003, BIOCHEM BIOPH RES CO, V310, P963, DOI 10.1016/j.bbrc.2003.09.104
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Salviati L, 2002, ANN NEUROL, V52, P311, DOI 10.1002/ana.10284
   Sangkhathat S, 2005, PEDIATR SURG INT, V21, P745, DOI 10.1007/s00383-005-1471-0
   SCHON EA, 1989, SCIENCE, V244, P346, DOI 10.1126/science.2711184
   SCHON EA, 1992, BIOCHIM BIOPHYS ACTA, V1101, P206, DOI 10.1016/0005-2728(92)90226-R
   Schon EA, 2003, GENETICS MITOCHONDRI, V0, P111
   SCHON EA, 2001, MITOCHONDRIA PATHOGE, V0, P53
   Schuelke M, 1999, NAT GENET, V21, P260, DOI 10.1038/6772
   Schwartz M, 2002, NEW ENGL J MED, V347, P576, DOI 10.1056/NEJMoa020350
   Shanske S, 2004, AM J MED GENET A, V130A, P134, DOI 10.1002/ajmg.a.30220
   SHAPIRA Y, 1975, NEUROLOGY, V25, P614, DOI 10.1212/WNL.25.7.614
   Siciliano G, 2003, NEUROMUSCULAR DISORD, V13, P162, DOI 10.1016/S0960-8966(02)00221-3
   Simonati A, 2003, J NEUROL, V250, P702, DOI 10.1007/s00415-003-1065-5
   Skladal D, 2003, BRAIN, V126, P1905, DOI 10.1093/brain/awg170
   Sohm B, 2003, J MOL BIOL, V328, P995, DOI 10.1016/S0022-2836(03)00373-5
   Sparaco M, 2003, ACTA NEUROPATHOL, V106, P202, DOI 10.1007/s00401-003-0716-z
   SPARACO M, 1993, J NEUROPATH EXP NEUR, V52, P1, DOI 10.1097/00005072-199301000-00001
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Spinazzola A, 2005, GENE, V354, P162, DOI 10.1016/j.gene.2005.03.025
   Spinazzola A, 2007, BIOSCIENCE REP, V27, P39, DOI 10.1007/s10540-007-9036-1
   Strachan J, 2001, J INHERIT METAB DIS, V24, P409, DOI 10.1023/A:1010573122748
   Sue CM, 1998, J NEUROL SCI, V161, P36, DOI 10.1016/S0022-510X(98)00179-8
   Suzuki Y, 2004, DIABETES RES CLIN PR, V63, P225, DOI 10.1016/j.diabres.2003.10.024
   Tanji K, 2001, SEMIN CELL DEV BIOL, V12, P429, DOI 10.1006/scdb.2001.0280
   Taylor RW, 2003, ANN NEUROL, V54, P521, DOI 10.1002/ana.10673
   Torroni A, 2003, AM J HUM GENET, V72, P1005, DOI 10.1086/373936
   Valnot I, 2000, AM J HUM GENET, V67, P1104
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Wittenhagen LM, 2002, NAT STRUCT BIOL, V9, P586, DOI 10.1038/nsb820
   WOLVETANG EJ, 1994, FEBS LETT, V339, P40, DOI 10.1016/0014-5793(94)80380-3
   Yang YL, 2006, CHINESE MED J-PEKING, V119, P373, DOI 10.1097/00029330-200603010-00004
   Yasukawa T, 2005, FEBS LETT, V579, P2948, DOI 10.1016/j.febslet.2005.04.038
   Yasukawa T, 2000, J BIOL CHEM, V275, P4251, DOI 10.1074/jbc.275.6.4251
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
   Zhu ZQ, 1998, NAT GENET, V20, P337, DOI 10.1038/3804
NR 149
TC 1
Z9 1
U1 0
U2 0
PU NOVA SCIENCE PUBLISHERS, INC
PI HAUPPAUGE
PA 400 OSER AVE, STE 1600, HAUPPAUGE, NY 11788-3635 USA
SN 
EI 
J9 NEUROL LAB CLIN RES
PD JUN 15
PY 2009
VL 0
IS 
BP 617
EP 651
DI 
PG 35
WC Clinical Neurology
SC Neurosciences & Neurology
GA BNU21
UT WOS:000275556300023
DA 2024-11-01
ER

PT J
AU Mimaki, M
   Hatakeyama, H
   Ichiyama, T
   Isumi, H
   Furukawa, S
   Akasaka, M
   Kamei, A
   Komaki, H
   Nishino, I
   Nonaka, I
   Goto, YI
AF Mimaki, Masakazu
   Hatakeyama, Hideyuki
   Ichiyama, Takashi
   Isumi, Hiroshi
   Furukawa, Susumu
   Akasaka, Manami
   Kamei, Atsushi
   Komaki, Hirofumi
   Nishino, Ichizo
   Nonaka, Ikuya
   Goto, Yu-ichi
TI Different effects of novel mtDNA G3242A and G3244A base changes adjacent to a common A3243G mutation in patients with mitochondrial disorders
SO MITOCHONDRION
LA English
DT Article
DE Mitochondrial DNA tRNA(Leu(UUR)) gene; Mutation; Mitochondrial myopathy encephalopathy lactic acidosis and stroke-like episodes (MELAS); Cybrid; ATP production; BN-PAGE
ID stroke-like episodes; respiratory-chain supercomplexes; kearns-sayre-syndrome; lactic-acidosis; point mutation; transfer-rnas; dna mutation; transcription termination; trna(leu(uur)) mutation; clinical-features
AB Two novel mitochondrial DNA base changes were identified at both sides of the 3243A > G mutation, the most common mutation associated with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS). One was a 3244G > A transition in a girl with MELAS. The other was a 3242G > A transition in a girl with a mitochondrial disorder without a MELAS phenotype. Although the two base changes were adjacent to the 3243A > G mutation, they had different effects on the clinical phenotype, muscle pathology, and respiratory chain enzyme activity. Investigations of the different effects of the 3244G > A and 3242G > A base changes may provide a better understanding of tRNA dysfunction in mitochondrial disorders. (C) 2009 Elsevier B.V. and Mitochondria Research Society. All rights reserved.
C1 [Mimaki, Masakazu; Hatakeyama, Hideyuki; Komaki, Hirofumi; Goto, Yu-ichi] Natl Ctr Neurol & Psychiat, Dept Mental Retardat & Birth Defect Res, Natl Inst Neurosci, Tokyo, Japan.
   [Ichiyama, Takashi; Isumi, Hiroshi; Furukawa, Susumu] Yamaguchi Univ, Dept Pediat, Sch Med, Yamaguchi, Japan.
   [Akasaka, Manami; Kamei, Atsushi] Iwate Med Univ, Dept Pediat, Morioka, Iwate, Japan.
   [Nishino, Ichizo] Natl Ctr Neurol & Psychiat, Dept Neuromuscular Res, Natl Inst Neurosci, Tokyo, Japan.
   [Nonaka, Ikuya] Natl Ctr Neurol & Psychiat, Natl Ctr Hosp Mental Nervous & Muscular Disorders, Tokyo, Japan.
C3 National Center for Neurology & Psychiatry - Japan; Yamaguchi University; Iwate Medical University; National Center for Neurology & Psychiatry - Japan; National Center for Neurology & Psychiatry - Japan
RP Goto, Y (corresponding author), Natl Ctr Neurol & Psychiat, Dept Mental Retardat & Birth Defect Res, Natl Inst Neurosci, 4-1-1 Ogawahigashi, Tokyo, Japan.
EM goto@ncnp.go.jp
FU Ministry of Health, Labor and Welfare of Japan [1513-4, 18A-5]; Japan Health Sciences Foundation [KHD2207]
CR Akanuma J, 2000, J HUM GENET, V45, P337, DOI 10.1007/s100380070004
   Campos Y, 2001, NEUROMUSCULAR DISORD, V11, P477, DOI 10.1016/S0960-8966(00)00223-6
   Chinnery PF, 1999, J MED GENET, V36, P505, DOI 10.1136/jmg.36.7.505
   Chomyn A, 2000, J BIOL CHEM, V275, P19198, DOI 10.1074/jbc.M908734199
   CHOMYN A, 1992, P NATL ACAD SCI USA, V89, P4221, DOI 10.1073/pnas.89.10.4221
   DAurelio M, 2006, HUM MOL GENET, V15, P2157, DOI 10.1093/hmg/ddl141
   Gattermann N, 2004, BLOOD, V103, P1499, DOI 10.1182/blood-2003-07-2446
   GOTO Y, 1991, BIOCHIM BIOPHYS ACTA, V1097, P238, DOI 10.1016/0925-4439(91)90042-8
   GOTO Y, 1992, NEUROLOGY, V42, P545, DOI 10.1212/WNL.42.3.545
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   GOTO Y, 1995, MUSCLE NERVE, V0, PS107
   GOTO YI, 1994, BIOCHEM BIOPH RES CO, V202, P1624, DOI 10.1006/bbrc.1994.2119
   Habano W, 2000, GASTROENTEROLOGY, V118, P835, DOI 10.1016/S0016-5085(00)70169-7
   Hadjigeorgiou GM, 1999, J NEUROL SCI, V164, P153, DOI 10.1016/S0022-510X(99)00062-3
   Hao HL, 1996, J BIOL CHEM, V271, P2347, DOI 10.1074/jbc.271.4.2347
   HASEGAWA H, 1991, ANN NEUROL, V29, P601, DOI 10.1002/ana.410290606
   Helm M, 2000, RNA, V6, P1356, DOI 10.1017/S1355838200001047
   HESS JF, 1991, NATURE, V351, P236, DOI 10.1038/351236a0
   HIRANO M, 1994, J CHILD NEUROL, V9, P4, DOI 10.1177/088307389400900102
   Jaksch M, 2001, NEUROLOGY, V57, P1930, DOI 10.1212/WNL.57.10.1930
   Kawarai T, 1997, NEUROLOGY, V49, P598, DOI 10.1212/WNL.49.2.598
   KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477
   KING MP, 1992, MOL CELL BIOL, V12, P480, DOI 10.1128/MCB.12.2.480
   Kirino Y, 2005, P NATL ACAD SCI USA, V102, P7127, DOI 10.1073/pnas.0500563102
   KOGA Y, 1995, MUSCLE NERVE, V0, PS119
   Komaki H, 2003, MITOCHONDRION, V2, P293, DOI 10.1016/S1567-7249(03)00003-5
   McFarland R, 2004, TRENDS GENET, V20, P591, DOI 10.1016/j.tig.2004.09.014
   McKenzie M, 2006, J MOL BIOL, V361, P462, DOI 10.1016/j.jmb.2006.06.057
   MORAES CT, 1992, AM J HUM GENET, V50, P934
   MORTEN KJ, 1993, HUM MOL GENET, V2, P2081, DOI 10.1093/hmg/2.12.2081
   Nijtmans LGJ, 2002, METHODS, V26, P327, DOI 10.1016/S1046-2023(02)00038-5
   Nishigaki Y, 2003, NEUROMUSCULAR DISORD, V13, P334, DOI 10.1016/S0960-8966(02)00283-3
   Nishino I, 1996, MUSCLE NERVE, V19, P1603, DOI 10.1002/(SICI)1097-4598(199612)19:12<1603::AID-MUS10>3.0.CO;2-S
   Robinson B H, 1996, METHODS ENZYMOL, V264, P454, DOI 10.1016/S0076-6879(96)64041-5
   SAKUTA R, 1989, ANN NEUROL, V25, P594, DOI 10.1002/ana.410250611
   Seneca S, 2001, ARCH NEUROL-CHICAGO, V58, P1113, DOI 10.1001/archneur.58.7.1113
   SEVIDEI S, 2002, NEUROMUSCULAR DISORD, V12, P524
   Suzuki T, 2002, EMBO J, V21, P6581, DOI 10.1093/emboj/cdf656
   Trounce I A, 1996, METHODS ENZYMOL, V264, P484, DOI 10.1016/S0076-6879(96)64044-0
   Yasukawa T, 2000, J BIOL CHEM, V275, P4251, DOI 10.1074/jbc.275.6.4251
NR 40
TC 22
Z9 26
U1 0
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD APR 15
PY 2009
VL 9
IS 2
BP 115
EP 122
DI 10.1016/j.mito.2009.01.005
PG 8
WC Cell Biology; Genetics & Heredity
SC Cell Biology; Genetics & Heredity
GA 428PO
UT WOS:000264861400005
PM 19460299
DA 2024-11-01
ER

PT J
AU Yoon, MK
   Roorda, A
   Zhang, Y
   Nakanishi, C
   Wong, LJC
   Zhang, Q
   Gillum, L
   Green, A
   Duncan, JL
AF Yoon, Michael K.
   Roorda, Austin
   Zhang, Yuhua
   Nakanishi, Chiaki
   Wong, Lee-Jun C.
   Zhang, Qing
   Gillum, Leslie
   Green, Ari
   Duncan, Jacque L.
TI Adaptive Optics Scanning Laser Ophthalmoscopy Images in a Family with the Mitochondrial DNA T8993C Mutation
SO INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
LA English
DT Article
ID living human eye; 3 cone classes; retinal degeneration; leighs-syndrome; mtdna mutation; point mutation; narp syndrome; rod; disease; photoreceptors
AB PURPOSE. This study was designed to assess the effect of mitochondrial DNA (mtDNA) mutation T8993C on cone structure in a family expressing neurogenic muscle weakness, ataxia, and retinitis pigmentosa (NARP) syndrome. METHODS. Five family members were studied, using clinical examination, nerve conduction studies, perimetry, optical coherence tomography (OCT) measures of central retinal thickness, and electroretinography. High-resolution images of cone structure using adaptive optics scanning laser ophthalmoscopy (AOSLO) were obtained in four subjects with stable fixation. Cone spacing was compared to 18 age-similar normal subjects and converted to z-scores at each location where unambiguous cones were identified. Tissue levels of T8993C mutant heteroplasmy in blood and hair follicles were quantified using realtime allele-refractory mutations system (ARMS) quantitative polymerase chain reaction (qPCR). RESULTS. Subjects expressing the T8993C mutation showed varying levels of disease severity. The subject with the lowest mutant load (42%-54%) showed no neurologic or retinal abnormalities. The remaining four subjects with over 77% mutant load all expressed severe neurologic and/or retinal abnormalities. AOSLO images revealed three patterns of cone spacing: pattern 1, normal; pattern 2, increased cone spacing within a contiguous cone mosaic; and pattern 3, patchy cone loss with increased cone spacing. Visual function was most severely affected in pattern 3. CONCLUSIONS. High levels of T8993C mutant load were associated with severe neurologic or visual dysfunction, while lower levels caused no detectable abnormalities. Visual function was better in patients with a contiguous and regular cone mosaic. Patients expressing high levels of the mtDNA T8993C mutation show abnormal cone structure, suggesting normal mitochondrial DNA is necessary for normal waveguiding by cones. (Invest Ophthalmol Vis Sci. 2009; 50: 1838-1847) DOI:10.1167/iovs.08-2029
C1 [Yoon, Michael K.; Nakanishi, Chiaki; Duncan, Jacque L.] Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA 94143 USA.
   [Gillum, Leslie; Green, Ari] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA.
   [Roorda, Austin; Zhang, Yuhua] Univ Calif Berkeley, Sch Optometry, Berkeley, CA 94720 USA.
   [Wong, Lee-Jun C.; Zhang, Qing] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.
C3 University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Berkeley; Baylor College of Medicine
RP Duncan, JL (corresponding author), Univ Calif San Francisco, Sch Med, Beckman Vis Ctr, 10 Koret Way,Rm K-129, San Francisco, CA 94143 USA.
EM duncanj@vision.ucsf.edu
FU Intramural NIH HHS [Z01 EY000415] Funding Source: Medline; NCRR NIH HHS [KL2 RR024130, KL2RR024130] Funding Source: Medline; NEI NIH HHS [P30 EY002162, EY002162, R01 EY014375, EY014375, K08 EY000415, R01 EY023591] Funding Source: Medline
CR Bai RK, 2004, CLIN CHEM, V50, P996, DOI 10.1373/clinchem.2004.031153
   Baraas RC, 2007, J OPT SOC AM A, V24, P1438, DOI 10.1364/JOSAA.24.001438
   Brainard DH, 2000, J OPT SOC AM A, V17, P607, DOI 10.1364/JOSAA.17.000607
   Carroll J, 2004, P NATL ACAD SCI USA, V101, P8461, DOI 10.1073/pnas.0401440101
   Choi SS, 2006, INVEST OPHTH VIS SCI, V47, P2080, DOI 10.1167/iovs.05-0997
   Chowers I, 1999, BRIT J OPHTHALMOL, V83, P190, DOI 10.1136/bjo.83.2.190
   Debray FG, 2007, AM J MED GENET A, V143A, P2046, DOI 10.1002/ajmg.a.31880
   DEVRIES DD, 1993, ANN NEUROL, V34, P410, DOI 10.1002/ana.410340319
   Duncan JL, 2007, INVEST OPHTH VIS SCI, V48, P3283, DOI 10.1167/iovs.06-1422
   Enns GM, 2006, MOL GENET METAB, V88, P364, DOI 10.1016/j.ymgme.2006.02.001
   Galli-Resta L, 1999, EUR J NEUROSCI, V11, P1461, DOI 10.1046/j.1460-9568.1999.00555.x
   Hayashi N, 2000, OPHTHALMOLOGY, V107, P1397, DOI 10.1016/S0161-6420(00)00110-X
   Hoang QV, 2002, VISUAL NEUROSCI, V19, P395, DOI 10.1017/S0952523802194028
   Hogan MJ, 1971, HISTOLOGY OF THE HUMAN EYE: AN ATLAS AND TEXT-BOOK, V0, P687
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   LAHIRI DK, 1991, NUCLEIC ACIDS RES, V19, P5444, DOI 10.1093/nar/19.19.5444
   Li KY, 2007, J OPT SOC AM A, V24, P1358, DOI 10.1364/JOSAA.24.001358
   Liang JZ, 1997, J OPT SOC AM A, V14, P2884, DOI 10.1364/JOSAA.14.002884
   Liang JZ, 1997, J OPT SOC AM A, V14, P2873, DOI 10.1364/JOSAA.14.002873
   Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292
   MAKELABENGS P, 1995, PEDIATR RES, V37, P634
   Marmor MF, 2004, DOC OPHTHALMOL, V108, P107, DOI 10.1023/B:DOOP.0000036793.44912.45
   MITSUMOTO H, 1983, NEUROLOGY, V33, P452, DOI 10.1212/WNL.33.4.452
   MULLIE MA, 1985, ARCH OPHTHALMOL-CHIC, V103, P1825, DOI 10.1001/archopht.1985.01050120059020
   Neitz J, 2002, NEURON, V35, P783, DOI 10.1016/S0896-6273(02)00818-8
   Newman NJ, 1992, OPHTHALMOL CLIN N AM, V5, P405
   ORTIZ RG, 1993, ARCH OPHTHALMOL-CHIC, V111, P1525, DOI 10.1001/archopht.1993.01090110091031
   Pallikaris A, 2003, INVEST OPHTH VIS SCI, V44, P4580, DOI 10.1167/iovs.03-0094
   Perkins GA, 2004, MITOCHONDRION, V4, P695, DOI 10.1016/j.mito.2004.07.020
   Perkins GA, 2003, MOL VIS, V9, P60
   Porto FBO, 2001, AM J OPHTHALMOL, V132, P935, DOI 10.1016/S0002-9394(01)01187-4
   Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311
   Rantamäki MT, 2005, ANN NEUROL, V58, P337, DOI 10.1002/ana.20555
   Roorda A, 2001, VISION RES, V41, P1291, DOI 10.1016/S0042-6989(01)00043-8
   Roorda A, 1999, NATURE, V397, P520, DOI 10.1038/17383
   Roorda A, 2007, INVEST OPHTH VIS SCI, V48, P2297, DOI 10.1167/iovs.06-1450
   Roorda A, 2002, J VISION, V2, P404, DOI 10.1167/2.5.4
   Santorelli FM, 1996, PEDIATR RES, V39, P914, DOI 10.1203/00006450-199605000-00028
   Schmiedel J, 2003, J NEUROL, V250, P267, DOI 10.1007/s00415-003-0978-3
   Sciacco M, 2003, J NEUROL, V250, P1498, DOI 10.1007/s00415-003-0246-6
   SHAPIRO MB, 1985, J AM STAT ASSOC, V80, P803, DOI 10.2307/2288535
   Sieving PA, 2006, P NATL ACAD SCI USA, V103, P3896, DOI 10.1073/pnas.0600236103
   Suzuki Y, 1998, PEDIATR NEUROL, V19, P283, DOI 10.1016/S0887-8994(98)00070-8
   TATUCH Y, 1992, AM J HUM GENET, V50, P852
   Tsao CY, 2001, J CHILD NEUROL, V16, P533, DOI 10.1177/088307380101600716
   Uziel G, 1997, J NEUROL NEUROSUR PS, V63, P16, DOI 10.1136/jnnp.63.1.16
   White SL, 1999, AM J HUM GENET, V65, P474, DOI 10.1086/302488
   Wolfing JI, 2006, OPHTHALMOLOGY, V113, P1014, DOI 10.1016/j.ophtha.2006.01.056
   Wong LJC, 1997, CLIN CHEM, V43, P1241
NR 49
TC 50
Z9 56
U1 0
U2 5
PU ASSOC RESEARCH VISION OPHTHALMOLOGY INC
PI ROCKVILLE
PA 12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA
SN 0146-0404
EI 1552-5783
J9 INVEST OPHTH VIS SCI
JI Invest. Ophthalmol. Vis. Sci.
PD APR 15
PY 2009
VL 50
IS 4
BP 1838
EP 1847
DI 10.1167/iovs.08-2029
PG 10
WC Ophthalmology
SC Ophthalmology
GA 424CP
UT WOS:000264543400049
PM 18997096
DA 2024-11-01
ER

PT J
AU Park, JY
   Wang, PY
   Matsumoto, T
   Sung, HJ
   Ma, WZ
   Choi, JW
   Anderson, SA
   Leary, SC
   Balaban, RS
   Kang, JG
   Hwang, PM
AF Park, Joon-Young
   Wang, Ping-yuan
   Matsumoto, Takumi
   Sung, Ho Joong
   Ma, Wenzhe
   Choi, Jeong W.
   Anderson, Stasia A.
   Leary, Scot C.
   Balaban, Robert S.
   Kang, Ju-Gyeong
   Hwang, Paul M.
TI p53 Improves Aerobic Exercise Capacity and Augments Skeletal Muscle Mitochondrial DNA Content
SO CIRCULATION RESEARCH
LA English
DT Article
DE aerobic; exercise; mitochondrial DNA; p53; TFAM
ID transcription factor-a; ribonucleotide reductase; physical-fitness; biogenesis; mice; activation; expression; mortality; apoptosis; disease
AB Rationale: Exercise capacity is a physiological characteristic associated with protection from both cardiovascular and all-cause mortality. p53 regulates mitochondrial function and its deletion markedly diminishes exercise capacity, but the underlying genetic mechanism orchestrating this is unclear. Understanding the biology of how p53 improves exercise capacity may provide useful insights for improving both cardiovascular as well as general health. Objective: The purpose of this study was to understand the genetic mechanism by which p53 regulates aerobic exercise capacity. Methods and Results: Using a variety of physiological, metabolic, and molecular techniques, we further characterized maximum exercise capacity and the effects of training, measured various nonmitochondrial and mitochondrial determinants of exercise capacity, and examined putative regulators of mitochondrial biogenesis. As p53 did not affect baseline cardiac function or inotropic reserve, we focused on the involvement of skeletal muscle and now report a wider role for p53 in modulating skeletal muscle mitochondrial function. p53 interacts with Mitochondrial Transcription Factor A (TFAM), a nuclear-encoded gene important for mitochondrial DNA ( mtDNA) transcription and maintenance, and regulates mtDNA content. The increased mtDNA in p53(+/+) compared to p53(-/-) mice was more marked in aerobic versus glycolytic skeletal muscle groups with no significant changes in cardiac tissue. These in vivo observations were further supported by in vitro studies showing overexpression of p53 in mouse myoblasts increases both TFAM and mtDNA levels whereas depletion of TFAM by shRNA decreases mtDNA content. Conclusions: Our current findings indicate that p53 promotes aerobic metabolism and exercise capacity by using different mitochondrial genes and mechanisms in a tissue-specific manner. (Circ Res. 2009; 105: 705-712.)
C1 [Park, Joon-Young; Wang, Ping-yuan; Matsumoto, Takumi; Sung, Ho Joong; Ma, Wenzhe; Choi, Jeong W.; Anderson, Stasia A.; Balaban, Robert S.; Kang, Ju-Gyeong; Hwang, Paul M.] NHLBI, Translat Med Branch, NIH, Bethesda, MD 20892 USA.
   [Park, Joon-Young] Temple Univ, Philadelphia, PA 19122 USA.
   [Leary, Scot C.] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada.
   [Leary, Scot C.] McGill Univ, Dept Human Genet, Montreal, PQ, Canada.
C3 National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; McGill University; McGill University
RP Hwang, PM (corresponding author), NHLBI, Translat Med Branch, NIH, 10CRC-5-5330,10 Ctr Dr, Bethesda, MD 20892 USA.
EM hwangp@mail.nih.gov
FU Division of Intramural Research; National Heart, Lung, and Blood Institute; National Institutes of Health; Japan Society for the Promotion of Science
CR Achanta G, 2005, EMBO J, V24, P3482, DOI 10.1038/sj.emboj.7600819
   Akimoto T, 2005, J BIOL CHEM, V280, P19587, DOI 10.1074/jbc.M408862200
   Bakhanashvili M, 2008, CELL DEATH DIFFER, V15, P1865, DOI 10.1038/cdd.2008.122
   Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036
   Bernal-Mizrachi C, 2005, NATURE, V435, P502, DOI 10.1038/nature03527
   Boopathi E, 2008, MOL CELL, V32, P32, DOI 10.1016/j.molcel.2008.09.008
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   Calvo JA, 2008, J APPL PHYSIOL, V104, P1304, DOI 10.1152/japplphysiol.01231.2007
   Chen DX, 2006, CANCER RES, V66, P3485, DOI 10.1158/0008-5472.CAN-05-4103
   Chen YW, 2002, J PHYSIOL-LONDON, V545, P27, DOI 10.1113/jphysiol.2002.021220
   DSouza AD, 2007, MITOCHONDRION, V7, P374, DOI 10.1016/j.mito.2007.08.001
   Eaton JS, 2007, J CLIN INVEST, V117, P2723, DOI 10.1172/JCI31604
   Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109
   Erikssen G, 1998, LANCET, V352, P759, DOI 10.1016/S0140-6736(98)02268-5
   Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478
   Gates AC, 2007, CELL METAB, V6, P497, DOI 10.1016/j.cmet.2007.10.010
   Gautier CA, 2008, P NATL ACAD SCI USA, V105, P11364, DOI 10.1073/pnas.0802076105
   Héron-Milhavet L, 2004, ENDOCRINOLOGY, V145, P4667, DOI 10.1210/en.2003-1543
   HOLLOSZY JO, 1984, J APPL PHYSIOL, V56, P831, DOI 10.1152/jappl.1984.56.4.831
   Hwang PM, 2001, NAT MED, V7, P1111, DOI 10.1038/nm1001-1111
   Ibrahim MM, 1998, BBA-MOL CELL RES, V1403, P254, DOI 10.1016/S0167-4889(98)00066-4
   Johnson DT, 2007, AM J PHYSIOL-CELL PH, V292, PC689, DOI 10.1152/ajpcell.00108.2006
   Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604
   Kokkinos P, 2008, CIRCULATION, V117, P614, DOI 10.1161/CIRCULATIONAHA.107.734764
   Kulawiec Mariola, 2009, J CARCINOG, V8, P8, DOI 10.4103/1477-3163.50893
   Laptenko O, 2006, CELL DEATH DIFFER, V13, P951, DOI 10.1038/sj.cdd.4401916
   Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231
   Lebedeva MA, 2009, BBA-BIOENERGETICS, V1787, P328, DOI 10.1016/j.bbabio.2009.01.004
   Marchenko ND, 2007, EMBO J, V26, P923, DOI 10.1038/sj.emboj.7601560
   Mason SD, 2007, AM J PHYSIOL-REG I, V293, PR2059, DOI 10.1152/ajpregu.00335.2007
   Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863
   Matsumoto K, 1996, J APPL PHYSIOL, V81, P1843, DOI 10.1152/jappl.1996.81.4.1843
   MCLEOD CJ, 2005, J BIOL CHEM, V0, P0
   Papadopoulou LC, 1999, NAT GENET, V23, P333
   Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024
   Patino WD, 2005, P NATL ACAD SCI USA, V102, P3423, DOI 10.1073/pnas.0408032102
   POOL CW, 1979, HISTOCHEMISTRY, V64, P251, DOI 10.1007/BF00495025
   RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275
   Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395
   Saleem A, 2009, PHYSIOL GENOMICS, V37, P58, DOI 10.1152/physiolgenomics.90346.2008
   SANDVIK L, 1993, NEW ENGL J MED, V328, P533, DOI 10.1056/NEJM199302253280803
   Sankaran VG, 2008, GENE DEV, V22, P463, DOI 10.1101/gad.1627208
   Shadel GS, 2008, AM J PATHOL, V172, P1445, DOI 10.2353/ajpath.2008.071163
   SULLIVAN SM, 1987, AM J PHYSIOL, V252, PH149, DOI 10.1152/ajpheart.1987.252.1.H149
   Wang H, 1999, EUR J APPL PHYSIOL O, V80, P22, DOI 10.1007/s004210050553
   Weibel ER, 1979, STEREOLOGICAL METHOD, V1, P0
   Wende AR, 2007, J BIOL CHEM, V282, P36642, DOI 10.1074/jbc.M707006200
   Whittemore LA, 2003, BIOCHEM BIOPH RES CO, V300, P965, DOI 10.1016/S0006-291X(02)02953-4
   Wisloff U, 2005, SCIENCE, V307, P418, DOI 10.1126/science.1108177
   Wong TS, 2009, NUCLEIC ACIDS RES, V37, P568, DOI 10.1093/nar/gkn974
   Yoshida Y, 2003, CANCER RES, V63, P3729
NR 51
TC 160
Z9 173
U1 3
U2 16
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0009-7330
EI 1524-4571
J9 CIRC RES
JI Circ.Res.
PD SEP 25
PY 2009
VL 105
IS 7
BP 705
EP U110
DI 10.1161/CIRCRESAHA.109.205310
PG 19
WC Cardiac & Cardiovascular Systems; Hematology; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology; Hematology
GA 498OJ
UT WOS:000270150800013
PM 19696408
DA 2024-11-01
ER

PT J
AU Udar, N
   Atilano, SR
   Memarzadeh, M
   Boyer, DS
   Chwa, M
   Lu, S
   Maguen, B
   Langberg, J
   Coskun, P
   Wallace, DC
   Nesburn, AB
   Khatibi, N
   Hertzog, D
   Le, K
   Hwang, D
   Kenney, MC
AF Udar, Nitin
   Atilano, Shari R.
   Memarzadeh, Masood
   Boyer, David S.
   Chwa, Marilyn
   Lu, Stephanie
   Maguen, Barak
   Langberg, Jonathan
   Coskun, Pinar
   Wallace, Douglas C.
   Nesburn, Anthony B.
   Khatibi, Nikan
   Hertzog, Dieter
   Le, Khoi
   Hwang, Daniel
   Kenney, M. Cristina
TI Mitochondrial DNA Haplogroups Associated with Age-Related Macular Degeneration
SO INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
LA English
DT Article
ID factor-h polymorphism; parkinsons-disease; alzheimer-disease; skeletal-muscle; risk-factors; complement; mtdna; gene; maculopathy; population
AB PURPOSE. To examine the mtDNA control regions in normal and age-related macular degeneration (AMD) retinas. To identify the mtDNA variations associated with AMD. METHODS. Retinas from 10 normal and 11 AMD globes were isolated and analyzed for mtDNA rearrangements by long extension-polymerase chain reaction (LX-PCR) and for the nature and frequency of single-nucleotide polymorphisms (SNPs) in the mtDNA control region by direct sequencing. Blood DNA was extracted from 99 AMD and 92 age-matched control subjects. The sequence variations that define haplogroups H, I, J, K, T, V, X, and U were characterized by PCR, restriction enzyme digestion, and/or sequencing. RESULTS. LX-PCR of retinal mtDNAs revealed high levels of rearrangements in the patients with AMD and the control subjects, consistent with the decline in mitochondrial function with age. However, the AMD retinas had higher oxidized DNA levels and a higher number of SNPs than controls (P = 0.02). The control region SNPs T16126C and A73G, commonly found in haplogroups J and T, were more frequent in the AMD retinas than in normal retinas. The associations between AMD and haplogroups J and T were confirmed and extended by analysis of blood DNA. SNPs at position a T16126C (J; odds ratio [OR] = 3.66), T16126C+G13368A (JT; OR = 10.27), A4917G + A73G (T4; OR = 5), and T3197C + A12308G (U5; OR = infinity), were all strongly associated with AMD. CONCLUSIONS. AMD retinas exhibited increased mtDNA control region SNPs compared to normal retinas. This correlated with an increased frequency of mtDNA SNPs associated with haplogroups J, T and U in patients with AMD. These results implicate mitochondrial alterations in the etiology of AMD. ( Invest Ophthalmol Vis Sci. 2009; 50: 2966-2974) DOI:10.1167/iovs.08-2646
C1 [Kenney, M. Cristina] Univ Calif Irvine, Med Ctr, Dept Ophthalmol, Orange, CA 92868 USA.
   [Boyer, David S.] Retina Vitreous Associates Med Grp, Beverly Hills, CA USA.
   [Coskun, Pinar; Wallace, Douglas C.] Univ Calif Irvine, Dept Biol Chem, Ctr Mol & Mitochondrial Med & Genet, Irvine, CA 92717 USA.
   [Coskun, Pinar; Wallace, Douglas C.] Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Ctr Mol & Mitochondrial Med & Genet, Irvine, CA 92717 USA.
   [Coskun, Pinar; Wallace, Douglas C.] Univ Calif Irvine, Dept Pediat, Ctr Mol & Mitochondrial Med & Genet, Irvine, CA 92717 USA.
   [Nesburn, Anthony B.] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA.
   [Khatibi, Nikan] Kansas City Med Sch, Kansas City, MO USA.
   [Hertzog, Dieter] Loma Linda Med Ctr, Loma Linda, CA USA.
   [Le, Khoi] Dartmouth Hitchcock Med Ctr, Hanover, NH USA.
C3 University of California System; University of California Irvine; Retina Vitreous Associates Medical Group; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; Cedars Sinai Medical Center; Loma Linda University; Dartmouth College
RP Kenney, MC (corresponding author), Univ Calif Irvine, Med Ctr, Dept Ophthalmol, 101 City Dr, Orange, CA 92868 USA.
EM mkenney@uci.edu
FU Discovery Eye Foundation; Lincy Foundation; Henry L. Guenther Foundation; Iris and B. Gerald Cantor Foundation; Gilbert Foundation; Research to Prevent Blindness
CR Andrews R, 2006, BRIT J OPHTHALMOL, V90, P488, DOI 10.1136/bjo.2005.084335
   Atilano SR, 2005, INVEST OPHTH VIS SCI, V46, P1256, DOI 10.1167/iovs.04-1395
   Brown MD, 1997, AM J HUM GENET, V60, P381
   Canter JA, 2008, PLOS ONE, V3, P0, DOI 10.1371/journal.pone.0002091
   Castro MG, 2006, INT J CARDIOL, V112, P202, DOI 10.1016/j.ijcard.2005.09.008
   Chagnon P, 1999, AM J MED GENET, V85, P20, DOI 10.1002/(SICI)1096-8628(19990702)85:1<20::AID-AJMG6>3.0.CO;2-K
   Conley YP, 2005, HUM MOL GENET, V14, P1991, DOI 10.1093/hmg/ddi204
   Coskun PE, 2004, P NATL ACAD SCI USA, V101, P10726, DOI 10.1073/pnas.0403649101
   Dewan A, 2007, CURR OPIN GENET DEV, V17, P228, DOI 10.1016/j.gde.2007.04.004
   Donoso LA, 2006, SURV OPHTHALMOL, V51, P137, DOI 10.1016/j.survophthal.2005.12.001
   Dunaief JL, 2002, ARCH OPHTHALMOL-CHIC, V120, P1435, DOI 10.1001/archopht.120.11.1435
   Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189
   Fesahat F, 2007, CELL MOL NEUROBIOL, V27, P329, DOI 10.1007/s10571-006-9126-9
   Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309
   Gu GY, 2002, J NEUROPATH EXP NEUR, V61, P634, DOI 10.1093/jnen/61.7.634
   Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359
   Hamdi HK, 2003, FRONT BIOSCI-LANDMRK, V8, PE305, DOI 10.2741/1019
   Hassani-Kumleh H, 2006, CELL MOL NEUROBIOL, V26, P119, DOI 10.1007/s10571-006-9026-z
   Hofmann S, 1997, GENOMICS, V39, P8, DOI 10.1006/geno.1996.4474
   Huerta C, 2005, J NEUROL SCI, V236, P49, DOI 10.1016/j.jns.2005.04.016
   Jessie BC, 2001, EXP GERONTOL, V37, P169, DOI 10.1016/S0531-5565(01)00153-X
   Jones MM, 2007, ARCH OPHTHALMOL-CHIC, V125, P1235, DOI 10.1001/archopht.125.9.1235
   Khusnutdinova E, 2008, ANN NY ACAD SCI, V1147, P1, DOI 10.1196/annals.1427.001
   Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557
   Melov S, 1997, NUCLEIC ACIDS RES, V25, P974, DOI 10.1093/nar/25.5.974
   MELOV S, 1995, NUCLEIC ACIDS RES, V23, P4122, DOI 10.1093/nar/23.20.4122
   Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100
   Montiel-Sosa F, 2006, GENE, V368, P21, DOI 10.1016/j.gene.2005.09.015
   Moshfeghi DM, 2007, RETINA-J RET VIT DIS, V27, P269, DOI 10.1097/IAE.0b013e31802e3e9b
   Muller-Eberhard H J, 1980, ADV IMMUNOL, V29, P1, DOI 10.1016/S0065-2776(08)60042-5
   Narayanan R, 2007, OPHTHALMOLOGY, V114, P1327, DOI 10.1016/j.ophtha.2006.10.035
   Reynier P, 1999, EUR J HUM GENET, V7, P404, DOI 10.1038/sj.ejhg.5200293
   Roquet W, 2004, BRIT J OPHTHALMOL, V88, P638, DOI 10.1136/bjo.2003.017632
   Rozen S, 2000, METHODS MOL BIOL, V132, P365
   Ruiz-Pesini E, 2004, SCIENCE, V303, P223, DOI 10.1126/science.1088434
   Seddon JM, 2006, OPHTHALMOLOGY, V113, P260, DOI 10.1016/j.ophtha.2005.11.001
   Shastry BS, 2006, OPHTHALMOLOGICA, V220, P291, DOI 10.1159/000094617
   Subrarnaniam V, 2008, BBA-BIOENERGETICS, V1777, P666, DOI 10.1016/j.bbabio.2008.03.015
   Tanimoto S, 2007, NEUROSCI LETT, V414, P71, DOI 10.1016/j.neulet.2006.12.011
   Tomany SC, 2004, OPHTHALMOLOGY, V111, P1280, DOI 10.1016/j.ophtha.2003.11.010
   Torroni A, 1996, GENETICS, V144, P1835
   TORRONI A, 1993, AM J HUM GENET, V53, P563
   van der Walt JM, 2004, NEUROSCI LETT, V365, P28, DOI 10.1016/j.neulet.2004.04.051
   van der Walt JM, 2003, AM J HUM GENET, V72, P804, DOI 10.1086/373937
   WALLACE DC, 1994, J BIOENERG BIOMEMBR, V26, P241, DOI 10.1007/BF00763096
   Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751
   WALLACE DC, 1992, ANNU REV BIOCHEM, V61, P1175, DOI 10.1146/annurev.bi.61.070192.005523
   Wang AL, 2008, MOL VIS, V14, P644
   Yang ZL, 2006, SCIENCE, V314, P992, DOI 10.1126/science.1133811
   Yoshida T, 2007, MOL VIS, V13, P545
NR 50
TC 100
Z9 111
U1 0
U2 7
PU ASSOC RESEARCH VISION OPHTHALMOLOGY INC
PI ROCKVILLE
PA 12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA
SN 0146-0404
EI 1552-5783
J9 INVEST OPHTH VIS SCI
JI Invest. Ophthalmol. Vis. Sci.
PD JUN 15
PY 2009
VL 50
IS 6
BP 2966
EP 2974
DI 10.1167/iovs.08-2646
PG 9
WC Ophthalmology
SC Ophthalmology
GA 450ME
UT WOS:000266403800059
PM 19151382
DA 2024-11-01
ER

PT J
AU Rao, M
   Li, LJ
   Demello, C
   Guo, DQ
   Jaber, BL
   Pereira, BJG
   Balakrishnan, VS
AF Rao, Madhumathi
   Li, Lijun
   Demello, Caren
   Guo, Daqing
   Jaber, Bertrand L.
   Pereira, Brian J. G.
   Balakrishnan, Vaidyanathapurarn S.
TI Mitochondrial DNA Injury and Mortality in Hemodialysis Patients
SO JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
LA English
DT Article
ID skeletal-muscle; biogenesis; mutations; deletion; cells; metabolism; exercise; diseases; damage; pcr
AB The role of mitochondrial injury in the pathogenesis of complications of uremia is incompletely defined, although diminished bioenergetic capacity and the accumulation of mitochondrial DNA (mtDNA) mutations have been reported. This study was undertaken to evaluate the prevalence of mtDNA injury in 180 patients who had ESRD and were enrolled into the baseline phase of the HEMO study and to relate these markers to all-cause mortality. The mitochondrial injury markers studied in peripheral blood mononuclear cells were the mtDNA copy number per cell, measured by quantitative PCR, and the presence of the mtDNA(4977) mutation. After frequency-matching healthy control subjects for age, mtDNA copy number was lower among older dialysis patients compared with older healthy subjects (P = 0.01). A one-log increase in mtDNA copy number was independently associated with a decreased hazard for mortality (adjusted hazard ratio 0.64; 95% confidence interval 0.46 to 0.89). The mtDNA(4977) deletion was present in 48 (31%) patients and was independently associated with a decreased hazard for mortality (adjusted hazard ratio 0.33; 95% confidence interval 0.19 to 0.56). In summary, the mtDNA(4977) seems to predict survival in ESRD, but a reduced mitochondrial copy number seems to predict a poor outcome. Although further exploration of these associations is needed, evaluation of mitochondrial DNA copy number and somatic mtDNA mutations may provide simple genomic biomarkers to predict clinical outcomes among patients with ESRD.
C1 [Rao, Madhumathi; Li, Lijun; Demello, Caren; Guo, Daqing; Jaber, Bertrand L.; Pereira, Brian J. G.; Balakrishnan, Vaidyanathapurarn S.; Grp, HS] Tufts New England Med Ctr Hosp, Dept Med, Div Nephrol, Boston, MA USA.
RP Rao, M (corresponding author), Tufts Univ New England Med Ctr, 35 Kneeland St, Boston, MA 02111 USA.
EM mrao@tufts-nemc.org
FU National Institutes Of Health [DK 2819-O1A1]; Satellite Healthcare
CR ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Botto N, 2005, MUTAT RES-FUND MOL M, V570, P81, DOI 10.1016/j.mrfmmm.2004.10.003
   Chabi B, 2005, MED SCI SPORT EXER, V37, P2102, DOI 10.1249/01.mss.0000177426.68149.83
   Eknoyan G, 2002, NEW ENGL J MED, V347, P2010, DOI 10.1056/NEJMoa021583
   Frahm T, 2005, MECH AGEING DEV, V126, P1192, DOI 10.1016/j.mad.2005.06.008
   Greene T, 2000, CONTROL CLIN TRIALS, V21, P502, DOI 10.1016/S0197-2456(00)00062-3
   He LP, 2002, NUCLEIC ACIDS RES, V30, P0, DOI 10.1093/nar/gnf067
   Heilbronn L, 2004, INT J OBESITY, V28, PS12, DOI 10.1038/sj.ijo.0802853
   Heilbronn LK, 2007, J CLIN ENDOCR METAB, V92, P1467, DOI 10.1210/jc.2006-2210
   Hood DA, 2007, NUTR METAB CARDIOVAS, V17, P332, DOI 10.1016/j.numecd.2007.02.009
   Jin SK, 2006, AUTOPHAGY, V2, P80, DOI 10.4161/auto.2.2.2460
   Kalantar-Zadeh K, 2005, SEMIN DIALYSIS, V18, P365, DOI 10.1111/j.1525-139X.2005.00074.x
   Kim I, 2007, ARCH BIOCHEM BIOPHYS, V462, P245, DOI 10.1016/j.abb.2007.03.034
   Krishnan KJ, 2007, ANN NY ACAD SCI, V1100, P227, DOI 10.1196/annals.1395.024
   Lai LP, 2003, CHEST, V123, P539, DOI 10.1378/chest.123.2.539
   Lim PS, 2002, J BIOMED SCI, V9, P549, DOI 10.1159/000064728
   Liu CS, 2001, NEPHROL DIAL TRANSPL, V16, P561, DOI 10.1093/ndt/16.3.561
   Masuyama M, 2005, BBA-GEN SUBJECTS, V1723, P302, DOI 10.1016/j.bbagen.2005.03.001
   McKenzie D, 2002, EUR J BIOCHEM, V269, P2010, DOI 10.1046/j.1432-1033.2002.02867.x
   Menshikova EV, 2006, J GERONTOL A-BIOL, V61, P534, DOI 10.1093/gerona/61.6.534
   Miller FJ, 2003, NUCLEIC ACIDS RES, V31, P0, DOI 10.1093/nar/gng060
   Miskulin DC, 2001, KIDNEY INT, V60, P1498, DOI 10.1046/j.1523-1755.2001.00954.x
   Mohamed SA, 2004, EXP GERONTOL, V39, P181, DOI 10.1016/j.exger.2003.10.011
   Nisoli E, 2007, CIRC RES, V100, P795, DOI 10.1161/01.RES.0000259591.97107.6c
   Pieczenik SR, 2007, EXP MOL PATHOL, V83, P84, DOI 10.1016/j.yexmp.2006.09.008
   POUTSIAKA DD, 1991, BLOOD, V78, P1275
   Rasbach KA, 2007, J BIOL CHEM, V282, P2355, DOI 10.1074/jbc.M608009200
   Rolo AP, 2006, TOXICOL APPL PHARM, V212, P167, DOI 10.1016/j.taap.2006.01.003
   Rötig A, 2003, J AM SOC NEPHROL, V14, P2995, DOI 10.1097/01.ASN.0000095481.24091.C9
   THOMPSON CH, 1993, NEPHROL DIAL TRANSPL, V8, P218
   Ukropcova B, 2007, DIABETES, V56, P720, DOI 10.2337/db06-0521
   WALLACE DC, 1995, BBA-MOL BASIS DIS, V1271, P141, DOI 10.1016/0925-4439(95)00021-U
   WEI YH, 1992, MUTAT RES, V275, P145, DOI 10.1016/0921-8734(92)90019-L
NR 33
TC 56
Z9 63
U1 0
U2 1
PU AMER SOC NEPHROLOGY
PI WASHINGTON
PA 1725 I ST, NW STE 510, WASHINGTON, DC 20006 USA
SN 1046-6673
EI 1533-3450
J9 J AM SOC NEPHROL
JI J. Am. Soc. Nephrol.
PD JAN 15
PY 2009
VL 20
IS 1
BP 189
EP 196
DI 10.1681/ASN.2007091031
PG 8
WC Urology & Nephrology
SC Urology & Nephrology
GA 397QM
UT WOS:000262677200026
PM 18684894
DA 2024-11-01
ER

PT J
AU Di Donato, S
AF Di Donato, Stefano
TI Multisystem manifestations of mitochondrial disorders
SO JOURNAL OF NEUROLOGY
LA English
DT Review
DE Mitochondrial disorders; Respiratory chain; Oxidative phosphorylation; Multisystem manifestations
ID cytochrome-c-oxidase; progressive external ophthalmoplegia; kearns-sayre syndrome; inherited hypertrophic cardiomyopathy; complex-iii deficiency; diabetes-mellitus; point mutation; oxidative-phosphorylation; respiratory-chain; dna mutation
AB Mitochondria are cytoplasmic organelles in eukaryotic cells that accomplish several distinct vital functions, including oxidative phosphorylation, metabolic anaplerotic and degradative pathways, and integration of signaling for apoptosis. Impaired oxidative phosphorylation, the common final pathway of mitochondrial metabolism, results in a variety of clinical manifestations, and the term mitochondrial disorders is currently ascribed to (mostly) genetic diseases of the respiratory chain associated with mitochondrial DNA mutation or nuclear DNA mutations. Genetic disorders with impaired oxidative phosphorylation are extremely heterogeneous, as their clinical presentation ranges from lesions of single tissues or specialized structures, such as the optic nerve in the mitochondrial DNA-associated Leber's hereditary optic neuropathy and in the nuclear DNA-associated dominant optic atrophy, to more widespread pathologies, including myopathies, peripheral neuropathies, encephalomyopathies, cardiopathies, or complex multisystem disorders. The age at onset ranges from neonatal to adult life. This review focuses on mitochondrial diseases that find significant expression outside the central nervous system and the peripheral neuromuscular system, and manifest with substantial clinical signs and symptoms in tissues and organs such as the heart, endocrine system, liver, kidney, blood, and gastrointestinal tract. The available information on putative genotype-phenotype correlations and the related pathogenic mechanisms are summarized when appropriate.
C1 [Di Donato, Stefano] Fdn IRCCS Ist Neurol Carlo Besta, Milano Via Celoria 11, I-20133 Milan, Italy.
C3 Fondazione IRCCS Istituto Neurologico Carlo Besta
RP Di Donato, S (corresponding author), Fdn IRCCS Ist Neurol Carlo Besta, Milano Via Celoria 11, I-20133 Milan, Italy.
EM didonato@istituto-besta.it
FU Ministero della Salute; Fondazione Cariplo [2005-1602]
CR Alcolado JC, 2002, DIABETIC MED, V19, P89, DOI 10.1046/j.1464-5491.2002.00675.x
   Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944
   Allikmets R, 1999, HUM MOL GENET, V8, P743, DOI 10.1093/hmg/8.5.743
   Andreu AL, 1999, NEW ENGL J MED, V341, P1037, DOI 10.1056/NEJM199909303411404
   AnkelSimons F, 1996, P NATL ACAD SCI USA, V93, P13859, DOI 10.1073/pnas.93.24.13859
   Antonicka H, 2003, HUM MOL GENET, V12, P2693, DOI 10.1093/hmg/ddg284
   Antonicka H, 2003, AM J HUM GENET, V72, P101, DOI 10.1086/345489
   Antozzi C, 1997, CARDIOVASC RES, V35, P184, DOI 10.1016/S0008-6363(97)00141-7
   Astuti D, 2001, AM J HUM GENET, V69, P49, DOI 10.1086/321282
   BABCOCK GT, 1992, NATURE, V356, P301, DOI 10.1038/356301a0
   BALLINGER SW, 1992, NAT GENET, V1, P11, DOI 10.1038/ng0492-11
   Baughman JM, 2006, NAT GENET, V38, P1232, DOI 10.1038/ng1106-1232
   Baysal BE, 2000, SCIENCE, V287, P848, DOI 10.1126/science.287.5454.848
   Baysal BE, 2002, J MED GENET, V39, P178, DOI 10.1136/jmg.39.3.178
   Bénit P, 2003, HUM MUTAT, V21, P582, DOI 10.1002/humu.10225
   BERNES SM, 1993, J PEDIATR-US, V123, P598, DOI 10.1016/S0022-3476(05)80962-X
   Betts J, 2008, NEUROLOGY, V70, P1290, DOI 10.1212/01.wnl.0000308940.38092.74
   Bione S, 1996, NAT GENET, V12, P385, DOI 10.1038/ng0496-385
   Bornstein B, 2008, NEUROMUSCULAR DISORD, V18, P453, DOI 10.1016/j.nmd.2008.04.006
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   BOURGERON T, 1995, NAT GENET, V11, P144, DOI 10.1038/ng1095-144
   Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423
   CASALI C, 1995, BIOCHEM BIOPH RES CO, V213, P588, DOI 10.1006/bbrc.1995.2172
   Casari G, 1998, CELL, V93, P973, DOI 10.1016/S0092-8674(00)81203-9
   CHINNERY PF, 2007, NEUROMUSCULAR DISORD, V18, P259
   Cree LM, 2008, NAT GENET, V40, P249, DOI 10.1038/ng.2007.63
   de Lonlay P, 2001, NAT GENET, V29, P57, DOI 10.1038/ng706
   De Meirleir L, 2004, J MED GENET, V41, P120, DOI 10.1136/jmg.2003.012047
   Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936
   Di Donato S, 2000, J INHERIT METAB DIS, V23, P247, DOI 10.1023/A:1005684029429
   DiMauro S, 2008, ANNU REV NEUROSCI, V31, P91, DOI 10.1146/annurev.neuro.30.051606.094302
   DiMauro S, 2007, J CLIN INVEST, V117, P587, DOI 10.1172/JCI31423
   Dunning CJR, 2007, EMBO J, V26, P3227, DOI 10.1038/sj.emboj.7601748
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   Elpeleg O, 2005, AM J HUM GENET, V76, P1081, DOI 10.1086/430843
   Estivill X, 1998, AM J HUM GENET, V62, P27, DOI 10.1086/301676
   EVIATAR L, 1990, NEUROLOGY, V40, P1761, DOI 10.1212/WNL.40.11.1761
   Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786
   Fernández-Vizarra E, 2009, BBA-MOL CELL RES, V1793, P200, DOI 10.1016/j.bbamcr.2008.05.028
   FINOCCHIARO G, 1988, NEUROLOGY, V38, P1292, DOI 10.1212/WNL.38.8.1292
   Gámez J, 1998, NEUROLOGY, V51, P258, DOI 10.1212/WNL.51.1.258
   Gattermann N, 1997, BLOOD, V90, P4961, DOI 10.1182/blood.V90.12.4961.4961_4961_4972
   GILES RE, 1980, P NATL ACAD SCI-BIOL, V77, P6715, DOI 10.1073/pnas.77.11.6715
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Grasso M, 2001, EUR J HUM GENET, V9, P311, DOI 10.1038/sj.ejhg.5200622
   Guéry B, 2003, J AM SOC NEPHROL, V14, P2099, DOI 10.1097/01.ASN.0000080180.51098.02
   HAMMANS SR, 1995, BRAIN, V118, P721, DOI 10.1093/brain/118.3.721
   HANNA MG, 1995, AM J HUM GENET, V56, P1026
   HAO HL, 1995, AM J HUM GENET, V56, P1017
   Haut S, 2003, HUM GENET, V113, P118, DOI 10.1007/s00439-003-0946-0
   Hinson JT, 2007, NEW ENGL J MED, V356, P809, DOI 10.1056/NEJMoa055262
   Hirano M, 2004, NEUROLOGIST, V10, P8, DOI 10.1097/01.nrl.0000106919.06469.04
   HIRANO M, 1992, NEUROMUSCULAR DISORD, V2, P125, DOI 10.1016/0960-8966(92)90045-8
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Hsieh RH, 2001, J BIOMED SCI, V8, P328, DOI 10.1159/000054051
   Hutchin TP, 2000, CELL MOL LIFE SCI, V57, P1927, DOI 10.1007/PL00000673
   Jaksch M, 2000, HUM MOL GENET, V9, P795, DOI 10.1093/hmg/9.5.795
   Janssen RJRJ, 2006, J INHERIT METAB DIS, V29, P499, DOI 10.1007/s10545-006-0362-4
   Jonckheere AI, 2008, J MED GENET, V45, P129, DOI 10.1136/jmg.2007.052084
   Kameoka K, 1998, BIOCHEM BIOPH RES CO, V245, P523, DOI 10.1006/bbrc.1998.8437
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   Lee WS, 2007, HEPATOLOGY, V45, P1555, DOI 10.1002/hep.21710
   LEIGH D, 1951, J NEUROL NEUROSUR PS, V14, P216, DOI 10.1136/jnnp.14.3.216
   Loeffen J, 2001, ANN NEUROL, V49, P195, DOI 10.1002/1531-8249(20010201)49:2<195::AID-ANA39>3.0.CO;2-M
   Lynn S, 1998, DIABETES, V47, P1800, DOI 10.2337/diabetes.47.11.1800
   Malfatti E, 2007, BRAIN, V130, P1894, DOI 10.1093/brain/awm114
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   Maniura-Weber K, 2004, EUR J HUM GENET, V12, P509, DOI 10.1038/sj.ejhg.5201185
   MANOUVRIER S, 1995, J MED GENET, V32, P654, DOI 10.1136/jmg.32.8.654
   Marti R, 2002, MITOCHONDRION, V2, P143, DOI 10.1016/S1567-7249(02)00036-3
   Massa V, 2008, AM J HUM GENET, V82, P1281, DOI 10.1016/j.ajhg.2008.05.002
   MERANTE F, 1994, AM J HUM GENET, V55, P437
   Merante F, 1996, HUM MUTAT, V8, P216, DOI 10.1002/(SICI)1098-1004(1996)8:3<216::AID-HUMU4>3.0.CO;2-7
   MITA S, 1989, P NATL ACAD SCI USA, V86, P9509, DOI 10.1073/pnas.86.23.9509
   MORAES CT, 1991, AM J HUM GENET, V48, P492
   NIAUDET P, 1994, PEDIATR NEPHROL, V8, P164, DOI 10.1007/BF00865468
   Niaudet P, 1998, ARCH DIS CHILD, V78, P387, DOI 10.1136/adc.78.4.387
   Niemann S, 2000, NAT GENET, V26, P268, DOI 10.1038/81551
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   OSTERGAARD E, 2008, J INHERIT M IN PRESS, V0, P0
   Papadopoulou LC, 1999, NAT GENET, V23, P333
   Piruat JI, 2005, J BIOL CHEM, V280, P42676, DOI 10.1074/jbc.M507044200
   POULTON J, 1995, DIABETOLOGIA, V38, P868, DOI 10.1007/s001250050366
   Poyton RO, 1996, ANNU REV BIOCHEM, V65, P563, DOI 10.1146/annurev.bi.65.070196.003023
   PREZANT TR, 1993, NAT GENET, V4, P289, DOI 10.1038/ng0793-289
   Quinzii CM, 2007, MITOCHONDRION, V7, PS122, DOI 10.1016/j.mito.2007.03.004
   Rajasimha HK, 2008, AM J HUM GENET, V82, P333, DOI 10.1016/j.ajhg.2007.10.007
   ROBERTS NK, 1979, AM J CARDIOL, V44, P1396, DOI 10.1016/0002-9149(79)90459-4
   Roesch K, 2002, HUM MOL GENET, V11, P477, DOI 10.1093/hmg/11.5.477
   ROTIG A, 1990, J CLIN INVEST, V86, P1601, DOI 10.1172/JCI114881
   ROTIG A, 1992, AM J HUM GENET, V50, P364
   Rötig A, 2007, MITOCHONDRION, V7, PS112, DOI 10.1016/j.mito.2007.02.008
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Santorelli FM, 1996, AM J HUM GENET, V58, P933
   Santorelli FM, 2001, AM HEART J, V141, P1
   Saraste M, 1999, SCIENCE, V283, P1488, DOI 10.1126/science.283.5407.1488
   Sarzi E, 2007, ANN NEUROL, V62, P579, DOI 10.1002/ana.21207
   Scaglia F, 2003, AM J MED GENET A, V123A, P172, DOI 10.1002/ajmg.a.20315
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   SCHON EA, 1989, SCIENCE, V244, P346, DOI 10.1126/science.2711184
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   SILVESTRI G, 1994, HUM MUTAT, V3, P37, DOI 10.1002/humu.1380030107
   SIMONSZ HJ, 1992, DOC OPHTHALMOL, V82, P73, DOI 10.1007/BF00156996
   Smeitink JA, 2006, CELL METAB, V3, P9, DOI 10.1016/j.cmet.2005.12.001
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Spinazzola A, 2008, ARCH NEUROL-CHICAGO, V65, P1108, DOI 10.1001/archneur.65.8.1108
   SWEENEY MG, 1993, Q J MED, V86, P435
   Taroni F, 2004, NAT REV NEUROSCI, V5, P641, DOI 10.1038/nrn1474
   TATUCH Y, 1992, AM J HUM GENET, V50, P852
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Taylor RW, 2003, J AM COLL CARDIOL, V41, P1786, DOI 10.1016/S0735-1097(03)00300-0
   Tiranti V, 2004, AM J HUM GENET, V74, P239, DOI 10.1086/381653
   Tiranti V, 1998, AM J HUM GENET, V63, P1609, DOI 10.1086/302150
   Tzen CY, 2001, KIDNEY INT, V59, P846, DOI 10.1046/j.1523-1755.2001.00567.x
   Valianpour F, 2002, J PEDIATR-US, V141, P729, DOI 10.1067/mpd.2002.129174
   Valnot I, 2000, AM J HUM GENET, V67, P1104
   Valnot I, 1999, HUM GENET, V104, P460, DOI 10.1007/s004390050988
   Valnot I, 2000, HUM MOL GENET, V9, P1245, DOI 10.1093/hmg/9.8.1245
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368
   Verma A, 1997, PEDIATR RES, V42, P448, DOI 10.1203/00006450-199710000-00005
   Visapää I, 2002, AM J HUM GENET, V71, P863, DOI 10.1086/342773
   WALLACE DC, 1988, CELL, V55, P601, DOI 10.1016/0092-8674(88)90218-8
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Whittaker RG, 2007, DIABETOLOGIA, V50, P2085, DOI 10.1007/s00125-007-0779-9
   Wibrand F, 2001, ANN NEUROL, V50, P540, DOI 10.1002/ana.1224
   Yaffe MP, 1999, SCIENCE, V283, P1493, DOI 10.1126/science.283.5407.1493
   ZEVIANI M, 1988, NEUROLOGY, V38, P1339
   ZEVIANI M, 1991, LANCET, V338, P143, DOI 10.1016/0140-6736(91)90136-D
   Zeviani M, 2004, BRAIN, V127, P2153, DOI 10.1093/brain/awh259
   Zeviani M, 1997, J BIOENERG BIOMEMBR, V29, P121, DOI 10.1023/A:1022633912917
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
   Zeviani M, 2008, BRAIN, V131, P314, DOI 10.1093/brain/awm339
NR 136
TC 76
Z9 82
U1 0
U2 12
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0340-5354
EI 1432-1459
J9 J NEUROL
JI J. Neurol.
PD MAY 15
PY 2009
VL 256
IS 5
BP 693
EP 710
DI 10.1007/s00415-009-5028-3
PG 18
WC Clinical Neurology
SC Neurosciences & Neurology
GA 447AX
UT WOS:000266165100001
PM 19252802
DA 2024-11-01
ER

PT J
AU Collins, J
   Bove, KE
   Dimmock, D
   Morehart, P
   Wong, LJ
   Wong, B
AF Collins, James
   Bove, Kevin E.
   Dimmock, David
   Morehart, Paula
   Wong, Lee-Jun
   Wong, Brenda
TI Progressive myofiber loss with extensive fibro-fatty replacement in a child with mitochondrial DNA depletion syndrome and novel thymidine kinase 2 gene mutations
SO NEUROMUSCULAR DISORDERS
LA English
DT Article
DE Mitochondrial DNA depletion syndrome; Thymidine kinase 2; Myopathy; Respiratory chain
ID mtdna depletion; myopathy
AB The mitochondrial DNA depletion syndromes (MDS) are autosomal recessive disorders with a decreased mitochondrial DNA copy number. Mutations in thymidine kinase 2 (TK2) have been responsible for the myopathic form of MDS. We describe a child with congenital muscle weakness who had a progressive mitochondrial myopathy associated with extensive fibro-fatty replacement of myofibers resembling muscular dystrophy. MDS was suspected based upon findings in the initial muscle biopsy. Sequence analysis of the TK2 gene revealed two novel heterozygous mutations: the frame shift mutation, c.255_c.258delAGAA and the heterozygous missense mutation, c.515G>A, (p.R172Q). This report extends the phenotype and genotype of TK2 defects. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Collins, James; Morehart, Paula; Wong, Brenda] Cincinnati Childrens Hosp, Div Neurol, Med Ctr, Cincinnati, OH 45229 USA.
   [Bove, Kevin E.] Cincinnati Childrens Hosp, Div Pathol & Lab Med, Med Ctr, Cincinnati, OH 45229 USA.
   [Dimmock, David; Wong, Lee-Jun] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.
C3 Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Baylor College of Medicine
RP Wong, B (corresponding author), Cincinnati Childrens Hosp, Div Neurol, Med Ctr, MLC 2015,3333 Burnet Ave, Cincinnati, OH 45229 USA.
EM brenda.wong@cchmc.org
FU NCRR NIH HHS [K12 RR017665] Funding Source: Medline
CR Barthélémy C, 2001, ANN NEUROL, V49, P607, DOI 10.1002/ana.1002.abs
   Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   Carrozzo R, 2003, HUM MUTAT, V21, P0, DOI 10.1002/humu.9135
   Dimmock DP, 2008, HUM MUTAT, V29, P330, DOI 10.1002/humu.9519
   Galbiati S, 2006, PEDIATR NEUROL, V34, P177, DOI 10.1016/j.pediatrneurol.2005.07.013
   Saada A, 2003, MOL GENET METAB, V79, P1, DOI 10.1016/S1096-7192(03)00063-5
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Vilá MR, 2008, J NEUROL SCI, V267, P137, DOI 10.1016/j.jns.2007.10.019
   Vilà MR, 2003, NEUROLOGY, V60, P1203, DOI 10.1212/01.WNL.0000055928.58122.47
   Wong LJC, 2003, J MED GENET, V40, P0
NR 10
TC 15
Z9 18
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8966
EI 1873-2364
J9 NEUROMUSCULAR DISORD
JI Neuromusc. Disord.
PD NOV 15
PY 2009
VL 19
IS 11
BP 784
EP 787
DI 10.1016/j.nmd.2009.08.002
PG 4
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 522SZ
UT WOS:000272020400010
PM 19736010
DA 2024-11-01
ER

PT J
AU El-Khoury, R
   Sainsard-Chanet, A
AF El-Khoury, Riyad
   Sainsard-Chanet, Annie
TI Suppression of Mitochondrial DNA Instability of Autosomal Dominant Forms of Progressive External Ophthalmoplegia-Associated <i>ANT1</i> Mutations in <i>Podospora anserina</i>
SO GENETICS
LA English
DT Article
ID adenine-nucleotide translocator; saccharomyces-cerevisiae; adp/atp carrier; multiple deletions; life-span; gene; protein; genome; respiration; senescence
AB Maintenance and expression of mitochondrial DNA (mtDNA) are essential for the cell and the organism. In humans, several mutations in the adenine nucleotide translocase gene ANTI are associated with multiple mtDNA deletions and autosomal dominant for-ins of progressive external ophthalmoplegia (adPEO). The mechanisms underlying the mtDNA instability are still obscure. A current hypothesis proposes that these pathogenic mutations primarily uncouple the mitochondrial inner membrane, which secondarily causes mtDNA instability Here we show that the three adPEO-associated mutations equivalent to A114P, L98P, and V289M introduced into the Podaspora anserina ANT1 ortholog dominantly cause severe growth defects, decreased reactive oxygen species production (RCS), decreased mitochondrial inner membrane potential (Delta psi), and accumulation of large-scale mtDNA deletions leading to premature death. Interestingly, we show that, at least for the adPEO-type M106P and A121P mutant alleles, the associated mtDNA instability cannot be attributed only to a reduced membrane potential or to an increased ROS level since it can be suppressed without restoration of the Delta psi or modification of the ROS production. Suppression of mtDNA instability due to the M106P and A121P mutations was obtained by an allele of the rmp1 gene involved in nucleo-mitochondrial cross-talk and also by an allele of the AS1 gene encoding a cytosolic ribosomal protein. In contrast, die mtDNA instability caused by the S296M mutation was not suppressed by these alleles.
C1 [El-Khoury, Riyad; Sainsard-Chanet, Annie] CNRS, Ctr Genet Mol, F-91198 Gif Sur Yvette, France.
   [Sainsard-Chanet, Annie] Univ Paris 11, F-91405 Orsay, France.
C3 Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Universite Paris Saclay
RP Sainsard-Chanet, A (corresponding author), CNRS, Ctr Genet Mol, Allee Terrasse, F-91198 Gif Sur Yvette, France.
EM annie.sainsard@cgm.cnrs-gif.fr
FU Association Francaise contre les Myopathies; European Community [LSHM-CT-200-512020]
CR [Anonymous], 1974, BACTERIA, V0, P0
   ARENDS H, 1984, EMBO J, V3, P377, DOI 10.1002/j.1460-2075.1984.tb01815.x
   Bamber L, 2007, J MOL BIOL, V371, P388, DOI 10.1016/j.jmb.2007.05.072
   Begel O, 1999, MOL CELL BIOL, V19, P4093
   BELCOUR L, 1991, P NATL ACAD SCI USA, V88, P3579, DOI 10.1073/pnas.88.9.3579
   BELCOUR L, 1999, MITOCHONDRIAL DIS, V0, P209
   BERGES T, 1989, J GEN MICROBIOL, V135, P601
   Borghouts C, 2002, BIOGERONTOLOGY, V3, P143, DOI 10.1023/A:1015696404723
   Chen XJ, 2004, GENETICS, V167, P607, DOI 10.1534/genetics.103.023655
   Chen XJ, 2002, HUM MOL GENET, V11, P1835, DOI 10.1093/hmg/11.16.1835
   Chinnery PF, 2003, TRENDS GENET, V19, P60, DOI 10.1016/S0168-9525(02)00030-6
   Contamine V, 1996, GENETICS, V144, P541
   Contamine W, 2004, GENETICS, V166, P135, DOI 10.1534/genetics.166.1.135
   Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646
   Coppin E, 2000, GENETICS, V155, P657
   COPPINRAYNAL E, 1981, BIOCHEM GENET, V19, P729, DOI 10.1007/BF00484005
   CUMMINGS DJ, 1990, CURR GENET, V17, P375, DOI 10.1007/BF00334517
   DEQUARDCHABLAT M, 1994, J BIOL CHEM, V269, P14951
   Dienhart MK, 2008, MOL BIOL CELL, V19, P3934, DOI 10.1091/mbc.E08-04-0402
   Dolce V, 2005, FEBS LETT, V579, P633, DOI 10.1016/j.febslet.2004.12.034
   Dufour E, 2000, P NATL ACAD SCI USA, V97, P4138, DOI 10.1073/pnas.070501997
   El-Khoury R, 2008, CURR GENET, V53, P249, DOI 10.1007/s00294-008-0180-3
   Espagne E, 2008, GENOME BIOL, V9, P0, DOI 10.1186/gb-2008-9-5-r77
   Esposito LA, 1999, P NATL ACAD SCI USA, V96, P4820, DOI 10.1073/pnas.96.9.4820
   Fiore C, 1998, BIOCHIMIE, V80, P137, DOI 10.1016/S0300-9084(98)80020-5
   Fontanesi F, 2004, HUM MOL GENET, V13, P923, DOI 10.1093/hmg/ddh108
   Graham BH, 1997, NAT GENET, V16, P226, DOI 10.1038/ng0797-226
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Kaukonen J, 1999, AM J HUM GENET, V65, P256, DOI 10.1086/302445
   Klingenberg M, 2008, BBA-BIOMEMBRANES, V1778, P1978, DOI 10.1016/j.bbamem.2008.04.011
   Komaki H, 2002, ANN NEUROL, V51, P645, DOI 10.1002/ana.10172
   LECELLIER G, 1994, CURR GENET, V25, P122, DOI 10.1007/BF00309536
   Lorin S, 2001, MOL MICROBIOL, V42, P1259, DOI 10.1046/j.1365-2958.2001.02690.x
   Lousa CD, 2002, BIOCHEMISTRY-US, V41, P14412, DOI 10.1021/bi02641490
   Maxwell DP, 1999, P NATL ACAD SCI USA, V96, P8271, DOI 10.1073/pnas.96.14.8271
   Napoli L, 2001, NEUROLOGY, V57, P2295, DOI 10.1212/WNL.57.12.2295
   Nury H, 2006, ANNU REV BIOCHEM, V75, P713, DOI 10.1146/annurev.biochem.75.103004.142747
   Palmieri F, 2004, PFLUG ARCH EUR J PHY, V447, P689, DOI 10.1007/s00424-003-1099-7
   Palmieri L, 2005, HUM MOL GENET, V14, P3079, DOI 10.1093/hmg/ddi341
   Riccio P, 1975, FEBS LETT, V56, P192
   RIZET GEORGES, 1952, REV CYTOL ET BIOL VEG, V13, P51
   Sainsard-Chanet A, 1998, CURR GENET, V34, P326, DOI 10.1007/s002940050403
   Sellem CH, 2007, FUNGAL GENET BIOL, V44, P648, DOI 10.1016/j.fgb.2006.09.005
   Siciliano G, 2003, NEUROMUSCULAR DISORD, V13, P162, DOI 10.1016/S0960-8966(02)00221-3
   Silar P, 2001, BIOGERONTOLOGY, V2, P1, DOI 10.1023/A:1010000816277
   Silar P, 1995, FUNG GENET NEWSLETT, V42, P73, DOI 10.4148/1941-4765.1353
   STEPIEN G, 1992, J BIOL CHEM, V267, P14592
   Stumpferl SW, 2004, EUKARYOT CELL, V3, P200, DOI 10.1128/EC.3.1.200-211.2004
   Wang XW, 2008, NAT CELL BIOL, V10, P1090, DOI 10.1038/ncb1769
   Wang XW, 2008, HUM MOL GENET, V17, P4036, DOI 10.1093/hmg/ddn306
NR 50
TC 12
Z9 12
U1 1
U2 1
PU GENETICS SOCIETY AMERICA
PI BETHESDA
PA 9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA
SN 0016-6731
EI 1943-2631
J9 GENETICS
JI Genetics
PD NOV 15
PY 2009
VL 183
IS 3
BP 861
EP 871
DI 10.1534/genetics.109.107813
PG 11
WC Genetics & Heredity
SC Genetics & Heredity
GA 526NA
UT WOS:000272295800010
PM 19687137
DA 2024-11-01
ER

PT J
AU Srivastava, S
   Diaz, F
   Iommarini, L
   Aure, K
   Lombes, A
   Moraes, CT
AF Srivastava, Sarika
   Diaz, Francisca
   Iommarini, Luisa
   Aure, Karine
   Lombes, Anne
   Moraes, Carlos T.
TI PGC-1α/β induced expression partially compensates for respiratory chain defects in cells from patients with mitochondrial disorders
SO HUMAN MOLECULAR GENETICS
LA English
DT Article
ID inducible coactivator; muscle-fibers; biogenesis; myopathy; transcription; activation; pgc-1-beta; mtdna
AB Members of the peroxisome proliferator-activated receptor gamma coactivator (PGC) family are potent inducers of mitochondrial biogenesis. We have tested the potential effect of increased mitochondrial biogenesis in cells derived from patients harboring oxidative phosphorylation defects due to either nuclear or mitochondrial DNA mutations. We found that the PGC-1 alpha and/or PGC-1 beta expression improved mitochondrial respiration in cells harboring a complex III or IV deficiency as well as in transmitochondrial cybrids harboring mitochondrial encephalomyopathy lactic acidosis and stroke A3243G tRNA((Leu)UUR) gene mutation. The respiratory function improvement was found to be associated with increased levels of mitochondrial components per cell, although this increase was not homogeneous. These results reinforce the concept that increased mitochondrial biogenesis is a promising venue for the treatment of mitochondrial diseases.
C1 [Srivastava, Sarika; Diaz, Francisca; Iommarini, Luisa; Moraes, Carlos T.] Univ Miami, Sch Med, Dept Neurol, Miami, FL 33136 USA.
   [Moraes, Carlos T.] Univ Miami, Sch Med, Dept Cell Biol & Anat, Miami, FL 33136 USA.
   [Iommarini, Luisa] Univ Bologna, Dipartimento Sci Neurol, Bologna, Italy.
   [Aure, Karine; Lombes, Anne] Univ Paris 06, Inserm 582, AP HP, F-75013 Paris, France.
C3 University of Miami; University of Miami; University of Bologna; Assistance Publique Hopitaux Paris (APHP); Institut National de la Sante et de la Recherche Medicale (Inserm); Sorbonne Universite
RP Moraes, CT (corresponding author), Univ Miami, Sch Med, Dept Neurol, 1095 NW 14th Terrace, Miami, FL 33136 USA.
EM cmoraes@med.miami.edu
FU Muscular Dystrophy Association and PHS [NS041777, CA085700, EY10804]; James & Esther King Biomedical Research Program
CR Andersson U, 2001, MOL CELL BIOL, V21, P3738, DOI 10.1128/MCB.21.11.3738-3749.2001
   Bacman SR, 2007, METHOD CELL BIOL, V80, P503, DOI 10.1016/S0091-679X(06)80025-7
   Barrientos A, 1998, J BIOL CHEM, V273, P14210, DOI 10.1074/jbc.273.23.14210
   Bastin J, 2008, J CLIN ENDOCR METAB, V93, P1433, DOI 10.1210/jc.2007-1701
   DiMauro S, 2008, ANNU REV NEUROSCI, V31, P91, DOI 10.1146/annurev.neuro.30.051606.094302
   Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037
   KING MP, 1992, MOL CELL BIOL, V12, P480, DOI 10.1128/MCB.12.2.480
   Krupp G, 2000, BIOTECHNOL ANNU REV, V6, P103, DOI 10.1016/S1387-2656(00)06020-8
   Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268
   Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904
   Lin JD, 2002, J BIOL CHEM, V277, P1645, DOI 10.1074/jbc.C100631200
   MORAES CT, 1992, NAT GENET, V1, P359, DOI 10.1038/ng0892-359
   Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5
   Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007
   Scarpulla RC, 2008, ANN NY ACAD SCI, V1147, P321, DOI 10.1196/annals.1427.006
   SCIACCO M, 1994, HUM MOL GENET, V3, P13, DOI 10.1093/hmg/3.1.13
   Spiegelman BM, 2007, NOVARTIS FDN S, V286, P6
   Spiegelman BM, 2007, NOVARTIS FDN S, V286, P196
   Spiegelman BM, 2007, NOVARTIS FDN S, V286, P162
   Spiegelman Bruce M, 2007, NOVARTIS FOUND SYMP, V286, P3
   Srivastava S, 2007, HUM MOL GENET, V16, P993, DOI 10.1093/hmg/ddm045
   St-Pierre J, 2003, J BIOL CHEM, V278, P26597, DOI 10.1074/jbc.M301850200
   Vempati UD, 2009, J BIOL CHEM, V284, P4383, DOI 10.1074/jbc.M805972200
   Villani G, 2007, METHOD CELL BIOL, V80, P121, DOI 10.1016/S0091-679X(06)80005-1
   Wenz T, 2008, CELL METAB, V8, P249, DOI 10.1016/j.cmet.2008.07.006
   Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X
NR 26
TC 91
Z9 102
U1 0
U2 4
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0964-6906
EI 1460-2083
J9 HUM MOL GENET
JI Hum. Mol. Genet.
PD MAY 15
PY 2009
VL 18
IS 10
BP 1805
EP 1812
DI 10.1093/hmg/ddp093
PG 8
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA 437ZJ
UT WOS:000265525400007
PM 19297390
DA 2024-11-01
ER

PT J
AU McInerny, SC
   Brown, AL
   Smith, DW
AF McInerny, Simone C.
   Brown, Amanda L.
   Smith, Doug W.
TI Region-specific changes in mitochondrial D-loop in aged rat CNS
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE Mitochondrial genome mutation; Hypothesis of aging; Real-time quantitative PCR; Mitochondrial genome deletions; Mitochondrial replication; Mitochondrial transcription
ID caloric restriction diet; human skin fibroblasts; mtdna point mutations; dna copy number; oxidative-phosphorylation; parkinsons-disease; substantia-nigra; individual cells; skeletal-muscle; human brain
AB Impaired mitochondrial oxidative phosphorylation (OXPHOS) is considered a cause of aging. A reduction in mitochondrial DNA (mtDNA) replication and/or transcription may contribute to this OXPHOS diminution. Impairments in the displacement (D) loop, or non-coding, region of the mitochondrial genome, or accumulation of mtDNA mutations, may affect mtDNA replication and transcription. We determined the effects of age on the D-loop and on mtDNA deletion mutations in the spinal cord, medulla, midbrain, cerebellum, striatum, and cerebral cortex of Fischer 344 rats. D-loop, 7S DNA levels were reduced by 3-fold in striatum, 2.5-fold in cortex, and 2-fold in the spinal cord of older animals. We did not detect a population of mtDNA affected by the most prevalent known (ND4-containing) deletions, indicating they do not comprise a significant portion of total mtDNA. However, we detected an age-related and region-specific increase in the common deletion, which comprised 0.0003-0.0007% of total mtDNA. Mitochondrial genome copy number varied between regions, in addition to an overall 18% decrease with age across the whole brain. These results suggest the age-related decline in OXPHOS may be related to a reduction in D-loop function. Crown Copyright (C) 2009 Published by Elsevier Ireland Ltd. All rights reserved.
C1 [McInerny, Simone C.; Brown, Amanda L.; Smith, Doug W.] Univ Newcastle, Discipline Anat, Sch Biomed Sci, Callaghan, NSW 2308, Australia.
   [McInerny, Simone C.; Brown, Amanda L.; Smith, Doug W.] Univ Newcastle, Ctr Brain & Mental Hlth Res, Callaghan, NSW 2308, Australia.
   [McInerny, Simone C.; Brown, Amanda L.; Smith, Doug W.] Hunter Med Res Inst, Newcastle, NSW 2310, Australia.
C3 University of Newcastle; University of Newcastle; University of Newcastle; Hunter Medical Research Institute
RP Smith, DW (corresponding author), Sch Biomed Sci, Room 306B,Med Sci Bldg,Univ Dr,Callaghan Campus, Callaghan, NSW 2308, Australia.
EM Douglas.smith@newcastle.edu.au
FU Hunter Medical Research Institute; University of Newcastle; Research Grants Scheme; Clive and Vera Ramaciotti Foundation
CR Barrientos A, 1997, MOL BRAIN RES, V52, P284, DOI 10.1016/S0169-328X(97)00278-7
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Brown TA, 2002, NUCLEIC ACIDS RES, V30, P2004, DOI 10.1093/nar/30.9.2004
   Cantuti-Castelvetria I, 2005, NEUROBIOL AGING, V26, P1343, DOI 10.1016/j.neurobiolaging.2004.11.008
   Cassano P, 2006, REJUV RES, V9, P211, DOI 10.1089/rej.2006.9.211
   Cassano P, 2004, ANN NY ACAD SCI, V1019, P269, DOI 10.1196/annals.1297.045
   Chen XJ, 2005, NAT REV GENET, V6, P815, DOI 10.1038/nrg1708
   Conde JR, 2006, J NEUROPATH EXP NEUR, V65, P199, DOI 10.1097/01.jnen.0000202887.22082.63
   CONLEY K, 2006, EXP PHYSL, V0, P0
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   Dinardo MM, 2003, BIOCHEM BIOPH RES CO, V301, P187, DOI 10.1016/S0006-291X(02)03008-5
   Falkenberg M, 2007, ANNU REV BIOCHEM, V76, P679, DOI 10.1146/annurev.biochem.76.060305.152028
   Fernández-Silva P, 2003, EXP PHYSIOL, V88, P41, DOI 10.1113/eph8802514
   Filburn CR, 1996, MECH AGEING DEV, V87, P35, DOI 10.1016/0047-6374(96)01696-X
   Finsterer J, 2006, ACTA NEUROL SCAND, V114, P217, DOI 10.1111/j.1600-0404.2006.00671.x
   Frahm T, 2005, MECH AGEING DEV, V126, P1192, DOI 10.1016/j.mad.2005.06.008
   Frietsch T, 2001, ANESTHESIOLOGY, V94, P290, DOI 10.1097/00000542-200102000-00019
   GADALETA MN, 1990, EUR J BIOCHEM, V187, P501, DOI 10.1111/j.1432-1033.1990.tb15331.x
   GADALETA MN, 1992, MUTAT RES, V275, P181, DOI 10.1016/0921-8734(92)90022-H
   Gerhard GS, 2002, MECH AGEING DEV, V123, P155, DOI 10.1016/S0047-6374(01)00328-1
   Greco M, 2003, FASEB J, V17, P1706, DOI 10.1096/fj.02-1009fje
   He JY, 2007, J CELL BIOL, V176, P141, DOI 10.1083/jcb.200609158
   He LP, 2002, NUCLEIC ACIDS RES, V30, P0, DOI 10.1093/nar/gnf067
   Höglinger GU, 2003, J NEUROCHEM, V84, P491, DOI 10.1046/j.1471-4159.2003.01533.x
   Kanaan NM, 2008, NEUROBIOL AGING, V0, P0
   Khaidakov A, 2005, EXP GERONTOL, V40, P396, DOI 10.1016/j.exger.2005.02.007
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Lesnefsky EJ, 2006, AGEING RES REV, V5, P402, DOI 10.1016/j.arr.2006.04.001
   Lin MT, 2002, HUM MOL GENET, V11, P133, DOI 10.1093/hmg/11.2.133
   Marcinek DJ, 2005, J PHYSIOL-LONDON, V569, P467, DOI 10.1113/jphysiol.2005.097782
   Masuyama M, 2005, BBA-GEN SUBJECTS, V1723, P302, DOI 10.1016/j.bbagen.2005.03.001
   Meissner C, 2006, EXP GERONTOL, V41, P518, DOI 10.1016/j.exger.2006.03.010
   Michikawa Y, 1999, SCIENCE, V286, P774, DOI 10.1126/science.286.5440.774
   Miller PJ, 1997, EXP NEUROL, V146, P212, DOI 10.1006/exnr.1997.6522
   Nagley P, 2001, NEUROBIOL AGING, V22, P635, DOI 10.1016/S0197-4580(01)00228-7
   Navarro A, 2007, AM J PHYSIOL-CELL PH, V292, PC670, DOI 10.1152/ajpcell.00213.2006
   Nekhaeva E, 2002, P NATL ACAD SCI USA, V99, P5521, DOI 10.1073/pnas.072670199
   Olsson T, 2003, BRAIN RES, V982, P260, DOI 10.1016/S0006-8993(03)03014-2
   Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889
   PETRUZZELLA V, 1995, MOL CHEM NEUROPATHOL, V24, P193, DOI 10.1007/BF02962143
   Rex S, 2006, ANESTHESIOLOGY, V105, P936, DOI 10.1097/00000542-200611000-00014
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   Shadel GS, 1997, ANNU REV BIOCHEM, V66, P409, DOI 10.1146/annurev.biochem.66.1.409
   Simon DK, 2004, NEUROBIOL AGING, V25, P71, DOI 10.1016/S0197-4580(03)00037-X
   Smigrodzki R, 2004, NEUROBIOL AGING, V25, P1273, DOI 10.1016/j.neurobiolaging.2004.02.020
   SOONG NW, 1992, NAT GENET, V2, P318
   Storm T, 2002, EXP GERONTOL, V37, P1389, DOI 10.1016/S0531-5565(02)00121-3
   Stuart JA, 2005, FREE RADICAL BIO MED, V38, P737, DOI 10.1016/j.freeradbiomed.2004.12.003
   TANHAUSER SM, 1995, J BIOL CHEM, V270, P24769, DOI 10.1074/jbc.270.42.24769
   Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Van Remmen H, 2004, FREE RADICAL BIO MED, V36, P1625, DOI 10.1016/j.freeradbiomed.2004.03.016
   VanTuyle GC, 1996, MUTAT RES-FUND MOL M, V349, P95, DOI 10.1016/0027-5107(95)00165-4
   Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95
   Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988
   Zhang CF, 1997, BIOCHEM BIOPH RES CO, V230, P630, DOI 10.1006/bbrc.1996.6020
NR 56
TC 25
Z9 28
U1 0
U2 8
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND
SN 0047-6374
EI 
J9 MECH AGEING DEV
JI Mech. Ageing Dev.
PD MAY 15
PY 2009
VL 130
IS 5
BP 343
EP 349
DI 10.1016/j.mad.2009.01.008
PG 7
WC Cell Biology; Geriatrics & Gerontology
SC Cell Biology; Geriatrics & Gerontology
GA 442AO
UT WOS:000265812300009
PM 19428453
DA 2024-11-01
ER

PT J
AU Jeppesen, TD
   Duno, M
   Schwartz, M
   Krag, T
   Rafiq, J
   Wibrand, F
   Vissing, J
AF Jeppesen, T. D.
   Duno, M.
   Schwartz, M.
   Krag, T.
   Rafiq, J.
   Wibrand, F.
   Vissing, J.
TI Short- and long-term effects of endurance training in patients with mitochondrial myopathy
SO EUROPEAN JOURNAL OF NEUROLOGY
LA English
DT Article
DE mitochondrial myopathy; mtDNA; training
AB Background and purpose: It is unknown whether prolonged training is a safe treatment to alleviate exercise intolerance in patients with mitochondrial DNA (mtDNA) mutations. Methods: The effect of 3 and 12 months training and 3-12 months deconditioning was studied in four patients carrying different mtDNA mutations. Results: Three-month moderate-intensity training increased oxidative capacity by 23%, which was sustained after 6-12 months of low-intensity training. Training and deconditioning did not induce adverse effects on clinical symptoms, muscle morphology and mtDNA mutation load in muscle. Conclusion: Long-term training effectively improves exercise capacity in patients with mitochondrial myopathy, and appears to be safe.
C1 [Jeppesen, T. D.] Univ Copenhagen, Rigshosp, Sect 3342, Neuromuscular Res Unit,Dept Neurol, DK-2100 Copenhagen, Denmark.
   [Jeppesen, T. D.; Krag, T.; Rafiq, J.; Vissing, J.] Univ Copenhagen, Rigshosp, Copenhagen Muscle Res Ctr, DK-2100 Copenhagen, Denmark.
   [Duno, M.; Schwartz, M.; Wibrand, F.] Univ Copenhagen, Rigshosp, Dept Clin Genet, DK-2100 Copenhagen, Denmark.
C3 University of Copenhagen; Rigshospitalet; Rigshospitalet; University of Copenhagen; University of Copenhagen; Rigshospitalet
RP Jeppesen, TD (corresponding author), Univ Copenhagen, Rigshosp, Sect 3342, Neuromuscular Res Unit,Dept Neurol, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.
EM dysgaard@rh.dk
CR ADHIHETTY PJ, 2007, AM J PHYSIOL-ENDOC M, V293, P72
   Auré K, 2006, BRAIN, V129, P1249, DOI 10.1093/brain/awl061
   Jeppesen TD, 2006, BRAIN, V129, P3402, DOI 10.1093/brain/awl149
   Siciliano G, 2007, BIOSCIENCE REP, V27, P53, DOI 10.1007/s10540-007-9037-0
   Taivassalo T, 2001, ANN NEUROL, V50, P133, DOI 10.1002/ana.1050
   Taivassalo T, 2006, BRAIN, V129, P3391, DOI 10.1093/brain/awl282
NR 7
TC 32
Z9 34
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1351-5101
EI 1468-1331
J9 EUR J NEUROL
JI Eur. J. Neurol.
PD DEC 15
PY 2009
VL 16
IS 12
BP 1336
EP 1339
DI 10.1111/j.1468-1331.2009.02660.x
PG 4
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 522BT
UT WOS:000271973400014
PM 19486129
DA 2024-11-01
ER

PT J
AU Amiot, A
   Tchikviladzé, M
   Joly, F
   Slama, A
   Hatem, DC
   Jardel, C
   Messing, B
   Lombès, A
AF Amiot, Aurelien
   Tchikviladze, Maya
   Joly, Francisca
   Slama, Abdelhamid
   Hatem, Dominique Cazals
   Jardel, Claude
   Messing, Bernard
   Lombes, Anne
TI Frequency of Mitochondrial Defects in Patients With Chronic Intestinal Pseudo-Obstruction
SO GASTROENTEROLOGY
LA English
DT Article
ID progressive external ophthalmoplegia; phosphorylase gene-mutations; stroke-like episodes; polg mutations; encephalomyopathy mngie; parenteral-nutrition; lactic-acidosis; features; obstruction; management
AB BACKGROUND & AIMS: Chronic intestinal pseudo-obstruction (CIPO) is a rare disorder caused by intestinal dysmotility and characterized by chronic symptoms suggesting bowel obstruction in the absence of fixed, occluding lesions. CIPO has been associated with primary defects of the mitochondrial oxidative phosphorylation pathway, although the frequency of mitochondrial disorders in patients with CIPO is unknown. This study evaluates mitochondrial function in patients with CIPO. METHODS: A retrospective study was performed of data collected from 80 CIPO patients at a tertiary centre over a 25-year period. Mitochondrial disorders were detected by analysis of serum lactate and thymidine phosphorylase activities, brain magnetic resonance images, and muscle biopsies. Genes encoding thymidine phosphorylase, mitochondrial DNA tRNA(leu)(UUR) or tRNA(lys), and DNA polymerase-gamma were analyzed for mutations. RESULTS: Mirochondrial defects were identified in 15 patients (10 women, median age at diagnosis 32 years), representing 19% of the study cohort. All 15 patients had extra-digestive symptoms, 5 had mutations in the thymidine phosphorylase gene, 2 had mutations in tRNA(leu)(UUR), and 5 had mutations in the DNA polymerase-gamma gene. No genetic defect was detected in 3 of the patients with mitochondrial disorders. Patients with mitochondrial CIPO differed from patients without mitochondrial defects in their very severe nutritional status (frequent and long-term requirement for parenteral nutrition) and poor prognosis (frequent digestive and neurologic complications that led to a high incidence of premature death). CONCLUSION: Mitochondrial. disorders seem to be an important cause of CIPO. Patients with CIPO, especially severe cases with associated neurologic symptoms, should be tested for mitochondrial defects. To view this article's video abstract, go to the AGA's YouTube Channel.
C1 [Lombes, Anne] Hop La Pitie Salpetriere, AP HP, INSERM 975, Serv Biochim Metab, F-75651 Paris 13, France.
   [Amiot, Aurelien; Joly, Francisca; Messing, Bernard] Hop Beaujon, AP HP, Serv Gastroenterol & Assistance Nutrit, Clichy, France.
   [Amiot, Aurelien; Joly, Francisca; Hatem, Dominique Cazals; Messing, Bernard] Univ Paris Diderot Paris, Paris, France.
   [Amiot, Aurelien; Jardel, Claude; Lombes, Anne] Hop La Pitie Salpetriere, INSERM, U975, F-75651 Paris 13, France.
   [Tchikviladze, Maya] Hop La Pitie Salpetriere, AP HP, Ctr Reference Malad Neuromusculaires, F-75651 Paris 13, France.
   [Slama, Abdelhamid] Hop Bicetre, AP HP, Serv Biochim, Le Kremlin Bicetre, France.
   [Hatem, Dominique Cazals] Hop Beaujon, AP HP, Serv Anat Pathol, Clichy, France.
   [Lombes, Anne] Univ Paris 06, Paris, France.
C3 Institut National de la Sante et de la Recherche Medicale (Inserm); Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris Cite; Hopital Universitaire Beaujon - APHP; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP; Hopital Universitaire Bicetre - APHP; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Universite Paris Cite; Hopital Universitaire Beaujon - APHP; Sorbonne Universite
RP Lombès, A (corresponding author), Hop La Pitie Salpetriere, AP HP, INSERM 975, Serv Biochim Metab, F-75651 Paris 13, France.
EM a.lombes@institut-myologie.org
CR Attar A, 1999, GASTROENTEROLOGY, V117, P794, DOI 10.1016/S0016-5085(99)70336-7
   Bertinet DB, 2000, JPEN-PARENTER ENTER, V24, P223, DOI 10.1177/0148607100024004223
   Blondon H, 2005, GASTROEN CLIN BIOL, V29, P773, DOI 10.1016/S0399-8320(05)86346-8
   Buchman AL, 2006, HEPATOLOGY, V43, P9, DOI 10.1002/hep.20997
   Chang TM, 2004, PEDIATR NEUROL, V31, P374, DOI 10.1016/j.pediatrneurol.2004.05.009
   Chinnery P F, 2003, NEUROMUSCUL DISORD, V13, P757, DOI 10.1016/S0960-8966(03)00097-X
   Chinnery PF, 1997, J NEUROL NEUROSUR PS, V63, P559, DOI 10.1136/jnnp.63.5.559
   Chinnery PF, 2001, GUT, V48, P121, DOI 10.1136/gut.48.1.121
   Cho YP, 2004, HEPATO-GASTROENTEROL, V51, P253
   Connor FL, 2006, GASTROENTEROLOGY, V130, PS29, DOI 10.1053/j.gastro.2005.06.081
   Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646
   Davidzon G, 2005, ANN NEUROL, V57, P921, DOI 10.1002/ana.20498
   De Giorgio R, 2004, GUT, V53, P1549, DOI 10.1136/gut.2004.043968
   DiMauro S, 2004, BBA-BIOENERGETICS, V1658, P80, DOI 10.1016/j.bbabio.2004.03.014
   Dubowitz V, 1973, MUSCLE BIOPSY MODERN, V0, P0
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   Filosto M, 2003, ARCH NEUROL-CHICAGO, V60, P1279, DOI 10.1001/archneur.60.9.1279
   García-Velasco A, 2003, J INTERN MED, V253, P381, DOI 10.1046/j.1365-2796.2003.01095.x
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   Hirano M, 2006, NEUROLOGY, V67, P1458, DOI 10.1212/01.wnl.0000240853.97716.24
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Joly F, 2006, HOME PARENTERAL NUTRITION, V0, PP84, DOI 10.1079/9781845931568.0084
   Leonard JV, 2000, LANCET, V355, P299, DOI 10.1016/S0140-6736(99)05225-3
   Messing B, 2006, GASTROENTEROLOGY, V130, PS43, DOI 10.1053/j.gastro.2005.09.064
   Narbonne H, 2004, DIABETES METAB, V30, P61, DOI 10.1016/S1262-3636(07)70090-3
   Naviaux RK, 2004, MITOCHONDRION, V4, P351, DOI 10.1016/j.mito.2004.07.002
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Rudolph CD, 1997, J PEDIATR GASTR NUTR, V24, P102, DOI 10.1097/00005176-199701000-00021
   Said G, 2005, J NEUROL, V252, P655, DOI 10.1007/s00415-005-0712-4
   SCHUFFLER MD, 1982, ACTA GASTRO-ENT BELG, V45, P447
   Shimotake T, 1998, J PEDIATR SURG, V33, P1837, DOI 10.1016/S0022-3468(98)90301-3
   Slama A, 2005, MOL GENET METAB, V84, P326, DOI 10.1016/j.ymgme.2004.12.004
   Sternberg D, 2001, BRAIN, V124, P984, DOI 10.1093/brain/124.5.984
   Tanji K, 2003, ACTA NEUROPATHOL, V105, P69, DOI 10.1007/s00401-002-0604-y
   Van Goethem G, 2004, NEUROLOGY, V63, P1251, DOI 10.1212/01.WNL.0000140494.58732.83
   Van Goethem G, 2003, EUR J HUM GENET, V11, P547, DOI 10.1038/sj.ejhg.5201002
   Van Goethem G, 2003, NEUROMUSCULAR DISORD, V13, P133, DOI 10.1016/S0960-8966(02)00216-X
   Winterthun S, 2005, NEUROLOGY, V64, P1204, DOI 10.1212/01.WNL.0000156516.77696.5A
NR 39
TC 47
Z9 51
U1 0
U2 2
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0016-5085
EI 1528-0012
J9 GASTROENTEROLOGY
JI Gastroenterology
PD JUL 15
PY 2009
VL 137
IS 1
BP 101
EP 109
DI 10.1053/j.gastro.2009.03.054
PG 9
WC Gastroenterology & Hepatology
SC Gastroenterology & Hepatology
GA 463DU
UT WOS:000267410100020
PM 19344718
DA 2024-11-01
ER

PT J
AU Baranowska, I
   Jäderlund, KH
   Nennesmo, I
   Holmqvist, E
   Heidrich, N
   Larsson, NG
   Andersson, G
   Wagner, EGH
   Hedhammar, Å
   Wibom, R
   Andersson, L
AF Baranowska, Izabella
   Jaderlund, Karin Hultin
   Nennesmo, Inger
   Holmqvist, Erik
   Heidrich, Nadja
   Larsson, Nils-Goran
   Andersson, Goran
   Wagner, E. Gerhart H.
   Hedhammar, Ake
   Wibom, Rolf
   Andersson, Leif
TI Sensory Ataxic Neuropathy in Golden Retriever Dogs Is Caused by a Deletion in the Mitochondrial <i>tRNA<SUP>Tyr</SUP></i> Gene
SO PLOS GENETICS
LA English
DT Article
ID respiratory-chain enzymes; skeletal-muscle; dna mutations; lactic-acidosis; human-disease; myopathy; rna; deficiency; mice
AB Sensory ataxic neuropathy (SAN) is a recently identified neurological disorder in golden retrievers. Pedigree analysis revealed that all affected dogs belong to one maternal lineage, and a statistical analysis showed that the disorder has a mitochondrial origin. A one base pair deletion in the mitochondrial tRNA(Tyr) gene was identified at position 5304 in affected dogs after re-sequencing the complete mitochondrial genome of seven individuals. The deletion was not found among dogs representing 18 different breeds or in six wolves, ruling out this as a common polymorphism. The mutation could be traced back to a common ancestor of all affected dogs that lived in the 1970s. We used a quantitative oligonucleotide ligation assay to establish the degree of heteroplasmy in blood and tissue samples from affected dogs and controls. Affected dogs and their first to fourth degree relatives had 0-11% wild-type (wt) sequence, while more distant relatives ranged between 5% and 60% wt sequence and all unrelated golden retrievers had 100% wt sequence. Northern blot analysis showed that tRNA(Tyr) had a 10-fold lower steady-state level in affected dogs compared with controls. Four out of five affected dogs showed decreases in mitochondrial ATP production rates and respiratory chain enzyme activities together with morphological alterations in muscle tissue, resembling the changes reported in human mitochondrial pathology. Altogether, these results provide conclusive evidence that the deletion in the mitochondrial tRNA(Tyr) gene is the causative mutation for SAN.
C1 [Baranowska, Izabella; Andersson, Goran; Andersson, Leif] Swedish Univ Agr Sci, Dept Anim Breeding & Genet, S-75007 Uppsala, Sweden.
   [Jaderlund, Karin Hultin; Hedhammar, Ake] Swedish Univ Agr Sci, Dept Clin Sci, S-75007 Uppsala, Sweden.
   [Jaderlund, Karin Hultin] Norwegian Sch Vet Sci, Dept Compan Anim Clin Sci, Oslo, Norway.
   [Nennesmo, Inger; Larsson, Nils-Goran; Wibom, Rolf] Karolinska Inst, Dept Lab Med, Stockholm, Sweden.
   [Holmqvist, Erik; Heidrich, Nadja] Uppsala Univ, Dept Cell & Mol Biol, Uppsala, Sweden.
   [Andersson, Leif] Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden.
C3 Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences; Norwegian University of Life Sciences; Karolinska Institutet; Uppsala University; Uppsala University
RP Baranowska, I (corresponding author), Swedish Univ Agr Sci, Dept Anim Breeding & Genet, S-75007 Uppsala, Sweden.
EM Leif.Andersson@imbim.uu.se
FU Swedish Foundation for Strategic Research; Swedish Research Council for Environment, Agricultural Sciences, and Spatial Planning, Agria Insurance Company, Sweden; Funds of the Karolinska Institutet; Golden Retriever Club of Sweden; Swedish Kennel Club
CR BINDOFF LA, 1991, J NEUROL SCI, V102, P17, DOI 10.1016/0022-510X(91)90088-O
   Bourgeois JM, 2004, MITOCHONDRION, V4, P441, DOI 10.1016/j.mito.2004.07.036
   BREITSCHWERDT EB, 1992, J AM VET MED ASSOC, V201, P731
   Chinnery PF, 2000, ANN NEUROL, V48, P188, DOI 10.1002/1531-8249(200008)48:2<188::AID-ANA8>3.3.CO;2-G
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   Dimauro S, 2005, ANN MED, V37, P222, DOI 10.1080/07853890510007368
   Dufour E, 2008, HUM MOL GENET, V17, P1418, DOI 10.1093/hmg/ddn030
   Graff C, 2002, BEST PRACT RES CL OB, V16, P715, DOI 10.1053/beog.2002.0315
   Greaves LC, 2006, IUBMB LIFE, V58, P143, DOI 10.1080/15216540600686888
   Jäderlund KH, 2007, J VET INTERN MED, V21, P1307, DOI 10.1892/07-005.1
   Li FY, 2006, NEUROBIOL DIS, V21, P35, DOI 10.1016/j.nbd.2005.06.009
   Olby NJ, 1997, J SMALL ANIM PRACT, V38, P213, DOI 10.1111/j.1748-5827.1997.tb03346.x
   Pulkes T, 2000, NEUROLOGY, V55, P1210, DOI 10.1212/WNL.55.8.1210
   Raffelsberger T, 2001, NEUROLOGY, V57, P2298, DOI 10.1212/WNL.57.12.2298
   Rozen S, 2000, METHODS MOL BIOL, V132, P365
   Sahashi K, 2001, J MED GENET, V38, P703, DOI 10.1136/jmg.38.10.703
   Scaglia F, 2003, AM J MED GENET A, V123A, P172, DOI 10.1002/ajmg.a.20315
   Scaglia F, 2008, MUSCLE NERVE, V37, P150, DOI 10.1002/mus.20917
   Stewart JB, 2008, PLOS BIOL, V6, P63, DOI 10.1371/journal.pbio.0060010
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Taylor RW, 2003, J AM COLL CARDIOL, V41, P1786, DOI 10.1016/S0735-1097(03)00300-0
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Udekwu KI, 2005, GENE DEV, V19, P2355, DOI 10.1101/gad.354405
   Vielhaber S, 2002, J NEUROPATH EXP NEUR, V61, P885, DOI 10.1093/jnen/61.10.885
   VIJAYASARATHY C, 1994, COMP BIOCHEM PHYS A, V109, P887, DOI 10.1016/0300-9629(94)90236-4
   VONDOBELN U, 1993, ACTA PAEDIATR, V82, P1079, DOI 10.1111/j.1651-2227.1993.tb12818.x
   Wakshlag JJ, 2004, AM J VET RES, V65, P480, DOI 10.2460/ajvr.2004.65.480
   Wibom R, 2002, ANAL BIOCHEM, V311, P139, DOI 10.1016/S0003-2697(02)00424-4
   Wittenhagen LM, 2003, TRENDS BIOCHEM SCI, V28, P605, DOI 10.1016/j.tibs.2003.09.006
   Wredenberg A, 2002, P NATL ACAD SCI USA, V99, P15066, DOI 10.1073/pnas.232591499
   YUWAIMAN P, 2008, J MED G IN PRES 1117, V0, P0
NR 31
TC 34
Z9 34
U1 0
U2 9
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA
SN 1553-7390
EI 
J9 PLOS GENET
JI PLoS Genet.
PD MAY 15
PY 2009
VL 5
IS 5
BP 
EP 
DI 10.1371/journal.pgen.1000499
PG 9
WC Genetics & Heredity
SC Genetics & Heredity
GA 459EH
UT WOS:000267083000007
PM 19492087
DA 2024-11-01
ER

PT J
AU Siu, PM
   Alway, SE
AF Siu, Parco M.
   Alway, Stephen E.
TI Response and adaptation of skeletal muscle to denervation stress: the role of apoptosis in muscle loss
SO FRONTIERS IN BIOSCIENCE-LANDMARK
LA English
DT Review
DE Apoptosis; Skeletal Myofiber; Satellite Cell; Nerve Innervation; Denervation; Review
ID spinal muscular-atrophy; programmed cell-death; cytochrome-c release; bcl-2 family proteins; permeability transition pore; lifelong calorie restriction; mitochondrial-dna mutations; nitric-oxide synthase; satellite cells; rat muscles
AB Apoptosis is a well-conserved cellular destructive event which has been implicated in a variety of diseases such as cancers and neurodegenerative diseases. The comprehensive investigation of apoptosis has been emerged in the field of skeletal muscle biology. Results have been consistent in demonstrating the activation of apoptotic machinery in different pathologic and physiologic muscle atrophic conditions including muscle disuse, hindlimb unloading, muscle dystrophy, sarcopenia, and neuromuscular diseases. Together with the other identified muscle atrophy-related signaling mechanisms such as NF kappa B, FOXOs/MuRF1/MAFbx and ubiquitin-proteasome, apoptosis has been advocated as an important candidate in regulating denervation-induced muscle loss. The purpose of this article is to review the role and signaling mechanisms of apoptosis during denervation in skeletal muscle including myofibers and satellite cells.
C1 [Siu, Parco M.] Hong Kong Polytech Univ, Dept Hlth Technol & Informat, Kowloon, Hong Kong, Peoples R China.
   [Alway, Stephen E.] W Virginia Univ, Sch Med, Div Exercise Physiol, Morgantown, WV 26506 USA.
C3 Hong Kong Polytechnic University; West Virginia University
RP Siu, PM (corresponding author), Hong Kong Polytech Univ, Dept Hlth Technol & Informat, Kowloon, Hong Kong, Peoples R China.
EM htpsiu@inet.polyu.edu.hk
FU National Institute on Aging Grant [R01 AG-021530]; The Hong Kong Polytechnic University ICRG funds
CR Abmayr S, 2004, HUM MOL GENET, V13, P213, DOI 10.1093/hmg/ddh018
   Acehan D, 2002, MOL CELL, V9, P423, DOI 10.1016/S1097-2765(02)00442-2
   Adams GR, 2006, APPL PHYSIOL NUTR ME, V31, P782, DOI 10.1139/H06-053
   Adhihetty PJ, 2007, J APPL PHYSIOL, V102, P1143, DOI 10.1152/japplphysiol.00768.2006
   Adhihetty PJ, 2005, AM J PHYSIOL-CELL PH, V289, PC994, DOI 10.1152/ajpcell.00031.2005
   Agustí AGN, 2002, AM J RESP CRIT CARE, V166, P485, DOI 10.1164/rccm.2108013
   Allen DL, 1999, MUSCLE NERVE, V22, P1350, DOI 10.1002/(SICI)1097-4598(199910)22:10<1350::AID-MUS3>3.0.CO;2-8
   Allen DL, 1997, AM J PHYSIOL-CELL PH, V273, PC579, DOI 10.1152/ajpcell.1997.273.2.C579
   Almendro V, 2003, EUR CYTOKINE NETW, V14, P256
   Alway SE, 2003, J GERONTOL A-BIOL, V58, P687
   ANSARI B, 1993, J PATHOL, V170, P1, DOI 10.1002/path.1711700102
   Antonsson B, 2000, BIOCHEM J, V345, P271, DOI 10.1042/0264-6021:3450271
   ASAYAMA K, 1986, J NEUROCHEM, V46, P604, DOI 10.1111/j.1471-4159.1986.tb13010.x
   Astrakas LG, 2005, FASEB J, V19, P1431, DOI 10.1096/fj.04-2005com
   Attaix D, 2005, ESSAYS BIOCHEM, V41, P173, DOI 10.1042/EB0410173
   Basañez G, 1999, P NATL ACAD SCI USA, V96, P5492, DOI 10.1073/pnas.96.10.5492
   Blink E, 2004, CELL DEATH DIFFER, V11, P937, DOI 10.1038/sj.cdd.4401409
   Borisov AB, 2000, ANAT RECORD, V258, P305
   Broccolini A, 1999, NEUROREPORT, V10, P1637, DOI 10.1097/00001756-199906030-00003
   Candé C, 2002, J CELL SCI, V115, P4727, DOI 10.1242/jcs.00210
   Candé C, 2002, BIOCHIMIE, V84, P215, DOI 10.1016/S0300-9084(02)01374-3
   Cartron PF, 2002, FEBS LETT, V512, P95, DOI 10.1016/S0014-5793(02)02227-5
   Chang HY, 2000, MICROBIOL MOL BIOL R, V64, P821, DOI 10.1128/MMBR.64.4.821-846.2000
   Chao DT, 1998, ANNU REV IMMUNOL, V16, P395, DOI 10.1146/annurev.immunol.16.1.395
   CHAO DT, 1995, J EXP MED, V182, P821, DOI 10.1084/jem.182.3.821
   Chargé SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003
   Csukly K, 2006, J PHYSIOL-LONDON, V574, P319, DOI 10.1113/jphysiol.2006.109702
   Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7
   DARR KC, 1989, J APPL PHYSIOL, V67, P1827, DOI 10.1152/jappl.1989.67.5.1827
   DAWSON BA, 1988, DEV BIOL, V127, P362, DOI 10.1016/0012-1606(88)90322-3
   Rodrigues ADC, 2006, MICROSURG, V26, P396, DOI 10.1002/micr.20258
   Degterev A, 2003, ONCOGENE, V22, P8543, DOI 10.1038/sj.onc.1207107
   Desagher S, 2000, TRENDS CELL BIOL, V10, P369, DOI 10.1016/S0962-8924(00)01803-1
   Deveraux QL, 1999, J CLIN IMMUNOL, V19, P388, DOI 10.1023/A:1020502800208
   Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239
   Deveraux QL, 1998, EMBO J, V17, P2215, DOI 10.1093/emboj/17.8.2215
   Dirks A, 2002, AM J PHYSIOL-REG I, V282, PR519, DOI 10.1152/ajpregu.00458.2001
   Dirks AJ, 2005, SPORTS MED, V35, P473, DOI 10.2165/00007256-200535060-00002
   Dirks AJ, 2004, FREE RADICAL BIO MED, V36, P27, DOI 10.1016/j.freeradbiomed.2003.10.003
   Dirks AJ, 2006, J NUTR BIOCHEM, V17, P501, DOI 10.1016/j.jnutbio.2005.11.002
   Dirks AJ, 2006, AGEING RES REV, V5, P179, DOI 10.1016/j.arr.2006.03.002
   Duke RC, 1996, SCI AM, V275, P80, DOI 10.1038/scientificamerican1296-80
   Dupont-Versteegden EE, 2005, EXP GERONTOL, V40, P473, DOI 10.1016/j.exger.2005.04.003
   Dupont-Versteegden EE, 2006, WORLD J GASTROENTERO, V12, P7463, DOI 10.3748/wjg.v12.i46.7463
   Dupont-Versteegden EE, 2006, AM J PHYSIOL-REG I, V291, PR1730, DOI 10.1152/ajpregu.00176.2006
   Earnshaw WC, 1999, ANNU REV BIOCHEM, V68, P383, DOI 10.1146/annurev.biochem.68.1.383
   Edelblum KL, 2006, INFLAMM BOWEL DIS, V12, P413, DOI 10.1097/01.MIB.0000217334.30689.3e
   ELLIS RE, 1991, ANNU REV CELL BIOL, V7, P663, DOI 10.1146/annurev.cellbio.7.1.663
   ER E, 2007, J BIOL CHEM, V0, P0
   Fernández-Solà J, 2003, HUM PATHOL, V34, P1247, DOI 10.1016/j.humpath.2003.07.017
   FIDZIANSKA A, 1991, ACTA NEUROPATHOL, V81, P572, DOI 10.1007/BF00310140
   FIDZIANSKA A, 1990, BRAIN, V113, P433, DOI 10.1093/brain/113.2.433
   Fidzianska A, 2002, FOLIA NEUROPATHOL, V40, P27
   Filippatos GS, 2003, INT J CARDIOL, V90, P107, DOI 10.1016/S0167-5273(02)00535-1
   Franch HA, 2005, CURR OPIN CLIN NUTR, V8, P271, DOI 10.1097/01.mco.0000165005.01331.45
   GENNARELLI M, 1995, BIOCHEM BIOPH RES CO, V213, P342, DOI 10.1006/bbrc.1995.2135
   Glass DJ, 2005, INT J BIOCHEM CELL B, V37, P1974, DOI 10.1016/j.biocel.2005.04.018
   Glass DJ, 2003, TRENDS MOL MED, V9, P344, DOI 10.1016/S1471-4914(03)00138-2
   Golding JP, 2007, EXP CELL RES, V313, P341, DOI 10.1016/j.yexcr.2006.10.019
   Gorman AM, 2000, DEV NEUROSCI-BASEL, V22, P348, DOI 10.1159/000017460
   Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320
   Grütter MG, 2000, CURR OPIN STRUC BIOL, V10, P649, DOI 10.1016/S0959-440X(00)00146-9
   Gustafsson ÅB, 2004, J BIOL CHEM, V279, P21233, DOI 10.1074/jbc.M400695200
   HALL PA, 1994, J CELL SCI, V107, P3569
   Hawke TJ, 2001, J APPL PHYSIOL, V91, P534, DOI 10.1152/jappl.2001.91.2.534
   Hegde R, 2002, J BIOL CHEM, V277, P432, DOI 10.1074/jbc.M109721200
   Heslop L, 2000, J CELL SCI, V113, P2299
   Hsu YT, 1997, P NATL ACAD SCI USA, V94, P3668, DOI 10.1073/pnas.94.8.3668
   Hughes SM, 1998, CURR BIOL, V8, PR892, DOI 10.1016/S0960-9822(07)00554-4
   Hyatt JPK, 2003, AM J PHYSIOL-CELL PH, V285, PC1161, DOI 10.1152/ajpcell.00128.2003
   Ikezoe K, 2002, ACTA NEUROPATHOL, V103, P531, DOI 10.1007/s00401-001-0502-8
   Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657
   Ishido M, 2004, AM J PHYSIOL-CELL PH, V287, PC484, DOI 10.1152/ajpcell.00080.2004
   Ishiko O, 2001, ANTICANCER RES, V21, P2363
   Ishiko O, 2001, INT J MOL MED, V8, P279
   Jejurikar SS, 2003, APOPTOSIS, V8, P573, DOI 10.1023/A:1026127307457
   Jejurikar SS, 2002, PLAST RECONSTR SURG, V110, P160, DOI 10.1097/00006534-200207000-00027
   JEJURIKAR SS, 2006, EXP GERONTOL, V0, P0
   Jin HM, 2001, J TRAUMA, V50, P31, DOI 10.1097/00005373-200101000-00005
   Joza N, 2005, MOL CELL BIOL, V25, P10261, DOI 10.1128/MCB.25.23.10261-10272.2005
   Joza N, 2001, NATURE, V410, P549, DOI 10.1038/35069004
   Kadi F, 2004, MUSCLE NERVE, V29, P120, DOI 10.1002/mus.10510
   Kandarian SC, 2006, MUSCLE NERVE, V33, P155, DOI 10.1002/mus.20442
   KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33
   Korsmeyer SJ, 1999, CANCER RES, V59, P0
   KORSMEYER SJ, 1995, TRENDS GENET, V11, P101, DOI 10.1016/S0168-9525(00)89010-1
   KORSMEYER SJ, 1995, BBA-MOL BASIS DIS, V1271, P63, DOI 10.1016/0925-4439(95)00011-R
   Koseki T, 1998, P NATL ACAD SCI USA, V95, P5156, DOI 10.1073/pnas.95.9.5156
   Kowaltowski AJ, 2004, FREE RADICAL BIO MED, V37, P1845, DOI 10.1016/j.freeradbiomed.2004.09.005
   Krajnak K, 2006, MUSCLE NERVE, V34, P720, DOI 10.1002/mus.20656
   Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Kusner LL, 1996, BRAIN RES, V730, P238
   Lalier L, 2007, APOPTOSIS, V12, P887, DOI 10.1007/s10495-007-0749-1
   Lawler JM, 2003, FREE RADICAL BIO MED, V35, P9, DOI 10.1016/S0891-5849(03)00186-2
   Lee SC, 2007, INT J BIOCHEM CELL B, V39, P497, DOI 10.1016/j.biocel.2006.09.007
   Leeuwenburgh C, 2005, AM J PHYSIOL-REG I, V288, PR1288, DOI 10.1152/ajpregu.00576.2004
   Leeuwenburgh C, 2003, J GERONTOL A-BIOL, V58, P999
   Lefebvre S, 1998, HUM MOL GENET, V7, P1531, DOI 10.1093/hmg/7.10.1531
   LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3
   Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1
   Li LY, 2001, NATURE, V412, P95, DOI 10.1038/35083620
   Lipton SA, 2002, CELL, V111, P147, DOI 10.1016/S0092-8674(02)01046-2
   Lu DX, 1997, ANAT REC, V248, P355
   Marzetti E, 2006, EXP GERONTOL, V41, P1234, DOI 10.1016/j.exger.2006.08.011
   MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493
   Menasché P, 2001, LANCET, V357, P279, DOI 10.1016/S0140-6736(00)03617-5
   Migheli A, 1997, NEUROGENETICS, V1, P81, DOI 10.1007/s100480050012
   Mikhailov V, 2003, J BIOL CHEM, V278, P5367, DOI 10.1074/jbc.M203392200
   Mikhailov V, 2001, J BIOL CHEM, V276, P18361, DOI 10.1074/jbc.M100655200
   Miller JB, 2006, TRENDS MOL MED, V12, P279, DOI 10.1016/j.molmed.2006.04.003
   Miró O, 2005, AIDS RES HUM RETROV, V21, P702, DOI 10.1089/aid.2005.21.702
   Mitch WE, 2006, J RENAL NUTR, V16, P208, DOI 10.1053/j.jrn.2006.04.014
   Mukasa T, 1999, BIOCHEM BIOPH RES CO, V260, P139, DOI 10.1006/bbrc.1999.0829
   Nader GA, 2005, INT J BIOCHEM CELL B, V37, P1985, DOI 10.1016/j.biocel.2005.02.026
   Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513
   Nakagawa T, 2000, J CELL BIOL, V150, P887, DOI 10.1083/jcb.150.4.887
   Narita M, 1998, P NATL ACAD SCI USA, V95, P14681, DOI 10.1073/pnas.95.25.14681
   Negroni E, 2006, PATHOL BIOL, V54, P100, DOI 10.1016/j.patbio.2005.09.001
   Olivé M, 2000, MUSCLE NERVE, V23, P1862, DOI 10.1002/1097-4598(200012)23:12<1862::AID-MUS10>3.0.CO;2-Q
   Olivé M, 2004, MUSCLE NERVE, V29, P261, DOI 10.1002/mus.10550
   Pette D, 2001, J APPL PHYSIOL, V90, P1119, DOI 10.1152/jappl.2001.90.3.1119
   Phaneuf S, 2002, AM J PHYSIOL-REG I, V282, PR423, DOI 10.1152/ajpregu.00296.2001
   Phillips T, 2005, FASEB J, V19, P668, DOI 10.1096/fj.04-2870fje
   Pistilli EE, 2006, J GERONTOL A-BIOL, V61, P245, DOI 10.1093/gerona/61.3.245
   Pistilli EE, 2007, AM J PHYSIOL-CELL PH, V292, PC1298, DOI 10.1152/ajpcell.00496.2006
   Pistilli EE, 2006, APOPTOSIS, V11, P2115, DOI 10.1007/s10495-006-0194-6
   Pollack M, 2002, ANN NY ACAD SCI, V959, P93, DOI 10.1111/j.1749-6632.2002.tb02086.x
   Pollack M, 2001, J GERONTOL A-BIOL, V56, PB475, DOI 10.1093/gerona/56.11.B475
   Reed JC, 2006, CELL DEATH DIFFER, V13, P1378, DOI 10.1038/sj.cdd.4401975
   Reed JC, 1997, NATURE, V387, P773, DOI 10.1038/42867
   Reed JC, 1998, BBA-BIOENERGETICS, V1366, P127, DOI 10.1016/S0005-2728(98)00108-X
   Renault V, 2002, AGING CELL, V1, P132, DOI 10.1046/j.1474-9728.2002.00017.x
   RODRIGUES AD, 1995, ANAT RECORD, V243, P430
   ROY N, 1995, CELL, V80, P167, DOI 10.1016/0092-8674(95)90461-1
   Salvesen GS, 2002, NAT REV MOL CELL BIO, V3, P401, DOI 10.1038/nrm830
   Sandri M, 2001, J NEUROPATH EXP NEUR, V60, P302, DOI 10.1093/jnen/60.3.302
   Sandri M, 1997, J NEUROPATH EXP NEUR, V56, P45, DOI 10.1097/00005072-199701000-00005
   Sandri M, 1998, LAB INVEST, V78, P1005
   Sandri M, 1999, INT J BIOCHEM CELL B, V31, P1373, DOI 10.1016/S1357-2725(99)00063-1
   SANDRI M, 1995, FEBS LETT, V373, P291, DOI 10.1016/0014-5793(95)00908-R
   Schmalbruch H, 1996, J NEUROPATH EXP NEUR, V55, P310, DOI 10.1097/00005072-199603000-00006
   Schoser BGH, 2001, MUSCLE NERVE, V24, P1083, DOI 10.1002/mus.1114
   SCHULTZ E, 1994, REV PHYSIOL BIOCH P, V123, P213, DOI 10.1007/BFb0030904
   SCHWARTZ LM, 1993, P NATL ACAD SCI USA, V90, P980, DOI 10.1073/pnas.90.3.980
   Sharpe JC, 2004, BBA-MOL CELL RES, V1644, P107, DOI 10.1016/j.bbamcr.2003.10.016
   Shi YG, 2002, MOL CELL, V9, P459, DOI 10.1016/S1097-2765(02)00482-3
   Shi YG, 2004, PROTEIN SCI, V13, P1979, DOI 10.1110/ps.04789804
   Shi YG, 2002, STRUCTURE, V10, P285, DOI 10.1016/S0969-2126(02)00732-3
   Shimizu S, 1999, NATURE, V399, P483, DOI 10.1038/20959
   Shiozaki EN, 2002, P NATL ACAD SCI USA, V99, P4197, DOI 10.1073/pnas.072544399
   Siu PM, 2006, APOPTOSIS, V11, P967, DOI 10.1007/s10495-006-6315-4
   Siu PM, 2005, AM J PHYSIOL-CELL PH, V288, PC1058, DOI 10.1152/ajpcell.00495.2004
   Siu PM, 2005, AM J PHYSIOL-REG I, V289, PR1015, DOI 10.1152/ajpregu.00198.2005
   Siu PM, 2005, J PHYSIOL-LONDON, V565, P309, DOI 10.1113/jphysiol.2004.081083
   Siu PM, 2005, AM J PHYSIOL-CELL PH, V288, PC338, DOI 10.1152/ajpcell.00239.2004
   Spierings D, 2005, SCIENCE, V310, P66, DOI 10.1126/science.1117105
   STELLER H, 1995, SCIENCE, V267, P1445, DOI 10.1126/science.7878463
   Stennicke HR, 1999, J BIOL CHEM, V274, P8359, DOI 10.1074/jbc.274.13.8359
   Stockholm D, 2001, AM J PHYSIOL-CELL PH, V280, PC1561, DOI 10.1152/ajpcell.2001.280.6.C1561
   Strassburg S, 2005, INT J BIOCHEM CELL B, V37, P1938, DOI 10.1016/j.biocel.2005.03.013
   SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0
   Sun XM, 1999, J BIOL CHEM, V274, P5053, DOI 10.1074/jbc.274.8.5053
   Suzuki Y, 2004, CELL DEATH DIFFER, V11, P208, DOI 10.1038/sj.cdd.4401343
   Tang H, 2000, MOL CELL NEUROSCI, V16, P127, DOI 10.1006/mcne.2000.0864
   Tews DS, 1997, ACTA NEUROL SCAND, V96, P380
   Tews DS, 1997, NEUROPATH APPL NEURO, V23, P331, DOI 10.1046/j.1365-2990.1997.5998059.x
   Tews DS, 1998, CLIN IMMUNOL IMMUNOP, V87, P240, DOI 10.1006/clin.1998.4527
   Tews DS, 2005, MUSCLE NERVE, V32, P443, DOI 10.1002/mus.20348
   Tews DS, 2005, MUSCLE NERVE, V31, P175, DOI 10.1002/mus.20253
   Tews DS, 1997, J NEUROPATH EXP NEUR, V56, P150, DOI 10.1097/00005072-199702000-00005
   Tews DS, 1996, NEUROMUSCULAR DISORD, V6, P265, DOI 10.1016/0960-8966(96)00018-1
   Tews DS, 2002, NEUROMUSCULAR DISORD, V12, P613, DOI 10.1016/S0960-8966(02)00030-5
   Tews DS, 2001, MICROSC RES TECHNIQ, V55, P181, DOI 10.1002/jemt.1169
   Tews DS, 1997, J NEUROPATH EXP NEUR, V56, P1283, DOI 10.1097/00005072-199712000-00003
   Tews DS, 1997, NEUROPATH APPL NEURO, V23, P141
   THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464
   Trachtenberg JT, 1998, DEV BIOL, V196, P193, DOI 10.1006/dbio.1998.8871
   Tsujimoto Y, 2005, CELL DEATH DIFFER, V12, P1528, DOI 10.1038/sj.cdd.4401777
   Tsujimoto Y, 2000, CELL DEATH DIFFER, V7, P1174, DOI 10.1038/sj.cdd.4400780
   Tsujimoto Y, 2006, BBA-BIOENERGETICS, V1757, P1297, DOI 10.1016/j.bbabio.2006.03.017
   Ventadour S, 2006, CURR OPIN RHEUMATOL, V18, P631, DOI 10.1097/01.bor.0000245731.25383.de
   Vescovo G, 2000, HEART, V84, P431, DOI 10.1136/heart.84.4.431
   Viguie CA, 1997, ANAT REC, V248, P346
   VOYTIK SL, 1993, DEV DYNAM, V198, P214, DOI 10.1002/aja.1001980307
   Walters EH, 2000, J MUSCLE RES CELL M, V21, P647, DOI 10.1023/A:1005683825960
   Webb J N, 1971, J PATHOL, V104, P0
   WEBB JN, 1972, J PATHOL, V106, P221, DOI 10.1002/path.1711060403
   WEBB JN, 1977, J PATHOL, V123, P175, DOI 10.1002/path.1711230307
   WILLIAMS GT, 1991, CELL, V65, P1097, DOI 10.1016/0092-8674(91)90002-G
   Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281
   WOOD KA, 1993, NEURON, V11, P621, DOI 10.1016/0896-6273(93)90074-2
   Yamada H, 2000, J NEUROL SCI, V173, P97, DOI 10.1016/S0022-510X(99)00306-8
   Yasuhara S, 1999, J BURN CARE REHABIL, V20, P462, DOI 10.1097/00004630-199920060-00007
   Ye H, 2002, NAT STRUCT BIOL, V9, P680, DOI 10.1038/nsb836
   YIN XM, 1994, NATURE, V369, P321, DOI 10.1038/369321a0
   Yoshimura K, 1999, J SURG RES, V81, P139, DOI 10.1006/jsre.1998.5504
   Yuan JY, 2000, NATURE, V407, P802, DOI 10.1038/35037739
   YUAN JY, 1995, CURR OPIN CELL BIOL, V7, P211, DOI 10.1016/0955-0674(95)80030-1
   Yuan JY, 1996, J CELL BIOCHEM, V60, P4, DOI 10.1002/(SICI)1097-4644(19960101)60:1<4::AID-JCB2>3.0.CO;2-1
   Yuan JY, 1997, CURR OPIN CELL BIOL, V9, P247, DOI 10.1016/S0955-0674(97)80069-5
   Zha HB, 1996, J BIOL CHEM, V271, P7440, DOI 10.1074/jbc.271.13.7440
NR 202
TC 46
Z9 54
U1 0
U2 20
PU BIOSCIENCE RESEARCH INST-BRI
PI SINGAPORE
PA 7 TEMZASEK BLVD, SUNTEC TOWER ONE, SINGAPORE, SINGAPORE
SN 2768-6701
EI 2768-6698
J9 FRONT BIOSCI-LANDMRK
JI Front. Biosci.
PD JAN 1
PY 2009
VL 14
IS 
BP 432
EP 452
DI 10.2741/3253
PG 21
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 393DZ
UT WOS:000262352400026
PM 19273076
DA 2024-11-01
ER

PT J
AU Nicholas, A
   Kraytsberg, Y
   Guo, XH
   Khrapko, K
AF Nicholas, Alexander
   Kraytsberg, Yevgenya
   Guo, Xinhong
   Khrapko, Konstantin
TI On the timing and the extent of clonal expansion of mtDNA deletions: Evidence from single-molecule PCR
SO EXPERIMENTAL NEUROLOGY
LA English
DT Article
ID mitochondrial-dna deletions; point mutations; muscle-fibers; stem-cells; skeletal-muscle; impairment; abundant; tissue; burden; mice
AB mtDNA deletions are pathogenic mutations that remove Substantial portions of the mitochondrial genome. mtDNA deletions accumulate with age and have been implicated in various degenerative diseases There are. multiple mtDNA per cell and mtDNA mutations become toxic only if they accumulate to substantial intracellular levels, i.e. exceed so-called "phenotypic threshold". This is usually achieved via clonal expansion of a single initial mutated molecule. Intracellular mitochondrial genomes are analogous to a population of individuals in that mitochondria are born by division and die by degradation, Clonal expansion within cells is thus analogous to genetic drift within populations and is driven by a combination of random processes and selection. mtDNA mutations Occurring early in development are expected to end up spread across tissues, while mutations of late origin are expected to be localized, i.e. limited a single post-mitotic cell or progeny of a single stern cell. We have explored the extent and timing of clonality of mtDNA deletion in human muscle Using single-molecule PCR. We analyzed deletions from two nearby locations within the same tissue sample. Altogether we analyzed over 130 mutant molecules, but almost every deletion type detected was represented by several identical mutant molecules, so that altogether there were only 21 different kinds of deletions, implying that essentially all deletions were clonal. At the same time the sets of deletions in the two locations were completely different. This observation implies that all of the clonal expansions spanned very small areas and therefore that the corresponding mutations were likely events of older age. More Studies are necessary to further validate these findings in muscle and to explore the other tissues. (C) 2009 Elsevier Inc. All rights reserved.
C1 [Nicholas, Alexander; Kraytsberg, Yevgenya; Guo, Xinhong; Khrapko, Konstantin] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02215 USA.
C3 Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School
RP Khrapko, K (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, 330 Brookline Ave, Boston, MA 02215 USA.
EM khrapko@hms.harvard.edu
FU NIH [NS058988, AG19787]
CR Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Coller HA, 2005, MUTAT RES-FUND MOL M, V578, P256, DOI 10.1016/j.mrfmmm.2005.05.014
   Coller HA, 2002, ANN NY ACAD SCI, V959, P434, DOI 10.1111/j.1749-6632.2002.tb02113.x
   Del Bo R, 2003, NEUROBIOL AGING, V24, P829, DOI 10.1016/S0197-4580(02)00233-6
   Dubec SJ, 2008, REJUV RES, V11, P611, DOI 10.1089/rej.2007.0617
   Fayet G, 2002, NEUROMUSCULAR DISORD, V12, P484, DOI 10.1016/S0960-8966(01)00332-7
   Greaves LC, 2006, P NATL ACAD SCI USA, V103, P714, DOI 10.1073/pnas.0505903103
   Herbst A, 2007, J GERONTOL A-BIOL, V62, P235, DOI 10.1093/gerona/62.3.235
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   Jockusch H, 2003, J CELL SCI, V116, P1611, DOI 10.1242/jcs.00364
   Khaidakov A, 2005, EXP GERONTOL, V40, P396, DOI 10.1016/j.exger.2005.02.007
   Khrapko K, 2004, ANN NY ACAD SCI, V1019, P240, DOI 10.1196/annals.1297.040
   Khrapko K, 2003, MUTAT RES-FUND MOL M, V522, P13, DOI 10.1016/S0027-5107(02)00306-8
   Khrapko K, 2009, TRENDS GENET, V25, P91, DOI 10.1016/j.tig.2008.11.007
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Kraytsberg Y, 2005, EXPERT REV MOL DIAGN, V5, P809, DOI 10.1586/14737159.5.5.809
   Kraytsberg Y, 2008, METHODS, V46, P269, DOI 10.1016/j.ymeth.2008.10.005
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   MULLERHOCKER J, 1993, VIRCHOWS ARCH A, V422, P7, DOI 10.1007/BF01605127
   Nakada K, 2001, NAT MED, V7, P934, DOI 10.1038/90976
   Nekhaeva E, 2002, P NATL ACAD SCI USA, V99, P5521, DOI 10.1073/pnas.072670199
   Sato A, 2007, GENETICS, V177, P2031, DOI 10.1534/genetics.107.081026
   SCHWARZE SR, 1995, MECH AGEING DEV, V83, P91, DOI 10.1016/0047-6374(95)01611-3
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435
   Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988
NR 27
TC 23
Z9 25
U1 0
U2 9
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0014-4886
EI 1090-2430
J9 EXP NEUROL
JI Exp. Neurol.
PD AUG 15
PY 2009
VL 218
IS 2
BP 316
EP 319
DI 10.1016/j.expneurol.2009.04.029
PG 4
WC Neurosciences
SC Neurosciences & Neurology
GA 472GE
UT WOS:000268117400017
PM 19426731
DA 2024-11-01
ER

PT J
AU Fukui, H
   Moraes, CT
AF Fukui, Hirokazu
   Moraes, Carlos T.
TI Mechanisms of formation and accumulation of mitochondrial DNA deletions in aging neurons
SO HUMAN MOLECULAR GENETICS
LA English
DT Article
ID substantia-nigra neurons; multiple mtdna deletions; central-nervous-system; aged muscle-fibers; oxidative stress; helicase twinkle; mutations; mice; disease; neurodegeneration
AB Age-dependent accumulation of partially deleted mitochondrial DNA (Delta mtDNA) has been suggested to contribute to aging and the development of age-associated diseases including Parkinson's disease. However, the molecular mechanisms underlying the generation and accumulation of Delta mtDNA have not been addressed in vivo. In this study, we have developed a mouse model expressing an inducible mitochondria-targeted restriction endonuclease (PstI). Using this system, we could trigger mtDNA double-strand breaks (DSBs) in adult neurons. We found that this transient event leads to the generation of a family of Delta mtDNA with features that closely resemble naturally-occurring mtDNA deletions. The formation of these deleted species is likely to be mediated by yet uncharacterized DNA repairing machineries that participate in homologous recombination and non-homologous end-joining. Furthermore, we obtained in vivo evidence that Delta mtDNAs with larger deletions accumulate faster than those with smaller deletions, implying a replicative advantage of smaller mtDNAs. These findings identify DSB, DNA repair systems and replicative advantage as likely mechanisms underlying the generation and age-associated accumulation of Delta mtDNA in mammalian neurons.
C1 [Moraes, Carlos T.] Univ Miami, Sch Med, Dept Neurol, Miami, FL 33136 USA.
   [Fukui, Hirokazu; Moraes, Carlos T.] Univ Miami, Sch Med, Neurosci Program, Miami, FL 33136 USA.
   [Moraes, Carlos T.] Univ Miami, Sch Med, Dept Cell Biol & Anat, Miami, FL 33136 USA.
C3 University of Miami; University of Miami; University of Miami
RP Moraes, CT (corresponding author), Univ Miami, Sch Med, Dept Neurol, 1095 NW 14th Terrace, Miami, FL 33136 USA.
EM cmoraes@med.miami.edu
FU US Public Health Service Grant [R01-NS41777, R01-EY10804, R01-CA85700]; University of Miami Neuroscience Center; Lois Pope LIFE Fellowship
CR Alemi M, 2007, FREE RADICAL BIO MED, V42, P32, DOI 10.1016/j.freeradbiomed.2006.09.014
   Auerbach W, 2001, HUM MOL GENET, V10, P2515, DOI 10.1093/hmg/10.22.2515
   Bayona-Bafaluy MP, 2005, P NATL ACAD SCI USA, V102, P14392, DOI 10.1073/pnas.0502896102
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Brierley EJ, 1998, ANN NEUROL, V43, P217, DOI 10.1002/ana.410430212
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Cao ZJ, 2001, NUCLEIC ACIDS RES, V29, P4502, DOI 10.1093/nar/29.21.4502
   Diaz F, 2002, NUCLEIC ACIDS RES, V30, P4626, DOI 10.1093/nar/gkf602
   Dragatsis I, 2000, NAT GENET, V26, P300, DOI 10.1038/81593
   Elson JL, 2001, AM J HUM GENET, V68, P802, DOI 10.1086/318801
   Fishel ML, 2007, MUTAT RES-FUND MOL M, V614, P24, DOI 10.1016/j.mrfmmm.2006.06.007
   Fukui H, 2008, TRENDS NEUROSCI, V31, P251, DOI 10.1016/j.tins.2008.02.008
   Fukui H, 2007, P NATL ACAD SCI USA, V104, P14163, DOI 10.1073/pnas.0705738104
   Fukui H, 2007, HUM MOL GENET, V16, P783, DOI 10.1093/hmg/ddm023
   Herbst A, 2007, J GERONTOL A-BIOL, V62, P235, DOI 10.1093/gerona/62.3.235
   Kleinle S, 1997, HUM GENET, V100, P643, DOI 10.1007/s004390050567
   Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678
   ODriscoll M, 2006, NAT REV GENET, V7, P45, DOI 10.1038/nrg1746
   Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, PD823, DOI 10.1093/nar/gkl927
   Srivastava S, 2005, HUM MOL GENET, V14, P893, DOI 10.1093/hmg/ddi082
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95
   Wanagat J, 2001, FASEB J, V15, P322, DOI 10.1096/fj.00-0320com
   Wanrooij S, 2007, NUCLEIC ACIDS RES, V35, P3238, DOI 10.1093/nar/gkm215
   Wiesner RJ, 2006, FREE RADICAL RES, V40, P1284, DOI 10.1080/10715760600913168
NR 28
TC 146
Z9 172
U1 0
U2 13
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0964-6906
EI 1460-2083
J9 HUM MOL GENET
JI Hum. Mol. Genet.
PD MAR 15
PY 2009
VL 18
IS 6
BP 1028
EP 1036
DI 10.1093/hmg/ddn437
PG 9
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA 413XT
UT WOS:000263828100004
PM 19095717
DA 2024-11-01
ER

PT J
AU Alexeyev, MF
AF Alexeyev, Mikhail F.
TI Is there more to aging than mitochondrial DNA and reactive oxygen species?
SO FEBS JOURNAL
LA English
DT Review
DE antioxidants; lifespan extension; mitochondria; mitochondrial DNA degradation; mitochondrial DNA mutations; mitochondrial DNA repair; mitochondrial theory of aging; oxidative damage
ID targeted plastoquinone derivatives; base excision-repair; endogenous oxidative damage; hydrogen-peroxide release; cultured skin fibroblasts; zn-superoxide-dismutase; life-span; glutathione-peroxidase; interrupt execution; skeletal-muscle
AB With the aging of the population, we are seeing a global increase in the prevalence of age-related disorders, especially in developed countries. Chronic diseases disproportionately affect the older segment of the population, contributing to disability, a diminished quality of life and an increase in healthcare costs. Increased life expectancy reflects the success of contemporary medicine, which must now respond to the challenges created by this achievement, including the growing burden of chronic illnesses, injuries and disabilities. A well-developed theoretical framework is required to understand the molecular basis of aging. Such a framework is a prerequisite for the development of clinical interventions that will constitute an efficient response to the challenge of age-related health issues. This review critically analyzes the experimental evidence that supports and refutes the Free Radical/Mitochondrial Theory of Aging, which has dominated the field of aging research for almost half a century.
C1 [Alexeyev, Mikhail F.] Univ S Alabama, Dept Cell Biol & Neurosci, 307 Univ Blvd,MSB1201, Mobile, AL 36688 USA.
   [Alexeyev, Mikhail F.] Ukrainian Acad Sci, Inst Mol Biol & Genet, UA-252627 Kiev, Ukraine.
C3 University of South Alabama; National Academy of Sciences Ukraine; Institute of Molecular Biology & Genetics of NASU
RP Alexeyev, MF (corresponding author), Univ S Alabama, Dept Cell Biol & Neurosci, 307 Univ Blvd,MSB1201, Mobile, AL 36688 USA.
EM malexeye@jaguar1.usouthal.edu
FU National Institutes of Health [P01 HL06629907, R21RR02396101]
CR Agapova LS, 2008, BIOCHEMISTRY-MOSCOW+, V73, P1300, DOI 10.1134/S0006297908120031
   Akbari M, 2008, DNA REPAIR, V7, P605, DOI 10.1016/j.dnarep.2008.01.002
   Alam TI, 2003, NUCLEIC ACIDS RES, V31, P1640, DOI 10.1093/nar/gkg251
   Alexe G, 2007, HUM GENET, V121, P347, DOI 10.1007/s00439-007-0330-6
   ALEXEYEV M, 2006, HDB MODELS HUMAN AGI, V0, P507
   Alexeyev MF, 2008, GENE THER, V15, P516, DOI 10.1038/sj.gt.2008.11
   ALLEN JA, 1980, NATURE, V287, P244, DOI 10.1038/287244a0
   AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915
   ANDERSON CTM, 1980, NUCLEIC ACIDS RES, V8, P875
   Andreyev AI, 2005, BIOCHEMISTRY-MOSCOW+, V70, P200, DOI 10.1007/s10541-005-0102-7
   Anisimov VN, 2008, BIOCHEMISTRY-MOSCOW+, V73, P1329, DOI 10.1134/S0006297908120055
   Anson RM, 2000, FASEB J, V14, P355, DOI 10.1096/fasebj.14.2.355
   Anson RM, 1999, FREE RADICAL BIO MED, V27, P456, DOI 10.1016/S0891-5849(99)00091-X
   Antonenko YN, 2008, BIOCHEMISTRY-MOSCOW+, V73, P1273, DOI 10.1134/S0006297908120018
   Antunes F, 2002, FREE RADICAL BIO MED, V33, P1260, DOI 10.1016/S0891-5849(02)01016-X
   BACKER JM, 1980, SCIENCE, V209, P297, DOI 10.1126/science.6770466
   Bai JX, 2000, J BIOL CHEM, V275, P19241, DOI 10.1074/jbc.M000438200
   Bakeeva LE, 2008, BIOCHEMISTRY-MOSCOW+, V73, P1288, DOI 10.1134/S000629790812002X
   Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x
   Barreiro E, 2006, FREE RADICAL BIO MED, V41, P797, DOI 10.1016/j.freeradbiomed.2006.05.027
   Bass TM, 2007, MECH AGEING DEV, V128, P546, DOI 10.1016/j.mad.2007.07.007
   Bayne ACV, 2002, FREE RADICAL BIO MED, V32, P1229, DOI 10.1016/S0891-5849(02)00849-3
   Beckman KB, 1999, MUTAT RES-FUND MOL M, V424, P51, DOI 10.1016/S0027-5107(99)00007-X
   Bilal E, 2008, PLOS ONE, V3, P0, DOI 10.1371/journal.pone.0002421
   BLAKELY WF, 1990, RADIAT RES, V121, P338, DOI 10.2307/3577785
   BLUM J, 1985, ARCH BIOCHEM BIOPHYS, V240, P500, DOI 10.1016/0003-9861(85)90056-6
   Bohr VA, 2002, FREE RADICAL BIO MED, V32, P804, DOI 10.1016/S0891-5849(02)00787-6
   Bota DA, 2002, FEBS LETT, V532, P103, DOI 10.1016/S0014-5793(02)03638-4
   BOVERIS A, 1972, BIOCHEM J, V128, P617, DOI 10.1042/bj1280617
   BRAND FN, 1992, J CLIN EPIDEMIOL, V45, P169, DOI 10.1016/0895-4356(92)90009-C
   Brandon MC, 2005, NUCLEIC ACIDS RES, V33, P0
   BRAWN K, 1981, ARCH BIOCHEM BIOPHYS, V206, P414, DOI 10.1016/0003-9861(81)90108-9
   BROWN WM, 1979, P NATL ACAD SCI USA, V76, P1967, DOI 10.1073/pnas.76.4.1967
   Capel F, 2005, MECH AGEING DEV, V126, P505, DOI 10.1016/j.mad.2004.11.001
   CARMAGNOL F, 1983, BIOCHIM BIOPHYS ACTA, V759, P49, DOI 10.1016/0304-4165(83)90188-5
   Carmeli E, 2002, EXP GERONTOL, V37, P477, DOI 10.1016/S0531-5565(01)00220-0
   Castri L, 2009, HUM HERED, V67, P147, DOI 10.1159/000181152
   Chae HZ, 1999, DIABETES RES CLIN PR, V45, P101, DOI 10.1016/S0168-8227(99)00037-6
   Chang TS, 2004, J BIOL CHEM, V279, P41975, DOI 10.1074/jbc.M407707200
   Christmann M, 2003, TOXICOLOGY, V193, P3, DOI 10.1016/S0300-483X(03)00287-7
   Clayton D A, 1975, BASIC LIFE SCI, V5B, P589
   CLAYTON DA, 1974, P NATL ACAD SCI USA, V71, P2777, DOI 10.1073/pnas.71.7.2777
   Collins A, 2003, FREE RADICAL BIO MED, V34, P1089, DOI 10.1016/s0891-5849(03)00041-8
   Crawford DR, 1998, FREE RADICAL BIO MED, V25, P1106, DOI 10.1016/S0891-5849(98)00143-9
   CULLIS PM, 1987, NATURE, V330, P773, DOI 10.1038/330773a0
   De Benedictis G, 1999, FASEB J, V13, P1532, DOI 10.1096/fasebj.13.12.1532
   De Bont R, 2004, MUTAGENESIS, V19, P169, DOI 10.1093/mutage/geh025
   de Haan JB, 1998, J BIOL CHEM, V273, P22528, DOI 10.1074/jbc.273.35.22528
   de Souza-Pinto NC, 2009, DNA REPAIR, V8, P704, DOI 10.1016/j.dnarep.2009.01.021
   de Souza-Pinto NC, 2001, CANCER RES, V61, P5378
   DeLaAsuncion JG, 1996, FASEB J, V10, P333, DOI 10.1096/fasebj.10.2.8641567
   DRIGGERS WJ, 1993, J BIOL CHEM, V268, P22042
   Driggers WJ, 1997, NUCLEIC ACIDS RES, V25, P4362, DOI 10.1093/nar/25.21.4362
   Driggers WJ, 1996, CANCER RES, V56, P1262
   Druzhyna N, 1998, MUTAT RES-DNA REPAIR, V409, P81, DOI 10.1016/S0921-8777(98)00042-1
   Enright H, 1996, CARCINOGENESIS, V17, P1175, DOI 10.1093/carcin/17.5.1175
   ENRIGHT HU, 1992, NUCLEIC ACIDS RES, V20, P3341, DOI 10.1093/nar/20.13.3341
   Evans MD, 2004, MUTAT RES-REV MUTAT, V567, P1, DOI 10.1016/j.mrrev.2003.11.001
   Filosto M, 2002, ACTA NEUROPATHOL, V103, P215, DOI 10.1007/s004010100455
   FRAGA CG, 1990, P NATL ACAD SCI USA, V87, P4533, DOI 10.1073/pnas.87.12.4533
   Friguet B, 2006, FEBS LETT, V580, P2910, DOI 10.1016/j.febslet.2006.03.028
   Frimer AA, 1996, FREE RADICAL BIO MED, V20, P843, DOI 10.1016/0891-5849(95)02148-5
   Gardner PR, 1997, BIOSCIENCE REP, V17, P33, DOI 10.1023/A:1027383100936
   GARDNER PR, 1991, J BIOL CHEM, V266, P19328
   Gedik CM, 2005, FASEB J, V19, P82, DOI 10.1096/fj.04-1767fje
   Geromel V, 2002, FREE RADICAL RES, V36, P375, DOI 10.1080/10715760290021216
   Geromel V, 2001, HUM MOL GENET, V10, P1221, DOI 10.1093/hmg/10.11.1221
   Gianni P, 2004, EXP GERONTOL, V39, P1391, DOI 10.1016/j.exger.2004.06.002
   Giulivi C, 2001, J BIOL CHEM, V276, P24129, DOI 10.1074/jbc.M010697200
   Gouliaeva NA, 2006, BIOFIZIKA+, V51, P692
   Grishko VI, 1999, NUCLEIC ACIDS RES, V27, P4510, DOI 10.1093/nar/27.22.4510
   GROSS NJ, 1969, J BIOL CHEM, V244, P1563
   HALLIWELL B, 1991, FEBS LETT, V281, P9, DOI 10.1016/0014-5793(91)80347-6
   Hanes JW, 2006, J BIOL CHEM, V281, P36241, DOI 10.1074/jbc.M607965200
   Hansford RG, 1997, J BIOENERG BIOMEMBR, V29, P89, DOI 10.1023/A:1022420007908
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Helbock HJ, 1998, P NATL ACAD SCI USA, V95, P288, DOI 10.1073/pnas.95.1.288
   Henle ES, 1996, J BIOL CHEM, V271, P21177, DOI 10.1074/jbc.271.35.21177
   Henle ES, 1996, BIOCHEMISTRY-US, V35, P12212, DOI 10.1021/bi961235j
   Ho YS, 1997, J BIOL CHEM, V272, P16644, DOI 10.1074/jbc.272.26.16644
   HODGSON EK, 1975, BIOCHEMISTRY-US, V14, P5299, DOI 10.1021/bi00695a011
   Honda Y, 2008, EXP GERONTOL, V43, P520, DOI 10.1016/j.exger.2008.02.009
   Howes RM, 2006, ANN NY ACAD SCI, V1067, P22, DOI 10.1196/annals.1354.004
   Ibeas JI, 1997, APPL ENVIRON MICROB, V63, P7, DOI 10.1128/AEM.63.1.7-12.1997
   Ikeda S, 1997, BIOCHEM BIOPH RES CO, V235, P291, DOI 10.1006/bbrc.1997.6786
   Iñarrea P, 2007, BIOCHEM J, V405, P173, DOI 10.1042/BJ20061809
   Indo HP, 2007, MITOCHONDRION, V7, P106, DOI 10.1016/j.mito.2006.11.026
   Ishchenko A, 2003, MED SCI MONITOR, V9, P0
   Ivanova R, 1998, GERONTOLOGY, V44, P349, DOI 10.1159/000022041
   Jacobs HT, 2003, AGING CELL, V2, P11, DOI 10.1046/j.1474-9728.2003.00032.x
   Jang YC, 2009, EXP GERONTOL, V44, P256, DOI 10.1016/j.exger.2008.12.006
   Jornot L, 1998, BIOCHEM J, V335, P85, DOI 10.1042/bj3350085
   Judge S, 2005, FASEB J, V19, P419, DOI 10.1096/fj.04-2622fje
   Kamel HK, 2002, DRUG AGING, V19, P865, DOI 10.2165/00002512-200219110-00004
   Keaney M, 2003, FREE RADICAL BIO MED, V34, P277, DOI 10.1016/S0891-5849(02)01290-X
   Kennedy MA, 2003, EXP GERONTOL, V38, P997, DOI 10.1016/S0531-5565(03)00164-5
   Khrapko K, 2006, AGING CELL, V5, P279, DOI 10.1111/j.1474-9726.2006.00209.x
   Kim J, 2008, MECH AGEING DEV, V129, P322, DOI 10.1016/j.mad.2008.02.011
   KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477
   Kitani K, 2003, BIOGERONTOLOGY, V4, P401, DOI 10.1023/B:BGEN.0000006561.15498.68
   Knoops B, 1999, J BIOL CHEM, V274, P30451, DOI 10.1074/jbc.274.43.30451
   Knopp EA, 1999, MAMM GENOME, V10, P601, DOI 10.1007/s003359901053
   Korshunov SS, 1997, FEBS LETT, V416, P15, DOI 10.1016/S0014-5793(97)01159-9
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Kukat A, 2008, NUCLEIC ACIDS RES, V36, P0, DOI 10.1093/nar/gkn124
   Kunishige M, 2003, MUSCLE NERVE, V28, P484, DOI 10.1002/mus.10466
   Lardinois OM, 1996, BBA-PROTEIN STRUCT M, V1295, P222, DOI 10.1016/0167-4838(96)00043-X
   LEDOUX SP, 1993, CARCINOGENESIS, V14, P913, DOI 10.1093/carcin/14.5.913
   LeDoux SP, 1999, MUTAT RES-DNA REPAIR, V434, P149, DOI 10.1016/S0921-8777(99)00026-9
   LEDOUX SP, 1992, CARCINOGENESIS, V13, P1967, DOI 10.1093/carcin/13.11.1967
   LeDoux SP, 2001, PROG NUCLEIC ACID RE, V68, P273
   Legros F, 2004, J CELL SCI, V117, P2653, DOI 10.1242/jcs.01134
   LESKO SA, 1980, BIOCHEMISTRY-US, V19, P3023, DOI 10.1021/bi00554a029
   Liang Q, 2001, CHEM RES TOXICOL, V14, P416, DOI 10.1021/tx0002278
   Liang R, 1999, CARCINOGENESIS, V20, P893, DOI 10.1093/carcin/20.5.893
   Lim KS, 2005, ANN NY ACAD SCI, V1042, P210, DOI 10.1196/annals.1338.023
   Liochev SI, 2007, FREE RADICAL BIO MED, V42, P1465, DOI 10.1016/j.freeradbiomed.2007.02.015
   Liu BW, 2008, OPT EXPRESS, V16, P14987, DOI 10.1364/OE.16.014987
   LJUNGMAN M, 1992, MOL CARCINOGEN, V5, P264, DOI 10.1002/mc.2940050406
   Lu CY, 1999, MUTAT RES-FUND MOL M, V423, P11, DOI 10.1016/S0027-5107(98)00220-6
   Lu CY, 2003, MOL GENET METAB, V80, P321, DOI 10.1016/j.ymgme.2003.08.005
   LYNCH RE, 1978, J BIOL CHEM, V253, P4697
   Maklashina E, 2004, AGING CELL, V3, P21, DOI 10.1111/j.1474-9728.2003.00078.x
   Mandavilli BS, 2002, MUTAT RES-FUND MOL M, V509, P127, DOI 10.1016/S0027-5107(02)00220-8
   Mansouri A, 1999, GASTROENTEROLOGY, V117, P181, DOI 10.1016/S0016-5085(99)70566-4
   Mansouri A, 2001, J PHARMACOL EXP THER, V298, P737
   MAO GD, 1992, FEBS LETT, V305, P233, DOI 10.1016/0014-5793(92)80675-7
   Margis R, 2008, FEBS J, V275, P3959, DOI 10.1111/j.1742-4658.2008.06542.x
   Marzetti E, 2009, BIOFACTORS, V35, P28, DOI 10.1002/biof.5
   Mathews ST, 2006, BIOCHEM BIOPH RES CO, V350, P437, DOI 10.1016/j.bbrc.2006.09.071
   Mattiazzi M, 2004, HUM MOL GENET, V13, P869, DOI 10.1093/hmg/ddh103
   Mauriz JL, 2007, J PINEAL RES, V42, P222, DOI 10.1111/j.1600-079X.2006.00409.x
   McClung JP, 2004, P NATL ACAD SCI USA, V101, P8852, DOI 10.1073/pnas.0308096101
   MECOCCI P, 1993, ANN NEUROL, V34, P609, DOI 10.1002/ana.410340416
   MIQUEL J, 1980, EXP GERONTOL, V15, P575, DOI 10.1016/0531-5565(80)90010-8
   Mitsuishi M, 2009, DIABETES, V58, P710, DOI 10.2337/db08-0949
   MIYAKI M, 1977, CHEM-BIOL INTERACT, V17, P321, DOI 10.1016/0009-2797(77)90095-3
   Montier LLC, 2009, J GENET GENOMICS, V36, P125, DOI 10.1016/S1673-8527(08)60099-5
   MORAES EC, 1990, CARCINOGENESIS, V11, P283, DOI 10.1093/carcin/11.2.283
   Muller FL, 2004, J BIOL CHEM, V279, P49064, DOI 10.1074/jbc.M407715200
   Muller FL, 2008, BIOCHEM J, V409, P491, DOI 10.1042/BJ20071162
   Muller FL, 2007, FREE RADICAL BIO MED, V43, P477, DOI 10.1016/j.freeradbiomed.2007.03.034
   MYERS KA, 1988, CARCINOGENESIS, V9, P285, DOI 10.1093/carcin/9.2.285
   Nakada K, 2009, INT J BIOCHEM CELL B, V41, P1907, DOI 10.1016/j.biocel.2009.05.010
   Neroev VV, 2008, BIOCHEMISTRY-MOSCOW+, V73, P1317, DOI 10.1134/S0006297908120043
   NEUBERT D, 1981, ARCH TOXICOL, V48, P89, DOI 10.1007/BF00310481
   NIRANJAN BG, 1982, SCIENCE, V215, P73, DOI 10.1126/science.6797067
   Nohl H, 2005, BIOCHEM PHARMACOL, V69, P719, DOI 10.1016/j.bcp.2004.12.002
   Núñez ME, 2002, CHEM BIOL, V9, P403, DOI 10.1016/S1074-5521(02)00121-7
   OGURA Y, 1983, J BIOCHEM, V94, P403, DOI 10.1093/oxfordjournals.jbchem.a134369
   OHKOSHI N, 1995, MUSCLE NERVE, V18, P1265, DOI 10.1002/mus.880181108
   Ono T, 2001, NAT GENET, V28, P272, DOI 10.1038/90116
   Orr WC, 2003, J BIOL CHEM, V278, P26418, DOI 10.1074/jbc.M303095200
   Pallardó FV, 1998, FREE RADICAL RES, V29, P617, DOI 10.1080/10715769800300671
   PETTEPHER CC, 1991, J BIOL CHEM, V266, P3113
   PRICE GB, 1971, SCIENCE, V171, P917, DOI 10.1126/science.171.3974.917
   RADI R, 1991, J BIOL CHEM, V266, P22028
   Ran Q, 2007, J GERONTOL A-BIOL, V62, P932, DOI 10.1093/gerona/62.9.932
   Rasmussen UF, 2003, EXP GERONTOL, V38, P877, DOI 10.1016/S0531-5565(03)00092-5
   Rasmussen UF, 2003, PFLUG ARCH EUR J PHY, V446, P270, DOI 10.1007/s00424-003-1022-2
   REVEILLAUD I, 1991, MOL CELL BIOL, V11, P632, DOI 10.1128/MCB.11.2.632
   Rhee SG, 2005, ANTIOXID REDOX SIGN, V7, P619, DOI 10.1089/ars.2005.7.619
   RICHTER C, 1988, P NATL ACAD SCI USA, V85, P6465, DOI 10.1073/pnas.85.17.6465
   RODRIGUEZ H, 1995, J BIOL CHEM, V270, P17633, DOI 10.1074/jbc.270.29.17633
   Ross OA, 2001, EXP GERONTOL, V36, P1161, DOI 10.1016/S0531-5565(01)00094-8
   ROSSI SC, 1988, CHEM RES TOXICOL, V1, P101, DOI 10.1021/tx00002a003
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   ROWLEY DA, 1983, BIOCHIM BIOPHYS ACTA, V761, P86, DOI 10.1016/0304-4165(83)90365-3
   Sacconi S, 2008, HUM MOL GENET, V17, P1814, DOI 10.1093/hmg/ddn073
   SATOH MS, 1988, J BIOL CHEM, V263, P6854
   SAWADA M, 1987, MECH AGEING DEV, V41, P125, DOI 10.1016/0047-6374(87)90057-1
   Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653
   Selman C, 2006, MECH AGEING DEV, V127, P897, DOI 10.1016/j.mad.2006.09.008
   Seo MS, 2000, J BIOL CHEM, V275, P20346, DOI 10.1074/jbc.M001943200
   SETO NOL, 1990, P NATL ACAD SCI USA, V87, P4270, DOI 10.1073/pnas.87.11.4270
   SHEN CC, 1995, MUTAT RES-DNA REPAIR, V337, P19, DOI 10.1016/0921-8777(95)00008-8
   Shen GP, 2003, DNA REPAIR, V2, P673, DOI 10.1016/S1568-7864(03)00006-5
   Shokolenko I, 2009, NUCLEIC ACIDS RES, V37, P2539, DOI 10.1093/nar/gkp100
   SKULACHEV VP, 2008, BIOCHIM BIOPHYS ACTA, V1787, P437
   SOHAL RS, 1991, MECH AGEING DEV, V57, P187, DOI 10.1016/0047-6374(91)90034-W
   Sohal RS, 2002, FREE RADICAL BIO MED, V33, P37, DOI 10.1016/S0891-5849(02)00856-0
   SOHAL RS, 1994, FREE RADICAL BIO MED, V16, P621, DOI 10.1016/0891-5849(94)90062-0
   St-Pierre J, 2002, J BIOL CHEM, V277, P44784, DOI 10.1074/jbc.M207217200
   Stadtman ER, 2006, FREE RADICAL RES, V40, P1250, DOI 10.1080/10715760600918142
   Staniek K, 1999, BBA-BIOENERGETICS, V1413, P70, DOI 10.1016/S0005-2728(99)00083-3
   Staniek K, 2000, BBA-BIOENERGETICS, V1460, P268, DOI 10.1016/S0005-2728(00)00152-3
   Starkov AA, 2008, ANN NY ACAD SCI, V1147, P37, DOI 10.1196/annals.1427.015
   Starner TE, 2003, IEEE PERVAS COMPUT, V2, P86, DOI 10.1109/MPRV.2003.1251172
   Suliman HB, 2003, AM J RESP CRIT CARE, V167, P570, DOI 10.1164/rccm.200206-518OC
   Suter M, 1999, BIOCHEMISTRY-US, V38, P459, DOI 10.1021/bi9811922
   Szczesny B, 2008, J BIOL CHEM, V283, P26349, DOI 10.1074/jbc.M803491200
   TAKAHASHI MA, 1983, ARCH BIOCHEM BIOPHYS, V226, P558, DOI 10.1016/0003-9861(83)90325-9
   Tatarenkov A, 2007, P R SOC B, V274, P1795, DOI 10.1098/rspb.2007.0169
   Thorslund T, 2002, DNA REPAIR, V1, P261, DOI 10.1016/S1568-7864(02)00003-4
   Tirosh O, 2004, ANN NY ACAD SCI, V1019, P439, DOI 10.1196/annals.1297.080
   TKESHELASHVILI LK, 1991, J BIOL CHEM, V266, P6401
   TOMASI A, 1987, BIOCHEM J, V246, P313, DOI 10.1042/bj2460313
   Trapp C, 2007, MUTAT RES-FUND MOL M, V625, P155, DOI 10.1016/j.mrfmmm.2007.06.006
   Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Van Raamsdonk JM, 2009, PLOS GENET, V5, P0, DOI 10.1371/journal.pgen.1000361
   Van Remmen H, 2003, PHYSIOL GENOMICS, V16, P29, DOI 10.1152/physiolgenomics.00122.2003
   Van Remmen H, 2004, FREE RADICAL BIO MED, V36, P1625, DOI 10.1016/j.freeradbiomed.2004.03.016
   Van Remmen H, 2009, J GERONTOL A-BIOL, V64, P171, DOI 10.1093/gerona/gln058
   VANEYK AD, 1992, INT J BIOCHEM, V24, P1101, DOI 10.1016/0020-711X(92)90380-J
   VERMULST M, 2007, NAT GENET, V0, P0
   Wang D, 1998, MUTAT RES-FUND MOL M, V400, P99, DOI 10.1016/S0027-5107(98)00066-9
   Wei Yau-Huei, 2009, CHANG GUNG MED J, V32, P113
   Wheatcroft SB, 2007, DIABETES, V56, P285, DOI 10.2337/db06-0436
   WHEELER KT, 1974, P NATL ACAD SCI USA, V71, P1862, DOI 10.1073/pnas.71.5.1862
   WUNDERLIV, 1970, BIOCHEM J, V118, P99, DOI 10.1042/bj1180099
   Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514
   Yamashita H, 1999, J BIOL CHEM, V274, P29897, DOI 10.1074/jbc.274.42.29897
   Yang W, 2007, GENETICS, V177, P2063, DOI 10.1534/genetics.107.080788
   Zhou ZX, 2000, J HISTOCHEM CYTOCHEM, V48, P585, DOI 10.1177/002215540004800502
NR 216
TC 138
Z9 173
U1 0
U2 18
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1742-464X
EI 1742-4658
J9 FEBS J
JI FEBS J.
PD OCT 15
PY 2009
VL 276
IS 20
BP 5768
EP 5787
DI 10.1111/j.1742-4658.2009.07269.x
PG 20
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 499AE
UT WOS:000270187700007
PM 19796285
DA 2024-11-01
ER

PT J
AU Acin-Perez, R
   Salazar, E
   Brosel, S
   Yang, H
   Schon, EA
   Manfredi, G
AF Acin-Perez, Rebeca
   Salazar, Eric
   Brosel, Sonja
   Yang, Hua
   Schon, Eric A.
   Manfredi, Giovanni
TI Modulation of mitochondrial protein phosphorylation by soluble adenylyl cyclase ameliorates cytochrome oxidase defects
SO EMBO MOLECULAR MEDICINE
LA English
DT Article
DE mitochondria; sAC; cytochrome oxidase; mtDNA; ROS
ID camp-dependent phosphorylation; bovine heart-mitochondria; stop-codon mutation; c-oxidase; oxidative-phosphorylation; complex-i; subunit-i; tyrosine phosphorylation; skeletal-muscle; cultured-cells
AB Phosphorylation of respiratory chain components has emerged as a mode of regulation of mitochondrial energy metabolism, but its mechanisms are still largely unexplored. A recently discovered intramitochondrial signalling pathway links CO2 generated by the Krebs cycle with the respiratory chain, through the action of a mitochondrial soluble adenylyl cyclase (mt-sAC). Cytochrome oxidase (COX), whose deficiency causes a number of fatal metabolic disorders, is a key mitochondrial enzyme activated by mt-sAC. We have now discovered that the mt-sAC pathway modulates mitochondrial biogenesis in a reactive oxygen species dependent manner, in cultured cells and in animals with COX deficiency. We show that upregulation of mt-sAC normalizes ROS production and mitochondrial biogenesis, thereby restoring mitochondrial function. This is the first example of manipulation of a mitochondrial signalling pathway to achieve a direct positive modulation of COX, with clear implications for the development of novel approaches to treat mitochondrial diseases.
C1 [Acin-Perez, Rebeca; Manfredi, Giovanni] Cornell Univ, Weill Med Coll, Dept Neurol & Neurosci, New York, NY 10021 USA.
   [Salazar, Eric] Cornell Univ, Weill Med Coll, Triinst MD PhD Program, New York, NY 10021 USA.
   [Salazar, Eric] Cornell Univ, Weill Med Coll, Dept Pharmacol, New York, NY 10021 USA.
   [Brosel, Sonja; Yang, Hua; Schon, Eric A.] Cornell Univ, Dept Neurol, New York, NY 10021 USA.
C3 Cornell University; Weill Cornell Medicine; Cornell University; Weill Cornell Medicine; Cornell University; Weill Cornell Medicine; Cornell University
RP Manfredi, G (corresponding author), Cornell Univ, Weill Med Coll, Dept Neurol & Neurosci, New York, NY 10021 USA.
EM gim2004@mail.med.cornell.edu
FU NIH; Muscular Dystrophy Association; United Mitochondrial Disease Foundation; Milstein Foundation; MSTP; Marriot Foundation
CR Acín-Pérez R, 2003, HUM MOL GENET, V12, P329, DOI 10.1093/hmg/ddg021
   Acin-Perez R, 2009, CELL METAB, V9, P265, DOI 10.1016/j.cmet.2009.01.012
   Bender E, 2000, FEBS LETT, V466, P130, DOI 10.1016/S0014-5793(99)01773-1
   Birch-Machin MA, 2001, METHOD CELL BIOL, V65, P97, DOI 10.1016/S0091-679X(01)65006-4
   Bronner M, 2004, BIOCHEM J, V384, P295, DOI 10.1042/BJ20040955
   Bruno C, 1999, AM J HUM GENET, V65, P611, DOI 10.1086/302546
   Chen RM, 2004, J BIOL CHEM, V279, P26036, DOI 10.1074/jbc.M402710200
   Chen YQ, 2000, SCIENCE, V289, P625, DOI 10.1126/science.289.5479.625
   CHIJIWA T, 1990, J BIOL CHEM, V265, P5267
   DAurelio M, 2001, J BIOL CHEM, V276, P46925, DOI 10.1074/jbc.M106429200
   DAurelio M, 2006, HUM MOL GENET, V15, P2157, DOI 10.1093/hmg/ddl141
   De Rasmo D, 2008, CELL SIGNAL, V20, P989, DOI 10.1016/j.cellsig.2008.01.017
   Dimauro S, 2005, ANN MED, V37, P222, DOI 10.1080/07853890510007368
   Feliciello A, 2005, CELL SIGNAL, V17, P279, DOI 10.1016/j.cellsig.2004.09.009
   Fernández-Vizarra E, 2002, METHODS, V26, P292, DOI 10.1016/S1046-2023(02)00034-8
   Handschin C, 2003, P NATL ACAD SCI USA, V100, P7111, DOI 10.1073/pnas.1232352100
   HANSFORD RG, 1991, J BIOENERG BIOMEMBR, V23, P823, DOI 10.1007/BF00786004
   Hao HL, 1996, J BIOL CHEM, V271, P2347, DOI 10.1074/jbc.271.4.2347
   Helling S, 2008, MOL CELL PROTEOMICS, V7, P1714, DOI 10.1074/mcp.M800137-MCP200
   Hess KC, 2005, DEV CELL, V9, P249, DOI 10.1016/j.devcel.2005.06.007
   Hofhaus G, 1996, METHODS ENZYMOL, V264, P476, DOI 10.1016/S0076-6879(96)64043-9
   Horbinski C, 2005, FREE RADICAL BIO MED, V38, P2, DOI 10.1016/j.freeradbiomed.2004.09.030
   Irrcher I, 2009, AM J PHYSIOL-CELL PH, V296, PC116, DOI 10.1152/ajpcell.00267.2007
   Jäger S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104
   Kadenbach B, 2003, BBA-BIOENERGETICS, V1604, P77, DOI 10.1016/S0005-2728(03)00027-6
   Kadenbach B, 2009, TRENDS MOL MED, V15, P139, DOI 10.1016/j.molmed.2009.02.004
   KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477
   Kwong JQ, 2006, J NEUROCHEM, V97, P1659, DOI 10.1111/j.1471-4159.2006.03990.x
   Lee I, 2005, J BIOL CHEM, V280, P6094, DOI 10.1074/jbc.M411335200
   Lewitt MS, 2001, GROWTH HORMONE AND IGF RESEARCH, V11, P303
   LINN TC, 1969, P NATL ACAD SCI USA, V62, P234, DOI 10.1073/pnas.62.1.234
   Livigni A, 2006, MOL BIOL CELL, V17, P263, DOI 10.1091/mbc.e05-09-0827
   Lochmüller H, 1999, EXP CELL RES, V248, P186, DOI 10.1006/excr.1999.4407
   Lu G, 2007, GENE DEV, V21, P784, DOI 10.1101/gad.1499107
   Manfredi G, 2002, NAT GENET, V30, P394, DOI 10.1038/ng851
   MANFREDI G, 2002, NAT GENET, V25, P25
   Mattiazzi M, 2004, HUM MOL GENET, V13, P869, DOI 10.1093/hmg/ddh103
   Miyazaki T, 2003, J CELL BIOL, V160, P709, DOI 10.1083/jcb.200209098
   Moreno-Loshuertos R, 2006, NAT GENET, V38, P1261, DOI 10.1038/ng1897
   Pagliarini DJ, 2006, TRENDS BIOCHEM SCI, V31, P26, DOI 10.1016/j.tibs.2005.11.005
   Papa S, 1996, FEBS LETT, V379, P299, DOI 10.1016/0014-5793(95)01532-9
   Papadopoulou LC, 1999, NAT GENET, V23, P333
   Piccoli C, 2006, FEBS LETT, V580, P4539, DOI 10.1016/j.febslet.2006.06.085
   Prabu SK, 2006, J BIOL CHEM, V281, P2061, DOI 10.1074/jbc.M507741200
   Rana M, 2000, ANN NEUROL, V48, P774, DOI 10.1002/1531-8249(200011)48:5<774::AID-ANA11>3.3.CO;2-9
   Ryu H, 2005, P NATL ACAD SCI USA, V102, P13915, DOI 10.1073/pnas.0502878102
   Salviati L, 2002, BIOCHEM J, V363, P321, DOI 10.1042/0264-6021:3630321
   Samavati L, 2008, J BIOL CHEM, V283, P21134, DOI 10.1074/jbc.M801954200
   Sardanelli AM, 1995, FEBS LETT, V377, P470, DOI 10.1016/0014-5793(95)01407-1
   Scacco S, 2000, J BIOL CHEM, V275, P17578, DOI 10.1074/jbc.M001174200
   Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007
   SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A
   SCHWOCH G, 1990, BIOCHEM J, V270, P181, DOI 10.1042/bj2700181
   Shoubridge EA, 2001, AM J MED GENET, V106, P46, DOI 10.1002/ajmg.1378
   Signorile A, 2002, FEBS LETT, V512, P91, DOI 10.1016/S0014-5793(02)02226-3
   St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024
   Steenaart NAE, 1997, FEBS LETT, V415, P294, DOI 10.1016/S0014-5793(97)01145-9
   Thomson M, 2002, CELL MOL LIFE SCI, V59, P213, DOI 10.1007/s00018-002-8417-7
   Vives-Bauza C, 2006, NEUROSCI LETT, V391, P136, DOI 10.1016/j.neulet.2005.08.049
   Vives-Bauza C, 2007, METHOD CELL BIOL, V80, P155, DOI 10.1016/S0091-679X(06)80007-5
   Wenz T, 2008, CELL METAB, V8, P249, DOI 10.1016/j.cmet.2008.07.006
   Xia Y, 1997, P NATL ACAD SCI USA, V94, P11399, DOI 10.1073/pnas.94.21.11399
   Zippin JH, 2002, FASEB J, V16, P82, DOI 10.1096/fj.02-0598fje
   Zippin JH, 2001, TRENDS ENDOCRIN MET, V12, P366, DOI 10.1016/S1043-2760(01)00454-4
   Zuckerbraun BS, 2007, FASEB J, V21, P1099, DOI 10.1096/fj.06-6644com
NR 65
TC 94
Z9 108
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1757-4676
EI 1757-4684
J9 EMBO MOL MED
JI EMBO Mol. Med.
PD NOV-DEC 15
PY 2009
VL 1
IS 8-9
BP 392
EP 406
DI 10.1002/emmm.200900046
PG 15
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA 543HB
UT WOS:000273563500006
PM 20049744
DA 2024-11-01
ER

PT J
AU Holmlund, T
   Farge, G
   Pande, V
   Korhonen, J
   Nilsson, L
   Falkenberg, M
AF Holmlund, Teresa
   Farge, Geraldine
   Pande, Vineet
   Korhonen, Jenny
   Nilsson, Lennart
   Falkenberg, Maria
TI Structure-function defects of the twinkle amino-terminal region in progressive external ophthalmoplegia
SO BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
LA English
DT Article
DE DNA replication; Mitochondrion; DNA helicase; TWINKLE
ID bacteriophage t7 primase; nucleotide-binding site; dna-polymerase-gamma; helicase-primase; mutations; protein; gene; contributes; subunit; kinase
AB TWINKLE is a DNA helicase needed for mitochondrial DNA replication. In lower eukaryotes the protein also harbors a primase activity, which is lost from TWINKLE encoded by mammalian cells. Mutations in TWINKLE underlie autosomal dominant progressive external ophthalmoplegia (adPEO), a disorder associated with multiple deletions in the mtDNA. Four different adPEO-causing mutations (W315L, K319T, R334Q, and P335L) are located in the N-terminal domain of TWINKLE. The mutations cause a dramatic decrease in ATPase activity, which is partially overcome in the presence of single-stranded DNA. The mutated proteins have defects in DNA helicase activity and cannot support normal levels of DNA replication. To explain the phenotypes, we use a molecular model of TWINKLE based on sequence similarities with the phage T7 gene 4 protein. The four adPEO-causing mutations are located in a region required to bind single-stranded DNA. These mutations may therefore impair an essential element of the catalytic cycle in hexameric helicases, i.e. the interplay between single-stranded DNA binding and ATP hydrolysis. (c) 2008 Elsevier B.V. All rights reserved. IF
C1 [Falkenberg, Maria] Univ Gothenburg, Dept Med Biochem & Cell Biol, SE-40530 Gothenburg, Sweden.
   [Pande, Vineet; Nilsson, Lennart] Karolinska Inst, Dept Biosci & Nutr, SE-14157 Huddinge, Sweden.
   [Holmlund, Teresa; Farge, Geraldine; Korhonen, Jenny; Falkenberg, Maria] Karolinska Inst, Div Metab Dis, Dept Lab Med, SE-14186 Stockholm, Sweden.
C3 University of Gothenburg; Karolinska Institutet; Karolinska Institutet
RP Falkenberg, M (corresponding author), Univ Gothenburg, Dept Med Biochem & Cell Biol, Box 440, SE-40530 Gothenburg, Sweden.
EM maria.falkenberg@medkem.gu.se
FU Swedish Research Council; Swedish Cancer Society, European Commission; The Swedish Strategic Foundation; Knut and Alice Wallenberg Foundation
CR BERNSTEIN JA, 1989, J BIOL CHEM, V264, P13066
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   Cao LQ, 2007, NAT GENET, V39, P386, DOI 10.1038/ng1970
   CHANG DD, 1985, P NATL ACAD SCI USA, V82, P351, DOI 10.1073/pnas.82.2.351
   Elpeleg O, 2005, AM J HUM GENET, V76, P1081, DOI 10.1086/430843
   Falkenberg M, 1997, J BIOL CHEM, V272, P22766, DOI 10.1074/jbc.272.36.22766
   Farge G, 2008, NUCLEIC ACIDS RES, V36, P393, DOI 10.1093/nar/gkm1025
   Farge G, 2007, NUCLEIC ACIDS RES, V35, P902, DOI 10.1093/nar/gkl1116
   Frick DN, 1998, P NATL ACAD SCI USA, V95, P7957, DOI 10.1073/pnas.95.14.7957
   Gaspari M, 2004, EMBO J, V23, P4606, DOI 10.1038/sj.emboj.7600465
   GORBALENYA AE, 1993, CURR OPIN STRUC BIOL, V3, P419, DOI 10.1016/S0959-440X(05)80116-2
   Hakonen AH, 2007, BRAIN, V130, P3032, DOI 10.1093/brain/awm242
   Kato M, 2003, MOL CELL, V11, P1349, DOI 10.1016/S1097-2765(03)00195-3
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   Korhonen JA, 2003, J BIOL CHEM, V278, P48627, DOI 10.1074/jbc.M306981200
   Korhonen JA, 2008, J MOL BIOL, V377, P691, DOI 10.1016/j.jmb.2008.01.035
   Kusakabe T, 1999, P NATL ACAD SCI USA, V96, P4295, DOI 10.1073/pnas.96.8.4295
   Lee SJ, 2005, J BIOL CHEM, V280, P26984, DOI 10.1074/jbc.M504817200
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   Matsushima Y, 2007, J BIOL CHEM, V282, P9436, DOI 10.1074/jbc.M610550200
   MENDELMAN LV, 1993, J BIOL CHEM, V268, P27208
   NOTARNICOLA SM, 1995, J BIOL CHEM, V270, P20215, DOI 10.1074/jbc.270.34.20215
   Patel SS, 2000, ANNU REV BIOCHEM, V69, P651, DOI 10.1146/annurev.biochem.69.1.651
   Powers L, 1999, BIOCHEMISTRY-US, V38, P7413, DOI 10.1021/bi983059f
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Sarzi E, 2007, ANN NEUROL, V62, P579, DOI 10.1002/ana.21207
   Shutt TE, 2006, J MOL EVOL, V62, P588, DOI 10.1007/s00239-005-0162-8
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Stewart JB, 2008, PLOS BIOL, V6, P63, DOI 10.1371/journal.pbio.0060010
   Van Goethem G, 2002, ACTA NEUROL BELG, V102, P39
   Wanrooij S, 2004, NUCLEIC ACIDS RES, V32, P3053, DOI 10.1093/nar/gkh634
NR 34
TC 30
Z9 36
U1 1
U2 2
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0925-4439
EI 1879-260X
J9 BBA-MOL BASIS DIS
JI Biochim. Biophys. Acta-Mol. Basis Dis.
PD FEB 15
PY 2009
VL 1792
IS 2
BP 132
EP 139
DI 10.1016/j.bbadis.2008.11.009
PG 8
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 408JH
UT WOS:000263430800006
PM 19084593
DA 2024-11-01
ER

PT J
AU Jeppesen, TD
   Orngreen, MC
   van Hall, G
   Haller, RG
   Vissing, J
AF Jeppesen, Tina Dysgaard
   Orngreen, Mette Cathrine
   van Hall, Gerrit
   Haller, Ronald G.
   Vissing, John
TI Fat Metabolism During Exercise in Patients With Mitochondrial Disease
SO ARCHIVES OF NEUROLOGY
LA English
DT Article
ID fuel utilization; mcardle-disease; mutation load; glucose; tolerance; myopathy; carbohydrate; deficiency; capacity; kinetics
AB Objective: To determine whether patients with defects of the respiratory chain have metabolic adaptations that promote a preferential use of fats or carbohydrates, similar to what is observed in metabolic myopathies affecting glycolysis or fat oxidation. Design: Causation and case-control study. Fat metabolism was determined by means of indirect calorimetry and stable isotope technique in patients and healthy subjects. Patients carried various types and loads (mean [SE], 72% [5%]) of mitochondrial DNA (mtDNA) mutations in skeletal muscle. All subjects exercised at the same absolute workload (mean [SE], 65 [10] W), corresponding to 72% (in patients) and 30% (in healthy subjects) of maximum oxygen consumption. Setting: Neuromuscular research unit. Participants: Ten patients with mtDNA mutations and 10 sex-matched healthy subjects. Main Outcome Measures: Fat turnover, plasma concentrations of palmitate and total free fatty acids, glucose mobilization, and total carbohydrate oxidation. Results: Fat turnover and plasma concentrations of palmitate and total free fatty acids were similar in patients and healthy subjects at rest and during exercise. In line with the higher relative workload of the patients, glucose mobilization and total carbohydrate oxidation were higher in the patients compared with the healthy subjects. Conclusion: During moderate-intensity exercise, the balance between fat and carbohydrate use in patients with mtDNA mutations matches that seen in healthy subjects, indicating that manipulating dietary fat and carbohydrate content is not a feasible therapeutic option to improve exercise intolerance in these disorders.
C1 [Jeppesen, Tina Dysgaard; Orngreen, Mette Cathrine; van Hall, Gerrit; Vissing, John] Univ Copenhagen, Rigshosp, Dept Neurol, Neuromuscular Res Unit, DK-2100 Copenhagen, Denmark.
   [Jeppesen, Tina Dysgaard; Orngreen, Mette Cathrine; van Hall, Gerrit; Vissing, John] Univ Copenhagen, Rigshosp, Copenhagen Muscle Res Ctr, DK-2100 Copenhagen, Denmark.
   [Haller, Ronald G.] Univ Copenhagen, Rigshosp, Dept Biomed Sci, DK-2100 Copenhagen, Denmark.
   [Haller, Ronald G.] Neuromuscular Ctr, Inst Exercise & Environm Med, Dallas, TX USA.
C3 University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet
RP Jeppesen, TD (corresponding author), Univ Copenhagen, Rigshosp, Neuromuscular Res Unit 3342, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.
EM Dysgaard@yahoo.dk
FU Copenhagen Hospital Community Foundation; Faculty of Healthy Sciences; Novo Nordic Foundation; Danish Medical Research Council; Elsass Foundation
CR ABUMRAD NN, 1981, METABOLISM, V30, P936, DOI 10.1016/0026-0495(81)90074-3
   Andersen ST, 2008, J NEUROL NEUROSUR PS, V79, P1359, DOI 10.1136/adc.2008.146548
   Anitori R, 2005, MOL GENET METAB, V84, P176, DOI 10.1016/j.ymgme.2004.10.003
   Becker R, 2002, EXP CLIN ENDOCR DIAB, V110, P291, DOI 10.1055/s-2002-34592
   BERIO A, 1994, OPHTHALMOLOGICA, V208, P342, DOI 10.1159/000310536
   BERNSEN PLJA, 1993, J NEUROL SCI, V118, P181, DOI 10.1016/0022-510X(93)90108-B
   BORG G, 1970, SCANDINAVIAN JOURNAL OF REHABILITATION MEDICINE, V2, P92
   Chen RS, 1997, EUR NEUROL, V37, P212, DOI 10.1159/000117445
   Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713
   de Meer K, 2005, J INHERIT METAB DIS, V28, P95, DOI 10.1007/s10545-005-1485-8
   Frederiksen AL, 2006, J MED GENET, V43, P0, DOI 10.1136/jmg.2005.039339
   GALBO H, 1995, ENDOCRINOLOGY, V0, P0
   Haller RG, 2002, ARCH NEUROL-CHICAGO, V59, P1395, DOI 10.1001/archneur.59.9.1395
   Haller RG, 2004, MYOLOGY, V0, P665
   Hepple RT, 1999, CLIN SCI, V97, P569, DOI 10.1042/CS19980343
   Jeppesen TD, 2003, ANN NEUROL, V54, P86, DOI 10.1002/ana.10594
   Jeppesen TD, 2006, ARCH NEUROL-CHICAGO, V63, P1701, DOI 10.1001/archneur.63.12.1701
   LEWIS SF, 1986, J APPL PHYSIOL, V61, P391, DOI 10.1152/jappl.1986.61.2.391
   Nielsen JN, 2002, J PHYSIOL-LONDON, V541, P979, DOI 10.1113/jphysiol.2002.018044
   Orngreen MC, 2007, NEUROLOGY, V69, P313, DOI 10.1212/01.wnl.0000265854.41013.84
   Orngreen MC, 2004, ANN NEUROL, V56, P279, DOI 10.1002/ana.20168
   Orngreen MC, 2003, NEUROLOGY, V61, P559, DOI 10.1212/01.WNL.0000078195.05396.20
   Orngreen MC, 2002, NEUROLOGY, V59, P1046, DOI 10.1212/WNL.59.7.1046
   PERONNET F, 1991, CAN J SPORT SCI, V16, P23
   Robertshaw HA, 2008, MUSCLE NERVE, V37, P431, DOI 10.1002/mus.20947
   Roef MJ, 2002, AM J CLIN NUTR, V75, P237, DOI 10.1093/ajcn/75.2.237
   Schwartz M, 2002, NEW ENGL J MED, V347, P576, DOI 10.1056/NEJMoa020350
   STEELE R, 1959, ANN NY ACAD SCI, V82, P420, DOI 10.1111/j.1749-6632.1959.tb44923.x
   Taivassalo T, 1996, NEUROLOGY, V47, P529, DOI 10.1212/WNL.47.2.529
   Taivassalo T, 2003, BRAIN, V126, P413, DOI 10.1093/brain/awg028
   Tanaka J, 1997, BRAIN DEV-JPN, V19, P262, DOI 10.1016/S0387-7604(97)00573-1
   van Hall G, 2002, J PHYSIOL-LONDON, V543, P1033, DOI 10.1113/jphysiol.2002.022392
   van Hall G, 1999, P NUTR SOC, V58, P979, DOI 10.1017/S0029665199001299
   van Loon LJC, 2003, EUR J APPL PHYSIOL, V89, P377, DOI 10.1007/s00421-003-0810-x
   van Loon LJC, 2001, J PHYSIOL-LONDON, V536, P295, DOI 10.1111/j.1469-7793.2001.00295.x
   Vissing J, 1998, J CLIN INVEST, V101, P1654, DOI 10.1172/JCI555
   Vissing J, 2003, NEW ENGL J MED, V349, P2503, DOI 10.1056/NEJMoa031836
   Vissing J, 2001, ANN NEUROL, V49, P672, DOI 10.1002/ana.1026
   Wolfe RR, 1992, RADIOACTIVE STABLE I, V0, P0
NR 39
TC 16
Z9 16
U1 0
U2 1
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 0003-9942
EI 1538-3687
J9 ARCH NEUROL-CHICAGO
JI Arch. Neurol.
PD MAR 15
PY 2009
VL 66
IS 3
BP 365
EP 370
DI 10.1001/archneurol.2009.24
PG 6
WC Clinical Neurology
SC Neurosciences & Neurology
GA 416EY
UT WOS:000263989600012
PM 19273755
DA 2024-11-01
ER

PT J
AU Kasiviswanathan, R
   Longley, MJ
   Chan, SSL
   Copeland, WC
AF Kasiviswanathan, Rajesh
   Longley, Matthew J.
   Chan, Sherine S. L.
   Copeland, William C.
TI Disease Mutations in the Human Mitochondrial DNA Polymerase Thumb Subdomain Impart Severe Defects in Mitochondrial DNA Replication
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID progressive external ophthalmoplegia; type-1 reverse-transcriptase; p55 accessory subunit; i klenow fragment; alpers-syndrome; polg mutations; frameshift fidelity; angstrom resolution; autosomal-dominant; nucleoside analogs
AB Forty-five different point mutations in POLG, the gene encoding the catalytic subunit of the human mitochondrial DNA polymerase (pol gamma), cause the early onset mitochondrial DNA depletion disorder, Alpers syndrome. Sequence analysis of the C-terminal polymerase region of pol gamma revealed a cluster of four Alpers mutations at highly conserved residues in the thumb subdomain (G848S, c.2542g -> a; T851A, c.2551a -> g; R852C, c.2554c -> t; R853Q, c.2558g -> a) and two Alpers mutations at less conserved positions in the adjacent palm subdomain (Q879H, c.2637g -> t and T885S, c.2653a -> t). Biochemical characterization of purified, recombinant forms of pol gamma revealed that Alpers mutations in the thumb subdomain reduced polymerase activity more than 99% relative to the wild-type enzyme, whereas the palm subdomain mutations retained 50-70% wildtype polymerase activity. All six mutant enzymes retained physical and functional interaction with the pol gamma accessory subunit (p55), and none of the six mutants exhibited defects in misinsertion fidelity in vitro. However, differential DNA binding by these mutants suggests a possible orientation of the DNA with respect to the polymerase during catalysis. To our knowledge this study represents the first structure-function analysis of the thumb subdomain in pol gamma and examines the consequences of mitochondrial disease mutations in this region.
C1 [Kasiviswanathan, Rajesh; Longley, Matthew J.; Chan, Sherine S. L.; Copeland, William C.] NIEHS, Mol Genet Lab, NIH, Res Triangle Pk, NC 27709 USA.
C3 National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)
RP Copeland, WC (corresponding author), NIEHS, Mol Genet Lab, NIH, 111 TW Alexander Dr,Bldg 101,Rm E316, Res Triangle Pk, NC 27709 USA.
EM copelan1@niehs.nih.gov
FU National Institutes of Health Grant [ES 065078]
CR Alpers BJ, 1931, ARCH NEURO PSYCHIATR, V25, P469, DOI 10.1001/archneurpsyc.1931.02230030027002
   Ashley N, 2008, HUM MOL GENET, V17, P2496, DOI 10.1093/hmg/ddn150
   Baruffini E, 2007, BBA-MOL BASIS DIS, V1772, P1225, DOI 10.1016/j.bbadis.2007.10.002
   BEARD WA, 1994, J BIOL CHEM, V269, P28091
   BEBENEK K, 1995, J BIOL CHEM, V270, P19516, DOI 10.1074/jbc.270.33.19516
   BEESE LS, 1993, SCIENCE, V260, P352, DOI 10.1126/science.8469987
   Chan SSL, 2006, HUM MOL GENET, V15, P3473, DOI 10.1093/hmg/ddl424
   Chan SSL, 2009, BBA-BIOENERGETICS, V1787, P312, DOI 10.1016/j.bbabio.2008.10.007
   Chan SSL, 2005, DNA REPAIR, V4, P1381, DOI 10.1016/j.dnarep.2005.08.010
   Chan SSL, 2005, J BIOL CHEM, V280, P31341, DOI 10.1074/jbc.M506762200
   Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646
   Davidzon G, 2006, ANN NEUROL, V59, P859, DOI 10.1002/ana.20831
   Davidzon G, 2005, ANN NEUROL, V57, P921, DOI 10.1002/ana.20498
   de Vries MC, 2007, EUR J PEDIATR, V166, P229, DOI 10.1007/s00431-006-0234-9
   Deschauer M, 2007, NEUROLOGY, V68, P1741, DOI 10.1212/01.wnl.0000261929.92478.3e
   Dimauro S, 2005, ANN MED, V37, P222, DOI 10.1080/07853890510007368
   Doublié S, 1998, NATURE, V391, P251, DOI 10.1038/34593
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   González-Vioque E, 2006, ARCH NEUROL-CHICAGO, V63, P107, DOI 10.1001/archneur.63.1.107
   Graziewicz MA, 2004, NAT STRUCT MOL BIOL, V11, P770, DOI 10.1038/nsmb805
   Graziewicz MA, 2006, CHEM REV, V106, P383, DOI 10.1021/cr040463d
   HARDING BN, 1995, J NEUROL NEUROSUR PS, V58, P320, DOI 10.1136/jnnp.58.3.320
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Hudson G, 2006, HUM MOL GENET, V15, PR244, DOI 10.1093/hmg/ddl233
   JACOBOMOLINA A, 1993, P NATL ACAD SCI USA, V90, P6320, DOI 10.1073/pnas.90.13.6320
   Johnson AA, 2000, BIOCHEMISTRY-US, V39, P1702, DOI 10.1021/bi992104w
   Johnson AA, 2001, J BIOL CHEM, V276, P40847, DOI 10.1074/jbc.M106743200
   Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455
   Kollberg G, 2005, EUR J HUM GENET, V13, P463, DOI 10.1038/sj.ejhg.5201341
   Kollberg G, 2006, J NEUROPATH EXP NEUR, V65, P758, DOI 10.1097/01.jnen.0000229987.17548.6e
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   Lim SE, 2003, J MOL BIOL, V329, P45, DOI 10.1016/S0022-2836(03)00405-4
   Lim SE, 2001, J BIOL CHEM, V276, P23616, DOI 10.1074/jbc.M101114200
   Lim SE, 1999, J BIOL CHEM, V274, P38197, DOI 10.1074/jbc.274.53.38197
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   Longley MJ, 1998, BIOCHEMISTRY-US, V37, P10529, DOI 10.1021/bi980772w
   Longley MJ, 2001, J BIOL CHEM, V276, P38555, DOI 10.1074/jbc.M105230200
   Luoma PT, 2005, HUM MOL GENET, V14, P1907, DOI 10.1093/hmg/ddi196
   McFarland R, 2008, ARCH DIS CHILD, V93, P151, DOI 10.1136/adc.2007.122911
   Minnick DT, 1996, J BIOL CHEM, V271, P24954, DOI 10.1074/jbc.271.40.24954
   Minnick DT, 1999, J BIOL CHEM, V274, P3067, DOI 10.1074/jbc.274.5.3067
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Naviaux RK, 1999, ANN NEUROL, V45, P54, DOI 10.1002/1531-8249(199901)45:1<54::AID-ART10>3.0.CO;2-B
   Nguyen KV, 2006, J HEPATOL, V45, P108, DOI 10.1016/j.jhep.2005.12.026
   Nguyen KV, 2005, NEUROLOGY, V65, P1493, DOI 10.1212/01.wnl.0000182814.55361.70
   OLLIS DL, 1985, NATURE, V313, P762, DOI 10.1038/313762a0
   OLLIS DL, 1985, NATURE, V313, P818, DOI 10.1038/313818a0
   REARDON JE, 1990, J BIOL CHEM, V265, P20302
   Ropp PA, 1996, GENOMICS, V36, P449, DOI 10.1006/geno.1996.0490
   Stewart JD, 2009, J MED GENET, V46, P209, DOI 10.1136/jmg.2008.058180
   Taanman JW, 2009, HUM MUTAT, V30, P248, DOI 10.1002/humu.20852
   Wiltshire E, 2008, ARCH NEUROL-CHICAGO, V65, P121, DOI 10.1001/archneurol.2007.14
   Wong LJC, 2008, HUM MUTAT, V29, PE150, DOI 10.1002/humu.20824
   Yakubovskaya E, 2006, J BIOL CHEM, V281, P374, DOI 10.1074/jbc.M509730200
NR 54
TC 42
Z9 45
U1 0
U2 5
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
SN 
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD JUL 17
PY 2009
VL 284
IS 29
BP 19501
EP 19510
DI 10.1074/jbc.M109.011940
PG 10
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 469OE
UT WOS:000267908300042
PM 19478085
DA 2024-11-01
ER

PT J
AU Yajima, N
   Yazaki, Y
   Yoshida, K
   Sano, K
   Takahashi, W
   Sasaki, Y
   Ikeda, U
AF Yajima, Noriyuki
   Yazaki, Yoshikazu
   Yoshida, Kunihiro
   Sano, Kenji
   Takahashi, Wataru
   Sasaki, Yasuyuki
   Ikeda, Uichi
TI A case of mitochondrial cardiomyopathy with pericardial effusion evaluated by <SUP>99m</SUP>Tc-MIBI myocardial scintigraphy
SO JOURNAL OF NUCLEAR CARDIOLOGY
LA English
DT Article
DE Mitochondrial cardiomyopathy; pericardial effusion; heart failure; myocardial scintigraphy; Tc-99m-MIBI
ID heart-failure; dysfunction; involvement; disease; dna
AB Heart failure is important in determining the prognosis of cardiomyopathy caused by mitochondrial gene abnormalities. We report herein the case of a patient with pericardial effusion and heart failure in whom mitochondrial cardiomyopathy was definitively diagnosed. A 56-year-old woman consulted her primary physician with exertional dyspnea. Examination revealed edema and pericardial effusion, and diuretics were prescribed. However, after marked left ventricular hypertrophy (LVH) was noted, she was admitted to our hospital for further evaluation. Further examination revealed short stature, ptosis, generalized muscle atrophy, and sensorineural hearing loss. Echocardiography showed LVH, a global decrease in wall motion, and pericardial effusion. Physical and laboratory findings, including glucose intolerance and elevated serum lactate, suggested mitochondrial cardiomyopathy. Genetic testing confirmed cardiomyopathy due to a mitochondrial a3243g mutation. After treatment to improve heart failure, marked washout was shown on Tc-99m-MIBI (methoxyisobutylisonitrile) myocardial scintigraphy, suggesting a correlation with mitochondrial dysfunction.
C1 [Yajima, Noriyuki; Takahashi, Wataru; Sasaki, Yasuyuki] Nagano Natl Hosp, Div Cardiol, Ueda, Nagano 3868610, Japan.
   [Yazaki, Yoshikazu; Ikeda, Uichi] Shinshu Univ, Sch Med, Dept Cardiovasc Med, Matsumoto, Nagano 390, Japan.
   [Yoshida, Kunihiro] Shinshu Univ, Sch Med, Div Clin Genet, Matsumoto, Nagano 390, Japan.
   [Sano, Kenji] Shinshu Univ, Sch Med, Dept Lab Med, Matsumoto, Nagano 390, Japan.
C3 Shinshu University; Shinshu University; Shinshu University
RP Yajima, N (corresponding author), Nagano Natl Hosp, Div Cardiol, 1-27-21 Midorigaoka, Ueda, Nagano 3868610, Japan.
EM n.yajima@nagano-hosp.go.jp
CR ANAN R, 1995, CIRCULATION, V91, P955, DOI 10.1161/01.CIR.91.4.955
   Higashikata T, 2001, INTERNAL MED, V40, P405, DOI 10.2169/internalmedicine.40.405
   Ikawa M, 2007, MITOCHONDRION, V7, P164, DOI 10.1016/j.mito.2006.11.008
   Matsuo S, 2007, J NUCL CARDIOL, V14, P215, DOI 10.1016/j.nuclcard.2006.10.022
   Matsuo Shinro, 2008, EXP CLIN CARDIOL, V13, P93
   Matsuoka Rumiko, 2002, NIHON RINSHO, V60 Suppl 4, P662
   Momiyama Y, 1999, JPN CIRC J, V63, P130, DOI 10.1253/jcj.63.130
   Nardin RA, 2001, MUSCLE NERVE, V24, P170, DOI 10.1002/1097-4598(200102)24:2<170::AID-MUS30>3.0.CO;2-0
   OBAYASHI T, 1992, AM HEART J, V124, P1263, DOI 10.1016/0002-8703(92)90410-W
   OKADA RD, 1988, CIRCULATION, V77, P491, DOI 10.1161/01.CIR.77.2.491
   Okajima Y, 1998, HEART, V80, P292, DOI 10.1136/hrt.80.3.292
   Richardson P, 1996, CIRCULATION, V93, P841, DOI 10.1161/01.CIR.93.5.841
   Russell LK, 2005, J MOL CELL CARDIOL, V38, P81, DOI 10.1016/j.yjmcc.2004.10.010
   Sugiura T, 2006, J NUCL CARDIOL, V13, P64, DOI 10.1016/j.nuclcard.2005.10.003
   Suzuki Yoshihiko, 1995, JOURNAL OF THE JAPAN DIABETES SOCIETY, V38, P39
   TAIRA K, 2003, RESP CIRC, V51, P419
NR 16
TC 5
Z9 6
U1 0
U2 0
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1071-3581
EI 
J9 J NUCL CARDIOL
JI J. Nucl. Cardiol.
PD DEC 15
PY 2009
VL 16
IS 6
BP 989
EP 994
DI 10.1007/s12350-009-9149-y
PG 6
WC Cardiac & Cardiovascular Systems; Radiology, Nuclear Medicine & Medical Imaging
SC Cardiovascular System & Cardiology; Radiology, Nuclear Medicine & Medical Imaging
GA 518ZR
UT WOS:000271735300021
PM 19777318
DA 2024-11-01
ER

PT J
AU Sotiriou, E
   Çoku, J
   Tanji, K
   Huang, HB
   Hirano, M
   DiMauro, S
AF Sotiriou, Evangelia
   Coku, Jorida
   Tanji, Kurenai
   Huang, Hua-bin
   Hirano, Michio
   DiMauro, Salvatore
TI The m.3244G&gt;A mutation in mtDNA is another cause of progressive external ophthalmoplegia
SO NEUROMUSCULAR DISORDERS
LA English
DT Article
DE mtDNA; CPEO; tRNA(Leu(UUR)); Mutation
ID mitochondrial-dna mutations; features; encephalomyopathy; disease; cells; merrf
AB We sequenced all mitochondrial tRNA genes in a 61-year-old man with chronic progressive external ophthalmoplegia and mitochondrial myopathy but Without mtDNA rearrangements, and identified a heteroplasmic m.3244G>A mutation in the tRNA(Leu(UUR)) gene. This mutation had been previously associated with the MELAS phenotype, but not described ill any detail. The Mutation load in muscle was 84% and COX-negative fibers harbored greater levels of mutant genomes than COX-positive fibers. The m.3244G>A Mutation affects a highly conserved nucleotide in the dihydrouridine loop and has been associated with a wobble modification deficiency of the mutant tRNA. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Sotiriou, Evangelia; Coku, Jorida; Tanji, Kurenai; Huang, Hua-bin; Hirano, Michio; DiMauro, Salvatore] Columbia Univ, Med Ctr, Dept Neurol, New York, NY 10032 USA.
   [Tanji, Kurenai] Columbia Univ, Med Ctr, Dept Pathol, New York, NY 10032 USA.
C3 Columbia University; Columbia University
RP DiMauro, S (corresponding author), Columbia Univ, Med Ctr, Dept Neurol, New York, NY 10032 USA.
EM sd12@columbia.edu
FU NIH [HD32062]; Marriott Mitochondrial Disorders Clinical Research Fund (MMDCRF)
CR Carew JS, 2003, LEUKEMIA, V17, P1437, DOI 10.1038/sj.leu.2403043
   Dimauro S, 2005, ANN MED, V37, P222, DOI 10.1080/07853890510007368
   Hutchison WM, 2005, ARCH NEUROL-CHICAGO, V62, P1920, DOI 10.1001/archneur.62.12.1920
   Kirino Y, 2005, P NATL ACAD SCI USA, V102, P7127, DOI 10.1073/pnas.0500563102
   MORAES CT, 1993, NEUROMUSCULAR DISORD, V3, P43, DOI 10.1016/0960-8966(93)90040-Q
   Nishigaki Y, 2003, NEUROMUSCULAR DISORD, V13, P334, DOI 10.1016/S0960-8966(02)00283-3
   Pulkes T, 2001, ADV DRUG DELIVER REV, V49, P27, DOI 10.1016/S0169-409X(01)00124-7
   Schon EA, 1997, J BIOENERG BIOMEMBR, V29, P131, DOI 10.1023/A:1022685929755
   Yao YG, 2007, BLOOD, V109, P756, DOI 10.1182/blood-2006-01-011007
   Yasukawa T, 2000, FEBS LETT, V467, P175, DOI 10.1016/S0014-5793(00)01145-5
NR 10
TC 7
Z9 7
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8966
EI 1873-2364
J9 NEUROMUSCULAR DISORD
JI Neuromusc. Disord.
PD APR 15
PY 2009
VL 19
IS 4
BP 297
EP 299
DI 10.1016/j.nmd.2009.01.014
PG 3
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 442VK
UT WOS:000265868500011
PM 19285865
DA 2024-11-01
ER

PT J
AU Lönnqvist, T
   Paetau, A
   Valanne, L
   Pihko, H
AF Lonnqvist, Tuula
   Paetau, Anders
   Valanne, Leena
   Pihko, Helena
TI Recessive twinkle mutations cause severe epileptic encephalopathy
SO BRAIN
LA English
DT Article
DE Twinkle; IOSCA; epileptic encephalopathy
ID onset spinocerebellar ataxia; stroke-like episodes; mitochondrial disorders; sensory neuropathy; mtdna depletion; melas; gene; pathophysiology; spectrum; features
AB The C10orf2 gene encodes the mitochondrial DNA helicase Twinkle, which is one of the proteins important for mitochondrial DNA maintenance. Dominant mutations cause multiple mitochondrial DNA deletions and progressive external ophthalmoplegia, but recent findings associate recessive mutations with mitochondrial DNA depletion and encephalopathy or hepatoencephalopathy. The latter clinical phenotypes resemble those associated with recessive POLG1 mutations. We have previously described patients with infantile onset spinocerebellar ataxia (MIM271245) caused either by homozygous (Y508C) or compound heterozygous (Y508C and A318T) Twinkle mutations. Our earlier reports focused on the spinocerebellar degeneration, but the 20-year follow-up of 23 patients has shown that refractory status epilepticus, migraine-like headaches and severe psychiatric symptoms are also pathognomonic for the disease. All adolescent patients have experienced phases of severe migraine, and seven patients had antipsychotic medication. Epilepsia partialis continua occurred in 15 patients leading to generalized epileptic statuses in 13 of them. Eight of these patients have died. Valproate treatment was initiated on two patients, but had to be discontinued because of a severe elevation of liver enzymes. The patients recovered, and we have not used valproate in infantile onset spinocerebellar ataxia since. The first status epilepticus manifested between 15 and 34 years of age in the homozygotes, and at 2 and 4 years in the compound heterozygotes. The epileptic statuses lasted from several days to weeks. Focal, stroke-like lesions were seen in magnetic resonance imaging, but in infantile onset spinocerebellar ataxia these lesions showed no predilection. They varied from resolving small cortical to large hemispheric oedematous lesions, which reached from cerebral cortex to basal ganglia and thalamus and caused permanent necrotic damage and brain atrophy. Brain atrophy with focal laminar cortical necrosis and hippocampal damage was confirmed on neuropathological examination. The objective of our study was to describe the development and progression of encephalopathy in infantile onset spinocerebellar ataxia syndrome, and compare the pathognomonic features with those in other mitochondrial encephalopathies.
C1 [Lonnqvist, Tuula; Pihko, Helena] Univ Helsinki, Cent Hosp, Div Child Neurol, Helsinki 00029, Finland.
   [Paetau, Anders] Univ Helsinki, Dept Pathol, Helsinki 00029, Finland.
   [Paetau, Anders] HUSLAB, Helsinki, Finland.
   [Valanne, Leena] Univ Helsinki, Helsinki Med Imaging Ctr, Helsinki 00029, Finland.
C3 University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki
RP Lönnqvist, T (corresponding author), Univ Helsinki, Cent Hosp, Div Child Neurol, POB 280, Helsinki 00029, Finland.
EM tuula.lonnqvist@hus.fi
FU Helsinki University Central Hospital EVO; Finnish Foundation for Pediatric Research
CR Bartynski WS, 2008, AM J NEURORADIOL, V29, P1043, DOI 10.3174/ajnr.A0929
   Canafoglia L, 2001, NEUROLOGY, V56, P1340, DOI 10.1212/WNL.56.10.1340
   Deschauer M, 2007, NEUROLOGY, V68, P1741, DOI 10.1212/01.wnl.0000261929.92478.3e
   Engelsen BA, 2008, BRAIN, V131, P818, DOI 10.1093/brain/awn007
   Fattal O, 2007, CNS SPECTRUMS, V12, P429, DOI 10.1017/S1092852900015303
   Feddersen B, 2003, NEUROLOGY, V61, P1149, DOI 10.1212/01.WNL.0000092497.53706.1B
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   Finsterer J, 2006, ACTA NEUROL SCAND, V114, P217, DOI 10.1111/j.1600-0404.2006.00671.x
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   Hakonen AH, 2008, HUM MOL GENET, V17, P3822, DOI 10.1093/hmg/ddn280
   Hakonen AH, 2007, BRAIN, V130, P3032, DOI 10.1093/brain/awm242
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Iizuka T, 2005, CURR NEUROVASC RES, V2, P29, DOI 10.2174/1567202052773544
   Iizuka T, 2003, NEUROLOGY, V61, P1238, DOI 10.1212/01.WNL.0000091888.26232.FE
   Iizuka T, 2002, NEUROLOGY, V59, P816, DOI 10.1212/WNL.59.6.816
   Knott AB, 2008, NAT REV NEUROSCI, V9, P505, DOI 10.1038/nrn2417
   KOSKINEN T, 1994, J NEUROL SCI, V121, P50, DOI 10.1016/0022-510X(94)90156-2
   KOSKINEN T, 1995, NEUROPEDIATRICS, V26, P263, DOI 10.1055/s-2007-979769
   KOSKINEN T, 1994, MUSCLE NERVE, V17, P509, DOI 10.1002/mus.880170507
   KOSKINEN T, 1995, AM J NEURORADIOL, V16, P1427
   Kovács R, 2002, J NEUROPHYSIOL, V88, P2909, DOI 10.1152/jn.00149.2002
   Kunz WS, 2002, CURR OPIN NEUROL, V15, P179, DOI 10.1097/00019052-200204000-00009
   Liang LP, 2006, FREE RADICAL BIO MED, V40, P316, DOI 10.1016/j.freeradbiomed.2005.08.026
   Lönnqvist T, 1998, J NEUROL SCI, V161, P57, DOI 10.1016/S0022-510X(98)00249-4
   Michelson DJ, 2004, MITOCHONDRION, V4, P665, DOI 10.1016/j.mito.2004.07.019
   Nguyen KV, 2005, NEUROLOGY, V65, P1493, DOI 10.1212/01.wnl.0000182814.55361.70
   Nikali K, 2005, HUM MOL GENET, V14, P2981, DOI 10.1093/hmg/ddi328
   Pandolfo M, 2008, ARCH NEUROL-CHICAGO, V65, P1296, DOI 10.1001/archneur.65.10.1296
   Sarzi E, 2007, ANN NEUROL, V62, P579, DOI 10.1002/ana.21207
   Tzoulis C, 2006, BRAIN, V129, P1685, DOI 10.1093/brain/awl097
   Van Goethem G, 2003, NEUROLOGY, V61, P1811, DOI 10.1212/01.WNL.0000098997.23471.65
NR 31
TC 80
Z9 84
U1 0
U2 6
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0006-8950
EI 
J9 BRAIN
JI Brain
PD JUN 15
PY 2009
VL 132
IS 
BP 1553
EP 1562
DI 10.1093/brain/awp045
PG 10
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 451VG
UT WOS:000266498400022
PM 19304794
DA 2024-11-01
ER

PT J
AU Machado, P
   Miller, A
   Holton, J
   Hanna, M
AF Machado, Pedro
   Miller, Adrian
   Holton, Janice
   Hanna, Michael
TI SPORADIC INCLUSION BODY MYOSITIS: AN UNSOLVED MYSTERY
SO ACTA REUMATOLOGICA PORTUGUESA
LA English
DT Review
DE Inclusion Body Myositis; Myositis; Myopathy; Inflammation; Degeneration
ID idiopathic inflammatory myopathy; precursor protein gene; major histocompatibility complex; mitochondrial-dna deletions; heat-shock proteins; acetylglucosamine 2-epimerase/n-acetylmannosamine kinase; monoclonal-antibody analysis; autosomal-dominant myopathy; paired-helical filaments; randomized pilot trial
AB Sporadic inclusion body myositis (sIBM) is considered to be the most common acquired muscle disease associated with aging. It is a disabling disorder still without effective treatment. sIBM causes weakness and atrophy of the distal and proximal muscles. Involvement of quadriceps and deep finger flexors are clues to early diagnosis. Dysphagia in the course of the disease is common. Muscle biopsy shows chronic myopathic features, lymphocytic infiltration invading non-necrotic fibbers, rimmed vacuoles and accumulation of amyloid-related proteins. It remains uncertain whether sIBM is primarily an immune-mediated inflammatory myopathy or a degenerative myopathy with an associated inflammatory component. This review describes the epidemiology and clinical features of the disease as well as the current genetic and pathogenic concepts and therapeutic approaches. Despite recent clues, in many respects sIBM remains an unsolved mystery.
C1 [Machado, Pedro] Coimbra Univ Hosp, Dept Rheumatol, Coimbra, Portugal.
   [Machado, Pedro; Miller, Adrian; Holton, Janice; Hanna, Michael] Natl Hosp Neurol & Neurosurg, UCL Inst Neurol, MRC Ctr Neuromuscular Dis, London WC1N 3BG, England.
C3 Universidade de Coimbra; Centro Hospitalar e Universitario de Coimbra (CHUC); University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust
RP Machado, P (corresponding author), Hosp Univ Coimbra, Serv Reumatol, P-3000075 Coimbra, Portugal.
EM pedrommcmachado@gmail.com
FU EULAR; MRC [G0601943] Funding Source: UKRI
CR ADAMS EM, 1995, RADIOGRAPHICS, V15, P563, DOI 10.1148/radiographics.15.3.7624563
   ADAMS RD, 1965, TRANS AMER NEUROL ASS, V90, P213
   Alexanderson H, 2005, CURR OPIN RHEUMATOL, V17, P164, DOI 10.1097/01.bor.0000152665.41493.49
   Alexanderson H, 1999, RHEUMATOLOGY, V38, P608, DOI 10.1093/rheumatology/38.7.608
   Amato AA, 1996, ANN NEUROL, V40, P581, DOI 10.1002/ana.410400407
   Amato AA, 1998, NEUROLOGY, V51, P598, DOI 10.1212/WNL.51.2.598
   Amato AA, 1998, NEUROLOGY, V51, P1646, DOI 10.1212/WNL.51.6.1646
   AMATO AA, 1994, NEUROLOGY, V44, P1516, DOI 10.1212/WNL.44.8.1516
   ARAHATA K, 1984, ANN NEUROL, V16, P193, DOI 10.1002/ana.410160206
   Argov Z, 2003, NEUROLOGY, V60, P1519, DOI 10.1212/01.WNL.0000061617.71839.42
   Argov Z, 1998, MUSCLE NERVE, V21, P1523, DOI 10.1002/(SICI)1097-4598(199811)21:11<1523::AID-MUS22>3.0.CO;2-#
   ARGOV Z, 1984, J NEUROL SCI, V64, P33, DOI 10.1016/0022-510X(84)90053-4
   Arnardottir S, 2003, J REHABIL MED, V35, P31, DOI 10.1080/16501970306110
   Askanas V, 2006, NEUROLOGY, V66, PS39, DOI 10.1212/01.wnl.0000192128.13875.1e
   Askanas V, 2005, MICROSC RES TECHNIQ, V67, P114, DOI 10.1002/jemt.20186
   Askanas V, 2003, CURR OPIN RHEUMATOL, V15, P737, DOI 10.1097/00002281-200311000-00009
   Askanas V, 2002, CURR OPIN NEUROL, V15, P525, DOI 10.1097/00019052-200210000-00002
   Askanas V, 1996, ANN NEUROL, V39, P389, DOI 10.1002/ana.410390318
   Askanas V, 1996, P NATL ACAD SCI USA, V93, P1314, DOI 10.1073/pnas.93.3.1314
   ASKANAS V, 1992, NEUROLOGY, V42, P460, DOI 10.1212/WNL.42.2.460
   Askanas V, 2001, J NEUROPATH EXP NEUR, V60, P1
   ASKANAS V, 1994, AM J PATHOL, V144, P177
   ASKANAS V, 1996, NEUROLOGY, V46, P487
   Askanas Valerie, 1993, CURRENT OPINION IN RHEUMATOLOGY, V5, P732
   Badrising UA, 2000, NEUROLOGY, V55, P1385, DOI 10.1212/WNL.55.9.1385
   Badrising UA, 2005, J NEUROL, V252, P1448, DOI 10.1007/s00415-005-0884-y
   Badrising UA, 2004, NEUROLOGY, V63, P2396, DOI 10.1212/01.WNL.0000148588.15052.4C
   Badrising UA, 2002, ANN NEUROL, V51, P369, DOI 10.1002/ana.10121
   Banwell BL, 2000, NEUROLOGY, V54, P1033, DOI 10.1212/WNL.54.5.1033
   BAROHN RJ, 1995, NEUROLOGY, V45, P1302, DOI 10.1212/WNL.45.7.1302
   Barohn RJ, 2006, NEUROLOGY, V66, PS123, DOI 10.1212/01.wnl.0000192258.32408.54
   BEYENBURG S, 1993, CLIN INVESTIGATOR, V71, P351
   BILAK M, 1993, ACTA NEUROPATHOL, V85, P378, DOI 10.1007/BF00334447
   Blume G, 1997, BRAIN, V120, P39, DOI 10.1093/brain/120.1.39
   Bradshaw EM, 2007, J IMMUNOL, V178, P547, DOI 10.4049/jimmunol.178.1.547
   CALABRESE LH, 1987, ARTHRITIS RHEUM-US, V30, P397, DOI 10.1002/art.1780300406
   Cantwell C, 2005, CLIN RADIOL, V60, P261, DOI 10.1016/j.crad.2004.06.027
   Chahin N, 2008, NEUROLOGY, V70, P418, DOI 10.1212/01.wnl.0000277527.69388.fe
   Cherin P, 2002, NEUROLOGY, V58, P326, DOI 10.1212/WNL.58.2.326
   Choi YC, 2000, NEUROLOGY, V54, P65, DOI 10.1212/WNL.54.1.65
   CHOU SM, 1986, HUM PATHOL, V17, P765, DOI 10.1016/S0046-8177(86)80197-6
   CHOU SM, 1967, SCIENCE, V158, P1453, DOI 10.1126/science.158.3807.1453
   Christen U, 2004, CURR OPIN IMMUNOL, V16, P759, DOI 10.1016/j.coi.2004.09.002
   Christensen RA, 2004, J BIOL CHEM, V279, P53524, DOI 10.1074/jbc.M408473200
   Civatte M, 2005, NEUROPATH APPL NEURO, V31, P70, DOI 10.1111/j.1365-2990.2004.00591.x
   COHEN MR, 1989, ARTHRITIS RHEUM-US, V32, P734, DOI 10.1002/anr.1780320611
   Confalonieri P, 2000, J NEUROPATH EXP NEUR, V59, P164, DOI 10.1093/jnen/59.2.164
   Dahlbom K, 2002, NEUROMUSCULAR DISORD, V12, P853, DOI 10.1016/S0960-8966(02)00098-6
   Dalakas MC, 2007, ANN NEUROL, V62, P0
   Dalakas MC, 2007, ANN NEUROL, V61, P466, DOI 10.1002/ana.21103
   Dalakas MC, 2006, NAT CLIN PRACT NEURO, V2, P437, DOI 10.1038/ncpneuro0261
   Dalakas MC, 1998, ARCH NEUROL-CHICAGO, V55, P1509, DOI 10.1001/archneur.55.12.1509
   Dalakas MC, 2006, NEUROMUSCULAR DISORD, V16, P223, DOI 10.1016/j.nmd.2005.12.008
   Dalakas MC, 2004, CURR OPIN NEUROL, V17, P561, DOI 10.1097/00019052-200410000-00006
   Dalakas MC, 2001, NEUROLOGY, V56, P323, DOI 10.1212/WNL.56.3.323
   Dalakas MC, 1997, NEUROLOGY, V48, P712, DOI 10.1212/WNL.48.3.712
   Darin N, 1998, ANN NEUROL, V44, P242, DOI 10.1002/ana.410440215
   DARROW DH, 1992, ARCH OTOLARYNGOL, V118, P313
   De Bleecker JL, 1999, NEUROMUSCULAR DISORD, V9, P239, DOI 10.1016/S0960-8966(98)00126-6
   De Bleecker JL, 2002, NEUROLOGY, V58, P1779, DOI 10.1212/WNL.58.12.1779
   De Paepe B, 2008, FRONT BIOSCI-LANDMRK, V13, P2548, DOI 10.2741/2866
   De Paepe B, 2007, ANN NY ACAD SCI, V1109, P441, DOI 10.1196/annals.1398.050
   DeBleecker JL, 1996, J NEUROPATH EXP NEUR, V55, P563, DOI 10.1097/00005072-199605000-00009
   Dehmel T, 2007, NEUROBIOL DIS, V25, P665, DOI 10.1016/j.nbd.2006.11.008
   Dion E, 2004, REV MED INTERNE, V25, P435, DOI 10.1016/j.revmed.2004.01.021
   Dion E, 2002, J RHEUMATOL, V29, P1897
   Eisenberg I, 2001, NAT GENET, V29, P83, DOI 10.1038/ng718
   ENGEL AG, 1984, ANN NEUROL, V16, P209, DOI 10.1002/ana.410160207
   Eriksen JL, 2003, J CLIN INVEST, V112, P440, DOI 10.1172/JCI200318162
   Felice KJ, 2001, MEDICINE, V80, P320, DOI 10.1097/00005792-200109000-00006
   Felice KJ, 1998, MUSCLE NERVE, V21, P659, DOI 10.1002/(SICI)1097-4598(199805)21:5<659::AID-MUS17>3.0.CO;2-Q
   Ferrer I, 2004, J NEUROPATH EXP NEUR, V63, P484, DOI 10.1093/jnen/63.5.484
   FIGARELLABRANGER D, 1992, REV NEUROL, V148, P281
   Fox SA, 1996, MUSCLE NERVE, V19, P23, DOI 10.1002/(SICI)1097-4598(199601)19:1<23::AID-MUS4>3.3.CO;2-Y
   Fukuchi K, 1998, AM J PATHOL, V153, P1687, DOI 10.1016/S0002-9440(10)65682-9
   Garcia J, 2000, SKELETAL RADIOL, V29, P425, DOI 10.1007/s002560000238
   Garlepp MJ, 1996, ANN NEUROL, V40, P826, DOI 10.1002/ana.410400603
   GARLEPP MJ, 1994, CLIN EXP IMMUNOL, V98, P40
   GOLDGABER D, 1989, P NATL ACAD SCI USA, V86, P7606, DOI 10.1073/pnas.86.19.7606
   Gossrau G, 2004, EUR NEUROL, V51, P215, DOI 10.1159/000078488
   Greenberg SA, 2005, NEUROLOGY, V65, P1782, DOI 10.1212/01.wnl.0000187124.92826.20
   Greenberg SA, 2007, MUSCLE NERVE, V35, P17, DOI 10.1002/mus.20649
   Griggs RC, 2006, NEUROLOGY, V66, PS30, DOI 10.1212/01.wnl.0000192262.29924.9e
   GRIGGS RC, 1995, ANN NEUROL, V38, P705, DOI 10.1002/ana.410380504
   GRILLI M, 1995, J BIOL CHEM, V270, P26774, DOI 10.1074/jbc.270.45.26774
   Grilli M, 1996, J BIOL CHEM, V271, P15002, DOI 10.1074/jbc.271.25.15002
   HEWER E, 2008, PATHOL RES PRACT, V0, P0
   Hinderlich S, 1997, J BIOL CHEM, V272, P24313, DOI 10.1074/jbc.272.39.24313
   HOPKINSON ND, 1993, ANN RHEUM DIS, V52, P147, DOI 10.1136/ard.52.2.147
   Horvath R, 1998, J NEUROPATH EXP NEUR, V57, P396, DOI 10.1097/00005072-199805000-00003
   Jaworska-Wilczynska M, 2002, NEUROLOGY, V58, P438, DOI 10.1212/WNL.58.3.438
   Jin LW, 1998, AM J PATHOL, V153, P1679, DOI 10.1016/S0002-9440(10)65681-7
   JOFFE MM, 1993, AM J MED, V94, P379, DOI 10.1016/0002-9343(93)90148-I
   Johnson LG, 2007, CLIN NEUROMUSCUL DIS, V8, P187
   Kalmar B, 2003, EXP NEUROL, V184, P636, DOI 10.1016/S0014-4886(03)00343-1
   Kalmar B, 2002, EXP NEUROL, V176, P87, DOI 10.1006/exnr.2002.7945
   KARPATI G, 1988, ANN NEUROL, V23, P64, DOI 10.1002/ana.410230111
   Keppler OT, 1999, SCIENCE, V284, P1372, DOI 10.1126/science.284.5418.1372
   Kieran D, 2004, NAT MED, V10, P402, DOI 10.1038/nm1021
   Kieseier BC, 2001, BRAIN, V124, P341, DOI 10.1093/brain/124.2.341
   Kitazawa M, 2008, ANN NEUROL, V0, P0
   Kitazawa M, 2006, AM J PATHOL, V168, P1986, DOI 10.2353/ajpath.2006.051232
   Koffman BM, 1998, MUSCLE NERVE, V21, P115, DOI 10.1002/(SICI)1097-4598(199801)21:1<115::AID-MUS15>3.3.CO;2-G
   Koffman BM, 1998, J NEUROIMMUNOL, V84, P139, DOI 10.1016/S0165-5728(97)00245-2
   Kok CC, 1999, IMMUNOGENETICS, V49, P508, DOI 10.1007/s002510050528
   Kovach MJ, 2001, MOL GENET METAB, V74, P458, DOI 10.1006/mgme.2001.3256
   KULA R W, 1989, CURRENT OPINION IN RHEUMATOLOGY, V1, P460
   Lampe J, 2001, NEUROLOGY, V57, P368
   Lampe J, 1999, LANCET, V353, P465, DOI 10.1016/S0140-6736(98)05208-8
   Lampe JB, 2003, J NEUROL, V250, P1313, DOI 10.1007/s00415-003-0204-3
   LEFF RL, 1993, MEDICINE, V72, P225, DOI 10.1097/00005792-199307000-00002
   LEFF RL, 1992, LANCET, V339, P1192, DOI 10.1016/0140-6736(92)91134-T
   Lindberg C, 2003, NEUROLOGY, V61, P260, DOI 10.1212/01.WNL.0000071852.27182.C7
   LINDBERG C, 1994, ACTA NEUROL SCAND, V89, P123
   Liu LWC, 2004, CAN J GASTROENTEROL, V18, P397, DOI 10.1155/2004/360537
   Lodi R, 1998, BRAIN, V121, P2119, DOI 10.1093/brain/121.11.2119
   LOTZ BP, 1989, BRAIN, V112, P727, DOI 10.1093/brain/112.3.727
   LOVE LA, 1991, MEDICINE, V70, P360, DOI 10.1097/00005792-199111000-00002
   Lu DC, 2003, ANN NEUROL, V54, P781, DOI 10.1002/ana.10761
   Lundberg I, 1997, ARTHRITIS RHEUM, V40, P865, DOI 10.1002/art.1780400514
   Lünemann JD, 2007, ANN NEUROL, V61, P476, DOI 10.1002/ana.21115
   Martinsson T, 1999, AM J HUM GENET, V64, P1420, DOI 10.1086/302375
   Martinsson T, 2000, P NATL ACAD SCI USA, V97, P14614, DOI 10.1073/pnas.250289597
   MEDSGER TA, 1970, AM J MED, V48, P715, DOI 10.1016/S0002-9343(70)80006-7
   MENDELL JR, 1991, ARCH NEUROL-CHICAGO, V48, P1229, DOI 10.1001/archneur.1991.00530240033013
   MHIRI C, 1990, NEUROPATH APPL NEURO, V16, P333, DOI 10.1111/j.1365-2990.1990.tb01267.x
   MICHAELIS D, 1993, AM J PATHOL, V143, P1142
   Mirabella M, 1996, ANN NEUROL, V40, P864, DOI 10.1002/ana.410400608
   Mowzoon N, 2001, J NEUROL SCI, V185, P119, DOI 10.1016/S0022-510X(01)00478-6
   Muchowski PJ, 2005, NAT REV NEUROSCI, V6, P11, DOI 10.1038/nrn1587
   Müntzing K, 2003, SCAND J IMMUNOL, V58, P195, DOI 10.1046/j.1365-3083.2003.01251.x
   Nagaraju K, 2005, ARTHRITIS RHEUM, V52, P1824, DOI 10.1002/art.21103
   Nagaraju K, 2000, P NATL ACAD SCI USA, V97, P9209, DOI 10.1073/pnas.97.16.9209
   Naumann M, 1996, J NEUROL, V243, P126, DOI 10.1007/BF02444002
   Needham M, 2008, NEUROMUSCULAR DISORD, V18, P6, DOI 10.1016/j.nmd.2007.11.001
   Needham M, 2007, LANCET NEUROL, V6, P620, DOI 10.1016/S1474-4422(07)70171-0
   Needham M, 2008, J CLIN NEUROSCI, V15, P1350, DOI 10.1016/j.jocn.2008.01.011
   Nirmalananthan N, 2004, CURR OPIN RHEUMATOL, V16, P684, DOI 10.1097/01.bor.0000143441.27065.bc
   Nishino I, 2002, NEUROLOGY, V59, P1689, DOI 10.1212/01.WNL.0000041631.28557.C6
   NONAKA I, 1981, J NEUROL SCI, V51, P141, DOI 10.1016/0022-510X(81)90067-8
   OHanlon TP, 2005, MEDICINE, V84, P338, DOI 10.1097/01.md.0000189818.63141.8c
   ODDIS CV, 1990, J RHEUMATOL, V17, P1329
   Ogura T, 2001, GENES CELLS, V6, P575, DOI 10.1046/j.1365-2443.2001.00447.x
   Oldfors A, 2006, NEUROLOGY, V66, PS49, DOI 10.1212/01.wnl.0000192127.63013.8d
   Oldfors A, 2005, CURR OPIN NEUROL, V18, P497, DOI 10.1097/01.wco.0000183115.14175.29
   OLDFORS A, 1993, BRAIN, V116, P325, DOI 10.1093/brain/116.2.325
   OLDFORS A, 1995, J NEUROPATH EXP NEUR, V54, P581, DOI 10.1097/00005072-199507000-00012
   Orth M, 2000, NEUROLOGY, V55, P1235, DOI 10.1212/WNL.55.8.1235
   Ozden S, 2004, J VIROL, V78, P10320, DOI 10.1128/JVI.78.19.10320-10327.2004
   Paciello O, 2006, ACTA MYOL, V25, P13
   Page G, 2004, ARTHRITIS RHEUM, V50, P199, DOI 10.1002/art.11428
   Pak JW, 2003, AGING CELL, V2, P1, DOI 10.1046/j.1474-9728.2003.00034.x
   Park J H, 2001, CURR RHEUMATOL REP, V3, P334, DOI 10.1007/s11926-001-0038-x
   Peng A, 2000, NEUROLOGY, V55, P296, DOI 10.1212/WNL.55.2.296
   Phillips BA, 2000, MUSCLE NERVE, V23, P970, DOI 10.1002/(SICI)1097-4598(200006)23:6<970::AID-MUS20>3.0.CO;2-I
   Phillips BA, 2001, MUSCLE NERVE, V24, P1526, DOI 10.1002/mus.1178
   Prayson RA, 2001, ARCH PATHOL LAB MED, V125, P1326
   Price P, 2004, TISSUE ANTIGENS, V64, P575, DOI 10.1111/j.1399-0039.2004.00310.x
   Querfurth HW, 2001, MOL CELL NEUROSCI, V17, P793, DOI 10.1006/mcne.2001.0972
   Raju R, 2005, BRAIN, V128, P1887, DOI 10.1093/brain/awh518
   Raju R, 2003, J NEUROIMMUNOL, V141, P125, DOI 10.1016/S0165-5728(03)00218-2
   Ranque-Francois B, 2005, ANN RHEUM DIS, V64, P634, DOI 10.1136/ard.2004.025494
   Rider LG, 1998, ARTHRITIS RHEUM, V41, P710, DOI 10.1002/1529-0131(199804)41:4<710::AID-ART19>3.0.CO;2-K
   RINGEL SP, 1987, ARCH NEUROL-CHICAGO, V44, P1154, DOI 10.1001/archneur.1987.00520230042011
   Rose MR, 2001, NEUROLOGY, V57, P548, DOI 10.1212/WNL.57.3.548
   Rutkove SB, 2002, NEUROLOGY, V58, P1081, DOI 10.1212/WNL.58.7.1081
   SADEH M, 1993, BRAIN, V116, P217, DOI 10.1093/brain/116.1.217
   Santorelli FM, 1996, ANN NEUROL, V39, P789, DOI 10.1002/ana.410390615
   SARKOZI E, 1994, AM J PATHOL, V145, P1280
   SARKOZI E, 1993, NEUROREPORT, V4, P815, DOI 10.1097/00001756-199306000-00055
   SAYERS ME, 1992, J RHEUMATOL, V19, P1385
   Schmidt J, 2004, BRAIN, V127, P1182, DOI 10.1093/brain/awh148
   Schmidt J, 2008, BRAIN, V131, P1228, DOI 10.1093/brain/awn053
   Schoser BGH, 2002, ACTA NEUROL SCAND, V105, P309, DOI 10.1034/j.1600-0404.2002.1o104.x
   SCHWEITZER ME, 1995, AM J ROENTGENOL, V165, P1469, DOI 10.2214/ajr.165.6.7484589
   Scott AP, 2006, NEUROMUSCULAR DISORD, V16, P311, DOI 10.1016/j.nmd.2006.02.002
   Sekul EA, 1997, NEUROLOGY, V48, P863, DOI 10.1212/WNL.48.4.863
   Selcen D, 2004, BRAIN, V127, P439, DOI 10.1093/brain/awh052
   Semino-Mora C, 1998, HUM PATHOL, V29, P1128, DOI 10.1016/S0046-8177(98)90425-7
   Shamim EA, 2002, ARTHRITIS RHEUM, V46, P1885, DOI 10.1002/art.10358
   SHIFTMAN A, 2008, NEUROBIOL AGING, V0, P0
   Sivakumar K, 1997, BRAIN, V120, P653, DOI 10.1093/brain/120.4.653
   SIVAKUMAR K, 1995, ANN NEUROL, V38, P267, DOI 10.1002/ana.410380222
   Sivakumar K, 1996, NEUROLOGY, V47, P977, DOI 10.1212/WNL.47.4.977
   SOUEIDAN SA, 1993, NEUROLOGY, V43, P876, DOI 10.1212/WNL.43.5.876
   Spector SA, 1997, MUSCLE NERVE, V20, P1242, DOI 10.1002/(SICI)1097-4598(199710)20:10<1242::AID-MUS6>3.3.CO;2-X
   Sugarman MC, 2006, NEUROBIOL AGING, V27, P423, DOI 10.1016/j.neurobiolaging.2005.02.011
   SUNOHARA N, 1989, BRAIN, V112, P65, DOI 10.1093/brain/112.1.65
   Tateyama M, 2003, INTERNAL MED, V42, P1035, DOI 10.2169/internalmedicine.42.1035
   Tawil R, 2004, NEUROLOGY, V63, P718
   Tawil R, 2002, CURR OPIN RHEUMATOL, V14, P653, DOI 10.1097/00002281-200211000-00004
   Tawil R, 2001, NEUROLOGY, V57, P1566
   TEMIZ P, 2008, J NEUROL SCI, V0, P0
   TERRACCIANO C, 2008, FREE RADIC BIOL MED, V0, P0
   Tews DS, 1996, J NEUROPATH EXP NEUR, V55, P342, DOI 10.1097/00005072-199603000-00009
   Tian L, 2005, P NATL ACAD SCI USA, V102, P13544, DOI 10.1073/pnas.0506577102
   Tournadre Anne, 2007, CURR RHEUMATOL REP, V9, P286, DOI 10.1007/s11926-007-0046-6
   Tsuruta Y, 2002, ACTA NEUROPATHOL, V103, P59, DOI 10.1007/s004010100428
   Tucker W S Jr, 1982, TRANS ASSOC AM PHYSICIANS, V95, P126
   Udd B, 2001, CURR OPIN NEUROL, V14, P561, DOI 10.1097/00019052-200110000-00003
   van der Meulen MFG, 1998, J NEUROL NEUROSUR PS, V64, P396, DOI 10.1136/jnnp.64.3.396
   van der Meulen MFG, 2001, NEUROMUSCULAR DISORD, V11, P447, DOI 10.1016/S0960-8966(00)00219-4
   Voermans NC, 2004, NEUROLOGY, V63, P2191, DOI 10.1212/01.WNL.0000145834.17020.86
   Walter MC, 2000, J NEUROL, V247, P22, DOI 10.1007/s004150050005
   Watts GDJ, 2004, NAT GENET, V36, P377, DOI 10.1038/ng1332
   Weihl CC, 2008, J NEUROL NEUROSUR PS, V79, P1186, DOI 10.1136/jnnp.2007.131334
   Wiendl H, 2005, TRENDS IMMUNOL, V26, P373, DOI 10.1016/j.it.2005.05.003
   Wiesinger GF, 1998, BRIT J RHEUMATOL, V37, P196
   Wilson FC, 2008, J RHEUMATOL, V35, P445
   Yakushiji Y, 2004, NEUROLOGY, V63, P587, DOI 10.1212/01.WNL.0000133411.10574.BA
   YOOD RA, 1985, J RHEUMATOL, V12, P568
   Yosipovitch G, 1999, ARCH DERMATOL, V135, P721, DOI 10.1001/archderm.135.6.721
   YUNIS EJ, 1971, LAB INVEST, V25, P240
NR 213
TC 11
Z9 11
U1 0
U2 5
PU PUBLISAUDE-EDICOES MEDICAS LDA
PI ALGES
PA ALAMEDA ANTONIO SERGIO 22, 4 B EDIF AMADEO SOUZA-CARDOSO, ALGES, 1495-132, PORTUGAL
SN 0303-464X
EI 
J9 ACTA REUMATOL PORT
JI Acta Reumatol. Port.
PD APR-JUN 15
PY 2009
VL 34
IS 2
BP 161
EP 182
DI 
PG 22
WC Rheumatology
SC Rheumatology
GA 447VL
UT WOS:000266220000002
PM 19474772
DA 2024-11-01
ER

PT J
AU Jang, YC
   Van Remmen, H
AF Jang, Youngmok C.
   Van Remmen, Holly
TI The mitochondrial theory of aging: Insight from transgenic and knockout mouse models
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Review
DE Mitochondria; Mitochondrial theory of aging; Oxidative stress; Aging; Transgenic and knockout mouse models
ID manganese superoxide-dismutase; life-span; oxidative stress; dna-damage; skeletal-muscle; mice; overexpression; mutations; brain; restriction
AB A substantial body of evidence has accumulated over the past 35 years in support of a role for oxidative damage to the mitochondrial respiratory chain and mitochondrial DNA in the determination of mammalian lifespan. The goal of this review is to provide a concise summary of recent studies using transgenic and knockout mouse models with altered expression of mitochondrial antioxidant enzymes (MnSOD (Sod2Tg and Sod2(+/-)), thioredoxin 2 (Trx2(+/-)), mitochondrial targeted catalase (mCAT) and mutant mice models that have been genetically manipulated to increase mitochondrial deletions or mutations (Poly(D257A/D257A) mutant mice) to examine the role of mitochondrial oxidative stress in aging. The majority of studies using these strategies do not support a clear role for mitochondrial oxidative stress or a vicious cycle of oxidative damage in the determination of lifespan in mice and furthermore do not support the free radical theory of aging. However, several key questions remain to be addressed and clearly more studies are required to fully understand the role of mitochondria in age-related disease and aging. (C) 2009 Elsevier Inc. All rights reserved.
C1 [Jang, Youngmok C.; Van Remmen, Holly] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA.
   [Jang, Youngmok C.; Van Remmen, Holly] Univ Texas Hlth Sci Ctr San Antonio, Barshop Inst Longev & Aging Studies, San Antonio, TX 78229 USA.
   [Van Remmen, Holly] S Texas Vet Hlth Care Syst, San Antonio, TX 78229 USA.
C3 University of Texas System; University of Texas Health Science Center at San Antonio; University of Texas System; University of Texas Health Science Center at San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital
RP Van Remmen, H (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, 7703 Floyd Curl Dr,MSC 7762, San Antonio, TX 78229 USA.
EM vanremmen@uthscsa.edu
CR AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915
   Andreyev AI, 2005, BIOCHEMISTRY-MOSCOW+, V70, P200, DOI 10.1007/s10541-005-0102-7
   Barja G, 2000, FASEB J, V14, P312, DOI 10.1096/fasebj.14.2.312
   Barja G, 2004, BIOL REV, V79, P235, DOI 10.1017/S1464793103006213
   Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547
   Boveris A, 2008, IUBMB LIFE, V60, P308, DOI 10.1002/iub.46
   Croteau DL, 1999, MUTAT RES-DNA REPAIR, V434, P137, DOI 10.1016/S0921-8777(99)00025-7
   Figueiredo PA, 2008, BIOGERONTOLOGY, V9, P67, DOI 10.1007/s10522-007-9121-7
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Hu DY, 2007, NEUROBIOL LEARN MEM, V87, P372, DOI 10.1016/j.nlm.2006.10.003
   Jezek P, 2005, INT J BIOCHEM CELL B, V37, P2478, DOI 10.1016/j.biocel.2005.05.013
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Lebovitz RM, 1996, P NATL ACAD SCI USA, V93, P9782, DOI 10.1073/pnas.93.18.9782
   LI YB, 1995, NAT GENET, V11, P376, DOI 10.1038/ng1295-376
   Longo VD, 1996, J BIOL CHEM, V271, P12275, DOI 10.1074/jbc.271.21.12275
   Mansouri A, 2006, MECH AGEING DEV, V127, P298, DOI 10.1016/j.mad.2005.11.004
   Miller RA, 2005, SCIENCE, V310, P441, DOI 10.1126/science.310.5747.441
   MIQUEL J, 1980, EXP GERONTOL, V15, P575, DOI 10.1016/0531-5565(80)90010-8
   Mitsui A, 2002, ANTIOXID REDOX SIGN, V4, P693, DOI 10.1089/15230860260220201
   Muller FL, 2004, J BIOL CHEM, V279, P49064, DOI 10.1074/jbc.M407715200
   Muller FL, 2007, FREE RADICAL BIO MED, V43, P477, DOI 10.1016/j.freeradbiomed.2007.03.034
   Perez VI, 2008, FREE RADICAL BIO MED, V44, P882, DOI 10.1016/j.freeradbiomed.2007.11.018
   Pérez VI, 2009, AGING CELL, V8, P73, DOI 10.1111/j.1474-9726.2008.00449.x
   Rikke BA, 2006, PHYSIOL GENOMICS, V27, P122, DOI 10.1152/physiolgenomics.00068.2006
   Scheckhuber CQ, 2007, NAT CELL BIOL, V9, P99, DOI 10.1038/ncb1524
   Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653
   Sun JT, 2002, GENETICS, V161, P661
   Taguchi A, 2007, SCIENCE, V317, P369, DOI 10.1126/science.1142179
   Treuting PM, 2008, J GERONTOL A-BIOL, V63, P813, DOI 10.1093/gerona/63.8.813
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Trinei M, 2002, ONCOGENE, V21, P3872, DOI 10.1038/sj.onc.1205513
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Van Remmen H, 2003, PHYSIOL GENOMICS, V16, P29, DOI 10.1152/physiolgenomics.00122.2003
   Van Remmen H, 2001, EXP GERONTOL, V36, P957
   Van Remmen H, 1999, ARCH BIOCHEM BIOPHYS, V363, P91, DOI 10.1006/abbi.1998.1060
   Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95
   Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988
   Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514
   Yamamoto M, 2005, J BIOL CHEM, V280, P38029, DOI 10.1074/jbc.M509039200
   Yoshida T, 2003, ANTIOXID REDOX SIGN, V5, P563, DOI 10.1089/152308603770310211
NR 42
TC 131
Z9 149
U1 0
U2 13
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
EI 1873-6815
J9 EXP GERONTOL
JI Exp. Gerontol.
PD APR 15
PY 2009
VL 44
IS 4
BP 256
EP 260
DI 10.1016/j.exger.2008.12.006
PG 5
WC Geriatrics & Gerontology
SC Geriatrics & Gerontology
GA 435JQ
UT WOS:000265340600004
PM 19171187
DA 2024-11-01
ER

PT J
AU Tarnopolsky, MA
AF Tarnopolsky, M. A.
TI Mitochondrial DNA shifting in older adults following resistance exercise training
SO APPLIED PHYSIOLOGY NUTRITION AND METABOLISM-PHYSIOLOGIE APPLIQUEE NUTRITION ET METABOLISME
LA English
DT Article
DE mitochondrial disease; resistance exercise; satellite cells; gene shifting
ID human skeletal-muscle; free-radical theory; elderly-men; protein-synthesis; oxidative damage; creatine supplementation; deletion mutations; body-composition; life-span; young men
AB Aging is associated with a reduction in muscle mass and strength, which compromises functional independence. Skeletal muscle also shows an increase in mitochondrial dysfunction and oxidative stress in older adults. Resistance-exercise training is an important countermeasure for aging-associated muscle weakness. It has been shown that resistance-exercise training increases muscle strength and function in older adults, in association with a reduction in markers of oxidative stress and an improvement in mitochondrial function. Patients with sporadic mitochondrial cytopathies show an accumulation of mitochondrial DNA mutations and deletions in mature muscle, but not in satellite cells. Such patients have shown an activation of the satellite cells following myotoxic trauma and resistance, likely due to a fusion of the relatively quiescent satellite cells with mature muscle, which dilutes the mutational burden, a process called mitochondrial DNA shifting. Preliminary data strongly suggest that mitochondrial DNA shifting occurs in skeletal muscle from older adults following resistance-exercise training.
C1 McMaster Univ, Dept Pediat & Med, Hamilton, ON L8N 3Z5, Canada.
C3 McMaster University
RP Tarnopolsky, MA (corresponding author), McMaster Univ, Dept Pediat & Med, Hamilton, ON L8N 3Z5, Canada.
EM tarnopol@mcmaster.ca
CR Ades PA, 1996, ANN INTERN MED, V124, P568, DOI 10.7326/0003-4819-124-6-199603150-00005
   Aiken J, 2002, ANN NY ACAD SCI, V959, P412, DOI 10.1111/j.1749-6632.2002.tb02111.x
   ALWAY SE, 1988, J APPL PHYSIOL, V64, P1114, DOI 10.1152/jappl.1988.64.3.1114
   Ashok BT, 1999, EXP GERONTOL, V34, P293, DOI 10.1016/S0531-5565(99)00005-4
   Baker DJ, 2006, EXP GERONTOL, V41, P1149, DOI 10.1016/j.exger.2006.08.007
   Balagopal P, 1997, AM J PHYSIOL-ENDOC M, V273, PE790, DOI 10.1152/ajpendo.1997.273.4.E790
   Brierley EJ, 1998, ANN NEUROL, V43, P217, DOI 10.1002/ana.410430212
   Brose A, 2003, J GERONTOL A-BIOL, V58, P11
   Bua EA, 2002, J APPL PHYSIOL, V92, P2617, DOI 10.1152/japplphysiol.01102.2001
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Candow DG, 2007, J NUTR HEALTH AGING, V11, P185
   Castillo EM, 2003, AM J PREV MED, V25, P226, DOI 10.1016/S0749-3797(03)00197-1
   Chabi B, 2008, AGING CELL, V7, P2, DOI 10.1111/j.1474-9726.2007.00347.x
   Clark KM, 1997, NAT GENET, V16, P222, DOI 10.1038/ng0797-222
   COGGAN AR, 1992, J GERONTOL, V47, PB71, DOI 10.1093/geronj/47.3.B71
   deGrey ADNJ, 1997, BIOESSAYS, V19, P161, DOI 10.1002/bies.950190211
   Dirks A, 2002, AM J PHYSIOL-REG I, V282, PR519, DOI 10.1152/ajpregu.00458.2001
   Dirks AJ, 2006, AGEING RES REV, V5, P179, DOI 10.1016/j.arr.2006.03.002
   Esmarck B, 2001, J PHYSIOL-LONDON, V535, P301, DOI 10.1111/j.1469-7793.2001.00301.x
   FIATARONE MA, 1990, JAMA-J AM MED ASSOC, V263, P3029, DOI 10.1001/jama.263.22.3029
   FRONTERA WR, 1988, J APPL PHYSIOL, V64, P1038, DOI 10.1152/jappl.1988.64.3.1038
   Gianni P, 2004, EXP GERONTOL, V39, P1391, DOI 10.1016/j.exger.2004.06.002
   Gillette-Goyonnet S, 2003, MECH AGEING DEV, V124, P311, DOI 10.1016/S0047-6374(02)00198-7
   Giresi PG, 2005, PHYSIOL GENOMICS, V21, P253, DOI 10.1152/physiolgenomics.00249.2004
   Greenlund LJS, 2003, MECH AGEING DEV, V124, P287, DOI 10.1016/S0047-6374(02)00196-3
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Janssen I, 2004, J AM GERIATR SOC, V52, P80, DOI 10.1111/j.1532-5415.2004.52014.x
   KLITGAARD H, 1990, ACTA PHYSIOL SCAND, V140, P41, DOI 10.1111/j.1748-1716.1990.tb08974.x
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Lau EMC, 2005, J GERONTOL A-BIOL, V60, P213, DOI 10.1093/gerona/60.2.213
   Leeuwenburgh C, 2003, J GERONTOL A-BIOL, V58, P999
   LEXELL J, 1995, J GERONTOL A-BIOL, V50, P11
   LEXELL J, 1988, J NEUROL SCI, V84, P275, DOI 10.1016/0022-510X(88)90132-3
   Mecocci P, 1999, FREE RADICAL BIO MED, V26, P303, DOI 10.1016/S0891-5849(98)00208-1
   Melov S, 2000, SCIENCE, V289, P1567, DOI 10.1126/science.289.5484.1567
   Melov S, 2002, ANN NY ACAD SCI, V959, P330, DOI 10.1111/j.1749-6632.2002.tb02104.x
   Melov S, 2007, PLOS ONE, V2, P0, DOI 10.1371/journal.pone.0000465
   Melton LJ, 2000, J AM GERIATR SOC, V48, P625
   Moore DR, 2005, AM J PHYSIOL-ENDOC M, V288, PE1153, DOI 10.1152/ajpendo.00387.2004
   Muller FL, 2007, FREE RADICAL BIO MED, V43, P477, DOI 10.1016/j.freeradbiomed.2007.03.034
   Murphy JL, 2008, BRAIN, V131, P2832, DOI 10.1093/brain/awn252
   NICHOLS JF, 1993, J AM GERIATR SOC, V41, P205, DOI 10.1111/j.1532-5415.1993.tb06692.x
   Olsen S, 2006, J PHYSIOL-LONDON, V573, P525, DOI 10.1113/jphysiol.2006.107359
   ORR WC, 1994, SCIENCE, V263, P1128, DOI 10.1126/science.8108730
   Parise G, 2005, FREE RADICAL BIO MED, V39, P289, DOI 10.1016/j.freeradbiomed.2005.03.024
   Parise G, 2005, EXP GERONTOL, V40, P173, DOI 10.1016/j.exger.2004.09.002
   ROGERS MA, 1990, J APPL PHYSIOL, V68, P2195, DOI 10.1152/jappl.1990.68.5.2195
   Rooyackers OE, 1996, P NATL ACAD SCI USA, V93, P15364, DOI 10.1073/pnas.93.26.15364
   Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653
   Shoubridge EA, 1997, HUM MOL GENET, V6, P2239, DOI 10.1093/hmg/6.13.2239
   SKELTON DA, 1995, J AM GERIATR SOC, V43, P1081, DOI 10.1111/j.1532-5415.1995.tb07004.x
   SOHAL RS, 1994, MECH AGEING DEV, V76, P215, DOI 10.1016/0047-6374(94)91595-4
   Taivassalo T, 1999, HUM MOL GENET, V8, P1047, DOI 10.1093/hmg/8.6.1047
   Tamilselvan J, 2007, FREE RADICAL BIO MED, V43, P1656, DOI 10.1016/j.freeradbiomed.2007.08.028
   Tang JE, 2006, APPL PHYSIOL NUTR ME, V31, P495, DOI 10.1139/H06-026
   Tarnopolsky M, 2007, PLOS ONE, V2, P0, DOI 10.1371/journal.pone.0000991
   Tarnopolsky MA, 2008, APPL PHYSIOL NUTR ME, V33, P213, DOI 10.1139/H07-142
   TESCH PA, 1988, MED SCI SPORT EXER, V20, PS132, DOI 10.1249/00005768-198810001-00008
   TOMONAGA M, 1977, J AM GERIATR SOC, V25, P125, DOI 10.1111/j.1532-5415.1977.tb00274.x
   Tracy BL, 1999, J APPL PHYSIOL, V86, P195, DOI 10.1152/jappl.1999.86.1.195
   Trappe S, 2000, J APPL PHYSIOL, V89, P143, DOI 10.1152/jappl.2000.89.1.143
   Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Vincent KR, 2002, ARCH INTERN MED, V162, P673, DOI 10.1001/archinte.162.6.673
   Wanagat J, 2001, FASEB J, V15, P322, DOI 10.1096/fj.00-0320com
   Welle S, 2004, EXP GERONTOL, V39, P369, DOI 10.1016/j.exger.2003.11.011
   Welle S, 2000, J APPL PHYSIOL, V89, P297, DOI 10.1152/jappl.2000.89.1.297
   Wilkinson SB, 2008, J PHYSIOL-LONDON, V586, P3701, DOI 10.1113/jphysiol.2008.153916
   YARASHESKI KE, 1993, AM J PHYSIOL, V265, PE210, DOI 10.1152/ajpendo.1993.265.2.E210
   Yasuda N, 2005, J APPL PHYSIOL, V99, P1085, DOI 10.1152/japplphysiol.00247.2005
   Zahn JM, 2006, PLOS GENET, V2, P1058, DOI 10.1371/journal.pgen.0020115
NR 71
TC 48
Z9 54
U1 2
U2 3
PU NATL RESEARCH COUNCIL CANADA-N R C RESEARCH PRESS
PI OTTAWA
PA BUILDING M 55, OTTAWA, ON K1A 0R6, CANADA
SN 1715-5312
EI 
J9 APPL PHYSIOL NUTR ME
JI Appl. Physiol. Nutr. Metab.
PD JUN 15
PY 2009
VL 34
IS 3
BP 348
EP 354
DI 10.1139/H09-022
PG 7
WC Nutrition & Dietetics; Physiology; Sport Sciences
SC Nutrition & Dietetics; Physiology; Sport Sciences
GA 450ZV
UT WOS:000266441400007
PM 19448697
DA 2024-11-01
ER

PT J
AU DiMauro, S
   Hirano, M
AF DiMauro, Salvatore
   Hirano, Michio
TI Pathogenesis and Treatment of Mitochondrial Disorders
SO INHERITED NEUROMUSCULAR DISEASES: TRANSLATION FROM PATHMECHANISMS TO THERAPIES
LA English
DT Article; Proceedings Paper
DE Mitochondrial diseases; Respiratory chain defects; Energy failure; Oxidative stress; Symptomatic therapy; Pharmacological therapy; Gene therapy
ID hereditary optic neuropathy; progressive external ophthalmoplegia; complex-i activity; optimized allotopic expression; congenital lactic-acidosis; coenzyme-q deficiency; kearns-sayre-syndrome; stroke-like episodes; oxidative-phosphorylation; cerebellar-ataxia
AB In the past 50 years, our understanding of the biochemical and molecular causes of mitochondrial diseases, defined restrictively as disorders due to defects of the mitochondrial respiratory chain (RC), has made great strides. Mitochondrial diseases can be due to mutations in mitochondrial DNA (mtDNA) or in nuclear DNA (nDNA) and each group can be subdivided into more specific classes. Thus, mtDNA-related disorders can result from mutations in genes affecting protein synthesis in toto or mutations in protein-coding genes. Mendelian mitochondrial disorders can be attributed to mutations in genes that (i) encode subunits of the RC ("direct hits"); (ii) encode assembly proteins or RC complexes ("indirect hits"); (iii) encode factors needed for mtDNA maintenance, replication, or translation (intergenomic signaling); (iv) encode components of the mitochondrial protein import machinery; (v) control the synthesis and composition of mitochondrial membrane phospholipids; and (vi) encode proteins involved in mitochondrial dynamics. In contrast to this wealth of knowledge about etiology, our understanding of pathogenic mechanism is very limited. We discuss pathogenic factors that can influence clinical expression, especially ATP shortage and reactive oxygen radicals (ROS) excess. Therapeutic options are limited and fall into three modalities: (;) symptomatic interventions, which are palliative but crucial for day-to-day management; (ii) radical approaches aimed at correcting the biochemical or molecular error, which are interesting but still largely experimental; and (iii) pharmacological means of interfering with the pathogenic cascade of events (e.g. boosting ATP production or scavenging ROS), which are inconsistently and incompletely effective, but can be safe and helpful.
C1 [DiMauro, Salvatore; Hirano, Michio] Columbia Univ, Med Ctr, Dept Neurol, New York, NY 10032 USA.
C3 Columbia University
RP DiMauro, S (corresponding author), Columbia Univ, Med Ctr, Dept Neurol, 3-313 Russ Berrie Med Sci Pavil, New York, NY 10032 USA.
EM sd12@columbia.edu
FU NICHD NIH HHS [R01 HD056103, P01 HD032062, P01 HD080642, HD32062] Funding Source: Medline; NINDS NIH HHS [P01 NS011766, RC1 NS070232] Funding Source: Medline
CR Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944
   ALLEN RJ, 1983, ANN NEUROL, V13, P679, DOI 10.1002/ana.410130620
   Amati-Bonneau P, 2005, ANN NEUROL, V58, P958, DOI 10.1002/ana.20681
   Andreu AL, 1999, NEW ENGL J MED, V341, P1037, DOI 10.1056/NEJM199909303411404
   Antonicka H, 2006, HUM MOL GENET, V15, P1835, DOI 10.1093/hmg/ddl106
   Bacman SR, 2007, GENE THER, V14, P1309, DOI 10.1038/sj.gt.3302981
   Bai YD, 2001, J BIOL CHEM, V276, P38808, DOI 10.1074/jbc.M106363200
   BAKER SK, 2003, EXPERT OPIN INV DRUG, V12, P1
   Baracca A, 2000, J BIOL CHEM, V275, P4177, DOI 10.1074/jbc.275.6.4177
   Baracca A, 2005, ARCH NEUROL-CHICAGO, V62, P730, DOI 10.1001/archneur.62.5.730
   Baracca A, 2007, BBA-BIOENERGETICS, V1767, P913, DOI 10.1016/j.bbabio.2007.05.005
   Barbiroli B, 1999, BIOFACTORS, V9, P253, DOI 10.1002/biof.5520090221
   Barth PG, 1999, J INHERIT METAB DIS, V22, P555, DOI 10.1023/A:1005568609936
   Bastin J, 2008, J CLIN ENDOCR METAB, V93, P1433, DOI 10.1210/jc.2007-1701
   Betts J, 2006, NEUROPATH APPL NEURO, V32, P359, DOI 10.1111/j.1365-2990.2006.00731.x
   Bianchi K, 2004, BBA-MOL CELL RES, V1742, P119, DOI 10.1016/j.bbamcr.2004.09.015
   Bione S, 1996, NAT GENET, V12, P385, DOI 10.1038/ng0496-385
   Blok RB, 1997, AM J HUM GENET, V60, P1495, DOI 10.1086/515453
   Bonnet C, 2008, BBA-MOL CELL RES, V1783, P1707, DOI 10.1016/j.bbamcr.2008.04.018
   Bonnet D, 2001, HEART, V86, P570, DOI 10.1136/heart.86.5.570
   Brini M, 1999, NAT MED, V5, P951, DOI 10.1038/11396
   Bykhovskaya Y, 2004, AM J HUM GENET, V74, P1303, DOI 10.1086/421530
   Carelli V, 2004, BBA-BIOENERGETICS, V1658, P172, DOI 10.1016/j.bbabio.2004.05.009
   Carelli V, 2002, ARCH NEUROL-CHICAGO, V59, P264, DOI 10.1001/archneur.59.2.264
   Carelli V, 2006, MITOCHONDRIAL MEDICINE, V0, P105
   Carrozzo R, 2001, NEUROLOGY, V56, P687, DOI 10.1212/WNL.56.5.687
   Carrozzo R, 2000, FEBS LETT, V486, P297, DOI 10.1016/S0014-5793(00)02244-4
   Chan DC, 2007, NEW ENGL J MED, V356, P1707, DOI 10.1056/NEJMp078040
   Chinnery PF, 1999, GENE THER, V6, P1919, DOI 10.1038/sj.gt.3301061
   Chinnery PF, 2000, ANN NEUROL, V47, P381, DOI 10.1002/1531-8249(200003)47:3<381::AID-ANA17>3.0.CO;2-2
   CHOMYN A, 1992, P NATL ACAD SCI USA, V89, P4221, DOI 10.1073/pnas.89.10.4221
   Cortelli P, 1997, J NEUROL SCI, V148, P25, DOI 10.1016/S0022-510X(96)00311-5
   Cortés-Hernández P, 2007, J BIOL CHEM, V282, P1051, DOI 10.1074/jbc.M606828200
   Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936
   Di Giovanni S, 2001, NEUROLOGY, V57, P515, DOI 10.1212/WNL.57.3.515
   Di Prospero NA, 2007, LANCET NEUROL, V6, P878, DOI 10.1016/S1474-4422(07)70220-X
   DiMauro S, 2003, BASIC APPL MYOL, V13, P145
   DIMAURO S, 2006, MITOCHONDRIAL MED, V0, P0
   DiMauro S, 2006, MITOCHONDRIAL MEDICINE, V0, P261
   DiMauro S, 2008, ANNU REV NEUROSCI, V31, P91, DOI 10.1146/annurev.neuro.30.051606.094302
   DiMauro S, 2006, MUSCLE NERVE, V34, P265, DOI 10.1002/mus.20598
   Diomedi-Camassei F, 2007, J AM SOC NEPHROL, V18, P2773, DOI 10.1681/ASN.2006080833
   DOUGADOS M, 1983, ANN NEUROL, V13, P687, DOI 10.1002/ana.410130624
   Dröge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001
   Edmonds JL, 2004, MITOCHONDRION, V4, P543, DOI 10.1016/j.mito.2004.07.012
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   Ellouze S, 2008, AM J HUM GENET, V83, P373, DOI 10.1016/j.ajhg.2008.08.013
   Elpeleg O, 2005, AM J HUM GENET, V76, P1081, DOI 10.1086/430843
   ENGEL WK, 1963, NEUROLOGY, V13, P919, DOI 10.1212/WNL.13.11.919
   Felitsyn N, 2007, J NEUROCHEM, V100, P429, DOI 10.1111/j.1471-4159.2006.04248.x
   Fernandez-Vizarra E, 2007, J MED GENET, V44, P173, DOI 10.1136/jmg.2006.045252
   Ferraris S, 2008, ARCH NEUROL-CHICAGO, V65, P125, DOI 10.1001/archneurol.2007.9
   Fichera M, 2004, NEUROLOGY, V63, P1108, DOI 10.1212/01.WNL.0000138731.60693.D2
   Freisinger P, 2006, ARCH NEUROL-CHICAGO, V63, P1129, DOI 10.1001/archneur.63.8.1129
   García JJ, 2000, J BIOL CHEM, V275, P11075, DOI 10.1074/jbc.275.15.11075
   Gempel K, 2007, BRAIN, V130, P2037, DOI 10.1093/brain/awm054
   Gironi M, 2004, NEUROLOGY, V62, P818, DOI 10.1212/01.WNL.0000113719.67643.B7
   Graziewicz MA, 2006, CHEM REV, V106, P383, DOI 10.1021/cr040463d
   GVOZDJAKOVA A, 2008, MITOCHONDRIAL MED, V0, P0
   Hakkaart GAJ, 2006, EMBO REP, V7, P341, DOI 10.1038/sj.embor.7400601
   HALLER RG, 2004, MYOLOGY, V1, P665
   Hirano M, 2006, NEUROLOGY, V67, P1458, DOI 10.1212/01.wnl.0000240853.97716.24
   Hirano M, 2005, ARCH NEUROL-CHICAGO, V62, P711, DOI 10.1001/archneur.62.5.711
   HIRANO M, 1994, NEUROLOGY, V44, P721, DOI 10.1212/WNL.44.4.721
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   Hudson G, 2005, AM J HUM GENET, V77, P1086, DOI 10.1086/498176
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   Hudson G, 2007, AM J HUM GENET, V81, P228, DOI 10.1086/519394
   Jacobs HT, 2005, TRENDS GENET, V21, P312, DOI 10.1016/j.tig.2005.04.003
   Karadimas CL, 2006, AM J HUM GENET, V79, P544, DOI 10.1086/506913
   Kaufmann P, 2006, NEUROLOGY, V66, P324, DOI 10.1212/01.wnl.0000196641.05913.27
   Kaufmann P, 2004, NEUROLOGY, V62, P1297, DOI 10.1212/01.WNL.0000120557.83907.A8
   Kaufmann P, 2006, ARCH NEUROL-CHICAGO, V63, P746, DOI 10.1001/archneur.63.5.746
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477
   Kirino Y, 2004, P NATL ACAD SCI USA, V101, P15070, DOI 10.1073/pnas.0405173101
   Klopstock T, 1999, NEUROLOGY, V52, P0
   Koga Y, 2006, NEUROLOGY, V66, P1766, DOI 10.1212/01.wnl.0000220197.36849.1e
   Koga Y, 2005, NEUROLOGY, V64, P710, DOI 10.1212/01.WNL.0000151976.60624.01
   Koga Y, 2002, NEUROLOGY, V58, P827, DOI 10.1212/WNL.58.5.827
   Kolesnikova OA, 2004, HUM MOL GENET, V13, P2519, DOI 10.1093/hmg/ddh267
   Kubota M, 2004, BRAIN DEV-JPN, V26, P481, DOI 10.1016/j.braindev.2004.01.006
   Lagier-Tourenne C, 2008, AM J HUM GENET, V82, P661, DOI 10.1016/j.ajhg.2007.12.024
   Lalani SR, 2005, ARCH NEUROL-CHICAGO, V62, P317, DOI 10.1001/archneur.62.2.317
   Lamperti C, 2003, NEUROLOGY, V60, P1206, DOI 10.1212/01.WNL.0000055089.39373.FC
   Lawson VH, 2005, NEUROLOGY, V65, P197, DOI 10.1212/01.wnl.0000168898.76071.70
   Lee WS, 2007, HEPATOLOGY, V45, P1555, DOI 10.1002/hep.21710
   Lenaz G, 2004, BBA-BIOENERGETICS, V1658, P89, DOI 10.1016/j.bbabio.2004.03.013
   Lodi R, 2002, J NEUROL NEUROSUR PS, V72, P805, DOI 10.1136/jnnp.72.6.805
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   López LC, 2006, AM J HUM GENET, V79, P1125, DOI 10.1086/510023
   LUFT R, 1962, J CLIN INVEST, V41, P1776, DOI 10.1172/JCI104637
   LUFT R, 1994, P NATL ACAD SCI USA, V91, P8731, DOI 10.1073/pnas.91.19.8731
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   Manfredi G, 2002, NAT GENET, V30, P394, DOI 10.1038/ng851
   Manwaring N, 2007, MITOCHONDRION, V7, P230, DOI 10.1016/j.mito.2006.12.004
   Marriage BJ, 2004, MOL GENET METAB, V81, P263, DOI 10.1016/j.ymgme.2003.12.008
   Massa V, 2008, AM J HUM GENET, V82, P1281, DOI 10.1016/j.ajhg.2008.05.002
   McFarland R, 2004, ANN NEUROL, V55, P478, DOI 10.1002/ana.20004
   Miller C, 2004, ANN NEUROL, V56, P734, DOI 10.1002/ana.20282
   Millhouse-Flourie TJ, 2004, MITOCHONDRION, V4, P549, DOI 10.1016/j.mito.2004.07.013
   Minczuk M, 2008, NUCLEIC ACIDS RES, V36, P3926, DOI 10.1093/nar/gkn313
   MIT, 2003, MITOMAP HUM MIT GEN, V0, P0
   Mollet J, 2008, AM J HUM GENET, V82, P623, DOI 10.1016/j.ajhg.2007.12.022
   Mollet J, 2007, J CLIN INVEST, V117, P765, DOI 10.1172/JCI29089
   MOUDY AM, 1995, P NATL ACAD SCI USA, V92, P729, DOI 10.1073/pnas.92.3.729
   Musumeci O, 2001, NEUROLOGY, V56, P849, DOI 10.1212/WNL.56.7.849
   Naini A, 2005, J NEUROL SCI, V229, P187, DOI 10.1016/j.jns.2004.11.026
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Niemann A, 2005, J CELL BIOL, V170, P1067, DOI 10.1083/jcb.200507087
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   OGASAHARA S, 1989, P NATL ACAD SCI USA, V86, P2379, DOI 10.1073/pnas.86.7.2379
   Oskoui M, 2006, ARCH NEUROL-CHICAGO, V63, P1122, DOI 10.1001/archneur.63.8.1122
   Ostergaard E, 2007, AM J HUM GENET, V81, P383, DOI 10.1086/519222
   Pallotti F, 2004, BIOCHEM J, V384, P287, DOI 10.1042/BJ20040561
   Papadopoulou LC, 1999, NAT GENET, V23, P333
   Parone PA, 2008, PLOS ONE, V3, P0, DOI 10.1371/journal.pone.0003257
   Pedrola L, 2005, HUM MOL GENET, V14, P1087, DOI 10.1093/hmg/ddi121
   Pineda M, 2006, ANN NEUROL, V59, P394, DOI 10.1002/ana.20746
   Pitkanen S, 1996, J CLIN INVEST, V98, P345, DOI 10.1172/JCI118798
   Quinzii C, 2006, AM J HUM GENET, V78, P345, DOI 10.1086/500092
   QUINZII C, 2008, FASEB J IN PRESS, V0, P0
   Quinzii CM, 2005, NEUROLOGY, V64, P539, DOI 10.1212/01.WNL.0000150588.75281.58
   Rimessi A, 2008, BBA-BIOENERGETICS, V1777, P808, DOI 10.1016/j.bbabio.2008.05.449
   Roesch K, 2002, HUM MOL GENET, V11, P477, DOI 10.1093/hmg/11.5.477
   Rötig A, 2000, LANCET, V356, P391, DOI 10.1016/S0140-6736(00)02531-9
   Rotig A, 2006, MITOCHONDRIAL MEDICINE, V0, P197
   Sabatini S, 2009, J AM SOC NEPHROL, V20, P692, DOI 10.1681/ASN.2007121329
   Sacconi S, 2008, HUM MOL GENET, V17, P1814, DOI 10.1093/hmg/ddn073
   Salviati L, 2005, NEUROLOGY, V65, P606, DOI 10.1212/01.wnl.0000172859.55579.a7
   SANTORELLI FM, 1993, ANN NEUROL, V34, P827, DOI 10.1002/ana.410340612
   Sato A, 2005, P NATL ACAD SCI USA, V102, P16765, DOI 10.1073/pnas.0506197102
   Scheper GC, 2007, NAT GENET, V39, P534, DOI 10.1038/ng2013
   Schlame M, 2006, FEBS LETT, V580, P5450, DOI 10.1016/j.febslet.2006.07.022
   Schon EA, 1997, J BIOENERG BIOMEMBR, V29, P131, DOI 10.1023/A:1022685929755
   Schon EA, 2001, SEMIN CELL DEV BIOL, V12, P441, DOI 10.1006/scdb.2001.0281
   Seo BB, 2002, MOL THER, V6, P336, DOI 10.1006/mthe.2002.0674
   Sgarbi G, 2006, BIOCHEM J, V395, P493, DOI 10.1042/BJ20051748
   Shankar SP, 2008, OPHTHALMIC GENET, V29, P17, DOI 10.1080/13816810701867607
   Shanske S, 2008, ARCH NEUROL-CHICAGO, V65, P368, DOI 10.1001/archneurol.2007.67
   SHAPIRA Y, 1977, ISRAEL J MED SCI, V13, P161
   SHY GM, 1966, BRAIN, V89, P133, DOI 10.1093/brain/89.1.133
   SHY GM, 1964, SCIENCE, V145, P493, DOI 10.1126/science.145.3631.493
   Sinnathuray AR, 2003, OTOL NEUROTOL, V24, P418, DOI 10.1097/00129492-200305000-00012
   Smeitink JAM, 2006, AM J HUM GENET, V79, P869, DOI 10.1086/508434
   Sobreira C, 1997, NEUROLOGY, V48, P1238, DOI 10.1212/WNL.48.5.1238
   Solaini G, 2008, BBA-BIOENERGETICS, V1777, P941, DOI 10.1016/j.bbabio.2008.04.034
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Spinazzola A, 2005, GENE, V354, P162, DOI 10.1016/j.gene.2005.03.025
   Spinazzola A, 2002, J BIOL CHEM, V277, P4128, DOI 10.1074/jbc.M111028200
   Sproule DM, 2008, ANN NY ACAD SCI, V1142, P133, DOI 10.1196/annals.1444.011
   Stacpoole PW, 2008, PEDIATRICS, V121, PE1223, DOI 10.1542/peds.2007-2062
   Stacpoole PW, 2006, PEDIATRICS, V117, P1519, DOI 10.1542/peds.2005-1226
   STACPOOLE PW, 1989, METABOLISM, V38, P1124, DOI 10.1016/0026-0495(89)90051-6
   SZADBADKAI G, 2006, BIOCHIM BIOPHYS ACTA, V1763, P442
   Taivassalo T, 2005, MED SCI SPORT EXER, V37, P2094, DOI 10.1249/01.mss.0000177446.97671.2a
   Tanaka M, 2002, J BIOMED SCI, V9, P534, DOI 10.1007/BF02254980
   Tanji K, 2000, J NEUROL SCI, V178, P29, DOI 10.1016/S0022-510X(00)00354-3
   Tanji K, 2001, SEMIN CELL DEV BIOL, V12, P429, DOI 10.1006/scdb.2001.0280
   Tarnopolsky MA, 1999, MUSCLE NERVE, V22, P1228, DOI 10.1002/(SICI)1097-4598(199909)22:9<1228::AID-MUS9>3.3.CO;2-Y
   Tarnopolsky MA, 1997, MUSCLE NERVE, V20, P1502, DOI 10.1002/(SICI)1097-4598(199712)20:12<1502::AID-MUS4>3.0.CO;2-C
   TATUCH Y, 1992, AM J HUM GENET, V50, P852
   TATUCH Y, 1994, EUR J HUM GENET, V0, P0
   Taylor RW, 2003, J AM COLL CARDIOL, V41, P1786, DOI 10.1016/S0735-1097(03)00300-0
   Taylor RW, 1997, NAT GENET, V15, P212, DOI 10.1038/ng0297-212
   THYAGARAJAN D, 1995, ANN NEUROL, V38, P468, DOI 10.1002/ana.410380321
   Valentino ML, 2006, J MED GENET, V43, P0, DOI 10.1136/jmg.2005.037507
   Valnot I, 2000, AM J HUM GENET, V67, P1104
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Maldergem L, 2002, ANN NEUROL, V52, P750, DOI 10.1002/ana.10371
   Vázquez-Memije ME, 1998, J INHERIT METAB DIS, V21, P829, DOI 10.1023/A:1005418718299
   VazquezMemije ME, 1996, J INHERIT METAB DIS, V19, P43, DOI 10.1007/BF01799347
   Verkaart S, 2007, BBA-MOL BASIS DIS, V1772, P373, DOI 10.1016/j.bbadis.2006.12.009
   Wallace DC, 2005, GENE, V354, P169, DOI 10.1016/j.gene.2005.05.001
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Wenz T, 2008, CELL METAB, V8, P249, DOI 10.1016/j.cmet.2008.07.006
   White SL, 1999, J INHERIT METAB DIS, V22, P899, DOI 10.1023/A:1005639407166
   Zanna C, 2008, BRAIN, V131, P352, DOI 10.1093/brain/awm335
   Züchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341
NR 181
TC 28
Z9 30
U1 0
U2 6
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 0065-2598
EI 2214-8019
J9 ADV EXP MED BIOL
JI Adv.Exp.Med.Biol.
PD JUN 15
PY 2009
VL 652
IS 
BP 139
EP 170
DI 10.1007/978-90-481-2813-6_10
PG 32
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA BOT76
UT WOS:000277561400010
PM 20225024
DA 2024-11-01
ER

PT J
AU Chan, SSL
   Copeland, WC
AF Chan, Sherine S. L.
   Copeland, William C.
TI DNA polymerase gamma and mitochondrial disease: Understanding the consequence of <i>POLG</i> mutations
SO BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS
LA English
DT Article; Proceedings Paper
DE Mitochondria; Mitochondrial disease; DNA polymerase gamma; Mitochondrial DNA replication; Oxidative stress
ID progressive external ophthalmoplegia; cag repeat; saccharomyces-cerevisiae; alpers-syndrome; w748s mutation; gene polg; polymorphism; defects; toxicity; patient
AB DNA polymerase gamma is the only known DNA polymerase in human mitochondria and is essential for mitochondrial DNA replication and repair. It is well established that defects in mtDNA replication lead to mitochondrial dysfunction and disease. Over 160 coding variations in the gene encoding the catalytic subunit of DNA polymerase gamma (POLG) have been identified. Our group and others have characterized a number of the more common and interesting mutations, as well as those disease mutations in the DNA polymerase gamma accessory subunit. We review the results of these studies, which provide clues to the mechanisms leading to the disease state. Published by Elsevier B.V.
C1 [Chan, Sherine S. L.; Copeland, William C.] Natl Inst Environm Hlth Sci, Mol Genet Lab, NIH, Res Triangle Pk, NC 27709 USA.
C3 National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)
RP Chan, SSL (corresponding author), Natl Inst Environm Hlth Sci, Mol Genet Lab, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.
EM sherine.s.l.chan@gmail.com; copelan1@niehs.nih.gov
FU Intramural NIH HHS [Z01 ES065078-14, Z01 ES065080-13] Funding Source: Medline; NIEHS NIH HHS [R00 ES015555, 1K99-ES015555-01, K99 ES015555-01, K99 ES015555] Funding Source: Medline
CR Aknin-Seifer IE, 2005, HUM REPROD, V20, P736, DOI 10.1093/humrep/deh666
   Baruffini E, 2007, BBA-MOL BASIS DIS, V1772, P1225, DOI 10.1016/j.bbadis.2007.10.002
   Baruffini E, 2006, HUM MOL GENET, V15, P2846, DOI 10.1093/hmg/ddl219
   Bebenek K, 2004, ADV PROTEIN CHEM, V69, P137
   Bowmaker M, 2003, J BIOL CHEM, V278, P50961, DOI 10.1074/jbc.M308028200
   Brown TA, 2005, GENE DEV, V19, P2466, DOI 10.1101/gad.1352105
   Brusco A, 2006, J ENDOCRINOL INVEST, V29, P1
   Calvo S, 2006, NAT GENET, V38, P576, DOI 10.1038/ng1776
   Chan SSL, 2007, ENVIRON MOL MUTAGEN, V48, P190, DOI 10.1002/em.20191
   Chan SSL, 2006, HUM MOL GENET, V15, P3473, DOI 10.1093/hmg/ddl424
   Chan SSL, 2005, DNA REPAIR, V4, P1381, DOI 10.1016/j.dnarep.2005.08.010
   Chan SSL, 2005, J BIOL CHEM, V280, P31341, DOI 10.1074/jbc.M506762200
   Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646
   DEVRIES MC, 2006, EUR J PEDIAT, V0, P0
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   Ferraris S, 2008, ARCH NEUROL-CHICAGO, V65, P125, DOI 10.1001/archneurol.2007.9
   Graziewicz MA, 2004, NAT STRUCT MOL BIOL, V11, P770, DOI 10.1038/nsmb805
   Graziewicz MA, 2006, CHEM REV, V106, P383, DOI 10.1021/cr040463d
   Graziewicz MA, 2007, HUM MOL GENET, V16, P2729, DOI 10.1093/hmg/ddm227
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Hudson G, 2006, HUM MOL GENET, V15, PR244, DOI 10.1093/hmg/ddl233
   Jensen M, 2004, HUM REPROD, V19, P65, DOI 10.1093/humrep/deh038
   Jensen MB, 2008, ANN ONCOL, V19, P1910, DOI 10.1093/annonc/mdn407
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   Krausz C, 2004, J CLIN ENDOCR METAB, V89, P4292, DOI 10.1210/jc.2004-0008
   Lewis W, 2003, NAT REV DRUG DISCOV, V2, P812, DOI 10.1038/nrd1201
   Lewis W, 2007, LAB INVEST, V87, P326, DOI 10.1038/labinvest.3700523
   Lim SE, 2001, J BIOL CHEM, V276, P23616, DOI 10.1074/jbc.M101114200
   Lim SE, 1999, J BIOL CHEM, V274, P38197, DOI 10.1074/jbc.274.53.38197
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   Luoma PT, 2007, NEUROLOGY, V69, P1152, DOI 10.1212/01.wnl.0000276955.23735.eb
   Luoma PT, 2005, HUM MOL GENET, V14, P1907, DOI 10.1093/hmg/ddi196
   Naviaux RK, 2005, ANN NEUROL, V58, P491, DOI 10.1002/ana.20544
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Nguyen KV, 2006, J HEPATOL, V45, P108, DOI 10.1016/j.jhep.2005.12.026
   Nowak R, 2005, ANN ONCOL, V16, P1211, DOI 10.1093/annonc/mdi205
   Ponamarev MV, 2002, J BIOL CHEM, V277, P15225, DOI 10.1074/jbc.C200100200
   Ropp PA, 1996, GENOMICS, V36, P449, DOI 10.1006/geno.1996.0490
   Rovio AT, 2001, NAT GENET, V29, P261, DOI 10.1038/ng759
   Rovio AT, 2004, MAMM GENOME, V15, P492, DOI 10.1007/s00335-004-3049-x
   Shadel GS, 1997, ANNU REV BIOCHEM, V66, P409, DOI 10.1146/annurev.biochem.66.1.409
   Spelbrink JN, 2000, J BIOL CHEM, V275, P24818, DOI 10.1074/jbc.M000559200
   Stuart GR, 2006, HUM MOL GENET, V15, P363, DOI 10.1093/hmg/ddi454
   Sweasy JB, 2006, RADIAT RES, V166, P693, DOI 10.1667/RR0706.1
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2003, HUM MUTAT, V22, P175, DOI 10.1002/humu.10246
   Westerveld GH, 2008, MOL HUM REPROD, V14, P245, DOI 10.1093/molehr/gan012
   Winterthun S, 2005, NEUROLOGY, V64, P1204, DOI 10.1212/01.WNL.0000156516.77696.5A
   Wong LJC, 2008, HUM MUTAT, V29, PE150, DOI 10.1002/humu.20824
   Yakubovskaya E, 2006, J BIOL CHEM, V281, P374, DOI 10.1074/jbc.M509730200
   Yamanaka H, 2007, J INFECT DIS, V195, P1419, DOI 10.1086/513872
NR 52
TC 122
Z9 150
U1 0
U2 15
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0005-2728
EI 1879-2650
J9 BBA-BIOENERGETICS
JI Biochim. Biophys. Acta-Bioenerg.
PD MAY 15
PY 2009
VL 1787
IS 5
BP 312
EP 319
DI 10.1016/j.bbabio.2008.10.007
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 451MX
UT WOS:000266475400005
PM 19010300
DA 2024-11-01
ER

PT J
AU Ryu, JS
   Lee, SJ
   Sung, IY
   Ko, TS
   Yoo, HI
AF Ryu, Ju Seok
   Lee, Sook Joung
   Sung, In Young
   Ko, Tae Sung
   Yoo, Han Ik
TI Depressive Episode With Catatonic Features in a Case of Mitochondrial Myropathy, Encephalopathy, Lactic Acidosis, and Stroke-Like Episodes (MELAS)
SO JOURNAL OF CHILD NEUROLOGY
LA English
DT Article
DE MELAS; A3243G; depression
ID clinical-features; dna; mutation; myopathy
AB Three months previously, a 17-year-old girl had complained of right-hand side hemiparesis, and her brain magnetic resonance imaging (MRI) showed a signal change in the left temporoparietooccipital area. The 3243A>G mutation was found in mitochondrial DNA. She was diagnosed with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) and was prescribed dichloroacetic acid to treat lactic acidosis. Her health improved. Two months later, she developed drowsiness and generalized weakness. A New lesion was not found on brain MRI, and electrodiagnostic findings were compatible with acute motor sensory axonal neuropathy. Her negative symptoms, such as depressed mood, loss of interest in activities, psychomotor retardation, and hypersomnia, were aggravated. She was prescribed antidepressants and psychostimulants by a psychiatrist after diagnosis of severe depression episode with catatonic features. One month later, her catatonic condition had improved with medication. Our experience shows that psychiatric diagnostic evaluation of abruptly regressed neurologic and clinical features is important, even in a patient with devastating underlying disease.
C1 [Ryu, Ju Seok; Lee, Sook Joung; Sung, In Young] Univ Ulsan, Coll Med, Dept Rehabil Med, Seoul 138736, South Korea.
   [Ko, Tae Sung] Univ Ulsan, Coll Med, Dept Pediat, Seoul 138736, South Korea.
   [Yoo, Han Ik] Univ Ulsan, Coll Med, Dept Psychiat, Seoul 138736, South Korea.
C3 University of Ulsan; University of Ulsan; University of Ulsan
RP Sung, IY (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Phys Med & Rehabil, 388-1 Pungnap 2Dong, Seoul 138736, South Korea.
EM iysung@amc.seoul.kr
CR Chae JH, 2004, BRAIN DEV-JPN, V26, P459, DOI 10.1016/j.braindev.2004.01.002
   Frye CB, 1997, AM J HEALTH-SYST PH, V54, P2510, DOI 10.1093/ajhp/54.21.2510
   GOTO Y, 1992, NEUROLOGY, V42, P545, DOI 10.1212/WNL.42.3.545
   HIRANO M, 1994, J CHILD NEUROL, V9, P4, DOI 10.1177/088307389400900102
   Hoschl Cyril, 2008, EXPERT REV NEUROTHER, V8, P537, DOI 10.1586/14737175.8.4.537
   Huang CC, 2002, J BIOMED SCI, V9, P527, DOI 10.1007/BF02254979
   Miyaoka H, 1997, BIOL PSYCHIAT, V42, P524, DOI 10.1016/S0006-3223(97)00280-1
   Munakata K, 2005, BIOL PSYCHIAT, V57, P525, DOI 10.1016/j.biopsych.2004.11.041
   Sadock BJ, 2007, KAPLAN SADOCKS SYNOPSIS OF PSYCHIATRY, V10th, P0
   SUOMALAINEN A, 1992, J CLIN INVEST, V90, P61, DOI 10.1172/JCI115856
NR 10
TC 7
Z9 7
U1 0
U2 3
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0883-0738
EI 1708-8283
J9 J CHILD NEUROL
JI J. Child Neurol.
PD OCT 15
PY 2009
VL 24
IS 10
BP 1307
EP 1309
DI 10.1177/0883073809334380
PG 3
WC Clinical Neurology; Pediatrics
SC Neurosciences & Neurology; Pediatrics
GA 502ZJ
UT WOS:000270499500015
DA 2024-11-01
ER

PT J
AU DeBrosse, S
   Ubogu, EE
   Yaniglos, S
   Hassan, MO
   Leigh, RJ
AF DeBrosse, S.
   Ubogu, E. E.
   Yaniglos, S.
   Hassan, M. O.
   Leigh, R. J.
TI Dynamic properties of eye movements in mitochondrial chronic progressive external ophthalmoplegia
SO EYE
LA English
DT Article
DE extraocular muscle; saccades; diplopia; vestibulo-ocular reflex
ID brain-stem; saccades
AB Aims To relate dynamic properties of eye movements to visual disability in a patient with chronic progressive external ophthalmoplegia ( CPEO) due to mitochondrial DNA deletion. Methods Visual function was evaluated by neuro-ophthalmological examination and visual function index (VF-14). Eye movements were measured using the magnetic search coil technique. Results The patient denied diplopia or oscillopsia at rest or during locomotion. His range of eye movements was limited to <12 degrees horizontally, and <19 degrees vertically with smaller movements of the left eye. All classes of movements were impaired, but the eyes accelerated to over 1000 degrees/s/s at the onset of saccades and in response to brisk head rotations. Conclusions Diplopia and oscillopsia were suppressed, probably due to visual system adaptation during the slow disease progression. We postulate that relative sparing of pale global extraocular fibres accounted for preserved acceleration of saccades and vestibular eye movements.
C1 [DeBrosse, S.; Ubogu, E. E.; Leigh, R. J.] Case Western Reserve Univ, Dept Neurol, Vet Affairs Med Ctr, Cleveland, OH 44106 USA.
   [Yaniglos, S.; Leigh, R. J.] Case Western Reserve Univ, Dept Optometry, Vet Affairs Med Ctr, Cleveland, OH 44106 USA.
   [Hassan, M. O.] Case Western Reserve Univ, Dept Pathol, Vet Affairs Med Ctr, Cleveland, OH 44106 USA.
C3 University System of Ohio; Case Western Reserve University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Louis Stokes Cleveland Veterans Affairs Medical Center; University System of Ohio; Case Western Reserve University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Louis Stokes Cleveland Veterans Affairs Medical Center; University System of Ohio; Case Western Reserve University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Louis Stokes Cleveland Veterans Affairs Medical Center
RP Leigh, RJ (corresponding author), Case Western Reserve Univ, Dept Neurol, Vet Affairs Med Ctr, 11100 Euclid Ave, Cleveland, OH 44106 USA.
EM rjl4@case.edu
FU NEI NIH HHS [EY06717, R01 EY006717, R01 EY006717-24] Funding Source: Medline
CR Auré K, 2007, BRAIN, V130, P1516, DOI 10.1093/brain/awm067
   Engle EC, 2007, ARCH NEUROL-CHICAGO, V64, P633, DOI 10.1001/archneur.64.5.633
   GROSSMAN GE, 1988, EXP BRAIN RES, V70, P470
   HALMAGYI GM, 1988, ARCH NEUROL-CHICAGO, V45, P737, DOI 10.1001/archneur.1988.00520310043015
   KHANNA S, 2007, J NEUROL, V0, P0
   Kumar AN, 2005, ANN NY ACAD SCI, V1039, P404, DOI 10.1196/annals.1325.038
   Leigh RJ, 2006, NEUROLOGY EYE MOVEME, V4th, P0
   Lossos A, 2005, BRAIN, V128, P42, DOI 10.1093/brain/awh338
   Man CYW, 2006, EYE, V20, P564, DOI 10.1038/sj.eye.6701924
   McFarland R, 2002, LANCET NEUROL, V1, P343, DOI 10.1016/S1474-4422(02)00159-X
   Porschke H, 1997, NEUROMUSCULAR DISORD, V7, PS57, DOI 10.1016/S0960-8966(97)00084-9
   Ramat S, 1999, EXP BRAIN RES, V129, P500, DOI 10.1007/s002210050920
   Ramat S, 1999, INVEST OPHTH VIS SCI, V40, P1681
   Richardson C, 2005, EYE, V19, P258, DOI 10.1038/sj.eye.6701488
   SCOTT AB, 1973, ARCH OPHTHALMOL-CHIC, V90, P319
   Spencer RF, 2006, PROG BRAIN RES, V151, P43, DOI 10.1016/S0079-6123(05)51002-1
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Versino M, 2002, J NEUROL NEUROSUR PS, V72, P236, DOI 10.1136/jnnp.72.2.236
   YEE RD, 1987, OPHTHALMOLOGY, V94, P219
   Yu CY, 2005, NEUROMUSCULAR DISORD, V15, P17, DOI 10.1016/j.nmd.2004.10.002
   ZEE DS, 1992, J NEUROPHYSIOL, V68, P1624, DOI 10.1152/jn.1992.68.5.1624
NR 21
TC 2
Z9 2
U1 0
U2 5
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0950-222X
EI 1476-5454
J9 EYE
JI Eye
PD FEB 15
PY 2009
VL 23
IS 2
BP 382
EP 388
DI 10.1038/sj.eye.6703024
PG 7
WC Ophthalmology
SC Ophthalmology
GA 406US
UT WOS:000263321000024
PM 17962819
DA 2024-11-01
ER

PT J
AU Huang, JH
   Hood, DA
AF Huang, Julianna H.
   Hood, David A.
TI Age-associated Mitochondrial Dysfunction in Skeletal Muscle: Contributing Factors and Suggestions for Long-term Interventions
SO IUBMB LIFE
LA English
DT Review
DE ageing; biogenesis; exercise; mitochondria; oxidative stress; reactive oxygen species
ID dna-deletion mutations; cytochrome-c-oxidase; lifelong calorie restriction; antioxidant enzyme-activity; oxidative stress; protein import; transcription factor; gene-expression; contractile activity; h2o2 release
AB It has been established that the impairment of mitochondrial function is associated with various disorders, such as type 2 diabetes and Alzheimer's disease. In addition, mitochondria have been implicated in the progression of cellular aging through a multitude of studies that connect increased mitochondrial dysfunction, such as increased reactive oxygen species production and decreased ATP synthesis, with skeletal muscle undergoing sarcopenia. Studies reveal an inverse relationship between mitochondrial biogenesis and aging such that as an individual increases in age, mitochondrial function, and content decreases. This review aims to summarize the relationship of mitochondria with skeletal muscle function, the regulation of mitochondrial biogenesis, and the alterations in skeletal muscle and mitochondrial function that result due to the aging process. (C) 2009 IUBMB
C1 [Huang, Julianna H.; Hood, David A.] York Univ, Sch Kinesiol & Hlth Sci, N York, ON M3J 1P3, Canada.
   [Hood, David A.] York Univ, Muscle Hlth Res Ctr, Toronto, ON M3J 2R7, Canada.
C3 York University - Canada; York University - Canada
RP Hood, DA (corresponding author), York Univ, Sch Kinesiol & Hlth Sci, Farqhuarson Life Sci Bldg,Rm 302,4700 Keele St, N York, ON M3J 1P3, Canada.
EM dhood@yorku.ca
CR Adamo ML, 2006, AGEING RES REV, V5, P310, DOI 10.1016/j.arr.2006.05.001
   Adhihetty PJ, 2007, AM J PHYSIOL-ENDOC M, V293, PE672, DOI 10.1152/ajpendo.00043.2007
   Adhihetty PJ, 2007, J APPL PHYSIOL, V102, P1143, DOI 10.1152/japplphysiol.00768.2006
   Adhihetty PJ, 2007, AM J PHYSIOL-ENDOC M, V292, PE748, DOI 10.1152/ajpendo.00311.2006
   Adhihetty PJ, 2005, AM J PHYSIOL-CELL PH, V289, PC994, DOI 10.1152/ajpcell.00031.2005
   Adhihetty PJ, 2003, EXP PHYSIOL, V88, P99, DOI 10.1113/eph8802505
   Aiken J, 2002, ANN NY ACAD SCI, V959, P412, DOI 10.1111/j.1749-6632.2002.tb02111.x
   Amara CE, 2007, P NATL ACAD SCI USA, V104, P1057, DOI 10.1073/pnas.0610131104
   Ames BN, 2004, ANN NY ACAD SCI, V1019, P406, DOI 10.1196/annals.1297.073
   Armeni T, 2003, J BIOENERG BIOMEMBR, V35, P181, DOI 10.1023/A:1023754305218
   Aspnes LE, 1997, FASEB J, V11, P573, DOI 10.1096/fasebj.11.7.9212081
   Baker DJ, 2006, EXP GERONTOL, V41, P1149, DOI 10.1016/j.exger.2006.08.007
   Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001
   Baragona R, 2001, QUADERNI STAT, V3, P1
   Barazzoni R, 2000, J BIOL CHEM, V275, P3343, DOI 10.1074/jbc.275.5.3343
   Barreiro E, 2006, FREE RADICAL BIO MED, V41, P797, DOI 10.1016/j.freeradbiomed.2006.05.027
   Beal MF, 2002, FREE RADICAL BIO MED, V32, P797, DOI 10.1016/S0891-5849(02)00780-3
   Beal MF, 2005, ANN NEUROL, V58, P495, DOI 10.1002/ana.20624
   BEREGI E, 1988, Z GERONTOL, V21, P83
   Bernardi P, 1999, ITAL J NEUROL SCI, V20, P395
   Berneburg M, 2006, PHOTOCH PHOTOBIO SCI, V5, P190, DOI 10.1039/b507380d
   Bevilacqua L, 2005, AM J PHYSIOL-ENDOC M, V289, PE429, DOI 10.1152/ajpendo.00435.2004
   Bézaire V, 2007, FASEB J, V21, P312, DOI 10.1096/fj.06-6966rev
   Bizeau ME, 1998, J APPL PHYSIOL, V85, P1279, DOI 10.1152/jappl.1998.85.4.1279
   Boily G, 2008, PLOS ONE, V3, P0, DOI 10.1371/journal.pone.0001759
   Bolender N, 2008, EMBO REP, V9, P42, DOI 10.1038/sj.embor.7401126
   Bota DA, 2002, NAT CELL BIOL, V4, P674, DOI 10.1038/ncb836
   Bota DA, 2002, FEBS LETT, V532, P103, DOI 10.1016/S0014-5793(02)03638-4
   Brierley EJ, 1996, QJM-MON J ASSOC PHYS, V89, P251
   Bua EA, 2004, FASEB J, V18, P582, DOI 10.1096/fj.03-0668fje
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Cannon B, 2006, BBA-BIOENERGETICS, V1757, P449, DOI 10.1016/j.bbabio.2006.05.016
   Capel F, 2005, MECH AGEING DEV, V126, P505, DOI 10.1016/j.mad.2004.11.001
   Capel F, 2004, MECH AGEING DEV, V125, P367, DOI 10.1016/j.mad.2004.02.005
   Chabi B, 2005, BIOCHEM BIOPH RES CO, V332, P542, DOI 10.1016/j.bbrc.2005.04.153
   Chabi B, 2008, AGING CELL, V7, P2, DOI 10.1111/j.1474-9726.2007.00347.x
   Chapman IM, 2006, MED CLIN N AM, V90, P887, DOI 10.1016/j.mcna.2006.05.010
   Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200
   Chicco AJ, 2007, AM J PHYSIOL-CELL PH, V292, PC33, DOI 10.1152/ajpcell.00243.2006
   Chilibeck PD, 1998, EXP PHYSIOL, V83, P107, DOI 10.1113/expphysiol.1998.sp004087
   Christians ES, 2002, CRIT CARE MED, V30, PS43, DOI 10.1097/00003246-200201001-00006
   CHRZANOWSKALIGHTOWLERS ZMA, 1993, ANAL BIOCHEM, V214, P45, DOI 10.1006/abio.1993.1454
   Civitarese AE, 2007, PLOS MED, V4, P485, DOI 10.1371/journal.pmed.0040076
   COGGAN AR, 1993, J APPL PHYSIOL, V75, P2125, DOI 10.1152/jappl.1993.75.5.2125
   COGGAN AR, 1992, J APPL PHYSIOL, V72, P1780, DOI 10.1152/jappl.1992.72.5.1780
   COGGAN AR, 1992, J GERONTOL, V47, PB71, DOI 10.1093/geronj/47.3.B71
   COGSWELL AM, 1993, AM J PHYSIOL, V264, PC383, DOI 10.1152/ajpcell.1993.264.2.C383
   Conley KE, 2000, J PHYSIOL-LONDON, V526, P203, DOI 10.1111/j.1469-7793.2000.t01-1-00203.x
   Conley KE, 2007, CURR OPIN CLIN NUTR, V10, P688, DOI 10.1097/MCO.0b013e3282f0dbfb
   Conley KE, 2007, EXERC SPORT SCI REV, V35, P43
   Corsetti G, 2008, AM J CARDIOL, V101, P26E, DOI 10.1016/j.amjcard.2008.02.078
   Craig EE, 1997, AM J PHYSIOL-HEART C, V272, PH2983, DOI 10.1152/ajpheart.1997.272.6.H2983
   de Cavanagh EMV, 2003, FASEB J, V17, P1096, DOI 10.1096/fj.02-0063fje
   de Grey ADNJ, 2004, REJUV RES, V7, P171, DOI 10.1089/rej.2004.7.171
   Deveaud C, 2004, MOL CELL BIOCHEM, V267, P157, DOI 10.1023/B:MCBI.0000049374.52989.9b
   Dhar SS, 2008, J BIOL CHEM, V283, P3120, DOI 10.1074/jbc.M707587200
   DIRKS A, 2002, AM J PHYSIOL-REG I, V282, P0
   Dirks AJ, 2004, FREE RADICAL BIO MED, V36, P27, DOI 10.1016/j.freeradbiomed.2003.10.003
   Dirks AJ, 2006, AGEING RES REV, V5, P179, DOI 10.1016/j.arr.2006.03.002
   Drew B, 2004, ACTA PHYSIOL SCAND, V182, P333, DOI 10.1111/j.1365-201X.2004.01371.x
   Drew B, 2003, AM J PHYSIOL-REG I, V284, PR474, DOI 10.1152/ajpregu.00455.2002
   DUGAN LL, 2005, SCI AGING KNOWLEDGE, V0, PE20
   Feige JN, 2008, CURR OPIN CELL BIOL, V20, P303, DOI 10.1016/j.ceb.2008.03.012
   FISHER RP, 1985, J BIOL CHEM, V260, P1330
   FISHER RP, 1988, MOL CELL BIOL, V8, P3496, DOI 10.1128/MCB.8.8.3496
   FISHER RP, 1987, CELL, V50, P247, DOI 10.1016/0092-8674(87)90220-0
   Fontenay M, 2006, ONCOGENE, V25, P4757, DOI 10.1038/sj.onc.1209606
   Freyssenet D, 2004, AM J PHYSIOL-CELL PH, V286, PC1053, DOI 10.1152/ajpcell.00418.2003
   Gabaldón T, 2004, BBA-BIOENERGETICS, V1659, P212, DOI 10.1016/j.bbabio.2004.07.011
   Gabaldón T, 2007, PLOS COMPUT BIOL, V3, P2209, DOI 10.1371/journal.pcbi.0030219
   Gordon JW, 2001, J APPL PHYSIOL, V90, P389, DOI 10.1152/jappl.2001.90.1.389
   Hagen JL, 2004, J GERONTOL A-BIOL, V59, P1099, DOI 10.1093/gerona/59.11.1099
   Hamilton ML, 2001, P NATL ACAD SCI USA, V98, P10469, DOI 10.1073/pnas.171202698
   Handschin C, 2007, J CLIN INVEST, V117, P3463, DOI 10.1172/JCI31785
   Handschin C, 2007, J BIOL CHEM, V282, P30014, DOI 10.1074/jbc.M704817200
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Harman D, 2006, ANN NY ACAD SCI, V1067, P10, DOI 10.1196/annals.1354.003
   Harper ME, 2004, ACTA PHYSIOL SCAND, V182, P321, DOI 10.1111/j.1365-201X.2004.01370.x
   Haus JM, 2007, J APPL PHYSIOL, V103, P2068, DOI 10.1152/japplphysiol.00670.2007
   Herbst A, 2007, J GERONTOL A-BIOL, V62, P235, DOI 10.1093/gerona/62.3.235
   Hollander J, 2000, MECH AGEING DEV, V116, P33, DOI 10.1016/S0047-6374(00)00130-5
   HOLLOSZY JO, 1991, J APPL PHYSIOL, V70, P1529, DOI 10.1152/jappl.1991.70.4.1529
   HOLLOSZY JO, 1993, J GERONTOL, V48, PB97, DOI 10.1093/geronj/48.3.B97
   Hood DA, 2003, MED SCI SPORT EXER, V35, P86, DOI 10.1097/00005768-200301000-00015
   HOOD DA, 1994, CAN J APPL PHYSIOL, V19, P12, DOI 10.1139/h94-002
   Hood DA, 2006, J EXP BIOL, V209, P2265, DOI 10.1242/jeb.02182
   Hoogenraad NJ, 2002, BBA-MOL CELL RES, V1592, P97, DOI 10.1016/S0167-4889(02)00268-9
   Hoppel CL, 2002, BIOGERONTOLOGY, V3, P41, DOI 10.1023/A:1015251212039
   HOPPELER H, 1987, J PHYSIOL-LONDON, V385, P661, DOI 10.1113/jphysiol.1987.sp016513
   Huang H, 2004, FRONT BIOSCI-LANDMRK, V9, P1100, DOI 10.2741/1298
   Hütter E, 2007, AGING CELL, V6, P245, DOI 10.1111/j.1474-9726.2007.00282.x
   Jackson MJ, 2008, FREE RADICAL BIO MED, V44, P132, DOI 10.1016/j.freeradbiomed.2007.06.003
   JI LL, 1990, AM J PHYSIOL, V258, PR918, DOI 10.1152/ajpregu.1990.258.4.R918
   Jubrias SA, 2001, J APPL PHYSIOL, V90, P1663, DOI 10.1152/jappl.2001.90.5.1663
   Judge S, 2005, FASEB J, V19, P419, DOI 10.1096/fj.04-2622fje
   Jung T, 2007, ANN NY ACAD SCI, V1119, P97, DOI 10.1196/annals.1404.008
   Kent-Braun JA, 2000, J APPL PHYSIOL, V89, P1072, DOI 10.1152/jappl.2000.89.3.1072
   Kerner J, 2001, AM J PHYSIOL-ENDOC M, V281, P0
   Khodorov B, 1996, FEBS LETT, V397, P230, DOI 10.1016/S0014-5793(96)01139-8
   Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027
   Kiselyov K, 2007, AUTOPHAGY, V3, P259, DOI 10.4161/auto.3906
   Kontani Y, 2002, J BIOCHEM, V132, P309, DOI 10.1093/oxfordjournals.jbchem.a003225
   Koves TR, 2005, AM J PHYSIOL-CELL PH, V288, PC1074, DOI 10.1152/ajpcell.00391.2004
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Kumaran S, 2005, MOL CELL BIOCHEM, V280, P83, DOI 10.1007/s11010-005-8234-z
   Kumaran S, 2004, CHEM-BIOL INTERACT, V148, P11, DOI 10.1016/j.cbi.2003.10.010
   Kurz T, 2007, ARCH BIOCHEM BIOPHYS, V462, P220, DOI 10.1016/j.abb.2007.01.013
   Kushnareva Y, 2002, BIOCHEM J, V368, P545, DOI 10.1042/BJ20021121
   Lambert AJ, 2007, AGING CELL, V6, P417, DOI 10.1111/j.1474-9726.2007.00316.x
   Lanza IR, 2005, J APPL PHYSIOL, V99, P1736, DOI 10.1152/japplphysiol.00566.2005
   Lass A, 1998, FREE RADICAL BIO MED, V25, P1089, DOI 10.1016/S0891-5849(98)00144-0
   Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390
   Lee CM, 1998, ANN NY ACAD SCI, V854, P182, DOI 10.1111/j.1749-6632.1998.tb09901.x
   Lee HJ, 2006, LIPIDS HEALTH DIS, V5, P0, DOI 10.1186/1476-511X-5-2
   Leeuwenburgh C, 2005, AM J PHYSIOL-REG I, V288, PR1288, DOI 10.1152/ajpregu.00576.2004
   Leeuwenburgh C, 2003, J GERONTOL A-BIOL, V58, P999
   LEEUWENBURGH C, 1994, AM J PHYSIOL, V267, PR439, DOI 10.1152/ajpregu.1994.267.2.R439
   Leick L, 2008, AM J PHYSIOL-ENDOC M, V294, PE463, DOI 10.1152/ajpendo.00666.2007
   Leone TC, 2005, PLOS BIOL, V3, P672, DOI 10.1371/journal.pbio.0030101
   Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904
   Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004
   Lister R, 2006, CURR BIOL, V16, PR197, DOI 10.1016/j.cub.2006.02.024
   Liu VWS, 1998, NUCLEIC ACIDS RES, V26, P1268, DOI 10.1093/nar/26.5.1268
   Loeb LA, 2005, P NATL ACAD SCI USA, V102, P18769, DOI 10.1073/pnas.0509776102
   Lombard DB, 2008, J INTERN MED, V263, P128, DOI 10.1111/j.1365-2796.2007.01902.x
   Lopez ME, 2000, MUTAT RES-FUND MOL M, V452, P123, DOI 10.1016/S0027-5107(00)00059-2
   LUHTALA TA, 1994, J GERONTOL, V49, PB231, DOI 10.1093/geronj/49.5.B231
   MAKRIDES SC, 1983, BIOL REV, V58, P343, DOI 10.1111/j.1469-185X.1983.tb00394.x
   Mansouri A, 2006, MECH AGEING DEV, V127, P298, DOI 10.1016/j.mad.2005.11.004
   Marcinek DJ, 2005, J PHYSIOL-LONDON, V569, P467, DOI 10.1113/jphysiol.2005.097782
   Martin C, 2007, AGING CELL, V6, P165, DOI 10.1111/j.1474-9726.2007.00271.x
   Marzetti E, 2008, FREE RADICAL BIO MED, V44, P160, DOI 10.1016/j.freeradbiomed.2007.05.028
   Masuyama M, 2005, BBA-GEN SUBJECTS, V1723, P302, DOI 10.1016/j.bbagen.2005.03.001
   McArdle A, 2001, AM J PHYSIOL-CELL PH, V280, PC621, DOI 10.1152/ajpcell.2001.280.3.C621
   McKenzie D, 2002, EUR J BIOCHEM, V269, P2010, DOI 10.1046/j.1432-1033.2002.02867.x
   Melov S, 1997, NUCLEIC ACIDS RES, V25, P974, DOI 10.1093/nar/25.5.974
   Melov S, 2007, PLOS ONE, V2, P0, DOI 10.1371/journal.pone.0000465
   Menshikova EV, 2006, J GERONTOL A-BIOL, V61, P534, DOI 10.1093/gerona/61.6.534
   Merry BJ, 2004, AGING CELL, V3, P7, DOI 10.1046/j.1474-9728.2003.00074.x
   Mihara K, 1996, TRENDS CELL BIOL, V6, P104, DOI 10.1016/0962-8924(96)81000-2
   Mihara K, 1996, EXPERIENTIA, V52, P1063, DOI 10.1007/BF01952103
   Milenkovic D, 2007, BIOL CHEM, V388, P891, DOI 10.1515/BC.2007.097
   Moghaddas S, 2002, J GERONTOL A-BIOL, V57, PB22, DOI 10.1093/gerona/57.1.B22
   Muller FL, 2006, FREE RADICAL BIO MED, V40, P1993, DOI 10.1016/j.freeradbiomed.2006.01.036
   Musatov A, 2006, FREE RADICAL BIO MED, V41, P238, DOI 10.1016/j.freeradbiomed.2006.03.018
   Nair KS, 2005, AM J CLIN NUTR, V81, P953
   Naito H, 2001, MED SCI SPORT EXER, V33, P729
   Nargang FE, 2002, J BIOL CHEM, V277, P12846, DOI 10.1074/jbc.M112099200
   Nauratil M, 2008, EXP CELL RES, V314, P164, DOI 10.1016/j.yexcr.2007.09.013
   OhIshi S, 1995, MECH AGEING DEV, V84, P65, DOI 10.1016/0047-6374(95)01637-F
   OLIVE M, 1995, J ANAT, V187, P127
   Pak JW, 2003, AGING CELL, V2, P1, DOI 10.1046/j.1474-9728.2003.00034.x
   PALMER JW, 1977, J BIOL CHEM, V252, P8731
   PALMER JW, 1985, ARCH BIOCHEM BIOPHYS, V236, P691, DOI 10.1016/0003-9861(85)90675-7
   Paradies G, 2002, GENE, V286, P135, DOI 10.1016/S0378-1119(01)00814-9
   Parise G, 2005, FREE RADICAL BIO MED, V39, P289, DOI 10.1016/j.freeradbiomed.2005.03.024
   Parise G, 2005, EXP GERONTOL, V40, P173, DOI 10.1016/j.exger.2004.09.002
   PARISI MA, 1993, MOL CELL BIOL, V13, P1951, DOI 10.1128/MCB.13.3.1951
   Pastoris O, 2000, EXP GERONTOL, V35, P95, DOI 10.1016/S0531-5565(99)00077-7
   Payne AM, 2003, J APPL PHYSIOL, V95, P2554, DOI 10.1152/japplphysiol.00758.2003
   Pesce V, 2001, FREE RADICAL BIO MED, V30, P1223, DOI 10.1016/S0891-5849(01)00517-2
   Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889
   Phillips T, 2005, FASEB J, V19, P668, DOI 10.1096/fj.04-2870fje
   Pistilli EE, 2006, APOPTOSIS, V11, P2115, DOI 10.1007/s10495-006-0194-6
   Poderoso C, 2008, PLOS ONE, V3, P0, DOI 10.1371/journal.pone.0001443
   POWERS SK, 1994, AM J PHYSIOL, V266, PR375, DOI 10.1152/ajpregu.1994.266.2.R375
   Primeau AJ, 2002, CAN J APPL PHYSIOL, V27, P349, DOI 10.1139/h02-020
   Proctor DN, 1997, J APPL PHYSIOL, V82, P1411, DOI 10.1152/jappl.1997.82.5.1411
   Prokisch H, 2006, NUCLEIC ACIDS RES, V34, PD705, DOI 10.1093/nar/gkj127
   Prokisch H, 2004, PLOS BIOL, V2, P795, DOI 10.1371/journal.pbio.0020160
   Puigserver P, 1999, SCIENCE, V286, P1368, DOI 10.1126/science.286.5443.1368
   Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5
   Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012
   Radák Z, 2002, PFLUG ARCH EUR J PHY, V445, P273, DOI 10.1007/s00424-002-0918-6
   Radák Z, 1999, FREE RADICAL BIO MED, V27, P69, DOI 10.1016/S0891-5849(99)00038-6
   Raha S, 2000, TRENDS BIOCHEM SCI, V25, P502, DOI 10.1016/S0968-0004(00)01674-1
   Rasmussen UF, 2003, EXP GERONTOL, V38, P877, DOI 10.1016/S0531-5565(03)00092-5
   Ren J, 2007, MECH AGEING DEV, V128, P276, DOI 10.1016/j.mad.2006.12.007
   Rooyackers OE, 1996, P NATL ACAD SCI USA, V93, P15364, DOI 10.1073/pnas.93.26.15364
   ROSENBERG IH, 1995, ANN INTERN MED, V123, P727, DOI 10.7326/0003-4819-123-9-199511010-00014
   Rosenberg IH, 1997, J NUTR, V127, PS990, DOI 10.1093/jn/127.5.990S
   Sammut IA, 2003, CLIN EXP PHARMACOL P, V30, P110, DOI 10.1046/j.1440-1681.2003.03799.x
   Saraste M, 1999, SCIENCE, V283, P1488, DOI 10.1126/science.283.5407.1488
   Scarpulla RC, 2002, GENE, V286, P81, DOI 10.1016/S0378-1119(01)00809-5
   Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653
   Schulz TJ, 2007, CELL METAB, V6, P280, DOI 10.1016/j.cmet.2007.08.011
   Servais S, 2003, FREE RADICAL BIO MED, V35, P24, DOI 10.1016/S0891-5849(03)00177-1
   Sharman MJ, 2001, EUR J APPL PHYSIOL, V84, P127, DOI 10.1007/s004210000334
   Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102
   Sirk D, 2007, J NEUROCHEM, V103, P1989, DOI 10.1111/j.1471-4159.2007.04907.x
   Siu PM, 2005, J PHYSIOL-LONDON, V565, P309, DOI 10.1113/jphysiol.2004.081083
   Skorjanc D, 1998, J APPL PHYSIOL, V85, P437, DOI 10.1152/jappl.1998.85.2.437
   Song W, 2006, ANTIOXID REDOX SIGN, V8, P517, DOI 10.1089/ars.2006.8.517
   Stangel M, 1996, J NEUROPATH EXP NEUR, V55, P36, DOI 10.1097/00005072-199601000-00004
   Takahashi M, 1998, AM J PHYSIOL-CELL PH, V274, PC1380, DOI 10.1152/ajpcell.1998.274.5.C1380
   Takahashi M, 1996, J BIOL CHEM, V271, P27285, DOI 10.1074/jbc.271.44.27285
   Tamilselvan J, 2007, FREE RADICAL BIO MED, V43, P1656, DOI 10.1016/j.freeradbiomed.2007.08.028
   Terman A, 2007, J PATHOL, V211, P134, DOI 10.1002/path.2094
   Terman A, 2006, ANTIOXID REDOX SIGN, V8, P197, DOI 10.1089/ars.2006.8.197
   Terman A, 2006, CHEM-BIOL INTERACT, V163, P29, DOI 10.1016/j.cbi.2006.04.013
   Tonkonogi M, 2003, PFLUG ARCH EUR J PHY, V446, P261, DOI 10.1007/s00424-003-1044-9
   Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102
   Tuominen EKJ, 2002, J BIOL CHEM, V277, P8822, DOI 10.1074/jbc.M200056200
   VANLOON APGM, 1987, EMBO J, V6, P2433, DOI 10.1002/j.1460-2075.1987.tb02522.x
   VANLOON APGM, 1986, CELL, V44, P801, DOI 10.1016/0092-8674(86)90846-9
   Venditti P, 1999, ARCH BIOCHEM BIOPHYS, V372, P315, DOI 10.1006/abbi.1999.1494
   Vidal-Puig AJ, 2000, J BIOL CHEM, V275, P16258, DOI 10.1074/jbc.M910179199
   Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751
   WALLACE DC, 1992, SCIENCE, V256, P628, DOI 10.1126/science.1533953
   Weber K, 2002, ENDOCRINOLOGY, V143, P177, DOI 10.1210/en.143.1.177
   Welle S, 2004, EXP GERONTOL, V39, P369, DOI 10.1016/j.exger.2003.11.011
   Welle S, 2000, J APPL PHYSIOL, V89, P297, DOI 10.1152/jappl.2000.89.1.297
   Welle S, 2003, J APPL PHYSIOL, V94, P1479, DOI 10.1152/japplphysiol.01061.2002
   Westphal CH, 2007, TRENDS BIOCHEM SCI, V32, P555, DOI 10.1016/j.tibs.2007.09.008
   Wiedemann N, 2004, J BIOL CHEM, V279, P14473, DOI 10.1074/jbc.R400003200
   Williams AD, 2007, J CARD FAIL, V13, P79, DOI 10.1016/j.cardfail.2006.10.017
   XIA EN, 1995, J NUTR, V125, P195
   Yarian CS, 2005, BIOCHEM BIOPH RES CO, V330, P151, DOI 10.1016/j.bbrc.2005.02.135
   Young JC, 2003, CELL, V112, P41, DOI 10.1016/S0092-8674(02)01250-3
   Zahn JM, 2006, PLOS GENET, V2, P1058, DOI 10.1371/journal.pgen.0020115
   Zainal TA, 2000, FASEB J, V14, P1825, DOI 10.1096/fj.99-0881com
NR 221
TC 53
Z9 62
U1 0
U2 10
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1521-6543
EI 1521-6551
J9 IUBMB LIFE
JI IUBMB Life
PD MAR 15
PY 2009
VL 61
IS 3
BP 201
EP 214
DI 10.1002/iub.164
PG 14
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 417PV
UT WOS:000264089500002
PM 19243006
DA 2024-11-01
ER

PT J
AU Yasukawa, T
   Poulton, J
AF Yasukawa, Takehiro
   Poulton, Joanna
TI Mitochondrial DNA Replication
SO MOLECULAR THEMES IN DNA REPLICATION
LA English
DT Article; Book Chapter
ID transcription-factor-a; progressive external ophthalmoplegia; mtdna copy number; polymerase-gamma; human-cells; lagging-strand; thymidine phosphorylase; gel-electrophoresis; yeast mitochondria; depletion syndrome
C1 [Yasukawa, Takehiro] UCL, Wolfson Inst Biomed Res, London WC1E 6BT, England.
   [Poulton, Joanna] Univ Oxford, John Radcliffe Hosp, Womens Ctr, Nuffield Dept Obstet & Gynaecol, Oxford OX3 9DU, England.
C3 University of London; University College London; University of Oxford
RP Yasukawa, T (corresponding author), UCL, Wolfson Inst Biomed Res, Gower St, London WC1E 6BT, England.
CR Achanta G, 2005, EMBO J, V24, P3482, DOI 10.1038/sj.emboj.7600819
   Alam TI, 2003, NUCLEIC ACIDS RES, V31, P1640, DOI 10.1093/nar/gkg251
   ALBRING M, 1977, P NATL ACAD SCI USA, V74, P1348, DOI 10.1073/pnas.74.4.1348
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   ARNAUDO E, 1991, LANCET, V337, P508, DOI 10.1016/0140-6736(91)91294-5
   ARNBERG A, 1971, BIOCHIM BIOPHYS ACTA, V246, P353, DOI 10.1016/0005-2787(71)90147-X
   Ashley N, 2005, EXP CELL RES, V303, P432, DOI 10.1016/j.yexcr.2004.10.013
   Ashley N, 2008, HUM MOL GENET, V17, P2496, DOI 10.1093/hmg/ddn150
   Ashley N, 2007, HUM MOL GENET, V16, P1400, DOI 10.1093/hmg/ddm090
   Ashley N, 2009, BIOCHEM BIOPH RES CO, V378, P450, DOI 10.1016/j.bbrc.2008.11.059
   Bax BE, 2007, EUR J HAEMATOL, V79, P338, DOI 10.1111/j.1600-0609.2007.00927.x
   Blanche S, 1999, LANCET, V354, P1084, DOI 10.1016/S0140-6736(99)07219-0
   BOGENHAGEN D, 1977, CELL, V11, P719, DOI 10.1016/0092-8674(77)90286-0
   Bogenhagen DF, 2008, J BIOL CHEM, V283, P3665, DOI 10.1074/jbc.M708444200
   Bogenhagen DF, 2003, MOL CELL PROTEOMICS, V2, P1205, DOI 10.1074/mcp.M300035-MCP200
   Bogenhagen DF, 2003, TRENDS BIOCHEM SCI, V28, P357, DOI 10.1016/S0968-0004(03)00132-4
   Bornstein B, 2008, NEUROMUSCULAR DISORD, V18, P453, DOI 10.1016/j.nmd.2008.04.006
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   Bowmaker M, 2003, J BIOL CHEM, V278, P50961, DOI 10.1074/jbc.M308028200
   Bradshaw PC, 2005, AM J PHYSIOL-CELL PH, V288, PC989, DOI 10.1152/ajpcell.00530.2004
   BREWER BJ, 1987, CELL, V51, P463, DOI 10.1016/0092-8674(87)90642-8
   BREWER BJ, 1988, CELL, V55, P637, DOI 10.1016/0092-8674(88)90222-X
   Brown TA, 2005, GENE DEV, V19, P2466, DOI 10.1101/gad.1352105
   CARRE D, 1978, BIOCHEMISTRY-US, V17, P3263, DOI 10.1021/bi00609a014
   Casteels K, 1999, LANCET, V353, P1499, DOI 10.1016/S0140-6736(98)05817-6
   Cerritelli SM, 2003, MOL CELL, V11, P807, DOI 10.1016/S1097-2765(03)00088-1
   Chinnery PF, 2005, LANCET, V366, P1650, DOI 10.1016/S0140-6736(05)67492-2
   CHINNERY PF, 2007, NEUROMUSCULAR DISORD, V18, P259
   Ciliberti N, 2007, BIOORGAN MED CHEM, V15, P3065, DOI 10.1016/j.bmc.2007.01.049
   Clayton DA, 2003, IUBMB LIFE, V55, P213, DOI 10.1080/1521654031000134824
   CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6
   CLAYTON DA, 1987, PHILOS T ROY SOC B, V317, P473, DOI 10.1098/rstb.1987.0074
   Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646
   Cotney J, 2007, NUCLEIC ACIDS RES, V35, P4042, DOI 10.1093/nar/gkm424
   Díez-Sánchez C, 2003, BIOL REPROD, V68, P180, DOI 10.1095/biolreprod.102.005140
   DIFFLEY JFX, 1992, J BIOL CHEM, V267, P3368
   DIFFLEY JFX, 1991, P NATL ACAD SCI USA, V88, P7864, DOI 10.1073/pnas.88.17.7864
   Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109
   Elpeleg O, 2005, AM J HUM GENET, V76, P1081, DOI 10.1086/430843
   Estivill X, 1998, AM J HUM GENET, V62, P27, DOI 10.1086/301676
   Farge G, 2008, NUCLEIC ACIDS RES, V36, P393, DOI 10.1093/nar/gkm1025
   FISHER RP, 1988, MOL CELL BIOL, V8, P3496, DOI 10.1128/MCB.8.8.3496
   FISHER RP, 1991, J BIOL CHEM, V266, P9153
   Friedman KL, 1995, METHOD ENZYMOL, V262, P613
   Garrido N, 2003, MOL BIOL CELL, V14, P1583, DOI 10.1091/mbc.E02-07-0399
   Goffart S, 2009, HUM MOL GENET, V18, P328, DOI 10.1093/hmg/ddn359
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   Hakonen AH, 2007, BRAIN, V130, P3032, DOI 10.1093/brain/awm242
   HAN ZY, 1994, CHROMOSOMA, V103, P162, DOI 10.1007/BF00368008
   He JY, 2007, J CELL BIOL, V176, P141, DOI 10.1083/jcb.200609158
   Holt IJ, 2000, CELL, V100, P515, DOI 10.1016/S0092-8674(00)80688-1
   Holt IJ, 2003, TRENDS BIOCHEM SCI, V28, P355, DOI 10.1016/S0968-0004(03)00133-6
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Howell N, 2005, TRENDS GENET, V21, P583, DOI 10.1016/j.tig.2005.08.012
   Iborra FJ, 2004, BMC BIOL, V2, P0, DOI 10.1186/1741-7007-2-9
   Iida R, 2006, BIOCHEM BIOPH RES CO, V344, P948, DOI 10.1016/j.bbrc.2006.04.008
   Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455
   Kajander OA, 2001, EMBO REP, V2, P1007, DOI 10.1093/embo-reports/kve233
   Kanki T, 2004, MOL CELL BIOL, V24, P9823, DOI 10.1128/MCB.24.22.9823-9834.2004
   KASAMATSU H, 1971, P NATL ACAD SCI USA, V68, P2252, DOI 10.1073/pnas.68.9.2252
   Kaufman BA, 2007, MOL BIOL CELL, V18, P3225, DOI 10.1091/mbc.E07-05-0404
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Khogali SS, 2001, LANCET, V357, P1265, DOI 10.1016/S0140-6736(00)04422-6
   KIRSCHNER RH, 1968, P NATL ACAD SCI USA, V60, P1466, DOI 10.1073/pnas.60.4.1466
   KOIKE K, 1974, J CELL BIOL, V61, P14, DOI 10.1083/jcb.61.1.14
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   Korhonen JA, 2003, J BIOL CHEM, V278, P48627, DOI 10.1074/jbc.M306981200
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   KUNKEL TA, 1988, BIOCHIM BIOPHYS ACTA, V951, P1, DOI 10.1016/0167-4781(88)90020-6
   Lakshmipathy U, 1999, MOL CELL BIOL, V19, P3869
   Lakshmipathy U, 2001, NUCLEIC ACIDS RES, V29, P668, DOI 10.1093/nar/29.3.668
   Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231
   LEDWITH BJ, 1986, J BIOL CHEM, V261, P6571
   Legros F, 2004, J CELL SCI, V117, P2653, DOI 10.1242/jcs.01134
   Li PF, 1999, EMBO J, V18, P6027, DOI 10.1093/emboj/18.21.6027
   Lightowlers RN, 1997, TRENDS GENET, V13, P450, DOI 10.1016/S0168-9525(97)01266-3
   Liu P, 2008, MOL CELL BIOL, V28, P4975, DOI 10.1128/MCB.00457-08
   Livesey KJ, 2004, J MED GENET, V41, P6, DOI 10.1136/jmg.2003.008805
   LOCKSHON D, 1995, CELL, V81, P947, DOI 10.1016/0092-8674(95)90014-4
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   Magnusson J, 2003, EXP CELL RES, V289, P133, DOI 10.1016/S0014-4827(03)00249-0
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   Maniura-Weber K, 2004, NUCLEIC ACIDS RES, V32, P6015, DOI 10.1093/nar/gkh921
   May-Panloup P, 2005, HUM REPROD, V20, P593, DOI 10.1093/humrep/deh667
   MAYHOOK AG, 1992, P ROY SOC B-BIOL SCI, V248, P85, DOI 10.1098/rspb.1992.0046
   MEGRAW TL, 1993, J BIOL CHEM, V268, P12758
   Moreno-Loshuertos R, 2006, NAT GENET, V38, P1261, DOI 10.1038/ng1897
   Morten K, 2005, AM J PHYSIOL-ENDOC M, V289, PE1115, DOI 10.1152/ajpendo.00226.2005
   Morten KJ, 2007, MITOCHONDRION, V7, P386, DOI 10.1016/j.mito.2007.09.001
   NASS MMK, 1966, P NATL ACAD SCI USA, V56, P1215, DOI 10.1073/pnas.56.4.1215
   NASS MMK, 1963, J CELL BIOL, V19, P593, DOI 10.1083/jcb.19.3.593
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Nikali K, 2005, HUM MOL GENET, V14, P2981, DOI 10.1093/hmg/ddi328
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Ohgaki K, 2007, J BIOCHEM, V141, P201, DOI 10.1093/jb/mvm020
   Ostergaard E, 2007, AM J HUM GENET, V81, P383, DOI 10.1086/519222
   PARISI MA, 1993, MOL CELL BIOL, V13, P1951, DOI 10.1128/MCB.13.3.1951
   Park KS, 2008, DIABETOLOGIA, V51, P602, DOI 10.1007/s00125-008-0933-z
   PICAMATTOCCIA L, 1972, J MOL BIOL, V64, P465, DOI 10.1016/0022-2836(72)90511-6
   Ponamarev MV, 2002, J BIOL CHEM, V277, P15225, DOI 10.1074/jbc.C200100200
   Pontarin G, 2007, J BIOL CHEM, V282, P16820, DOI 10.1074/jbc.M701310200
   Pontarin G, 2006, J BIOL CHEM, V281, P22720, DOI 10.1074/jbc.M604498200
   POSAKONY JW, 1977, J CELL BIOL, V74, P468, DOI 10.1083/jcb.74.2.468
   POULTON J, 1995, DIABETOLOGIA, V38, P868, DOI 10.1007/s001250050366
   Poulton J, 2002, HUM MOL GENET, V11, P1581, DOI 10.1093/hmg/11.13.1581
   Reyes A, 2005, J BIOL CHEM, V280, P3242, DOI 10.1074/jbc.M411916200
   Reyes Aurelio, 2007, METHODS MOL BIOL, V372, P219, DOI 10.1007/978-1-59745-365-3_16
   ROBBERSON DL, 1972, P NATL ACAD SCI USA, V69, P737, DOI 10.1073/pnas.69.3.737
   Saada A, 2003, BIOCHEM BIOPH RES CO, V310, P963, DOI 10.1016/j.bbrc.2003.09.104
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Salviati L, 2002, ANN NEUROL, V52, P311, DOI 10.1002/ana.10284
   Santos TA, 2006, FERTIL STERIL, V85, P584, DOI 10.1016/j.fertnstert.2005.09.017
   SATOH M, 1991, EXP CELL RES, V196, P137, DOI 10.1016/0014-4827(91)90467-9
   Shadel GS, 1997, ANNU REV BIOCHEM, V66, P409, DOI 10.1146/annurev.biochem.66.1.409
   SIMPSON MV, 1989, BIOCHEM PHARMACOL, V38, P1033, DOI 10.1016/0006-2952(89)90245-1
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Spinazzola A, 2002, J BIOL CHEM, V277, P4128, DOI 10.1074/jbc.M111028200
   Spinazzola A, 2008, NEUROMUSCULAR DISORD, V18, P315, DOI 10.1016/j.nmd.2007.12.007
   Taanman JW, 2003, HUM MOL GENET, V12, P1839, DOI 10.1093/hmg/ddg192
   Takamatsu C, 2002, EMBO REP, V3, P451, DOI 10.1093/embo-reports/kvf099
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Trinei M, 2006, BBA-BIOENERGETICS, V1757, P624, DOI 10.1016/j.bbabio.2006.05.029
   Tyynismaa H, 2004, HUM MOL GENET, V13, P3219, DOI 10.1093/hmg/ddh342
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   VANTUYLE GC, 1985, J CELL BIOL, V100, P251, DOI 10.1083/jcb.100.1.251
   Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95
   Viguera E, 2001, EMBO J, V20, P2587, DOI 10.1093/emboj/20.10.2587
   Walker Ulrich A, 2003, J HIV THER, V8, P32
   Wang YS, 2006, J BIOL CHEM, V281, P25791, DOI 10.1074/jbc.M604501200
   Wanrooij S, 2004, NUCLEIC ACIDS RES, V32, P3053, DOI 10.1093/nar/gkh634
   Wanrooij S, 2008, P NATL ACAD SCI USA, V105, P11122, DOI 10.1073/pnas.0805399105
   Wanrooij S, 2007, NUCLEIC ACIDS RES, V35, P3238, DOI 10.1093/nar/gkm215
   Warburg O, 1930, METABOLISM TUMOURS, V0, P0
   WERNETTE CM, 1988, BIOCHEMISTRY-US, V27, P6046, DOI 10.1021/bi00416a033
   WILLIAMS RS, 1986, J BIOL CHEM, V261, P2390
   WISEMAN A, 1978, MOL GEN GENET, V167, P51, DOI 10.1007/BF00270321
   WOLSTENHOLME DR, 1973, J CELL BIOL, V56, P230, DOI 10.1083/jcb.56.1.230
   Wong LJC, 2007, HEPATOLOGY, V46, P1218, DOI 10.1002/hep.21799
   WONG TW, 1985, J BIOL CHEM, V260, P1530
   Yang MY, 2002, CELL, V111, P495, DOI 10.1016/S0092-8674(02)01075-9
   Yasukawa T, 2005, MOL CELL, V18, P651, DOI 10.1016/j.molcel.2005.05.002
   Yasukawa T, 2006, EMBO J, V25, P5358, DOI 10.1038/sj.emboj.7601392
   Zhang HL, 2001, P NATL ACAD SCI USA, V98, P10608, DOI 10.1073/pnas.191321998
   Zhang HL, 2007, BIOCHIMIE, V89, P474, DOI 10.1016/j.biochi.2006.11.002
   Zheng L, 2008, MOL CELL, V32, P325, DOI 10.1016/j.molcel.2008.09.024
NR 147
TC 1
Z9 1
U1 0
U2 3
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, CAMBRIDGE CB4 4WF, CAMBS, ENGLAND
SN 
EI 
J9 
PD JUN 15
PY 2009
VL 0
IS 
BP 316
EP 345
DI 10.1039/9781847559852-00316
PG 30
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA BLV56
UT WOS:000271175600011
DA 2024-11-01
ER

